Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
Back Matter (PDF) - Clinical Chemistry
- TAGS
- clinical
- www.clinchem.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Journal of the American Association of <strong>Clinical</strong> <strong>Chemistry</strong><br />
Volume 33, 1987<br />
AUTHOR INDEX<br />
Aalbers, Tb. G.; Houtman, J. P. W.; Makk ink,<br />
B., 2057<br />
Abano, D.; Wong, S. T., 994<br />
Abbas, Sadiq J. See Al-Hakiem, Mohainmad H.<br />
H.<br />
Abbondanzo, Susan L; Gootenberg, J. E.;<br />
McPherson, R. A., 1003<br />
Abbott, Mark See Rashtchian, Ayoub<br />
Abbott, S.D. See Kobos, R. K.<br />
Abbott, S. R. See van Heyningen, V.<br />
Abbott, William A.; Byrne, Rita S., 991<br />
Abbottsmith, Charles See Chen, 1-Wen<br />
Abdul-Dayem, U. M. See Hassan, M<br />
Abe, Akira; Kawade, M.; Seishima, M.; Makino,<br />
K.; Maeda, S.; Nakamura, 5., 919<br />
Abel, C. See Bush, G. A.<br />
Abernethy, Maxwell H. See Walmsley, Trevor<br />
A.<br />
Ablin, R. J., 1935<br />
Abrams, Billy See Toffaletti, John<br />
Abrass, Christine K. See Pillsworth, Thomas J.,<br />
Jr.<br />
Abuglia, Mustafa Au See Hugh, Duncan<br />
Accinni, Roberto See Gianazza, Elisabetta<br />
Achour, U. See Najjar, M. F.<br />
Ackerman, C. See Verstraete, Alain<br />
Ackerman, Steven See Gulaxnali-Majid, Fizza<br />
Acosta, A. See Kiss, Janice<br />
Acosta, Anibal See Gulamali-Majid, Fizza<br />
Acrey, Charlotte L. See Nelson, Christine D.<br />
Adachi, Hideki See Noguchi, Masato<br />
Adachi-Kirkland, Joyce See Gosney, Kimiko<br />
Adam, A. See Collette, J.; Gobbels, P.<br />
Adams, James D.; Johannessen, Jan N.; Bacon,<br />
John P., 1675<br />
Adlouni, H. A. See Katrib, K.<br />
Adolf, Paul See Portnoy, Sue<br />
Agarwal, Raghunatb P.; Threatte, Gregory A.;<br />
McPherson, Richard A., 481<br />
Agman, Jacob See Rotenberg, Jvi<br />
Agmon, Jacob See Rotenberg, Zvi<br />
Ahmad, S. See Dasgupta, Amitava<br />
Ahmann, F. R. See Schifman, Ron B.<br />
Ahmann, Frederick R. See Schifman, Ron B.<br />
Ahmann, M. E. See Schifman, Ron B.<br />
Ahmann, Marie See Schifman, Ron B.<br />
Aickin, D. H. See Evans, J. J.<br />
Akai, Toshihiro See Yoshikawa, Chikao<br />
Akingbe, 0. See Armbruster, M. A.<br />
Akov, Shoshana See Barash, Hanina<br />
Al-Abdulla, Ibrahim H. See Sidki, Ahniad M.<br />
Alaupovic, P. See Koren, E.; Puchois, P.; Smith,<br />
S. J.<br />
Al-Awqati, MA. See Hassan, M<br />
Albarella, J. P. See Skjold, A. C.<br />
Albers, John J. See McNamara, Judith R.<br />
Albertini, A. See Ghielmi, S.; Panzali, A.;<br />
Zucchelli, G. C.<br />
Albertini, Alberto See Barbanti, P.; Curello,<br />
Salvatore; lacobello, C.<br />
-; Signorini, C.; lacobello, C.; Pizzocolo, G., 907<br />
-; Panzali, A.; Signorini, C., 922<br />
Albrecbt, J.; Muller, H. A. G., 1619<br />
Aldwin, Lois See Sheldon, Edward<br />
Aleshire, S. L. See Bradley, C. A.<br />
Aleshire, Stephen L. See Bradley, Charles A.<br />
Alexander, L. See Billet, W.; Rosen, Michael<br />
Alexander, Roy L.; Moore, Terry L., 903<br />
Alexandrovich, Susan K. See Danielson, Susan<br />
J.<br />
Aleyassine, H.; Yaffe, M. J., 990<br />
Alfthan, Henrik See Koistinen, Riitta<br />
Al-Hakiem, Mohammad H. H.; Abbas, Sadiq J.,<br />
191<br />
Al-Humaidan, Abdulkarim See El-Yazigi,<br />
Adnan<br />
Au, Akhtar See Mackowiak, Jim<br />
Aliberti, Ludovica Malaguti See Severini,<br />
Giancarlo<br />
Allaben, William T., 877<br />
Allam, Charles K. See Wakid, Nabil W.<br />
Allard, Karen; Deutsch, Dale, 973<br />
Allaway, James R. See Brown, Charles Eric<br />
Allen, B. See Ryan, P. J.<br />
Allen, B. K.; Grenier, R. E.; Moran, R. F., 982<br />
Allen, D.; Breglio, S.; DeChene, N.; Haley, J.;<br />
Seto,E.,880<br />
Allen, G. J. See Mashiter, K.<br />
Allen, Joyce C. See Rattenbury, J. M.<br />
Allen, Steven K. See Passey, Richard B.<br />
AiIm, Ronald K. See McBride, James H.<br />
Altaffer, Marcia See Ng, Ronald H.; O’Neill,<br />
Mary<br />
Aitchison, John M. See Desai, Rajesh K.<br />
Altmiller, Dale H. See Binder, Steven R.<br />
Alyea, K. See Witherspoon, L.<br />
Alyea, Kristin See Witherspoon, Lynn<br />
Amakawa, Tsutomu See Makise, Junko<br />
Amamou, H. See Najjar, M. F.<br />
Ambrocio, E. See Hammad, N.; Izutsu, A.<br />
Amenta, Joseph S.; Brocher, Steffanie C.;<br />
Serenko-Aber, Andrea L., 647, 715<br />
Amino, Nobuyuki See Hats, Naoshige; Iwatani,<br />
Yoshinori<br />
Ainmirati, Erika See Crisp, David<br />
Amory, D. W. See Yeo, K.-T.<br />
Amyx, C. See Sacks, David B.<br />
Amyx, Cheryl See Thode, Jorgen<br />
Andersen, S. Kruse See Blaabjerg, Ole<br />
Anderson, Christopher P. See Maturen,<br />
Andrew<br />
Anderson, M. See Kapur, B. M.<br />
Anderson, S. M. See Ashcraft, Tracey L.<br />
Andia, I. See Zumarraga, M.<br />
Andoh, Yukio See Nakashima, Koji<br />
Andrade, R. See Heal, A.<br />
Andreux, J. P. See Callais, F.<br />
Angstadt, D. S. See Witte, D. L.<br />
Annesley, Thomas M. See Coon, Michael J.<br />
Anonick, P. K. See Herold, D. A.<br />
Anstall, Harold B. See Knight, Joseph A.<br />
Anthony, Marvin L. See Feeley, Brian P.<br />
Anton, Aaron H.; Berk, Ana I., 600<br />
Aoki, Etsuo See Noguchi, Maaato<br />
Aoki, Kikumaro See Yamamoto, Hideaki<br />
Aoki, Yoshikazu; Ogawa, Zenauke; Hanada,<br />
Mutsuo; Itoh, Hajime, 1035<br />
Aoyama, Norihito See Makise, Junko<br />
Appelman, Zvi; Golbus, Mitchell S., 1953<br />
Apple, Fred S. See Googins, Mary Kay; Preese,<br />
Lynne<br />
-; Sharkey, Scott W.; Werdick, Michael;<br />
Elaperger, K. Joseph; Tilbury, R. Thomas,<br />
507<br />
Appleby, C. See Fruhman, J.<br />
Applegarth, D. A. See Wong, J.<br />
Arakawa, Hidetoshi See Maeda, Masako<br />
Arakawa, Masaaki See Matsue, Hajime<br />
Ardisson, L. J. See van Heyningen, V.<br />
Arendt, Josephine See Bojkowski, Christopher<br />
J.<br />
Argyle, J. Craig See Ibarra, Frank S.<br />
Arick, Steven See Miller, William W.<br />
Armbruster, David A., 742, 1673, 2153<br />
Armbruster, F. P. See SchillinE, M.<br />
Armbruster, Franz Paul See Blind, Eberhard<br />
Armbruster, M. A.; Koch, T. R; Lewis, L. M.;<br />
Akingbe, 0.; Vaughn, R., 950<br />
Armitage, Edwin K. See Miller, W. Greg<br />
-; King, Mary E., 897<br />
-; Miller, W. Greg, 1891<br />
Arnaud, Pierre See Speich, Michelle<br />
Arnold, Lora L. See Haven, Mary C.<br />
Arnold, Mark A., 1061<br />
Arnqvist, Hans; Olsson, Per-Olof; von Schenck,<br />
Henning, 93<br />
Arratoon, Cheryl See Pelletier, Omer<br />
Artiss, J. D. See Sharma, Ajit<br />
Arumainayagam, Geetha See Sein, Kyaw Tun<br />
Ash, Owen See Gordon, Bill<br />
Ashcraft, T. L. See Jones, Laurie A.<br />
Ashcraft, Tracey L.; Anderson, S. M.; Shimizu,<br />
S. Y.,967<br />
Ashwood, Edward R. See Tait, Jonathan F.<br />
-; Chamberlain, Blake V., 901<br />
Askienazy, Serge See Piketty, Marie-Liesse<br />
Aslam, M. See Mashiter, K.<br />
Assmann, G. See Smith, S. J.<br />
Assmann, Gerd See Schmitz, Gerd<br />
Astill, Mark E.; Johnson, LaVell R.; Thorne,<br />
Gale H.; Krauth, Gary H.; Smith. Roger K.;<br />
Smith, Randy W.; Witty, Thomas R., 1554<br />
Astles, J. Rex See Tietz, Norbert W.<br />
Astrua-Testori, Silvia See Gianazza, Elisabetta<br />
Atiyeh, Maurice See Chaleby, Kutalba<br />
Aubry, Claude See Dupuy, Georges<br />
Auditore-Hargreaves, Karen; Houghton,<br />
Raymond L.; Monji, Nobuo; Priest, John H.;<br />
Hoffman, Allan S.; Nowinski, Robert C.,<br />
1509<br />
Aulner, V. See Sylvestri, Mario F.<br />
Austin, Garth K. See Morin, Leo G.<br />
-; Mullins, Richard H.; Morin, Leo G.;<br />
O’Connell, Christine, 1002<br />
-; Mullins, Richard H.; Morin, Leo G., 2220<br />
Austin, Roland L. See Peterson, Kent W.<br />
Austin, Rowland L., biB<br />
Auzeby, Andre See Touitou, Yvan<br />
Avasthi, P.S. See Tzamaloukaa, A. H.<br />
Avelino, Evangelita See Palmer, John<br />
Averia, Evangeline See Warkentin, Donald L.<br />
Aviram, Alexander See Carel, Rafael S.<br />
Avis, Simon See Grewal, Kuldip<br />
Aw, T. C.; Koay, E. S. C.; Yuen, M.; Candlish, J.<br />
K., 1032<br />
Awdziej, Tania A. See Lodato, Denise T.<br />
Awdziej, Tania N.; Lodato, Denise T.; Kaufman.<br />
Richard A.; Tomaszek, Ann; Vitone,<br />
Stephen; Salamone, Salvatore J.; Schwartz,<br />
Alan, 1018<br />
Lodato, Denise T.; Kaufman, Richard A.;<br />
Ursell, Timothy S.; Choudhry, Satiah C.,<br />
1020<br />
Awni, Walid M. See Luke, David R.<br />
Aymard, P. See Pressac, M.<br />
Ayrault-Jarrier, M. See Pruvot, I.<br />
Aziz, Kaiser See Koch, Thomas R.<br />
Aziz, Oddette See Wong, Steven H.-Y.<br />
Azukas, John J.; Foster, L., 996<br />
Baas, Mahmoud See Monti, Jean-Pierre<br />
Baba, H. See Okamura, S.<br />
Babe, M. See Risco, F.<br />
Bach, Phil See Villa, Barbara<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2337
Bach, Phillip; Shu, Frank; Brandt, Barbara, 940<br />
-; Brandt, Barbara; Kessler, Jay, 1007<br />
Bachorik, P.S. See Smith, S. J.<br />
<strong>Back</strong>er, K. T.; Harff, G. A.; Beyer, C., 1937<br />
<strong>Back</strong>er, Egbert T. See Lentjes, Eef G. W. M.<br />
<strong>Back</strong>es, Dorothy See Kiang, Willie<br />
Bacon, B. L See Pardue, Harry L.<br />
Bacon, Bonnie L See Pardue, Harry L.<br />
Bacon, John P. See Adams, James D.<br />
Badcock, N. R.; Zoanetti, G. D., 1080<br />
Badenoch, Jane L.; O’Leary, Thomas D., 1476<br />
Bador, Rena; Dechaud, Henri; Claustrat,<br />
Francine; Desuzinges, Claude, 48<br />
Baer, D. M. See Goitein, Robert K.<br />
Bahnson, R. See Hortin, G.<br />
Bailey, Anne L; Rasums, A. S.; Goodman, B. H.;<br />
Montalbano, G., 920<br />
-; Goodman, B.; Montalbano, G., 924<br />
Bailey, Jimmy L. See Chou, Peter P.<br />
Bailey, Kim See Painter, Pennell<br />
Bailor, Thomas See Massey, Thomas<br />
Baker, John See Johnson, Roger<br />
-; Small, Charles; Johnson, Roger, 629<br />
Bakes-Martin, R. C.; Romth, P. C.; Pearson, J.<br />
R., 907<br />
Bakker, A. J. See Oversteegen, H. J.<br />
Bakker, Andries J.; Pejacovic, Maria; Peake,<br />
Michael, 198<br />
Baldwin, Jan; Hargreaves, W. R., 1566<br />
Baldwin, John C.. 1056<br />
Balfe, Alan, 2320<br />
Balistreri, W. F. See Clardy, C. W.<br />
Ball, D. J.; Campbell, D., 903<br />
Ballantyne, D. H.; Moran, R. F., 982<br />
Ballester, I.; Cortes, E.; Moya, M.; Campello, M.<br />
J., 796<br />
Balls, Frank M. See Murphy, Robert F.<br />
Balzan, S. See Clerico, A.<br />
Bandi, Zoltan L; Schoen, Irwin; DeLara, Mila,<br />
677<br />
Bandstra, E. See Heal, A.<br />
Banerjee, S. K. See Hoak, D. R.<br />
Banfi, Giuseppe See Mosca, Andrea<br />
Banitt, Elden H. See Hockerman, Gloria J.<br />
Banka, T. See Kapur, B. M.<br />
#{149} Bankson, D. D.; Rifai, N.; Silverman, L. M.;<br />
-;<br />
McMurray, R. G., 897<br />
Rifai, N.; Silverman, L. M., 935<br />
Bankson, Daniel D.; Rifai, NAder; Silverman,<br />
Lawrence M., 1942<br />
Bannister, Michael W. See Maguire, Gerald A.<br />
Baraka, Anis See Wakid, Nabil W.<br />
Baran,<br />
Baran<br />
D. See Kirkpatrick, C. A.<br />
M. See Butt, A. M.; Kumar, Harish;<br />
Po’llack, L.<br />
Mindicino, H.; Readio, J.; Leonard, N., 882<br />
Barash, Hanina; Akov, Shoshana. 176<br />
Barbanti, P.; lacobeilo, C.; Ruggeri, G.;<br />
Ingrassia, R.; Albertini, Alberto, 936<br />
Barbero,<br />
Barcelon,<br />
J. Arenas See Hernandez,<br />
M. See Johnston, D.<br />
D. Martinez<br />
Barcena,<br />
Barenghi,<br />
B. See Zumarraga, M.<br />
L. See Bonini, P. A.<br />
Barenghi, Livia; Ceriotti, Ferruccio; Ripamonti,<br />
Marilena; Luzzana, Massimo; Bonini,<br />
Pierangelo, 579<br />
Barling,<br />
Barlow,<br />
Peter M. See Keelan,<br />
Eve H. See Piran, Un<br />
Jeffrey A.<br />
Barlow, Ian M.; Harrison, Stephen P., 309<br />
-; Harrison, Stephen P.; Milner, John R.; Sykes,<br />
Miles 0., 722, 855,2128<br />
Barnard, G.; Schulkamp, K.; Bellet, N., 886<br />
Barnard, H. C. See Vermaak, William J. H.<br />
Barnes, A. See Hillyard, C. J.<br />
Barnes, Diana M.; Healy, Karen; Morten,<br />
Helen; Howell, Tony; Swindell, Ric, 741<br />
Barnes, Grady; Danna, Anthony; Miceli,<br />
Caroline; Maasie, Donna; Laos, Valerie;<br />
Shaw, Norman, 919<br />
Barnett, A. H. See Taylor, A. J.<br />
Barnett, Anthony H. See Jones, Alan F.<br />
Barnett, Craig See Ryan, Francis<br />
Barrantes, Denny M. See Irish, Glenn R.<br />
Barron, J. L. See Smith, G.<br />
Barson, William G. See Chen, 1-Wen<br />
Barta, Alice See Murphy, Beverly E. Pearson<br />
Bartilson, Mary See Branum, Earl<br />
Bartl, K. See Kientsch-Engel, R.<br />
Bartlett, Clifford; Jeleako, John; Collins, Chris;<br />
Kempe, Tom; Pankey, Sue; Lin, Cheng-I;<br />
Hu, Mae; Jaklitsch, Anna, 1024<br />
Bartlett,<br />
Bartling,<br />
S. See Izutsu, A.<br />
Don See Tanaka, Steve<br />
Barton, Earl G. See Morin, Leo G.<br />
Barzilai, D. See Beck, R<br />
Basalt, David R. See Basalt, Randall C.<br />
Basalt, Randall C.; Baselt, David R., 747<br />
Bassi, Francesca See Tode, Bettina<br />
2338 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Bates, Diane Albergo See Kirkpatrick, Marilyn<br />
Battaglia, Danlelle J. See Frings, Christopher<br />
Battocletti, Joseph H. See Brown, Charles Eric<br />
Baudner, S. See Dati, Francesco<br />
Baxter, Robert C.; De Mellow, John S.;<br />
Burleigh, B. Dan, 544<br />
Bayer, Monika F., 630<br />
-; Macoviak, John A.; McDougall, 1. Ross, 882<br />
-; Macoviak, John A.; McDougall, 1. Ross, 2178<br />
Baylink, David J. See Lou, K.-H. William<br />
Baylor, Michael R. See Gene, Jeffrey A.<br />
Beattie, David J. See Parker, K. Michael<br />
Beatty, J. DavId, 1053<br />
Beber, J. H. See Carper, W. R.<br />
Beck, J. See Ladouceur, P. R.<br />
Beck, H.; Orr, Z. Shen; Lischinsky, S.; Barzilai,<br />
D., 337<br />
Beck, Haunts See Hoffmann, GeorgE.<br />
Beck-Davis, Susan See Christenson, Robert H.<br />
Becker, Rosette See Crisp, David<br />
Becker, U. See Dati, Francesco<br />
Beckett, G. J. See Caldwell, G.<br />
Bedevia, J. See Lucas, F.<br />
Bednar, Linda K. See Koch, Marlene<br />
Beethani, Robert; Silver, Anne; Dawnay, Anne,<br />
713<br />
Begon, F. See Bounaud, M. P.; Metaye, T.<br />
Beilby, John P.; Chin, Christine, 2327<br />
Beinlich, Cathy J.; Carpenter, Richard H., 167<br />
Bell, Judy L See Hursting, Marcie J.<br />
Bellem, Astrid C. See Chan, Marcia A.<br />
Bellet, N. See Barnard, G.<br />
Belsey, R. E. See Goitein, Robert K.<br />
Belyus, P.S.; Estelle, B. D.; Burgess, T. E., 986<br />
Belz, J. See Trundle, D.<br />
Bemelmans, S. See Stein, F.<br />
Ben Amor, MA. See Najjar, M. F.<br />
Bendel, Richard See Tsai, Michael Y.<br />
Benedetti, Massimno Massi See Mascini, Marco<br />
Benedetti, Thomas J. See Talt, Jonathan F.<br />
Benjamin, D.C. See Mifflin, T. E.<br />
Benniiloud, Moulay See Kazi-Aoul, Teldja<br />
Banner. C. W. See Miller, W. K.<br />
Bennett, Beth See Mullins, Richard K.<br />
Bennett, John E. See Huang, C. M.<br />
Bennett, W. H. See Schoenlein, D. J.<br />
Benson, Carol See Csako, Gyorgy<br />
Benson, Carol C. See Zweig, Mark H.<br />
Bentley, A. See Morgera, J.<br />
Benvenga, Salvatore; Calzi, Lorella Li;<br />
Robbins, Jacob, 1752<br />
Berendt, H. See LeGatt, Donald F.<br />
Berg, Chris See Bissell, Michael G.<br />
Berk, Anal. See Anton, Aaron H.<br />
Berlin, T. See Lindback, B.<br />
Bermes, E. W. See Collins, Sonia; Kahn, S. E.<br />
Bermes, E. W., Jr. See Garbincius, Jean<br />
Bernard, A. M.; OWed, A. A.; Lauwerys, R. R.;<br />
Lambert, A.; Vandeleene, B., 1264<br />
Bernard, Alfred M.; Vyskocil, Adolf A.; Mahieu,<br />
Pol; Lauwerys, Robert R., 775<br />
Bernard, Mark; Berryman, C. Richard, 984<br />
Bernard, S. See Orsonneau, J. L.<br />
Bernett, Ann See Clejan, Sands<br />
Bernier, David See Piran, Un<br />
Bernier, Lani L See Deuster, Patricia A.<br />
Bernstein, Larry See Sacha, Edward<br />
Bernstein, Larry H. See Sachs, Edward<br />
Berry, Helen K; Croft, Charles C., 1471<br />
Berrynian, C. Richard See Bernard, Mark<br />
Berthelot, Michel; Cornu, Guy; Daudon,<br />
Michel; Helbent, Maryvonne; Laurence,<br />
Christian, 780<br />
-; Cornu, Guy; Daudon, Michel; Helbert,<br />
Maryvonne; Laurence, Christian, 2070<br />
Bertholf, Max See Clark, Larry<br />
Berthol!, Roger L See Martin, R. Bruce<br />
Berti, Giovanni; Fossati, Piero; Melzi d’Enil,<br />
Gian Vice; Tarenghi, Giordano; Musitelli,<br />
Claudio, 312<br />
Bertoldo, Stefania See Donizzi, Romolo<br />
Bertorelle, H. See Burlina, A.<br />
Bertrand, P. V.; Rudd, B. P.; Weller, P. H.; Day,<br />
A. J., 2047<br />
Betz, William See Daly, John<br />
Beucler, I. See Pruvot, I.<br />
Beukeveld, Gerard J. J.; Wolthers, Bert G.; van<br />
Saene, JorisJ. M.; de Haan, Thijs H. IJ.; de<br />
Ruyter-Buitenhuis, Laid W.; van Saene, Rik<br />
H. P., 2164<br />
Bayer, C. See <strong>Back</strong>er, K. T.<br />
Beyerlnck, Ronald A.; Brass, Eric P., 1469<br />
Bhagavan, Nadhipuram V. See Loo, Stanley Y.<br />
Y.<br />
Bhalla, R. See Savoia, M.<br />
Bhalla, Ravi B.; Schwartz, Morton K., 1957<br />
Bhargava, A. See Michielson, C.; O’Donnell, A.<br />
Bhargava, A. K. See McElroy, P. D.; Myers, M.<br />
M.<br />
Bialek-Smith, S.; Henson, B.; Gitnick, G.;<br />
Govindarajan, S., 1031<br />
Blanchi, G. See Nespolo, A.<br />
Bianchi-Bosisio, Adriana See Sonnoche,<br />
Patricia<br />
Bichler, Alfred See Werner, Ernst R.<br />
Bienvenu, J. See Tuhy, P. M.<br />
Bieva, Claude J.; Ladmirant, Irene H.; Scheirs,<br />
Isabelle; Dardenne, Jean Pierre M., 1677<br />
Bigdali, M. G.; Dabir-Ashrafi, H.; Mogheisi, F.,<br />
889<br />
Bigorie, B. See Glikmanas, G.<br />
Bill, Mary Jo See Chan, Daniel W.<br />
Billet, W. See Salinas, R.<br />
-; Alexander, L.; Famulare A. J.; Worthy, T. K.,<br />
892<br />
-; Famulare, A. J.; Worthy, T. K., 925<br />
Binder, Steven H.; Aitmiller, Dale H., 887<br />
Binder, W. See Wiley, M.<br />
Biou, D. See Marchand, Martine; Therond,<br />
Patrice<br />
Birch, David See Sheldon, Edward<br />
Bird, Carrie See Bissell, Michael G.<br />
Birder, !. See Panel, J. M.; Stiller, R. L.<br />
Birkmeyer, Richard C.; Diaco, Robert; Hutson,<br />
Debra K.; Lau, H. Philip; Miller, Warren K.;<br />
Neelkantan, Neel V.; Pankratz, Thomas J.;<br />
Tseng, Susan Y.; Vickeny, Debra K.; Yang,<br />
Esther K., 1543<br />
Bissell, Michael G.; Ward, Edward; Sanghavi,<br />
Panna; Toffaletti, John; Bird, Carrie; Berg,<br />
Chris; Jerkunica, Ivanka; Hutton, Polly F.,<br />
951<br />
Bisse William I. K. See Butler, Anthony R.<br />
Bistrian, Bruce H. See Palombo, John D.<br />
Bitar, John G. See Wakid, Nabil W.<br />
Bittikofer, John A.; Stewart, Charles K.; Collin,<br />
Dennis P., 950<br />
Bjorkhem, I. See Lindback, B.<br />
Blaabjarg, Ole; von Eyben, F.; Hyltoft, P.;<br />
Horder, M.; Andersen, S. Knuse; Parley, K.,<br />
932<br />
Black, David L.; Goldberger, Bruce A.; Caplan,<br />
Yale H.. 367<br />
Black, E.G. See Sheppard, M. C.<br />
Black, Jeffrey See Gniffiths, John<br />
Blackburn, George L See Palombo, John D.<br />
Blackwell, H. D.; Chapman, J. F., 911<br />
Blair, P. C. See Thompson, M. B.<br />
Blair, Stephen C.; Schier, Gary M.; Gan,<br />
Ignatius K. T.; Lever, Michael; Fowler,<br />
Richart T.; Fneear, Grant J.; Dodds-Scarf,<br />
Patricia M., 446<br />
Blake, A. S. See Hillyard, C. J.; Hillyard, Carrie<br />
Blake, Dennis See Ratnaike, Sujiva<br />
Blanchardie, P. See Orsonneau, J. L<br />
Blank, David W. See Knoll, Martin H.<br />
Blank, Wolfram See Lampe, Dagmar<br />
Blanke, Robert V. See Dubowski, Kurt M.;<br />
Jatlow, Peter 1., 41B<br />
Blase, M. See Ivor, Linda<br />
Blecher, Melvin, 432<br />
Bleile, D. See Donohue, D.; McNally, A. J.;<br />
Niedbala, R. S.; Petnas, S.<br />
Bleile, Dennis M. See Reidy, Judith A.<br />
Blevins, H. D. See Maciejko, J. J.<br />
Blevins, Roger D. See Maciejko, James J.<br />
BUck, Kenneth E. See Bnubaker, Daniel B.<br />
-; Fuller, David; Passey, Richard B., 985<br />
Blickstein, Isaac See Shohamn (Schwartz), Zeev<br />
Blind, Eberhard; Schmidt-Gayk, Heinnich;<br />
Armbnuster, Franz Paul; Stadler, Angelika,<br />
1376<br />
Bloch, Will See Sheldon, Edward<br />
Bloch-Michel, E. See Helleboids, L.<br />
Bluestein, Barry, 1061<br />
Bocci, Lewis See Chu, Samuel Y.<br />
Boctor, F. N.; Farid, Z.; El-Sheneif, N.; Shokry,<br />
S.; El-Gohry, M.; Peter, J. B., 1570<br />
Boctor, Found N.; Peter, J. B.; Perry, R. J., 917<br />
Bodman, V. See Novnos, Joel<br />
Bodourian, Selma H. See Pesce, Michael A.<br />
Boeckx, Roger L See Hicks, Jocelyn M., 974<br />
-; Iosefsohn, Mariet; Hicks, Jocelyn M., 1022<br />
Boerman, 0. C.; Thomas, C. M. G.; Segers, M. F.<br />
G.; Kenemans, P.; Lovgren, P.; Zurawski, V.<br />
R.; Haisma, H. J.; Poels, L. G., 2191<br />
Bogavich, Michael See Fnicker, Robert F.<br />
Bogdan, Andre See Touitou, Yvan<br />
Bogema, Stuart See Ronald, Beverly<br />
Bojkowski, Christopher J.; Arendt, Josephme;<br />
Shih, Ming C.; Markey, Sanford P., 1343<br />
Bonn, Constantin A., 863<br />
Bonfanti, N. See Wirquin, K.<br />
Bonini, P. A.; Ceniotti, F.; Barenghi, L.; Luzzana,
M.; Mosca, A.; Ripamonti, M., 1558<br />
Bonini, Pierangelo See Barenghi, Livia; Mosca,<br />
Andrea<br />
Bonnin, M. H.; Gonzalez, M. T.; Navarro, M. A.,<br />
2312<br />
Bookbinder, Michael J.; Panosian, Kim J., 1170<br />
Boone, D. Joe; Caudill, Samuel P., 908<br />
Boos, Mark See Lee, Chul<br />
Boosalis, M. G. See Konstantinides, Frank N.<br />
Borasi, Gianni See Dotti, Claudio<br />
Borden, K. K. See Hutton, Jean M.; Shaw,<br />
Norman Y.<br />
Borel, Jacques-Paul See Gillery, Philippe<br />
Bornzin, Gene A., 872<br />
Borocco, Sylvia See Viallard, Jean-Louis<br />
Borque, LA.; Cambiaso, C. L.; Masson, P. L.,<br />
704<br />
Bosnian, H. See Widdershoven, J.<br />
Botie, Philip N. See Lambent, Patricia A.<br />
Bottorff, Michael B. See Hockerman, Gloria J.;<br />
Straka, Robert J.<br />
Bouin-Pineau, M. H. See Bounaud, M. P.<br />
Boulanger, J. See Gobbela, P.<br />
Bounaud, J. Y. See Bounaud, M. P.; Metaye, T.<br />
Bounaud, M. P.; Bounaud, J. Y.; Bouin-Pineau,<br />
M. H.; Orget, L.; Begon, F., 2096<br />
Bourdon, Raymond See Bourdon, Sylvia<br />
Bourdon, Sylvia; House, Pascal; Bourdon,<br />
Raymond, 132<br />
Bourdoux, P. See Chanoine, J. P.<br />
Boutagy, John; O’Shea, Kaylene, 1069<br />
Bove, Joseph R.; DePalma, Louis; Weirich, Fey,<br />
308<br />
Bovill, E.G. See Howard, P. R.<br />
Bowers, G. N., Jr. See Okorodudu, A. 0.; Syed,<br />
D. B.<br />
Bowers, George N., Jr.; Edwards, G. C.;<br />
Edwards, J., 993<br />
Bowie, Lemuel J.; Dohnal, James C., 946<br />
-; Kirkpatrick, Peter B.; Dohnal, James C., 1467<br />
Bowness, Kathleen Mary See Evans, R. P.<br />
Boyce, P. A. See Ryan, P. J.<br />
Boyd, J. See Johnston, Mary<br />
Boyd, James C. See Felder, Robin A.; Thode,<br />
Jorgen<br />
-; Felder, Robin A.; Mangrey, Keith S.;<br />
Martinez, Antonio; Savory, John, 1560<br />
Boyd, Theophilus See Endahi, Gerald L.<br />
Boyle, William J., Jr. See Regina, Francis J.<br />
Bracey, Arthur See LeMaistre, Anne<br />
Bradley, C. A.; Aleshine, S. L.; Parl, F. F., 1076<br />
Bradley, Charles A. See Wofford, Beth D.<br />
Salhany, Kevin E.; Entman, Stephen S.;<br />
Aleshire, Stephen L.; Parl, Fritz F., 81<br />
Crean, Deborah M.; Posey, Yvonne F.; Parl,<br />
Fritz F., 1032<br />
Brady, A. See Izutsu, A.<br />
Braguer, Diane See Monti, Jean Pierre<br />
Brandt, Barbara See Bach, Philip<br />
Brandt, Jason, 876<br />
Branumn, Earl; Pruett, Sara; Cummins, Laura;<br />
Bartilson, Mary; Hopper, Mary; O’Brien,<br />
John F., 915<br />
Brass, Eric P. See Beyeninck, Ronald A.<br />
Braun, C. B. See Rosano, C. L.<br />
Braun, H.-P.; Deneke, U.; Rittersdorf, W., 988<br />
Braun, J. P. See Papadou1o, I.<br />
Braun, K. See Wileczek, K.<br />
Braunstein, Glenn D.; Kelley, Lynne; Farber,<br />
Sergio; Wade, Maclyn E., 1947<br />
Braunstein, J. D.; Furgiuele, J.; Lent, R. W., 899<br />
Braunsteiner, Herbert See Drexel, Heinz<br />
Brewer, M. See Schifman, Ron B.<br />
Brewer, Michael K. See Schifman, Ron B.<br />
Bray, K. H. See Gaun, Pramod K.<br />
Brazil, N. See Mulryan, G.<br />
Breckenridge, W. Carl See Pelletier, Omer<br />
Breglio, S. See Allen, D.<br />
Breier, Christoph See Drexel, Heinz<br />
Brennan, George L. See Nusabaum, Samuel R.<br />
Breutxmann, David A. See Hockerman, Gloria<br />
J.<br />
Brewster, Marge; Turley, Charles P.; Kearns,<br />
Gregory L.; Fiser, Debra, 914<br />
Brocher, Steffanie C. See Amenta, Joseph S.<br />
Brock, David A.; Gantzer, Mary Lou, 1033<br />
I Brockie, Robert K. See Wu, Alan H. B.<br />
Brooks, Kathleen P.; Walczak, Chester M.;<br />
Toppin, Millicent C.; Edwards, Leila, 989<br />
Brooks, M. H. See Collins, Sonia<br />
Brophy, Kevin See O’Leary, Niall<br />
Brossier, Pierre See Ismail, Aahraf A.<br />
Brotherton, Mary See McCarthy, Matthew J.<br />
Brown, Charles Eric; Allaway, James R.;<br />
Brown, Kathy L.; Bsttocletti, Joseph H., 227<br />
Brown, G. M. See Viswanathan, M.<br />
Brown, Harold; Meola, J.; Yadegari, P.; Rosano,<br />
T.; Paquet, K., 1012<br />
Brown, J. M. See Cowley, D. M.<br />
Brown, Jennifer M. See McWhinney, Brett C.<br />
Brown, Kathy L. See Brown, Charles Eric<br />
Brown, Paul I.; Rabkin, Michael, 1016<br />
Brown, Steve See Wilson, Chuck<br />
Brown, Sue See Martin, R. Bruce<br />
-; Savory, J.; Wills, M. R., 933<br />
Brown, W. E III, 1567<br />
Brown, W. J.; Warfel, J.; Nachtigal, S.;<br />
Greenspan, P., 895<br />
Brown, Warren P. See Rettmer, Rebecca L.<br />
Brown, William E. See King, William J.<br />
Browning, D. M. See Premachandra, P.<br />
Browning, Margaret C. K. See Fraser, Callum<br />
G.; Gallacher, Ruth E.; Howey, Jacqueline E.<br />
A.; Johnson, Roger<br />
Brubaker, Daniel B.; Buck, Kenneth E.;<br />
Romine, Maxine, 126<br />
Bruegger, Berndt; Keenan, Donald H.;<br />
Sivoninovsky, Genrikh, 1001<br />
Bruning, Thomas See Schmitz, Gerd<br />
Bruno, V. See McCombs, M.<br />
Bruno, Valerie See Chen, Roulhwai<br />
Bruns, D. E. See Johnston, Mary; Mifflin, P. E.<br />
Bruns, David E. See Felder, Robin A.; Mifflin,<br />
Theodore E.<br />
Mifflin, Theodore E., 1695<br />
Bruzek, Debra See Chan, Daniel W.; Rock,<br />
Robert C.<br />
Bruzek, Debra J. See Chan, Daniel W.<br />
Bryant, M. F. See Churella, H. R.<br />
Buamab, P. K.; Cornell, C.; Skillen, A. W.;<br />
Cantwell, B. M. J.; Harris, A. L., 1124<br />
Bubis, Sylvia See Meites, Samuel<br />
Buck, H. H. See Norman, Robert<br />
Buck, Robert H. See Norman, Robert J.<br />
Buckley, M. G.; Sagnella, G. A.; MacGregor, G.<br />
A., 1104<br />
Buffington, K. See Ryder, K.<br />
Buffone, Gregory J., 1059<br />
Buijs, Henry See Ismail, Ashnaf A.<br />
Buitrago, Jose M. Gonzalez; Santiago, Jose M.;<br />
Cava, Fernando; del Campo, Antonio G.;<br />
Nav!jo, Jose A., 1072<br />
Bumol, Thomas F., 1053<br />
Bunce, P. See Chandler, H. M.<br />
Bunch, R. See Hillyard, C. J.<br />
Bundesen, P. G. See Hillyard, C. J.; Hillyard,<br />
Carrie<br />
Burden, M. R.; Mashford, A. P.; Capps, N. K.;<br />
Cudmore, A. P., 1254<br />
Burdick, B. A., 310<br />
Burgess, Mark S. See Oeltgen, Peter K.<br />
Burgess, T. E. See Belyus, P.S.<br />
Burgett, M. W. See Yeager, Elizabeth P.<br />
Burgoon, P. See Van Dreal, P. A.<br />
Burk, H. See Kunst, Albert<br />
Burke, M. See Fruhman, J.; Jones, J.<br />
Burkhalter, Ann See Mono, Leo G.<br />
Burkhardt, A. E. See Skjold, A. C.<br />
Burkhardt, Alan E., 1574<br />
Burleigh, B. D. See Petersen, J. K.<br />
Burleigh, B. Dan See Baxter, Robert C.; Scott,<br />
Mitchell G.<br />
Burlina, A.; Secchieno, S.; Bertorelle, R.;<br />
Piebani, M.; Zaninotto, M., 1085<br />
Burnett, D.; Goudie, J. H.; Tabossi-Reynolds, C.,<br />
191<br />
Burns, T. See Diaz, S.<br />
Burn, B. J.; Kutnink, M. A., 935<br />
Burrin, Jacky M.; Paterson, Jennifer L.; Sharp,<br />
Patrick S.; Yeo, Tom H., 1593<br />
Burritt, Mary F. See Scott, Richard E.<br />
Burtis, C. A.; Owings, J. H.; Leete, K. S., Jr., 46B<br />
-; Johnson, W. F.; Walker, W. A., 1558<br />
Burtis, Carl A. See Dubowski, Kurt M., 352<br />
Busch, Ronald P.; Warty, Vijay S.; Vinji,<br />
Mohamed A., 964<br />
Bush, D. See Mahaffey, K.<br />
Bush, G. A.; Maitaki, T.; York, D.; Klock, J.;<br />
Abel, C.; White, M.; Urnovitz, H., 905<br />
Bush, Valerie; Reed, Roberta G., 821<br />
Butler, A. R. See Westerlund, John<br />
Butler, Anthony H.; Glidewell, Christopher;<br />
McGinnis, Joseph; Bisset, William I. K., 490<br />
Butler, Julius See Tsai, Michael Y.<br />
Butler, Mary See Osikowicz, Gene<br />
Butler, Thorne J. See Dubowski, Kurt M.<br />
Butruni, Ritva H., 1062<br />
Butt, A. M.; Monfiston, B.; Rutner, H.; Readio,<br />
J.; Baran, M., 1023<br />
Buttery, J. E. See Stuart, 5., 1491<br />
Buttery, Joseph E.; Pannall, Peter R., 1931<br />
Butts, B. See Lewis, C.<br />
Buursma, A. See Zijlatra, Willem G.; Zwart, A.<br />
Buylaert, W. See Verstraete, Alain<br />
Byrne, Rita S. See Abbott, William A.<br />
Cabana, Veneracion G.; Noe, Constance, 896<br />
Cachera, C. See Parra, H. J.<br />
Cadoux, M. See Truchaud, A.<br />
Caffo, A. L.; Otley, M. J.; Deaton, M. L., 992<br />
Cal, F. See Miccoli, Roberto<br />
Cain, Shawn See Rudolph, Julie<br />
Caines, P. S. See Chu, J. W.<br />
Calabrese, Giuseppe See Mascini, Marco<br />
Caldwell, G.; Cow, S. M.; Sweeting, V. M.;<br />
Beckett, G. J.; Seth, J.; Toft, A. D., 303<br />
Caldwell, Michael D., 874<br />
Calibration See Karjalainen, Ulla<br />
Callais, F.; Roche, D.; Andreux, J. P., 1266<br />
Calvert, G. D. See Smith, S. J.<br />
Calvin, David See Chan, Kwok-Ming<br />
Calzi, Lorella Li See Benvenga, Salvatore<br />
Camara, Paul D. See Gniffiths, William C.<br />
Cambiaso, C. L See Borque, L. A.<br />
Casnbrowski, George S. See Lunetzky, Ellen S.<br />
Campbell, D. See Ball, D. J.<br />
Campbell, D. J.; Miyada D. S.; Hull, E. W., 910<br />
Campello, M. J. See Ballester, I.<br />
Campos, Hannia See McNamara, Judith K.<br />
Candlish, J. K. See Aw, P. C.; Tho, L. L.<br />
Cannella, Joseph M., 61B<br />
Cantor, E. H. See Ho, E. H.<br />
Cantwell, B. M. J. See Buamah, P. K.<br />
Capdevlla, Josep Ma. See FbI, Concepcio<br />
Caplan, Y. H. See Levine, B. S.<br />
Caplan, Yale H. See Black, David L<br />
-; Levine, Barry; Goldbenger, Bruce, 1200<br />
Capps, N.E. See Burden, M. R.<br />
Caravatti, Mario; Staehli Christian, 929<br />
Cardella, D. S.; Howlett, (. M.; Cross, R. E.;<br />
Parker, N. C.; Rifai, N., 1020<br />
Canel, Rafael S.; Silvenberg, Donald S.;<br />
Kaminsky, Ram; Aviram, Alexander, 2106<br />
Carenini, Angelo See Moeca, Andrea<br />
Carey, J. C. See Levinson, S. S.<br />
Carey, H. Neill; Harris, Eugene K., 2323<br />
Cargnoni, Anna See Curelo, Salvatone<br />
Canide, V. J. See Rzasa, Peter J.<br />
Carlone, George M. See Pau, Chou-Pong<br />
Canlson, Desiree A. See Daigneault, Robert W.<br />
Canison, lan See Lensmeyer, Gary<br />
Carleon, Ian H. See Lensmeyer, Gary L.<br />
Carlson, J. See Trundle, D.<br />
Carlson, Lana A. See Macknees. Michael I.<br />
Carlton, Esther See Pandian, M. K.<br />
Canon, Geoffrey See Sheehan, Michael<br />
Carpenter, Richard H. See Beinlich, Cathy J.<br />
Carper, W. H.; Dorey, K. C.; Beber, J. H., 1906<br />
Carpinelli, Assunta See Mosca, Andrea<br />
Carr, David See Thornes, Heather M.<br />
Carrasco, M. Encarnacion See Chueca,<br />
Patrocinio<br />
Carrico, J. See McCombs, M.<br />
Carrier, Robert See Forest, Jean-Claude<br />
Carroll, B. J. See Ritchie, James C.<br />
Carrubba, Janet M.; Klotzsch, S.; Miller, R.;<br />
Levy, 5., 900<br />
Carruthers, S. G. See Freeman, D. J.<br />
Caratens, K. S. See Romfh, P. C.<br />
-; Romfli, P.C., 1028<br />
Carstensen, C. See Freitag, H.<br />
Carstensen, C. A. See Koller, P. U.<br />
Carter, Laurenda; Gambhir, Kanwal K., 1004<br />
Casal, David See Demers, Laurence M.<br />
Casasnovas, Canlos H.; Gavan, Sheila, 985<br />
Caserta, .J. See Seballos, H. L.<br />
Casey, Clare K.; Goodall, Margaret A. Jacobs;<br />
Hambidje, K. Michael, 1253<br />
Caskey, C. Thomas, 876<br />
Cassani, Giovanni See Corti, Angelo<br />
Casselman, Charles W. See Zlotkin, Stanley H.<br />
Cassulis, Pauline Z. See Jarzabak, Jean I.<br />
Castaldo, Giuseppe See Sacchetti, Lucia<br />
Castaneda-Mendez, Klcab, 221<br />
Castel, Olivier See Mura, Patrick<br />
Catalona, W. See Hortin, G.<br />
Catanla, Salvatore See Delia, Salvatore<br />
Catapano, A. See Marcovina, Santica<br />
Cats, John C., IV See Hurd, Debbie D.<br />
Catlin, Don H.; Kammerer, R. Craig; Hatton,<br />
Caroline K.; Sekera, Michael H.; Merdink,<br />
JamesL., 319<br />
Cattell, J. A. See Skjold, A. C.<br />
Cattozzo, G. See Franzini, Carlo<br />
Cattozzo, Giampaolo See Franzini, Carlo<br />
Caudill, Samuel P. See Boone, D. Joe<br />
Cava, Fernando See Buitrago, Jose M. Gonzalez<br />
Cavalieri, Simona See Dotti, Claudio<br />
Cavanagh, Kevin T.; Veenendaal, Mark;<br />
Kapenga, Jeanne M., 1306<br />
Cavanaugh, A. See Shackelford, William<br />
Cavenaghi, Luigi See Conti, Angelo<br />
Ceconi, Claudio See Curello, Salvatore<br />
Cede, Gian Paolo See Dotti, Claudio<br />
Cejka, Jan; Kithier, Karel, 628<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2339
Cambrowski, George S. See Erickson,<br />
Katherine; Metzger, Louis F.<br />
Ceriotti, F. See Bonini, P. A.<br />
Cariotti, Ferruccio See Barenghi, Livia; Mosca,<br />
Andrea<br />
Cernosek, K. M. See Yeager, Elizabeth P.<br />
Cerqueti, P. See Helleboids, L.<br />
Cerra, F. B. See Konstantinides, Frank N.<br />
Cerra, Frank B., 875<br />
Cerrato, D. See Nespolo, A.<br />
Chakmakjian, Z. H. See Zachariah, N. V.<br />
Chaleby, Kutalba; El-Yazigi, Adnan; Atiyeh,<br />
Maurice, 1679<br />
Chall, J. See Chu, D.<br />
Chalmers, A. H. See Cowley, D. M.<br />
Chalmers, Ainsley H. See McWhinney, Brett C.<br />
Chamberlain, Blake V. See Ashwood, Edward<br />
R.<br />
Chamberlain, H. Thomas, 877<br />
Chamberlin, Beverly A.; Sweeley, Charles C.,<br />
572<br />
Chan, Daniel W. See Rock, Robert C.; Wu, Alan<br />
H. B.<br />
-; Bruzek, Debra; Rock, Robert; Oesterling,<br />
Joseph E.; Walsh, Patrick C., 927<br />
-; Waldron, Cynthia; Bill, Mary Jo; Drew,<br />
Helen, 947<br />
-; Bruzek, Debra J.; Oesterling, Joseph E.; Rock,<br />
Robert C.; Walsh, Patrick C., 1916<br />
Chan, Joseph L. W.; Wolley, Robert C., 917<br />
Chan, K.-M. See Hortin, G.<br />
Chan, Kwok-Ming See Kanan, Renee<br />
-; Koenig, John; Walton, Kim G.; Francoeur,<br />
Theresa A.; Lau, Brad W. C.; Ladenson, Jack<br />
H., 130<br />
-; Ladenson, Jack H., 1190<br />
-; Koenig, John; Calvin, David; Stahlschmidt,<br />
Gail; McClellan, Adraln C.; Skogen, William;<br />
Landt, Michael, 1670<br />
Chan, L.-T. See Chen, A. K.<br />
Chan, M. A.; Diamandis, E., 919<br />
Chan, Marcia A.; Bellem, Astnid C.; Diamandis,<br />
Eleftherios P., 2000<br />
Chan, Teresa H. See Sheiman, Mark I.<br />
Chan, Theodore C. See Garcia, Raymond E.<br />
Chandler, H. M.; Fuller, S. A.; Nakagawa, C. H.;<br />
Nagainis, P. A.; Hurrell, J. C. R., 498<br />
-; Bunce, P.; Hooker, E. J.; Hurrell, J. G. K., 959<br />
Chandler, Wayne L.; Clayson, Kathleen J.; Fine,<br />
James S., 2304<br />
Chandrasena, L. See El Fakhni, M.<br />
Chanoine, J. P.; Bourdoux, P.; Vo Phi, N. B.;<br />
Ermans, A. M., 1935<br />
Chantarangkul, V.; Tripodi, A.; Mannucci, P.<br />
M., 1888<br />
Chaplin, Linda See Fonland, Steven C.<br />
Chapman, Donna, 976<br />
Chapman, J. F. See Blackwell, K. D.<br />
Chapman, John F., 1060<br />
Chappuis, Philippe See Speich, Michelle<br />
Charie, Lori See Goodnow, Timothy<br />
Charlton, H. H. See Miller, W. K.<br />
Chariton, Robin R. See Wang, Chi-Chin<br />
Chastang, Claude See Touitou, Yvan<br />
Chavarria, Miguel A. See Schosinsky, Karl H.<br />
Chavez, Rodnigo See David, Harold<br />
Chee, Kew M. See Siguel, Edward N.<br />
Chen, A. C. See Yeager, Elizabeth P.<br />
Chen, A. K.; Chan, L.-T.; Yao, S. J., 980<br />
Chen, 1-Wen See Sperling, Matthew I.<br />
-; Gibler, W. Brian; Sperling, Matthew I.;<br />
Gibler, Clinton D.; Weinshenker, Eugene;<br />
Hedges, Jerris K.; Banson, William C.;<br />
Abbottsmith, Charles; Embry, Steven;<br />
Kereiakes, Dean, 989<br />
Chen, Katherine H. See Khayam-Bashi, H.<br />
Chen, Kwok-Ming See Matheke, Mary Lou<br />
Chen, Mei-Huei; Ross, Richandus; Tsang,<br />
Reginald, 907<br />
Chen, Roulhwai; Li, Thomas M.; Merrick,<br />
Holly; Parrish, Richard F.; Bruno, Valerie;<br />
Kwong, Angela; Stiso, Cindy; Litman, David<br />
J., 1521<br />
Chen, W. See Stivers, C.<br />
Cheney, J. A.; Kaminski, E. A.; Doherty, K. A.;<br />
Law, W. P., 944<br />
Cheng, C.; Nazareth, A.; Nolan, L.; Zinone, T.;<br />
McPartland, R., 914<br />
Cheng, Charles; LaTorre, Judy; McPartland, K.,<br />
889<br />
Cheng, E. See Ho, T. T.<br />
Cheng, M. H.; Huang, W. Y.; Lipsey, A. I., 414<br />
Cheng, Mary H. See Mahnovski, Vladimir<br />
-; Huang, William Y.; Lipsey, Allen I., 1027<br />
Cheng, Po-Jun See Chin, Bruce<br />
Cheret, Philippe See Ismail, Ashraf A.<br />
Cheung, C. K.; Swaminathan, R., 202<br />
-; Swaminathan, K., 204<br />
2340 CLINICAL CHEMISTRy, Vol.33, No. 12,1987<br />
-; Swaminathan, R.; Cockram, C., 1033<br />
Chiamoni, N. Y. See Zia, Priscilla<br />
Chiang, Betty T. See Rehak, Nadja N.<br />
Chiang, C. S., 1245<br />
Chickering, Elizabeth J.; Meunier, Jerome J.;<br />
Scanlon, Janet M.; Sharp, Gregory H.; Tracy,<br />
Russell P., 416<br />
Chiesa, M. H. See Pilo, A.; Zucchelli, G. C.<br />
Chihi, A. See Najjar, M. F.<br />
Childerstona, M. See Colbert, D. L.<br />
Chin, Bruce; Cheng, Po-Jun; Kirchick, Howard,<br />
906<br />
Chin, Christina See Beilby, John P.<br />
Chivite, J. See Smith, D.<br />
Cho, H. I. See Hwang, Yoo Sung<br />
Chockalingain, Uma M. See Murphy, Ednie<br />
Chong, J. See Wong, S. T.<br />
-; Wong, S. T., 903<br />
Chou, David, 1057<br />
Chou, Peter P. See Christopher, Charles W.<br />
-; Toms, Rick A.; Bailey, Jimmy L., 1003<br />
-; Toms, Rick A.; Bailey, Jimmy L., 1009<br />
Choudisry, Satish C. See Awdziej, Tania N.<br />
Chow, A. T. See Crouse, S. P.<br />
Choy, Janet; Weiss, A., 916<br />
-; Weiss, Alan, 1568<br />
Christenson, K. H. See Rifai, N.<br />
Christenson, Robert H. See Kifai, Nader<br />
-; Studenberg, Scott D.; Beck-Davis, Susan;<br />
Sedor, Frank A., 606<br />
-; Studenbeng, Scott D.; Sedor, Frank A.; Beck-<br />
Davis, Susan, 914<br />
Christian, Gary D., 871<br />
Christopher, Charles W.; Chou, Peter P.;<br />
Wysocki, Nancy, 911<br />
Chu, D.; Chall, J.; Vlastelica, D., 899<br />
Chu, J. W.; Fschnie, D.; Kobylak, L.; Foreback,<br />
C. C.; Goldberg, D.; Kahkonen, D.; Caines, P.<br />
5., 899<br />
Chu, Samuel Y.; MacLeod, Janet E.; Bocci,<br />
Lewis; Monteith, Mabel, 617<br />
Chu, T. M. See Killian, C. S.<br />
Chueca, Carmen See Chueca, Patrocinio<br />
Chueca, Patnocinio; Serrano, Santiago;<br />
Carrasco, M. Encarnacion; Chueca, Carmen,<br />
1304<br />
Churella, H. K.; Lagocki, K. J.; Neiden, K.;<br />
Bryant, M. F., 934<br />
Cirelli, Augusto See Delia, Salvatone<br />
Cinet, Patrick See Mare, Michel<br />
Clapper, Maureen See Zarling, Edwin J.<br />
Clapshaw, Patric See Warnick, G. Russell<br />
dandy, C. W. See Schroeder, T. J.<br />
-; Schroeder, T. J.; Wadhwa, N. K.; Pesce, A. J.;<br />
First, M. R.; Myra, S. A.; McEneny, P. P.;<br />
Baliatreni, W. F.; Harris, R. E.; Melvin, D. B.,<br />
978<br />
Clank, Dennis See lobes, Roger<br />
Clark, Dennis H.; Hajar, Tarek M., 118<br />
Clank, Fred See Spnitzer, Lawrence<br />
Clark, Gary B. See Gene, Jeffrey A.<br />
Clank, Larry; Bertholf, Max; Stafford, Many Jo,<br />
938<br />
Clark, Penelope M. S.; Price, Christopher P.;<br />
Ellis, David H., 414<br />
Clarkson, Jay T. See Luke, David R.<br />
Clarridge, Jill E. See Singh, Jagat<br />
Claudel, Jean-Pierre See Marre, Michel<br />
Claustrat, Francine See Bador, Rene<br />
Clay, P. See Jones, J.<br />
Claybonn, Joan K. See Nelson, Christine D.<br />
Clayson, Kathleen J. See Chandler, Wayne L.;<br />
Root, Charles F., Jr.<br />
Clayton, Frederic; Wu, James T.; Wilson,<br />
Lorraine W., 929<br />
Clejan, S. See Glatt, G.<br />
Clejan, Sanda; Bernett, Ana, 901<br />
Clement, Gerald E. See Murphy, Anne<br />
Clements, Helen M. See Nelson, Christine D.<br />
Clerc, Michel See Manabe, Takashi; Visvikis,<br />
Sophia<br />
Clenico, A.; Ghione, S.; Del Chicca, M. G.;<br />
Balzan, 5., 340<br />
Cloarec, J. P. See Truchaud, A.<br />
Coaklay, John See Couttie, Kate<br />
Coburn, Elaine See Rule, Allyn H.<br />
Coburn, Stephen P. See Schaltenbrand, Wayne<br />
E., 1297<br />
Coeco, Claudio See Lippi, Ugo<br />
Cockram, C. See Cheung, C. K.<br />
Coffee, M. E. See Combs, G. L.<br />
Cohen-Giecek, Cheni See Hockerman, Gloria J.<br />
Cohn, Jeffrey S.; Schaefer, Ernst J.; Poapst,<br />
Mary; Uffelman, Kriatine; Steiner, George,<br />
338<br />
Colbert, D. L.; Childerstone, M., 1921<br />
Coldwell, Ruth See Makin, H. L. J.<br />
Cole, K. See Ladouceur, P. R.<br />
Coles, Philip; Naidoo, Days, 1074<br />
Cohn, Y. See Helleboids, L.<br />
Colinet, Elisabeth See Schiele, Francoise<br />
Coll, Julio M. See Martinez, Jesus A., 1258<br />
Collette, J.; Adam, A.; Ers, P.; Parmantier, M.;<br />
Notche, M.; Demoulin, A.; Franchimont, P.,<br />
715<br />
Collin, Dennis P. See Bittikofer, John A.;<br />
Huenke, JoAnn<br />
Collins, C. See Hammad, N.; Izutsu, A.;<br />
Kennedy, P.<br />
Collins, Chris See Bartlett, Clifford<br />
Collins, J. A. See Schroeder, T. J.<br />
Collins, Sonia; Kanamarlapudi, L.; Bermes, E.<br />
W.; Brooks, M. H., 884<br />
Collinsworth, W. L.; Gadsden, K.; Perry, R., 921<br />
Collies, J. S.; Fry, A. J., 1696<br />
Columbus, Richard L.; Palmer, Harvey J., 1531<br />
Cobvin, S. See Melby, J. M.<br />
Combs, G. L.; Coffee, M. E.; Hranitzky, K. W.;<br />
Melerski, J. J.; DeGnella, K. F., 901<br />
Computers See Karjalainen, ills<br />
donnelly, P. W. See Smith, S. J.<br />
Conroy, Lynn C. See Huang, Pih-kuei C.<br />
Constantine, H. I. See Killian, C. S.<br />
Conte, A. See Millan, A.<br />
Cook, J. See Haden, B.<br />
Cook, Janine Denis See Koch, Thomas K.<br />
-; Koch, Thomas R.; Cook, Michael S.;<br />
Knoblock, Edward C., 1015<br />
Cook, Michael S. See Cook, Janine Denis<br />
Coon, Michael J.; England, Barry C.; Annesley,<br />
Thomas M.; Gischenio, Donald A., 619<br />
Cooper, C. See Kapke, G. F.<br />
Cooper, G. H. See Smith, S. J.<br />
Cooper, Gerald H. See Henderson, L. Omar;<br />
Myers, Gary L., 1052<br />
Cope, June See Painter, Pennell<br />
Copeland, Kenneth H. See Yatscloff, Randall<br />
W.<br />
Corbin, Debra K. See Keenan, Edward J.<br />
Cordy, P. A. See Kubasik, N. P.<br />
Corey, P. F. See Skold, A. C.<br />
Cornacchiari, Adniana See Curello, Salvatone<br />
Cornell, C. See Buamah, P. K.<br />
Cornu, Guy See Berthelot, Michel<br />
Cortes, K. See Ballester, I.<br />
Cortes-Rius, M. See Rodriguez-Espinosa, J.<br />
Conti, Angelo; Cavenaghi, Luigi; Giani,<br />
Emanuela; Cassani, Giovanni, 1615<br />
Cortner, Jean S. See Fisher, Edward A.<br />
Coryn, Timothy See Kurchacova, Elva<br />
Cossitt, Nancy L. See Smith, F. A.<br />
Costa, Jackson M. L. See Dorea, Jose G.<br />
Costa, H. See Klotzsch, Sigrid<br />
Costa, Robert; Varady, R., 956<br />
Costales, Fernando See Strand, Calvin L.<br />
Costello, J. See Kumar, Harish<br />
Costello, H. See Papadopoulos, N. M.<br />
-; Papadopoulos, N. M., 905<br />
Cote, Debbie See Ishii, Steve; Williams, Michae<br />
Cote, Deborah; Williams, Michael; Flores,<br />
Orlando; Hango, Melanie, 940<br />
Coty, William A. See Kramen, Donald L.<br />
Coude, M. See Kamoun, P.<br />
Coulis, K. See Schifman, Ron B.<br />
Coulis, Karen See Schifman, Ron B.<br />
Courouce, Anne-Marie See Lefrene, Jean-<br />
Jacques<br />
Courtina, Christine See Monti, Jean Pierre<br />
Couttie, Kate; Earle, John; Coakley, John, 1674<br />
Covault, H. P. See Diamond, S. K.; Frye, S. L.;<br />
Mahaffey, R.; Ruhnau, S. K.; Smith, M.<br />
Covington, A. K. See Flea, Cecil T. C.<br />
Cowell, David C.; Ford, Pamela A. E., 1458<br />
Cowan, K. See Ellis, M.<br />
Cowley, D. M.; McWhinney, B. C.; Brown, J. M.<br />
Chalmers, A. H., 243<br />
Cowbey, David M. See McWhinney, Brett C.<br />
Cox, Timothy M. See Echetebu, Zeinep 0.<br />
Cragle, L. See Haden, B.<br />
Crawford, Ralph G.; Levy, Arthur L., 984<br />
Crean, Deborah M. See Bradley, Charles A.<br />
Crenshaw, Canlyle, Jr. See Koch, Thomas K.<br />
Cravat, Alma See Monti, Jean Pierre; Monti,<br />
Jean-Pierre<br />
Crews, H. M. See Gadsden, K. H., Sr.<br />
Crisp, David; Danisch, Robert; Gonzales, Lisa;<br />
Ammirati, Enika; Sugiyama, Sharon; Becker<br />
Rosette, 921<br />
Cristofani, K. See Miccoli, Roberto<br />
Croft, Charles C. See Berry, Helen K<br />
Crofton, Patricia M., 1778<br />
-; Hume, Robert, 1783<br />
Crooms, S. See Johnston, D.<br />
Cross, H. E. See Cardella, D. S.; Rifai, N.<br />
Crouse, S. P.; Luddy, M. A.; Chow, A. T.; Tuhy,<br />
P. M.; Pierson-Perry, J. F.; Lawnuk, P., 889
Crouse, Steven P., 1303<br />
Crowley, George See Haven, Mary C.<br />
Crown, J. See Lauderdale, V.<br />
Crowther, F. H.; Doherty, E. A.; Roman, J. K.;<br />
Scully, D.; Law, W. T.; Schmid, C., 950<br />
Csako, Gyorgy See Wilkins, Terence A.; Zweig,<br />
Mark H.<br />
-; Zweig, Mark H.; Benson, Carol; Kuddel,<br />
Mark, 87, 289,2321<br />
Cuca, Gregory C. See Scott, Mitchell C.<br />
Cuccia, Claudio See Panteghini, Mauro<br />
Cuche, Jean-Louis; Selz, Francoise; Kuget,<br />
Gerard; Centil, Monique; Gaudin,<br />
Chnistophe, 408<br />
Cudmone, A. P. See Burden, M. R.<br />
Cudny, Bogumila See Wong, Steven H.-Y.<br />
Cuevas, Eleanore C.; Kiser, Ernest J., 956<br />
Cullia, P. See Spanks, D. L.<br />
Cummings, K. M. See McElroy, P. D.<br />
Cummings, K. Harris; Pardue, Harry L., 493<br />
Cuinmins, Laura See Branum, Earl<br />
Cunningham, A. M. See Goldsmith, K. F.<br />
Curello, Salvatore; Ceconi, Claudio; Cargnoni,<br />
Anna; Connacchiani, Adniana; Ferrari,<br />
Roberto; Albertini, Alberto, 1448<br />
Curmaci, Barbara L. See Plucinsky, Mark C.<br />
-; Plucinsky, Mark; Kiser, Ernest J., 945<br />
Cuthbertson, Carol See Endahi, Gerald L.<br />
Cutler, Ralph K. See Forland, Steven C.<br />
Cynober, L.; Morgant, G.; Morelet, L.;<br />
Giboudeau, J., 123<br />
Czarnecky, K. See Pollack, L.<br />
Czinner, Ant.al See Szabo, Ibdiko<br />
Czmiel, K. See Toth, Edmund C.<br />
Daae, L. N. W., 1669<br />
Dabin-Ashrafi, H. See Bigdeli, M. C.<br />
Daft, M. See Hortin, C.<br />
Daigneault, Robert W.; Canison, Desinee A., 981<br />
Daiss, John L. See Danielson, Susan J., 986<br />
Dajani, Adnan S. See Miceli, Joseph N.<br />
Daka, Joseph See Hinberg, Irwin<br />
Dalal, Fram H. See Murphy, Anne<br />
Dalbow, M. H. See Hutton, Jean M.; Shaw,<br />
Norman V.<br />
Daly, John; Betz, William, 1002<br />
Dandona, P. See Pal, B.<br />
Danella, S. See DiStaslo, Karen<br />
Daniel, D. S. See Van Brunt, Nicholas<br />
Daniel, S. G. See van Heyningen, V.<br />
Danielson, Susan J.; Detty, Michael R.;<br />
Alexandrovich, Susan K., 923<br />
-; Daiss, John L., 923<br />
Danisch, Robert See Crisp, David<br />
Danna, Anthony See Barnes, Grady<br />
Dardenne, Jean Pierre M. See Bieva, Claude J.<br />
Dasgupta, Amitava; Kenny, M.; Heywood, A.;<br />
Ahmad, S., 890<br />
Dastugue, Bernard See Viallard, Jean-Louis<br />
Dati, Francesco; Stienen, L., 902<br />
-; Baudner, S.; Metzmann, E.; Toth, T.;<br />
Tuenglen, P., 902<br />
-; Becker, U.; Heimburger, N., 1004<br />
Datiles, Theresa B.; Humphrey, R. L.; Johnson,<br />
R.J.,904<br />
Daudon, Michel See Berthelot, Michel<br />
Daughaday, W. H. See Petersen, J. K.<br />
Daughaday, William H. See Scott, Mitchell C.<br />
David, B. See Helleboids, L.<br />
David, Harold; Winn-Deen, Emily S.; Sigler,<br />
Gerald; Chavez, Rodrigo; Lewis, Evan, 997<br />
David, Joan A. See Naito, Herbert K.<br />
-; Mooney, Cathryn K.; Naito, Herbert K., 898<br />
David, H. M.; Shihabi, Z. K., 1006<br />
Davidson, Ehud See Rotenbeng, Jvi<br />
Davila, K. See Zuinarnags, M.<br />
Davis, Laura See Doumas, Basil T.<br />
Davis, Melba A. See Wells, David J.<br />
Davis, Susan J. See Erickson, Katherine<br />
Dawes, Clive See Shine, Brian<br />
Dawnay, A. See Silver, A. C.<br />
Dawnay, Anne See Beetham, Robert; Irish, G.<br />
K.<br />
Dawson, Samuel R. See Rugg, James A.<br />
Daxenbichler, Gunter See Werner, Ernst K.<br />
Day, A. J. See Bertrand, P. V.<br />
Day, B. See Van Brunt, Nicholas<br />
Day, B. S. See Powers, D. M.<br />
Day, Richard A. See Wallace, John A.<br />
Day-Cody, D. See Mulryan, C.<br />
DCCT Research Group, The. 2267<br />
De Abneu, K. See Widdershoven, J.<br />
Deam, David See Ratnaike, Sujiva<br />
Deaton, M. L. See Caffo, A. L.; Stnasser, B. L.<br />
DeBari, V. A.; Weber, K., 1029<br />
DeBaun, Michael K.; Kadebaugh, J.; Flessel, P.;<br />
Cuthnie, R., 309<br />
de Boer, J. See Oversteegen, H. J.<br />
De Broe, M. E. See D’Haese, P. C.; D’Haese,<br />
Patrick C.<br />
de Bruyne, J. J. See Joles, J. A.<br />
Do Buyzere, Marc See Delanghe, Joris<br />
Decapnio, Lauren; Hardister, Nancy;<br />
MacMillan, Donna; Welch, Robin;<br />
Widdowson, Graham, 1668<br />
Dechaud, Henri See Bador, Kene<br />
DeChene, N. See Allen, D.<br />
Degal, Fritz; Zuman, Petr; Jandik, Petr; Gilch,<br />
Certnaud, 108<br />
Degenaan, C. P.; Frenken, L. A. M.; v Hooff, J.<br />
P., 1070<br />
DeGrella, R. F. See Combs, C. L.<br />
de Haan, Thijs H. IJ. See Beukeveld, Gerard J.<br />
J.<br />
de La Farge, F. See Papadopulo, I.<br />
de Ia Iglesia, Albento See Viedma, Jose A.<br />
Delaney, Collena J. See Pillsworth, Thomas J.,<br />
Jr.<br />
Delanghe, Jonis; De Buyzere, Marc; De<br />
Scheerder, Ivan; Vandenborght, Jan; Wieme,<br />
Roger, 1103<br />
DeLana, Mila See Bandi, Zoltan L.<br />
Delattre, C. See Cuyon, F.<br />
Del Bane, A. See Kahn, S. E.<br />
del Campo, Antonio G. See Buitrago, Jose M.<br />
Gonzalez<br />
Del Chicca, M. G. See Clerico, A.<br />
Delfert, D. M. See Makese, James J.<br />
Delfent, Dennis M.; Kea, Marcia K.; Kessler,<br />
Gerald; Siegfried, Barry A.; Valdes, Roland,<br />
Jr., 150<br />
Delfoun, C. See Cuyon, F.<br />
Delia, Salvatore; Mastroianni, Claudio Maria;<br />
Massetti, Anna Paola; Turbessi, Ciuseppe;<br />
Cirelli, Augusto; Catania, Salvatore; Vullo,<br />
Vincenzo, 1675<br />
Dell’Anna, Lucio See Franceschin, Armando<br />
-; Morosini, Lorenzo, 1071<br />
Del Vecchio, Mark See Wesolowski, Alex<br />
-; Kaufman, Richard A.; Sinsheimer, Janet;<br />
Usategui-Gomez, Mag#{231}lalena, 997<br />
Demacker, P. N. M. See Smith, S. J.<br />
De Meirleir, K. See Gerlo, E.<br />
Demelier, J. F. See Marchand, Martine;<br />
Therond, Patrice<br />
Do Mellow, John S. See Baxter, Robert C.<br />
Demers, Laurence M.; White, Susan; Casal,<br />
David; Gaur, Premed K., 929<br />
DeMontier, P. See Diamond, S. K.<br />
Demoulin, A. See Colette, J.<br />
Deneke, U. See Braun, H-P.; Hiller, Cerhard<br />
Dent, A. H. See Mashiter, K.<br />
Dente, A. R. See Wolford, S. T.<br />
Denti, Licia See Dotti, Claudio<br />
DePalma, Louis See Bove, Joseph R.<br />
Deprun, C. See Kamoun, P.<br />
DeQuattro, Vincent See Foti, Andras<br />
Den, Channing J., 641<br />
Der-Babian, G. See Rowley, C. L.<br />
de Ruytar-Buitenhuis, Laid W. See Beukeveld,<br />
GerardJ.J.<br />
Dasai, Rajesh K.; Jialal, Ishwarial; Altchison,<br />
John M.; Joubert, Septimus M., 1445<br />
De Scheerder, Ivan See Delanghe, Jonis<br />
DeShon, P. See Reason, Craig<br />
Desjardins, P.R. K. See Yatscoff, K. W.<br />
Desjardins, Paul H. K.; Mactavish, Gloria;<br />
Schoemperlen, Jim, 712<br />
-; Frith, Evelyn; Mactavish, Gloria;<br />
Schoempenlen, Jim, 712<br />
Desjobert, Andre; Larget-Piet, Luc, 1879<br />
Dasmecht, P. See Stein, F.<br />
De Smet, F. H. See Fraeyman, N. H.<br />
Dassy, Raymond K., 869<br />
Desuzinges, Claude See Bador, Rena<br />
Detty, Michael K. See Danielson, Susan J.<br />
Deuster, Patricia A.; Trostmann, Ulrike H.;<br />
Bernier, Lani L.; Dolev, Eran, 529<br />
Deutsch, Dale See Allard, Karen<br />
Develay, A. See Wirquin, E.<br />
Devarill, I. See Winkles, J.<br />
DeWoskin, K. See Sehgal, L. K.<br />
Deyo, D. F. See Thompson, M. B.<br />
Dgani, Ram See Shoham (Schwartz), Zeev<br />
D’Haese, P.C.; Lamberts, L. V.; Diaz, J. B.; Van<br />
de Vyver, F. L.; De Broe, M. K., 933<br />
D’Haese, Patrick C.; Lamberts, L. V.; De Broe,<br />
M.E.,934<br />
Diaco, Robert See Birkmeyer, Richard C.<br />
Diamandis, K. See Chan, M. A.<br />
Diamandis, Elefthenios P. See Chan, Marcia A.;<br />
Khosravi, Moharnmad J.<br />
Diamond, D. L. See Dionio, Alfred F.<br />
Diamond, S. E. See Lin, Spencer H.<br />
Diamond, S. K. See Kuhnau, S. R.<br />
-; Kuhnau, S. K.; Nyberg, S. A.; DeMontier, P.;<br />
Covault, H. P.; Tejero, N., 952<br />
-; Nybeng, S. A.; Paredes, M. J.; Joseph, K. P.,<br />
952<br />
Diamond, Steven E. See Regina, Francis J.<br />
Diax, D. P. See Poortman, Jan<br />
Diaz, Dominador; Poortman, Jan, 957<br />
Diaz, J. B. See D’Haese, P. C.<br />
Dies, S.; Singh, J.; Dudley, A. W., 944<br />
-; Burns, T.; Dudley, A. W., 945<br />
-; Singh, J.; Dudley, A. W., 945<br />
-; Lucco, L.; Dudley, A. W., 1028<br />
-; Singh, J.; Dudley, A. W., 1028<br />
Dickinson, J. W. See Kobos, R. K.<br />
Dietemann-Molard, Anita See Maier, Eddie A.<br />
Dietzler, David N. See Kanan, Renee; Landt,<br />
Yvonne<br />
DiLoro, A. See Michielson, C.<br />
Dinison, Phil See Kabra, Poka M.<br />
Dinovo, K. C.; Howarth, P. L.; Warren, C.;<br />
Florsheim, W., 886<br />
Dinwoodie, A. See LeGatt, Donald F.<br />
Diorio, Alfred F.; Hammer, P. A.; Shah, V. D.;<br />
Diamond, D. L., 1034<br />
DiStasio, Karen; Danella, S.; Szulc, M.; Martin,<br />
Robert F., 946<br />
Diver, Michael J., 1934<br />
Dnistnian, A. See Savoia, M.<br />
Dnistrian, Ann M. See Savoia, Macella<br />
Dobson, Susan; White, Anne; Hoadley,<br />
Margaret; Lovgren, Timo; Ratcliffe, John,<br />
1747<br />
Dodds-Scarf, Patricia M. See Blair, Stephen C.<br />
Dodge, Larry A. See Klee, George C.<br />
Dodson-Lehrer, L. See Jones, J.<br />
Doherty, E. See Mongers, J.<br />
Doherty, E. A. See Cheney, J. A.; Crowther, F.<br />
H.<br />
Dohnal, James C. See Bowie, Lemuel J.<br />
Doi, Kel See Hats, Naoshige<br />
Dolev, Enan See Deuster, Patricia A.<br />
Dolphin, P. J. See Smith, S. J.<br />
Dols, Jan L. S. See Sanders, Gerard T. B.<br />
Dominiczak, M. H. See Orrell, J. M.<br />
-; Orrell, J. M.; Pettigrew, A. K., 937<br />
Dons, Valanio, 422<br />
Donato, L. See Pilo, A.<br />
Donion, Jerome A. See Koch, Thomas R.<br />
Donohue, D. See Petras, S.<br />
-; Niedbala, K.; Petras, S.; McNally, A. J.;<br />
Bleile, D.; Usategui, M.; Meade, N.; Stephon,<br />
R.; Foeny, R.; Frings, C. 5., 970<br />
Doran, Gerard P. See Erickson, Katherine<br />
D’Orazio, Paul, 1005<br />
Dorea, Jose G.; Costa, Jackson M. L.;<br />
Holzbecher, Jini; Ryan, Douglas E.; Marsden,<br />
Phillip D., 2081<br />
Doney, R. C. See Carper, W. R.<br />
Dorizzi, Romolo; Pradella, Marco; Bertoldo,<br />
Stefania; Kigolin, Franco, 190<br />
Dotti, Claudlo; Ceda, Cian Paolo; Denti, Licia;<br />
Cavalieri, Simona; Borasi, Gianni; Valenti,<br />
Giorgio, 658<br />
Doumas, Basil T. See Lemann, Jacob, Jr.<br />
-; Wu, Psi-Wing; Jendrzejczak, Bernadine, 769<br />
-; Perry, Billy; Jendrzejczak, Bernadine; Davis,<br />
Laura, 1349<br />
Douville, P. See Forest, J.-C.<br />
Dove, Janet L. See Prior, Thomas W.<br />
Dowd, Dennis; Koch, David; Wiebe, Donald;<br />
Feldbruegge, Donald, 1010<br />
Downs, D. See Van Brunt, Nicholas<br />
Doyle, C. See Nugent, D. W.<br />
Dracon, M. See Parra, H. J.<br />
Drawbaugh, Addle See Massey, Thomas<br />
Drehner, Dennis M.; Wians, Frank H., Jr.;<br />
Staples, Nona, 1936<br />
Drew, Helen See Chan, Daniel W.<br />
Drexel, Heinz; KIcker, Hehnut; Patach, Josef<br />
R.; Breien, Chnistoph; Braunsteiner, Herbert,<br />
1656<br />
Drexler, G. See Sieghart, W.<br />
Drobnies, Adrienne See Inloes, Roger<br />
Drogomir, George See Suit, Paula<br />
Drummer, John M. See Kost, Gerald J.<br />
D’Souza, J. P. See Kubasik, N. P.<br />
Dubler, Robert E.; Thacker, Susan; Wang, Neil,<br />
972<br />
Dubois, H. See Poppe, W.<br />
Dubowski, Kurt M., 5B<br />
-; Blanke, Robert V.; Burtis, Carl A.; Butler,<br />
Thorne J.; Finkle, Bryan S.; Imwinkelnied,<br />
Edward J.; McBay, Arthur J., 49B<br />
-; Essary, Natalie A., 968<br />
Duda, Marysia See Spencer, Carole<br />
Dudley, A. W. See Diaz, S.<br />
Dudley, Alden W., Jr. See Singh, Jagat<br />
Dufoun, D. Robert See LaCrenade, Alana;<br />
Schwartz, Ann Marie<br />
-; Mesonero, Clara; Miller, Kirk, 914<br />
CLINICAL CHEMISTRY, Vol.33,No. 12,1987 2341
-; Comez, Dana, 989, 990<br />
-; Mikhnovsky, Eugene; Nashel, David;<br />
Kuzmovych, Truvon, 1033<br />
Duggan, P. Finbarr See O’Leary, Niall<br />
Dujardin, B. C. G.; Hafkenscheid, J. C. M.;<br />
Roijers, A. F. M.; Schooni, M.; van der Van-<br />
Jongeknijg, J., 138<br />
Dula, B. See McNally, A. J.<br />
Dumon, Marie-France See Manabe, Takashi;<br />
Visvikis, Sophia<br />
Dumont, J. K. See Kirkpatrick, C. A.<br />
Dunn, Peter J. See Jury, Denis K.<br />
Dunne, W. Michael, Jr. See Reddy, M.<br />
Narahari<br />
Duong, Ly Thi See Ou, Ching-Nan; Kognerud,<br />
Cheryl L.<br />
Dupeyron, J. P. See Guyon, F.<br />
Dupuy, Georges; Hilaine, Genevieve; Aubry,<br />
Claude, 524<br />
Dupuy, J.-L. See Nicot, C.<br />
Dunand, D. See Pressac, M.<br />
Dunbnidge, Timothy C. See Kazmierczak, S. C.<br />
Dusenbury, Sandra L. See Garrett, Patricia K.<br />
Dye, Judy See Finley, Paul B.<br />
Dyer, C. H. See Jovanovic, Lois<br />
Dyer, H. D. See Shihabi, Z. K.<br />
Dyszel, Susan M. See Pettitt, Bruce C.<br />
Kaker, K. See Rutman, Michael<br />
Karl, J. W. See Goldsmith, K. F.<br />
Earle, John See Couttie, Kate<br />
Eastenling, Ronald E. See Verrill, Haland L.<br />
Eastin, William See Esber, Henry J.<br />
Eastman, Creswall J. See Waite, Kay V.<br />
Eaton, S.; Tsay, H. M.; Yost, F.; Tweedle, M.,<br />
1470<br />
Eberly, J. Patrick See Magnotti, Ralph A., Jr.<br />
Kchetebu, Zeinep 0.; Cox, Timothy M.; Moss,<br />
Donald W., 1832<br />
Eckalman, W. C. See Tu, J.-I.<br />
Edmonds, M. K.; John, P. N., 341<br />
Edwards, G. C. See Bowers, George N., Jr.<br />
Edwards, J. See Bowers, George N., Jr.<br />
Edwards, Jill B. See Sasae, Edward A.<br />
Edwards, Leila See Brooks, Kathleen P.<br />
Khrhardt, V. See Riesen, W.<br />
Ehrlich, S. A. See Pennington, Robin M.<br />
Ehrmeyer, Sharon S.; Laessig, Ronald H., 784<br />
-; Laessig, Ronald H., 788<br />
-; Laessig, Ronald H., 908<br />
-; Laesaig, Konald H., 910<br />
-; Laessig, Ronald H., 1901<br />
Kigen, Andrea See Spencer, Carole<br />
Eisenberg, Shlomo See Slutzky, Gerald M.<br />
Eisenbrey, A. Bradley; Mathew, Kanjit;<br />
Kiechle, Frederick L., 2308<br />
Ekins, Roger, 2137<br />
Ekpoom, Naruemol See Huebers, Helmut A.<br />
Kldredge, John See Kashtchian, Ayoub<br />
El Fakhri, M. See Sheriff, D. S.<br />
-; Sheriff, D. S.; Chandrasena, L.; Gupta, J. D.;<br />
Rai, S. T.; Qureshi, M. 5., 1936<br />
Elgengan, K. B. See Sheriff, D. S.<br />
El-Gohny, M. See Boctor, F. N.<br />
KIln, Ronald J. See Knoll, Martin H.; Kehak,<br />
Nadja N., 982<br />
-; Ruddel, Mark; Sliva, Clara, 997<br />
-; Hosseini, Jeanette M., 1006<br />
-; Hoaseini, Jeanette M.; Yang, Xiu Ying;<br />
Ruddel, Mark, 1006, 1965<br />
Elkins, Barry N., 966, 966<br />
Ellefson, Ralph D. See Gninstead, Gregory F.<br />
Ellenba, P.M. See Sniegoski, L. P.<br />
Ellis, David H. See Clark, Penelope M. S.<br />
Ellis, G. See Makela, S. K.<br />
Ellis, Kathy J. See Ovenfield, C. V.<br />
Ellis, M.; Cowen, R.; Hughes, J., 2122<br />
Elmquist, Henrietta See Kovary, Peter M.<br />
Elms, M. J. See Hillyard, C. J.; Hilyard, Carrie<br />
El-Shereif, N. See Boctor, F. N.<br />
Elspergen, K. Joseph See Apple, Fred S.<br />
Klvick, A. See Schifman, Ron B.<br />
Elvick, Alan See Schifman, Ron B.<br />
El-Yazigi, Adnan See Chaleby, Kutalba<br />
-; Martin, Cazemino R., 803<br />
-; Yusuf, Ahmed; Al-Humaidan, Abdulkarim,<br />
1814<br />
Emamian, S. See Rutledge, J. C.<br />
Embry, Steven See Chen, I-Wan<br />
Emnich, L J. See Kilhian, C. S.<br />
Endahl, Gerald L.; Fowler, Mary C.; Kubasik,<br />
Norman P., 883<br />
-; Boyd, Theophilus; Cuthbentson, Carol;<br />
Matthews, W. Stephen, 951<br />
Endo, Keigo See Noguchi, Masato<br />
Kndo, Masahiko See Matsue, Hajime<br />
Endo, Yuichi See Hats, Naoshige<br />
Eng, Many J. See Huebens, Helmut A.<br />
England, Barry G. See Coon, Michael J.<br />
2342 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Ennis, A. K. See Strassen, B. L.<br />
Entman, Stephen S. See Bradley, Charles A.<br />
Epstein, Emanuel See Hawrylak, Ken; Ranjan,<br />
Parveen; Sykes, Elizabeth<br />
Erali-Woodward, M.; Krauth, C. H., 891<br />
Eranio, Sue See Sheiman, Mark I.<br />
Eremin, S. A.; Calacher, C.; Lotey, H.; Smith,<br />
D. S.; Landon, J., 1903<br />
Erickson, Katherine; Cembrowski, George S.;<br />
Young, Donald S.; Doran, Gerard P.; Davis,<br />
Susan J.,965<br />
Enlandson, Gene See Preese, Lynne<br />
Erlich, Henry See Sheldon, Edward<br />
Erlichinan, C. See Hardy, Robert<br />
Ermans, A. M. See Chanoine, J. P.<br />
Ers, P. See Collette, J.; Cobbels, P.<br />
Esber, Henry J.; Lilja, Herman S.; Zavorskas,<br />
Paul A.; Eastin, William; Maronpot, Robert<br />
K., 1037<br />
Esders, Theodore W. See Findlay, John B.<br />
Esquivel, Alba Lux See Schosinsky, Karl H.<br />
Essary, Natalie A. See Dubowski, Kurt M.<br />
Esteban, H. Garcia See Hernandez, D. Martinez<br />
Estelle, B. D. See Belyus, P. S.<br />
Kthirajan, Sukumar See Ng, Ronald H.<br />
-; O’Neill, Mary; Ng, Ronald H.; Statland,<br />
Bernard K., 930<br />
Eto, Yoshikatsu See Yamamoto, Hideaki<br />
Eure, K. L. See Osaki, S.<br />
Evangelatos, Gregory P. See Livaniou,<br />
Evangelia<br />
Evans, J. J.; Sin, I. L.; Aickin, D. K., 1476<br />
Evans, John See Painter, Pennell<br />
Evans, John H., 746<br />
Evans, Peter K. See John, Khys<br />
Evans, H. P.; Walker, Andrea; Bowness,<br />
Kathleen Mary, 823<br />
Evans, Susan See Coodnow, Timothy<br />
Evans, Susan A. See McCarthy, Matthew J.;<br />
Rugg, James A.<br />
Fachnie, D. See Chu, J. W.<br />
Falk, II. B. See Wolford, S. T.<br />
Famulare, A. J. See Billet, W.; Salinas, K.<br />
-; Salinas, K.; Wernlund, S.; Cinidhar, C.;<br />
Worthy, T. E., 972<br />
Famulane A. J. See Billet, W.<br />
Fan, Der-Fong, 632<br />
Faraji, Bahrani; Kang, Han K.; Valentine, Jane<br />
L., 539<br />
Fanb, Harry See Tsai, Michael Y.<br />
Farber, Sargio See Braunstein, Glenn D.<br />
Farber, Sargio J. See Kepique, Eliseo V.<br />
Fanid, Z. See Bctor, F. N.<br />
Farinelli, M. P. See Skjold, A. C.<br />
Farley, John H. See Valenzuela, Guillermo J.<br />
Farrar, John J., 864<br />
Farrenkopf, Bruce C. See Feeley, Brian P.<br />
-; Feeley, Brian P.; Vitone, Stephen; Salainone,<br />
Salvatore J.; Kaufman, Richard A.;<br />
Schwartz, Alan, 1017<br />
Faulkner, Robert D. See McAteer, Joy A.<br />
Faye, Sherry See Panteghini, Mauro<br />
Fazlo, V. See Zama, N.<br />
Feduska, Nicholas J., 1055<br />
Feelay, Brian P. See Farenkopf, Bruce C.<br />
-; Kaufman, Richard A.; Farenkopf, Bruce C.;<br />
Lodato, Denise T.; Anthony, Marvin L.;<br />
Salarnone, Salvatone; Vitone, Stephen;<br />
Schwartz, Alan, 1021<br />
Feistel, C. Sea Umall, L.<br />
Feld, H. D. See Pennell, B. J.<br />
-; Pennell, B. J., 980<br />
Feldbruegge, Donald See Dowd, Dennis<br />
Feldbnuegge, Donald H. See Koch, David D.<br />
Felder, Robin A. See Boyd, James C.<br />
-; MacMillan, K. Hunt, III; Bruna, David E., 700<br />
-; Boyd, James C.; Martinez, Antonio; Magrey,<br />
Keith; Savory, John, 960<br />
FeIgner, Philip See Ullaran, Edwin F.<br />
Feller, D. K. See Noel, S. A.<br />
Fellows, Ian W. See Nee, Patrick A.<br />
Fellows, P. F. See Haven, M. C.<br />
Fenton, John, 981<br />
Ferard, G. See Katnib, K.<br />
Ferdeghini, M. See Pilo, A.<br />
Ferment, Olivier See Touitou, Yvan<br />
Fernandez, Zoe See Mastropaolo, Walter<br />
Ferrari, Roberto See Curello, Salvatore<br />
Ferris, H., 1012<br />
Fesmire, J. See Koran, E.<br />
Fetterhoff, Terry J. See McCarthy, Kobent C.<br />
Fialkowski, D. M. See Rock, M. P. Perlstein<br />
Fiereck, E. A.; Pealman, E. S., 900<br />
Fietx, M. See Zachaiah, N. V.<br />
Fievet, C. See Pruvot, I.<br />
Fifield, K. See Whicher, J. T.<br />
Finch, Clement A. See Huebers, Helmut A.;<br />
Rettmer, Rebecca L.<br />
Finco, Bruno; Schiavon, Koasella, 1305<br />
Findlay, John B.; Esders, Theodore W.; Lynn,<br />
Shirley Y.; Wu, Annie L., 1008<br />
Fine, James S. See Chandler, Wayne L.; Root,<br />
Charles F., Jr.<br />
Fine, Jean-Marie See Lefrere, Jean-Jacques<br />
Fink, L. M. See Wilson, Michael<br />
Finkle, Bryan S. See Dubowski, Kurt M.;<br />
Jatlow, Peter I., 13B<br />
Finley, Paul B.; Fletcher, Carla; Dye, Judy, 1004<br />
Finnstrom, 0. See Nelson, N.<br />
Fiol, Concepcio; Pinto, Xavier; Santamaria,<br />
Pere; Simeon, Josep Ma.; Capdevila, Josep<br />
Ma., 417<br />
First, M. H. See Clardy, C. W.; Schroeder, P. J.<br />
Fisen, Debra See Brewster, Marge<br />
Fisher, Delbert See Pandian, M. R.<br />
Fisher, Edward A.; Jung, Andrew; Contner, Jean<br />
S., 2304<br />
Fitzgerald, Hugh P. See Walmsley, Trevor A.<br />
Fitzpatrick, J. See Michielson, C.<br />
Fitzpatrick, J. E. See McElroy, P. D.; Myers, M.<br />
M.; O’Donnell, A.<br />
Fitzsimons, Edward J. See Reddy, M. Narahani<br />
Flax, Catherine W. See Kugg, James A.<br />
Flean, Cecil T. G.; Roberts, Susan W.; Hayes, S.;<br />
Stoddart, J. C.; Covington, A. K., 13<br />
Flechner, Stuart M., 1056<br />
Fleisher, M.; Gladstone, M.; Schwartz, M. K.,<br />
939<br />
Fleisher, Martin; Stankievic, Kalsa; Schwartz,<br />
Della; Schwartz, Morton K., 293<br />
Flessel, P. See DeBaun, Michael K.<br />
Fletcher, Carla See Finley, Paul B.<br />
Flick, Jonathan A.; Schnaa, Ronald L.;<br />
Penman, Jay A., 1211<br />
Flom, Kenny J.; McCroskey, Ralph, 982<br />
Flood, James G. See Puopolo, Patricia R.<br />
Flones, David, 940<br />
Flones, Orlando See Cote, Deborah; Ishii, Steve;<br />
Williams, Michael<br />
Florsheim, W. See Dinovo, E. C.<br />
Focella, Antonino See Lodato, Denise T.<br />
Foerder, Charles A. See Tait, Jonathan F.<br />
Foeny, H. See Donohue, D.; Petras, S.<br />
Foglia, J. P. See Perel, J. M.; Stiller, R. L.<br />
-; Stiller, K. L.; Panel, J. M.; Lin, F. C.;<br />
Narayanan, 5., 1024<br />
Fok, David See Yu, Stephen S.<br />
Foo, A. Ying See Stein, Penelope<br />
Ford, Pamela A. E. See Cowell, David C.<br />
Ford, Robert P., 1073<br />
Foreback, C. C. See Chu, J. W.<br />
Forest, J.-C.; Rousseau, F.; Talbot, J.; Douville,<br />
P.; Cauvin, K.; Gosselin, M., 2312<br />
Forest, Jean-Claude; Rousseau, Francois;<br />
Caner, Robert; Hivon, Pierre; Goaaelin,<br />
Michele, 1233<br />
Forland, Steven C.; Chaplin, Linda; Cutler,<br />
KalphE., 1938<br />
Forman, Donald T., 1059<br />
Forney, Robert B., 82B<br />
Forney, Robert B., Sr. See Jatlow, Peter I.<br />
Fonshaw, Karen M.; van Heyningen, Charles,<br />
2093<br />
Forsman, H. W. See Mifflin, T. E.<br />
Forsman, Rodney W. See Pruett, Sara<br />
Fortunato, Giuliana See Sacchetti, Lucia<br />
Fossati, Piano See Berti, Giovanni<br />
Foster, L. See Azukas, John J.<br />
Foti, Andras; Kimura, Shinobu; DeQuattro,<br />
Vincent; Lee, Deborah, 2209<br />
Fottnall, P. F. See Nuent, D. W.<br />
Fowler, Mary C. See Endahl, Gerald L.<br />
Fowler, Richart T. See Blair, Stephen C.<br />
Fraeyman, N. H.; Van de Velde, K. J.; De Smet,<br />
F. H., 2275<br />
Fragnoli, Joanne See Kwong, Tai C.<br />
France, John T. See Keelan, Jeffrey A.<br />
Franceschin, Anmando; Morosini, Lorenzo;<br />
Dell’Anna, Lucio, 2125<br />
Franchijnont, P. See Colette, J.<br />
Francis, P. L.; Leone, A. M.; Young, I. M.;<br />
Stovell, P.; Silman, K. E., 453<br />
Francoeur, T. A. See Kahn, S. E.<br />
Francoeur, Theresa A. See Chan, Kwok-Ming<br />
Francoaun, Thanese A. See Maturen, Andrew<br />
Francois, Georges See Monti, Jean Pierre<br />
Frandsen, N. J.; McNair, P., 719<br />
Frank, P. See Kahn, S. E.<br />
Frank, Thomas; Senior, Marilyn B.; Cadson,<br />
Mattie; Goodman, David B. P., 1029<br />
Frantz, Ivan D., Jr. See Kuba, Kanta<br />
Franzini, Carlo; Cattozzo, Ciampaolo, 597<br />
-; Cattozzo, C.; Spagliardi, C., 1013<br />
Fraser, Callum G. See Callacher, Ruth K.;<br />
Gowans, Elizabeth M. S.; Hallworth, Michael<br />
J.; Harding, Philip J.; Higgins, Trefor;
Howey, Jacqueline E. A.; Johnson, Koger,<br />
387<br />
-; Browning, Margaret C. K., 1436<br />
Fraser, David K. See Kost, Gerald J.<br />
Frawley, Vicki L. See Kognerud, Cheryl L.<br />
Frayn, Keith N. See Maycck, Paula F.<br />
Frederick, M. See Mack, M.<br />
Frederick, M. M. See Kaminski, K. M.<br />
Freear, Grant J. See Blair, Stephen C.<br />
Freeman, D. J.; Koegler, J.; Carruthens, S. C.,<br />
978<br />
Freeman, Vicki S.; Haven, Mary C., 906<br />
Fneier, Esther F. See Hanson, Naomi Quast<br />
Freitag, H.; Pollmann, K.; Carstensen, C., 1011<br />
French, C. K.; Strzempko, M. N.; Savitt, C. S.;<br />
Vaccaro, K. K., 963<br />
French, Carol; Spanks, Charles E.; Williams,<br />
Diane; Morris, Kelly; Rudick, Richard A.,<br />
904<br />
French, H. L. See Wolford, S. T.<br />
Frenken, LA. M. See Dagenaar, C. P.<br />
Frey, M. See Crassick, F.; Levy, S.<br />
Fnicker, Robert F. See Crendahl, Jan<br />
-; Bogavich, Michael, 992<br />
Friadmann, Theodore, 876<br />
Fniel, Patrick N. See Skogerboe, Kristen J.<br />
Frings, C. S. See Donohue, D.; Petras, S.<br />
Fringe, Christopher S.; White, Robert M.;<br />
Battaglia, Danielle J., 1683<br />
Fnith, Evelyn See Desjardins, Paul K. E.<br />
Fnitscha, H. A. See Hutton, Jean M.<br />
Fritsehe, Herbert A. See Liu, Frank J.; Wong,<br />
Shan S.<br />
Fritsche, Herbert A., Jr. See Shahangian,<br />
Shahram<br />
Frohlich, J. See Lutsky, P. M.; Sparks, D. L.<br />
Fnuchant, J. C. See Parra, H. J.; Pruvot, I.;<br />
Smith, S. J.<br />
Fruchart, J.-C. See Koran, E.<br />
Fruhman, J.; Burke, M.; Appleby, C., 982 -<br />
Fry, A. J. See Collies, J. S.<br />
Frye, Roger; Mathews, Samuel E., 629<br />
-; Lijewski, Jane, 979<br />
Frye, S. L.; Joseph, K. P.; Han, C. Arthur;<br />
Ruhnau, S. K.; Covault, H. P.; Tejero, N., 953<br />
Frye, Stephen L. See Han, C. Arthur<br />
Fu, F. See Hemans, Bert<br />
Fu, Joseph See Hsu, Brand R. S.<br />
Fuchs, Diatman See Werner, Ernst K.<br />
Fuchs, Jacob See Rotenberg, Jvi; Rotenberg, Zvi<br />
Fuith, Lothan C. See Werner, Ernst R.<br />
Fujita, Kiyotaka; Sakurabayashi, Ikunosuke;<br />
Kusanagi, Mutsuko; Kawai, Tadashi, 1478<br />
Fujiwara, Kaiko See Sakoguchi, Takafumi<br />
Fukui, Miyoshi See Kasuya, Fumiyo<br />
Fulchen, Leak M. See Norden, Anthony C. W.<br />
Fuller, David See Blick, Kenneth K.<br />
Fuller, Mark; Hulman, Geoffrey; Macintyre,<br />
Andrew, 2301<br />
Fuller, S. A. See Chandler, H. M.<br />
Fulton, C. See Niedbala, K. S.<br />
Fungiuale, J. See Braunstein, J. D.<br />
Funiya, Shin See Kasahara, Yasushi<br />
Furst, Peter; Cloggler, Annemanie, 1956<br />
Gabor, Mike J. See King, David L.<br />
Gachalyi, Bela See Szabo, Ildiko<br />
Gadsden, R. See Collinsworth, W. L.<br />
Gadsden, R. H., Sr.; Crews, R. M., 948,968<br />
Gadson, Mattia See Frank, Thomas<br />
Gaff, S. See Pedersen, C.<br />
Gaghan, Violet See Warkentin, Donald L.<br />
Gal, J.; Lichtenstein, P. S., 1678<br />
Galan, Robert S., 867<br />
Galiounghi, A. See Shukla, R.<br />
Gallacher, Cl. See Eremin, S. A.<br />
Gallacher, Ruth K.; Browning, Margaret C. K.;<br />
Fraser, Callum C.; Wilkinson, Stephen P.;<br />
MacLennan, William J., 1326<br />
Gallagher, M. See Mansbach, L.; Swirski, C.<br />
Gallagher, S. K.; Johnson, L. K.; Milne, D. B.,<br />
935<br />
Gallar, F. Navarro See Hernandez, D. Martinez<br />
Gallice, Philippe See Monti, Jean-Pierre<br />
Gallo, P. P. See Wolford, S. T.<br />
Gallus, G. See Marcovina, Santica<br />
Galteau, Marie-Madeleine See Viavikis, Sophia<br />
Gambhin, Kanwal K. See Cater, Laurenda<br />
Gambino, S. Raymond; O’Brien, Joseph K.;<br />
Mallon, Peter, 2321<br />
Gamlan, Timothy H. See Willing, Shelley K.<br />
Gan, Ignatius E. T. See Blair, Stephen C.<br />
Gantzer, Mary Lou See Brck, David A.<br />
Garay, E. A. Rodriguez See Maninelli, K. A.<br />
Garbincius, Jean; Benmes, E. W., Jr.; Holmes,<br />
K. W., 887<br />
Garcia, Herbert See Strand, Calvin L.<br />
Garcia, Laura See Sheiman, Mark I.<br />
Garcia, Raymond K.; Schwartz, Jason J.; Khan,<br />
Ilyas; Khosla, Anuradha; Chan, Theodore C.;<br />
Woo, Deborah, 897<br />
Garcia-Raso, A. See Millan, A.<br />
Garfield, H. See Lauderdale, V.<br />
Garner, William See Osikowicz, Gene<br />
Garovoy, Marvin H., 870<br />
Garrett, Patricia E.; Dusenbury, Sandra L.;<br />
Gaworski, John M.; Kuntz, Sanford R., 416<br />
Garrison, Laster; McDonald, Donna M.; Schuff,<br />
William R., 1006<br />
Gerry, Philip J.; Herberth, Bernard; Zittoun,<br />
Jacqueline; La Devehat, Claude; Lemoine,<br />
Main; Potier de Courcy, Genevieve, 441<br />
Gaudin, Christophe See Cuche, Jean-Louis<br />
Gauldie, J. See Smith, S. J.<br />
Gault, H. See Vasdev, S.<br />
Gault, M. H., 1052<br />
Gaun, Pramod K. See Demers, Laurence M.<br />
-; Shimizu, S. Y.; Bray, K. K., 930<br />
Gauvin, H. See Forest, J.-C.<br />
Gavan, Sheila See Casasnovas, Carlos K.<br />
Gawin, Frank H. See Jatlow, Peter I.; Peterson,<br />
Kent W., 95B<br />
Gaworski, John M. See Gannett, Patricia E.<br />
Gazettas, T. See Whiting, M. J.<br />
Gebauer, C. K.; Zeitler, M.; Saini, M.; Kuma,<br />
Anand, 1009<br />
Gebhant, Suzanne S. P. See Mullins, Richard E.<br />
Gejyo, Fumitake See Matsue, Hajime<br />
Gelder, Frank B. See Shahangian, Shahram<br />
Galfi, Cecilia See Sorrche, Patricia<br />
Gelman, B. B. See Rifai, N.<br />
Gelman, Benjamin B. See Rifai, Nader<br />
Gelot, Simone See Speich, Michelle<br />
Gentil, Monique See Cuche, Jean-Louis<br />
Gentile, Joseph See Griffiths, William C.<br />
George, Margaret See Villa, Barbara<br />
George, Sosamma See King, William J.<br />
Georgewill, Dawaye A.; Graham, C. A.; Schoen,<br />
I., 966<br />
Georgieff, Michael K. See Murphy, Ednie<br />
Gerard, Stephen See Khayam-Bashi, H.<br />
Genbaut, Lucile See Macart, Michel, 1260<br />
Genbeck, C. See Reid, K. W.<br />
Gerber, M. See Klein, C.<br />
-; Naujoks, K.; Lenz, H.; Wulff, K., 1158<br />
Gerber, Martin; Wulff, Karl, 997<br />
Gene, Jeffrey A.; Baylor, Michael R.; Clark,<br />
Gay B., 971<br />
Garb, E.; Corns, F.; Dc Meinleir, K., 188<br />
Gerson, Benjamin, 1056<br />
Ghielmi, S.; Mantero, C.; Albertini, A., 888<br />
Ghione, S. See Clenico, A.<br />
Ghwansha, K. See Sheriff, D. S.<br />
Giacherio, Donald A. See Coon, Michael J.<br />
Giacoino, Donald F. See Peace, Michael A.<br />
Giampietro, 0. See Miccoli, Roberto<br />
Giampietro, Ottavio See Lenzi, Silvia<br />
Gianazza, Klisabetta; Osio, Licia; Crazioli,<br />
Ciordana; Astnua-Testoni, Silvia; Kighetti,<br />
Pier Giongio; Accinni, Roberto; Renoldi,<br />
Isabella; Kepossini, Alberta, 2011<br />
Giani, Emanuela See Corti, Angelo<br />
Gibbons, Ian See UlIman, Edwin F.<br />
Gibber, Clinton D. See Chen, 1-Wen<br />
Gibber, W. Brian See Chen, I-Wan<br />
Giboudeau, J. See Cynoben, L.<br />
Gil, P. See Smith, D.<br />
Gilbert, S. See Witherspoon, L.<br />
Gilbert, Susan See Withenspoon, Lynn<br />
Gilch, Gentraud See Degel, Fritz<br />
Gillery, Philippe; Rousselle, Patricia; Malgras,<br />
Alain; Maquart, Fnancois-Xavier; Borel,<br />
Jacques-Paul, 717<br />
Gillespy, William G.; Terry, Frederick W., 1307<br />
Ginsberg, H. See Smith, S. J.<br />
Giovannitti, Giovanna See Lenzi, Silvia<br />
Girault, A. See Pruvot, I.<br />
Girgis, Rada E. See Verrill, Haland L.<br />
Giridhar, Cl. See Famulare, A. J.; Watson, J.<br />
Gitnick, Cl. See Bialek-Smith, S.<br />
Gladstone, M. See Fleisher, M.<br />
Glatt, G.; McCarrick, J.; Zoll, L.; Mikkelsen, C.;<br />
Clejan, S., 983<br />
Glick, John H., Jr., 419, 980, 1268<br />
Glick, Melvin H. See Yarrison, C. L.<br />
-; Ryder, Kenneth W., 964<br />
-; Ryder, Kenneth W., 1453<br />
Glidewell, C. See Westenlund, John<br />
Glidewall, Christopher See Butler, Anthony R.<br />
Glikmanas, G.; Haioun, B.; Couget, B.; Samini,<br />
H.; Bigonie, B.; Truchaud, A., 954<br />
Glogglen, Annemarie See Funst, Peter<br />
Gluvna, Judith A.; Seadler, Alan W., 917<br />
Gobbels, P.; Boulanger, J.; Ers, P.; Adam, A.,<br />
1077<br />
Godard, Jean-Pierre See Touitou, Yvan<br />
Godolphin, William, 1057<br />
Godwin, Ira D. See Ronald, Beverly<br />
Goin, James K., 868<br />
Goitein, Robert K.; Sykes, K. L.; Baen, D. M.;<br />
Belsey, K. K., 938<br />
Golbach, A. J. See Peters, K. H. M.<br />
Golbus, Mitchell S. See Appelman, Zvi<br />
Goldberg, D. See Chu, J. W.<br />
Goldberg, H. B. See Smith, S. J.<br />
Goldbenger, Bruce See Caplan, Yale H.<br />
Goldbengar, Bruce A. See Black, David L.<br />
Goldman, J. See Maciejko, J. J.<br />
Goldman, J. 0. See Levinson, S. S.<br />
Goldsmith, Barbara M. See Morales, Antonio J.<br />
-; Munson, Sara, 161<br />
-; Iosefsokm, Marieta, 915<br />
Goldsmith, H. F.; Earl, J. W.; Cunningham, A.<br />
M., 1736<br />
Goldstein, David E. See Little, Randie K.<br />
Goldstein, P. J. See Manimekalai, S.; Sundaram,<br />
ShanC.<br />
Goldstein, S. See Pruvot, I.<br />
Golub, Maxine; Wertlake, Paul, 984<br />
Gomez, Dana See Dufour, D. Robert<br />
Gomez de Terneros, F. J. See Hennandez, D.<br />
Martinez<br />
Gong, Junxian See Siguel, Edward N.<br />
Gonnet, C. See Nicot, C.<br />
Gonzales, Lisa See Crisp, David<br />
Gonzalez, M. See Smith, M.<br />
Gonzalez, M. T. See Bonnin, M. K.<br />
Gonzalez-Sastre, F. See Rodriguez-Espinosa, J.<br />
Goodall, G. I.See Mackay, C. A.<br />
Goodall, Margaret A. Jacobs See Casey, Clara<br />
E.<br />
Goodman, B. See Bailey, Anne L.<br />
Goodman, B. H. See Bailey, Anne L.<br />
Goodman, David B. P.See Frank, Thomas<br />
Goodman, H. 0.; Shihabi, Z. K., 835<br />
-; Shihabi, Z. K., 962<br />
Goodnow, Timothy; LeBlanc, Michael; Koski,<br />
Kent; Welsh, Muriel; Leung, Kathy; Chaie,<br />
Loni; Evans, Susan, 988<br />
Goodson, Robert See Sheldon, Edward<br />
Goodwin, Max See Ratnaike, Sujiva<br />
Googins, Mary Kay; Apple, Fred 5., 972<br />
Gootenberg, J. E. See Abbondanzo, Susan L.<br />
Gordon, Bill; Smith, Art; Ash, Owen, 952<br />
Conan, Marshall P. See Li, Jackie P. L.; Viar,<br />
Mary Jane<br />
-; Osborne, Susan; Simmons, Mark J., 711, 1058<br />
Gorman, E. C. See Troll, Andrew K.; Tuhy, P.<br />
M.<br />
Gornet, Tarnie G. See Wu, Alan H. B.<br />
Gorua, F. See Carlo, K.<br />
Gosney, Kimiko; Schilber, Harvey 5., 986<br />
-; Adachi-Kirkland, Joyce; Schiller, Harvey S.,<br />
2311<br />
Gosselin, M. See Forest, J.-C.<br />
Gossebin, Michele See Forest, Jean-Claude<br />
Goth, Lasxlo, 2302<br />
Gotthebf, Joan See Webster, Joseph C.<br />
Goudie, J. H. See Burnett, D.<br />
Gouget, B. See Clikmanas, C.<br />
Gould, S. A. See Sehgal, H. L.; Sehgal, L. R.<br />
Gourmelin, Y. See Truchaud, A.<br />
Govindanajan, S. See Bialek-Smith, S.<br />
Gow, S. M. See Caldwell, C.<br />
-; Koulston, J. E., 1103<br />
Gowans, Elizabeth M. S.; Fraser, Callum C., 717<br />
-; Fraser, Callum C., 847<br />
-; Fraser, Callum C., 1080<br />
-; Fraser, Callum C., 1267<br />
Gowland, Eric See Neary, Kichard H.<br />
Graff, T.; Wong, S.T., 996<br />
Graham, C. A. See Georgewill, Dawaye A.;<br />
Johnson, Linda<br />
Graham, Peter; Naidoo, Daya, 1490<br />
Gram, Jorgen; Jespersen, Jorgen; Kobde, H.-J.,<br />
441<br />
Granados, E. See Crenier, F.<br />
Granados, Edward N. See Grenien, Frank C.<br />
Granata, Simonetta See Zoppi, Francesco<br />
Graces, F. See Miblan, A.<br />
Grass, Linda; Locke, Sandra; Rapoport,<br />
Abraham; Oreopoulos, Dimitnios, 1074<br />
Grassick, F. See Levy, S.<br />
-; Frey, M.; Levy, S.; Levine, J., 956<br />
Gray, Faye See Ratnaike, Sujiva<br />
Graziani, M. See Marcovina, Sahtica<br />
Graziani, Maria Stebla; Kighetti, Gabniella,<br />
1079<br />
Grazioli, Giordana See Cianazza, Elisabetta<br />
Greco, Frank A., 1954<br />
Greden, John F. See Haiharan, M.<br />
Green, C. A. See Leaky, F. D.<br />
Green, Joyce See Knoll, Martin H.<br />
Green, P. See Zia, Priscilla<br />
Greene, Joyce See Kroll, Martin H.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2343
Greanspan, P. See Brown, W. J.<br />
Greiling, H. See Kleesiek, K.<br />
Cramer, J. C. See Yeager, Elizabeth P.<br />
Grendahl, Jan; Fricker, Robert F.; Powers,<br />
Donald M.; Slickers, Kenneth A., 1492<br />
Greniar, F.; Schick, B.; Cranados, K.; Wang, N.;<br />
Hansen, J.; Pry, T., 923<br />
Grenien, Frank C.; Cranados, Edward N.;<br />
Schick, Bernice C.; Kolaczkowski, Lawrence;<br />
Pry, Terry A., 1570<br />
Greniar, K. E. See Allen, B. K.<br />
Grennan, Anne See Hugh, Duncan<br />
Cretan, Joachim; Jacobson, Cal-Eric, 473<br />
Grewab, Kuldip; Hyam, Philip; Avis, Simon;<br />
Prabhakaran, Varagur M., 1036<br />
Grey, Joseph See Miles, Andrew<br />
Grey, Joseph K. See Miles, Andrew<br />
Griffin, Jeanine See Odell, William D.<br />
Gniffiths, I. D. See Pal, B.<br />
Gniffiths, John; Black, Jeffrey, 2171<br />
Griffiths, William C.; Camaa, Paul D.; Gentile,<br />
Joseph, 999<br />
Grinstead, G. F. See Scott, Richard K.<br />
Gninstead, Gregory F.; Ellefson, Ralph D., 896<br />
-; Scott, Richard K.; Stevens, Bernadine S.;<br />
Wilson, David M., 980<br />
-; Scott, Richard K.; Stevens, Bernadine S.;<br />
Ward, Virginia L.; Wilson, David M., 1660<br />
Groner, W. See Wyatt, J. L.<br />
Groopman, Jerome E., 864<br />
Gros, Nathalia See Muna, Patrick<br />
Gros, P. See Truchaud, A.<br />
Gross, S. J. See Mule, S. J.<br />
Gross, Susan F.; Sabharwal, Nilima; Khayain-<br />
Bashi, H., 1031<br />
Gross, Werner See Marz, Winfnied<br />
Grove, Barbara See King, William J.<br />
Grove, Rebecca C. See Ou, Ching-Nan<br />
Gruemer, H.-D. See Prior, Thomas W.<br />
Gnutzmann, Klaus-D. See Jung, Klaus<br />
Grzych, Claudia See Sykes, Elizabeth<br />
Guizani, L. See Najjar, M. F.<br />
Gulamali-Majid, Fizza; Ackerman, Steven;<br />
Veeck, Lucinda; Acosta, Anibal; Pleban,<br />
Patricia, 1185<br />
Gupta, J. D. See El Fakhri, M.<br />
Gupta, M. K.; Johnson, C.; Schumacher, 0. P.,<br />
1032<br />
Gupta, Ram N.; Steiner, Main; Law, Maely,<br />
2078<br />
Gupta, Ramesh Chandra See Singh, Prem<br />
Prakash<br />
Guthnie, R. See DeBaun, Michael K.<br />
Gutman, Steven See Solomon, Ruth<br />
Guyon, F.; Delfour, C.; Delattre, C.; Dupeyron, J.<br />
P., 190<br />
Haag, C. See Kapke, G. F.<br />
Habig, Robert L., 1501, 1682<br />
Haden, B. See Ladouceur, P. R.; Lauderdale, V.;<br />
Lewis, C.<br />
-; Rood, F.; Tietz, N.; Steinberg, W.; Kubasik,<br />
N., 958<br />
-; Cragle, L.; Kubasik, N.; Cook, J., 958<br />
Hadley, W. K. See Ng, V. L.<br />
Hafkanscheid, J. C. M. See Dujadin, B. C. G.<br />
Haga, K. See Okamura, S.<br />
Haghighi, Mi Z. See Opplt, Jan J.<br />
Hagihara, Masako; Ohhashi, Masaru; Nagatsu,<br />
Toshiharu, 1463<br />
Hahn, Nancy C. See Hockenman, Gloria J.<br />
Hainline, Adrian See Knoll, Martin H.<br />
Haioun, B. See Clikmanas, C.<br />
Haisma, H. J. See Boerman, 0. C.<br />
Hajar, Tarek M. See Clark, Dennis K.<br />
Hajos, Peter; Kener, Agota; Horvath, Mihaly,<br />
617<br />
Hakky, M. See Kahn, S. E.<br />
Haley, J. See Allen, D.<br />
Hall, James K., 866<br />
Hall, P. W. See Vacca, Christina<br />
Hall, H. H.; Woenker, W. E., 1561<br />
Hall, Reginald See John, Rhys<br />
Hall, W. Carey See Merritt, Gerald J.<br />
Hallworth, Michael J.; Fraser, Callum C.; Ooi,<br />
Daylily S.; Perkins, Sherry L., 1299<br />
Halstead, A. C. See Lockitch, C.<br />
Halter, Catherine M.; Mickelson, Kenneth K.;<br />
Wilcox, Julie F.; Thompson, Stephan C.,<br />
1020<br />
Hambidge, K. Michael See Casey, Clare K.<br />
Hainby, K. K. See Hills, L. P.<br />
Hamdi, A. See Nsjjar, M. F.<br />
Hamilton, Robert C.; Rodkey, L. Scott, 963,<br />
1707<br />
Hamlin, Clive R.; Pankowsky, Dan A., 144<br />
Hainmad, N. See Izutsu, A.; Kennedy, P.<br />
-; Ambrocio, E.; Izutsu, A.; Masover, B.;<br />
Kennedy, P.; Collins, C.; Jaklitsch, A., 975<br />
2344 CLINICAL CHEMISTRY, Vol. 33, No. 12,1987<br />
Hammer, P. A. See Dionio, Alfred F.<br />
Hams, Graham A., 719<br />
Han, C. Arthur See Frye, S. L.<br />
-; Frye, Stephen L.; Trafton, John E., 953<br />
Han, P. See O’Donnell, A.<br />
Hanada, Mutsuo See Aoki, Yoshikszu<br />
Hanai, Junji; Kawai, Tsuneaki; Sato, Yasumasa;<br />
Takasugi, Nobuo; Nishi, Motoi; Takeda,<br />
Takeo, 2043<br />
Hand, C. W. See Moore, R. A.; Stewart, A.<br />
-; Moore, R. A.; Jones, S.; McQuay, H. J., 969<br />
Haneef, Kaazia See Norman, Robert J.<br />
Hanford, H. See Lessad, Cynthia<br />
Hango, Melanie See Cote, Deborah; Williams,<br />
Michael<br />
Hanjan, S. N. See McCombs, M.<br />
Hanks, Bryant M. See Wells, David J.<br />
Hannon, W. H. See Smith, S. J.<br />
Hannon, W. Harry See Henderson, L. Oman<br />
Hansen, J. See Crenier, F.<br />
Hansen, Steen Ingemann; HoIm, Jan; Nezo,<br />
Ebba, 1360<br />
Hanson, Naomi Quest; LeGeault, Tammy S.;<br />
Fneien, Esther F., 1882<br />
Hansson, Lars-Olof; Tiainen, Kaarmna;<br />
Swanljung, Patnik, 889<br />
Hao, Henry See McBride, James H.<br />
Hara, Hiroka See linuma, Kazushige<br />
Harding, Phillip J.; Fraser, Callum C., 1416<br />
Hardister, Nancy See Decaprio, Lauren<br />
Handy, Robert; Moore, M.; Thiessen, J.;<br />
Erlichman, C.; Soldin, 5., 1035<br />
Hanff, C. A. See <strong>Back</strong>er, E. T.<br />
Hanff, Gottfnied A. See Lentjes, Eef C. W. M.<br />
-; Helversteijn, Wim T., 1262<br />
Hangreaves, W. H. See Baldwin, Jan<br />
Hariharan, M.; Van Noord, Ted; Greden, John<br />
F., 975<br />
Harris, A. L. See Buamah, P. K.<br />
Harris, Arthur See Hickman, Peter K.<br />
Harris, Eugene K. See Carey, K. Neill<br />
Harris, Kurt See King, William J.<br />
Harris, Nick S.See Rock, Helene Sue<br />
Harris, H. K. See Clady, C. W.<br />
Harrison, Stephen P. See Barlow, Ian M., 421,<br />
616<br />
-; Hutchison, A. S.; O’Reilly, D. St. J., 740, 1261<br />
Hart, Nan K. See Keenan, Edward J.<br />
Hantman, Burr; Miyada, Don S.; Sedgwick,<br />
Paul; Tenant, Forest S., Jr., 974<br />
Haruki, Eiichi See Maeda, Masako<br />
Hasegawa, Tohru See Tomokuni, Katsumaro<br />
Hashimoto, Takuma; Matsubara, Fujitsugu,<br />
1291<br />
Hassan, M; Al-Awqati, M. A.; Abdul-Dayem, H.<br />
M., 1253<br />
Hassell, Alan E. See Schran, Horst F.<br />
Hasz, B. See Keegan, C.<br />
Hata, Naoshige; Miyai, Kiyoshi; Endo, Yuichi;<br />
lijima, Yasushi; Doi, Kel; Amino, Nobuyuki;<br />
Ichihaa, Kiyoshi, 172<br />
Hathaway, W. See Wilson, Michael<br />
Hatton, Carolina K. See Catlin, Don H.<br />
Hattoni, S. See Komoda, T.<br />
Hattori, T.See Komoda, T.<br />
Haug, H. See Kunst, Albert<br />
Hausen, Arno See Werner, Ernst K.<br />
Havassay, Joann See Murphy, Anne<br />
Havekes, L. See Smith, S. J.<br />
Haven, M. C. See Huth, Jeff; Orsulak, P. J.;<br />
Otten, U. P.<br />
-; Fellows, P. F.; Markin, K. 5., 919<br />
-; Meyer, I. J.; Lorenzen, K. M.; Markin, K. S.,<br />
988<br />
-; Orsulak, P. J.; Huth, J. A.; Makin, R. S., 1024<br />
Haven, Mary C. See Freeman, Vicki S.; Orsulak,<br />
Paul J.<br />
-; Orsulak, Paul J.; Arnold, Lana L.; Crowley,<br />
George, 1207<br />
-; Orsulak, Paul J.; Huth, Jeffrey A.; Makin,<br />
Rodney S., 1472<br />
Haven, Virginia M. See Kao, Pal C.; Pillsworth,<br />
Thomas J., Jr.<br />
Hawnylak, Ken; Stinson, Robert A.; Sykes,<br />
Elizabeth; Kiechle, Frederick L.; Epstein,<br />
Emanuel, 337<br />
Hayashi, Chozo See Yamaguchi, Yoshihisa<br />
Hayashi, S. See Okamura, S.<br />
Hayashi, Taizo See Taniuchi, Koji<br />
Hayden, F. C. See Harold, D. A.<br />
Hayes, LW.; Mueggler, P. A., 969<br />
-; Knasselt, W.; Muegglen, P. A., 969<br />
Hayes, Lyle W.; Krasselt, Wendell C.; Mueggler,<br />
Paul A., 806<br />
Hayes, S. See Fleer, Cecil T. C.<br />
He, Y. J.; Richards, C.; Sato, N.; Hogancamp, W.<br />
K.; Wittliff, J. L., 930<br />
Heal, A.; Kestrepo, W.; Bandstna, E.; Andrade,<br />
R.; O’Sullivan, M., 990<br />
Heal, Mbert, 1001<br />
Haaly, Karen See Barnes, Diana M.<br />
Hedges, Jernis R. See Chen, I-Wan<br />
Haiman, D. See Keean, C.<br />
Heiman, Daniel F. See Hockenman, Gloria J.<br />
Haunburgar, Douglas C., 873<br />
Heiinburger, N. See Dati, Francesco<br />
Heimburgar, Robert See Maier, Eddie A.<br />
Helbent, Maryvonne See Berthelot, Michel<br />
Helanius, T. See Liewendahl, K.<br />
Helleboids, L.; Bloch-Michel, E.; Susini de Luca,<br />
H.; David, B.; Hennesaen, U.; Cohn, Y.;<br />
Cerqueti, P.; Zouaghi H., 918<br />
Hailer, Kathleen See Solomon, Ruth<br />
Helmer, George R., Jr. See Welch, Elaine<br />
Hebversteijn, Wim P. See Haff, Cottfnied A.<br />
Hemans, Bert; Kbotzsch, S.; Fu, F., 1012<br />
Hemingen, Linda A. See Sperling, Matthew I.<br />
Hemmila, Ilkka; Holttinen, Sirkku; Pettersson,<br />
Kim; Lovgren, Timo, 2281<br />
Henderson, A. H. See Knijnen, Pamela; Moses,<br />
CC.<br />
Henderson, A. Ralph See Knijnen, Pamela M.<br />
W.; Paler, Thomas G.; Rawal, Naresh;<br />
Smith, Deborah A.<br />
Henderson, Gary L., 1055<br />
Henderson, J. Michael See Hollins, Bettye;<br />
Noe, Beverly<br />
Henderson, L. 0.See Smith, S. J.<br />
Henderson, L. Oman; Hamion, W. Harry; Smith,<br />
S. Jay; Cooper, Gerald K., 2250<br />
Hennessen, U. See Helleboids, L.; Najjar, M. F.<br />
Henriksson, T. See Rowley, C. L.<br />
Henniksson, Thomas See Louie, Alan<br />
-; Kramer, Mary; Louie, Alan; Nguyen, Phuc H.;<br />
Rowley, Gerald L., 918<br />
Hens, Agustina Gomez See Valcarcel, Miguel<br />
Henson, B. See Bialek-Smith, S.<br />
Herak, Carol See Stavljenic, Ana<br />
Herbert, P. N. See Smith, S. J.<br />
Herberth, Bernard See Carry, Philip J.<br />
Hermos, K. J. See Mitchell, M. L.<br />
Hernadex, Walkinia See Lineback, Janet<br />
Hernandaz, D. Martinez; Banbero, J. Arenas;<br />
Gallar, F. Navarro; Ksteban, R. Garcia;<br />
Sancho, J. M. Santos; Comez de Terreros, F.<br />
J., 1477<br />
Herold, D. A. See Hundley, J.<br />
-; Savory, J.; Kinter, M.; Ross, K.; Wills, M. K.,<br />
891<br />
-; Anonick, P. K.; Kinter, M.; Hayden, F. C.,<br />
1022<br />
Harold, David A.; Magrey, Marilyn H., 955<br />
Hershman, J. D. See Pekary, A. K.<br />
Hershman, J. M. See Pekary, A. K.; Smith, V. P.<br />
Hershman, Jerome M. See Lee, Hsin-Yu<br />
Hetzel, Heinz See Werner, Ernst K.<br />
Heyden, S. See Sedor, F. A.<br />
Hays, Anthony D. See Norden, Anthony C. W.<br />
Heywood, A. See Dasgupta, Amitava<br />
Hickman, Peter E.; Silvester, William; Musk,<br />
Alexander A.; McLellan, Graham H.; Harris,<br />
Arthur, 622<br />
-; Harris, Arthur, 2131<br />
Hicks, J. M.; Iosefsohn, M.; Welborn, L. C., 1676<br />
Hicks, Jocelyn M. See Boeckx, Roger L.<br />
-; Ioaefsohn, Mariet, 817<br />
-; Boeckx, Roger L.; Ioaefeohn, Mariet; Lacey,<br />
Karen J., 968<br />
Higgins, Sharon See McBride, James H.<br />
Higgins, Trefor, 612<br />
Fraser, Callum G., 1298<br />
Hilaire, Genevieve See Dupuy, Georges<br />
Hilborn, Sandra; Krahn, John, 203<br />
Hilborne, Lee H. See McBride, James H.;<br />
Renner, Stephen W.<br />
Hill, B. See Ryder, K.; Wood, P. L.<br />
Hill, P.C. See Premachandra, P.; Wood, P. L.<br />
Hill, Peter C. See Nec, Patrick A.<br />
Hillar, Cenhard; Deneke, U.; Rittersdorf, W.;<br />
Plumer-Wilk, K., 895<br />
Hillock, Ronald H. See Visyak, Paula A.<br />
Hills, L. P.; Tiffany, T. 0.; Hamby, K. K.; Scott,<br />
R. E.; Moyer, P. P., 977<br />
Hillyard, C. J.; Blake, A. S.; Wilson, K.; Kylatt,<br />
D. B.; Miles, S.; Bunch, K.; Elms, M. J.;<br />
Barnes, A.; Bundesen, P. C., 1837<br />
Hillyard, Carrie; Blake, A. S.; Wilson, K.;<br />
Kylatt, D. B.; Bundesen, P. C.; Elms, M. J.,<br />
1003<br />
Hiltke, Mark F. See McAteen, Joy A.<br />
Hinberg, Irwin See Nanji, Amin A.<br />
-; Daka, Joseph, 912<br />
-; Poon, Raymond, 981<br />
Hinai, Yukio See Tomokuni, Katsumano<br />
Hirasawa. O.See Komoda, T.<br />
Hinoishi, Shingo; Matsuyama, Shigeyuki;
Kunooka, Shigeru; Sunahaa, Noriyuki;<br />
Inoue, Shuji; Ida, Takeshi, 1235<br />
Hische, E. A. H.; van der Helm, H. J., 113<br />
Hiti, John See Welch, Robin<br />
Hivon, Pierre See Forest, Jean-Claude<br />
Hjalm, M. See Stein, Penelope<br />
Ho, E. H.; Cantor, K. H., 893<br />
Ho, S. See Lucas, F.<br />
Ho, P. See Lucas, F.<br />
Ho, T. T.; Cheng, E., 1010<br />
Hoadley, Margaret See Dobson, Susan<br />
Hoak, D. H.; Banenjee, S. K.; Kaldor, C. J., 2305<br />
Hockerman, Gloria J.; Heiman, Daniel F.;<br />
Wang, Philip P.; Cohen-Giecek, Charm;<br />
Bottorff, Michael B.; Breutzmann, David A.;<br />
Hahn, Nancy C.; Banitt, Elden H., 1017<br />
Hoffman, Allan S.See Auditore-Hargreaves,<br />
Karen<br />
Hoffman, Richard J.; Pennell, Beverly, 1006<br />
Hoffmann, G.E. See Schmidt, D.<br />
Hoffmann, Georg K.; Kozumplik, Vlado; Beck,<br />
Kenate; Kellermann, Wolfgang, 1259<br />
Hogan, S. See Maciejko, J. J.<br />
Hogancamp, W. E. See He, Y. J.<br />
Hogue, T. S. See Klee, C. C.<br />
Hohnadel, David C. See Huenke, JoAnn<br />
Holbrook, Janet See Smith, J. Cecil, Jr.<br />
Holian, J. See Mashiter, K.<br />
Holleman, C. M. See Sedor, F. A.<br />
Holleman, Cathy M. See Sedor, Frank A.<br />
Hollins, Bettye; Noe, Beverly; Henderson, J.<br />
Michael, 765<br />
Hollis, Dannie See Pau, Chou-Pong<br />
Holloway, S. See Reason, Craig<br />
HoIm, Jan See Hansen, Steen Ingemann<br />
Holmes, E. W. See Carbincius, Jean<br />
Holttinen, Sirkku See Hemmila, Ilkka<br />
Holzbecher, Jini See Dorea, Jose C.<br />
Hoizal, Wieland G.E., 57, 670, 1133<br />
Honda, Ken-ichi See Matsue, Hajime<br />
Hood, Leroy E., 875<br />
Hood, Lyal V. S. See Pettitt, Bruce C.<br />
Hooker, E. J. See Chandler, H. M.<br />
Hoon, Timothy J. See Straka, Robert J.<br />
Hopfer, Sidney M. See Wong Steven H. Y.<br />
Hopper, Mary See Branum, Earl<br />
Honder, M. See Blsabjerg, Ole<br />
Horn, Glenn See Sheldon, Edward<br />
Horowitz, Michael S. See Sandhu, Kandhir S.<br />
Horsfall, K.; Tlsel, W.; Pranis, B., 916<br />
Honsfall, Kathy See Pranis, Robert<br />
Hortin, G.; Daft, M.; Chan, K.-M.; Bahnson, K.;<br />
Catalona, W.; Ladanson, J., 926<br />
Honvath, Milialy See Hajos, Peter<br />
Hoshiro, Mitsuo See Paniuchi, Koji<br />
Bosseini, Jeanette M. See Elm, Ronald J.<br />
Hotchkiss, Richard S., 865<br />
Houghton, Raymond L. See Auditore-<br />
Hargreaves, Karen<br />
Houtman, J. P. W. See Aalbers, Ph. C.<br />
Houze, Pascal See Bourdon, Sybvie<br />
Howanitz, Joan H. See Renner, Stephen W.<br />
Howanitz, Peter J. See Renner, Stephen W.<br />
Howard, P.R.; Lawler, C. M.; Bovill, E. C.;<br />
Mann, K. C.; Tracy, K. P., 1003<br />
Howarth, P. L. See Dinovo, E. C.<br />
Howell, Tony See Barnes, Diana M.<br />
Howey, Jacqueline E. A. See Johnson, Roger<br />
-; Browning, Margaret C. K.; Fraser, Callum C.,<br />
269<br />
-; Browning, Margaret C. K.; Fraser, Callum C.,<br />
2034<br />
Howlett, C. M. See Cardella, D. S.; Rifai, N.<br />
Howlett, Paul J.; Wilding, Peter, 1002<br />
Hoyhtya, Matti; Vihko, Pirkko; Vuolas, Leena;<br />
Tryggvason, Karl; Vihko, Reijo, 103<br />
Hranitzky, K. W. See Combs, G. L.<br />
Hsiah, Sherie See Yu, Stephen S.<br />
Hsiah, Shanie W.; Yu, Stephen S.; Osterloh,<br />
John; Khayam-Bashi, H., 976<br />
Hailing, C. H. C. See Zia, Priscilla<br />
Hsu, Brand H. S.; Fu, Joseph; Lu, Wuan, 925<br />
Hu, Mae See Bartlett, Clifford<br />
Huang, C. M.; Knoll, Martin H.; Ruddel, Mark;<br />
Washburn, Ronald C.; Bennett, John E.,<br />
1022, 2120<br />
Huang, Ching-Shan; Hung, Kun-Long, 1013<br />
Huang, Hung M. See Wei, Jeng S.<br />
Huang, Pib-kuei C.; Connoy, Lynn C.; Schmidt,<br />
Barbara A.; Jensen, Mona D., 903<br />
Huang, W. Y. See Cheng, M. H.<br />
Huang, William Y. See Cheng, Mary H.<br />
Huang, Yung-Sheng; Kyte, Vicky, 1071<br />
Hubbuch, A. See Klein, C.; Poppe, W.<br />
Ruben, M.D.; Joseph, K. P.; Kuhnau, S.; Mazza,<br />
J. C., 913<br />
Hudson, Gail A.; Poulin, Sue E.; Ritehie, Robert<br />
F., 917<br />
Hudson-Civetta, J. See Steele, B. W.<br />
Huebers, Helmut A. See Rettmen, Rebecca L.<br />
-; Eng, Mary J.; Josephson, Betty M.; Ekpoom,<br />
Naruemol; Rettmer, Rebecca L.; Labbe,<br />
Robert F.; Pootnakul, Pensni; Finch, Clement<br />
A., 273<br />
Huenke, JoAnn; Hohnadel, David C.; Collin,<br />
Dennis P., 949<br />
Hugh, Duncan; Crennan, Anne; Abuglia,<br />
Muatafa All; Weinkove, Cyril, 569<br />
Hughes, J. See Ellis, M.<br />
Hughes, John I. See Shahangian, Shahram<br />
Hughes, Peter E.; Mertens, Cindy D.; Pistulka,<br />
Louis; Peterson, Connie L.; Weias, J. Jay, 918<br />
Hugi, H. See Skjold, A. C.<br />
Hul, Henry K. See Miller, William W.<br />
Hull, E. W. See Campbell, D. J.<br />
Huller, Hansgaorg See Lampe, Dagmar<br />
Hulman, Geoffrey See Fuller, Mark<br />
Hultberg, Bjorn See Masson, Parvesh<br />
Hume, Robert See Crofton, Patricia M.<br />
Humphrey, H. L See Datiles, Theresa B.<br />
Humphries, Gillian M. K. See Kung, Viola P.<br />
Hundlay, J.; Kinter, M.; Harold, D. A.; Wills, M.<br />
K.; Savory, J., 894<br />
Hung, Kun-Long See Huang, Ching-Shan<br />
Hunter, Barney H. See Merritt, Gerald J.<br />
Hunter, H. See Ladouceun, P. K.<br />
Hunter, Robert L., Jr. See Mullins, Richard E.<br />
Huntington, M. See Lin, Spencer H.<br />
Hund, Debbie D.; Cats, John C., IV; Skogen,<br />
William F., 943<br />
Hurrell, George E., Jr., 2128<br />
Hurralb, J. C. R. See Chandler, H. M.<br />
Hurst, Paul L, 1947<br />
-; Kitto, John B., 1952<br />
Hursting, Marcie J.; Raisys, Vidniantas A.;<br />
Opheixn, Kent E.; Bell, Judy L.; Trobaugh,<br />
Gene B.; Smith, Thomas W., 1652<br />
Hurwitz, C. See Kosano, C. L.<br />
Hutchans, T. William; Porath, Jerker 0., 1502<br />
Hutchison, A. S. See Harrison, Stephen P.<br />
Ruth, J. A. See Haven, M. C.; Orsulak, P. J.<br />
Ruth, Jeff; Sobeski, L. M.; Haven, M. C.;<br />
Makin, K. S., 1023<br />
Ruth, Jeffrey A. See Haven, Mary C.; Orsulak,<br />
PaulJ.<br />
Hutson, D. K. Sea Miller, W. K.<br />
Hutson, Debra K. See Binkmeyer, Richard C.<br />
Hutton, J. M. See Klee, C. C.; Shaw, Norman Y.<br />
Hutton, Jean M.; Dalbow, M. H.; Fnitsche, H. A.;<br />
Markese, J. J.; Borden, K. K.; Shaw, N. Y.,<br />
1034<br />
Hutton, Pobly F. See Bissell, Michael C.<br />
Hwang, B. See Tang, Ken Bin<br />
Hwang, K. M. See Ng, V. L.<br />
Hwang, Yoo Sung; Kim, J. Q.; Cho, H. I., 1003<br />
Hyam, Philip See Crewal, Kuldip<br />
Hyde, Mark See Woo, Jannie<br />
Hyltoft, P. See Bbaabjerg, Ole<br />
Iaccheri, Ennio See Prencipe, Lorenzo<br />
Lacobello, C. Sea Albertini, Alberta; Barbanti, P.<br />
-; Signonini, C.; Vicini, M.; Kuggeri, C.;<br />
Albertini, Alberto, 946<br />
Ibarra, Frank S.; Zeiglen, Mark; Rudy, Jack L.;<br />
Argyle, J. Craig, 2323<br />
Ichiba, Masayoshi See Tomokuni, Katsumaro<br />
Ichihara, Kiyoshi See Hats, Naoshige<br />
Ichiki, Hitoshi; Imamura, Yasushi; Saheki,<br />
Takeyori; Kobayashi, Keiko; Yagi, Yukio;<br />
Node, Pakashi; Inoue, Ituro, 1941<br />
Ida, Takeshi See Hiroishi, Shingo<br />
Igarashi, Kazuo See Kasuya, Fumiyo<br />
lida, Yasuhino See Noguchi, Masato<br />
lijima, Yasushi See Hats, Naoshige<br />
Iinuma, Kazushige; Ikeda, Isao; Ogihara,<br />
Toshio; Hare, Hiroka; Shima, Junko; Kunata,<br />
Kunio; Kumahara, Yuichi, 674<br />
Ikeda, lsao See linuma, Kazushige<br />
Iliano, Luc See Scharpe, S<br />
Imal, Kyoko See Nomuna, Yasushi<br />
Imai, Toshio See Kasahara, Yasushi<br />
Imamura, Shigeyuki; Kagimoto, Yoshitaka;<br />
Misaki, Hideo, 962<br />
Imamuna, Yasushi See Ichiki, Hitoshi<br />
Imbrogno, Diane See Sandhu, Randhir S.<br />
Imwinkelried, Edward, 1054<br />
Imwinkelriad, Edward J. See Dubowski, Kurt<br />
M., 19B<br />
Inbar, M. See Slutzky, Gerald M.<br />
Ingrassia, H. See Barbanti, P.<br />
Inboes, Roger; Clark, Dennis; Drobnies,<br />
Adrienne, 2126<br />
Innanen, V. T.; Maalihan, E.; Lips, P.; Konogyi,<br />
N.; Recknagel, F., 1945<br />
Innenarity, Thomas L., 1051<br />
lnoua, Ituro See Ichiki, Hitoshi<br />
Inoue, Shuji See Hinoishi, Shingo<br />
losefsohn, M. See Hicks, J. M.<br />
losefsohn, Mariet See Boeckx, Roger L.; Hicks,<br />
Jocelyn M.<br />
Iosefsohn, Manieta See Goldsmith, Barbara M.<br />
Irish, C. H. See Ledue, P. B.<br />
-; Silver, Anne; Smith, D. S.; Dawnay, Anne, 202<br />
Irish, Glenn H. See Ledue, Thomas B.<br />
-; Ledue, Thomas B.; Barrantes, Denny M.,<br />
1266<br />
-; Barantes, Denny M.; Ledue, Thomas B.,<br />
1267<br />
Irmen, Judy See Osikowicz, Gene<br />
Irving, J. See Paul, B. D.<br />
Ishii, Steve; Williams, Michael; Cots, Debbie;<br />
Flores, Orlando, 940<br />
Isniail, Ashraf A.; Jaouen, Gerard; Brossier,<br />
Pierre; Cheret, Philippe; Buija, Henry, 924<br />
Isozaki, Akio See Maeda, Massko<br />
Itano, M. See Symons, Judy<br />
Ithakissios, Dionyssis S. See Livaniou,<br />
Evanelia<br />
Itoh, Hajime See Aoki, Yoshikazu<br />
Ivie, W. Michael; Swanson, J. Robert, 1194<br />
lyle, Wm. Michael; Novy, Miles J.; Reynolds,<br />
John W.; O’Grady, Patrick; Swanson, J.<br />
Robert, 24<br />
-; Swanson, J. Robert, 892<br />
Ivor, Linda; Schioppi, L.; Blase, M.; Smith, C.,<br />
928<br />
Iwasaki, Eisaku, 1412<br />
Iwatani, Yoshinoni; Amino, Nobuyuki;<br />
Tanizawa, Osamu; Mori, Hidemitsu;<br />
Kawashima, Minoru; Yabu, Yokiko; Miyai,<br />
Kiyoshi, 1217<br />
Izutsu, A. See Hammad, N.; Kennedy, P.<br />
-; Kennedy, P.; Hammad, N.; Ambrocio, E.;<br />
Quinn, K. Toton; Masover, B.; Collins, C.;<br />
Bartlett, S.; Brady, A., 975<br />
Jablonsky, George See Smith, Deborah A.<br />
Jack, Rhona M.; Noble, Wibla, 845<br />
Jackson, Agatha J. See Kroll, Martin H.<br />
Jackson, Donny See Ladouceur, P. R.<br />
Jackson, J. K. See Tzamaloukas, A. H.<br />
Jacobs, E. See Mayer, L.<br />
Jacobs, M. See Norton, Gary; Novros, Joel<br />
Jacobson, B. See Lockitch, C.<br />
Jacobson, Carl-Eric See Grater, Joachim<br />
Jacobsson, Marie-Louise See von Schenck,<br />
Henning<br />
Jaecob, E. See Ong, C. N.<br />
Jaklitsch, A. See Hammad, N.; Kennedy, P.<br />
Jaklitseh, Anna See Bartlett, Clifford<br />
James, David K.; Price, Christopher P., 826<br />
James, Kent H.; Jones, Mark C. F.; Mikkelsen,<br />
Donald J., 1077<br />
Jamin, C. See Pruchaud, A.<br />
Janata, Jiri, 873<br />
Janatsch, G. See Kaiser, C.<br />
Janatsch, Guenter See Knuse-Jarnes, Juergen<br />
D.<br />
Jandik, Petr See Degel, Fritz<br />
Jaouen, Gerard See Ismail, Ashraf A.<br />
Jardel, C. See Pressac, M.<br />
Jarzabek, Jean I.; Cassulis, Pauline Z.; Kampa,<br />
IngoS., 310<br />
-; Shabet, Elise M.; Kampa, Ingo 5., 1018<br />
Jatlow, Peter I., 66B<br />
-; Blanke, Robert V.; Finkle, Bryan S.; Forney,<br />
Robert B., Sr.; Gawin, Frank H.; Jones,<br />
KeeceT., 87B<br />
Jay, Dennis W.; Miller, W. Gregory, 901<br />
Jeffery, B. See Saito, Tokuko<br />
Jeffrey, John H. See Yatacoff, Randall W.<br />
Jelesko, John See Bartlett, Clifford<br />
Jandrzejczak, Bernadine See Doumas, Basil P.<br />
Jenkins, Louise See Watson, Ian<br />
Jenkins, Sue See Lawson, Nigel<br />
Jennings, P. E. See Taylor, A. J.<br />
Jennings, Paul K. See Jones, Alan F.<br />
Jensen, M. See Lessard, Cynthia<br />
Jensen, Mona D. See Huang, Pih-kuei C.<br />
Jerkunica, Ivanka See Bissell, Michael C.<br />
Jespensen, Jorgen See Gram, Jorgen<br />
Jesse, Ute See Kramer, Bernhard K.<br />
Jialal, Ishwariab See Desai, Rajesh K.<br />
Jiang, N.-S. See Nelson, Robert K.<br />
Ji-lu, Wei See Ji-qing, Wei<br />
Jimenez-Nachen, I. See Portoles, M.<br />
Ji-qing, Wei; Xian-teng, Zhou; Ji-lu, Wei, 1354<br />
Jitsukata, K. See Komoda, P.<br />
Johannassen, Jan N. See Adams, James D.<br />
Johansson, C. E. K. See Viswanathan, M.<br />
John, P. N. See Edmonds, M. E.<br />
John, Rhys; Evans, Peter K.; Scanlon, Maurice<br />
F.; Hall, Reginald, 566<br />
Johnson, Barry L., 878<br />
Johnson, C. See Gupta, M. K.<br />
Johnson, K. See Vasdev, S.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2345
Johnson, C. F. See Pennell, B. J.; Roberts, P. L.<br />
Johnson, L. K. See Gallagher, S. K.<br />
Johnson, L. H. See Nielsen, L.<br />
Johnson, LaVell K. See Astill, Mark E.<br />
Johnson, Linda; Graham, G. A., 1007<br />
Johnson, K. J. See Datiles, Phenese B.<br />
Johnson, Roger See Baker, John<br />
-; Baker, John; Howey, Jacqueline K. A.;<br />
Browning, Margaret C. K.; Fraser, Callum<br />
G., 1955<br />
Johnson, W. F. See Burtis, C. A.<br />
Johnson-Proctor, E. See Mashiter, K.<br />
Johnston, D.; Nario, A.; Mayer, M., 942<br />
-; Barcebon, M.; Lavernia, M.; Naybor, N., 942<br />
-; Crooms, S.; Sobis, N., 965<br />
Johnston, Many; Sanborn, C.; Mangrey, M.;<br />
Savory, M. C.; Bruns, D. E.; Boyd, J.; Savory,<br />
J., 912<br />
Joles, J. A.; Kortlandt, W.; de Bruyne, J. J., 2121<br />
Jolliff, C. K. See Sylvestni, Mario F.<br />
Jomain, Patricia A. See Nisbet, Jennifer A.<br />
Jones, A. W.; Nan, A., 1469<br />
-; Simpson, C., 1701<br />
-; Simpson, C., 2128<br />
Jones, Alan F.; Winkles, John W.; Phornalley,<br />
Paul J.; Lunec, Joseph; Jennings, Paul E.;<br />
Barnett, Anthony H., 147<br />
Jones, Clifton W., 1017<br />
Jones, J.; Burke, M.; Clay, P.; Dodson-Lehrer,<br />
L., 901<br />
Jones, J. Tim See Love, James E., Jr.<br />
Jones, Jeffery K.; Lehn, Robert, 955<br />
Jones, Laurie A.; Ashcnaft, T. L.; Rice, L. S.;<br />
Shimizu, S. Y., 892<br />
Jones, Mark G. F. See James, Kent K.<br />
Jones, Reece T. See Jatbow, Peter I.<br />
Jones, Reese P., 72B<br />
Jones, S. See Hand, C. W.<br />
Jorda, A. See Portoles, M.<br />
Joseph, R. P. See Diamond, S. K.; Frye, S. L.;<br />
Huber, M. D.<br />
Joseph, S. See Schoenlein, D. J.<br />
Josephson, Betty M. See Huebens, Helmut A.;<br />
Rettmer, Rebecca L.<br />
Joubert, S. M. See Norman, Robert<br />
Joubert, Septimus M. See Desai, Rajesh K.;<br />
Norman, Robert J.<br />
Jovanovic, Lois; Dyer, C. K.; Peterson, Charles<br />
M., 985<br />
Julian, Thomas See Tsai, Michael Y.<br />
Jung, Andrew See Fisher, Edward A.<br />
Jung, Klaus; Crutzmann, Klaus-D., 200<br />
Junglee, D. See Pal, B.<br />
Junker, A. See Lockitch, C.<br />
Jury, Denis K.; Dunn, Peter J., 158<br />
Kabra, Pokar M.; Wall, Jeffrey H.; Dimson,<br />
Phil, 2272<br />
Kagimoto, Yoshitaka See Imamura, Shigeyuki<br />
Kahkonen, D. See Chu, J. W.<br />
Kable, E. Bowie See Ward, Kory M.<br />
Kahn, Barbara B. See Zweig, Mark H.<br />
Kahn, S. E.; Del Bene, A.; Hakky, M.; Bermes, K.<br />
W.; Frank, P.; Fnancoeur, P. A., 945<br />
Kaiser, C.; Janatsch, G.; Kruse-Jares, J. D., 998<br />
Kaldor, Antal See Szabo, Ildiko<br />
Kaldor, G. J. See Hock, D. K.<br />
Kalra, J.; Walker, S. D.; Laxdal, V. A.; Massey,<br />
K. L., 959<br />
-; Smith, Harold M. B.; Laxdal, V.A., 995<br />
Kamatani, Naoyuki See Kojima, Tsukasa<br />
Kamada, N. See Rowley, G. L.; Stivers, C.<br />
Kaminiski, J.; Wong, S. T., 993<br />
Kaminski, E. A. See Cheney, J. A.<br />
Kaminski, E. M.; Frederick, M. M.; Law, W. P.;<br />
Vormbrock, K.; Scholz, B., 950<br />
Kamiasky, Ram See Cad, Rafael S.<br />
Kammerer, K. Craig See Catlin, Don H.<br />
Kamoun, P.; Coude, M.; Deprun, C.; Rabier, D.,<br />
713<br />
Kampa, Ingo S.See Jarzabek, Jean I.<br />
-; Keffer, Priscilla, 988<br />
Kanamarlapudi, L See Collins, Sonia<br />
Kanan, Henee; Chan, Kwok-Ming; Dietzler,<br />
David N., 446<br />
Kanayama, Masaaki See Makise, Junko<br />
Kandoussi, A. See Koran, E.<br />
Kaneda, Yasutaka See Paniuchi, Koji<br />
Kaneko, J. J., 1058<br />
Rang, Edward P.; Wang, James J. C.; Waiters,<br />
D. Wayne; Yang, Chang Yi, 905<br />
Rang, Han K. See Faraji, Bahram<br />
Kanno, Takashi See Sugaya, Nonio<br />
Kao, Psi C.; Klee, George; Haver, Virginia M.,<br />
744<br />
Kapenga, Jeanne M. See Cavanagh, Kevin T.<br />
Kapke, C. F. See Lahn, K.<br />
-; Haas, C.; Cooper, C., 951<br />
Kaplan, J. M. See Kaplan, L. A.<br />
2346 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Kaplan, L. A.; Stein, K. A.; Kaplan, J. M., 935<br />
Kapur, B. M.; Anderson, M.; Banka, T., 976<br />
Karabl, S. See Sieghart, W.<br />
Karcher, Raymond E. See Ranjan, Parveen<br />
Kanjalainen, Erkki, 962<br />
Karjalainen, Ulla; Radioimmunosssay;<br />
Computers; Calibration, 983<br />
Karman, Arthur; Lent, Richard W., 1011<br />
Karow, W. C. See Zia, Priscilla<br />
Karube, Isao See Suzuki, Massyasu<br />
Kasagi, Kanji See Noguchi, Masato<br />
Kasahana, Yasushi; Funiya, Shin; Imsi, Poshio,<br />
962<br />
Kashik, Mark See Osikowicz, Gene<br />
Kasuya, Fumiyo; Igarashi, Kazuo; Fukui,<br />
Miyoshi, 697<br />
Katan, Mantijn B. See Rottendam, Ernest P.<br />
Kataoka, Tetsuro See Suzuki, Masayasu<br />
Katrak, A. See Pal, B.<br />
Katnib, K.; Adlouni, H. A.; Ferard, C., 533<br />
Katsumoto, Hitoko See Kobayashi, Kunio<br />
Katz, Allan See LeMaistne, Anne<br />
Katz, Emil See Shoham (Schwartz), Zeev<br />
Katz, Zvi See Shoham (Schwartz), Zeev<br />
Kauffman, R. E. See Misiak, Paul M.<br />
Kaufman, J.; Seaton, C. B.; Zakowski, J., 951<br />
Kaufman, Richard A. See Awdziej, Penis N.;<br />
Del Vecchio, Mark; Farrenkopf, Bruce C.;<br />
Feeley, Brian P.; Lodato, Denise T.;<br />
Wesolowski, Alex<br />
Kawade, M. See Abe, Akira<br />
Kawaguchi, Seiji; Shindo, Yoshiyuki;<br />
Takahashi, Hiroaki, 887<br />
Kawai, Tadashi See Fujita, Kiyotaka<br />
Kawai, Tsuneald See Hanai, Junji<br />
Kawashima, Minonu See Iwatani, Yoshinori<br />
Kazi-Aoul, Teldja; Benmiloud, Moulay, 1301<br />
Kazmierczak, S.C.; Lott, John A.; Durbnidge,<br />
Timothy C., 985<br />
Keane, P.M.; Thompson, L.; Nimrod, C., 1033<br />
Kaarns, Gregory L. See Brewster, Marge<br />
Kaagan, C.; Wang, N.; Heiman, D.; Simpson, J.;<br />
Hasz, B., 973<br />
Keelan, Jeffrey A.; France, John P.; Baling,<br />
Peter M., 2292<br />
Kaanan, Don See Tanaka, Steve<br />
Keenan, Donald H. See Brueggen, Berndt<br />
Keenan, Edward See Kule, Allyn H.<br />
Keenan, Edward J.; Hart, Nan K.; Corbin,<br />
Debra K., 959<br />
Keffan, Priscilla See Kampa, In4o S.<br />
Kegelmeyer, A. E. See Kitchie, James C.<br />
Kellehen, Brian P.; Walshe, Kieran C.; Scott,<br />
John M.; O’Bnoin, Sean D., 52<br />
Kellermann, Wolfgang See Hoffmann, Ceorg E.<br />
Kelley, L. See Pollack, L.<br />
Kelley, Lynne See Bnaunstein, Glenn D.<br />
Kellogg, David E. See Sheldon, Edward<br />
Kelly, R. H. See Vertoaick, Frank P., Jr.<br />
Kelner, Michael J. See Roberts, Randall T.<br />
Kempe, Tom See Bartlett, Clifford<br />
Kenemans, P. See Boerman, 0. C.<br />
Kener, Agota See Hajos, Peter<br />
Kennedy, J. C. See Slaats, K. H.<br />
Kennedy, Maureen S. See Schaltenbrand,<br />
Wayne E.<br />
Kennedy, P. See Hammad, N.; Izutsu, A.<br />
-; Quinn, K. Toton; Hammad, N.; Masover, B.;<br />
Coblins, C.; Jaklitsch, A.; Izutsu, A., 971<br />
Kanney, Michael L., 328,725, 1087<br />
Kenny, M. See Dasgupta, Amitava; Yeo, K.-T.<br />
Kenny, Margaret See Metzger, Greg, 872<br />
Kereiakes, Dean See Chen, 1-Wen<br />
Karen, D. F. See Levinson, S. S.<br />
Kessler, A. Ch. See Riesen, W.<br />
Kessler, A.-Ch.; Kuppers, K., 924<br />
Kessler, C. See Sacks, David B.<br />
Kessler, Gerald See Debfert, Dennis M.;<br />
Matheke, Mary Lou; Thode, Jorgen<br />
Kessler, Jay See Bach, Philip<br />
Ketchum, Catherine H.; Robinson, C. Andrew,<br />
995<br />
Kautmann, Henry T. See Nussbaum, Samuel K.<br />
Kayomarsi, Kbandan See Mahnovski, Vladimir<br />
Khaja, C. See Keddy, M. Narahai<br />
Khalid, B. A. K. See Ng, M. L.<br />
Khan, Ilyas See Garcia, Raymond K.<br />
Kharasch, E. D. See Yeo, K-P.<br />
Kbayam-Bashi, H. See Cross, Susan F.; Hsieh,<br />
Shenie W.; Ng, V. L.<br />
-; Chen, Katherine H., 902<br />
-; Gerard, Stephen, 1031<br />
Khosla, Anuradha See Garcia. Raymond K.<br />
Khosravi, Mohammad J.; Diamandis,<br />
Elefthenios P., 1994<br />
Khushlani, Krishna See Singh, Pram Prakash<br />
Kiang, John J.; Kim, Jack; Onlshi, Patrick; Lu,<br />
Julie; Le-Thi, Phuong; Zahradnik, Richard<br />
J., 888<br />
Kiang, Willie; <strong>Back</strong>es, Dorothy, 973<br />
Kiachbe, Frederick L. See Eisenbrey, A.<br />
Bradley; Hawnylak, Ken; Ranjan, Parveen;<br />
Sykes, Elizabeth<br />
Kientsch-Engel, R.; Kleinhammer, C.; Batl, K.<br />
921<br />
Kilbourn, J. P., 1297<br />
Kibkson, H. See Kobos, K. K.<br />
Kiblian, C. S.; Emnich, L. J.; Constantine, K. I.;<br />
Kubasik, N.; Chu, P. M., 928<br />
Kim, J. See Umali, L.<br />
Kim, J. Q. See Hwang, Yoo Sung<br />
Kim, Jack See Kiang, John J.<br />
Kim, Joanne See Sheiman, Mark I.<br />
Kim, Joseph M. See Lin, Kyih<br />
Kim, Lance Y. See Nuasbaum, Samuel K.<br />
Kimball, K. J. See McElroy, P. D.<br />
Kimuna, Shinobu See Foti, Andras<br />
Kin, N. M. K. Ng Ying, 44<br />
Kinder, Vaughn E. See Knight, Joseph A.<br />
Kineiko, Robert See Lehmann, Craig A.<br />
King, David L.; Gabor, Mike J.; Martel, Patricia<br />
A.; O’Donnell, C. Michael, 972<br />
King, E. See LeCatt, Donald F.<br />
King, J. S., 205, 346, 451, 637, 750, 1111, 1310,<br />
1498, 1700, 1961, 2134, 2333<br />
King, Mary K. See Armitage, Edwin K.<br />
King, William J.; Brown, William E.; George,<br />
Sosamma; Middleton, Julie; Grove, Barbara;<br />
Lavieni, Connie; Harris, Kurt, 920<br />
Kingma, Anneke W. See van den Berg, Gita A.<br />
Kinn, C. See Zama, N.<br />
Kinter, M. See Herold, D. A.; Hundley, J.<br />
Kirchick, Howard See Chin, Bruce<br />
Kirkpatrick, C. A.; Lecocq, K.; Lamy, F.; Baran,<br />
D.; Kodeach, F.; Dumont, J. E., 2310<br />
Kirkpatrick, 0.; Patsch, W., 948<br />
Kirkpatrick, Marilyn; Moody, Carolyn; Bates,<br />
Diane Albergo; Shaffan, Mark, 1466<br />
Kirkpatrick, Peter B. See Bowie, Lemuel J.<br />
Kirvan, Kathyrn E. See Sedor, Frank A.<br />
Kiser, Ernest J. See Cuevas, Eleanore C.;<br />
Curmaci, Barbara L.; Legenzoff, Denise C.;<br />
Plucinsky, Mark C.<br />
Kiss, Janice; Plaban, P.; Swanson, J.; Acosta, A.,<br />
1025<br />
Kiss, Z.; Simo, I. E.; Ooi, P. C., 418<br />
Kissa, EnIk, 253<br />
Kisseb, Thomas H. See Van Brunt, Nicholas<br />
Kitamura, Motoshi See Kojima, Tsukasa;<br />
Sakuma, Ryozo<br />
Kitamura, Toshinoni See Oka, Kitaro<br />
Kithier, Renal See Cejka, Jan<br />
Kitto, John B. See Hurst, Paul L.<br />
Kiyasu, John Y., 1951<br />
Klee, G. G. See Preisaner. C. M.<br />
-; Hogue, P. 5.; Schryven, M. H.; Hutton, J. M.,<br />
926<br />
-; Schloegel, I. W., 926<br />
Kbae, George See Kao, Pai C.<br />
Kiee, George C.; Dodge, Larry A.; Reynoso,<br />
Custavo, 563<br />
Kleesiek, K.; Reinards, K.; Wolf, B.; Okusi, J.;<br />
Greiling, H., 1000<br />
Klein, C.; Poppe, W.; Hubbuch, A.; Gerber, M.,<br />
998<br />
Klein, Gerhard; Poppe, W.; Rauscher, E., 957<br />
Klein, P. See Zama, N.<br />
Klein, Paul See Koch, David<br />
Klein, S. M. See Simenson, P. B.<br />
Klein, Sigrid M.; Parker, James K.; Knauth,<br />
Cay H.; Witty, P. K., 888<br />
Kleinhammer, C. See Kientseh-Engel, K.<br />
Kley, Robof See Kovary, Peter M.<br />
Klinger, Jeffrey See Rashtchian, Ayoub<br />
Klock, J. See Bush, C. A.<br />
Kbocken, Helmut See Drexel, Heinz<br />
Kiotzsch, S. See Carrubba, Janet M.; Hemans,<br />
Bert; Kutman, Michael<br />
Klotzsch, Sigrid; Kutman, M.; Costa, K., 900<br />
-; Poth, A.; Ponte, K., 994<br />
Klukas, Carob See Reason, Craig<br />
KIute, M. C. See Yeager, Elizabeth P.<br />
Knadel, M.; Stockmann, W., 958<br />
Knight, Joseph A. See Miya, Terry C.; Wong,<br />
Steven H. Y.<br />
-; Smith, Stanley E.; Kinder, Vaughn K.;<br />
Anat.all, Harold B., 2289<br />
Knight, William S. See Rugg, James A.<br />
Knoblock, Edward C. See Cook, Janine Denis<br />
Knodel, Elinor L., 944<br />
Knox, Knik C. See Tsai, Michael Y.<br />
Knulinan, Jan T. See Rotterdam, Ernest P.<br />
Koay, E. S.C. See Aw, P. C.; Pho, L. L.<br />
Kobayashi, Keiko See Ichiki, Hitoshi<br />
Kobayashi, Kunio See Sakoguchi, Takafumi<br />
-; Katsumoto, Hitoko; Murakoso, Keiko;
Matsuoka, Akira, 1940<br />
Kobos, H. K.; Abbott, S. D.; Levin, H. W.;<br />
Kilkson, H.; Peterson, D. K.; Dickinson, J.<br />
W., 153<br />
Kobos, Robert K., 1061<br />
Kobylak, L. See Chu, J. W.<br />
Koch, David See Dowd, Dennis; Reich, Scott<br />
-; Miller, Richard; Koenig, Laura; Klein, Paul,<br />
944<br />
Koch, David D. See Koch, Marlene<br />
-; Polzin, Greg L., 886<br />
-; Feldbruegge, Donald H., 1761<br />
Koch, Marlene; Bednar, Linda K.; Koch, David<br />
D., 936<br />
Koch, T. H. See Armbrustar, M. A.; Obzansky, D.<br />
M.<br />
Koch, Thomas K. See Cook, Janine Denis<br />
-; Nagey, David A.; Cook, Janine Denis;<br />
Crenshaw, Carlyle, Jr., 1001<br />
Mehta, Uday; Lee, Henry; Aziz, Kaiser;<br />
Temeb, Seniye; Donion, Jerome A.; Sherwin,<br />
Roger, 2262<br />
Koda, Naoya See Yamamoto, Hideaki<br />
Koedam, Hans C. See Vink, Kees L. J.<br />
Koegler, J. See Freeman, D. J.<br />
Koenig, John See Chan, Kwok.Ming<br />
Koenig, Laura See Koch, David<br />
Kohl, Herbert IL; Parish, Edward J.; Nanduri,<br />
Venkata B.; Nusbaum, Kenneth E., 1035<br />
Kohlmeyer, Lianna See Truscott, Gail<br />
Kohn, Diane W. See Piran, Un<br />
Kohno, H. See Seth, K.<br />
Kohnl, Kosuke See Sakoguchi, Takafumi<br />
Kohse, Klaus P. See Ratge, Dieter<br />
Koistinen, Hlitta; Stenman, Ulf-Hakan;<br />
Alfthan, Henrik; Seppala, Markku, 1126<br />
Kojima, Tsukasa; Nishina, Toshthiro; Kitamura,<br />
Motoahi; Kamatani, Naoyuki; Nishioka,<br />
Kusuki, 2052<br />
Kolaczkowski, Lawrence See Crenien, Frank C.<br />
Kolanowaki, J. See Stein, F.<br />
Kolde, H.-J. See Cram, Jorgen<br />
KolIer, P. U.; Tnitsehler, W.; Carstensen, C. A.,<br />
916<br />
-; Tnitschler, W., 992<br />
Kolvunen, Erkki See Purpeinen, Ursula<br />
Komoda, T. See Miura, M.<br />
-; Koyama, I.; Okano, K.; Sakagishi, Y.; Miura,<br />
M.; Matsuzaki, H.; Hattoni, S.; Hattoni, T.;<br />
Hirasawa, 0.; Jitsukata, K., 999<br />
Konishi, Junji See Noguchi, Masato<br />
Konno, M. See Sato, K.<br />
Konstantinides, Frank N.; Singh, K. K.; Woods,<br />
W. K.; Monsour, L.; Mitchell, D. K.; Boosalis,<br />
M. C.; Cerra, F. B., 936<br />
Koopman, B. J.; Van den Molen, J. C.; Wolthers,<br />
B. C.; Waterreus, R. J., 142<br />
Kordal, Richard Sea Yeo, Linda<br />
Koren, E.; Puchois, P.; Alaupovic, P.; Fesmire,<br />
J.; Kandoussi, A.; Fruchart, J.-C., 38<br />
Korogyl, N. See Innanen, V. T.<br />
Kortlandt, W. See Joles, J. A.<br />
Reeks, Kent See Coodnow, Timothy<br />
Kost, Gerald J. See Vogelsang, PhilipJ.<br />
-; Fraser, David K.; Drummer, John M., 1473<br />
Kostner, G.M. See Smith, S. J.<br />
Koumantakis, George; Raddliff, Frank J., 502<br />
Kovary, P.M.; Kensinghoff, W., 2306<br />
Kovary, Peter M.; Schmitz, Laurence C.; Kley,<br />
Rolof, 921<br />
-; Elmquist, Henrietta; Quick, Peter, 979<br />
Koyama, I. See Komoda, P.; Miura, M.<br />
Kozuk, Terry See Osikowicz, Gene<br />
Kozumplik, Vlado See Hoffmann, Georg K.<br />
Knahn, J. See Yatscoff, K. W.<br />
Krahn, John See Hilborn, Sandra, 135<br />
Kramer, Bernhard K.; Jesse, Uta; Ress,<br />
Klaudia M.; Schmulling, Reinhold-Michael;<br />
Risler, Peut, 609<br />
Kramer, Donald L; Woodruni, David L; Coty,<br />
William A.; Zipp, Adam P., 1571<br />
Kramer, M. See Rowley, C. L.<br />
Kramer, Mary See Henniksson, Thomas<br />
Krassalt, W. See Hayes, L. W.<br />
Krasselt, Wendell G. See Hayes, Lyle W.<br />
Krauth, C. H. See Erali-Woodward, M.; Nielsen,<br />
L.; Simenson, P. B.; Perry, A. H.<br />
Krauth, Gary H. See Astill, Mark K.; Klein,<br />
Signid M.<br />
Krenc, C. A. See Pennington, Robin M.<br />
Knieg, Arthur F. See Woo, Jannie<br />
Knijnen, Pamela; Leung, F. Y.; Henderson, A.<br />
K., 991<br />
Knijnen, Pamela M. W.; Leung, Fred Y.;<br />
Henderson, A. Ralph, 1289<br />
Kris, M. G. See Savoia, M.<br />
Knoll, Martin H. See Huang, C. M.<br />
-; Lindsey, Helen; Greene, Joyce; Elm, Ronald<br />
J.; Hainline, Adrian, 894<br />
-; Lindsey, Helen; Green, Joyce; Elm, Ronald J.;<br />
Hemline, Adrian, 894<br />
-; Lindsey, Helen; Greene, Joyce; Elm, Ronald<br />
J.; Hainline, Adrian, 894<br />
-; Ruddel, Mark; Blank, David W.; Elm, Ronald<br />
J., 1121<br />
-; Roach, Neil A.; Poe, Brent; Elm, Ronald J.,<br />
1129<br />
-; Jackson, Agatha J.; Elm, Ronald J., 1219<br />
Krouwen, Jan S., 910<br />
-; Stewart, William N., 1104, 2305<br />
Kruijswijk, H. See Slaats, K. H.<br />
Krupinski, Ann V. See Metzgen, Louis F.<br />
Knuse-Jarres, J. D. See Kaiser, C.<br />
Knuse-Jarres, Juergen 0.; Schmitt, York, 933<br />
Janatsch, Guenter, 961<br />
Kuba, Kanta; Frantz, Ivan D., Jr., 896<br />
Kubasik, N. See Haden, B.; Killian, C. S.; Lewis,<br />
C.<br />
Kubasik, N. P.; Nichols, D.; Saeva, L., 885<br />
-; Cordy, P. A.; Murray, C.; Sine, H. E.; Mayer,<br />
P. K.; D’Souza, J. P., 958<br />
-; Condy, P. A.; Murray, C.; Sine, H. K.; Mayer,<br />
P. K.; D’Souza, J. P., 996<br />
Kubasik, Norman P. See Endahl, Gerald L.<br />
Kucera, Bob See Osikowicz, Gene<br />
Kulaots, Ingnid A.; Pudek, Morris K.; Seccombe,<br />
DavidW., 1490<br />
Kumahara, Yuichi See linuma, Kazushige<br />
Kumar, Anand See Cebauer, C. K.<br />
Kuman, Harish; Baran, M.; Costello, J.; Readio,<br />
J.; Rutner, H., 883<br />
Kummar, K. See Stavljenic, Ana<br />
Kung, C. C. See McCombs, M.<br />
Kung, Viola T.; Humphries, Cillian M. K., 1573<br />
Kunst, Albert; Seidenschwarz, E.; Burk, H.;<br />
Schauer, S.; Haug, H.; Lehmann, P., 884<br />
Kupke, Ingeborg H., 1468<br />
Kuppers, H. See Kessler, A.-Ch.<br />
Kurata, Kunio See linuma, Kazushige<br />
Kunchacova, Elva; McCleary, Alan; Coryn,<br />
Timothy. 1011<br />
Kurooka, Shigeru See Hiroishi, Shingo<br />
Kurtz, Sanford K. See Garrett, Patricia K.<br />
Kusanagi, Mutsuko See Fujita, Kiyotaka<br />
Kushnen, B. See Savoia, M.<br />
Kutner, Michael H. See Noe, Beverly<br />
Kutnink, MA. See Burn, B. J.<br />
Kuzmovych, Truvor See Dufour, D. Robert<br />
Kvlnnaland, Stener See Lien, Ernst Asbjorn<br />
Kwant, G. See Zwat, A.<br />
Kwant, Gerard; Oeseburg, B.; Zwart, A.; Zijlstra,<br />
W.C., 1001<br />
Kwong, Angela See Chen, Roulhwai<br />
Kwong, Tai C.; Fragnoli, Joanne, 1026<br />
Kyne, Frank See Maguine, Sean<br />
Kyte, Vicky See Huang, Yung-Sheng<br />
Labbe, Robert F. See Huebers, Helmut A.;<br />
Rettmer, Rebecca L.<br />
Labrousse, F. See Lequang, N. P.<br />
Lacey, Karen J. See Hicks, Jocelyn M.<br />
LaChnpelle, J. See Trundle, Diana<br />
Lachatre, C. See Nicot, C.<br />
Ladenson, J. See Hortin, C.<br />
Ladenson, Jack H. See Chan, Kwok-Ming;<br />
Landt, Yvonne; Thode, Jongen<br />
Ladmirant, Irene H. See Bieva, Claude J.<br />
Ladouceur, P.R.; Haden, B.; Smith, M.; Hunter,<br />
R., 941<br />
-; Wilton, K.; Haden, B.; Cole, R.; Sheehan, M.,<br />
942<br />
-; Haden, B.; Pierre, K.; Purcell, George;<br />
Poulsworth, Judy; Jackson, Donny; Moore,<br />
Frank, 956<br />
-; Haden, B.; Beck, J.; Lewis, C.; Smith, C., 957<br />
Laassig, Honald H. See Ehrxneyen, Sharon S.<br />
Lagocki, K. J. See Churela, H. K.<br />
LaGrenade, Alana; Dufour, D. Robert, 990<br />
Lal, K. N. See Robertshaw, A. M.<br />
Laker, Michael F. See Parkinson, Ian S.<br />
Lalonde, Richard L. See Straka, Robert J.<br />
Lam, Stanley See Malikin, Calina<br />
Lamb, David H. See Wad, Kory M.<br />
Lamb, Emmnet J. See Wu, Ted-Fang<br />
Lambent, A. See Bernard, A. M.<br />
Lambert, Patricia A.; Woodbridge, Peter A.;<br />
Botie, Philip N., 977<br />
Lainberts, LV. See D’Haese, P. C.; D’Haese,<br />
Patrick C.<br />
Lambin, Patrick See Lefrere, Jean-Jacques<br />
Lampe, Dagmar; Scholz, Dietmar; Prumke,<br />
Hans-Jong; Blank, Wolfram; Huller,<br />
Hansgeorg, 1643<br />
Lamy, F. See Kirkpatrick, C. A.<br />
Lancet, Moshe See Shoham (Schwartz), Zeev<br />
Landon, J. See Eremin, S. A.; Silver, A. C.<br />
Landruns, E. See Lucas, F.<br />
Landt, Michael See Chan, Kwok-Ming<br />
Landt, Michael L. See Stahlschmidt, Gail K.<br />
Landt, Yvonne; Vaidya, Hemant C.; Dietzler,<br />
David N.; Ladenson, Jack H., 987<br />
Lane, Joseph M. See Savoia, Macella<br />
Lane, Kathy L. See Vogebsang, Philip J.<br />
Langen, Robert See Mullon, Claudy J.-P.<br />
Lapointe, Odette See Laclerc, Pierre<br />
Laposky, L See Yeo, K.-T.<br />
Larget-Piet, Luc See Desjobert, Andre<br />
Larriva, M. L See Melby, J. M.<br />
Larsson, Lease See Nelson, N.<br />
Lash, Julia M. See Ward, Kory M.<br />
Lasky, F. D.; Green, G. A.; Powers, D. M.;<br />
Warren, K. L.; Li, Z. M., 909<br />
Leaky, Fred 0. See Powers, D. M.<br />
Lasley, Bill L, 1058<br />
LaTorre, Judy See Cheng, Charles<br />
Lao, Brad W. C. See Chan, Kwok-Ming<br />
-; Reed, B.; Valdes, R., Jr., 890<br />
Lou, H. P. See Milan, W. K.<br />
Lou, H. Phlllip See Birkmayen, Richard C.<br />
-; Thompson, Cynthia B., 888<br />
Lou, K.-H. William; Onishi, Tomoyuki;<br />
Wergedal, Jon E.; Singer, Frederick R.;<br />
Baylink, David J., 458<br />
Lauderdale, V.; Haden, B.; Garfield, H.;<br />
Liedtke, R.; Crown, J., 966<br />
-; Haden, B.; Megie, S.; Lucido, P., 967<br />
Launois, X. See Truchaud, A.<br />
Laurence, Christian See Benthelot, Michel<br />
Lauwerys, H. H. See Bernard, A. M.<br />
Lauwerys, Robert H. See Bernard, Alfred M.<br />
Lavelle, Peter H. See Nee, Patrick A.<br />
Lavernia, M. See Johnston, D.<br />
Lavieri, Connie See King, William J.<br />
Lavigne, Jeffrey H. See Nussbaum, Samuel K.<br />
Law, W. P. See Cheney, J. A.; Crowther, F. H.;<br />
Kaminski, E. M.<br />
Lawler, C. M. See Howard, P. K.<br />
Lawnuk, T. See Crouse, S. P.<br />
Lawson, N. See Taylor, A. J.<br />
Lawson, Nigal; Jenkins, Sue; Pandov, Harry,<br />
2131<br />
Laxdal, V.A. See Kalra, J.<br />
Lazic, Ivana See Regina, Francis J.<br />
Leach, Charles N., Jr. See Wong, Steven H. Y.<br />
LeBlanc, Michael See Coodnow, Timothy<br />
Leclerc, Pianre; Lapointe, Odette; Masse,<br />
Jacques, 1671<br />
Lecocq, K. See Kirkpatrick, C. A.<br />
La Devehat, Claude See Canny, Philip J.<br />
Ledue, T. B.; Irish, C. K.; Rifai, N.; Silverman, L.<br />
M., 902<br />
Ledue, Thomas B. See Irish, Glenn K.<br />
-; Kifai, Nader; Irish, Glenn K.; Silverman,<br />
Lawrence M., 1260<br />
Lee, B. L See Ong, C. N.<br />
Lee, C. See Zachariah, N. Y.<br />
Lee, C. K.; Lewis, L. M., 1016<br />
Lea, Chub; Boos, Mark, 1466<br />
Lea, Deborah See Foti, Andrea<br />
Lee, Gregory; Tung, Jim, 882<br />
Lee, Henry See Koch, Thomas K.<br />
Lee, Hsin-Yu; Pekary, A. Eugene; Smith, Vierka<br />
P.; Sbadek, Julia; Herahman, Jerome M.,<br />
1223<br />
Lee, James K. See Osuch, Mary Ann V.<br />
Lee, Peggy See Wei, Jeng S.<br />
Leete, H. S., Jr. See l3urtis, C. A.<br />
Lefiar, C. C. See Miller, W. K.<br />
Lafrere, Jean-Jacques; Fine, Jean-Marie;<br />
Lambin, Patrick; Muller, Jean-Yves;<br />
Courouce, Anne-Marie; Salmon, Charles,<br />
1697<br />
LeGatt, Donald F.; Berendt, K.; Dinwoodie, A.;<br />
Passenini. L.; King, K., 969<br />
LeGeault, Tammy 8. See Hanson, Naomi Quast<br />
Legenzoff, Denise C.; Plucinsky, Mark; Kiser,<br />
ErnestJ., 945<br />
Lehmann, Craig A.; Leiken, Alan M.; Kineiko,<br />
Robert, 910<br />
Lahmann, P. See Kunat, Albert<br />
Lehn, H.; Kapke, C. F., 984<br />
Lehn, Robert See Jones, Jeffery E.<br />
Leiken, Alan M. See Lehniann, Craig A.<br />
Leinberger, K. See Rothe, A.<br />
LeMaistne, Anne; Bracey, Arthur, Katz, Allan;<br />
Wu, Alan H. B., 1908<br />
Lemann, Jacob, Jr.; Doumas, Basil P., 297<br />
Lemoine, Main See Carry, Philip J.<br />
Lemonnier, A. See Taulier, A.<br />
Lensmeyar, Gary; Wiebe, Donald; Carlson, Ian,<br />
979<br />
Lensmayer, Gary L.; Wiebe, Donald A.; Carbon,<br />
Ian H., 1841<br />
-; Wiebe, Donald A.; Carbon, Ian H., 1851<br />
Lent, H. W. See Braunstein, J. D.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2347
Lent, Richard W. See Kanmen, Arthur<br />
Lentjes, Eaf G. W. M.; Haff, Gottfried A.;<br />
<strong>Back</strong>er, Egbent T., 2089<br />
Lentrichia, Brian B.; Sclotto-Brown, Susan J.;<br />
Tunanchik, Michael F.; Roplak, Irene K.;<br />
Yeung, Kwok K., 1548<br />
Lenz, H. See Gerber, M.<br />
Lenzi, Silvia; Giampietro, Ottavio; Giovannitti,<br />
Giovanna; Sampletro, Tiziana; Miccoli,<br />
Roberto; Navalesi, Renzo, 55<br />
Leonard, N. See Baran, M.<br />
Leone, A. M. See Francis, P. L.<br />
Lepoutre, L. See Van Hoof, Viviane<br />
Lepp, Cyrus A. See Winiarski, Ralph<br />
Lequang, N. T.; Miguenes, C.; Roche, D.;<br />
Pelladeau, M. L.; Labrousse, F., 192<br />
Leroy, Maurice J. F. See Maien, Eddie A.<br />
Lessard, Cynthia; Hanford, H.; Jensen, M.;<br />
Majewski, C., 908<br />
Le-Thi, Phuong See Kiang, John J.<br />
Leung, D. See Wong, W. L.<br />
Leung, F. Y. See Knijnen, Pamela<br />
Leung, Fred Y. See Knijnen, Pamela M. W.;<br />
Pellan, Thomas C.; Smith, Deborah A.<br />
Leung, K. See Saito, Tokuko<br />
Leung, Kathleen S. See Kugg, James A.<br />
Leung, Kathy See Goodnow, Timothy<br />
Levanson, Corey See Sheldon, Edward<br />
Lever, Michael See Blair, Stephen C.<br />
Levillain, P. See Taulier, A.<br />
Levin, H. W. See Kobos, R. K.<br />
Levine, B. S.; Caplan, Y. H., 1264<br />
Levine, Barry See Caplan, Yale H.<br />
Levine, J. See Grassick, F.; Levy, S.<br />
Levinson, S. S. See Maciejko, J. J.<br />
-; Karen, D. F.; Carey, J. C.; Goldman, J. 0., 904<br />
Levinson, Stanley S. See Maciejko, James J.<br />
Levtzow, C. B. See Rifai, N.<br />
Levy, Arthur L. See Crawford, Ralph C.<br />
Levy, S. See Carnubba, Janet M.; Crassick, F.<br />
-; Frey, M.; Grassick, F.; Levine, J., 955<br />
Law, Maelly See Gupta, Ram N.<br />
Lewis, C. See Ladouceun, P. Ft.<br />
-; Haden, B.; Butts, B.; Kubasik, N.; Nodes, K.;<br />
Sheehan, M.; Van Dreal, P., 941<br />
-; Haden, B.; Butts, B.; Van Dreal, P., 941<br />
-; Haden, B.; Butts, B.; Kubasik, N.; Nodes, K.;<br />
Shaw, B., 941<br />
Lewis, Kvan See David, Harold<br />
Lewis, L M. See Armbruster, M. A.; Lee, C. K.<br />
Lewis, S.C., 1020, 1022<br />
Lewis, Sherwood C., 1013, 1018<br />
Lewis, Steve L See Rudy, Jack L.<br />
Lewis, Susan See Smith, J. Cecil, Jr.<br />
Li, Jackie P. L.; Conan, Marshall P.; Shah,<br />
Ramila J.; Peneba, Allan, 998<br />
Li, P.M. See McCombs, M.<br />
Li, Thomas M. See Chen, Roulhwai<br />
Li, Z. See Norton, Gary<br />
Li, Z. M. See Lasky, F. D.<br />
Liao, J. C. See Yuan, Catherine<br />
Lichtenstein, P.S. See Gal, J.<br />
Liedtka, R. See Lauderdale, V.<br />
Lien, Ernst Asbjorn; Ueland, Per Magne;<br />
Solheim, Kinar; Kvinnsland, Stener, 1608<br />
Liewandahl, K.; Tikanoja, 5; Helenius, T.;<br />
Mahonen, H., 716<br />
-; Tikanoja, S.; Mahonen, H.; Helenius, T.;<br />
Valimaki, M.; Tallgren, L. C., 1382<br />
Light, Richard Todd, 908<br />
Ligtenberg, H. C. G. See Oeseburg, Benend<br />
Lijewski, Jane See Frye, Roger<br />
Lilja, Herman S. See Ksber, Henry J.<br />
Limo, C. W. See Siebers, K. W. L.<br />
Lim,ChewW.,713<br />
Lim, K. See Lockitch, G.<br />
Lim, M. See Sacks, David B.<br />
Lin, Cheng-I See Bartlett, Clifford<br />
Lin, Eyih; Kim, Joseph M., 965<br />
Lin, F. C. See Foglia, J. P.; Perel, J. M.; Stiller,<br />
R. L.; Wong, Stephen H.-Y.<br />
Lin, C. See Umali, L.<br />
Lin, Spencer H.; Miyamoto, S.; Huntington, M.;<br />
Diamond, S. K., 922<br />
Linares, Lourdes See Lineback, Janet<br />
Lindback, B.; Berlin, T.; Bjorkhem, I., 1226<br />
Lindsey, Helen See Knoll, Martin H.<br />
Lindatedt, Conan See Nystrom, Ernst<br />
-; Nystrom, Ernst; Lundberg, Per-Ama, 1293<br />
Lineback, Janet; Hernadez, Walkinia; Linares,<br />
Lourdes; Pasquet, Luz, 906<br />
Linnet, Kristian, 381<br />
Linsken, S. See Winquin, E.<br />
Liotta, Lance, 862<br />
Lipa, T. See Innanen, V. T.<br />
Lippi, Ugo; Cocco, Claudio; Marmni, Maddalena,<br />
723<br />
Upset, J. See Mansbach, L.<br />
2348 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Lipsay, A. I. See Cheng, M. H.<br />
Lipsay, Allan I. See Cheng, Mary H.;<br />
Mahnovski, Vladimir<br />
Lischinsky, S. See Beck, K.<br />
Litin, Scott C. See Pruett, Sara<br />
Litman, David J. See Chen, Koulhwai<br />
Little, Randie H.; Goldstein, David E., 741<br />
Liu, Frank J.; Fritsche, Herbert A.; Pnujilbo,<br />
JoseM., 182<br />
Liu, Samuel S. See Liu, Teen Z.<br />
Liu, Tsan Z.; Liu, Samuel S., 1008<br />
Livaniou, Evangelia; Evangelatos, Gregory P.;<br />
Ithakissios, Dionyssis S., 1983<br />
Lloyd, Chris See Wu, James T.<br />
Locke, Sandra See Crass, Linda<br />
Lockitch, G.; Jacobson, B.; Lim, K.; Schneiber,<br />
W., 999<br />
-; Phomas, E. E.; Junker, A.; Putenman, M.;<br />
Quigley, C., 1029<br />
-; Halstead, A. C.; McCallum, C.; Quigley, C.,<br />
1029<br />
-; Halstead, A. C.; Quigley, C.; McCallum, C.,<br />
1029<br />
Lodato, Denise T. See Awdziej, Tania N.;<br />
Feeley, Brian P.<br />
-; Awdziej, Tania A.; Kaufman, Richard A.;<br />
Focella, Antonino, 1021<br />
Lohmann, P. See Withenspoon, L.<br />
Loizou, M. See Mashiter, K.<br />
Long, D. A. See Tzamaloukas, A. H.<br />
Long, Karen See Peterson, Kent W.<br />
Longanich, L. See Vasdev, S.<br />
Longhunst, S. See Ritchia, James C.<br />
Leo, Stanley Y. Y.; Bhagavan, Nadhipurani V.;<br />
Scottolini, Alfred C., 2317<br />
Loos, Valerie See Barnes, Grady<br />
Lope, Enrique Saenz See Pens, Mania Isabel<br />
Arranz<br />
Lopes-Virella, M. F. See Smith, S. J.<br />
Lopez, A.; Valera, C.; Kodenas, V.; Pedromingo,<br />
A.; Martinez-Hennandez, P., 1475<br />
Lopez-Anaya, Arturo; Mayersohn, Michael,<br />
1874<br />
Lonenzen, K. M. See Haven, M. C.<br />
Loner, M. A. See Sheat, J. M.<br />
Lorton, Linda S. See Ovenfield, C. V.<br />
Lotey, H. See Kremin, S. A.<br />
Lott, John A. See Kazmierczak, S. C.; Miller,<br />
Irene L.; Wimsatt, Dorothy K.<br />
Laugh, M.; Watson, I. D.; Stewart, M. J., 1072<br />
Leuie, A. See Rowley, C. L.<br />
Louie, Alan See Henniksson, Thomas<br />
-; Njuyen, Phuc H.; Woo, Wilson; Henriksson,<br />
Phomas; Rowley, Gerald L., 919<br />
Love, C. See Mashiter, K.<br />
Love, James E., Jr.; Jones, J. Tim; McGrath,<br />
Patricia C.; Moore, Eddie C., 898<br />
Lovern, Douglas See Rashtchian, Ayoub<br />
Lovgren, T. See Boenman, 0. C.<br />
Lovgnen, Timo See Dobson, Susan; Hemmila,<br />
Ilkka<br />
Lu, Julie See Kiang, John J.<br />
Lu, Wuan Sea Hsu, Brand R. S.<br />
Lucas, Diane See Pnuscott, Gail<br />
Lucas, F. See Shukla, K.<br />
-; Ho,S., 942<br />
-; Ho, S., 943<br />
-; Ho, P.; Landrum, E., 943<br />
-; Landrum, E.; Ho, S.; Ricardo, K.; Bedevia, J.,<br />
943<br />
-; Ho, P.; Bedevia, J., 1007<br />
-; Landrum, E.; Ho, 5., 1014<br />
Lucco, L. See Diaz, S.<br />
Lucco, Louis See Singh, Jagat<br />
Lucido, T. See Lauderdale, V.<br />
Luckey, Dennis W. See McCarthy, Robert C.<br />
Luddy, M. A. See Crouse, S. P.; Miller, W. K.<br />
Luis, Nuno See Mane, Michel<br />
Luke, David H.; Matzke, Gary Ft.; Clarkson, Jay<br />
T.; Awni, Walid M., 1450<br />
Luke, Karl K.; Morris, David A. N., 980<br />
Luley, C. See Puchois, P.<br />
Lundberg, Per-Ama See Lindstedt, Conan;<br />
Nystrom, Ernst<br />
Lundholm, Kent See Nystrom, Ernst<br />
Lundquist, Per; Kosling, Hans; Sorbo, Bo;<br />
Pibbling, Lita, 1228<br />
Lunec, J. See Winkles, J.<br />
Lunec, Joseph See Jones, Alan F.<br />
Lunetzky, Ellen S.; Cambnowski, George 5., 909<br />
Luquita, M. C. See Marmnelli, K. A.<br />
Lustenbergar, P. See Orsonnaau, J. L.<br />
Lustgarden, J. See Manimekalai, S.<br />
Luther, C. See Umali, L.<br />
Lutsky, P. M.; Frohlich, J., 421<br />
Luzzana, M. See Bonini, P. A.<br />
Luzzana, Massimo See Barenghi, Livia<br />
Lyle, L K. See Petersen, J. K.<br />
Lyle, Leon R. See Scott, Mitchell G.<br />
Lynch, Robert L., 911<br />
Lynn, Shirley Y. See Findlay, John B.<br />
Maalihan, E. Sea Innanen, V. T.<br />
Maas, A. H. J. See Oeseburg, Banand<br />
Maberly, Glen F. See Waite, Kay V.<br />
Macart, Michel; Cerbaut, Lucile, 199<br />
MacCrehan, William A.; Schonbargen, Emil,<br />
1585<br />
MacDonnell, Paul C. Sea Sheiman, Mark I.<br />
MacGregor, C. A. See Buckley, M. C.<br />
Maciajko, J. J.; Levinson, S. S.; Markyvech, L.;<br />
Hogan, S.; Pruitt, S. P.; Blevins, R. D.;<br />
Goldman, J.; Nathan, L. K., 898<br />
Maciejko, James J.; Levinson, Stanley S.;<br />
Markyvach, Lois; Smith, Michael P.; Blevins,<br />
Roger D., 2065<br />
Macintyre, Andrew See Fuller, Mark<br />
Mack, D. 0.; Reed, V. L.; Smith, L. D., 927<br />
Mack, M. See Wileczek, R.<br />
-; Roman, J.; Frederick, M., 950<br />
Mackay, C. A.; Goodall, C. I.; Woods, J.; Young,<br />
V. H., 2124<br />
Macknees, Michael I.; Walker, Cohn H.;<br />
Calson, Las A., 587<br />
Mackowiak, Jim; Ali, Akhtar, 947<br />
MacLennan, William J. Sea Callacher, Ruth E.<br />
MacLeod, Janet E. See Chu, Samuel Y.<br />
MacMillan, Donna See Decapnio, Lauren<br />
MacMillan, R. Hunt, III See Felder, Robin A.<br />
MacNeil, Mary Louise See Mueller, Patricia W.<br />
Macoviak, John A. See Bayer, Monika F.<br />
Macpherson, Nicol; Moscaallo, M. A., 1027<br />
Mactavish, Gloria Sea Deajardins, Paul K. K.<br />
Maeda, K. See Sato, K.<br />
Maeda, Masako; Arakawa, Hidetoshi; Tsuji,<br />
Akio; Yamagami, Yuji; Isozaki, Akio;<br />
Takahashi, Pakeo; Haruki, Eiichi, 761<br />
Maeda, S. See Abe, Akina<br />
Maggio, Vincent L. See Miller, Dayton P.<br />
Magic, S. See Lauderdale, V.; Van Dreal, P. A.<br />
Magnotti, Ralph A., Jr.; Eberly, J. Patrick;<br />
Quarm, Daisy E. A.; McConnell, Robert S.,<br />
1731<br />
Maguina, Gerald A.; Bannister, Michael W.,<br />
1304<br />
Maguire, Sean; Kyne, Frank; UaConaill,<br />
Diarmuid, 1493<br />
Mahaffay, K. See Smith, M.<br />
-; Phillips, K.; Bush, D.; Covault, H. P.; Tejero,<br />
N., 952<br />
Mahaffey, R. C. See Ruhnau, S. K.<br />
Mahieu, P. See Stein, F.<br />
Mahieu, Pol See Bernard, Alfred M.<br />
Mahmood, Nishat See McCarthy, Matthew J.<br />
Mabnovaki, Vladimir; Cheng, Mary H.; Lipsey,<br />
Allan I.; Keyomarsi, Khandan, 189<br />
Mahonan, H. See Liawendahl, K.<br />
Maier, Arthur See Maien, Eddie A.<br />
Maien, Eddie A.; Dietemann-Molad, Anita;<br />
Rastegar, Faramarz; Haimburgan, Robert;<br />
Ruch, Claude; Maien, Arthur; Roegel, Emila;<br />
Leroy, Maurice J. F., 2234<br />
Maitski, T. See Bush, C. A.<br />
Majewski, G. See Lessard, Cynthia<br />
Majumdar, Slain K.; Miles, Andrew, 1291<br />
Makeia, S. K.; Ellis, C., 886<br />
Makin, H. L. J.; Porteous, Caroline; Coldwell,<br />
Ruth; Trafford, D. J. H., 962<br />
Makino, K. See Abe, Akira<br />
Makise, Junko; Matsuda, Nobuko; Kanayama,<br />
Masaaki; Amakawa, Psutomu; Aoyama,<br />
Nonihito; Patano, Toshio; Yokote, Yasuhanu,<br />
1013<br />
Makkink, B. See Aalbers, Ph. C.<br />
Malgnas, Alain See Cilleny, Philippe<br />
Malhi, Balwinder, S. See Verrill, Harland L.<br />
Malhotra, Hanish C. See Nandadkar, Anvind K.<br />
N.<br />
Malikin, Calina; Murphy, Margaret; Lam,<br />
Stanley, 1016<br />
MaIm, M. J. See Wyatt, J. L.<br />
Maling, T. J. B. See Siebers, K. W. L.<br />
Malbon, Peter Sea Gambino, S. Raymond<br />
Malone, Winfred F., 1062<br />
Maluf, Karen C. See Passey, Richard B.<br />
Malya, P. A. Covinda, 1059<br />
Manabe, Takashi See Visvikis, Sophia<br />
-; Visvikis, Sophie; Dumon, Marie-France;<br />
Clerc, Michel; Siest, Gerard, 468<br />
Manes, M. E. See Patel, V. S.<br />
Manimekalai, S. See Sundaram, Shan C.<br />
Sundaram, C. S.; Unni, S.; Goldstein, P. J.;<br />
Lustgarden, J.; Paterson, D.; Wank, R. E.,<br />
880<br />
Mann, K. G. See Howard, P. R.<br />
Mannucci, P. M. See Chantarangkul, V.<br />
Mansbach, L.; Lipsat, J.; Gallagher, M., 881
Mantaro, C. Sea Ghialini, S.<br />
Manzati, Claudio Sea Prencipe, Loranzo<br />
Maquart, Fnancois-Xavier See Gillemy,<br />
Philippe<br />
Marchand, A. Sea Warkentin, D. L.<br />
Marchand, Anthony See Warkentin, Donald L.<br />
Marchand, M. See Therond, Patrice<br />
Marchand, Mantine; Tharond, P.; Navarro, J.;<br />
Biou, D.; Demelian, J. F., 934<br />
Marcial, C. See Trundle, D.<br />
Marcovina, Santica; Radaelli, C.; Gallus, C.;<br />
Graziani, M.; Vassanelli, C.; Catapano, A.,<br />
898<br />
Marcus, M.; Minza, P., 920<br />
Margrey, Keith See Felden, Robin A.<br />
Mangray, Keith S. Sea Boyd, James C.<br />
Mangray, M. See Johnston, Mary<br />
Margrey, Marilyn H. See Harold, David A.<br />
Marmnelli, H. A.; Luquita, M. C.; Caray, K. A.<br />
Rodriguez, 1475<br />
Marini, Maddalena See Lippi, Ugo<br />
Markello, S. See McElroy, P. D.<br />
Markese, J. J. Sea Hutton, Jean M.<br />
Markese, James J.; Delfart, D. M.; Swanson, P.;<br />
Shaw, N., 931<br />
Markey, Sanford P. See Bojkowski, Christopher<br />
J.<br />
Markin, K. S. See Haven, M. C.; Huth, Jeff;<br />
Otten, U. T.<br />
Markin, Rodney S. See Haven, Mary C.<br />
Markyvech, L See Maciejko, J. J.<br />
Mankyvech, Lois See Maciejko, James J.<br />
Manonpot, Robert K. See Ksbar, Henry J.<br />
Marra, Michel; Claudel, Jean-Pierre; Cinat,<br />
Patrick; Luis, Nuno; Suaraz, Laobando;<br />
Passa, Philippe, 209<br />
Marsden, Phillip D. Sea Domes, Jose C.<br />
Marshall, D. L See Thomas, B. A.<br />
Marshall, David L., 1572<br />
Marshall, Thomas; Williams, Katharine M., 577<br />
-; Williams, Katharine M., 1263<br />
-; Williams, Katherine M., 1886<br />
Marstein, Sverra, 1290<br />
Martel, Patricia A. See King, David L.<br />
Martin, Cazemiro K. Sea El-Yazigi, Adnan<br />
Martin, David M., 1033<br />
Martin, J. K. See Mashiter, K.<br />
Martin, K. Bruce; Savory, John; Brown, Sue;<br />
Bertholf, Roger L.; Wills, Michael R., 405<br />
Martin, Richard Sea Woo, Jannie<br />
Martin, Robert F. See DiStasio, Karen<br />
Martinez, Antonio See Boyd, James C.; Falder,<br />
Robin A.<br />
Martinez, Consuelo Sea Zugaza, Carmen<br />
Martinez, Jesus A.; Coll, Julio M., 2185<br />
Martinez, Sylvie See Monti, Jean Pierre<br />
Martinez-Hernandez, P. See Lopez, A.<br />
Maruhn, Dieter, 1057<br />
Marz, Winfried; Schank, Gunther; Cross,<br />
Warner, 664<br />
Marzouk, Nemat See Wong, Steven H.-Y.<br />
Mascini, Marco; Mazzei, Franco; Moscone,<br />
Danila; Calabrase, Giusappe; Benadatti,<br />
Massimo Massi, 591<br />
Mashford, A. P. Sea Burden, M. R.<br />
Mashiten, K.; Love, C.; Loizou, M.; Aslam, M.;<br />
Allan, C. J.; Holian, J., 892<br />
-; McCarthy, N. C.; Shepherd, H.; White, C. P.;<br />
Martin, J. K., 906<br />
-; Topliff, C. H.; Johnson-Proctor, E.; Dent, A.<br />
H.; Allan, C. J.; White, C. P., 1015<br />
Masini, S. Sea Pilo, A.; Zucchalli, C. C.<br />
Masovan, B. See Hammad, N.; Izutsu, A.;<br />
Kennedy, P.<br />
Masse, Jacques See Leclerc, Pierre<br />
Massetti, Anna Paola See Delia, Salvatona<br />
Massey, K. L. Sea Kalra, J.<br />
Massey, Thomas; Ness, Rhonda; Bailor,<br />
Thomas; Drawbaugh, Adelle, 998<br />
Massie, Donna See Barnes, Grady<br />
Masson, P. L. See Borque, L. A.<br />
Masson, Parvesh; Stenamyr, Maria; Huitbeng,<br />
Bjonn, 188<br />
Mastroianni, Claudio Maria Sea Delia,<br />
Salvatone<br />
Mastnopaolo, Walter; Fernandez, Zoe, 931<br />
Mathake, Mary Lou; Kessler, Gerald; Chen,<br />
Kwok-Min, 2109<br />
Mathew, Ranjit See Eisenbnay, A. Bradley<br />
Mathews, Judith L. Sea Welch, Elaine<br />
Mathews, Samuel E. See Frye, Roger<br />
Matsubara, Fujitsugu See Hashimoto, Pakuma<br />
Matsuda, I. Sea Widdershoven, J.<br />
Matsuda, Nobuko Sea Makiaa, Junko<br />
Matsue, Hajime; Pakagaki, Kaiichi; Honda,<br />
Kan-ichi; Nakagaws, Yoichi; Cejyo,<br />
Fumitaka; Arakawa, Masaaki; Endo,<br />
Masahiko, 2214<br />
Matsuoka, Akira See Kobayashi, Kunio;<br />
Sakoguchi, Takafumi; Taniuchi, Koji<br />
Matsuura, T. H. See Romth, P. C.<br />
Matsuyama, Shigeyuki See Hiroishi, Shingo<br />
Matsuzaki, H. See Komoda, P.; Miura, M.<br />
Matthews, W. Stephen See Endahl, Gerald L.<br />
Maturen, Andrew; Francoeur, Theresa A.;<br />
Wynn, Annette L.; Reid, David L.; Anderson,<br />
Christopher P., 1078<br />
Matzke, Gary K. Sea Luke, David R.<br />
Mauck, John C. See Smith-Lewis, Margaret J.<br />
-; Smith-Lewis, Margaret J.; Warren, Harold C.,<br />
902<br />
Maurar, G. See Quesniaux, V.<br />
Maury, C. P. J. See Tappo, Anna-Maija<br />
Mazon, Harry K. Sea Spanling, Matthew 1.<br />
May, Willie K., 1062<br />
Maycock, Paula F.; Frayn, Keith N., 286<br />
Mayer, L.; Jacobs, K.; Sarkozi, L., 955<br />
Mayer, M. See Johnston, D.<br />
Mayer, P. K. See Kubasik, N. P.<br />
Mayersohn, Michael See Lopez-Anaya, Arturo<br />
Mayo, Elizabeth See Sador, Frank A.<br />
Mazza, J. C. See Huben, M. D.<br />
Mazzei, Franco Sea Mascini, Marco<br />
MeAteer, Joy A.; Hiltke, Mark F.; Silber, B.<br />
Michael; Faulkner, Robert D., 1788<br />
McBay, Arthur J. See Dubowski, Kurt M., 33B<br />
McBride, James H. Sea Schottens, Susan B.<br />
-; Hao, Henry; Higgins, Sharon; Rodgerson,<br />
Denis 0., 721<br />
-; Hilborne, Lee H.; Rodgerson, Denis 0., 991<br />
-; Rodgenson, Denis 0.; AIIm, Ronald E., 1303<br />
McCaffrey, P. See Umali, L.<br />
McCallum, C. See Lockitch, G.<br />
McCarrick, J. Sea Glatt, G.<br />
McCarthy, Matthew J.; Mahmood, Nishat;<br />
Snebro, Sonia; Brotherton, Mary; Evans,<br />
Susan A., 904<br />
McCarthy, N. C. See Mashiten, K.<br />
McCarthy, H. C.; Ryan, F. J., 918<br />
McCarthy, Robert C.; Fattenhoff, Terry J.;<br />
Luckay, Dennis W., 1430<br />
McClaary, Alan See Kurchacova, Elva<br />
McClellan, Adrain C. See Chan, Kwok-Ming<br />
McComb, K. B. Sea Okorodudu, A. 0.; Syed, D.<br />
B.<br />
McCombs, M.; Carnico, J.; Bmuno, V.; Kung, C.<br />
C.; Hanjan, S. N.; Wong, E.; Li, P. M., 1019<br />
McConnell, Robert S. See Magnotti, Ralph A.,<br />
McCroskey, Ralph See Flom, Kenny J.<br />
McCrumb, Fred Sea Kennar, Stephen W.<br />
McCulloch, J. C.; Mendelsohn, D., 2123<br />
McCurdy, Walter, 2324<br />
McDonald, Donna M. See Garrison, Lester<br />
McDougall, I. Ross Sea Bayer, Monika F.<br />
McElroy, P. D.; Bhargava, A. K.; Kimball, K. J.;<br />
Volpe, D.; Fitzpatrick, J. K.; Cummings, K.<br />
M.; Markello, S., 975<br />
McEnery, P. T. Sea Clardy, C. W.<br />
McGinnis, Joseph Sea Butler, Anthony R.<br />
McGinnis, S. Sea Mongers, J.; Pssqua, J.<br />
McGonagle, B. See Zamna, N.<br />
McGrath, Michael S. See Ng, V. L.<br />
McGrath, Patricia C. Sea Love, James K., Jr.<br />
McKaon, P. Sea Mulryan, G.<br />
McKernan, J. See Sylvestni, Mario F.<br />
McLellan, Graham H. Sea Hickman, Peter K.<br />
McLeod, Dwight P. See Thornes, Heather M.<br />
McMunray, B.. C. See Bankson, D. D.<br />
McNair, P. See Frandsan, N.J.<br />
McNally, A. J. See Donohue, D.; Niadbala, R. S.;<br />
Petras, S.<br />
-; Dula, B.; Ng, C.; Ursall, E.; Schwartz, A.;<br />
Bleile, D.; Usategui, M., 972<br />
McNamara, Judith H.; Campos, Hannia;<br />
Ordovas, Jose M.; Schaefer, Ernst J.; Albers,<br />
JohnJ., 897<br />
McPartland, K. Sea Chang, C.; Chang, Charles<br />
McPherson, R. A. See Abbondanzo, Susan L.<br />
McPherson, Richard A. Sea Agarwal,<br />
Raghunath P.<br />
McQuay, H. J. See Hand, C. W.; Moore, K. A.;<br />
Stewart, A.<br />
McWhinney, B. C. See Cowley, D. M.<br />
McWhinney, Brett C.; Nsgel, Sonja L.; Cowley,<br />
David M.; Brown, Jennifer M.; Chalmers,<br />
AinslayH., 1118<br />
Meade, N. See Donohua, D.; Patras, S.<br />
Meerkin, Matthew See Strauss, Eric<br />
Mehta, Uday See Koch, Thomas K.<br />
Meiklejohn, Barbara A. See Tatrault, Gregory<br />
A.<br />
Meirowitz, Agnes See Yeo, Linda<br />
Meites, Samuel; Bubis, Sylvia, 100<br />
Melby, J. M.; Colvin, S.; Ransom, D. K.; Larniva,<br />
M. L., 881<br />
Melenski, J. J. Sea Combs, G. L.<br />
Mall, L D., Jr. See Paul, B. D.<br />
Melvin, D. B. See Clardy, C. W.; Schroeder, P. J.<br />
Melzi d’Eril, G. V. Sea Rizzo, V.<br />
Melzi d’Eril, Glass Vico See Barti, Giovanni<br />
Mendelsohn, D. See McCulloch, J. C.<br />
Menendez-Botet, C. J.; Stsnkievic, K.;<br />
Schwartz, M. K., 965<br />
Meola, J. Sea Brown, Harold<br />
Mercer, Donald, 991<br />
Merdink, James L See Catlin, Don H.<br />
Margin, A. See Wong, W. L.<br />
Mernick, Holly See Chan, Roulhwai<br />
Merritt, Gerald J.; Hunter, Barney H.; Hall, W.<br />
Carey, 2304<br />
Mertens, Cindy D. See Hughes, Peter E.<br />
Mesonero, Clara See Dufour, D. Robert<br />
Messenger, Koleen K. See Nelson, Christine D.<br />
Messani, Gianni Sea Toda, Bettina<br />
Metaye, T.; Bounaud, J. Y.; Begon, F., 2308<br />
Metzgen, Greg; Kenny, Margaret; Ng, Ronald<br />
H., 443<br />
Metzger, Louis F.; Stauffer, William B.;<br />
Krupinski, Ann V.; Millman, Richard P.;<br />
Cambrowski, George S.; Pack, Allan I., 512<br />
Metzsnann, K. See Dati, Fnancaeco<br />
Meunier, Jerome J. See Chickering, Elizabeth<br />
J.<br />
Meyer, I. J. See Haven, M. C.; Otten, U. T.<br />
Meyanhoff, Mark K., 1061<br />
Mezdoun, H. See Pars, H. J.<br />
Miccoli, Roberto See Lenzi, Silvia<br />
-; Penno, G.; Ciampietro, 0.; Cnistofani, R.;<br />
Piaggesi, A.; Cas, F.; Navalesi, K., 983<br />
Miceli, Caroline See Barnes, Grady<br />
Miceli, Joseph N.; Thinumoorthi, M. C.; Dejani,<br />
Adnan 5., 1030<br />
Michielson, C.; O’Donnell, A.; DiLoro, A.;<br />
Bhargava, A.; Fitzpatrick, J., 993<br />
Mickelson, Kenneth K. See Halter, Catherine<br />
M.; Nelson, Christina D.<br />
Middleton, Julie See King, William J.<br />
Midgley, A. Heas Sea Schrsmm, Willfniad<br />
Midgley, John E.; Moon, Carl K.; Wilkins,<br />
Tenence A., 2145<br />
Midgley, John K. M. See Wilkins, Perence A.<br />
Mifflin, T. E.; Savory, J., 963<br />
-; Benjamin, D. C.; Forsman, K. W.; Bruns, D.<br />
E., 998<br />
Mifflin, Theodore E. See Bruns, David E.<br />
-; Bruns, David K., 615<br />
Miguares, G. See Lequang, N. T.<br />
Mikami, Takeshi See Pojo, Minehiro<br />
Mikhnovsky, Eugene See Dufour, D. Robert<br />
Mikkelsen, Donald J. See James, Kent R.<br />
Mikkelsen, G. See Clatt, C.<br />
Miles, Andrew See Majumdar, Sisir K.<br />
-.; Philbnick, David K. S.; Thomas, D. Roger;<br />
Cray, Joseph, 1295<br />
-; Phomes, D. Roger; Cray, Joseph E.; Pugh,<br />
Andrew J., 1957<br />
Miles, S. See Hillyard, C. J.<br />
Milhaud, Gerard See Piketty, Marie-Liesse<br />
Millan, A.; Conte, A.; Carcia-Raso, A.; Greece, F.,<br />
1259<br />
Miller, Barbara B. See Miller, Dayton P.<br />
Miller, Dayton T.; Miller, Barbara B.; Maggio,<br />
Vincent L., 1004<br />
Miller, Irene L; Lott, John A., 996<br />
Miller, J. M. See Sniegoski, L. P.<br />
Miller, Kink See Dufour, D. Robert<br />
Miller, M. Sea Ryan, P. J.<br />
Miller, Peter; Taylor, Frances, 614<br />
Miller, H. See Camrubba, Janet M.<br />
Miller, Ralph K See Stahlschmidt, Cell E.<br />
Miller, Richard See Koch, David<br />
Miller, W. Greg See Armitage, Edwin K.; Jay,<br />
Dennis W.<br />
-; Armitaga, Edwin K., 942<br />
-; Armitaga, Edwin K., 1198<br />
Miller, W. K.; Benner, C. W.; Charlton, R. Ft.;<br />
Hutson, D. K.; Lau, H. P.; Leflar, C. C.;<br />
Luddy, M. A.; Pagels, W. K.; Pankratz, P. J.;<br />
Vickery, D. K.; Yang, E. K., 920<br />
Miller, Warren K. See Birkmayer, Richard C.<br />
Miller, William W.; Yafuso, Masao; Yan, Cheng<br />
F.; Hul, Henry K.; Anick, Steven, 1538<br />
Millman, Richard P. See Matzger, Louis F.<br />
Millner, S. N., 925<br />
Mime, D. B. See Gallagher, S. K.<br />
Milner, John K. See Barlow, Ian M.<br />
Mindicino, H. See Baran, M.<br />
Mirabel, Jose L See Zugaza, Carmen<br />
Mirza, P. See Marcus, M.<br />
Misaki, Hideo Sea Imamura, Shgeyuki<br />
Misiak, Paul M.; Kauffman, K. E., 1019<br />
Mitchell, D. R. See Konstantinides, Frank N.<br />
Mitchell, John M. See Paul, B. D.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2349
Mitchell, M. L.; Harmos, K. J.; Moses, A. C., 536<br />
Miura, M. See Komods, T.<br />
-; Matsuzaki, H.; Koyama, I.; Okano, K.;<br />
Sakagishi, Y.; Komods, P., 999<br />
Miya, Terry G.; Wu, James T.; Knight, Joseph<br />
A., 922<br />
Miyada, D. S. See Campbell, D. J.<br />
Miyada, Don S. See Hartman, Burr<br />
Miyai, Kiyoshi See Hate, Naoshiga; Iwatani,<br />
Yoshinoni; Yamaguchi, Yoshihisa<br />
Miyamoto, S. See Lin, Spencer H.<br />
Mizrahi, I. A. See Osaki, S.<br />
Mizzer, J. P. Sea Obzansky, D. M.<br />
Mizzer, John P. See Pierson-Perry, James F.<br />
Mock, Graham See Rashtchian, Ayoub<br />
Moghaisi, F. See Bigdeli, M. G.<br />
Monfiston, B. See Butt, A. M.<br />
Monji, Nobuo Sea Auditone-Hargraaves, Karen<br />
Monsour, L. See Konstantinides, Frank N.<br />
Montalbano, G. See Bailey, Anne L.<br />
Montalbetti, Norberto See Zoppi, Francesco<br />
Montani, A.; Vimercati, M. K., 1474<br />
Monteith, Mabel See Chu, Samuel Y.<br />
Monti, Jean Pierre; Martinez, Sylvia; Bnaguan,<br />
Diane; Courtina, Christine; Francois,<br />
Georges; Cravat, Aima, 2284<br />
Monti, Jean-Pierre; Callice, Philippe; Bass,<br />
Mahmoud; Munisasco, Antoine; Cravat,<br />
Aime, 76<br />
Moody, Carolyn See Kirkpatrick, Marilyn<br />
Moon, Carl R. See Midglay, John E.<br />
Mooney, Cathryn H. See David, Joan A.<br />
Moore, Eddie C. See Love, James E., Jr.<br />
Moore, Frank See Ladouceur, P. K.<br />
Moore, M. See Hardy, Robert<br />
Moore, K. A. See Hand, C. W.; Smith, R. F.;<br />
Stewart, A.<br />
-; Hand, C. W.; Sear, J. W.; McQuay, H. J., 969<br />
Moore, Terry L See Alexander, Roy L.<br />
Mora-Brugues, J. See Rodriguez-Espinosa, J.<br />
Morales, Antonio J.; Goldsmith, Barbara M.,<br />
964<br />
Moran, K. F. See Allen, B. K.; Ballantyne, D. B.<br />
Morelet, L. See Cynoben, L.<br />
Morgant, G. See Cynoban, L.<br />
Mongers, J.; Bentley, A.; Doherty, K.; McGinnis,<br />
S.; Vulimini, 5., 944<br />
Mori, Hidemitsu See Iwatani, Yoshinori<br />
Morin, Leo G. See Austin, Garth E.<br />
-; Barton, Earl C., 288<br />
-; Austin, Garth E.; Burkhalten, Ann, 692<br />
Morosini, Lorenso See Dall’Anna, Lucio;<br />
Franceschin, Anmando<br />
Morris, David A. N. See Luke. Karl K.<br />
Morris, Kelly See French, Carol<br />
Morris, H. W. See Thompson, M. B.<br />
Morten, Helen See Barnes, Diana M.<br />
Mosca, A. See Bonini, P. A.<br />
Mosca, Andrea See Staley, Michael J.; Zoppi,<br />
Francesco<br />
-; Carenini, Angelo; Zoppi, Francasco;<br />
Carpinelli, Assunta; Banfi, Ciuseppe;<br />
Ceriotti, Fernuccio; Bonini, Pierangelo;<br />
Pozza, Guido, 1141<br />
Moscanello, MA. See Macpherson, Nicol<br />
Moscone, Daniia Sea Mascini, Marco<br />
Moses, A. C. See Mitchell, M. L.<br />
Moses, G. C.; Henderson, A. R., 2111<br />
Moshides, James See Strauss, Eric<br />
Moshides, James 5., 1467<br />
Moss, C. Wayne See Psu, Chou-Pong<br />
Moss, Donald W. See Echetebu, Zeinep 0.<br />
Moss, G. S. See Sehgal, H. L.; Sehgal, L. K.<br />
Motohara, K. See Widdershovan, J.<br />
Moya, M. See Ballesten, I.<br />
Moyer, T. P. See Hills, L. P.<br />
Moyer, Thomas P. See Scott, Richard E., 878<br />
Mucke, K. See Rotha, A.<br />
Mueggler, P. A. See Hayes, L. W.<br />
Muagglar, Paul A. See Hayes, Lyle W.; Shaikh,<br />
Iqbal M.<br />
Mueller, Patricia W.; Phillips, Donald L.;<br />
Steinberg, Karen K., 363<br />
-; MacNeil, Mary Louise; Steinberg, Karen K.,<br />
1000<br />
Mueller, Rudolph G., 1108<br />
Mueller, Willys F. See Varnill, Harland L.<br />
Muesing, H. See Smith, S. J.<br />
Mukadam, Hyder All See Ng, Ronald H.<br />
Mukadani, HydenAli See Ng, Ronald H.;<br />
O’Neill, Mary<br />
Mukanjee, A. See Zachariah, N. Y.<br />
Mukanjee, H., 418<br />
Mulder, J. Sea Waijers, K. N. M.<br />
Mule, S. J.; Cross, S. J., 613<br />
Mull, Deborah See Reason, Craig<br />
Mullen, H. A. C. See Albrecht, J.<br />
Mullen, Jaan-Yves See Lefrere, Jean-Jacques<br />
2350 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Muller, Jocalyne See Schiele, Fnancoise<br />
Muller, L.; Phillipou, C., 256<br />
Muller-Eberhard, Hans J., 863<br />
Mullins, Marvin See Truscott, Gail, 932<br />
Mullins, Richard E.; Bennett, Beth; Hunter,<br />
Robert L., Jr., 193<br />
-; Gabhsrt, Suzanne S. P.; Wheaton, Robert N.,<br />
1002<br />
Mullins, Richard H. Sea Austin, Garth E.<br />
Mullon, Claudy J.-P.; Langer, Robert, 1822<br />
Mulryan, G.; Brazil, N.; Day-Cody, D.; McKeon,<br />
P., 1944<br />
Munneke, Gretha H. See van den Berg. Cite A.<br />
Munson, Laurel A. See Valenzuela, Guillermo J.<br />
Munson, Sara See Goldsmith, Barbara M.<br />
Mura, Patrick; Castel, Olivier; Cros, Nathalie;<br />
Suire, Roger, 716<br />
Murakoao, Keiko See Kobayashi, Kunio<br />
Munisasco, Antoine See Monti, Jean-Pierre<br />
Murphy. Anne; Dalal, Fram K., 954<br />
-; Hsvssaey, Joann; Clamant, Gerald K., 954<br />
Murphy, Beverly K. Pearson; Barta, Alice, 1137<br />
Murphy, Edna; Ophovan, Jan C.;<br />
Chockalingam, Uma M.; Ceongieff, Michael<br />
K., 934<br />
-; Ophoven, Jan C.; Gaorgieff, Michael K.;<br />
Chockalingam, Uma M., 934<br />
-; Ophoven, Jan C.; Chockalingam, Uma M.;<br />
Ceorgieff, Michael K., 1030<br />
Murphy, Margaret See Malikin, Calina<br />
Murphy, P. See Shukla, R.<br />
Murphy, Robert F.; Balls, Frank M.; Poplack,<br />
David C., 2299<br />
Murray, C. Sea Kubasik, N. P.<br />
Musitelli, Claudio See Banti, Giovanni<br />
Musk, Alexander A. See Hickman, Peter E.<br />
Muskiet, Fritz A. See van den Berg, Cite A.<br />
Myers, Gary L; Cooper, Gerald R.; Sampson,<br />
Eric J.; Schaffar, Robert, 894<br />
Myers, L. S. See Myers, M. M.<br />
Myers, M. M.; Myers, L. S.; Fitzpatrick, J. K.;<br />
Bhargava, A. K., 965<br />
Myra, S. A. See Clardy, C. W.; Schroeder, T. J.<br />
Nachtigal, S. See Brown, W. J.<br />
Nagainis, P. A. Sea Chandler, H. M.<br />
Nagatsu, Toshibaru See Hagihara, Masako<br />
Nagel, Sonja L. See McWhinnay, Brett C.<br />
Nagey, David A. See Koch, Thomas K.<br />
Naldoo, Daya See Colas, Philip; Graham, Peter<br />
Nain, B. H. See Reddy, M. Narahari<br />
Naito, Herbert K. See David, Joan A.<br />
-; David, Joan A.; Pakai, Joseph, 898, 1051<br />
Najjar, M. F.; Hamdi, A.; Cuizani, L.; Susini-Da<br />
Luca, H.; Hannessen, U.; Chihi, A.; Oueslati,<br />
A.; Ben Amor, M. A.; Amamou, K.; Achour,<br />
H.; Zouaghi, H., 907<br />
Naka, Keiichi See Yoshikawa, Chikao<br />
Nakagawa, C. H. See Chandler, H. M.<br />
Nakagawa, Yoichi See Matsue, Hajima<br />
Nakajima, Moto-o Sea Shirokane, Yoshio<br />
Nakamura, S.Sea Abe, Akira<br />
Nakashima, Koji; Takei, Hitoahi; Nasu,<br />
Yukihiro; Andoh, Yukio, 708<br />
Nakate, H. See Sate, K.<br />
Nandedkar, Arvind K. N.; Malhotra, Harish C.,<br />
1036<br />
Nanduni, Venkata B. See Kohl, Herbert H.<br />
Nanji, Amin A.; Sincennes, Fnancine; Poon,<br />
Raymond; Hinberg, Irwin, 915<br />
-; Sincennes, Francine; Poon, Raymond;<br />
Hinberg, Irwin, 1254<br />
-; Sincennes, Francine; Poon, Raymond;<br />
Hinbeng, Irwin, 1255<br />
-; Sincannes, Francine; Poon, Raymond;<br />
Hinbang, Irwin, 1255<br />
Nanayanan, S. See Foglia, J. P.; Peral, J. M.;<br />
Stiller, K. L.; Wong, Stephen H.-Y.<br />
Nanio, A. See Johnston, D.<br />
Nashel, David See Dufour, D. Robert<br />
Nasu, Yukihiro See Nakashims, Koji<br />
Nathan, L E. See Maciajko, J. J.<br />
Naujoks, K. See Gerber, M.<br />
Navajo, Jose A. See Buitrago, Jose M. Gonzalez<br />
Navalesi, H. See Miccoli, Roberto<br />
Navalesi, Renzo Sea Lenzi, Silvia<br />
Navarro, Adoracion See Viadma, Jose A.<br />
Navarro, J. See Machand, Martine<br />
Navanro, M. A. See Bonnin, M. K.<br />
Naylor, N. See Johnston, D.; Sawell, C. E.<br />
Nazareth, A. See Chang, C.<br />
Nealon, Linda Sea Kehak, Nadja N.<br />
Neany, Richard H.; Gowland, Eric, 1163<br />
Nec, Patrick A.; Scene, Andrew C.; Lavelle,<br />
Peter H.; Fellows, Ian W.; Hill, Peter C.,<br />
1083<br />
Neelkantan, Neal V. Sea Birkmeyer, Richard C.<br />
Naely, H. See Witherspoon, L.<br />
Neely, Harold See Witherspoon, Lynn<br />
Neiden, K. See Churala, H. R.<br />
Nelson, Christine D.; Acrey, Charlotte L.;<br />
Claybonn, Joan K.; Claments, Helen M.;<br />
Messenger, Koleen K.; Mickalson, Kenneth<br />
E., 1017<br />
Nelson, Gene See Winiarski, Ralph<br />
Nelson, L. D. See Steele, B. W.<br />
Nelson, N.; Finnstrom, 0.; Larason, Lease, 1030<br />
Nelson, Robert K.; Ranganathan, C.; Jiang, N.-<br />
S., 893<br />
Neptun, D. A. See Phompson, M. B.<br />
Nan, A. Sea Jones, A. W.<br />
Nespolo, A.; Bianchi, C.; Salmaggi, A.; Cemrato,<br />
D., 1669<br />
Ness, Hhonda See Massey, Thomas<br />
Nevius, M. C. Sea Pardue, Harry L.<br />
Nevius, Marilyn Croegen See Pardue, Harry L.<br />
Newman, H. A. I. See Noel, S. A.<br />
Nezo, Ebbs See Hansen, Steen Ingemann<br />
Ng, C. Sea McNally, A. J.<br />
Ng, M. L; Kajns, A.; Khalid, B. A. K., 2286<br />
Ng, Ronald H. See Ethirsjan, Sukumar;<br />
Matzger, Greg; O’Neill, Mary<br />
-; Altaffan, Macia; Statland, Bernard E., 913<br />
-; Altaffar, Marcia; O’Neill, Mary; Mukadam,<br />
HyderAli; Statland, Barnard E., 937<br />
-; Altaffer, Marcia; Mukadam, HyderAli;<br />
O’Neill, Mary; Ststland, Barnard K., 937<br />
-; Ethirajan, Sukuma; O’Neill, Mary; Statland,<br />
Bernard E., 1484<br />
-; Altaffer, Marcia; O’Neill, Mary; Mukadam,<br />
Hyder Ali; Statland, Barnard K., 1911<br />
-; Altaffar, Marcia, 1943<br />
Ng, V. L; Hadley, W. K.; Khsyam-Bashi, H.;<br />
Hwang, K. M.; McGrath, Michael S., 1028<br />
Nguyen, P. H. See Rowley, C. L.<br />
Nguyen, Phuc H. See Henniksson, Thomas;<br />
Louie, Alan<br />
Nguyen, S. Q.; Rice, L. S., 967<br />
Nguyen, T. See Nielsen, L.<br />
Nguyen, Van Gee See Speich, Michelle<br />
Ni, W. C. See Smith, D.<br />
Nichols, D. See Kubasik, N. P.<br />
Nicolas, Guy See Speich, Michelle<br />
Nicoloff, John See Spencer, Carole<br />
Nicot, G.; Lachatre, (,.; Gonnat, C.; Dupuy, J.-L.;<br />
Valatte, J.-P., 1796<br />
Niadbala, R. Sea Donohua, D.; Petras, S.<br />
Niedbala, K. S.; Patras, S.; Fulton, C.; McNally,<br />
A. J.; BIde, D.; Usategui, M., 973<br />
Nielsen, L.; Johnson, L. R.; Nguyen, T.; Knauth,<br />
C.H., 1014<br />
Niki, Yoshihito Sea Umeki, Shigenobu<br />
Niinrod, C. See Kaane, P. M.<br />
Nisbet, Jennifer A.; Jomain, Patricia A., 1672<br />
Nishi, Motoi See Hanai, Junji<br />
Nishi, Sueo See Takatsu, Akiko<br />
Nishlkawa, Alma See Wu, Alan H. B.<br />
Nishiki-Flnlay, K. See Yu, Stephen S.<br />
Nishina, Toshihiro See Kojima, Tsukasa;<br />
Sakuma, Kyozo<br />
Nishioka, Kusuki See Kojima, Tsukasa<br />
Nishitani, H. See Okamura, S.<br />
Nisselbaum, J. See Schwartz, M. K.<br />
-; Smith, C.; Schwartz, D.; Schwartz, M. K., 924<br />
Nisselbaum, Jerome S., 1496<br />
Nmswander, Christine A. See Piran, Un<br />
Niwa, Masaharu, 1294<br />
Niwa, Toshimitsu See Pakads, Naohito<br />
Noble, Willa See Jack, Khona M.<br />
Noda, Takashi Sea Ichiki, Hitoshi<br />
Nodes, K. See Lewis, C.<br />
Noe, Beverly See Hollins, Battye<br />
-; Henderson, J. Michael; Kutner, Michael H.,<br />
420<br />
Noe, Constance Sea Cabana, Veneracion C.<br />
Noel, S. A.; Newman, H. A. I.; Tehim, A.; Witiak<br />
D. P.; Feller, D. K., 895<br />
Noguchi, Makoto See Oka, Kitaro<br />
Noguchi, Masato; Adachi, Hideki; Aoki, Etsuo;<br />
lids, Yasuhiro; Kasagi, Kanji;Endo, Keigo;<br />
Konishi, Junji; Tonizuka,Ksnji, 97<br />
Noian, Chris; Przywara, Louisa; Weigand, Ray;<br />
Raain, Shanthi, 1105<br />
Nolan, L. See Chang, C.<br />
Nomoto, Show; Shoji, Shin ichi, 2004<br />
Nomura, Yasushi; Imai, Kyoko; Suzuki,<br />
Masumi; Okuda, Kiyoshi, 1565<br />
Norden, Anthony G. W.; Fulcher, Lash M.;<br />
Heys, Anthony D., 1433<br />
Norman, Robert; Buck, K. H.; Joubert, S. M.,<br />
889<br />
Norman, Robert J.; Haneaf, Kaazia; Buck,<br />
Robert H.; Joubent, Saptimus M., 1147<br />
Norton, Gary; Novros, J.; Jacobs, M.; Li, Z.,<br />
1023<br />
Notcha, M. Sea Colette, J.<br />
Noun, N. See Rosen, Michael
Novros, J. Sea Norton, Gary<br />
Novnos, Joel; Bodman, V.; Jacobs, M., 1007<br />
Novy, Miles J. See Ivie, Wm. Michael<br />
Nowiuski, Robert C. Sea Auditore-Hargreaves,<br />
Karen<br />
Nozaki, Osamu; Ohata, T.; Ohba, Y., 1026<br />
Nozaws-Ung, Kathleen See Nussbaum, Samuel<br />
K.<br />
Nugant, 13. W.; Doyle, C.; Fottrell, P. F., 1671<br />
Nusbaum, Kenneth K. See Kohl, Herbert H.<br />
Nussbaum, Samuel H.; Zahradnik, Richard J.;<br />
Lavigna, Jeffrey K.; Brennan, Ceorga L.;<br />
Nozawa-Ung, Kathleen; Kim, Lance Y.;<br />
Keutmann, Henry P.; Wang, Chiu-An; Potts,<br />
John T., Jr.; Segre, Gino V., 1364<br />
Nybeng, S. A. Sea Diamond, S. K.<br />
Nystrom, Ernst See Lindstedt, Conan<br />
Lindstedt, Conan; Lundberg, Per-Anna;<br />
Lundholm, Kent; Smith, Ulf, 429<br />
Nyyssonen, Kristiina; Parvianinen, Markku P.,<br />
1938<br />
O’Boyle, Elizabeth See Rule, Allyn H.<br />
O’Brien, John F. See Branum, Earl; Pruett,<br />
Sara<br />
O’Brien, Joseph E. Sea Cambino, S. Raymond<br />
O’Bnoin, Sean 13.See Kellehar, Brian P.<br />
Obzansky, 13.M.; Roy, S. B.; Kautela, C. S.;<br />
Mizzar, J. P.; Koch, T. K., 949<br />
-; Roy, S. B., 976<br />
Obzansky, David M. See Pierson-Perry, James<br />
F.<br />
Ochs, Luann, 1953<br />
O’Connell, Christina See Austin, Cath E.<br />
Odell, Joan See Prease, Lynna<br />
Odell, William D.; Griffin, Jeanina, 1603<br />
O’Donnell, A. Sea Michelson, C.<br />
-; Fitzpatrick, J. K.; Santiano, S.; Han, P.;<br />
Bhsrgava, A., 904<br />
O’Donnell, C. Michael See King, David L.<br />
Oei, T. See Ryder, K.<br />
Oeltgen, Peter H.; Welborn, John K.; Burgess,<br />
Mark S., 939<br />
Oeseburg, B. See Kwant, Gerard; Zijistra,<br />
Willem C.; Zwart, A.<br />
Oaseburg, Barend; Ligtenberg, H. C. C.; Meas,<br />
A. H. J.; Zijistra, W. C., 960<br />
Oestarling, Joseph Sea Rock, Robert C.<br />
Oestenling, Joseph K. Sea Chan, Daniel W.<br />
Ogawa, Zensuke See Aoki, Yoshikszu<br />
Ogihana, Toshio See linuma, Kazushiga<br />
O’Gnady, Patrick Sea Ivia, Wm. Michael<br />
Ohata, T. See Nozaki, Osamu<br />
Ohba, Y. See Nozaki, Osamu<br />
Ohhashi, Masaru See Hsgihara, Masako<br />
Ohkawa, Jiro See Yoshikawa, Chikao<br />
Ohueck, Barbara See Villa, Barbara<br />
Oka, Kitano; Noguchi, Makoto; Kitamura,<br />
Poshinori; Shims, Satonu, 1639<br />
Okaniuna, S.; Haga, K.; Babe, H.; Hayashi, S.;<br />
Nishitani, H., 2306<br />
Okano, K. Sea Komoda, P.; Miura, M.<br />
Okorodudu, A. 0.; Pellatier, P. K.; McComb, R.<br />
B.; Bowers, G. N., Jr., 993<br />
Okonodudu, Anthony See Syad, D. B.<br />
Okuda, Kiyoshi Sea Nomura, Yasushi;<br />
Yoshikawa, Chikao<br />
Okusi, J. See Kleesiek, K.<br />
Olazabal, 13. A. Vazquaz H. Sea Pnemachandra,<br />
P.<br />
O’Leary, Niall; Brophy, Kevin; Duggan, P.<br />
Finbarr, 615<br />
O’Leary, Thomas D. See Badenoch, Jane L.<br />
Olsson, Andens C. See von Schanck, Henning<br />
Olsson, Pen-Olof See Arnqvist, Hans<br />
O’Neill, Mary See Ethirsjan, Sukumar; Ng,<br />
Ronald H.<br />
-; Mukadam, HyderAli; Altaffer, Marcia; Ng,<br />
Ronald H.; Statland, Bernard E., 937<br />
Ong, C. N.; Lea, B. L.; Ong, H. Y.; Jaecob, K.,<br />
1262<br />
Ong, H. Y. Sea Ong, C. N.<br />
Onishi, Patrick See Kiang, John J.<br />
Onishi, Tomoyuki See Lau, K.-H. William<br />
Ool, D. S. See Perkins, S. L.<br />
Ooi, Daylily S. Sea Hallworth, Michael J.<br />
Ooi, T. C. See Kiss, Z.<br />
Opheiin, Kent E. Sea Hursting, Marcia J.<br />
Ophoven, Jan C. See Murphy, Edna<br />
Opplt, Jan J.; Haghighi, All Z., 896<br />
Ordonez-Llanos, J. See Rodriguez-Espinosa, J.<br />
Ondovas, Jose M. See McNamara, Judith K.<br />
O’Reilly, D. St. J. See Harrison, Stephen P.<br />
Oneopoulos, Dimitrios Sea Crass, Linda<br />
Onget, L See Bounaud, M. P.<br />
Orr, Z. Shag See Beck, K.<br />
Onnell, J. M. See Dominiczak, M. H.<br />
-; Pettigrew, A. R.; Dominiczak, M. H., 1078<br />
Orsonneau, J. L.; Blanchardie, P.; Lustenberger,<br />
P.; Bernard, S., 616<br />
Orsulak, P. J. See Haven, M. C.<br />
-; Haven, M. C.; Huth, J. A.; Studts, D. J., 1024<br />
Orsulak, Paul J. See Haven, Mary C.<br />
-; Haven, Mary C.; Huth, Jeffrey A.; Studts,<br />
David J., 1471<br />
Osaki, S.; Mizrahi, I. A.; Steusloff, P. M.; Seaton,<br />
C. B.; Eure, K. L., 967<br />
Osborne, Susan See Conan,Marshall P.<br />
O’Shea, J. P. See Rao, C. V. K.<br />
O’Shea, Kaylene See Boutagy, John<br />
Osikowicz, Gene; Garner, William; Kozuk,<br />
Perry; Irmen, Judy; Kashik, Mark; Butler,<br />
Mary; Vanderbilt, Anne S.; Sellers, Don, 883<br />
-; Straup-Brynas, Inge; Kucers, Bob;<br />
Vanderbilt, Anne S., 885<br />
Osio, Licia Sea Cianazza, Klisabetta<br />
Osterloh, John See Hsiah, Shanie W.; Yu,<br />
Stephen S.<br />
Osuch, Mary Ann V.; Lee, James K.; Prusinski,<br />
Klizabeth A., 952<br />
O’Sullivan, D. J. Sea Penney, M. D.<br />
O’Sullivan, M. Sea Heal, A.<br />
Otley, M. J. Sea Caffo, A. L<br />
Ottaviani, Margaret See Kashtchian, Ayoub<br />
Otten, U. T.; Haven, M. C.; Meyer, I. J.; Makin,<br />
K. 5., 977<br />
Ou, Ching-Nan See Rognarud, Cheryl L.<br />
-; Duong, Ly Thi; Grove, Rebecca C.; Rognerud,<br />
Cheryl L.; Pam, Kstella L.; Walker, Dee Ann,<br />
1001<br />
Oueslati, A. See Najjar, M. F.<br />
Oulad, A. A. See Bernard, A. M.<br />
Overfield, C. V.; Ellis, Kathy J.; Lonton, Linda<br />
5.. 743<br />
Oversteegen, H. J.; da Boar, J.; Bakkar, A. J.;<br />
van Leeuwan, C., 720<br />
Owings, J. H. See Burtis, C. A.<br />
Pacheco, A. M.; Romfh, P. C., 913<br />
Pack, Allan I. See Matzgar, Louis F.<br />
Padmore, G. H. A.; Padmora, S. F., 1695<br />
Padmore, S.F. Sea Padmore, C. K. A.<br />
Pagani, Franca See Panteghini, Mauro<br />
Pagels, W. H. See Miller, W. K.<br />
Painter, Pennall; Evans, John; Bailey, Kim;<br />
Cope, June, 885<br />
Paksi, Joseph Sea Naito, Herbert K.<br />
Pal, B.; Griffiths, I. D.; Katrak, A.; Junglee, D.;<br />
Dandona, P., 305<br />
Palmer, Harvey J. See Columbus, Richard L.<br />
Palmer, John; Avelino, Evangelita, 961<br />
Palombo, John D.; Bistnian, Bruce K.;<br />
Blackburn, George L., 308<br />
Pandian, M. R.; Calton, Esther; Fisher, Delbert,<br />
921<br />
Pandov, H. I. See Paylon, A. J.<br />
Pandov, Harry See Lawson, Nigel<br />
Pankey, Sue See Bartlett, Clifford<br />
Pankowsky, Dan A. See Hamlin, Cliva K.<br />
Panknatz, T. J. Sea Miller, W. K.<br />
Pankratz, Thomas J. See Binkmayar, Richard C.<br />
Pannall, Peter R. Sea Buttery, Joseph K.<br />
Panosian, Kim J. See Bookbinder, Michael J.<br />
Panteghini, Mauno; Pagani, Franca; Cuccia,<br />
Claudio, 67<br />
-; Payne, K. B.; Faye, Sherry, 625<br />
-; Pagani, Franca, 989<br />
-; Pagani, Franca, 2039<br />
Panzali, A. See Albertini, Alberto<br />
-; Signonini, C.; Albertini, A., 2311<br />
Papadopoulos, N.M. See Costello, K.<br />
-; Costello, K., 905<br />
Papadopulo, I.; de La Farga, F.; Braun, J. P.;<br />
Valdiguie, P.; Rico, A. C., 1081<br />
Paquet, R. See Brown, Harold<br />
Paquet, H. J. See Price, Gary<br />
Pardue, Harry L See Cummings, K. Harris;<br />
Waiser, William E.<br />
-; Bacon, Bonnie L.; Navius, Marilyn Groegar;<br />
Skoug,JohnW., 278<br />
-; Skoug, J. W., 917<br />
-; Bacon, B. L.; Navius, M. C.; Skoug, J. W.,<br />
1009<br />
Parades, C. Sea Pontolas, M.<br />
Parades, M. J. See Diamond, S. K.<br />
Panenta, M. See Pepin, Karen<br />
Panham, Marc See Rudolph, Julie<br />
Parish, Edward J. Sea Kohl, Herbert H.<br />
Parker, Donald H., 1019<br />
Parker, James K. See Klein, Signid M.<br />
Parker, K. Michael; White, Betty N.; Beattie,<br />
David J., 977<br />
Parker, N. C. Sea Cardalla, D. S.; Kifai, N.<br />
Parkinson, Ian S.; Sheldon, William L.; Laker,<br />
Michael F.; Smith, Percy A., 1203<br />
Parks, Penelope J.; Thibodeau, Stephen N.,<br />
1258<br />
Pan, F. F. See Bradley, C. A.<br />
Parl, Fritz F. See Bradley, Charles A.<br />
Parlay, E. See Blaabjerg, Ole<br />
Panmantier, M. See Collatte, J.<br />
Parnham, A. J.; Parbit, I. F., 1421<br />
Parra, H. J.; Mezdour, H.; Cachera, C.; Dracon,<br />
M.; Pacquet, A.; Fruchart, J. C., 721<br />
Parrish, Richard F. See Chen, Koulhwsi<br />
Parsons, George See Rashtchian, Ayoub<br />
Parvianinen, Markku T. See Nyyssonen,<br />
Kristiina<br />
Pascall, Enzo See Pezzoli, Antonio<br />
Pascual, C. See Komay, Ch.<br />
Pasqua, J. See Wileezek, R.<br />
-; Roman, J.; McGinnis, S.; Vonmbnock, K., 949<br />
Pasquet, Luz See Lineback, Janet<br />
Passa, Philippe See Mare, Michel<br />
Passerini, L See LeCatt, Donald F.<br />
Passey, Richard B. See Blick, Kenneth K.<br />
-; Maluf, Karen C.;Allen, Steven K., 1009<br />
Passler, Dorayne Sea Welch, Robin<br />
Patel, Malti See Shine, Brian<br />
Patel, V. S.; Manes, M. E.; Singh, P.; Sheiman,<br />
M., 1015<br />
Paterson, D. See Manimakalai, S.<br />
Paterson, Jennifer L. See Burnin, Jacky M.<br />
Patonay, Gabor See Psu, Chou-Pong<br />
Patach, Josef H. See Drezel, Heinz<br />
Patsch, W. See Kirkpatrick, D.; Smith, S. J.<br />
Pau, Chou-Pong; Patonsy, Cabor; Moss, C.<br />
Wayne; Hollis, Dannie; Carlone, George M.;<br />
Plikaytis, Brian D.; Warner, Isish M., 377<br />
Paul, B. D.; Mitchell, John M.; Mdl, L. D., Jr.;<br />
Sroka, R.; Irving, J., 971<br />
Paula, Robert C., 1063<br />
Payne, H. B. See Panteghini, Mauro<br />
Pazzagli, Mario See Tode, Bettina<br />
Peake, Michael See Bakkan,Andries J.<br />
Pearlinan, K. S. See Fiarack, E. A.<br />
Pearlman, S. See Swiraki, C.<br />
Pearson, J. H. See Bakes-Martin, K. C.; Romfli,<br />
P.C.<br />
Pedersen, C.; Ward, C.;Gaff, S.; Usategui, M.,<br />
973<br />
Pedromingo, A. See Lopez, A.<br />
Pei, Patrick; Vonderschmitt, D. J., 1005<br />
Pejacovic, Maria See Bakkan, Andrias J.<br />
Pekary, A. E. Sea Smith, V. P.<br />
-; Smith, V. P.; Harshman, J. D.; Harshman, J.<br />
M., 881<br />
Pekary, A. Eugene Sea Lee, Hsin-Yu<br />
Pall, Michael A. See Schran, Horst F.<br />
Pelladeau, ML. See Lequang, N. T.<br />
Pellar, Thomas C.; Leung, Fred Y.; Henderson,<br />
A. Ralph, 983<br />
Pelletier, Omen; Arratoon, Cheryl, 1397<br />
-; Wright, Leebert A.;Breckennidge, W. Carl,<br />
1403<br />
Pellatier, P. R. See Okorodudu, A. 0.<br />
Pena, Maria Isabel Arranz; Lope, Knrique<br />
Ssanz, 812<br />
Penn, Yolanda Sea Wong, Stephen H.-Y.<br />
Penberthy, Lloyd A. See Shephard, Mark D. S.<br />
Pendargrass, J. H. See Skjold, A. C.<br />
Pendergrass, James; Skjold, Arthur C.; Steven,<br />
Lon K., 981<br />
Pennell, B. J. See Feld, K. D.<br />
-; Johnson, C. F.; Fald, K. D., 903<br />
-; Fald, K. D., 961<br />
Pennell, Beverly See Hoffman, Richard J.<br />
Penney, M.D.; O’Sullivan, D. J., 170<br />
Pennington, Robin M.; Krenc, C. A.; Ehrlich, S.<br />
A.; Valdivia, L., 906<br />
Penno, G. See Miccoli, Roberto<br />
Penton, Zalda, 2094<br />
Papin, Karen; Parente, M.; Vallejo, K.; Yeh, S.;<br />
Simon, F., 892<br />
Panel, J. M. See Foglia, J. P.; Stiller, K. L.<br />
-; Foglia, J. P.; Birder, L.; Lin, F. C.; Narsyanan,<br />
S., 1025<br />
Perkins, S. L.; Ooi, D. S., 1944<br />
Perkins, Sherry L See Hallworth, Michael J.<br />
Penman, Jay A. Sea Flick, Jonathan A.<br />
Perry, Billy See Doumas, Basil T.<br />
Perry, H. See Collinsworth, W. L.<br />
Perry, K. J. See Boctor, Fousd N.<br />
Peace, A. J. See Clardy, C. W.; Schroeder, P. J.<br />
Peace, Michael A.; Giacomo, Donald F., 311<br />
-; Ciacomo, Donald F., 1000<br />
-; Bodourian, Selma H., 1016<br />
Pessa, Lisa See Welch, Robin<br />
Peter, F.; Wang, S. T.; Strunc, C., 881<br />
Peter, J. B. See Boctor, F. N.; Bocton, Fousd N.<br />
Peters, Jeffrey L See Wu, James P.<br />
Peters, K. H. M.; Colbach, A. J.; van den Bergh,<br />
F.A.J.P.M., 1248<br />
Peters, Theodore, Jr., 1317<br />
Petersen, J. H.; Scott, M. C.; Lyle, L. K.;<br />
Bunlaigh, B. D.; Daughaday, W. H., 893<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2351
Petersen, John R. See Scott, Mitchell C.<br />
Peterson, Charles M. See Jovanovic, Lois<br />
Peterson, Chris L.; Thrasher, K. Douglas, 991<br />
Peterson, Connie L. See Hughes, Peter E.<br />
Paterson, 13. ft. See Kobos, R. K.<br />
Peterson, Kent W., 54B<br />
-; Austin, Roland L.; Gawin, Frank H.; Long,<br />
Karen, 106B<br />
Petidiar, Ann See Valcarcel, Miguel<br />
Petras, S. See Donohue, D.; Niadbala, K. S.<br />
-; Niadbala, R.; Donohue, D.; McNally, A. J.;<br />
Bleile, D.; Usategui, M.; Fnings, C. S.; Meade,<br />
N.; Stephon, K.; Fosry, R., 971<br />
Petterseon, Kim See Hammila, Ilkka<br />
Pettigraw, A. K. See Dominiczak, M. H.; Onrell,<br />
J. M.<br />
Pettitt, Bruce C.; Dyszel, Susan M.; Hood, Lyal<br />
V. S., 1251<br />
Pezzoli, Antonio; Pascali, Enzo, 1923<br />
Phializ, Con J. See Vink, Keas L. J.<br />
Philbnick, David R. S. Sea Miles, Andrew<br />
Phillipou, C. Sea Muller, L.<br />
Phillips, Donald L. See Mueller, Patricia W.<br />
Phillips, E. See Mahaffey, R.<br />
Phillips, J. C. See Kifai, N.<br />
Phillips, Richard N., 908<br />
Piaggasi, A. See Miccoli, Roberto<br />
Piebani, M. See Burlina, A.<br />
Piaper, John A. See Straka, Robert J.<br />
Piaper, Robert K. See Wu, James P.<br />
Pierce, Sue, 957<br />
Piergantili, Carlo Sea Savois, Macella<br />
Pierre, K. See Ladouceun, P. K.<br />
Pierson-Perry, J. F. See Crouse, S. P.<br />
Pierson-Penny, James F.; Obzansky, David M.;<br />
Mizzer, John P., 1630<br />
Piketty, Manie-Liesse; Palbot, Jean-Noel;<br />
Askianazy, Serge; Milhaud, Gerard, 1237<br />
Pillai, D. N., 2122<br />
Pillsworth, Thomas J., Jr.; Haver, Virginia M.;<br />
Abrass, Christine K.; Delaney, Collene J.,<br />
1791<br />
Pilo, A. See Zucchelli, C. C.<br />
-; Zucchalli, C. C.; Chiesa, M. K.; Masini, S.;<br />
Donato, L., 978<br />
-; Zuchelli, G. C.; Chiasa, M. K.; Masini, S.;<br />
Ferdeghini, M., 1694<br />
Pinto, Xavier See Fiol, Concapcio<br />
Pippenger, C. K. See Suit, Paula; Zama, N.<br />
Pinan, Un; Kohn, Diana W.; Uretsky, Laura S.;<br />
Bernier, David; Barlow, Eve H.; Niswandar,<br />
Christine A.; Stastny, Milos, 1517<br />
Pistulka, Louis See Hughes, Peter K.<br />
Pizzocolo, G. See Albentini, Alberto<br />
Plaban, P. See Kiss, Janice<br />
Pleban, Patricia See Gulamali-Majid, Fizza<br />
Plikaytis, Brian D. See Pau, Chou-Pong<br />
Plucinsky, Mark See Curmaci, Barbara L.;<br />
Legenzoff, Denise C.<br />
Plucinsky, Mark C.; Kiser, Ernest J.; Curmaci,<br />
Barbara L., 946<br />
Plumer-Wilk, R. See Hiller, Gerhard<br />
Poapsi, Many See Cohn, Jeffrey S.<br />
Poblador, Jose V.S. Sea Vogalsang, Philip J.<br />
Poe, Brent See Knoll, Martin H.<br />
Poels, L. G. See Boerman, 0. C.<br />
Polister, Peter K., 868<br />
Pollack, L.; Sylvastne, M.; Czarnecky, K.; Kelley,<br />
L.; Keadio, J.; Kutnar, H.; Banan, M., 1015<br />
Pollmann, K. See Fraitag, H.<br />
Polzin, Greg L See Koch, David D.<br />
Ponta, K. Sea Klotzsch, Signid<br />
Poon, Raymond See Hinberg, Irwin; Nanji,<br />
Amin A.<br />
Poortman, Jan See Disz, Dominador<br />
-; Diaz, D. P., 995<br />
Pootrakul, Pensri See Huebers, Hehnut A.<br />
Poplack, David C. See Murphy, Robert F.<br />
Popp, J. A. See Phompson, M. B.<br />
Poppa, W. See Klein, C.; Klein, Cerhard<br />
-; Dubois, H.; Sowodniok, B.; Hubbuch, A.;<br />
Pown, M.-H., 956<br />
Ponath, Jerker 0. See Hutchens, T. William<br />
Portaous, Caroline See Makin, H. L. J.<br />
Portnoy, Sue; Adolf, Paul, 938<br />
Portoles, M.; Jimenez-Nachen, I.; Jonda, A.;<br />
Parades, C., 970<br />
Posay, Yvonne F. See Bradley, Charles A.<br />
Potgiater, G.M. See Vermaak, William J. H.<br />
Potier de Courcy, Genevieve See Canny, Philip<br />
J.<br />
Potter, Joseph L., 1265<br />
-; Silvidi, Anthony A., 2314<br />
Potts, John T., Jr. See Nussbaum, Samuel K.<br />
Poulin, Sue K. See Hudson, Gail A.<br />
Poulsworth, Judy See Ladouceur, P. K.<br />
Powers, fl M. See Lasky, F. D.<br />
-; Leaky, Fred D.; Day, B. S., 909<br />
2352 CLINICAL CHEMISTRY, Vol. 33, No. 12,1987<br />
Powers, Donald M. See Cnendahl, Jan<br />
Pozza, Guido See Mosca, Andrea<br />
Prabhakaran, V. See Vasdev, S.<br />
Prabhakaran, Vanagur M. See Grewal, Kuldip<br />
Pradella, Marco See Donizzi, Romolo<br />
Pragsy, Dasidar A. See Webster, Joseph C.<br />
Pranis, B. See Horsfall, K.<br />
Pranis, Robert; Pisel, William; Honsfall, Kathy,<br />
948<br />
Prssad, S. C. See Smith, S. J.<br />
Pratt, Charles B. See Via, Mary Jane<br />
Preese, Lynne; Erlandson, Gene; Odell, Joan;<br />
Apple, Fred S, 987<br />
Preissnar, C. M.; KIee, C. C., 891<br />
Premachandra, P.; Wood, P. L.; Hill, P. C.;<br />
Browning, D. M.; Olazabal, D. A. Vazquez K.,<br />
851<br />
Prencipe, Lorenzo; Iaccheri, Ennio; Manzati,<br />
Claudio, 486<br />
Pressac, M.; Jardal, C.; Durand, D.; Aymard, P.,<br />
415<br />
Price, C. P. See Trull, Andrew K.<br />
Price, Christopher P. See Clark, Penelope M.<br />
S.; James, David R.<br />
Price, Gary; Paquet, R. J.; Rosa, H. N., 1023<br />
Priest, John H. See Auditone-Hagreaves, Karen<br />
Prior, Thomas W.; Dove, Janet L.; Cruemen, H.-<br />
D., 1034<br />
Pritchard, P.11. See Sparks, D. L.<br />
Prokop, E. K. See Rzasa, Peter J.<br />
Proust, Jacques See Touitou, Yvan<br />
Pruett, Sara See Branum, Earl<br />
-; O’Brien, John F.; Litin, Scott C.; Foreman,<br />
Rodney W., 992<br />
Pruitt, S. P. See Msciejko, J. J.<br />
Pnumke, Hans-Jong See Lamps, Dagma<br />
Pnusinski, Elizabeth A. See Osuch, Mary Ann<br />
V.<br />
Pruvot, I.; Fievet, C.; Fruchart, J. C.; Beuclen, I.;<br />
Salmon, S.; Goldstein, S.; Ayrsult-Jarriar,<br />
M.; Ginault, A., 1070<br />
Pry, T. Sea Crenier, F.<br />
Pry, Terry A. See Grenien, Frank C.<br />
Pnzywana, Louise See Nolan, Chris<br />
Puchois, P. See Koran, E.<br />
-; Luley, C.; Alaupovic, P., 1597<br />
Pudek, Morris H. See Kulsots, Ingrid A.<br />
-; Whitte, Lynds, 1948<br />
Pugh, Andrew J. See Miles, Andrew<br />
Pumphney, John See Spnitzan, Lawrence<br />
Puopolo, Patricia R.; Flood, James C., 819<br />
Purcell, George See Ladouceur, P. R.<br />
Puterman, M. Sea Lockitch, C.<br />
Qadri, Firdausi See Shameem, C. M. M.<br />
Quails, Stephanie See Spencer, Carola<br />
Quarm, Daisy E. A. See Magnotti, Ralph A., Jr.<br />
Queralto-Companyo, J. M. See Rodriguez-<br />
Espinosa, J.<br />
Quesniaux, V.; Peas, R.; Schneier, M. H.;<br />
Maurer, C.; van Regenmortel, M. H. V., 32<br />
Quick, Peter See Kovsry, Peter M.<br />
Quigley, G. See Lockitch, C.<br />
Quinn, K. Toton See Izutsu, A.; Kennedy, P.<br />
Quneshi, M. S. See El Fakhri, M.<br />
Raam, Shanthi See Nolan, Chris<br />
Rabier, D. Sea Kamoun, P.<br />
Rabkin, Michael See Brown, Paul I.<br />
Radaelli, G. See Macovine, Santics<br />
Radcliff, Frank J. See Koumantakis, George<br />
Radebaugh, J. See DeBaun, Michael K.<br />
Radioimmunosssay See Karjalainen, Ulla<br />
Raften-Tadgell, Brenda See Young, Edward<br />
Rai, S. T. See El Fakhri, M.<br />
Raisys, Vidmantas A. See Hursting, Marcia J.;<br />
Skogarboe, Kristen J.<br />
Rajan, M. G. H.; Samuel, A. M., 372<br />
Rajna, A. See Ng, M. L.<br />
Kakhit, Ashok See Reydel-Bai, Patricia<br />
Ramasamy, I., 627<br />
Ranganathan, G. See Nelson, Robert E.<br />
Ranjan, Parveen; Karchen, Raymond E.;<br />
Epstein, Emanuel; Kiechle, Frederick L.,<br />
1884<br />
Ransom, 13. K. Sea Malby, J. M.<br />
Rao, G. V. K.; O’Shea, J. T.; Skinner, M. C., 964<br />
Rapopont, Abraham See Crass, Linda<br />
Rashid, M. See Schoenlain, D. J.<br />
Rashtchian, Ayoub; Eldredge, John; Ottaviani,<br />
Margaret; Abbott, Mark; Mock, Graham;<br />
Lovarn, Douglas; Klinger, Jeffrey; Parsons,<br />
George, 1526<br />
Rastegar, Faramanz See Maien, Eddie A.<br />
Rasums, A. S. See Bailey, Anne L.<br />
Ratciiffa, John See Dobson, Susan<br />
Ratga, Dieter; Kohse, Klaus P.; Wissen,<br />
Hermann, 420<br />
Ratnaike, Sujiva; Goodwin, Max; Deem, David,<br />
1213<br />
-; Gray, Faye; Deam, David, 1460<br />
-; Blake, Dennis; Shevanan, Patricia, 1807<br />
Rattenbury, J. M.; Allen, Joyce C., 414<br />
Rauscher, E. See Klein, Cerhard<br />
Rautela, G. S. See Obzansky, D. M.<br />
Rawal, Narash Sea Smith, Norman B.<br />
-; Henderson, A. Ralph, 1294<br />
Ray, John E; Stove, Jess; Williams, Kenneth M.,<br />
718<br />
Raa, Marcia H. See Delfert, Dennis M.; Skogan,<br />
William F.<br />
Read, A. See Umali, L.<br />
Keadio, J. See Baran, M.; Butt, A. M.; Kumar,<br />
Harish; Pollack, L.<br />
Reason, Craig; DeShon, P.; Pnuscott, C.;<br />
Holloway, S., 953<br />
-; Mull, Deborah, 953<br />
-; Klukas, Carol; Mull, Deborah, 1011<br />
Recknagel, F. See Innanen, V. T.<br />
Redalieu, Elliot See Reydal-Bax, Patricia<br />
Raddy, M. Narahari; Khaja, C.; Donna, W.<br />
Michael, Jr., 1021<br />
-; Tang, T. P.; Nair, B. R., 1031<br />
-; Fitzsimons, Edward J., 1034<br />
Redondo, Francisco L., 689, 2325<br />
Reed, B. See Lau, Brad W. C.<br />
Read, Roberta C. See Bush, Valerie, 1075<br />
Reed, V. L. See Mack, D. 0.<br />
Reader, Bernice L. Sea Vogelsang, Philip J.<br />
Regina, Francis J.; Boyle, William J., Jr.;<br />
Diamond, Steven K.; Lazic, Ivana, 1562<br />
Rehak, Nadja N.; Chiang, Betty P.; Naalon,<br />
Linda; KIm, Ronald J., 311<br />
Reibnegger, Gilbert See Werner, Ernst K.<br />
Reich, Scott; Wiebe, Donald; Koch, David, 1010<br />
Reid, David L. Sea Maturan, Andrew<br />
Reid, K. W.; Cerback, C., 970<br />
Raidy, Judith A.; Skoczenski, Brian A.; Bleile,<br />
Dennis M.; Usategui, Magdalena, 928<br />
Reinards, K. See Kleesiek, K.<br />
Raising, J. M. See Schroeder, T. J.<br />
Renner, Stephen W.; Howanitz, Joan H.;<br />
McCrumb, Fred; Howanitz, Peter J.;<br />
Hilborna, Lee H., 927<br />
-; Howanitz, Joan H.; McCrumb, Fred;<br />
Howanitz, Peter J.; Hilborne, Lee H., 927<br />
Renoldi, Isabella Sea Cianazza, Elisabetta<br />
Rensinghoff, W. See Kovery, P. M.<br />
Repique, Eliseo V.; Farber, Sergio J., 971<br />
Kepossini, Alberto See Cianazza, Elisabetta<br />
Kess, Klaudia M. See Kramer, Bernhard K.<br />
Restrepo, W. See Heal, A.<br />
Rettmer, Rebecca L. Sea Huabers, Helmut A.<br />
-; Labbe, Robert F.; Huabars, Helmut A.;<br />
Brown, Warren P.; Josephson, Betty M.;<br />
Finch, Clement A., 1215<br />
Raydel-Bax, Patricia; Kedalieu, Elliot; Rakhit,<br />
Ashok, 549<br />
Reynolds, John W. See Ivie, Wm. Michael<br />
Reynoso, Gustavo See Klee, George C.<br />
Rhodes, Michael A. See Wells, David J.<br />
Ricardo, H. See Lucas, F.<br />
Rice, Eugene W., 743<br />
Rica, L. S. See Jonas, Laurie A.; Nguyen, S. Q.<br />
Richards, C. See He, Y. J.<br />
Rico, A. G. See Papadopulo, I.<br />
Ridgway, K. Chester See van Heyningen, V.<br />
Riesen, W. See Smith, S. J.<br />
-; Kessler, A. Ch.; Khnhandt, V., 2123<br />
Kifsi, N. See Bankson, D. D.; Cardalla, D. S.;<br />
Ledue, P. B.<br />
-; Silverman, L. M., 896<br />
-; Howlett, C. M.; Levtzow, C. B.; Phillips, J. C.;<br />
Parker, N. C.; Cross, K. E., 1025<br />
-; Celmen, B. B.; Christenson, R. H.; Silverman,<br />
L. M., 1032<br />
Rifai, NAder See Bankson, Daniel D.; Ledue,<br />
Thomas B.<br />
-; Christenson, Robert H.; Celman, Benjamin<br />
B.; Silverman, Lawrence M., 1155<br />
Righetti, Gabniella See Graziani, Maria Stalls<br />
Righetti, Pier Giorgio See Cianazza, Elisabetta;<br />
Sorroche, Patricia<br />
Rigisni, Neil R.; Wavers, Ron A.; Rijk, Egon;<br />
Soons, Joop B. J., 757<br />
RigI, Charles T. See Rugg, James A.<br />
Rigolin, Franco See Donizzi, Romolo<br />
Rijk, Egon See Rigiani, Neil K.<br />
Ripamonti, M. See Bonini, P. A.<br />
Ripamonti, Manilena See Baranghi, Livis<br />
Rippon, W. Barton See Wolfer, George K., Jr.<br />
Kisco, F.; Babe, M.; Traba, M. L., 720<br />
Kisier, Taut See Kramer, Bernhard K.<br />
Ritchia, James C.; Kegelmeyar, A. K.; Walker, J.<br />
T.; Carroll, B. J.; Longhurst, 5., 959<br />
Ritchie, Robert F. Sea Hudson, Gail A.<br />
Rittersdorf, W. See Braun, H-P.; Hiller,<br />
Carhard
Rizzo, V.; Melzi d’Enil, C. V., 844<br />
Roach, Nail A. See Kroll, Martin H.<br />
Robbins, Jacob Sea Benvenga, Salvatone<br />
Roberts, K.; Tao, I., 949<br />
Roberts, P. L; Johnson, C. F., 968<br />
Roberts, Randall T.; Kalnan, Michael J., 916<br />
Kobents, Susan W. See Flea, Cecil T. C.<br />
Robertshaw, A. M.; Swaminathan, K.; Lai, K.<br />
N., 1009<br />
Robinet, Nichole See Speich, Michelle<br />
Robinson, C. A.; Upton, K.; Scott, J. W., 1028<br />
Robinson, C. Andrew See Ketehum, Catherine<br />
H.<br />
Roche, D. See Callais, F.; Lequang, N. P.<br />
Rock, Helene Sue; Scott, John K.; Harris, Nick<br />
5., 918<br />
Rock, M. T. Penlstain; Schneider, M. S.;<br />
Fialkowski, D. M., 922<br />
Rock, Robert See Chan, Daniel W.<br />
Rock, Robert C. See Chan, Daniel W.<br />
-; Chan, Daniel W.; Bruzek, Debra; Waldron,<br />
Cynthia; Oaatenling, Joseph; Walsh, Patrick,<br />
2257<br />
Rodenas, V. Sea Lopez, A.<br />
Rodesch, F. Sea Kirkpatrick, C. A.<br />
Hodgerson, Denis 0. See McBride, James H.;<br />
Schotters, Susan B.<br />
Rodkey, L. Scott See Hamilton, Robert C.<br />
Rodriguez, Carmen See Zugaza,Carmen<br />
Rodriguez-Espinosa, J.; Mora-Brugues, J.;<br />
Ordonaz-Llanos, J.; Cortes-Kius, M.;<br />
Quaralto-Companyo, J. M.; Gonzalaz-Sastra,<br />
F., 1439<br />
Roegel, Emile See Maier, Eddie A.<br />
Rognerud, Cheryl L. Sea Ou, Ching-Nan<br />
-; Ou, Ching-Nan; Duong, Ly Thi; Frawlay,<br />
Vicki L., 1014<br />
Roijers, A. F.M. See Dujardin, B. C. C.<br />
Roman, J. See Mack, M.; Pasqua, J.; Wileczek,<br />
K.<br />
Roman, J. K. Sea Crowther, F. H.<br />
Romay, Ch.; Pascual, C., 1949<br />
Romfb, P.C. Sea Bakes-Martin, K. C.; Carstens,<br />
K. S.; Pachaco, A. M.<br />
-; Pearson, J. K.; Matsuura, T. H.; Carstens, K.<br />
5., 985<br />
Romina, Maxine See Brubaker, Daniel B.<br />
Rona, Kalman Sea Szabo, Ildiko<br />
Ronald, Beverly; Bogema, Stuart; Godwin, Ira<br />
D., 977<br />
-; Bogema, Stuart; Codwin, Ira D., 1014<br />
Ronca, K. Sea Sieghart, W.<br />
Rood, F. See Hadan, B.<br />
Root, Charles F., Jr.; Fine, James S.; Clayson,<br />
Kathleen J., 830<br />
Roplak, Irene K. See Lentnichia, Brian B.<br />
Kosalki, S. B. See Stein, Penelope<br />
Rosano, C. L; Braun, C. B.; Hunwitz, C., 398<br />
Hosano, T. See Brown, Harold<br />
Hosano, Thomas G. Sea Schran, Horst F.<br />
Rose, Alice See Smith, J. Cecil, Jr.<br />
Rose, II. N. See Price, Gary<br />
Rosen, A. L Sea Sahgal, H. L.; Sehgal, L R.<br />
Rosen, Michael; Noun, N.; Alexander, L., 891<br />
Rosenfeld, Louis, 1687<br />
Rosenthal, Murray A.; Tocci, Paul M., 900<br />
Reeling, Hans See Lundquist, Per<br />
Ross, H. A., 200<br />
Ross, K. See Harold, D. A.<br />
Ross, Richandus See Chen, Mei-Huei<br />
Rossaneu, M. Sea Smith, S. J.<br />
Rotanberg, Jvi; Weinberger, Itzhak; Davidson,<br />
Ehud; Fuchs, Jacob; Sperling, Odad; Agman,<br />
Jacob, 2309<br />
Rotenbeng, Zvi; Weinberger, Itzhak; Sagle, Alex;<br />
Fuchs, Jacob; Sperling, Oded; Agmon, Jacob,<br />
1419<br />
Roth, J. See Van Brunt, Nicholas<br />
Rothe, A.; Mucke, K.; Leinberger, K.; Wilk, H.-<br />
E., 996<br />
Rottendam, Ernest P.; Katan, Martijn B.;<br />
Knulman, Jan T., 1913<br />
Roulston, J. K. See Gow, S. M., 2324<br />
Rousseau, F. See Forest, J.-C.<br />
Rousseau, Francois See Forest, Jean-Claude<br />
Rousselet, Francois See Speich, Michelle<br />
Roussalle, Patricia See Gillary, Philippe<br />
Rowall, Frederick J. See Sidki, Ahmad M.<br />
Rowley, C. L.; Henriksson, T.; Louie, A.;<br />
Nguyen, P. H.; Kramer, M.; Der-Balian, C.;<br />
Kameda, N., 1563<br />
Rowley, Gerald L. See Henniksson, Thomas;<br />
Louie, Alan<br />
Roy, S. B. See Obzansky, D. M.<br />
Rubin, Robert H., 1058<br />
Rubio, Soladad See Valcarcal, Miguel<br />
Huch, Claude See Maier, Eddie A.<br />
Rudd, B. T. See Bertrand, P. V.<br />
Ruddel, Mark See Csako, Gyorgy; Elm, Ronald<br />
J.; Huang, C. M.; Knoll, Martin H.<br />
Rudel, L. L. See Smith, S. J.<br />
Hudick, Richard A. See French, Carol<br />
Rudolph, Julie; Parhem, Mac; Van Dar Steur,<br />
Lucia; Cain, Shswn, 1568<br />
Rudy, J. See Rutledge, J. C.<br />
Rudy, Jack L See Ibarra, Frank S.<br />
-; Rutledge, Joe C.; Lewis, Steve L., 1152<br />
Rugat, Gerard See Cuche, Jean-Louis<br />
Rugg, James A.; Flaa, Catherine W.; Dawson,<br />
Samuel K.; Kigl, Charles T.; Leung, Kathleen<br />
S.; Knight, William S.; Evans, Susan A., 882<br />
Ruggeri, 6. Sea Barbanti, P.; lacobello, C.<br />
Ruhnau, S. See Huber, M. D.<br />
Huhnau, S. H. See Diamond, S. K.; Frye, S. L.;<br />
Schoenlein, D. J.<br />
-; Diamond, S. K.; Mahaffey, K. C.; Covault, H.<br />
P.; Tejero, N. K., 953<br />
Ruiz, Roberto See Zugaza, Carmen<br />
Rule, Allyn H.; Keenan, Edward; O’Boyla,<br />
Elizabeth; Coburn, Elaine, 930<br />
Russell, John C., 1177<br />
Rutledge, J. C.; Emamian, S.; Rudy, J., 1256<br />
Rutledge, Joe C. See Rudy, Jack L.<br />
Hutman, M. See Klotzsch, Signid<br />
Hutman, Michael; Klotzsch, S.; Eaker, K., 1010<br />
Rutnan, H. See Butt, A. M.; Kuma, Harish;<br />
Pollack, L.<br />
Ryan, Douglas K. See Dorea, Jose G.<br />
Ryan, F. J. See McCarthy, K. C.<br />
Ryan, Francis See Yarrison, C. L.<br />
-; Barnatt, Craig;Yarnison,C. L.; Smolan,<br />
Tarry, 912<br />
Ryan, Karen See Stewart, A.<br />
Ryan, P. J.; Allan, B.; Boyce, P. A.; Miller, M.,<br />
948<br />
Ryder, K.; Buffington, K.; Sutton, G.; Sample,<br />
M.; Hill, B.; Oei, T., 931<br />
Ryder, Kenneth W. See Click, Melvin K.<br />
Rylatt, D. B. See Hillyard, C. J.; Hillyad, Carrie<br />
Kzasa, Peter J.; Caride, V. J.; Prokop, K. K.;<br />
Zibuluk, J. A., 887<br />
Sabharwal, Nilima Sea Cross, Susan F.<br />
Sacchetti, Lucia; Castaldo, Giusappe;<br />
Fortunate, Ciulians; Salvatore, Francesco,<br />
994<br />
Sachs, Barbara Sea Sachs, Edward<br />
Sachs, Charles, 444<br />
Sachs, Edward; Sachs, Barbara; Bernstein,<br />
Larry, 939<br />
-; Bernstein, Larry H., 988<br />
-; Sachs, Barbara; Bernstein, Larry H., 1268<br />
Sacks, David B.; Amyx, C.; Lim, M.; Valdes, K.,<br />
Jr.; Kessler, G., 880<br />
Saeva, L. See Kubasik, N. P.<br />
Sagle, Alex See Rotenberg, Zvi<br />
Sagnella, C. A. See Buckley, M. C.<br />
Sabeki, Takayori See Ichiki, Hitoshi<br />
Semi, M. See Gabsuer, C. K.<br />
Saito, Tokuko; Schwartz, Kenneth, 893<br />
-; Jeffery, B.; Leung, K.; Sohmer, P., 914<br />
Sakagishi, Y. See Komods, T.; Miura, M.<br />
Sakoguchi, Takafumi; Kobayashi, Kunio;<br />
Fujiwera, Keiko; Taniuchi, Koji; Kohri,<br />
Koeuka;Matsuoka, Akira, 1021<br />
Sakuma, Ryozo; Nishina, Toshihiro; Kitamura,<br />
Motoshi, 1427<br />
Sakunabayashi, Ikunosuke See Fujita,<br />
Kiyotaka<br />
Salamona, Salvatore See Feelay, Brian P.<br />
Salamone, Salvatore J. See Awdziej, Tenia N.;<br />
Farrenkopf, Bruce C.<br />
Saldivar, L. See Smith, B. J.<br />
Salhany, Kevin K. See Bradley, Charles A.<br />
Salinas, R, Sea Famulare, A. J.<br />
-; Billet, W.; Famulare, A. J.; Worthy, T. E., 881<br />
-; Billet, W.; Famulara, A. J.; Worthy, T. E., 882<br />
Salmaggi, A. Sea Nespolo, A.<br />
Salmon, Charles See Lefrera, Jean-Jacques<br />
Salmon, S. See Pruvot, I.<br />
Salvatore, Francasco See Sacchetti, Lucia<br />
Semmons, Shirley See Symons, Judy<br />
Sample, M. See Ryder, K.<br />
Sampletro. Tiziana See Lenzi Silvia<br />
Sampson,<br />
Samuel,<br />
Sanborn,<br />
Eric J. See Myers, #{243}sry L.<br />
A. M. See Rajan, M. C. K.<br />
C. See Johnston, Mary<br />
Sancho, J. M. Santos See Harnandez, D.<br />
Martinez<br />
Sanders, Gerard T. B.; Terraneo, Gui; Dols, Jan<br />
L.S., 192<br />
Sandbu, Randhir S.; Imbrogno, Diane;<br />
Horowitz, Michael 5., 987<br />
Sanghavl, Panna See Bissall, Michael C.<br />
Santaniaria, Pare See FbI, Concepcio<br />
Santiago, Jose M. See Buitrago, Jose M.<br />
Gonzalez<br />
Santiano, S. See O’Donnell, A.<br />
Sarkozi, L. See Mayer, L.<br />
Sarmini, H. See Clikmsnas, G.<br />
Sasmito, Ediati Sea Scharpe, Simon<br />
Sasse, Edward A.; Edwards, Jill B., 189<br />
-; Edwards, Jill B., 711<br />
-; Edwards, Jill B., 722<br />
Sato, K.; Nakate, H.; Sogabe, S.; Kohno, H.;<br />
Maeda, K.; Konno, M.; Watanabe, S., 920<br />
Sato, N. Sea Ha, Y. J.<br />
Sate, Yasumasa See Hanai, Junji<br />
Savitt, G. S. Sea French, C. K.<br />
Savoia, M.; Schwartz, D.; Smith, C.; Bhalls, K.;<br />
Dnistnian, A.; Kushnar, B.; Knis, M. C.;<br />
Scher, H. I.; Schwartz, M. K., 928<br />
Savoia, Marcella; Dnistrian, Ann M.;<br />
Piergentili, Carlo; Lane, Joseph M.;<br />
Schwartz, Morton K., 929<br />
Savory, J. See Brown, Sue; Harold, D. A.;<br />
Hundley, J.; Johnston, Mary; Mifflin, T. K.<br />
Savory, John See Boyd, James C.; Felder, Robin<br />
A.; Martin, K. Bruce<br />
Savory, M. C. See Johnston, Mary<br />
Scandolari, L. See Toth, Edmund C.<br />
Scane, Andrew C. See Nee, Patrick A.<br />
Scanlon, Janet M. See Chickering, Elizabeth J.<br />
Scanlon, Maurice F. See John, Khys<br />
Schaefer, Ernst J. See Cohn, Jeffrey S.;<br />
McNamars, Judith R.; Siguel, Edward N.,<br />
1051<br />
Schaffer, Robert See Myens, Gary L.<br />
Schaltenbrand. Wayne E.; Kennedy, Maureen<br />
S.; Coburn, Stephen P., 631<br />
Scharpe, 5; Iliano, Luc, 5<br />
Schanpe, Simon; Varkerk, Robert; Sasmito,<br />
Ediati; Theeuws, Margareths, 1774<br />
Schauer. S. See Kunst, Albert<br />
Schema, Isabella See Bieva, Claude J.<br />
Schenk, Gunther See Mars, Winfnied<br />
Schen, H. I. See Savoia, M.<br />
Schiavon, Kossalla See Finco, Bnuno<br />
Schick, B. See Crenier, F.<br />
Schick, Bernice C. See Grenier, Frank C.<br />
Schiale, F. See Siast, G.<br />
Schiele, Francoise; Muller, Jocelyne; Colinet,<br />
Elisabath; Siest, Gerard, 1971<br />
-; Mullen,Jocelyne; Colinet, Elisabeth; Siest,<br />
Gerard, 1978<br />
Schier, Gary M. Sea Blair, Stephen C.<br />
Schifman, Ron B.; Ahmann, F. K.; Brewer, M.;<br />
Kivick, A.; Ahmann, M. E.; Coulia, K., 927<br />
-; Ahmann, Frederick K.; Elvick, Alan; Ahmann,<br />
Marie;Coulis, Karen; Bnawer,Michael K.,<br />
2086<br />
Schifreen, K. S. See Tuhy, P. M.<br />
Schillen, Harvey S. See Gosney, Kimiko<br />
Schilling, M.; Armbruster, F. P.; Schmidt-Gayk,<br />
H., 187<br />
Schioppi, L. See lyon, Linde<br />
Schloegel, I. W. See Klea, G. C.<br />
Schmid, G. See Crowther, F. H.<br />
Schmidt, Barbara A. See Huang, Pih-kuei C.<br />
Schmidt, Bruno; Steinmatz, Gertrude, 1070<br />
Schmidt, D.; Hoffmann, C. E., 594<br />
Schmidt-Gayk, H. See Schilliog, M.<br />
Schmidt-Gayk, Heinrich See Blind, Ebenhard<br />
Schmitt, York See Krusa-Jarras, Juergen D.<br />
Schinitz, Card; WuIf, Ganburg; Bruning,<br />
Thomas; Assmsnn, Card, 2195<br />
Schmitz, Laurence C. See Kovary, Peter M.<br />
Schmulling, Reinhold-Michael See Kramer,<br />
Bernhard K.<br />
Schnaar, Ronald L. See Flick, Jonathan A.<br />
Schneider, K. A. See Sador, F. A.<br />
Schneider, M. S.See Rock, M. T. Panistein<br />
Schoemperlen, Jim See Desjardins, Paul K. E.<br />
Schoen, I. See Georgawill, Dawaye A.<br />
Schoen, Irwin See Bandi, Zoltan L.<br />
Schoenlein, D. J.; Bennett, W. K.; Rashid, M.;<br />
Kuhnau, S. K.; Joseph, 5., 909<br />
Schols. B. See Kaminaki, E. M.<br />
Scholz, Dletman See Lampe, Dagmar<br />
Schonberger, Emil Sea MacCrehan, William A.<br />
Schonfeld, C. See Smith, S. J.<br />
Schooni, M. See Dujadin, B. C. C.<br />
Schosinsky, Karl H.; Vargas, Marianela;<br />
Esquival, Alba Luz; Chavarnis, Miguel A.,<br />
223<br />
Schotters, Susan B.; McBride, James H.;<br />
Kodgarson, Denia 0., 947<br />
Schramm, Willfried; Yang, Tony; Midglay, A.<br />
Keas, 1331<br />
-; Yang, Pony; Midgley, A. Reas, 1338<br />
Schran, Horst F.; Kosano, Phomas C.; Hassell,<br />
Alan E.; Pall, Michael A., 2225<br />
Schreiber, W. See Lockitch, C.<br />
Schreiber, William E.; Whitta, Lynda, 185<br />
-; Wadsworth, Louis D., 445<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2353
Schreier, M. H. See Quesniauz, V.<br />
Schroeder, T. J. See Clardy, C. W.<br />
-; Melvin, D. B.; Clardy, C. W.; Wedhwe, N. K.;<br />
Myra, S. A.; Raising, J. M.; Wolf, K. K.;<br />
Collins, J. A.; Pesce, A. J.; First, M. K., 979<br />
Schroer, K. A. See Wolfond, S. P.<br />
Schryver, M. H. See Klee, C. C.<br />
Schuff, William R. See Garrison, Lester<br />
Schulkamp, K. See Barnard, C.<br />
Schumacher, 0. P. Sea Gupta, M. K.<br />
Schuster, Charles H., 7B<br />
Schuunman, Wim See Vink, Kees L. J.<br />
Schwartz, A. Sea McNally, A. J.<br />
Schwartz, Alan See Awdziej, Pania N.;<br />
Farrenkopf, Bruce C.; Feeley, Brian P.<br />
Schwartz, Ann Maria; Dufour, D. Robert, 1030<br />
Schwartz, D. See Nisselbaum, J.; Savoia, M.;<br />
Schwartz, M. K.<br />
Schwartz, Della See Flaishar, Martin<br />
Schwartz, Jason J. Sea Garcia, Raymond E.<br />
Schwartz, Kenneth See Saito, Tokuko<br />
Schwartz, M. K. See Flaiaher, M.; Menandez-<br />
Botet, C. J.; Nisselbaum, J.; Ssvoia, M.<br />
-; Nisselbaum, J.; Stone, N.; Schwartz, D.;<br />
Stankievic, R., 928<br />
Schwartz, M. W. See Tuhy, P. M.<br />
Schwartz, Morton K. See Bhalla, Ravi B.;<br />
Fleisher, Martin; Savoia, Marcalle<br />
Schweitzer, J. K. See Witte, D. L.<br />
Sclotto-Brown, Susan J. See Lentnichia, Brian<br />
B.<br />
Scott, J. W. Sea Robinson, C. A.<br />
Scott, John M. See Kelleher, Brian P.<br />
Scott, John K. See Rock, Helena Sue<br />
Scott, M. G. See Petersen, J. K.<br />
Scott, Mitchell C.; Cuca, Gregory C.; Petersen,<br />
John R.; Lyle, Leon R.; Burlaigh, B. Dan;<br />
Daughaday, William H., 2019<br />
Scott, H. E. See Hills, L. P.<br />
Scott, Richard K. See Grinateed, Gregory F.<br />
-; Burritt, Mary F., 915<br />
-; Cninsteed, C. F.; Ward. V. L.; Stevens, B. S.;<br />
Wiison, D. M., 981<br />
-; Squillace, David P.; Moyer, Thomas P., 1951<br />
Scottolini, Alfred C. See Loo, Stanley Y. Y.<br />
Scully, D. See Cnowther, F. F!.<br />
Seadler, Alan W. See Gluvna, Judith A.<br />
Sealfon, Michael S., 986<br />
Sear, J. W. See Moore, K. A.<br />
Seaton, C. B. See Kaufman, J.; Osaki, S.<br />
Seballos, H. L.; Ceserta, J.; Wong, S. T., 1022<br />
Secchiero, S. See Burlina, A.<br />
Seccombe, David W. See Kulaots, Ingnid A.<br />
Sadgwick, Paul See Hartman, Burr<br />
Sedor, F. A.; Holleman, C. M.; Schneider, K. A.;<br />
Hayden, 5., 895<br />
Sedor, Frank A. See Christenson, Robert H.<br />
-; Mayo, Elizabeth; Kirvan, Kathyrn K., 1261<br />
-; Holleman, Cathy M., 1942<br />
Sagens, M. F. G. See Boerman, 0. C.; Thomas, C.<br />
M. C.<br />
Segra, Gino V. See Nussbsum, Samuel K.<br />
Sehgal, H. L. Sea Sehgal, L. K.<br />
-; Sehgal, L. K.; Gould, S. A.; Rosen, A. L.;<br />
Moss, C. S., 1036<br />
Sahgal, L K. See Sehgel, H. L.<br />
-; Sahgal, H. L.; Rosen, A. L.; Gould, S. A.;<br />
DeWoskin, K.; Moss, C. 5., 1036<br />
Seidel, Karen See Smith, J. Cecil, Jr.<br />
Seidenschwarz, K. Sea Kunst, Albert<br />
Sein, Kyaw Pun; Arumainsyagem, Geatha, 2303<br />
Seishinia, M. See Abe, Akira<br />
Sekera, Michael H. See Catlin, Don H.<br />
Sellers, Don See Osikowicz, Gene<br />
Selz, Francoisa See Cuche, Jean-Louis<br />
Senior, Marilyn B. See Frank, Thomas<br />
Seppala, Mankku See Koistinan, Riitta<br />
Serenko-Aber, Andrea L. See Amanta, Joseph<br />
S.<br />
Senio, Mario Sea Toda, Bettina<br />
Sernano, Santiago See Chueca, Patrocinio<br />
Seth, J. See Caldwall, G.<br />
Seto, K. See Allen, D.<br />
Sevanini, Giancarlo; Aliberti, Ludovica<br />
Malaguti, 2278<br />
Sewell, C. K.; Naylor, N., 943<br />
Seydoux, D. Sea Truchaud, A.<br />
Shabet, Else M. See Jarzabek, Jean I.<br />
Shackalford, William; Cavanaugh, A.; Vellajo,<br />
R.; Simon, F.; Yeh, 5., 921<br />
Shaffan, Mark See Kirkpatrick, Marilyn<br />
Shah, Ramila J. See Li, Jackie P. L.<br />
Shah, V. D. See Dionio, Alfred F.<br />
Shahangian, Shabram; Fnitscha, Herbert A.,<br />
Jr.; Hughes, John I., 583<br />
-; Fnitache, Herbert A., Jr.; Hughes, John I., 926<br />
-; Fnitsche, Herbert A., Jr.; Hughes, John I., 932<br />
-; Fnitscha, Herbert A., Jr.; Gelder, Frank B.;<br />
2354 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Hughes, John I., 932<br />
Shaikh, Iqbal M.; Muagglar, Paul A., 970<br />
Shamberger, Raymond J., 589, 992<br />
Shameeni, G. M. M.; Qadni, Firdausi, 248<br />
Sharkey, Scott W. See Apple, Fred S.<br />
Shanma, Ajit; Artiss, J. D.; Zak, B., 899<br />
Sharp, Gregory H. See Chickening, Elizabeth J.<br />
Sharp, Patrick S. See Burnin, Jacky M.<br />
Shaw, B. See Lewis, C.<br />
Shaw, M. A., 1674<br />
Shaw, N. See Makeae, James J.<br />
Shaw, N.Y. See Hutton, Jean M.<br />
Shaw, Norman See Barnes, Grady<br />
Shaw, Norman Y.; Hutton, J. M.; Dalbow, M.<br />
H.; Shawson, P. A.; Borden, K. K., 1034<br />
Shawson, P. A. See Shaw, Norman Y.<br />
Sheet, J. M.; Loner, M. A., 561<br />
Sheehan, M. See Ladoucaur, P. K.; Lewis, C.<br />
Sheehan, Michael, 987<br />
-; Caron, Geoffrey, 1019<br />
Sheeran, Sean K. Sea Wong, Steven H-Y.<br />
Sheiman, M. See Petal, V. S.<br />
Sheiman, Mark I.; Chan, Peresa H.; Garcia,<br />
Laura; Eranio, Sue; Kim, Joanne;<br />
MacDonnall, Paul C.; Smith, Cindy; Yeung,<br />
Kwok K., 967<br />
Sheinbeng, M. See Stivars, C.; Wong, W. L.<br />
Sheldon, Edward; Kellogg, David E.; Levenson,<br />
Corey; Bloch, Will; Aldwin, Lois; Birch,<br />
David; Goodson, Robert; Sheridan, Patrick;<br />
Horn, Glenn; Watson, Robert; Erlich, Henry,<br />
1368<br />
Sheldon, William L. See Parkinson, Ian S.<br />
Shen, Dennis See Spencer, Carole<br />
Shenknian, L. See Shilo, L.<br />
Shepherd, Mark D. S.; Penberthy, Lloyd A., 792<br />
Shepherd, H. Sea Mashiter, K.<br />
Sheppard, M. C.; Black, K. C., 179<br />
Sher, Paul P., 1056<br />
Sheridan, Patrick See Sheldon, Edward<br />
Sheriff, D. S. See El Fskhri, M.<br />
-; Ghwarsha, K.; Elgangan, K. B.; El Fakhri, M.,<br />
309<br />
Sherwin, Roger See Koch, Thomas K.<br />
Shevanan, Patricia See Ratnaika, Sujiva<br />
Shibata, Nobuyukl See Tojo, Minahiro<br />
Shils, Ming C. See Bojkowski, Christopher J.<br />
Shihabi, Z. K. See David, R. M.; Goodman, H. 0.<br />
-; Dyer, K. D., 1018<br />
-; Smith, B. L., 1026<br />
Shilo, L.; Solomon, C.; Shankman, L., 1470<br />
Shima, Junko See linuma, Kazushige<br />
Shima, Satoru See Oka, Kitaro<br />
Shimizu, S. Y. See Ashcraft, Pracey L.; Gaur,<br />
Pramod K.; Jones, Laurie A.<br />
Shimojo, Nobuo See Yoshikawa, Chikao<br />
Shindelman, Jeffrey; Suaamen, Howard, 913<br />
Shindo, Yoshlyuki Sea Kawaguchi, Seiji<br />
Shine, Brian; Patel, Malti; Dawes, Clive, 1564<br />
Shirokane, Yoshio; Utsushikawa, Masamichi;<br />
Nakajima, Moto-o, 394<br />
Shivji, Ally; Thibert, K. J., 1013<br />
Shoham (Schwartz), Zeav; Katz, Emil;<br />
Blickstein, Isaac; Katz, Zvi; Zosmer, Anal;<br />
Dgani, Ram; Lancet, Moshe, 800<br />
Shoji, Shin ichi See Nomoto, Shozo<br />
Shokry, S. See Boctor, F. N.<br />
Shu, Frank See Bach, Philip<br />
Shuey, Denise F. See Pietz, Norbert W.<br />
Shukla, H.; Lucas, F.; Murphy, P.; Galiounghi,<br />
A.; Szydlo, S., 960<br />
-; Szydlo, S., 997<br />
Shuler, S. See Witherspoon, L.<br />
Shuler, Stanton See Witharspoon, Lynn<br />
Shultz, Edward K. See Path, Michael Y.<br />
Sidki, Abmad M.; Al-Ahdulla, Ibrahim H.;<br />
Rowell, Frederick J., 463<br />
Siebers, H. W. L; Lim, C. W.; Maling, T. J. B.,<br />
1075<br />
Siegfried, Barry A. See Delfart, Dennis M.<br />
Sieghart, W.; Ronca, E.; Drazier, C.; Karall, S.,<br />
604<br />
Siest, C.; Varasteh, M.; Wellman-Bednawska,<br />
M.; Schiele, F., 993<br />
Siest, Gerard See Manabe, Takashi; Schiale,<br />
Fnancoise; Visvikis, Sophie<br />
Siglen, Gerald See David, Harold<br />
Signonini, C. See Albertini, Alberto; lacobello,<br />
C.; Panzali, A.<br />
Signal, Edward N.; Chee, Kew M.; Gong,<br />
Junxian; Schaefer, Ernst J., 1869<br />
Silber, B. Michael See McAteer, Joy A.<br />
Simian, K. K. See Francis, P. L.<br />
Silver, A. C.; Dawnay, A.; Landon, J., 199<br />
Silver, Anne See Beetham, Robert; Irish, C. K.<br />
Silverberg, Donald S. See Canal, Rafael S.<br />
Silverman, L M. See Bankson, D. D.; Ledue, P.<br />
B.; Rifai, N.<br />
Silverman, Lawrence M. See Bankson, Daniel<br />
D.; Ledue, Phomas B.; Rifai, Nader, 1060<br />
Silvester, William See Hickman, Peter E.<br />
Silvidi, Anthony A. See Potter, Joseph L.<br />
Simenson, P. B.; Knauth, C. H.; Klein, S. M.;<br />
Pang, J. C., 884<br />
Sheen, Josep Ma. See Fiol, Concepcio<br />
Simmons, Mark J. See Conan, Marshall P.<br />
Simo, I. E. Sea Kiss, Z.<br />
Simon, F. See Pepin, Karen; Shackelford,<br />
William<br />
Simon, J. P. See Truchaud, A.<br />
Simons, Enos L. See Singh, Jegat<br />
Simpkins, H.; Volpe, S., 618<br />
Simpson, G. See Jonas, A. W., 261, 753<br />
Simpson, J. See Keegan, C.<br />
Sin, I. L. See Evans, J. J.<br />
Sincennes, Francina See Nanji, Amin A.<br />
Sine, H. K. See Kubasik, N. P.<br />
Singer, Frederick R. See Lou, K.-H. William<br />
Singh, J. See Dies, S.<br />
Singh, Jagat; Lucco, Louis; Simons, Enos L.;<br />
Clarnidge, Jill E.; Dudley, Alden W., Jr., 911<br />
Singh, P. See Patel, V. S.; Smith, D.<br />
Singh, Pram Prakesh; Khushlani, Krishna;<br />
Vearwal, Pram Chend; Gupta, Ramesh<br />
Chandra, 1950<br />
Singh, H. K. See Konstantinidas, Frank N.<br />
Slake, Pranav K. See Sorroche, Patricia<br />
Sinsheimen, Janet See Del Vacchio, Mark;<br />
Wesolowski, Alex<br />
Sipenstein, Marvin D., 870<br />
Sivorinovsky, Gennikh See Brueggen, Benndt;<br />
Tanaka, Steve<br />
Skikne, Barry S., 1645<br />
Skillen, A. W. See Buamah, P. K.<br />
Skinner, M. G. See Rao, C. V. K.<br />
Skjold, A. C.; Stover, L. K.; Pendargrass, J. H.;<br />
Corey, P. F.; Cattail, J. A.; Burkhardt, A. E.;<br />
Farmneili, M. P.; Tyhach, R. J.; Albarelle, J.<br />
P.; Trimmer, R. W.; Ward, F. E.; Yip, M. T.;<br />
Hugi, H., 1242<br />
Skjold, Arthur C. See Pendergrass, James<br />
Skoczenski, Brian A. See Keidy, Judith A.<br />
Skogen, William See Chen, Kwok-Ming<br />
Skogen, William F. See Hurd, Debbie D.<br />
-; Rea, Marcia K.; Valdes, Roland, Jr., 401<br />
-; Rea, Marcia K.; Valdee, Roland, Jr., 837<br />
Skogarboe, Kristen J.; Kaisys, Vidmantas A.;<br />
Frial, Patrick N.; Yarby, Mark S., 1019<br />
Skoug, J. W. See Pardue, Harry L.<br />
Skoug, John W. See Pardue, Harry L.<br />
Skrha, Jan, 1474<br />
Slaats, K. IL; Kennedy, J. C.; Kruijswijk, H., 306<br />
Sladek, Julia See Lee, Hsin-Yu<br />
Slickers, Kenneth A. See Crendehl, Jan<br />
Sliva, Clara See Elm, Ronald J.<br />
Slutzky, Gerald M.; Inbar, M.; Eisenberg,<br />
Shlomo, 897<br />
Small, Charles See Baker, John<br />
Smut, Jan W. See van den Bang, Cite A.<br />
Smith, Art Sea Gordon, Bill<br />
Smith, B. See Smith, R F.<br />
Smith, B. J.; Saldiva, L., 1012<br />
Smith, B. L Sea Shihabi, Z. K.<br />
Smith, C. See lyon, Linda; Ledoucaur, P. K.;<br />
Nisselbaum, J.; Savois, M.; Pnundle, Diane<br />
Smith, Carl H. See Stahlschmidt, Gail K.<br />
Smith, Cindy See Sheiman, Mark L<br />
Smith, D.; Soto, A.; Chivite, J.; Gil, P.; Singh, P.;<br />
Ni, W. C., 885<br />
Smith, D. S. See Eramin, S-A.; Irish, G. K.<br />
SmIth, Deborah A.; Leung, Fred Y.; Jablonsky,<br />
George; Henderson, A. Ralph, 1863<br />
Smith, F. A,; Cossitt, Nancy L., 909,910<br />
Smith, G.; Wilcox, A. H.; Barron, J. L., 1497<br />
Smith, Harold M. B. See Kalrs, J.<br />
Smith, J. Cecil, Jr.; Lewis, Susan; Holbrook,<br />
Janet; Saidel, Karen; Rose, Alice, 814<br />
Smith, L. D. See Mack, D. 0.<br />
Smith, M. See Ladoucaur, P. K.<br />
-; Gonzalez, M.; Mahaffey, R.; Prsfton, J.;<br />
Covault, H. P.; Tejero, N., 1012<br />
Smith, Michael P. See Maciejko, James J.<br />
Smith, Norman B.; Kawel, Naresh, 2324<br />
Smith, Percy A. See Parkinson, Ian S.<br />
Smith, H. F.; Moore, K. A.; Smith, B., 970<br />
Smith, H. S. See Smith S.J.<br />
Smith, Randy W. See Astill,Mark E.<br />
Smith, Roger E. See Astill, Mark K.<br />
Smith, Ronald L., 1697<br />
Smith, S. J.; Cooper, C. K.; Henderson, L. 0.;<br />
Hannon, W. H.; Alaupovic, P.; Assmann, G.;<br />
Bachonik, P. 5.; Calvart, C. D.; Connally, P.<br />
W.; Demacker, P. N. M.; Dolphin, P. J.;<br />
Fruchart, J. C.; Gauldie, J.; Ginsberg, H.;<br />
Goldberg, K. B.; Hevakes, L.; Herbert, P. N.<br />
Kostner, C. M.; Lopes-Viralla, M. F.;
Muasing, K.; Prasad, S. C.; Patsch, W.;<br />
Kiesen, W.; Rossanau, M.; Kudel, L. L.;<br />
Schonfald, C.; Smith, R. S.; Stein, E. A.;<br />
Panake, A.; Waiswellar, P., 2240<br />
Smith, S. Jay See Henderson, L. Omar<br />
Smith, Stanley E. See Knight, Joseph A.<br />
Smith, T. See Van Brunt, Nicholas<br />
Smith, Thomas W. See Hursting, Marcia J.<br />
Smith, Ulf See Nystrom, Ernst<br />
Smith, V. P. See Pekary, A. E.<br />
-; Pekary, A. E.; Hershman, J. M., 1943<br />
Smith, Vierka P. See Lee, Hsin-Yu<br />
Smith-Lewis, Margaret J. See Mauck, John C.<br />
-; Mauck, John C.; Warren, Harold C., 932<br />
Smolen, Terry Sea Ryan, Francis<br />
Sniegoski, L. T.; Ellarbe, P. M.; Miller, J. M.;<br />
White V, K., 963<br />
Sobeski, L M. See Huth, Jeff<br />
Soc jima, Hinzo See Umeki, Shigenobu<br />
Sogabe, S. See Sate, K.<br />
Sohmer, P. See Saito, Tokuko<br />
Soldin, S. See Hardy, Robert<br />
Soldin, Steven J. Sea Tan, Yok K., 1053<br />
Solheim, Einar See Lien, Ernst Asbjorn<br />
Solis, N. See Johnston, D.<br />
Solomon, G. See Shilo, L.<br />
Solomon, Ruth; Helen, Kathleen; Cutman,<br />
Steven, 418<br />
Somyak, D. See Toth, Edmund C.<br />
Sonnemaken, H. Sea Witherspoon, L.<br />
Sonnemakan, Robert See Witherspoon, Lynn<br />
Soons, Joop B. J. See Rigiani, Neil R.<br />
Sorbo, Bo See Lundquist, Par<br />
Sorrocha, Patricia; Bianchi-Bosisio, Adniana;<br />
Sinha, Pranav K.; Celfi, Cecilia; Kighetti,<br />
Pier Giorgio, 653<br />
Soto, A. See Smith, D.<br />
Sowodniok, B. Sea Poppa, W.<br />
Spagliardi, G. See Franzini, Carlo<br />
Spanks, Charles K. See French, Carol; Tatrault,<br />
Gregory A.<br />
Sparks, D. L.; Fnohlich, J.; Cullis, P.; Pritchard,<br />
P. H., 390<br />
Speich, Michelle; Chappuis, Philippe; Rohinat,<br />
Nichole; Gelot, Simone; Arnaud, Pierre;<br />
Nguyen, Van Goc; Nicolas, Guy; Rousaelat,<br />
Francois, 21, 339, 739<br />
Spencer, Carole; Eigen, Andrea; Shan, Dennis;<br />
Duds, Marysia; Quails, Stephanie; Weiss,<br />
Steven; Nicoloff, John, 1391<br />
Spencer, D. H. Sea Perry, A. H.<br />
Sperling, Matthew I. See Chen, I-Wan<br />
-; Chen, I-Wan; Hemingar, Linda A.; Maxon,<br />
Harry K., 886<br />
Sperling, Oded See Kotenberg, Jvi; Rotenbeng,<br />
Zvi<br />
Spiekanman, A. Michael, 1060<br />
Spillman, Thomas See Wu, Alan H. B.<br />
Spitler, Lynn E., 1054<br />
Spoo, J. See Wong, S. P.<br />
Spnitzer, Lawrence; Pumphrey, John; Clark,<br />
Fred, 960<br />
Squillace, David P. See Scott, Richard K.<br />
Srebno, Sonia See McCarthy, Matthew J.<br />
Sroka, K. Sea Paul, B. D.<br />
Stadlen, Angelika See Blind, Eberhard<br />
Staehli, Christian See Caravatti, Mario<br />
Stafford, Mary Jo See Clark, Larry<br />
Stahlschmidt, Gail Sea Chan, Kwok-Ming<br />
Stahlachinidt, Gail E.; Smith, Cal H.; Miller,<br />
Ralph E.; Landt, Michael L., 883<br />
Staley, Michael J.; Mosca, Andrea, 2326<br />
Stankievic, H. See Menandez-Botet, C. J.;<br />
Schwartz, M. K.<br />
Stankievic, Raise See Fleisher, Martin<br />
Staneki, Donald K., 866<br />
Staples, Noun See Drehnen, Dennis M.<br />
Stark, Stephen See Wong, Steven H-Y.<br />
Stastny, Milos Sea Piran, Un<br />
Statland, Bernard E. See Ethinajan, Sukumar;<br />
Ng, Ronald H.; O’Neill, Mary<br />
Stauffer, William B. See Matzgar, Louis F.<br />
Stavljenic, Ana; Vrkic, Nada; Henak, Carol;<br />
Kummar, K.; Topic, K., 1672<br />
Steele, B. W.; Nelson, L. D.; Hudson-Civetta, J.,<br />
939<br />
Stein, E. A. Sea Kaplan, L.A.; Smith, S. J.<br />
Stein, F.; Kolanowski, J.; Desmecht, P.;<br />
Bemalmans, S.; Mahieu, P., 933<br />
Stein, Penelope; Kosalki, S. B.; Foo, A. Ying;<br />
Hjelm,M.,313<br />
Steinberg, Karen K. Sea Mueller, Patricia W.<br />
Steinberg, W. See Hadan, B.<br />
Steiner, George See Cohn, Jeffrey S.<br />
Steiner, Meir Sea Gupta, Ram N.<br />
Steinle, H. See Zama, N.<br />
Steinmatz, Gertrude Sea Schmidt, Bruno<br />
Steinmetz, Josiane See Visvikis, Sophie<br />
Stenman, Ulf-Hakan See Koistinan, Riitta;<br />
Purpeinan, Ursula<br />
Stensmyr, Maria Sea Masson, Parvesh<br />
Stephon, K. See Donohue, D.; Petras, S.<br />
Steusloff, P. M. See Osaki, S.<br />
Stevens, B. S. See Scott, Richard E.<br />
Stevens, Bernadine S. See Crinstead, Gregory<br />
F.<br />
Stevenson, David K. See Vreman, Handrik J.<br />
Stevenson, G. W. See Zia, Priscilla<br />
Stewart, A.; McQuay, H. J.; Hand, C. W.; Ryan,<br />
Karen; Moore, R. A., 1026<br />
Stewart, Charles K. See Bittikofer, John A.<br />
Stewart, M. J. See Lough, M.<br />
Stewart, Robert See Suit, Paula<br />
Stewart, William N. See Krouwer, Jan 5.<br />
Stickland, T. See Winton, M. K. J.<br />
Stianen, L. See Dati, Francasco<br />
Stiller, K. L. See Foglia, J. P.<br />
-; Penal, J. M.; Birder, L.; Foglia, J. P.; Lin, F.<br />
C.; Narayanan, 5., 1025<br />
Stinson, Robert A. See Hawnylek, Ken<br />
Stiso, Cindy See Chen, Koulhwei<br />
Stites, Daniel P., 869<br />
Stivers, C.; Wong, W. L.; Chan, W.; Sheinberg,<br />
M.; Kameda, N., 923<br />
Stockmann, W. See Knedal, M.<br />
Stoddart, J. C. See Flea, Cecil T. C.<br />
Stone, Kenneth See Trundle, D.<br />
Stone, N. See Schwartz, M. K.<br />
Stouffer, B. See Tu, J.-I.<br />
Stove, Jess See Ray, John E<br />
Stovall, P. See Francis, P. L.<br />
Stoven, L. K. See Skjold, A. C.<br />
Stovar, Lon K. See Pendanrass, James<br />
Straka, Robert J.; Hoon, Timothy J.; Lalonda,<br />
Richard L.; Pieper, John A.; Bottorff,<br />
Michael B., 1898<br />
Strand, Calvin L; Garcia, Herbert; Costalas,<br />
Fernando, 1941<br />
Stranup-Brynes, Inge See Osikowicz, Gene<br />
Strassen, B. L; Ennis, A. K.; Deaton, M. L., 994<br />
Strauss, Eric; Meerkin, Matthew; Moshides,<br />
James, 2301<br />
Strummer, D. See Sundaram, Shan C.<br />
Strunc, G. See Peter, F.<br />
Strzempko, M. N. See French, C. K.<br />
Stuart, S.; Buttery, J. K., 1940<br />
Studenbeng, Scott D. See Christenson, Robert<br />
H.<br />
Studts, D. J. See Orsulak, P. J.<br />
Studts, David J. See Orsulak, Paul J.<br />
Suarez, Leobando See Manna, Michel<br />
Subramanian, K. 5., 1298<br />
Sugahara, Mayumi Sea Taniuchi, Koji<br />
Sugaya, Nonio; Pakeuchi, Yoshinao; Kanno,<br />
Takashi, 661<br />
Sugiyama, Sharon See Crisp, David<br />
Suina, Roger See Mura, Patrick<br />
Suit, Paula; Pippenger, C. K.; Van Lente,<br />
Frederick; Drogomir, George; Stewart,<br />
Robert, 979<br />
Sumi, Masaru See Umaki, Shiganobu<br />
Sunahara, Noriyuki See Hiroishi, Shingo<br />
Sundaram, G. S. See Manimekalai, S.<br />
Sundaram, Shan C.; Manimakalai, S.; Unni, S.;<br />
Strummer, D.; Goldstein, P. J., 929<br />
Sunderman, F. William, Jr. Sea Wong, Steven<br />
H. Y.<br />
Susini de Luca, H. See Helleboids, L.; Najjar, M.<br />
F.<br />
Sussman, Howard See Shindelman, Jeffrey<br />
Sutton, C. See Ryder, K.<br />
Suzuki, Makoto Sea Takeda, Naohito<br />
Suzuki, Masayasu; Pamiya, Eiichi; Kateoka,<br />
Petauro; Pokunaga, Tohru; Karube, Isao, 558<br />
Suzuki, Masuko See Pojo, Minehino<br />
Suzuki, Mssumi See Nomura, Yasushi<br />
Suzuki, Shigeo See Tojo, Minehiro<br />
Swaminathan, R. See Cheung, C. K.;<br />
Robentahaw, A. M.<br />
Swanljung, Patnik See Hansson, Lars-Olof<br />
Swanson, J. See Kiss, Janice<br />
Swanson, J. Robert See lyle, W. Michael; Ivie,<br />
Wm. Michael<br />
Swanson, P. See Makase, James J.<br />
Swanson, H., 990<br />
Swealey, Charles C. See Chamberlin, Beverly A.<br />
Sweating, V. M. See Caldwell, C.<br />
Swindell, Ric See Barnes, Diana M.<br />
Swirski, C.; Paarlman, S.; Gallagher, M., 987<br />
Syed, 0. B.; Okorodudu, Anthony; McComb, R.<br />
B.; Bowers, C. N., Jr., 1000<br />
Sykes, Elizabeth See Hawrylak, Ken<br />
-; Grzych, Claudia; Epstein, Emanuel; Kiechle,<br />
Frederick L., 1073<br />
Sykes, Miles 0. See Barlow, Ian M.<br />
Sykes, K. L See Goitein, Robert K.<br />
Sylvestre, M. Sea Pollack, L.<br />
Sylvestri, Mario F.; Jolliff, C. K.; Aulnen, V.;<br />
McKernan, J., 1036<br />
Symons, Judy; Sammons, Shirley; Itano, M.,<br />
1007<br />
Szabo, Ildiko; Rona, Kslman; Czinner, Antal;<br />
Cachalyi, Bela; Kaldor, Antal, 742<br />
Szulc, M. See DiStasio, Karen<br />
Szydlo, S. See Shukla, K.<br />
Tabossi-Keynolds, C. See Burnett, D.<br />
Tacquet, A. Sea Parra, H. J.<br />
Tait, Jonathan F.; Foerder, Charles A.;<br />
Ashwood, Edward K.; Banedetti, Thomas J.,<br />
554<br />
Takagaki, Keiichi See Matsue, Hajime<br />
Takahashi, Hiroaki See Kawaguchi, Seiji<br />
TakahashI, Takao See Meade, Masako<br />
Takasugi, Nobuo See Hanai, Junji<br />
Takatsu, Akiko; Nishi, Sueo, 1113<br />
Takeda, Naohito; Niwa, Toshimitsu;<br />
Patematsu, Akirs; Suzuki, Makoto, 682<br />
Takeda, Takeo See Hansi, Junji<br />
Takei, Hitoshi See Nakashims, Koji<br />
Takeuchi, Yoshinao See Sugaya, Nonio<br />
Talbot, J. Sea Forest, J.-C.<br />
Talbot, Jean-Noel See Pikatty, Maie-Liesse<br />
Tallgren, L. C. See Liewandahl, K.<br />
Tam, Kstella L. See Ou, Ching-Nan<br />
Tamiya, Eiichi See Suzuki, Masayasu<br />
Tan, Yok K.; Soldin, Steven J., 1026<br />
Tanaka, A. See Smith, S. J.<br />
Tanaka, Steve; Bartling, Don; Keenan, Don;<br />
Sivoninovsky, Gennikh, 1002<br />
Tang, J. C. See Simanson, P. B.<br />
Tang, Ken Bin; Hwang, B.; Yuan, C., 1029<br />
Tang, T. T. See Reddy, M. Nsrshai<br />
Taniuchi, Koji See Sakoguchi, Pakafumi<br />
-; Hoshiro, Mitsuo; Matsuoka, Akira; Keneda,<br />
Yasutaka; Sugahaa, Msyumi; Hayashi,<br />
Paizo, 1011<br />
Tanizawa, Osamu See Iwatani, Yoshinoni<br />
Tao, I. See Roberts, K.<br />
Tarbaux, Nanine M. See Valenzuela, Guillanmo<br />
J.<br />
Tarbit, I. F. See Pannham, A. J.<br />
Tarenghi, Giordano See Berti, Giovanni<br />
Tannowski, Thomas Sea Ullman, Edwin F.<br />
Tatano, Toshio See Makise, Junko<br />
Tatematsu, Akira See Takeda, Naohito<br />
Taulier, A.; Levillain, P.; Lemonnier, A., 1767<br />
Taylor, A. J.; Jennings, P. E.; Barnett, A. H.;<br />
Pandov, H. I.; Lawson, N., 2083<br />
Taylor, Frances See Miller, Peter<br />
Taylor, J. Sea Wilson, Michael<br />
Tees, K. See Quesniaux, V.<br />
Tehiin, A. See Noel, S. A.<br />
Tejero, N. See Diamond, S. K.; Frye, S. L.;<br />
Mahaffey, R; Smith, M.<br />
Tejero, N.H. See Ruhnau, S. K.<br />
Pemel, Seniye See Koch, Thomas K.<br />
Tenant, Forest S., Jr. See Hartman, Burr<br />
Teppo, Anna-Maija; Maury, C. P. J., 2024<br />
Tareba, Allan See Li, Jackie T. L.<br />
Tarraneo, Gui See Sanders, Gerard T. B.<br />
Tarry, A. H.; Spencer, D. H.; Krauth, C. H., 936<br />
Terry, Frederick W. See Gillespy, William G.<br />
Tetrault, Gregory A.; Meiklejohn, Barbara A.;<br />
Sparks, Charles K., 1662<br />
Thacker, Susan See Dublar, Robert K.<br />
Thai, A. C. See Pho, L. L.<br />
Thacuws, Margaretha See Scharpe, Simon<br />
Thenond, P. Sea Machand, Martine<br />
Therond, Patrice; Machand, M.; Biou, D.;<br />
Demalier, J. F., 957<br />
Thibent, R. J. See Shivji, Ally<br />
Thibodeau, Stephen N. See Parks, Penelope J.,<br />
1726<br />
Thiessan, J. See Hardy, Robert<br />
Thirumoorthi, M. C. See Miceli, Joseph N.<br />
Thliveris, James A. See Yatscloff, Randall W.<br />
Tho, L. L; Koay, E. S. C.; Thai, A. C.; Candlish,<br />
J.K., 1948<br />
Thode, Jorgen; Amyx, Cheryl; Valdea, Roland,<br />
Jr.; Kessler, Gerald, 833<br />
-; Boyd, James C.; Ladanson, Jack H., 1811<br />
Thomas, B. A.; Marshall, D. L., 891<br />
Thomas, C. M. C. See Boanmsn, 0. C.<br />
-; van den Berg, K. J.; Sagers, M. F. C., 1946<br />
-; van den Berg, K. J.; Segars, M. F. C., 2120<br />
Thomas, 0. Roger See Miles, Andrew<br />
Thomas, K. E. See Lockitch, C.<br />
Thompson, Cynthia B. See Leu, H. Phillip<br />
Thompson, L See Keane, P. M.<br />
Thompson, M. B.; Blair, P. C.; Morris, K. W.;<br />
Neptun, D. A.; Deyo, D. F.; Popp, J. A., 1856<br />
Thompson, Stephan C. See Halter, Catherine<br />
M.<br />
Thompson, Theodore H. See Psai, Michael Y.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2355
Thornalley, Paul J. See Jones, Alan F.<br />
Thorns, Gale H. See Astill, Mark E.<br />
Thornes, Heather M.; McLeod, Dwight T.; Car,<br />
David, 1635<br />
Thrasher, K. Douglas See Peterson, Chris L.<br />
Threatte, Gregory A. See Agawal, Kaghunath<br />
P.<br />
Thuvasethakul, Phichal; Wajjwalku,<br />
Wonawidh, 614<br />
Tiainen, Kaanina See Hanason, Lars-Olof<br />
Tibbling, Lita See Lundquist, Per<br />
Tietz, N. See Haden, B.<br />
Tietz, Norbent W., 625<br />
-; Shuay, Denise F.; Astles, J. Rex, 1624<br />
Tiffany, T. 0. See Hills, L. P.<br />
Tiffany, Thomas 0., 1695<br />
Tikanoja, S See Liewendahl, K.<br />
Tilbuny, K. Thomas Sea Apple, Fred S.<br />
Tilling, Bjorn Sea von Schenck, Henning<br />
Tisel, W. See Horsfall, K.<br />
ThaI, William See Pranis, Robert<br />
Tocci, Paul M. See Rosenthal, Murray A.<br />
Toda, Bettina; Massani, Gianni; Bassi,<br />
Francesca; Pazzegli, Mario; Sanio, Mario,<br />
1989<br />
Toffaletti, John See Bissell, Michael C.<br />
-; Abrams, Billy, 1006<br />
Toft, A. 0. See Caldwell, C.<br />
Tojo, Minahiro; Shibata, Nobuyuki; Mikami,<br />
Pakeshi; Suzuki, Masuko; Suzuki, Shigao,<br />
1925<br />
Tokunaga, Tohru See Suzuki, Masayasu<br />
Tomaszek, Ann See Awdziej, Pania N.<br />
Tomena, Arlene See Yu, Stephen<br />
Tomokuni, Katsumano; Ichiba, Masayoahi;<br />
Hirai, Yukio; Hasegawa, Tohru, 1667<br />
Toms, Rick A. Sea Chou, Peter P.<br />
Toner, J. See Van Brunt, Nicholas<br />
Topic, E. Sea Stavljenic, Ana<br />
Topliff, C. H. See Mashiten, K.<br />
Toppin, Miilicent G. See Brooks, Kathleen P.<br />
Tonizuka, Kanji See Noguchi, Masato<br />
Toth, A. Sea Klotzsch, Sigrid<br />
Toth, Edmund C.; Czmiel, K.; Scandolari, L.;<br />
Somyak, D., 989<br />
Toth, T. See Dati, Francasco<br />
Touitou, Catherine See Touitou, Yvan<br />
Toultou, Yvan; Godard, Jean.Piarra; Ferment,<br />
Olivier; Chastang, Claude; Proust, Jacques;<br />
Bogdan, Andre; Auzeby, Andre; Touitou,<br />
Catherine, 518<br />
Town, M.-H. See Poppe, W.<br />
Towne, Rhonda, 895<br />
Traba, M. L See Risco, F.<br />
Tracy, K. P. Sea Howard, P. R.<br />
Tracy, Russell P. See Chickening, Elizabeth J.<br />
Tnaffond, D. J. H. See Makin, H. L. J.<br />
Trafton, ,J. See Smith, M.<br />
Trafton, John E. See Han, C. Arthur<br />
Traichi, Lienbard See von Schenck, Henning<br />
Trimmer, K. W. See Skjold, A. C.<br />
Tripodi, A. See Chanteran&kul, V.<br />
Tnltschlen, W. See Koller, P. U.<br />
Trobaugh, Gene B. See Hursting, Macia J.<br />
Trostmann, Ulnlke H. See Deuster, Patricia A.<br />
Truchaud, A. See Glikmanas, C.<br />
-; Gounmalin, Y.; Simon, J. P.; Jamin, C.; Gros,<br />
P.; Cadoux, M.; Seydoux, D.; Launois, X.;<br />
Cloarec, J. P., 1560<br />
Trujillo, Jose M. See Liu, Frank J.<br />
Trull, Andrew K.; Price, C. P.; Gorman, E. G.,<br />
884<br />
Trundle, D.; Belz, J.; Stone, Kenneth; Macial,<br />
G.; Carlson, J., 931<br />
Trundle, Diana; Smith, C.; LaChapelle, J., 912<br />
Truscott, C. See Reason, Craig<br />
Truscott, Gail; Kohlmayer, Lianne; Lucas,<br />
Diane, 966<br />
-; Mullins, Marvin, 1008<br />
Tryggvason, Karl See Hoyhtya, Matti<br />
Tsal, Jin Y. See Wei, Jang S.<br />
Teal, Michael Y.; Shultz, Edward K.; Williams,<br />
Preston P.; Bandel, Richard; Butler, Julius;<br />
Farb, Harry; Wager, Gail; Knox, Enik G.;<br />
Julian, Phomas; Thompson, Theodore K.,<br />
1648<br />
Tsang, Reginald See Chen, Mei-Huei<br />
T.ao, Te-Yun See Yu, Stephen S.<br />
T.ay, H. M. See Eaton, S.<br />
Tseng, Susan Y. See Birkmayer, Richard C.<br />
Tsuji, Akio See Maeda, Masako<br />
Tu, J.-L; Stouffer, B.; Eckelman, W. C., 1027<br />
Thenglar, P. See Dati, Frencesco<br />
Tuhy, P.M. See Crousa, S. P.<br />
-; Schwartz, M. W.; Gorman, K. G.; Schifreen,<br />
K. S.; Warkantin, D. L.; Bienvanu, J., 960<br />
Tung, Jim See Lee, Gregory<br />
Turanchik, Michael F. Sea Lentnichia, Brian B.<br />
2356 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Turbessi, Giuseppe See Delia, Salvatore<br />
Thrley, Charles P. Sea Brewster, Marga<br />
Turner, Canton E., 1054<br />
Turpeinen, Ursula; Kolvunen, Krkki; Stenman,<br />
Ulf-Hakan, 1756<br />
Tweedle, M. See Eaton, S.<br />
Tyhach, K. J. See Skjold, A. C.<br />
Tyreil, J. Blake, 871<br />
Tzamaloukas, A. H.; Avesthi, P. 5., 1076<br />
-; Jackson, J. E.; Long, D. A., 1944<br />
UaConaill, Diarmuid See Maguire, Sean<br />
Ueland, Per Magne Sea Lien, Ernst Asbjorn<br />
Uettwiiler-Gaigen, Denise L., 1014<br />
Uffelnian, Kristine See Cohn, Jeffrey S.<br />
Uilman, Edwin F.; Parnowski, Phomas; Feigner,<br />
Philip; Gibbons, Ian, 1579<br />
Umali, L; Read, A.; McCaffray, P.; Lin, C.; Kim,<br />
J.; Feistel, C.; Luther, C., 938<br />
Umeki, Shigenobu; Sunii, Masaru; Niki,<br />
Yoshihito; Soajima, Rinzo, 2230<br />
UnnI, S. See Manimakalai, S.; Sundaram, Shan<br />
C.<br />
Upton, K. See Robinson, C. A.<br />
Uretsky, Laura S. See Piran, Un<br />
Unnovitz, H. See Bush, C. A.<br />
Ursell, K. See McNally, A. J.<br />
Urseil, Timothy S. See Awdziaj, Tania N.<br />
Usategui, M. See Donohua, D.; McNally, A. J.;<br />
Niedbala, K. S.; Pedarsan, C.; Patras, S.<br />
Usategul, Magdalana See Reidy, Judith A.<br />
Usategui-Gomez, Magdalena See Del Vecchio,<br />
Mark<br />
Utley, David J. See Wilke, Timothy J.<br />
Utsushikawa, Mssamichi Sea Shirokane,<br />
Yoshio<br />
Vacca, Christina; Hell, P. W., 1037<br />
Vaccaro, K. K. See French, C. K.<br />
Vadala, David L. See Visyak, Paula A.<br />
Vaidya, Hemant C. See Landt, Yvonne<br />
Valcarcal, Miguel; Hans, Agustina Gomaz;<br />
Kubio, Soledad; Patidiar, Ana, 1826<br />
Valdes, H., Jr. See Lou, Brad W. C.; Sacks,<br />
David B.<br />
Valdes, Roland, Jr. See Dalfert, Dennis M.;<br />
Skogen, William F.; Phoda, Jorgan, 1052<br />
Valdigula, P. See Papadopulo, I.<br />
Valdi via, L See Pennington, Robin M.<br />
Valenti, Giorgio See Dotti, Claudio<br />
Valentine, Jane L See Faraji, Bahram<br />
Valanzuela, Guillernio J.; Munson, Laurel A.;<br />
Parbaux, Nanine M.; Farlay, John K., 1801<br />
Valera, C. See Lopez, A.<br />
Valette, J.-P. See Nicot, C.<br />
Valimaki, M. See Liewandahl, K.<br />
Vallejo, H. See Pepin, Karen; Shackelford,<br />
William<br />
Van Brunt, Nicholas; Day, B.; Downs, D.; Roth,<br />
J.; Smith, T.; Kissel, Thomas R.; Denial, I).<br />
S.; Toner, J., 1005<br />
Vandeleene, B. See Barnard, A. M.<br />
van den Berg, Cite A.; Munnake, Grathe H.;<br />
Kingma, Anneke W.; Smit, Jan W.; Muskiet,<br />
FnitsA., 1081<br />
van den Berg, R. J. See Thomas, C. M. C.<br />
van dan Bengh, F. A. J. T. M. See Peters, K. H.<br />
M.<br />
Vanderbilt, Anna S. See Osikowicz, Gene<br />
Vanderborght, Jan See Delanghe, Joris<br />
van der Helm, H. J. See Hische, K. A. H.<br />
Van den Molen, J. C. See Koopman, B. J.<br />
van den Putten-van Mayel, M. See<br />
Widdershoven, J.<br />
Van Den Steur, Lucia See Rudolph, Julia<br />
van den Ven-Jongeknijg, J. See Dujardin, B. C.<br />
C.<br />
Van de Valde, K. J. See Fraayman, N. H.<br />
Van de Vyven, F. L See D’Haaae, P. C.<br />
Van Dreal, P. Sea Lewis, C.<br />
Van Dreal, P. A.; Burgoon, P.; Magie, S., 978<br />
van Dreumel, Rick J. See Vink, Kees L. J.<br />
van Gansawinkal, Hiejean See Vink, Kees L. J.<br />
van Heyningen, Charles See Forshaw, Karen<br />
M.<br />
van Heyningen, V.; Abbott, S. K.; Daniel, S. C.;<br />
Ardisson, L. J.; Ridgway, K. Chester, 1387<br />
Van Roof, Viviane; Lepoutre, L., 958<br />
van Leeuwen, C. See Ovarsteegan, H. J.<br />
Van Lente, F. See Warkentin, D. L.; Zama, N.<br />
Van Lente, Frederick See Suit, Paula<br />
van Lith, Th. See Widdarshoven, J.<br />
van Munater, P. See Widdarshoven, J.<br />
Van Noord, Tad See Hariharan, M.<br />
van Regenmortel, M. H. V. Sea Quasnieux, V.<br />
van Saene, Jonis J. M. See Beukavald, Gerard J.<br />
J.<br />
van Saene, Rik H. F. See Baukaveld, Gerard J.<br />
J.<br />
Vanady, H. See Costa, Robert<br />
Vanasteh, M. See Siest, G.<br />
Verges, Manianela See Schosinsky, Karl H.<br />
Vasdev, S.; Johnson, K.; Longenich, L.;<br />
Prabhakaran, V.; Gault, H., 890<br />
Vassaneill, C. See Macovine, Santica<br />
Vaughn, K. See Armbruster, M. A.<br />
Veeck, Lucinda See Gulamali-Majid, Fizza<br />
Veenandaal, Mark Sea Cavanagh, Kevin T.<br />
Vaerwal, Pram Chand See Singh, Pram<br />
Prakash<br />
Ven Murthy, M. K. See Viallad, Jean-Louis<br />
Varkark, Robert See Scharpa, Simon<br />
Vermaak, William J. H.; Barnard, H. C.;<br />
Potgiater, C. M., 935<br />
Verrill, Hanland L.; Cirgis, Reds K.; Easterling,<br />
Ronald K.; Malhi, Balwindar, S.; Mueller,<br />
Willys F., 423<br />
Varstnaete, Alain; Buylaert, W.; Ackerman, C.;<br />
Vo?elaers, D., 1031<br />
Ventosick, Frank P., Jr.; Kelly, K. H., 1741<br />
v Hooff, J. P. See Deganear, C. P.<br />
Viallard, Jean-Louis; Van Murthy, M. K.;<br />
Borocco, Sylvia; Deatugue, Bernard, 164<br />
Viar, Mary Jane; Wright, Reba K.; Pratt,<br />
Charles B.; Goran, Marshall P., 913<br />
Vicini, M. See lacobello, C.<br />
Vickery, 0. K. Sea Miller, W. K.<br />
Vickery, Debra K. See Birkmayer, Richard C.<br />
Viadina, Jose A.; de la Iglasia, Alberto; Navarro,<br />
Adoracion, 1257<br />
Vihko, Pirkko See Hoyhtya, Matti<br />
Viliko, Reijo See Hoyhtya, Matti<br />
Villa, Barbara; Ohneck, Barbara; Bach, Phil;<br />
George, Margaret, 961<br />
Vunercati, M. E. See Montani, A.<br />
Vine, William; Yasminah, Walid, 995<br />
Vinet, Bernard, 2204<br />
Vink, Kaes L. J.; van Draumal, Riak J.;<br />
Schuurman, Wim; Wikkelin, Hugo; van<br />
Gansewinkal, Riejean; Phielix, Con J.;<br />
Koedam, Hans C., 1817<br />
Virji, Mohained A. Sea Busch, Ronald P.<br />
Vievikis, Sophia See Manabe, Pakashi<br />
-; Duinon, Marie-France; Steinmetz, Josiane;<br />
Manabe, Pakashi; Galteau, Marie-<br />
Madeleine; Clerc, Michel; Siest, Gerard, 120<br />
Viswanathan, M.; Johansson, C. K. K.; Brown,<br />
C. M., 415<br />
Visyak, Paula A.; Hillock, Ronald H.; Vedela,<br />
DavidL., 1023<br />
Vitone, Stephen See Awdziej, Penis N.;<br />
Fanrenkopf, Bruce C.; Feelay, Brian P.<br />
Vlastelica, 0. See Chu, D.<br />
Vogelaars, 0. See Verstraate, Main<br />
Vogelsang, Philip J.; Reader, Bernice L;<br />
Poblador, Jose V. S.; Lane, Kathy L.; Kost,<br />
Gerald J., 947<br />
Volpe, D. See McElroy, P. D.<br />
Volpe, S. See Simpkins, H.<br />
Vonderschmitt, 0. J. See Pai, Patrick<br />
von Eyben, F. See Blaabjarg, Ole<br />
von Schenck, Henning See Arnqvist, Hans<br />
-; Jacobsson, Marie-Louisa, 342, 938<br />
-; Pneichl, Lienhard; Tilling, Bjorn; Olsson,<br />
Anders C., 1230<br />
Vormbrock, H. See Kaminski, E. M.; Pasqua, J.;<br />
Wilaczek, R.<br />
Vo Thi, N. B. See Chanoine, J. P.<br />
Vreman, Handnik J.; Stevenson, David K.;<br />
Zwat, Albert, 694<br />
Vrkic, Nada See Stevljanic, Ana<br />
Vulimini, S. See Morgera, J.<br />
Vullo, Vincanzo See Delia, Salvatora<br />
Vuolas, Leana See Hoyhtya, Matti<br />
Vyskocil, Adolf A. See Barnard, Alfred M.<br />
Wachter, Helmut Sea Werner, Ernst R.<br />
Wade, Maclyn K. See Braunstein, Glenn D.<br />
Wadhwa, N. K. See Clady, C. W.; Schroeder, T.<br />
J.<br />
Wadsworth, Louis 0. See Schraiber, William K.<br />
Wager, Gail See Ted, Michael Y.<br />
Wajjwalku, Worawidh See Phuvasethakul,<br />
Phichai<br />
Wakid, Nabil W.; Banks, Anis, 746<br />
-; Biter, John C.; Allam, Charles K., 2008<br />
Walczak, Chester M. Sea Brooks, Kathleen P.<br />
Waldnon, Cynthia See Chan, Daniel W.; Rock,<br />
Robert C.; Wu, Alan H. B.<br />
Walker, Andrea See Evans, K. P.<br />
Walker, CoHn H. See Macknass, Michael I.<br />
Walker, Dee Ann Sea Ou, Ching-Nan<br />
Walker, J. T. Sea Kitchie, James C.<br />
Walker, S.D. See Kalra, J.<br />
Walker, W. A. See Burtis, C. A.<br />
Wall, Jeffrey H. See Kabra, Poker M.<br />
Wallace, Brian Sea Wu, James P.<br />
Wallace, John A.; Day, Kichard A., 1934<br />
-; Day, Richard A., 2121
Wailaga, M. Sea Whicher, J. T.<br />
Wallage, M. J.; Whicher, J. T., 448<br />
Waimsley, Trevor A.; Abernathy, Maxwell H.;<br />
Fitzgerald, Hugh P., 1928<br />
Walsh, Patrick See Rock, Robert C.<br />
Walsh, Patrick C. See Chan, Daniel W.<br />
Walshe, Klenan G. See Kelleher, Brian P.<br />
Waite, Kay V.; Maberly, Glen F.; Eastman,<br />
Cresweil J., 853<br />
Walters, D. Wayne See Kang, Edward P.<br />
Walton, Kim C. Sea Chan, Kwok-Ming<br />
Wang, ChI-Chin; Charlton, Robin K., 963<br />
Wang, Chiu-An Sea Nussbaum, Samuel R.<br />
Wang, James J. C. See Kang, Edward P.<br />
Wang, N. See Granier, F.; Keegan, C.<br />
Wang, Nail See Dubler, Robert K.<br />
Wang, Philip P. See Hockerman, Gloria J.<br />
Wang, S. T. See Peter, F.<br />
Ward, C. See Pedersen, C.<br />
Ward, Edward See Bissell, Michael C.<br />
Ward, F. E. See Skjold, A. C.<br />
Ward, Kory M.; Lash, Julia M.; Lamb, David K.;<br />
Kahla, K. Bowie; Zipf, William B., 1030<br />
Ward, V. L. Sea Scott, Richard K.<br />
Ward, Virginia L. See Gninstead, Gregory F.<br />
Warfel, J. See Brown, W. J.<br />
Wankentin, D. L. See Puhy, P. M.<br />
-; Marchand, A.; Van Lente, F., 1265<br />
Warkentin, Donald L.; Gaghen, Violet; Avania,<br />
Evangelina; Marchand, Anthony, 964<br />
Warner, Isiah M. See Psu, Chou-Pong<br />
Warnlck, G. Russell; Clapshaw, Patric, 2323<br />
Warren, C. See Dinovo, K. C.<br />
Warren, Harold C. See Mauck, John C.; Smith-<br />
Lewis, Margaret J.<br />
Warren, K. L. See Lasky, F. D.<br />
Warty, Vi jay S. See Busch, Ronald P.<br />
Washburn, Ronald G. Sea Huang, C. M.<br />
Watanabe, S. See Sato, K.<br />
Waterreus, K. J. See Koopman, B. J.<br />
Watson,!. D. See Lough, M.<br />
Watson, Ian; Jenkins, Louise, 2127<br />
Watson, J.; Ginidhar, C., 974<br />
Watson, Robert See Sheldon, Edward<br />
Weber, K. See DeBani, V. A.<br />
Webster, Joseph C.; Cotthalf, Joan; Pragey,<br />
Desider A., 1946<br />
Wai, Jeng S.; Lee, Peggy; Yeh, Chau T., 925<br />
-; Tsai, Jin Y.; Huang, Hung M., 1032<br />
Waigand, Ray See Nolan, Chris<br />
Wei jars, K. N. M.; Mulden, J., 745<br />
Weinbenger, !tzhak See Kotenberg, Jvi;<br />
Rotenberg, Zvi<br />
Weinkove, Cyril See Hugh, Duncan<br />
Wainshenker, Eugene See Chen, I-Wan<br />
Waintraub, Bruce D. See Zwaig, Mark H.<br />
Weirich, Fay See Bove, Joseph R.<br />
Waisen, William K.; Pardue, Harry L., 237<br />
Weiss, A. Sea Choy, Janet<br />
Weiss, Alan See Choy, Janet<br />
Weiss, J. Jay See Hughes, Peter K.<br />
Weiss, Steven Sea Spencer, Carole<br />
Weiswaller, P. See Smith, S. J.<br />
Welborn, John K. Sea Oeltgen, Peter K.<br />
Welborn, L C. See Hicks, J. M.<br />
Welch, Elaine; Helmer, George K., Jr.; Mathews,<br />
Judith L., 954<br />
Welch, Robin See Dacapnio, Lauren<br />
-; Hiti, John; Passler, Donayne; Pease, Lisa, 1027<br />
Weller, P.11. See Bertrand, P. V.<br />
Wellinan-Bednawska, M. See Siest, C.<br />
Wells, David J.; Rhodes, Michael A., 893<br />
-; Hanks, Bryant M.; Yarbrough, Clarke S.;<br />
Davis, Malba A., 975<br />
Welsh, Muriel See Goodnow, Timothy<br />
Wenham, P.R., 1302<br />
Weak, K. E. Sea Manimekalai, S.<br />
Wanke, David See Wu, Alan H. B.<br />
Werdick, Michael See Apple, Fred S.<br />
Wargedal, Jon E. See Lau, K-H. William<br />
Werner, Ernst R. ; Bichlar, Alfred;<br />
Daxanbichler, Gunter; Fuchs, Diatmar;<br />
Fuith, Lotha C.; Hausen, Arno; Hetzel,<br />
Heinz; Keibnaggar, Gilbert; Wachter,<br />
Helmut, 62<br />
-; Fuchs, Dietmar; Heusen, Arno; Keibnegger,<br />
Gilbert; Wachter, Helmut, 2028<br />
Werner, Mario, 1057<br />
Wernlund, S. See Famulara, A. J.<br />
Wertlake, Paul See Golub, Maxine<br />
Wesolowski, Alex; Kaufman, Richard A.;<br />
Sinsheimen, Janet; Del Vacchio, Mark, 954<br />
Westerlund, John; Butler, A. R.; Clidawell, C.,<br />
1693<br />
Wavers, Ron A. See Rigiani, Nail K.<br />
Wheaton, Robert N. See Mullins, Richard K.<br />
Whicher, J. T. Sea Wallage, M. J.<br />
-; Wallage, M.; Fifield, K., 1771<br />
White, Anne See Dobson, Susan<br />
White, Betty N. Sea Parker, K. Michael<br />
White, C. P. See Mashiter, K.<br />
White, M. See Bush, G. A.<br />
White, Robert M. Sea Fnings, Christopher S.<br />
White, Susan See Demers, Laurence M.<br />
White V, E. See Sniegoski, L. P.<br />
Whiting, M. J.; Gazettes, P., 187<br />
Whitta, Lynda See Pudek, Morris K.; Schreiber,<br />
William K.<br />
Wians, Frank H., Jr. See Drehner, Dennis M.<br />
Widdershoven, J.; van Munsten, P.; De Abreu,<br />
R.; Bosman, H.; van Lith, Ph.; van den<br />
Putten-van Meyel, M.; Motohara, K.;<br />
Mataude, I., 2074<br />
Widdowson, Graham See Decapnio, Lauren<br />
Wiebe, Donald See Dowd, Dennis; Lensmeyar,<br />
Gary; Reich, Scott<br />
Wiebe, Donald A. See Lensmeyen, Gary L.<br />
Wiema, Roger See Delanghe, Joris<br />
Wieringa, C. E., 719<br />
Wikkeling, Hugo See Vink, Keas L. J.<br />
Wilcox, A. H. Sea Smith, C.<br />
Wilcox, Julie F. See Halter, Catherine M.<br />
Wilding, Peter See Howlett, Paul J.<br />
Wileczek, K.; Pasqus, J.; Roman, J.; Mack, M.;<br />
Braun, K.; Vormbrock, K., 949<br />
Wiley, M.; Binder, W., 923<br />
Wilk, H.-E. See Rothe, A.<br />
Wilke, Timothy J.; Utley, David J., 1372<br />
Wilkins, Terence A. Sea Midgley, John K., 1293<br />
-; Midgley, John K. M.; Csako, (yorgy; Zweig,<br />
Mark H., 1494<br />
Wilkinson, Stephen P. See Gsllachar, Ruth E.<br />
Williams, Diana Sea French, Carol<br />
Williams, Katherine M. See Marshall, Thomas<br />
Williams, Kenneth M. See Ray, John K<br />
Williams, Michael See Cots, Deborah; Ishii,<br />
Steve<br />
-; Cote, Debbie; Floras, Orlando; Hango,<br />
Melanie, 940<br />
Williams, Preston P. See Psai, Michael Y.<br />
Willing, Shelley K.; Gamlen, Timothy R., 612<br />
Wills, M. K. See Brown, Sue; Harold, D. A.;<br />
Hundley, J.<br />
Wills, Michael K. See Martin, K. Bruce<br />
Wilson, Chuck; Brown, Steve, 1008<br />
Wilson, D. M. See Scott, Richard E.<br />
Wilson, David M. See Grinstead, Gregory F.<br />
Wilson, K. See Hillyard, C. J.; Hillyard, Carrie<br />
Wilson, Lorraine W. See Clayton, Frederic<br />
Wilson, Michael; Taylor, J.; Fink, L. M.;<br />
Hathaway, W., 1004<br />
Wilton, K. See Ladouceur, P. R.<br />
Wimsatt, Dorothy K.; Lott, John A., 905<br />
-; Lott, John A., 2099<br />
Winiarski, Ralph; Nelson, Gene; Lepp, Cyrus<br />
A., 946<br />
Winkel, Pen, 984<br />
Winkles, J.; Lunec, J.; Daverill, I., 685<br />
Winkles, John W. See Jonas, Alan F.<br />
Winn-Deen, Emily S. Sea David, Harold<br />
Winton, M. H. J.; Stickland, P., 613<br />
Winquin, K.; Develay, A.; Linsker, S.; Bonfanti,<br />
N., 188<br />
Wisser, Hermann See Ratge, Dieter<br />
Witherspoon, L.; Shuier, S.; Neely, H.;<br />
Sonnemaker, R.; Lohmsnn, T.; Gilbert, S.;<br />
Alyea, K., 884<br />
Withenspoon, Lynn; Shuler, Stanton; Neely,<br />
Harold; Sonnemakar, Robert; Alyas, Kristin;<br />
Gilbert, Susan, 420<br />
Witiak, D. T. See Noel, S. A.<br />
Witte, D. L.; Angstadt, D. S.; Schweitzer, J. K.,<br />
1035<br />
Wittliff, J. L. Sea He, Y. J.<br />
Witty, T. H. Sea Klein, Signid M.<br />
Witty, Thomas K. See Astill, Mark E.<br />
Woenken, W. E. See Hall, K. R.<br />
Wofford, Beth D.; Bradley, Charles A., 900<br />
Wolf, B. See Klaesiak, K.<br />
Wolf, K. K. Sea Schroeder, P. J.<br />
Wolfe, Bruce M., 874<br />
Wolfer, George K., Jr.; Rippon, W. Barton, 115<br />
Wolford, S. P.; Schroer, K. A.; Dente, A. K.; Falk,<br />
H. B.; French, K. L.; Gallo, P. P., 1035<br />
Wolley, Robert C. See Chan, Joseph L. W.<br />
Wolthers, B.C. See Koopman, B. J.<br />
Wolthers, Bert G. See Beukaveld, Gerard J. J.<br />
Wong, E. See McCombs, M.<br />
Wong, J.; Applagarth, D. A., 1302<br />
Wong, S. T. See Abano, D.; Chong, J.; Graff, P.;<br />
Kaminiski, J.; Seballos, H. L.<br />
-; Chong, J.; Spoo, J., 1005<br />
Wong, Shan S. See Wu, Alan H. B.<br />
-; Wu, Alan H. B.; Fritsche, Herbert A., 809<br />
Wong, Stephen H.-Y.; Pans, Yolands; Lin, F. C.;<br />
Naeyanan, S., 1017<br />
Wong, Steven H. Y.; Knight, Joseph A.; Hopfar,<br />
Sidney M.; Zaharis, Odette; Leach, Charles<br />
N., Jr.; Sunderman, F. William, Jr., 214<br />
-; Sheeran, Sean K.; Stark, Stephen, 1016<br />
-; Cudny, Bogumiis; Aziz, Oddette; Marzouk,<br />
Nemat; Sheeran, Sean R., 1021<br />
Wong, W. L. See Stivers, C.<br />
-; Sheinbeng, M.; Mergia, A.; Leung, D., 1020<br />
Woo, Deborah See Garcia, Raymond E.<br />
Woo, Jannie; Hyde, Mark; Martin, Richard;<br />
Krieg, Arthur F., 911<br />
Woo, Wilson See Louie, Alan<br />
Wood, P. L See Pnemschandre, P.<br />
-; Hill, B.; Hill, P. C., 723<br />
Woodbridge, Peter A. See Lambert, Patricia A.<br />
Woodnum, David L. See Kramer, Donald L.<br />
Woods, J. See Mackay, G. A.<br />
Woods, W. E. See Konstentinides, Frank N.<br />
Worlikar, V. R. See Zia, Priscilla<br />
Worthy, P. E. See Billet, W.; Famulara, A. J.;<br />
Salinas, R.<br />
Wright, Leebert A. See Pelletier, Omen<br />
Wright, Reba K. See Viar, Mary Jane<br />
Wu, Alan H. B. See LeMaistra, Anne; Wong,<br />
Shan S.<br />
-.--; Cornet, Ternia C.; Wu, Victor H.; Brockie,<br />
Robert K.; Nishikawa, Akira, 358<br />
-; Wong, Shsn S.; Spillmsn, Thomas; Wenke,<br />
David, 889<br />
-; Wong, Shan S.; Waldron, Cynthia; Chsn,<br />
Daniel W., 1424<br />
Wu, Annie L. See Findlsy, John B.<br />
Wu, James P. See Clayton, Frederic; Miya,<br />
Terry C.<br />
-; Lloyd, Chris; Pieper, Robert K.; Wallace,<br />
Brian; Peters, Jeffrey L., 1037<br />
Wu, Tai-Wing See Doumas, Basil T.<br />
Wu, Tsai-Feng; Lamb, Emmet J., 983<br />
Wu, Victor H. See Wu, Alan H. B.<br />
WuIf, Gerbung See Schmitz, Gerd<br />
Wulff, K. See Gerber, M.<br />
Wuiff, Karl See Gerber, Martin<br />
Wyatt, J. L.; Main, M. J.; Cronen, W., 1000<br />
Wynn, Annette L. See Maturen, Andrew<br />
Wysocki, Nancy See Christopher, Charles W.<br />
Xian-teng, Zhou See Ji-qing, Wei<br />
Yabu, Yukiko See Iwatani, Yoshinori<br />
Yadegani, P. See Brown, Harold<br />
Yaffe, M. J. See Aleyassine, H.<br />
Yafuso, Masao See Miller, William W.<br />
Yagi, Yukio Sea Ichiki, Hitoshi<br />
Yamagami, Yuji See Mseda, Meseko<br />
Yamaguchi, Shuichi See Ysrnamoto, Hideski<br />
Yamaguchi, Yoshihisa; Hsyashi, Chozo; Miysi,<br />
Kiyoshi, 418<br />
Yamamoto, Hideaki; Koda, Naoya; Yamaguchi,<br />
Shuichi; Kto, Yoshikatsu; Aoki, Kikumaro,<br />
714<br />
Yan, Cheng F. See Miller, William W.<br />
Yang, Chang Yi See Kang, Edward P.<br />
Yang, E. K. See Miller, W. K.<br />
Yang, Esther K. See Birkmeyer, Richard C.<br />
Yang, Tony See Schramm, Wilifried<br />
Yang, Xiu Ying See Elm, Ronald J.<br />
Yao, S. J. See Chen, A. K.<br />
Yarbrough, Clarke S. See Wells, David J.<br />
Yarnison, C. L. See Ryan, Francis<br />
-; Ryan, Francis; Click, Melvin K., 912<br />
Yasmineb, Walid See Vine, William, 995<br />
Yatscloff, Randall W.; Copeland, Kenneth R.;<br />
Thliveris, James A., 1037<br />
Yatscoff, K. W.; Desjardins, P. K. E.; Krahn, J.,<br />
1074<br />
Yatscoff, Randall D., 1052<br />
Yatscoff, Randall W.; Jeffrey John R., 1257<br />
Yeagar, Elizabeth P.; Chen, A. C.; KIute, M. C.;<br />
Cramer, J. C.; Cernosak, R. M.; Burgett, M.<br />
W., 883<br />
Yab, Chau T. See Wei, Jeng S.<br />
Yeh, S. See Pepin, Karen; Shackalford, William<br />
Yeo, K.-T.; Khsrasch, E. D.; Lsposky, L.; Amory,<br />
D. W.; Kenny, M., 890<br />
Yeo, Linda; Meirowitz, Agnes; Kordal, Richard,<br />
951<br />
Yeo, Tom H. See Burrin, Jacky M.<br />
Yerby, Mark S. See Skogarboe, Kristen J.<br />
Yeung, Kwok K. See Lentrichia, Brian B.;<br />
Sheiman, Mark I.<br />
Yip, M. T. See Skjold, A. C.<br />
Yokota, Yasuharu See Makise, Junko<br />
York, D. See Bush, C. A.<br />
Yoshikawa, Chikao; Shimojo, Nobuo; Naka,<br />
Keiichi; Akai, Toshihiro; Okuda, Kiyoshi;<br />
Ohkaws, Jino, 994<br />
Yost, F. See Eaton, S.<br />
Young, Donald S. See Erickson, Katherine<br />
Young, Edward; Rafter-Tadgall, Brenda, 2296<br />
Young,!. M. See Francis, P. L.<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2357
Young, V. H. See Mackay, C. A.<br />
Yu, K. See Yu, Stephen<br />
Yu, Stephen; Tomera, Arlene; Yu, E., 974<br />
Yu, Stephen S. See Hsieh, Shenie W.<br />
-; Fok, David; Hsieh, Sherie; Osterloh, John, 974<br />
-; Osterloh, John, 976<br />
-; Osterloh, John; Tsao, Te-Yun; Nishiki-Finley,<br />
K., 1025<br />
Yuan, C. See Tang, Ken Bin<br />
Yuan, Catherine; Liao, J. C., 959<br />
Yuan, M. See Aw, P. C.<br />
Yusuf, Ahmad See Kl-Yazigi, Adnan<br />
Zachaniah, N.Y.; Lee, C.; Fiats, M.;<br />
Cbakmakjian Z. H.; Mukerjee, A., 930<br />
Zahanla, Odette ee Wong, Steven H. Y.<br />
Zabradnik, Richard J. See Kiang, John J.;<br />
Nussbaum, Samuel K.<br />
Zak, B. See Shama, Ajit<br />
Zakowskl, J. See Kaufman, J.<br />
Zaloga, Gary P., 865<br />
Zama, N.; Pippenger, C. K.; Fazio, V.;<br />
McGonagle, B.; Klein, P.; Steinle, K.; Kinn,<br />
C.; Van Lente, F., 933<br />
2358 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Zamailoa, M. I. See Zumarrags, M.<br />
Zaninotto, M. See Burlina, A.<br />
Zarling, Edwin J.; Clappor, Maureen, 140<br />
Zavorskaa, Paul A. See Esber, Henry J.<br />
Zeigler, Mark See Ibarra, Frank S.<br />
Zeitlen, M. See Gebauer, C. K.<br />
Zia, Priscilla; Worlikar, V. K.; Stevenson, C. W.;<br />
Chiamori, N. Y.; Hailing, C. H. C.; Karow, W.<br />
C.; Green, P., 922<br />
Zlbuiuk, J. A. See Rzaaa, Peter J.<br />
Zljlstra, W. G. See Kwant, Gerard; Oeseburg,<br />
Berand; Zwart, A.<br />
Zijistra, Willem G.; Buursma, A.; Oeseburg, B.;<br />
Zwart, A., 939<br />
Zinona, T. See Cheng, C.<br />
Zlpf, William B. See Ward, Kory M.<br />
Zlpp, Adam P. Sea Kramer, Donald L<br />
Zittoun, Jacqueline See Carry, Philip J.<br />
Zlotkln, Stanley H.; Casselman, Charles W., 411<br />
Zoanetti, C. D. See Badcock, N. K.<br />
Zoll, L See Glatt, C.<br />
Zoppi, Francesco See Moses, Andrea<br />
-; Moses, Andrea; Granata, Sinionetta;<br />
Montalbetti, Norberto, 1895<br />
Zosmen, Ariel Sea Shoham (Schwartz), Zeev<br />
Zouaghi, H. See Helleboids, L.; Najja, M. F.<br />
Zucchefil, C. C. See Pio, A.<br />
-; Pilo, A.; Masini, S.; Chiesa, M. R.; Albertini,<br />
A., 924<br />
Zuchelli, C. C. See Pb, A.<br />
Zugaza, Carmen; Rodriguez, Carmen;Mirabel,<br />
Jose L.; Ruiz, Roberto; Martinez, Consuelo,<br />
1256<br />
Zuman, Petr See Degel, Fritz<br />
Zumarnaga, M.; Andia, I.; Bercens, B.;<br />
Zamallos, M. L; Davila, K., 72<br />
Zurawaki, V. K. See Boerinan, 0. C.<br />
Zwart, A. See Kwant, Gerard; Zijlstra, Wham G<br />
-; Buursma, A.; Kwant, G.; Oeseburg, B.;<br />
Zijistra, W. G., 2307<br />
Zwart, Albert See Vreman, Hendrik J.<br />
Zweig, Mark H. See Csako, Gyorgy; Wilkins,<br />
Penance A.<br />
Csako, Gyorgy; Benson, Carol C.; Weintraub,<br />
Bruce D.; Kahn, Barbara B., 840
A, abstractof meetingpaper<br />
CR, case report<br />
CC, case conference<br />
E, editorial<br />
H, history<br />
A.4CC<br />
Sea also History<br />
Awards, 1310<br />
mt. character of <strong>Clinical</strong> <strong>Chemistry</strong> (L), 2325<br />
39th natl. mtg., abstracts of papers, 880<br />
39th natL mtg., industry-sponsored workshops,<br />
1064<br />
39th natl. mtg., roundtables, 1049<br />
39th natl. mtg., sci. program, 859<br />
39th natl. mtg., selected topics, 1051<br />
39th nstL mtg., symposia abstracts, 862<br />
39th natl. mtg., workshops, 1038<br />
ABCC<br />
ABCC certifies 20,2333<br />
Abused drugs<br />
Abuacrean5 RIA for detection of<br />
benzodiezapinas and their matabolites (A),<br />
973<br />
alcohol, an abused drug (S), 82B<br />
anal. chem. at the Games of the XXIHrd<br />
Olympiad in Los Angeles, 1984 (SR), 319<br />
spplicn. of EMITamphetamine drug of abuse<br />
assay to the ETS system (A), 975<br />
applicn. of EMIT drugs of abuse assays to the<br />
ETS system (A), 975<br />
capillary GCand CC/MS of cocaine and heroin<br />
urinary metabolites (A), 970<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: morphine in<br />
urine (A), 970<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: cocaine<br />
metabolite (benzoylecgonine) in urine (A),<br />
971<br />
convenient enzyme immunoasasy system for<br />
detection of drugs of abuse: cannebinoids in<br />
urine (A), 972<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: barbiturates in<br />
urine (A), 973<br />
counseling, treatment, and employer response<br />
(panel discussion) (5), 106B<br />
designer drugs: past history and future trends<br />
(A), 1055<br />
detection and confirmation of cocaine use by<br />
chromatog. anal, for methylecgonine in urine<br />
(SN), 118<br />
development of TDx’ fluorescence polarization<br />
immunoassay for detection of cannabinoids<br />
in urine (A), 972<br />
drug abuse and the future (A), 1054<br />
drug abuse in the workplace: an industry’s<br />
point of view (S), 61B<br />
drug-anal. technol.: overview and state of the<br />
at(S), 13B<br />
drug-anal. technol-pitfalls, problems of drug<br />
testing(S), 33B<br />
drug of abuse profile: cannabis(S). 72B<br />
drug of abuse profile: cocaine (S), 66B<br />
drugs-of-abuse screen for the Analyst’ (A),<br />
976<br />
employee assistance programs (5), 1O1B<br />
employee drug screening: issues to be resolved<br />
in implementing a program (5), 54B<br />
evaln. of rapid TLC technique for detection of<br />
cannabinoid matabolites in urine (A), 972<br />
evaln. of threshold algorithm for drugs of abuse<br />
profiling on the Monarch random-access<br />
analyzer (A), 977<br />
fluorescence polarn. immunoassay evald. for<br />
screening for amphetamine and<br />
methamphetemine in urine (SN), 1200<br />
it’s time to take the initiative (K), 1682<br />
lab, assessments in treatments of substance<br />
abuse: utilization and effects on treatment<br />
design (5), 95B<br />
Volume 33, 1987<br />
SUBJECT INDEX<br />
KEY TO ABBREVIATIONS<br />
L, letter<br />
0, opinion<br />
obit, obituary<br />
A, review<br />
little cross reacty. of local anesthetics with<br />
Abuscreen, EMIT d.e.u., and TDX<br />
immunoassays for cocaine metabolite (L),<br />
747<br />
major drugs of abuse (panel discussion) (5),<br />
87B<br />
multiple drugs of abuse in urine detected with<br />
a single reagent and fluorescence<br />
polarization (SN), 1921<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
prelim. thoughts on the wisdom of govt.<br />
prohibition or regn. of private employee<br />
urinalysis testing (5), 19B<br />
preparation and evsln. of in-lab. EMIT<br />
calibrator for drugs of abuse assay (A), 976<br />
quality assurance in drug-use testing (5), 41B<br />
relationship of blood alcohol and morphine<br />
levels in heroin deaths (A), 969<br />
reliability of iminunoassays to detect<br />
tetrahydro-cannabinol in urine samples (A),<br />
972<br />
KM for methadone in urine with comparisons<br />
to other anal, techniques (A), 970<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
serum cocaine concns. by KIA after intranasal<br />
spplicn. (A), 1026<br />
serum neoptenin levels in newborns of opiateaddicted<br />
mothers (A), 970<br />
serum propoxyphene concns. in opiate addicts<br />
on long-term pnopoxyphannaintenanca<br />
therapy, evidence for drug tolerance in<br />
humans (A), 974<br />
single-reagent polarization fluoroimmunoassay<br />
of methamphetammne in urine (SN), 1903<br />
statistical considerations of the random<br />
selection process in a drug-testing program<br />
(S),46B<br />
status of drugs-of-abuse testing in urine: an<br />
AACC study (SK), 1683<br />
storage stability of urine PHC as measured by<br />
EMIT urine cannebinoid assay (A), 972<br />
technological and legal issues of drug-use<br />
testing (panel discussion) (S), 49B<br />
testing for drugs of abuse with the Abbott TDx<br />
(A), 976<br />
wisdom of proposals for govt. prohibition or<br />
regulation of urinalysis testing in private<br />
industry (A), 1054<br />
Acetaminophen<br />
anzymic method for scetaminophen adapted to<br />
an Abbott ABA-200 analyzer (TB), 612<br />
factors affecting urinary screens for<br />
scetaminophen (L), 1695<br />
incidence of drugs in a pediatric population as<br />
assessed through drug screening (A), 977<br />
rapid detn. of serum acetaminophan by HPLC<br />
with a column-switching technique-on-line<br />
punifn. and anal. (A), 1026<br />
rapid urinary screen for acetaminophen<br />
modified to avoid false-negative results<br />
(TB), 718<br />
Acetate<br />
modn. of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with 31P NMK,<br />
76<br />
Acetoacetate<br />
effects of a-ketobutyrate and ahydroxybutyrate<br />
on the enzymatic detn. of<br />
acetoacatate, fl-hydroxybutyrste (TB), 1469<br />
Acetyicholinestenase<br />
mess. of acetylcholmnesterasa in arythrocytes in<br />
the field. 1731<br />
S, symposium paper<br />
SM, Selected Methods<br />
SN, scientific note<br />
SR, specialreport<br />
TB, technical brief<br />
Acetylglucosaminidase<br />
avaln. of colonimetric assay of N-acatyl--Dglucosaminidase<br />
in urine (A), 1000<br />
Acetylpnocainamide<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: cardioactive<br />
drugs (A), 1013<br />
Acetylsalicylata<br />
serum thromboxana B2 test of patient<br />
compliance in din, studies of plateletaffecting<br />
drugs (A), 1004<br />
Acid-base status<br />
biol. variation of blood acid-base status:<br />
consequences for anal, goal-setting and<br />
interpnetn. of results, 1416<br />
Acid glycoprotein<br />
liq.-chromatog. deth. of l2-microglobulin, a1acid<br />
glycoprotein, and albumin in urine, 1756<br />
monoclonal antibody-based enzyme-linked<br />
immunosorbent assay of ai-acid glycoprotein<br />
(SN), 2275<br />
Acidosis<br />
osmolar gap, false isopropanol, and an amine in<br />
a child with boric acid ingestion (A), 914<br />
Acid phosphatase<br />
acid phosphatase ecty. in -<br />
glucunonidase/sulfatase preparation from<br />
Helix pomatia (TB), 418<br />
anal. and biol. variation of serum prostatic<br />
specific antigen compared with prostetic acid<br />
phosphatase (A), 927<br />
anal, and physiol. characteristics of prostatespecific<br />
antigen and prostetic acid<br />
phosphatasa in serum compared (SN), 2086<br />
antibodies to porcine uterofernin used in mess.<br />
of tartrste-reaiatant acid phoaphstaae, 1832<br />
characterization and assay of tartrate.resistant<br />
acid phosphatase acty. in serum: potential<br />
use to assess bone resorption, 458<br />
high-affinity monoclonal antibodies specific for<br />
prostatic acid phosphatase, 103<br />
intact tissue specimens obtained by fine-needle<br />
aspiration of the prostate used to<br />
demonstrate tissue acid phoaphatase<br />
isoenzymes (A), 927<br />
isoelectnic focusing of fine-needle aspirates of<br />
prostate: demonstration of tissue acid<br />
phosphatase isoenzyme pattern in<br />
hyperplasia and malignancy (A), 927<br />
isoelectrofocusing of serum prostatic acid<br />
phosphatase (A), 927<br />
Acquired isnmunodeficiency syndrome<br />
adenosine deaminase acty. and AIDS (TB), 1675<br />
AIDS: new developments and directions (A), 864<br />
anti-HPLV-III/LAV in pooled sara (TB), 308<br />
din. chem. anal, of samples from patients with<br />
AIDS (TB), 188<br />
affect of heat-inactivation of HIV on lab.<br />
results (TB), 1474<br />
monoclonal gammopethies in asymptomatic<br />
HIV-seropositiva patients (L), 1697<br />
serum protein electrophoresis and<br />
immunoglobulin measurements in subjects<br />
at risk for AIDS (A), 1028<br />
Acromegaly<br />
monoclonal and polyclonsi antibodies<br />
compared for KM of somatomedin-C in<br />
acromegaly or hypopituitarism, 1593<br />
ACTH<br />
See Corticotropin<br />
Acute-phase proteins<br />
concns. of superoxide dismutase and<br />
supanoxide anion in blood of patients with<br />
respiratory infections, compromised immune<br />
systems, 2230<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2359
enhanced-latex aggln. assay for C-reactive<br />
protein in serum, with use of a cantnif.<br />
analyzer (SN), 685<br />
enzymatic measurement of sislic acid in serum<br />
by Hitachi 736 analyzer and applicn. for<br />
maker of acute-phase reactants (A), 1011<br />
Acute-phase reactants<br />
serum amyloid A is major component of acutephase<br />
plasma vary-low-density lipoproteins<br />
(A),896<br />
Acute-phase reactions<br />
serum haptoglobin concns. in concurrent<br />
hemolysis and acute-phase reaction (TB),<br />
1265<br />
Acylcarnitine<br />
nonesterified and scylcarnitine in<br />
polymorphonuclear leukocytes and<br />
mononuclear cells, 533<br />
Adenocarcinoma<br />
plasma lipid-bound sialic acid in monitoring<br />
surgical therapy of patients with colonic<br />
adanocercinomes (A), 932<br />
predlin. imaging and therapy studies with<br />
radiolabeled anti-CEA antibodies (A), 1053<br />
preclin. immunotherapy studies with<br />
monoclonal antibody-drug conjugates (A),<br />
1053<br />
Adenosine deaminasa<br />
adanosine deaminasa acty. and AiDS (TB), 1675<br />
adenosine daaminase catalytic concna. in serum<br />
measured in the Technicon RA-1000<br />
analyzer (TB), 1477<br />
Adanosine triphosphate<br />
3’P nuclear NMR study of variations in intraenythrocytic<br />
Al? concn. end pH induced by<br />
surgical trauma (SN), 2284<br />
Adanylate kinase<br />
comparison of solutions for extracting CK, AK,<br />
and LD from brain samples (TB), 2304<br />
Adrenal disorders<br />
enzyme-linked immunosorbant assay for 17ahydroxyprogesterone<br />
in dried blood spotted<br />
on filter paper, 761<br />
Adrenal hyperplasia<br />
simultaneous mess, of eight corticoeteroids by<br />
liq..chromatog. and appin. to diagnosis of<br />
congenital adrenal hyperplasia, 13U<br />
Advanced analytical concepts<br />
See Oak Kidga Conference<br />
Age-nelated effects<br />
Sea Sex- and age-related effects<br />
MDS<br />
See Acquired immunodaficiancy syndrome and<br />
HIV<br />
Alanine aminopeptidasa<br />
alanine aminopeptidase in serum: automated<br />
optimized assay, and effects of age, sax,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
Alanine aminotransfenasa<br />
adaptation of IFCC-recommended method for<br />
ALT at 37 5C on Du Pont Dimension” cm.<br />
chem. system (A), 992<br />
anal, performance of Reflotron ALT and AST<br />
test methods (A), 949<br />
pynidoxal-5-phosphate depletion in renal<br />
dialysis patients causes cm. significant<br />
errors in ALT detns. (A), 992<br />
pyruvate interference with continuous-flow<br />
(SMAC) methods for aspartate and alanina<br />
aminotransfarases (TB), 616<br />
Keflotron assays of alanine aminotransfarase<br />
and glutamyltransfanase in whole-blood<br />
samples evald. (SN), 826<br />
Albumin<br />
albumin-dependence of free thyroxin in<br />
nonthyroidal illness (L), 1494<br />
albumin in analog VF4 essay reagents: the facts<br />
(L), 1293<br />
assay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of bioL variation, 269<br />
bromcrasol purple dye-binding methods<br />
underestimate albumin that is carrying<br />
covalently bound bilirubin (SN), 821<br />
bnomcresol purple method for albumin on the<br />
“Monarch” centrifugal analyzer (TB), 614<br />
caffeine-splitting of bilirubin/albumin<br />
complex: its relevance to spectrophotometry<br />
of bilirubin in serum (SN), 597<br />
changes in CSF IgG and spolipoprotein E<br />
indices in patients with multiple sclerosis<br />
during demyalination, remyehnation, 1155<br />
comment on the “albumin affect” in analog<br />
free-thyroxin detns. (L), I 2Q1<br />
competitive EM for urinary albumin (A), 979<br />
2360 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
correlation of Ames Micro-Bumintest”' tablet<br />
with total protein and albumin in diabetic<br />
urines (A), 980<br />
effect of albumin and lamella bodies on<br />
fluorescence polarn. of amniotic fluid (SN),<br />
1194<br />
effect ofalbumin on results ofan “improved”<br />
analog-type for free thyroxin, 337<br />
enzyme-linked immunosorbant assay for<br />
urinary albumin at low concns. (SN), 609<br />
evaln. of Tachnicon Demand improved total<br />
protein reagent and albumin method on the<br />
Olympus Demand chem. analyzer (A), 965<br />
immunochem. methods for early detection of<br />
microalbuminuris in diabetic nephropathy<br />
(A),902<br />
immunoturbidimetry of albumin in serum,<br />
CSF, and urine with a unique calibration<br />
curve (TB), 1260<br />
interference by an 1gM paraprotein in<br />
bromcresol green method for detn. of serum<br />
albumin (TB), 1075<br />
kinetic immunonephalometric measurement of<br />
very low concns. of alhumin in urine (A), 902<br />
laser immuhonephelometry for routine quanth.<br />
of urinary albumin, 209<br />
liq.-chromatog. detn. of 2-microglobulin, aacid<br />
glycoprotein, and albumin in urine, 1756<br />
massive overestimation of albumin in<br />
analbuminemic rat serum by bromcresol<br />
green (TB), 2121<br />
more on detn. of urinary albumin by<br />
centrifugal anal. (L), 1497<br />
more on immunoturbidimetry of urinary<br />
albumin (L), 198<br />
more on urinary sib. and creatinine (L), 740<br />
percentile estimates of ref. values for total<br />
protein and albumin in sara of prematures<br />
(SN), 411<br />
performance of two time-dependent analyses<br />
compared with an end-pomt analysis, in<br />
DataChem’s clinical analyzer (TB), 2121<br />
rapid, economical immunoturbidimatnic<br />
method for microalbuminuria (L), 204<br />
rate of synthesis of IgG within the blood-brain<br />
barrier and the IgG index compared in<br />
diagnosis of multiple sclerosis (SN), 113<br />
sensitive fluoronephelometnic assay of slight<br />
albuminunis (TB), 717<br />
specimen prepn. for assay of albumin in urine<br />
(L), 199<br />
spectrophotometry of urinary albumin by dyebinding<br />
with use of bromphenol blue, 223<br />
urinary alb. and retinol-binding protein in<br />
diabetes (TB), 713<br />
urinary N-acetyl--D-glucosaminidase and<br />
albumin not increased in mildly hypertensive<br />
subjects (TB), 1075<br />
Albuminuria<br />
selecting the optimum specimen for assessing<br />
slight albuminuria, ends strategy for din.<br />
investigation: novel uses of data on biol.<br />
variation, 2034<br />
Alcohol<br />
See also Alcoholism, Ethanol<br />
lack of interference of<br />
tnia(hydroxymethyl)mathylammne with the<br />
detn. of volatile alcohols or ethylene glycol in<br />
serum by capillary gas chromatog. (L), 2324<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
Alcohol dahydrogenasa<br />
assay of serum methanol and ethylene glycol<br />
with yeast alcohol dehydrogensse (A), 968<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in serum<br />
(SN), 2296<br />
disulfinam (Antabuse) inhibits alcohol<br />
dehydrogenase acty. (SN), 1906<br />
Alcoholism<br />
accuracy, precision of breath alcohol<br />
measurements for subjects in the absorptive<br />
state, 753<br />
elanine aminopeptidese in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
alcohol, an abused drug (S), 82B<br />
concerning accuracy and precision of breathalcohol<br />
measurements (0), 1701<br />
disturbed melatonin secretion in chronic<br />
alcoholism and withdrawal (L), 1291<br />
disulfiram (Antabuse) inhibits alcohol<br />
dehydrogenase acty. (SN), 1906<br />
reinvestigation of Widmark’s method for<br />
quent. evaln. of blood-ethanol profiles:<br />
influence of alcohol dose and mode of<br />
drinking (TB), 1469<br />
Aldosterone<br />
enzyme immunoassay of angiotensin I and<br />
renin, 1774<br />
Alkaline phosphatase<br />
elk. phosphatsse isoenzymes by isoelectric<br />
focusing: correlation with cm. findings (A),<br />
999<br />
alk, phosphatese isoenzymes incompletely<br />
resolved by “fast protein liq. chromatog.”<br />
(L),2327<br />
elk. phosphstaae isoenzymes in the plasma of<br />
preterm and term infants: serial<br />
measurements and cm. correlations, 1783<br />
changes in elk. phosphatese isozyma from<br />
normal subjects and patients with various<br />
diseases (A), 999<br />
evaln. of Isopal system (Analis/Belgium) for<br />
sepn. of elk. phosphatese isoenzymas (A),<br />
958<br />
isoelectric focusing of sialidase-trested elk.<br />
phosphatasa isoenzymes on agarose gel (SN),<br />
830<br />
isolation and purifn. of placental-type alk.<br />
phosphatase from a seminoma, 248<br />
new aspects of certain properties of human<br />
urinary alk. phosphatases (A), 999<br />
performance of KOdak Ektschem DTSC<br />
module for detn. of elk. phosphstese and<br />
GGT (A), 937<br />
potential of monoclonel antibodies to improve<br />
therapeutic monitoring of cyclosponine, 32<br />
ppth. of serum proteins by the lactin from<br />
wheat-germ (SN), 185<br />
probable source of discrepancies in alk.<br />
phosphatasa essays (L), 625<br />
props. of elk. phosphatase isoenzymes in<br />
plasma of preterm and term neonates, 1778<br />
relationship between -glutamyltransferase 1<br />
isoenzyme and “fast liver” elk. phosphatase<br />
isoenzyme in serum (A), 993<br />
sepn. and identn. of elk. phosphatase<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoelectnic focusing, 2171<br />
serum elk. phosphatasa isoenzymes in<br />
hepatobiliary disorders resolved by use of<br />
immobilized pH gradients, 653<br />
source of “intestinal” elk. phosphatase as<br />
observed with cellulose acetate<br />
alectrophoresis re-examined (A), 999<br />
time-dependent changes in bone, placental,<br />
intestinal, and hapatic elk. phosphatase<br />
activities in serum during pregnancy, 1801<br />
use of IFCC Kaf. Method for unification of elk.<br />
phosphatase results as determined on 4<br />
analyzers (A), 1000<br />
Alkanes<br />
gaa-chromatog. mesa, of volatile alkanes from<br />
single-breath samples (SN), 140<br />
Allergy<br />
fluorescence enzyme immunoassay for<br />
allergen-specific IgG4 (A), 918<br />
lacnimel IgE assessment with paper strips (A),<br />
918<br />
rapid (4-h) enzyme-linked KAST test for<br />
allergen-specific IgE (A), 918<br />
Aluminum<br />
absorption of Al from either citrate or Cl in rat<br />
averted gut sacs (A), 933<br />
dialyzed patients having high serum Al values<br />
(A), 933<br />
measurement of Al in micro tissue samples by<br />
electrothermal atomic absorption<br />
spectrometry (A), 933<br />
transfenrin binding of A13 and Fe3, 405<br />
American Board of <strong>Clinical</strong> Chamistny<br />
Sea ABCC<br />
Amikacin<br />
datn. of serum amikscin on Cobas Bio FP<br />
centrifugal analyzer (A), 1021<br />
Aminas<br />
liq.-chromatog. measurement of<br />
catecholamines and metabolites in plasma<br />
and urine, 2209<br />
Amino acids<br />
automated anal. for taurine in biol. fluids,<br />
tissues (SN), 835<br />
detn. of i-aminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase liq. chromatog., 1736<br />
affects of collection methods on amino acid<br />
profiles (A), 936<br />
phanylalanine and tyrosine in serum and<br />
eluates from dried blood spots as detd. by<br />
reversed-phase liq. chromatog., 1152<br />
Aniinolevulinate dehydratase<br />
enzymic glycation may decrease acty. of<br />
erythrocytic 6-aminolevulinate dahydratase<br />
in diabetes, 1807
Aminolavulinic acid<br />
optimized liq.-chromatog. method for<br />
fluorometny of urinary 6-aminolevulinic acid<br />
in workers exposed to Pb (SN), 1667<br />
Aminopeptidase<br />
alanine aminopeptidase in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
Aminotnansferases<br />
See also specific enzymes<br />
glycogan storage disease type I: lab, data,<br />
diagnosis, 2008<br />
performance characteristics of EM Diagnostic<br />
Systems test pack methods for<br />
aminotransferases in aca analyzer (A), 950<br />
Arniodarone<br />
assay of amiodarone and desethylamiodarone<br />
by HPLC and specimen preparation with Du<br />
Pont Prep (A), 1014<br />
liquid-chromatog. measurement of amiodarone<br />
end N-desethylamiodarone in serum (A),<br />
1014<br />
Ammonia<br />
evaln. of Du Pont ace plasma NH3 procedure<br />
for use with urine (A), 980<br />
Ammonium<br />
quant. detn. of NH4, N&’, K, Mg2, Ce2”,<br />
and creatinine in human urine by capillary<br />
isotachophoresis (A), 1005<br />
Amniotic fluid<br />
accurate quantn. of phospholipids in amniotic<br />
fluid by 31P-NMK (A), 901<br />
essay of disaturated phosphatidylcholina in<br />
amniotic fluid as a test of fatal lung<br />
mstunity- experience with 2000 analyses<br />
(SN), 1648<br />
automated enzymatic measurement of lecithin,<br />
sphingomyelin, and phosphatidylglycerol in<br />
amniotic fluid, 81<br />
calibrated fluorescence polarization assay for<br />
assessment of fetal lung maturity, 1177<br />
comparison of thin-layer chnomatog., immunol.<br />
and enzymatic methods for determining<br />
phosphatidylglycenol in amniotic fluid (A),<br />
900<br />
cost-effective screening of amniotic fluids for<br />
phosphatidylglycerol before the Amniostat-<br />
FLN procedure (TB), 715<br />
effect of albumin and lamellar bodies on<br />
fluorescence polarn. of amniotic fluid (SN),<br />
1194<br />
evalg. the din, effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
evaln. of quant. enzymatic assay for<br />
phosphatidylglycerol in amniotic fluid (A),<br />
900<br />
fluorescence polarization of amniotic fluid<br />
lameilar bodies compared with whole<br />
amniotic fluid (A), 901<br />
prospective clinical avaln. of an improved<br />
fluorescence polarization assay for predicting<br />
fetal lung maturity (SN), 554<br />
recovery studies with two methods of<br />
visualizing thin-layer chromatog. plates for<br />
detn. of L/S radio in amniotic fluid (A), 900<br />
time-resolved immunofluorometry of alphafatoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
time-resolved immunofluoromatry of 34-kDs<br />
aomstomadin.binding protein, 1126<br />
use of amniotic fluid enzymes for prenatal<br />
diagnosis of cystic fibrosis (A), 1059<br />
Ainperometry<br />
See also Electrochemical techniques<br />
Amphetamine<br />
applicn. of EMIT amphetamine drug of abuse<br />
assay to the ETS system (A), 975<br />
benzathina interference in the EMfl’-st urine<br />
amphetamine assay (TB), 1080<br />
fluorescence polarn. immunoassay evald. for<br />
screening for amphetamine and<br />
inethainphatemina in urine (SN), 1200<br />
isometheptene cross reacts in the EMIT<br />
amphetamine assay (TB), 1264<br />
single-reagent polarization fluoroimmunoassay<br />
of methamphetamine in urine (SN), 1903<br />
Amylase<br />
arty. of phospholipase A compared in serum in<br />
pancreatic and nonpancreatic diseases (SN),<br />
594<br />
a-amylase, new test in the Keflotron system<br />
(A),996<br />
applcn. of stable, chromogenic serum alphaamylase<br />
reagent to various din. cham.<br />
analyzers (A), 996<br />
automated fluorescence depolarization assay<br />
for total amylase acty. eveld. (TB), 615<br />
comparison of 4 methods for detg. amylase in<br />
serum and urine (A), 997<br />
datg. amylase arty. with EM Diagnostic<br />
Systems test packs (A), 950<br />
detn. of a-amylase acty. with a new<br />
chromogemc substrate, 524<br />
differential assay of salivary, pancreatic aamylesa<br />
in serum, urine, with usa of<br />
monoclonel antibody to human salivary<br />
amylase immobilized on bacterial cell wall<br />
(SN), 1235<br />
evaln. of pancreas-specific alpha-amylase<br />
antibody assay with different automated<br />
systems (A), 998<br />
improved measurement of serum emylase with<br />
a chromogenic substrate (A), 997<br />
kinetic amylase kit adapted to the Technicon<br />
KA-1000 (TB), 722<br />
likelihood calcn. by means of different aamylase<br />
and lipase tests in inflammatory<br />
pancneatitis (A), 998<br />
liquid, stable alpha-amylsse reagent for Abbott<br />
Vision5’ system (A), 996<br />
math, treatment of data for calculating<br />
activities of cs-amylase isoenzymes (SN), 689<br />
monoclonel antibody specific for salivary<br />
amylase (L), 1695<br />
monoclonel antibody that specifically inhibits<br />
salivary a-amylase, 1158<br />
multicenter evsln. of a-amylase assay with<br />
ethylidene-protected 4nitnophenylmeltoheptaosida<br />
as substrate<br />
(A), 957<br />
pancreas-specific alpha-amylase assay with<br />
synergistic action of two different<br />
monoclonal antibodies (A), 997<br />
reactivity of human macroamylases with mouse<br />
monoclonal anti-salivary amylase antibodies<br />
(A),998<br />
Roche Isomune amylase reagent-a pancreatic<br />
amylase immunosaparstion technique (A),<br />
997<br />
salivary amylase and pancreatic enzymes in<br />
Sjogren’s syndrome (SN), 305<br />
serum amylase and -y-glutamyltransferase<br />
assay in the Abbott “Vision” system (TB),<br />
722<br />
software program for calcn. of amylase<br />
isoenzymes (A), 982<br />
stable reagent for direct assay of aipha-amylese<br />
in patients’ samples using 2-chloro-4nitrophenyl-alpha-maltotrioside<br />
as substrate<br />
(A),997<br />
Amyloid A<br />
serum amyloid A is major component of acutephase<br />
plasma very-low-density lipoproteins<br />
(A),896<br />
Analog free thynoxin immunoassays<br />
validity of analog free thyroxin immunoassays.<br />
part II (response p. 2148) (0), 2145<br />
validity of analog free thyroxin immunoessays<br />
(response, p. 2150) (0), 2137<br />
Analytical error<br />
See also Variation, source of<br />
absorbance errors from usingpiaced-togethar<br />
rotors in the Roche Cobas-Bio cantnif.<br />
analyzer (SN), 1198<br />
absorbanca errors from using pieced-together<br />
rotors on Roche Cobas-Bio analyzer (A), 942<br />
accelerated-degradation testing of<br />
immunodiagnostic reagents (L), 202<br />
accuracy and precision of breath-alcohol<br />
measurements for a random subject in the<br />
postabsorptive state, 261<br />
accuracy and precision of simple method for<br />
hemoglobinometry (A), 1001<br />
accuracy, precision of breath alcohol -<br />
measurements for subjects in the absorptive<br />
state, 753<br />
acty. measurements of CaI+, Na, K+, and Cl<br />
after equilibrium dial, used to show lack of<br />
evidence for protein interference with Ca<br />
electrodes, 1811<br />
artefactual hyperkalemia induced by heparin<br />
in patients with extreme leukocytosis (A),<br />
914<br />
ertifactual increase in plasma lactate<br />
dehydrogenase acty. caused by a surfactant<br />
(TB), 192<br />
assessment of the use of fixed limits to<br />
characterize intrelab. performance by<br />
proficiency testing (SN), 1901<br />
avoiding serum matrix effect in calmagite<br />
compleximatnic measurements of Mg2” (TB),<br />
719<br />
benzethonium Cl interference with subsequent<br />
assays involving hperinizad plasma in a<br />
centnif. analyzer (TB), 615<br />
bias and precision of cholesterol anal. by<br />
physician’s office analyzers (SN), 2262<br />
bilirubin and free glycerol interferences in<br />
GPO Trinder triglyceride assays using BA-<br />
1000 (A), 899<br />
bilirubin interference with salicylate<br />
the RA-1000 analyzer (TB), 309<br />
method of<br />
bromcresol purple dye-binding<br />
underestimate albumin that<br />
methods<br />
is carrying<br />
covalently bound bilirubin (SN), 821<br />
Ca does not interfere with mass. of Mg in the<br />
DuPont “aca-III” (TB), 1936<br />
cefoxitin interferes with “Clini-Skreen”<br />
column method for urinary 17hydroxycorticoeteroids<br />
(SN), 1219<br />
choriogonadotropin interference in an assay for<br />
thyrotropin (L), 1303<br />
comparison of ascorbic acid interference in<br />
HDL-cholesterol astu. by six pptn. methods<br />
with use of a sensitive enzymic cholesterol<br />
neaent (TB), 1467<br />
criteria for evalg. nonquant. assays: appln. to<br />
serum choriogonadotropin (SN), 150<br />
degradation of methotrexate in an automated<br />
proced. for extracting it from serum (TB),<br />
1072<br />
desirable stds. of performance for therapeutic<br />
drug monitoring, 387<br />
detecting errors in blood.gas<br />
anal. with two instruments,<br />
measurement<br />
512<br />
by<br />
discrepancies in carcinoambryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
discrepancies in plasma estradiol values<br />
commercial kits (TB), 1672<br />
effect of enticoagulants on fructosamine<br />
with<br />
datn.<br />
(TB), 1947<br />
effect of detergent on triglyceride assay (L),<br />
202<br />
effect of free fatty acids and nonlipid inhibitors<br />
of thyroid hormone<br />
immunoradiomatric<br />
binding in the<br />
assay of thyroxinbinding<br />
globulin, 1752<br />
effect of heparin, citrate on measured concns.<br />
of various anelytas in plasma (SN), 814<br />
effect of iodinatad contrast media on a<br />
radioimmunoassay of C3a(TB), 1470<br />
effect of time of exposure of serum to gelbarrier<br />
tubes on results for progesterone and<br />
some other endocrine tests (L), 203<br />
effect of Trizma#{149} carbonate on results by the<br />
Kodak Ektachem single-slide method for<br />
creatinine (TB), 1476<br />
affects of lipemia on Technicon RA-1000<br />
measurements (A), 913<br />
electrophoresis indicates protein loss on<br />
centrifn. of whole saliva (TB), 1263<br />
error in assays of plasma catecholaminee by liq.<br />
chromatog. with electrochem. detection<br />
(TB), 1938<br />
evaln, of single-side<br />
Kodak Ektachem<br />
creatinine method in<br />
700 shows poe.<br />
interference from lignocaine metabolites<br />
(TB), 1674<br />
factors affecting urinary screens for<br />
acetaminophen (L), 1695<br />
false-positive urinalysis results with acidified<br />
urine (L), 2321<br />
glucose test “carryover” affects drug assays in<br />
the IL “Monarch” (L), 1695<br />
glucose test “carryover” affects drug assays on<br />
the IL Monarch (L), 743<br />
I contamination of urine samples by test strips<br />
(TB), 1935<br />
influence of ambient temp. on the Ektachem<br />
DT6O results for total bilirubin and total<br />
protein (SN), 138<br />
Inocor5’ (amrinone lactate) interferences with<br />
TD1 digoxin meas. (TB), 1944<br />
instrument artifact affects TDM assays in the<br />
IL “Monarch” (L), 1951<br />
mt. collaborative study on standn. of<br />
apolipoproteins A-land B. part II. evaln.<br />
contributions of antisera to among-<br />
of<br />
laboratory<br />
interference<br />
variance components,<br />
Br in detn. of serum<br />
2250<br />
C1 (TB),<br />
415<br />
interference by anti-immunoglobulin G<br />
antibodies<br />
thyrotropin<br />
in immunoradiometric assays<br />
involving mouse monoclonal<br />
of<br />
antibodies<br />
interference<br />
(SN), 840<br />
in an electrochem. detection<br />
system for peroxidase-linkad reactions based<br />
on a fluoride ion-selective electrode (SN),<br />
1458<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2361
interference of fluorescein, used in retinal<br />
angiography, with certain din, lab. tests (L),<br />
2126<br />
interference of the chemotherspeutic agent<br />
etoposida with the direct phosphotungstic<br />
acid method for uric acid (CR), 2109<br />
interference studies with physician office<br />
analyzers (A), 915<br />
interference with dipstick tests for glucose and<br />
Nb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
intra-individual variation of some analytes in<br />
serum in insulin-dependent diabetes, 57<br />
isometheptene cross reacts in the EMIT<br />
amphetamine assay (TB), 1264<br />
kinetic o-phthslaldehyde method for urea<br />
eliminates errors due to interference by<br />
monoclonal proteins (TB), 723<br />
little cross neacty. of local anesthetics with<br />
Abuscreen, EMIT d.a.u., and TDX<br />
immunoasasys for cocaine metabolite (L),<br />
747<br />
mechanism of interference with the Jaff#{233}<br />
reaction for creatinine, 1129<br />
metastable aqueous foams and flame at,<br />
absorp. spectnom. (TB), 719<br />
4-mathylumbelliferona and its glucunonide<br />
interfere with protein estn. by the Lowry<br />
method (TB), 1475<br />
model for assessing interference, 1121<br />
negative interference with the Du Pont ace<br />
method for measuring digoxin (L), 446<br />
optical kinetic method for calibration of<br />
spectrophotometer temp.: demonstration<br />
with the Cobss-Bio analyzer (SN), 1891<br />
parallelism of dilution curves in RIA (L), 2320<br />
phenylpropanolamine and (d)norpsaudophedrine<br />
are indistinguishable by<br />
Toxilsb (TB), 1678<br />
pyridoxsl-5-phosphate depletion in renal<br />
dialysis patients causes din, significant<br />
errors in ALT detns. (A), 992<br />
source of error in the assay of urinary orotic<br />
acid (TB), 713<br />
specimen collection in plastic containers gives<br />
rise to interferents in liq.-chromatog. assay<br />
of cyclosporine (L), 1493<br />
thyroid-function testing with the TDx:<br />
interference from endogenous fluorophore<br />
(TB), 1467<br />
tolerances for sample-loop vols. (L), 1297<br />
toxicity of Na nitroprusside, 490<br />
underestimation of monoclonal proteins by<br />
serum protein electrophoresis on cellulose<br />
acetate (SN), 182<br />
xsnthine interference in the Kodak<br />
“Ektachem” detn. of uric acid (TB), 1265<br />
Andnogens<br />
total testosterone, free-androgen index, calcd.<br />
free testosterone, and free testosterone by<br />
analog RIA compared in hirsute women and<br />
in otherwise-normal woman with altered<br />
binding of sex-hormone-binding globulin,<br />
1372<br />
Andnostanediol<br />
quantn. of 5a- and 5-sndrostanediols in urine<br />
by gas chromstog.-mass spectrom., 256<br />
Androstenedione<br />
evaln. of direct RIA for androstenedione (A),<br />
891<br />
Anemia<br />
erythrocytic glucose-6-phosphste<br />
dehydrogenasa measured by differential pH<br />
(SN), 579<br />
plasma Fe and transferrin iron-binding<br />
capacity evald. by colorimetnic and<br />
immunopptn. methods, 273<br />
ref. values for Fe, TIBC, and ferritin in a<br />
baboon colony (Papio species) (A), 1036<br />
Angiotansin<br />
enzyme immunoassay of angiotensin I and<br />
renin, 1774<br />
Angiotensin-converting enzyme<br />
automated detn. of angiotensin-converting<br />
enzyme in serum (SN), 1248<br />
detn. of angiotensin-converting enzyme acty. in<br />
vitro: dose-response study in human and dog<br />
serum (A), 893<br />
different ref. intervals for kinetic assay of<br />
angiotensin-converting enzyme (L), 2324<br />
direct detn. of angiotensin-converting enzyme<br />
inhibitors in plasma by nadioenzymatic<br />
assay, 549<br />
relation between thyroid hormones and<br />
angiotensin-conventing enzyme (L), 1103<br />
specific 1251 RIA for SQ 27,519 in human serum<br />
(A), 1027<br />
why are there different ref. intervals for the<br />
2362 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
kinetic angiotensin-converting enzyme<br />
assay? (L), 1491<br />
Animal models of disease<br />
See Veterinary chemistry<br />
Antiarrhythmic drugs<br />
assay of flecainide in serum by HPLC after<br />
microscale protein pptn. (A), 1016<br />
liq. chromatog. and fluorescence polarization<br />
immunoassay methods compared for<br />
measuring flecainide acetate in serum (SN),<br />
1898<br />
quantn. of serum flecainide by gas chromatog.<br />
with N-P detector (A), 1016<br />
Antibiotics<br />
See also specific antibiotic of interest<br />
evaln. of EMIT-chloramphenicol assay in a<br />
pediatric hosp. (A), 1021<br />
HPLC datn. of amphotenicin B in human urine<br />
and serum (A), 1021<br />
liq.-chrometog. detn. of five orally active<br />
cephalosponins-cefixime, cefsclor,<br />
cefsdroxil, caphalexin, and cephradine-in<br />
serum, 1788<br />
measurement of nimantadine in plasma by<br />
capillary GC/MS (A), 1022<br />
rapid enzymatic assay of flucytosine in serum<br />
with a centrifugal analyzer (A), 1022<br />
rapid fluorescence polarization immunoassay<br />
for antimicrobial drugs: gentainidin,<br />
tobramycin, and amikacin (A), 1020<br />
receptor-antibody “sandwich” assay for<br />
teicoplanin, 1615<br />
Anticoagulants<br />
effect of heparin, citrate on measured condos,<br />
of various analytes in plasma (SN), 814<br />
ref. intervals for plasma lipoperoxides: age-,<br />
sex-, and specimen-related variations (SN),<br />
2289<br />
Anticonvulsant drugs<br />
assessment of evacuated serum separator gel<br />
blood-collection tubas for antiepileptic<br />
monitoring by FPIA (A), 1017<br />
can a single measurement of carbamazepine<br />
suffice for therapeutic monitoring? (SN), 812<br />
detn. of methsuximide and Ndesmethylmethsuximide<br />
by capillary column<br />
GC (A), 1020<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: anticonvulsant<br />
drugs (A), 1018<br />
Antidepnessants<br />
See also Tricyclic antidapressants<br />
Antidiuretic hormone<br />
detn. of antidiuretic hormone in random urine<br />
and its din. epplicns. (A), 921<br />
Anti-DNA antibodies<br />
cross-reactivity of anti-DNA antibodies with<br />
polyanions (A), 1029<br />
Antiapilaptic drugs<br />
See Anticonvulsant drugs<br />
Antimony<br />
Sb accumn. in heir during treatment of<br />
leishmaniasis (SN), 2081<br />
Antithnombin<br />
effects of surfactants or aprotinin on<br />
sntithrombin III assay (L), 441<br />
evaln. of a fully automated centrifugal analyzer<br />
for hemostasis tests (SN), 1888<br />
kinetic immunonephelometnic detn. of protein<br />
concns. in follicular fluid, 1185<br />
Antitrypsin<br />
ai-antitrypsin in hyperlipidemia (TB), 421<br />
electrophonetic mobility, concn., and acty. of<br />
ni-antitrypsin in serum of patients<br />
undergoing bone-marrow transplantation<br />
(CR), 193<br />
kinetic immunonephelometric detn. of protein<br />
concne. in follicular fluid, 1185<br />
Apatite<br />
noninvasive evaln. of mineral content of bone<br />
without use of ionizing radiation, 227<br />
Apoenzyme reactivation immunoassay system<br />
dry-reagent immunoassay for valproic acid for<br />
use with Ames Seralyzer’ reflectance<br />
photometer (A), 1020<br />
dry-reagent immunoasssy strip for detn. of<br />
quinidine with Ames Seralyzer relectence<br />
photometer (A), 1017<br />
affect of vit. B2 and its derivatives on<br />
apoenzyme immunoassay (A), 1032<br />
evaln. of dry-reagent strip teat for<br />
carbamazepine (A), 1019<br />
experience in 3 physicians’ office labs, with<br />
carbamszepine dry-reagent strip system (A),<br />
1019<br />
Apolipoproteins<br />
anal, and din. evaln. of apolipoproteins (A),<br />
899<br />
anomalous apoprotein E isoforms in peripheral<br />
arteriopathy (TB), 417<br />
apolipoprotein concns. in cord sara of<br />
newborns from diabetic and nondiabetic<br />
mothers (A), 897<br />
apolipoproteina C-Il and C-Ill in serum<br />
quantified by zone immunoelectrophoresis,<br />
664<br />
biochem, and metabolism of apolipoproteins<br />
(A), 1051<br />
changes in CSF lgG and apolipoprotein E<br />
indices in patients with multiple sclerosis<br />
during demyalinstion, ramyelination, 1155<br />
chin. significance of apolipoprotein<br />
measurements (A), 1051<br />
comparison of Beckman, Bio-Rad, and Tsgo<br />
anal. systems for detn. of serum<br />
apolipoproteins A-I and B (A), 898<br />
CSF apolipoprotein E index in patients with<br />
multiple sclerosis during remission (A), 1032<br />
effect of personality type on biocham. risk<br />
factors of coronary heart disease (A), 897<br />
electroimmunoassay for detn. of ApoB in sara<br />
by using a mixture of monoclonal antibodies<br />
(TB), 1070<br />
evaln. of Beckman reagent for apo A-I and apo<br />
B lipoproteins (A), 898<br />
evaln. of lipoproteins and apolipoproteins in<br />
serum of a Tangier patient by micro-scale 2-<br />
D electrophonesis, 468<br />
four procedures compared for sepg.<br />
epolipoprotein A- and apolipoprotein Bcontaining<br />
lipoproteins in plasma, 1597<br />
genetic and environmental factors that affect<br />
plasma apolipoprotein concns. (A), 1051<br />
high-density alphas-lipoproteins: isolation and<br />
electrophoretic anal. (A), 896<br />
immunonephelom. of spolipoprotein B with a<br />
centrifugal analyzer (SN), 1882<br />
immunotunbidimetny for detg. apolipoprotein<br />
E(A),896<br />
immunoturbidimetry of apolipoprotein A-Il in<br />
a centrif. analyzer (L), 1302<br />
immunoturbidimetry of apolipoprotein B in<br />
serum (TB), 1267<br />
mt. collaborative study on stsndn. of<br />
apolipopnotemns A-I and B. part I. evsln. of a<br />
lyophilized candidate ref. and calibration<br />
material, 2240<br />
mt. collaborative study on standn. of<br />
apolipoproteins A-I and B. part II. evaln. of<br />
contributions of antisera to amonglaboratory<br />
variance components, 2250<br />
lab, considerations for reliable spolipoprotein<br />
measurements (A), 1052<br />
low A-esterase acty. in serum in fish-eye<br />
disease (SN), 587<br />
measurement of spolipoprotein A-I in serum<br />
with the Tachnicon RA-1000 system (TB),<br />
1266<br />
monoclonal antibodies-based radial<br />
immunodiffusion assay of apolipoprotein A-I<br />
and B in angiographically assessed coronary<br />
artery disease (A), 898<br />
new assay of apolipoproteins A-I and B by rate<br />
nephalometny eveld. (SN), 2065<br />
plasma apolipoproteins in Tangier disease, as<br />
studied with 2-D electrophoresis (SN), 120<br />
quant. detn. of spolipoproteins A-I and B with<br />
a rapid immunoturbidimetnic assay (A), 897<br />
quantn. of two different types of<br />
apolipoprotein A-i containing lipoprotein<br />
particles in plasma by enzyme-linked<br />
differential-antibody immunosorbent assay,<br />
38<br />
ref. intervals for spolipoproteins A-I and B by<br />
rate nephelometry and associated CHD risk<br />
assessment (A), 898<br />
RIA of apolipoprotein A-I in serum and EDTA<br />
plasma, and effects of freeze-thaw cycles<br />
(TB), 308<br />
sample lipolysis for quantn. of apolipoprotein<br />
B, 338<br />
simultaneous sandwich photometric<br />
immunoassay with tabletted reagents (A),<br />
920<br />
stability of free apolipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hyperlipidemic subjects, 1163<br />
Anginmnosuccinate synthetase<br />
enzyme-linked immunosorbent assay of serum<br />
argininosuccinste synthetaae (TB), 1941<br />
Arthnitis<br />
nephelometric assay of rheumatoid factor in<br />
patients with juvenile rheumatoid arthritis<br />
(A),903<br />
xylosyltnansferase as a marker of cartilage<br />
destruction in chronic joint diseases (A),<br />
1000
Artificial inteffigance<br />
applicn. of the EXPERT consultation s3istem to<br />
accelerated lab. testing and interpretation<br />
(A),867<br />
interpretive report generation with the Rutgers<br />
EXPERT artificial intelligence language (A),<br />
1057<br />
Aacitic fluid<br />
prelim. din, studies of C-reactive protein<br />
quantified by enzyme-linked immunoassey,<br />
2185<br />
receptor-antibody “sandwich” assay for<br />
taicoplanin, 1615<br />
studies of alpha-fetoprotein in ascitic fluid of<br />
hepatoms-bearing patients (A), 925<br />
Asconbata<br />
ascorbic acid as antioxidant in measurements<br />
of catacholamines in plasma (SN), 569<br />
ascorbic, dehydroascorbic acids simultaneously<br />
quantified in bioL fluids by liq. chromatog.<br />
with fluorescence detection; colonimetnic<br />
assay compared, 1874<br />
chem. factors important to Ca nephrolithiasis:<br />
evidence for impaired hydroxycarboxylic<br />
acid absorption causing hyperoxaluria, 243<br />
comparison of ascorbic acid interference in<br />
HDL-cholesterol estn. by six pptn. methods<br />
with use of a sensitive enzymic cholesterol<br />
reagent (TB), 1467<br />
data, of vit. C in non-fat powdered milk by<br />
isotope-dllution-mass spectnometny (A), 963<br />
interference with dipstick tests for glucose and<br />
Hb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
Aspartate anilnotnansfenasa<br />
acty. of serum aspartate aminotransfarase<br />
iaoanzymee in acute myocardiel infarction,<br />
67<br />
anal, performance of Reflotron ALT and AST<br />
test methods (A), 949<br />
3 cases of macro-AST exhibiting increased<br />
activation by pynidoxal-5’-phosphate (A),<br />
992<br />
immunolog. measurement of aspartate<br />
aminotransferase isoenzymes in health<br />
screening (A), 993<br />
liquid, stable reagent for detn. of glutamicoxaloacetic<br />
transaminase for Abbott Vision<br />
system (A), 993<br />
natl. ref. system for AST: RM 8430, a,primsry<br />
AST ref. material from NBS with UfLc<br />
assigned by the IFCC Ref. Method (A), 993<br />
natL ref. system for AST: use of IFCC Ref.<br />
Method and NBS/RM 8430 for unification of<br />
daily AST results as deed, on 3 analyzers (A),<br />
993<br />
pyruvate interference with continuous-flow<br />
(sMAc) methods for aspartate and alanine<br />
aminotransfarases (TB), 616<br />
ratios of creatine kinase to lactate<br />
dahydrogenase and aspartate<br />
eminotransferase in evaln. of patients with<br />
elevated CK (A), 990<br />
studies on reaction system of Reflotron AST<br />
assay, with cardiac and hepatic AST (A), 992<br />
Aspirin<br />
See Salicylate<br />
Atherosclerosis<br />
anomalous spoprotein B isoforms in peripheral<br />
artaniopathy (TB), 417<br />
cholesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
lipoprotein, 390<br />
Atomic absorption spectrometry<br />
See also Atomic absorption apectroscopy,<br />
Atomic absorption spectrophotometry<br />
comparative study between deuterium arc and<br />
Zeeman background correction systems for<br />
measurement of Pb in bioL fluids by<br />
electrothermal atomic absorption<br />
spectrometry (A), 934<br />
measurement of Al in micro tissue samples by<br />
electrothermal atomic absorption<br />
spectrometry (A), 933<br />
metastable aqueous foams and flame at.<br />
sbsorp. spectnom. (TB), 719<br />
performance of diammonium hydrogen<br />
phosphate-nitric acid-graphite furnace<br />
atomic absorp. spectrom. method for urinary<br />
Cd datn. (L), 1298<br />
plasma, erythrocyte, and urinary Zn in<br />
critically ill patients: effect of intravenous Zn<br />
therapy (A), 933<br />
Atomic absorption spectrophotometry<br />
atomic absorption spectrophotometry of Mn in<br />
plasma (TB), 1253<br />
dialyzed patients having high serum Al values<br />
(A), 933<br />
optimized at. absorp. spectrophotom. of Ca in<br />
erythrocytes, 2004<br />
Atomic absorption spectroscopy<br />
data. of Mg ingranuiocytes (A), 1006<br />
intestinal Zn, Cu, and Mn concns. in Crohn’s<br />
disease (A), 933<br />
Atomic emission spectromatry<br />
quanta. of desfernioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
ATP modn. of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with 3ip NMR,<br />
76<br />
ATPue<br />
effect of gossypol on the activity of erythrocyte<br />
Na-K ATPase ecty. in vitro (TB), 309<br />
Atnial natniuretic peptides<br />
plasma acidn. increases atnial natriuretic<br />
peptide as measured by RIA (L), 1104<br />
plasma levels of atriel natniuretic peptide and<br />
digoxin-like immunoreactiva substances in<br />
patients undergoing cardiopulmonary bypass<br />
(A), 890<br />
RIA of atrial natriuretic polypaptide in heattreated<br />
plasma, 674<br />
Autoantibodles<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidase IV in mice with lupus<br />
erythamatosus-like syndrome and in patients<br />
with lupus erythematosus and rheumatoid<br />
arthritis (SN), 1463<br />
autoantibody against diiodinated tynosinegastrin<br />
in a patient with Graves’ disease, 97<br />
detection of sutoantibodies in serum by<br />
antigens covalently linked to magnetizable<br />
solid phase (A), 1564<br />
detection of circulating platelet antibodies and<br />
platelet-associated IgG by flow cytometry<br />
(A), 1004<br />
ELISA for data. of insulin autoantibodies (A),<br />
921<br />
enzyme immunoassay for simultaneous mess.<br />
of autoantibodies against thyroglobulin and<br />
thyroid microsome in serum (SN), 2286<br />
sensitive, specific ELISA for detection of<br />
sutoantibody to n-DNA (A), 923<br />
Autoimmuna disease<br />
activities of dipeptidyl peptidase II and<br />
dipaptidyl peptidase Win mice with lupus<br />
erythematosus-lika syndrome and in patients<br />
with lupus erythematoeus and rheumatoid<br />
arthritis (SN), 1463<br />
Autoimmune reactions<br />
detection of autoantibodias in serum by<br />
antigens covalently linked to magnetizable<br />
solid phase (A), 1564<br />
Automated analyzers<br />
See Continuous-flow analysis, Discrete<br />
analysis, etc.<br />
Autoradiography<br />
pitfall in anal. of proteins synthesized by sweat<br />
glands from patients with cystic fibrosis by<br />
two-dimensional gel electnophoresis and<br />
double-label autoradiography (TB), 2310<br />
Avidin<br />
biotin radioligand essay with an ‘WI-labeled<br />
biotin deny., avidin, and avidin doubleantibody<br />
reagents, 1983<br />
Avidin-biotin interaction<br />
two-monoclonal-antibody “sandwich”-type<br />
assay of lutropin, with no cross reaction with<br />
choriogonadotropin, 1603<br />
Awards<br />
Sea AACC<br />
Bacteria<br />
DNA probe-based technol. and std. culture<br />
methodoL compared for detecting<br />
periodontal pathogens (A), 963<br />
Flavobactenium and Sphingobacterium<br />
species: enzyme profiles compared by use of<br />
pattern recognition of two-dimensional<br />
fluorescence data, 377<br />
Barbiturates<br />
Sea siso specific barbiturate of interest<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: barbiturates in<br />
urine (A), 973<br />
serum pentobarbital detn. by fluorescence<br />
polarization immunoassay (A), 1026<br />
Base excess<br />
biol. variation of blood acid-base status:<br />
consequences for anal, goal-setting and<br />
interpretn. of results, 1416<br />
BASO-DALT<br />
See Electrophoresis, two-dimensional<br />
Beckman Confenence<br />
preface(S), SB<br />
Reheat’s syndrome<br />
decreased drug absorption in a patient<br />
Behcet’s syndrome (CR), 1679<br />
with<br />
Bence Jones protein<br />
Bence Jones proteinunia in multiple sclerosis<br />
(SN), 1923<br />
simple silver-stainin technique for detecting<br />
Bence Jonas<br />
561<br />
proteins in unconcd. urine (SN),<br />
Benzodiazeplnes<br />
Abuscreen’ RIA for detection of<br />
benzodiazapines and their metabolitea (A),<br />
973<br />
chin. evaln. of TDx5 fluorescence polarization<br />
immunoassa, for detection of<br />
benzodiazepmes in urine (A), 973<br />
comparison of GDC’s EUSi and Syva’s Eacrr<br />
for qual. detg. benzodiazepines in human<br />
urine (A), 973<br />
FPIA for detecting<br />
(A), 973<br />
bensodiazepines in serum<br />
quanta. of antidepnessanta and<br />
benzodiazepines in a single HPLC system<br />
(A), 1025<br />
simple assay to detect and confirm urinary<br />
benzodiazepines by HPLC utilizing<br />
diode-array detection (A), 974<br />
photo-<br />
Benzoylecgonine<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse:<br />
metabolite (benzoylacgonine)<br />
cocaine<br />
in urine (A),<br />
971<br />
strategy for benzoylecgpnine testing-.<br />
confirmation by TLC/HPLC (A), 971<br />
Betbanechol<br />
bethanachol-induced hypenamylasemia of<br />
salivary and pancreatic types without P3 ins<br />
patient without acute psncreatitis (A), 998<br />
Bicarbonate<br />
bioL variation of blood acid-base status:<br />
consequences for anal. goal-setting<br />
interpretn. of results, 1416<br />
and<br />
extension of Abbott Spectrum#{149} HCO3- reagent<br />
stability (A), 1008<br />
modn. of intra-erythrocytic homeoetasis in<br />
uremic patients, as studied with alp NMR,<br />
76<br />
naproxen interference with the ion-selective<br />
electrode in the RA-1000 (TB), 421<br />
performance characteristics of Ca, Mg, alcohol,<br />
and IWO3- reagents in the EASY analyzer<br />
(A), 944<br />
pKj’ and bicarbonate concn. in plasma, 13<br />
Blchromatlc analysis<br />
evaln. of Paramax CSFglucoea assay (A), 952<br />
optimization of sodium dodecyl sulfate concns.<br />
in Coomassie Brilliant Blue G250 method for<br />
urinary light-chain proteins (A), 905<br />
performance characteristics of Paramaz anal.<br />
system for data. of HDL cholesterol (A), 952<br />
performance characteristics of Paramaz’ anal.<br />
system for data, of P; reduction of<br />
interference through serum blank correction<br />
(A), 952<br />
performance characteristics of Paramaz anal.<br />
system for detn. of lipase (A), 953<br />
Bile<br />
identn. and anal, of 9 metabolites of<br />
cyclosponina in blood by liq. chromatog. 1:<br />
purifn. of anal. stds. and assay optimization,<br />
1841<br />
rapid data. of the cholesterol seth. of bile by<br />
using a centnif. analyzer (TB), 187<br />
Bile acids<br />
method to assay serum concns. of total bile<br />
acids by using a sensitive<br />
(BARM) (A), 1013<br />
chromogen<br />
validation and appln. of a liq.chromatog./anzymic<br />
assay for individual<br />
acids in rat serum, 1856<br />
Bilirubin<br />
bile<br />
adaptation and evaln. of Dart total and direct<br />
bilirubin reagent to Coulter CPA (A), 942<br />
assay of neonatal total and direct bilirubin on<br />
Technicon RA 1000 system (A), 1012<br />
bilirubin and free glycerol interferences in<br />
GPO Trinder triglyceride assays using RA-<br />
1000 (A), 899<br />
bilirubin interference with salicylate<br />
the RA-1000 analyzer (TB), 309<br />
method of<br />
bromcresol purple dye-binding<br />
underestimate albumin that<br />
methods<br />
is carrying<br />
covalently bound bilirubin (SN), 821<br />
caffeine-splitting of bilirubin/albumin<br />
complex: its relevance to spectrophotometry<br />
of bilirubin in serum (SN), 597<br />
candidate std. for use in calibration<br />
biirubin in serum, 1817<br />
of total<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2363
din, utility of Ektachem5-detd. bilirubin<br />
fractions for classifying adult inpatients<br />
(SN), 1662<br />
Cobas.Bio and Technicon RA-1000 assays of<br />
direct bilirubin compared (TB), 1670<br />
delta bilirubin: absorption spectra, molar<br />
absorptivity, and reactivity in the diezo<br />
reaction, 769<br />
datn. of conjugated and total bilirubin in serum<br />
of neonates, with use of bilinubin oxidase,<br />
1822<br />
detn. of total bilirubin on Abbott Vision (A),<br />
1012<br />
development of reagent for measurement of<br />
total bilirubin (A), 1011<br />
differentiation of direct and total bilirubin by<br />
selection of appropriate surfactants (A), 1012<br />
direct bilirubin measured by use of bilirubin<br />
oxidase, 1349<br />
enzymatic assay for bilirubin using unidine<br />
diphosphate glucuronosyltransferese (A),<br />
1013<br />
immunoaffinity pretreatment method for<br />
improved chromatog. detn, of fractionated<br />
bilinubin (A), 1012<br />
improved direct bilirubin method for<br />
Parsmsx anal, system (A), 1012<br />
influence of ambient temp. on the Ektachem<br />
DT6O results for total bilirubin and total<br />
protein (SN), 138<br />
micro-chromatog. method for measuring deltabilirubin<br />
in serum (A), 1013<br />
new parameter in Reflotron5 system: total<br />
bilirubin (A), 1011<br />
serum or plasma oxidstive system: total<br />
bilirubin reagent with FeCI3 (A), 1011<br />
storage of specimens in “Microtainer Amber<br />
Tubes” protects bilirubin from degrsdn. by<br />
light (TB), 712<br />
Bilirubin oxidase<br />
“chromogen oxidase” acty. of bilinubin oxidase<br />
(L), 1304<br />
detn. of conjugated end total bilirubin in serum<br />
of neonates, with use of bilirubin oxidasa,<br />
1822<br />
direct bilirubin measured by use of bilirubin<br />
oxidase, 1349<br />
Biological variation<br />
See Variation, source of<br />
assay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of biol. variation, 269<br />
selecting the optimum specimen for assessing<br />
slight slbuminunia, and a strategy for din,<br />
investigation: novel uses of dsta on biol.<br />
variation, 2034<br />
Biometry<br />
See Statistics<br />
Biotin<br />
biotin radioligand assay with an ‘251-labeled<br />
biotin deny., evidin, and avidin doubleantibody<br />
reagents, 1983<br />
time-resolved immunofluorometny of alphafetoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
Birth defects<br />
Sea Heritable disorders, Genetics<br />
Blood donors<br />
drugs in blood donors (TB), 189<br />
Blood gases<br />
bimodal distribution in venous CO2 in healthy<br />
subjects (TB), 1473<br />
biol. variation of blood acid-base status:<br />
consequences for anal. goal-setting and<br />
interpnetn. of results, 1416<br />
din. and lab, perspectives on 02 utilization (A),<br />
865<br />
detecting errors in blood-gas measurement by<br />
anal. with two instruments, 512<br />
development of default interpretive criteria for<br />
flexible ‘map” system for on-line automatic<br />
interpretation of blood gas data (A), 982<br />
evsln. of NOVA Biomedical Stat Profile 1<br />
analyzer (A), 939<br />
% functional oxyhemoglobin saturation by<br />
pulse oximetry and oxyhemoglobin<br />
saturation compared in critically ill patients<br />
(A),939<br />
invasive sensors (A), 872<br />
modifn. of programmed, interactive, ‘map”<br />
system for blood gas result interpretation for<br />
management of patients needing ventiletory<br />
support: a teaching hospital’s experience (A),<br />
982<br />
performance of an in-vivo, continuous bloodgas<br />
monitor with disposable probe (S), 1538<br />
2364 CLINICAL CHEMISTRY, Vol.33,No. 12,1987<br />
performance of Radiometer OSM3<br />
hemoximeter compared with spectrophotom.<br />
multiwsvalength method (A), 939<br />
pK1’ and bicarbonate concn. in plasma, 13<br />
problems with blood gas anal. (TB), 719<br />
robotic automation of blood gas anal. in<br />
remote, unmanned critical-cane lab. (A), 960<br />
Blood groups<br />
elk. phosphatase isoenzymes in the plasma of<br />
pneterm end term infants: serial<br />
measurements and din. correlations, 1783<br />
Bone<br />
biochem. markers in bone cancer (A), 929<br />
noninvasive evaln. of mineral content of bone<br />
without use of ionizing radiation, 227<br />
Bone disease<br />
characterization and assay of tartrate-nesistant<br />
acid phosphatase scty. in serum: potential<br />
use to assess bone resorption, 458<br />
Bone marnow<br />
elactrophoretic mobility, concn., and acty. of<br />
a1-antitrypsin in serum of patients<br />
undergoing bone-marrow transplantation<br />
(CR), 193<br />
Bone-marrow transplants<br />
are cyclophosphamide and phosphoranaide<br />
mustard related in high-dose bone-marrow<br />
transplant patients? (A), 1035<br />
Book revaews<br />
Advances in Chromatography, 25, 450<br />
Advances in <strong>Clinical</strong> <strong>Chemistry</strong>, 25, 449<br />
Annual Review of Medicine: Selected Topics in<br />
<strong>Clinical</strong> Sciences, 38, 1699<br />
Biotechnology: Strategies for Life, 749<br />
Chronicle: The Human Side of AIDS, 1110<br />
<strong>Clinical</strong> Application of Laboratory Tests, 343<br />
<strong>Clinical</strong> Enzymology. A Case-Oriented<br />
Approach, 345<br />
<strong>Clinical</strong> Specimens. Analytical <strong>Chemistry</strong> by<br />
Open Learning, 2133<br />
Clinics in Laboratory Medicine, vol. 7, no, 2:<br />
Therapeutic Drug Monitoring-I:<br />
Pharmacokinetics, Technology, and<br />
Methodology, 1960<br />
Computerized Quality Control: Programs for<br />
the Analytical Laboratory, 1308<br />
Computer: Programs for Laboratory Statistics:<br />
ANOVA and LABSTAT, 343<br />
Cost-Effective Quality Control: Managing the<br />
Quality and Productivity of Analytical<br />
Processes, 635<br />
Drug Interferences and Drug Effects in <strong>Clinical</strong><br />
<strong>Chemistry</strong> 1986, 1110<br />
Electrochemistry, Sensors and Analysis<br />
(Analytical <strong>Chemistry</strong> Symposia Series, 25),<br />
1309<br />
Electrophorasis ‘86, 748<br />
Electnophoresis. Theory, Techniques, and<br />
Biochemical and <strong>Clinical</strong> Applications, 2nd<br />
ad. (Monographs on Physical Biochemistry),<br />
449<br />
Fundamentals of <strong>Clinical</strong> <strong>Chemistry</strong>, 634<br />
Handbook of Physiology, Section 3: The<br />
Respiratory System, Vol. IV, Gas Exchange,<br />
2328<br />
Hazards in the Chemical Laboratory, 344<br />
Human Genetic Diseases: A Practical<br />
Approach, 344<br />
Immunoassay Technology, 2, 634<br />
Laboratory Instrumentation, 2133<br />
Laboratory Quality Assurance, 748<br />
Mediators of Inflammation, 1308<br />
Medical Uses of Statistics, 1110<br />
Microbiological Applications of High-<br />
Performance Liquid Chromatography, 2329<br />
The Plasma Proteins: Structure, Function, and<br />
Genetic Control, 5, 1699<br />
A Practical Guide to Financial Management of<br />
the <strong>Clinical</strong> Laboratory, 635<br />
Progress in <strong>Clinical</strong> Biochemistry and<br />
Medicine, vols. 2 and 3, 635<br />
Quantitative Analysis of Catecholamines and<br />
Related Compounds, 749<br />
Study Guide to <strong>Clinical</strong> <strong>Chemistry</strong>, 2329<br />
Brain<br />
comparison of solutions for extracting CK, AK,<br />
and LD from brain samples (TB), 2304<br />
Breast cancer<br />
alphs-fetoprotein and estrogen/progestin<br />
receptors in breast cancer patients (A), 929<br />
distribution and levels of androgen receptors in<br />
human breast cancer (A), 930<br />
estrogen and progesterone receptor content in<br />
breast cancer cytosois: relationship to tumor<br />
marker expression (A), 930<br />
evaln. of new breast cancer tumor marker in<br />
patients with advanced stage breast cancer<br />
(A), 929<br />
immunoassay of estrogen and progesterone<br />
receptors in human breast cancer (A), 959<br />
MCA, a new serum marker for breast cancer<br />
(A), 929<br />
measurement of serum concns. of CA-549, an<br />
experimental breast cancer marker, by<br />
Photon Elite random-access analyzer (A),<br />
930<br />
Breath analysis<br />
accuracy and precision of breath-alcohol<br />
measurements for a random subject in the<br />
postabsorptive state, 261<br />
concerning accuracy and precision of breathalcohol<br />
measurements (0), 1701<br />
gas-chromatog. mess. of volatile alkanes from<br />
single-breath samples (SN), 140<br />
reliability of breath-alcohol mess. during the<br />
absorption phase (L), 2128<br />
results of breath-alcohol analyses on two<br />
consecutive samples (A), 968<br />
Bromide<br />
interference 8r in detn. of serum Cl (TB),<br />
415<br />
Bromocriptine<br />
detection of bnomocniptine-like substances in<br />
urine of an infant on soy formula (TB), 414<br />
Brucellosis<br />
using whole bacteria, lipopolysaccharide, and<br />
sol. antigens to detect IgG, 1gM, and IgA in<br />
bruceflosis by Dot-ELISA with nitrocalluose<br />
as solid phase (A), 1570<br />
Cachectin<br />
See Tumor necrosis factor<br />
Cadmium<br />
performance of dieinmonium hydrogen<br />
phosphate-nitric acid-graphite furnace<br />
atomic absorp. spectrom. method for urinary<br />
Cd detn. (L), 1298<br />
Caffeine<br />
adaptation of Syve caffeine EMIT reagents to<br />
Baker Encore System 11(A), 1023<br />
detn. of methylxanthine stimulants in urine of<br />
racing greyhounds by HPLC; resolution of a<br />
contested drug-administration case (A), 975<br />
Calcium<br />
biol. variation in analyte concns, in urine of<br />
apparently healthy men, women (SN), 847<br />
Ca/cholesterol relations in women (L), 1307<br />
correlation between Ce and Mg in plasma on<br />
serum? (L), 1304<br />
correlation between Ce and total cholesterol in<br />
plasma from women, 339<br />
do biol.-variation data shed light on the demise<br />
of some historical indices used to assess Ca<br />
homeostasis? (TB), 1267<br />
effect of 8-hydroxyquinoline on response to Ca<br />
and Mg of Beckman Astrs5 Ca detn, (A),<br />
1007<br />
evaln. of EM Diagnostic Systems Ca and Mg<br />
test packs on Du Pont aca5 (A), 950<br />
evaln. of optimized Cs dye reagent for<br />
Beckman Astna5 system (A), 1007<br />
improved Ca and uric acid methods for<br />
Technicon SMAC system (A), 956<br />
influences of sampling method and sample<br />
handling during anal, on ionized Ca results<br />
(A), 1007<br />
measurement of total serum Ca with Kodak<br />
Ektachem DTSC module (A), 1007<br />
more on detn. of Ca2 in blood with ionselective<br />
electrodes (L), 444<br />
optimized at. absonp. spectrophotom. of Ce in<br />
enythrocytes, 2004<br />
performance characteristics of Ca, Mg, alcohol,<br />
and HCO3 reagents in the EASY analyzer<br />
(A), 944<br />
ref. intervals for Ca2 in full-term and pre-term<br />
infants (A), 1030<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatina<br />
kinase concns, in men during 12 days after<br />
acute myocardial infarction, 21<br />
total protein, sIb., Ca, and Hb detd. with the<br />
Abbott “Vision” system (TB), 711<br />
Calculous disease<br />
automated enzymatic method for oxalate in<br />
urine (TB), 1076<br />
cham. factors important to Ca nephrolithiasis:<br />
evidence for impaired hydroxycarboxylic<br />
acid absorption causing hyperoxalunia, 243<br />
computer-aided IR anal, of urinary calculi<br />
(SN), 2070<br />
diffuse reflectance technique for infrared anal.<br />
of urinary calculi, 780<br />
effect of tetrasodium EDTA on enzymatic<br />
detns, of urinary oxalate, 833<br />
obviating interferences in assay of urinary<br />
oxalate (SN), 855
two-carbon oxalogenesis compared in recurrent<br />
Ca oxalate stone forinars, normal subjects,<br />
1118<br />
Calibration<br />
calibration stability of IL Monarch”1 systems<br />
(A),908<br />
affects of PO4 and HEPES/MOPS buffers on<br />
calibration of Ns and KF ion-selective<br />
electrodes for din, anal. (A), 1005<br />
evaln. of calibration stability on Coulter Dacoa<br />
chem. analyzer (A), 965<br />
impact of periodic recalibration on precision of<br />
stable anal. system: effect on two Kodak<br />
Ektachem analyzers (A), 909<br />
preparation and avaln. of in-lab. EMIT<br />
calibrator for drugs of abuse assay (A), 976<br />
Calibration materials<br />
Sea Control materials, Quality control<br />
Cancer<br />
anal. and physiol. characteristics of prostatespecific<br />
antigen and prostatic acid<br />
phosphatasa in serum compared (SN), 2086<br />
automated quantn. of choniogonadotropin:<br />
anal. correlation between serum and urine<br />
with creatinina correction (SN), 1424<br />
biochem. markers in bone cancer (A), 929<br />
biochem. mechanisms of tumor invasion and<br />
matastases (A), 862<br />
cellular oncogenes and carcinogenesis (R), 641<br />
chemopreventive agent development and<br />
future prospects (A), 1062<br />
cliii. avaln. and performance characteristics of<br />
enzyme immunoassay for CA 125 (A), 931<br />
din. avaln. of Abbott’s CEA-EIA and CA 125-<br />
RIA in patients with various malignant<br />
diseases (A), 1034<br />
clm, significance of naphrotoxicity asaocd. with<br />
cancer therapy (A), 1058<br />
din, trials of immunotoxins (A), 1054<br />
comparison of enzyme immunoassay and RIA<br />
for cancer antigen 125 (CA 125) (A), 931<br />
detection of leukemia cells with a complementmediated<br />
cytolytic reaction and an imaging<br />
sensor system (SN), 558<br />
detn. of neoptenin in serum and urine, 62<br />
dietary micronutnients in cancer prevention<br />
(A), 1062<br />
differential assay of salivary, pancreatic aamylase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
aniylase immobilized on bacterial cell wall<br />
(SN), 1235<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
double IgA bands in serum from a patient with<br />
lymphoplasmacytoid leukemia with hairycell<br />
morphology (CR), 2317<br />
double-monoclonal immunoenzymometnic<br />
essay for alphai-fatoprotein modified for<br />
increased anal, precision (SN), 583<br />
estrogen and progesterone receptors in cancer<br />
tissue of nonbreast origin (A), 930<br />
evaln. of a monoclonal immunoradiometnic<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
evaln. of CA 19-9 concns. as marker for<br />
pancreatic cancer (A), 1034<br />
avaln. of prostate-specific antigen for follow-up<br />
of prostate cancer using two commercially<br />
available kits (A), 928<br />
highly sensitive two-site immunoradiomatric<br />
assay of parathynin, and din. use in avalg.<br />
patients with hypercslcemia, 1364<br />
IgG subclass measurements in the din, lab.<br />
(R), 1707<br />
improved assay for etoposide in plasma by<br />
radial-compression liq. chromatog. with<br />
electrochem. detection, 803<br />
increased activities of CK-MB and LD-2 in a<br />
patient with matastatic ovarian tumor (A),<br />
930<br />
increased activities of crestine kinase and<br />
lactate dahydrogenase isoanzymas in a<br />
patient with metastatic ovarian tumor (CR),<br />
1484<br />
initial assessment of tumor-associated antigen<br />
CA-125 in patients with ovarian, cervical,<br />
testicular tumors, 1124<br />
interference of the chemotherspeutic agent<br />
etoposide with the direct phosphotungstic<br />
acid method for uric acid (CR), 2109<br />
intestinal Zn, Cu, and Mn concns. in Cnohn’s<br />
disease (A), 933<br />
isoelectnic focusing of fine-needle aspirates of<br />
prostate: demonstration of tissue acid<br />
phosphstase isoanzyma pattern in<br />
hyperplasie and malignancy (A), 927<br />
isolation and purifn. of placental-type alk.<br />
phoephatase from a semunoma,248<br />
measurement of progesterone receptors in<br />
breast-tumor cytosols by immunoenzymstic<br />
assay.. prelim. results (TB), 2308<br />
prostate-specific antigen as a marker for<br />
prostatic cancer: monoclonal and polyclonal<br />
immunoassay compared (SN), 1916<br />
qual. of measurements for micronutriants of<br />
interest to cancer prevention (A), 1063<br />
reassessment of creatina kinase BB as a marker<br />
for cancer of prostate, breast, and lung (SN),<br />
809<br />
relationship between -y-lutamyltransferase 1<br />
isoenzyme and “fast liver” alk. phosphatase<br />
isoenzyma in serum (A), 993<br />
RIA of tumor necrosis factor in serum, 2024<br />
serum pancreatic oncofatal antigen and<br />
carbohydrate antigen 19-9 in pancreatic<br />
cancer patients (A), 932<br />
simple ailver-stainin technique for detecting<br />
Bence Jonas proteins in unconcd. urine (SN),<br />
561<br />
simultaneous detn. of neopterin and creatinine<br />
in serum with solid-phase extraction and online<br />
elution liq. chromatog., 2028<br />
stability of 5-fluorourscil in whole blood and<br />
plasma (SN), 2299<br />
time-resolved immunofluorometry of ovarian<br />
carcinoma-associated antiganic determinant<br />
CA 125 in serum, 2191<br />
two indirect tests of exocrine pancreatic<br />
function evald. (R), 5<br />
use of immunoglobulin heavy- and light-chain<br />
measurements compared with existing<br />
techniques in typing monoclonal<br />
immunoglobulins, 1771<br />
vitamin A concns. in lung cancer (TB), 716<br />
xanthine lithiasis, nephrocalcinosis, renal<br />
failure in a leukemia patient treated with<br />
allopurunol (CR), 2314<br />
Candidiasis<br />
peptide moieties and adhesion of antigenid<br />
mannans of Candida albicans to the plastic<br />
microtiter plate in enzyme-linked<br />
immunoeorbent assay (SN), 1925<br />
Cannabinoida<br />
applicn. of EMIT cennabinoid 20 ng and 100 ng<br />
drugs of abuse (d.a.u.) assays to the ETS<br />
system (A), 971<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: cannabinoids in<br />
urine (A), 972<br />
development of TDx fluorescence polarization<br />
immunoassay for detection of cannsbinoids<br />
in urine (A), 972<br />
evaln. of rapid TLC technique for detection of<br />
cannabinoid matabolites in urine (A), 972<br />
quaL assurance ins forensic lab.: GC/MS<br />
confirmation of THC and cocaine (A), 971<br />
reliability of immunoassays to detect<br />
tetrehydno-cannabinol in urine samples (A),<br />
972<br />
storage stability of urine THC as measured by<br />
EMIT urine cannabinoid assay (A), 972<br />
Cannabis<br />
drug of abuse profile: cannabis (S), 72B<br />
Capillary flow<br />
“architexturad” fluid management of biol.<br />
liquids (S), 1531<br />
Captopnil<br />
effect of captopnil on reagent strip tests for<br />
urinary ketones (A), 981<br />
Carbamazapine<br />
can a single measurement of carbamazepina<br />
suffice for therapeutic monitoring? (SN), 812<br />
evaln. of dry-reagent strip test for<br />
carbamazepine (A), 1019<br />
evehn. of free phenytoin and free<br />
carbamazepine concns. by Abbott TDx<br />
neaent system for total drug detns. (A), 1018<br />
experience in 3 physicians’ office labs. with<br />
carbamaxapine dry-reagent strip system (A),<br />
1019<br />
noninstnumented enzyme immunochromatog.<br />
assay for quantn. of carbamazepine in whole<br />
blood (A), 1019<br />
serum carbamazepune detn. on Cobas Bio FP<br />
centrifugal analyzer (A), 1018<br />
serum injection onto HPLC column for<br />
carbamazepine assay (A), 1018<br />
simultaneous micro detn. of carbamazepine<br />
and its 10,11-epoxide in plasma by HPLC<br />
(A), 1019<br />
Carbon dioxide<br />
bimodal distribution in venous CO2 in healthy<br />
subjects (TB), 1473<br />
enzymatic CO2 method for Technicon RA”1<br />
systems (A), 1009<br />
Carboxyhemoglobin<br />
anal. for HbCO by gas chromatog. and<br />
multicomponent spectrophotom. compared<br />
(SN), 694<br />
improvement in lower CoHb range detn. by<br />
second-derivative spectrosdopy (TB), 2311<br />
Carboxylases<br />
biotin radioligand assay with an I-labeled<br />
biotin deny., avidin, and avidin doubleantibody<br />
reagents, 1983<br />
Carboxypeptidase<br />
poetsynthetic modn. of anolase isoenzymes, 757<br />
rate assay for detg. carboxypeptidase acty. in<br />
serum (A), 962<br />
Carcinoembnyonic antigen<br />
anomalous between-lab. variability in a<br />
collaborative study of CEA immunoassay<br />
(L), 1694<br />
automated latex photometric immunoassay for<br />
detn. of CEA (A), 920<br />
automated, microparticle-based fluonimetric<br />
enzyme immunoassay for CEA in human<br />
serum and plasma (A), 920<br />
chin. evaln. of Abbott’s CEA-EIA and CA 125-<br />
RIA in patients with various malignant<br />
diseases (A), 1034<br />
collaborative study on CEA immunoassay<br />
shows large variability of measurements and<br />
uncertainty of chin, assessment (A), 924<br />
comparison of Roche RIA, Roche EIA, and<br />
Hybnitech ELk methods for CEA (A), 924<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
estrogen and progesterone receptor content in<br />
breast cancer cytosols: relationship to tumor<br />
marker expression (A), 930<br />
evahn. of Enzymun-Test AFP and CEA on the<br />
Enzymun-test system ES-600 (A), 925<br />
increased diagnostic potential of a monoclonal<br />
assay of carcinoembryonic antigen (L), 2131<br />
individual variations of carcinoembryonic<br />
antigen in serum of healthy subjects (TB),<br />
2123<br />
MagiweP’1 enzyme immunoassay for CEA and<br />
AFP using microtiter wells as solid phase<br />
(A), 925<br />
prechin. imaging and therapy studies with<br />
radiolabeled anti-CEA antibodies (A), 1053<br />
two monoclonal-based assays for<br />
carcinoembryonic antigen compared (SN),<br />
700<br />
Carcinoid tumors<br />
effect of diet and specimen collection protocol<br />
on urinary 5-HIAA excretion as measured by<br />
direct HPLC: comparison of normals and<br />
carcinoid patients (A), 931<br />
elevated CK.BB isoenzyme condns. in a patient<br />
with carcinoid tumor (A), 1034<br />
Cardiac disease<br />
See Heart disease<br />
Cardiac reperfusion<br />
improved procedure for detg. glutathione in<br />
plasma as an index of myocardial oxidative<br />
stress (SN), 1448<br />
Cannitine<br />
nonestenified and acylcarnitine in<br />
polymorphonuclear leukocytea and<br />
mononuclear calls, 533<br />
reappraisal of carnitine concns. in blood (L),<br />
1956<br />
Carnitine palmitoyltransferase<br />
increased serum lactate dehydrogenase<br />
isoenzyme 1 and “flipped” LD-1ILD-2 ratio<br />
in myopathy associated with partial<br />
carnitine pelmitoyltranaferase deficiency<br />
(CR), 2111<br />
Carnosinasa<br />
subceflular localization of cannosinase enzyme<br />
acty. in liver (A), 995<br />
Carotene<br />
detn. of retinol, a-tocopherol, and $-carotena<br />
in serum by hiq. chromatog. with absorbance<br />
and electrochem. detection, 1585<br />
Canotenolds<br />
specificity of in vitro loading of lipoproteins<br />
with carotenoids (A), 935<br />
Cartilage<br />
xyloeyltransferase as a marker of cartilage<br />
destruction in chronic joint diseases (A),<br />
1000<br />
Case conferences<br />
(Washington Univ. case conference) dual<br />
porphyria-an undardiagnosed entity? (CC),<br />
1190<br />
CLINICALCHEMISTRY, Vol. 33, No. 12, 1987 2365
Catalase<br />
no cetalese isoenzymes in serum (TB), 2302<br />
Catecholamines<br />
ascorbic acid as antioxidant in measurements<br />
of catecholamines in plasma (SN), 569<br />
diln. of plasma with Tnis buffer increases<br />
measured catecholamines in plasma (SN),<br />
408<br />
effect of pratreating samples with boric acid<br />
before hiq. chromatography of urinary<br />
catecholamines, 108<br />
error in assays of plasma cstecholamines by liq.<br />
chrometog. with elactrochem. detection<br />
(TB), 1938<br />
evaln. of plasma catecholamine control<br />
material by two liquid-chromatog.<br />
approaches (A), 886<br />
inexpensive alternative to kit methods for<br />
extraction of urinary catecholamines (TB),<br />
2122<br />
liq.-chromatog. measurement of<br />
catechoismines and metabolites in plasma<br />
and urine, 2209<br />
simple liq.-chnomatog. meas. of<br />
vanillylmandelic acid and homovanillic acid<br />
in urine on filter paper for mess screening of<br />
neuroblastoma in infants, 2043<br />
triamtenene interference in datn. of urine free<br />
catecholamines by cation-exchange<br />
chrometog./fluorometry (A), 887<br />
urinary catecholamines, vanillyhnandehic acid,<br />
5-hydroxyindoleacetic acid, and<br />
homovanillic acid measured by liq.<br />
chnomatog. with electrochem. detection and<br />
use of a single mobile phase (L), 1696<br />
use of alumina columns to prepare plasma<br />
samples for hiq.-chnomatog. detn. of<br />
catecholamines (SN), 286<br />
Cell-mediated immunity<br />
simultaneous datn. of neoptenin and crestinina<br />
in serum with solid-phase extraction and online<br />
elution liq. chrometog., 2028<br />
Centrifugal analyzer<br />
absorbance errors from using pieded-together<br />
rotors in the Roche Cobas-Bio centrif.<br />
analyzer (SN), 1198<br />
sbsorbsnce errors from using pieced-together<br />
rotors on Roche Cobas-Bio analyzer (A), 942<br />
adaptation of Auszyme monoclonal test for<br />
detection of hepatitis B surface antigen to<br />
Encore”‘ centrif. analyzer (A), 906<br />
adaptation of manual citric acid method to<br />
Roche Cobas-Bio (A), 964<br />
adaptation of Syva caffeine EMIT reagents to<br />
Baker Encore System 11(A), 1023<br />
spphicn. of EMIT qusnt. tricyclic antidepresssnt<br />
assays to Encore’” centrifugal analyzer (A),<br />
1024<br />
essay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of biol. variation, 269<br />
automated detn. of angiotensin-converting<br />
enzyme in serum (SN), 1248<br />
automated enzymatic measurement of lecithin,<br />
sphingomyelin, and phosphatidylglycenol in<br />
amniotic fluid, 81<br />
automated method for phosphohexosa<br />
isomerase with a centnif. analyzer (TB), 2120<br />
automation of Abbott’s AFP on the Baker<br />
Procore”‘/Encore’” system (A), 919<br />
banrethonium Cl interference with subsequent<br />
assays involving heparmnized plasma in a<br />
centnif. analyzer (TB), 615<br />
blood collection to results: new system that<br />
performs all steps of din. anal. (A), 1560<br />
bromcresol purple method for albumin on the<br />
“Monarch” centrifugal analyzer (TB), 614<br />
calibration stability of IL Monarch” systems<br />
(A),908<br />
centrifugal anal, for serum fructosainine with<br />
the IL Multistat analyzer (A), 1003<br />
centrifugal anal, for urinary citrate with the IL<br />
Multistat analyzer (A), 1009<br />
cholinasterase assay automated in the Cobas-<br />
Bio centrifugal analyzer (SN), 1460<br />
citrate in urine estimated by a citrate lyase<br />
technique adapted to the Cobas-Bio (TB),<br />
1948<br />
Cobas-Bio and Technicon RA-1000 assays of<br />
direct bilirubin compared (TB), 1670<br />
Cobes-Fara-alternate reagents evald. (A), 942<br />
Cobas Mire-reagent alternatives (A), 941<br />
comparison of two digoxin immunoassays using<br />
a Lobes Bio with Kallestadt RIA (A), 1014<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in serum<br />
(SN), 2296<br />
2366 CLINICAL CHEMISTRY, Vol. 33, No. 12,1987<br />
convenient urine oxalate assay with an oxalate<br />
oxidese reagent and a cantrif. analyzer (TB),<br />
2301<br />
Coomassie Brilliant Blue end benzathonium Cl<br />
methods adapted to Cobas-Bio for<br />
measurement of urinary protein (A), 964<br />
Coomassie Brilliant Blue G250 method for<br />
urinary protein adapted to Cobas-Bio5<br />
centrifugal analyzer (A), 979<br />
detn. of serum amikscin on Cobas Bio FP<br />
centrifugal analyzer (A), 1021<br />
development of latex immunoassay of Creactive<br />
protein for Monarch’” centnif.<br />
analyzer (A), 903<br />
different reagent kits compared in centrif. anal.<br />
for cholesterol in plasma (TB), 1071<br />
drugs-of-abuse screen for the Analyst’” (A),<br />
976<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: anticonvulsant<br />
drugs (fl), 1018<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: theophylline<br />
(A), 1022<br />
enhanced-latex aggln. assay for C-reactive<br />
protein in serum, with use of a centnif.<br />
analyzer (SN), 685<br />
avaln. of a fully automated centrifugal analyzer<br />
for hemostasis tests (SN), 1888<br />
evaln. of CEDIA’” digoxin immunoassay on<br />
Cobes-Bio analyzer (A), 955<br />
evahn. of colorimetric assay of N-acetyl--Dglucosaminidasa<br />
in urine (A), 1000<br />
evaln. of Du Pont Chem 12 anal. test rotor on<br />
DuPont Analyst’” (A), 950<br />
evaln. of performance of Baker reagents on<br />
Roche Cobas-Bio analyzer (A), 954<br />
evaln. of Ransel kit for detn. of glutathione<br />
peroxidese acty. in plasma, possibility of<br />
intenlab. standardization (A), 957<br />
avaln. of 11 Roche fluorescence polarization<br />
assays (A), 955<br />
evaln. of Roche fructosamine test for<br />
monitoring diabetic patients (A), 954<br />
four methods compared for measuring descerboxy-prothrombin<br />
(PIVEA-Il) (SN), 2074<br />
HDL cholesterol assay using liquid-stable<br />
reagents (A), 895<br />
immunoassay of digoxin by differential<br />
centrifn. (S), 1548<br />
immunonapheloin. of apolipoprotein B with a<br />
centrifugal analyzer (SN), 1882<br />
immunotunbidimetnic measurement of retinolbinding<br />
protein (A), 935<br />
immunoturbidimetry of albumin in serum,<br />
CSF, and urine with a unique calibration<br />
curve (TB), 1260<br />
immunoturbidimetry of spolipoprotein A-lI in<br />
a centrif. analyzer (L), 1302<br />
lab, and field eveln. of three desktop<br />
instruments for assay of cholesterol and<br />
triglyceride (SN), 1230<br />
manual enzyxnic assay of non-esterified fatty<br />
acids adapted to a cantrif. analyzer (TB),<br />
1073<br />
measurement of serum fructosamine by Cobas<br />
chem. instruments (A), 954<br />
measurement of urine N-acetyl-fl-SMCNDglucosanuinidase<br />
with a centnif. analyzer<br />
(TB), 616<br />
more on detn. of urinary albumin by<br />
centrifugal anal. (L), 1497<br />
optical kinetic method for calibration of<br />
spectrophotometer temp.: demonstration<br />
with the Cobas-Bio analyzer (SN), 1891<br />
optimized kinetic automated detn. of -<br />
hydroxybutyrste, 1761<br />
optimized kinetic glutamate dehydrogenase<br />
assay adapted to the Cobas Bio centnif.<br />
analyzer (TB), 1673<br />
12-protein immunoassay profile on the Cobss<br />
FARA (A), 917<br />
protocol for EMIT-st reagents with a centrif,<br />
analyzer (TB), 1671<br />
rapid datn. of the cholesterol satn. of bile by<br />
using a centrif. analyzer (TB), 187<br />
rapid enzymatic assay of flucytosine in serum<br />
with a centrifugal analyzer (A), 1022<br />
rapid fluorescence polarization immunossssy<br />
for antimicrobial drugs: gentaxnicin,<br />
tobramycin, and emikacin (A), 1020<br />
ref. interval study for the IL Monarch’”<br />
analyzer (A), 946<br />
second-generation fluorescence polarization<br />
immunoassay for serum gentamicin detn. on<br />
Cobas5 Bio FP centrifugal analyzer (A). 1021<br />
second-generation serum procaunamide essay<br />
for Cobas Bio FP centrifugal analyzer using<br />
fluorescence polarization methodology (A),<br />
1017<br />
serum carbamazepine detn. on Cobas’ Bio FP<br />
centrifugal analyzer (A), 1018<br />
serum phenytoin detn. on Cobes’ Bio FP<br />
centrifugal analyzer (A), 1020<br />
simple role for automatically processing a<br />
single blood asmple into multiple microliten<br />
aliquots of plasma (A), 1558<br />
speeding assay of therapeutic drugs with the<br />
“Cobas-Bio-FP” (TB), 1256<br />
turbidimetric hipase assay adapted to a<br />
centrifugal analyzer (TB), 1946<br />
turbidimetry of trsnsthynetin (prealbumin)<br />
with a centnif. analyzer (SN), 144<br />
Centnifugation, two-dimensional<br />
colorimetnic K reagent for Abbott Vision<br />
system (A), 1005<br />
detn. oftotal bilirubin on Abbott Vision (A),<br />
1012<br />
enzyme immuno-inhibition assay for<br />
theophylhina on Abbott Vision system (A),<br />
1022<br />
evahn. of Abbott Vision’” assay for theophylline<br />
(A), 1022<br />
evaln. of Abbott Vision’” system (A), 945<br />
liquid reagent for data. of gammaglutamyltransferase<br />
on Abbott Vision system<br />
(A),994<br />
liquid, stable alphs-amylase reagent for Abbott<br />
Vision’” system (A), 996<br />
liquid, stable reagent for detn. of glutemicoxaloscatic<br />
transsminase for Abbott Vision’”<br />
system (A), 993<br />
measurement of human serum C-reactive<br />
protein on Abbott Vision’” system (A), 903<br />
performance of Abbott Vision”‘ system for<br />
anal. of albumin, ALT, AST, crastinine, Hb,<br />
and total protein (A), 945<br />
quantn. of Hb with the Vision din, analyzer<br />
(A), 1000<br />
Cephalosponins<br />
hiq.-chrometog. detn. of five orally active<br />
cephalosporins-cafixime, cefaclor,<br />
cefadnoxil, cephalexin, and cephradine-in<br />
serum, 1788<br />
Cerebrospinal fluid<br />
anal, performance of Kodak Ektachem 400 on<br />
misc, body fluids (A), 966<br />
automated anal, for taunine in biol. fluids,<br />
tissues (SN), 835<br />
benzethonium Cl interference with subsequent<br />
assays involving heparmnized plasma in a<br />
centnif. analyzer (TB), 615<br />
calibration of the aca for glucose in CSF, 311<br />
changes in CSF IgG and apohipoprotein E<br />
indices in patients with multiple sclerosis<br />
during demyehination, remyahination, 1155<br />
chin. applicn. of CSF glutainine measurements<br />
for diagnosis of hepatic encephahopathy (A),<br />
1031<br />
CSF apohipopnotein E index in patients with<br />
multiple sclerosis during remission (A), 1032<br />
CSF total protein detd. with the Hitachi 705<br />
Analyzer (TB), 711<br />
detn. of 1-aminobutynic acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase hiq. chromatog., 1736<br />
enzyme-amplified immunodetection of<br />
monoclonah proteins in unconcd. body fluids<br />
after immobilization on glyoxyl agarose (A),<br />
916<br />
evaln. of Paramsx CSF glucose assay (A), 952<br />
evaln. of plasma and CSF lactates on Abbott<br />
TDx (A), 961<br />
free 3-methoxy-4-hydroxyphenylethylene<br />
glycol detd. in plasma and in CSF by hiq.<br />
chromatog. with coulometric detection (SN),<br />
844<br />
immunoblotting on polyvinyldifluorida<br />
improves detection of ohigoclonal IgG bands<br />
in CSF (TB), 1669<br />
immunoturbidimetry of albumin in serum,<br />
CSF, and urine with a unique calibration<br />
curve (TB), 1260<br />
ohigochonal bands and post-’y-globulin in<br />
electrophonetograms of CSF (L), 628<br />
rate of synthesis of IgG within the blood-brain<br />
barrier and the IgG index compared in<br />
diagnosis of multiple sclerosis (SN), 113<br />
suitability of solid-phase chem. for quantn. of<br />
leukocytes in cerebrospinsl, seminal, and<br />
penitoneal fluid (TB), 1475<br />
thin-film colorimetnic assay for measuring CSF<br />
protein (A), 902
urinary and CSF protein measured with<br />
pynogallol rad-mohybdate on Hitachi 705 (A),<br />
980<br />
use of “gamma-protein index” and free kappa<br />
light chains in diagnosis of multiple sclerosis<br />
(A),904<br />
enebnotandinous xanthomatosis<br />
screening for cerabrotendinous xanthomatosis<br />
by enzymatic assay for 7a-hydroxyhsted<br />
steroids in urine (SN), 142<br />
eruloplasmin<br />
kinetic immunonephehometric detn. of protein<br />
concns. in follicular fluid, 1185<br />
hemiluminescance<br />
cm. application of a sensitive non-isotopic<br />
immunometnic assay of thyrotropin, 179<br />
hamilunsinascenca linjnunoassay<br />
chemiluminascence immunoassay for<br />
somatomedin C in serum, 1989<br />
chemiluminescence immunoassay of<br />
thyrotropin with acridinium-ester-labeled<br />
antibody evald, and compared with two<br />
other immunoassays (SN), 2096<br />
hemothenapy<br />
cm. significance of nephrotoxicity assocd. with<br />
cancer therapy (A), 1058<br />
cm. trials of immunotoxins (A), 1054<br />
detn. of tamoxifan and four metabolltes in<br />
serum by low-dispersion liq. chromatog.,<br />
1608<br />
double IgA bands in serum from a patient with<br />
hymphoplasmacytoid leukemia with hairycell<br />
morphology (CR), 2317<br />
initial assessment of tumor-associated antigen<br />
CA-125 in patients with ovarian, cervical,<br />
testicular tumors, 1124<br />
spurious katonuria after means therapy (A),<br />
913<br />
stability of 5-fluorouracil in whole blood and<br />
plasma (SN), 2299<br />
xanthine lithiasis, nephrocahcinosis, renal<br />
failure in a leukemia patient treated with<br />
silopurmnol (CR), 2314<br />
hhoramphenicol<br />
direct, simultaneous mass, of chloramphenicol<br />
and its monosuccinate ester in microsamples<br />
of plasma by radial-compression hiq.<br />
chromatog., 1814<br />
evaln. of EMIT-chloramphenicol assay in a<br />
pediatric hosp. (A)1 1021<br />
microbore hiquid-chromatog. anal, of<br />
chloramphenicol for pediatric drug<br />
monitoring (A), 1021<br />
‘blonde<br />
Cl’ binding to serum proteins (L), 625<br />
evaln. of Cl ion-selective electrode for the<br />
Paramax anal, system (A), 953<br />
interference Br- in detn. of serum Cl (TB),<br />
415<br />
hohesterol<br />
availability of plasma with target values for<br />
certain lipids (L), 2323<br />
bias among enzymatic methods for cholesterol<br />
(A), 894<br />
bias and precision of cholesterol anal. by<br />
physician’s office analyzers (SN), 2262<br />
Ca/cholesterol relations in women (L), 1307<br />
candidate Definitive Method for measurement<br />
of serum cholesterol (A), 894<br />
cham. synthesis, hypocholesterohemic acty. and<br />
hydroxymethylglutaryh-CoA reductesa<br />
inhibition of two oxyatarols (A), 1035<br />
cm. effect of methodolog. bias for cholesterol<br />
(A),894<br />
comparability of NatI. Ref. System total<br />
cholesterol Ref. and Definitive Methods (A),<br />
894<br />
comparison of ascorbic acid interference in<br />
HIlL-cholesterol estn. by six pptn. methods<br />
with use of a sensitive enzymic cholesterol<br />
reagent (TB), 1467<br />
comparison of physician office analyzers for<br />
cholesterol anal, in screening centers (A), 898<br />
correlation between Ca and total cholesterol in<br />
plasma from women, 339<br />
decentralization of cholesterol and triglyceride<br />
assays by using three “SPOT” instruments<br />
(A),938<br />
different reagent kits compared in centrif. anal.<br />
for cholesterol in plasma (TB), 1071<br />
dihydrocspsaicin, 4-(4-chlorophenyl)-2hydroxytetronic<br />
acid, and clofibrate and<br />
intestinal cholesterol absorption in the rat<br />
(A), 895<br />
evaln. of origin of bias between enzymatic<br />
methods and Ref. Method for cholesterol<br />
(A), 894<br />
avaln. of Reflotron as cholesterol screening<br />
system (A), 895<br />
evaln. of Reflotron cholesterol and triglycerides<br />
test methods (A), 948<br />
flow-cytometnic data. of high-densityhipoprotein<br />
binding sites on leukocytes, 2195<br />
four procedures compared for sepg.<br />
apolipoprotein A- and spolipoprotein Bcontaining<br />
lipoprotains in plasma, 1597<br />
Fniedewald formula another restriction? (L),<br />
1301<br />
HDL cholesterol assay on the Technicon Cham<br />
1’” system (A), 946<br />
HDL cholesterol assay using liquid-stable<br />
reagents (A), 895<br />
HDL-cholesterol assay with the Abbott “Vision<br />
System” evald. (TB), 1943<br />
HDL cholesterol on the Reflotron system (A),<br />
895<br />
importance of time between repeated mess, of<br />
total or high-density hipoprotein cholesterol<br />
when estg. an individual’s baseline condos.<br />
(SN), 1913<br />
isotope diln./mass spectrom. of serum<br />
cholesterol with [3,413ClcboIesteot proposed<br />
Definitive Method, 1403<br />
lab, and field evain. of three desktop<br />
instruments for assay of cholesterol and<br />
triglyceride (SN), 1230<br />
how A-esterase acty. in serum in fish-eye<br />
disease (SN), 587<br />
new assay of epolipoproteins A-I and B by rate<br />
nephelometry evald, (SN), 2065<br />
office-testing systems: cholesterol and<br />
triglycerides (A), 948<br />
performance characteristics of Paramax anal.<br />
system for detn, of MDL cholesterol (A), 952<br />
rapid detn. of the cholesterol satn. of bile by<br />
using a centnif. analyzer (TB), 187<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
solid-phase cholesterol assay involving a<br />
unique whole-blood separator (A), 1561<br />
total cholesterol in serum deed. by isotope<br />
diln.-mass spectrom., with liq.-chromatog.<br />
sepn., 1113<br />
triglycerides and cholesterol anal.-a<br />
sequential approach (A), 899<br />
value of polyacrylamide gradient gel<br />
electrophoresis of lipoproteins for<br />
determining HDL cholesterol (TB), 1266<br />
Cholesteryl ester<br />
chohesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
hipoprotein, 390<br />
use of Nile red in detecting cholesteryl ester<br />
accumulation in acid-hipase-deficient<br />
fibroblasts (A), 895<br />
Chohinestarasa<br />
chohinasterasa assay automated in the Cobas-<br />
Bio centrifugal analyzer (SN), 1460<br />
effect of daylight on the reaction of thiols with<br />
Ellman’s reagent (SN), 1928<br />
improved accuracy of cholinesterase<br />
phanotyping after participation in a<br />
proficiency survey (SN), 823<br />
succinyldicholine as substrate in measurement<br />
of cholinesterase activity (L), 746<br />
Choniogonadotropin<br />
accelerated enzyme immunoassay for<br />
choniogonadotropin in urine, involving reflow<br />
of specimen through capillary tubes, 498<br />
anal, and cm. evaln, of Enzymum-test HCG<br />
for detg. choniogonadotropin in serum (TB),<br />
715<br />
spphicn. of chromium dioxide magnetic<br />
particles to immunoassays (A), 920<br />
automated and manual quant. assays of<br />
choniogonadotropin in serum compared<br />
(SN), 167<br />
automated hCG assay: a rapid, quant. enzyme<br />
immunoassay (A), 888<br />
automated quantn. of choniogonadotropin:<br />
anal. correlation between serum and urine<br />
with creatinina correction (SN), 1424<br />
automation of a particle solid-phase hCG<br />
immunoassay (A), 888<br />
binding mechanism of hCG in a two-site<br />
sandwich immunoassay (A), 889<br />
choriogonadotropin and pregnancy testing:<br />
prozone phenomenon defmed (L), 742<br />
choriogonsdotropin detg. in serum is preferable<br />
for early diagnosis of ectopic pregnancy<br />
(TB), 1669<br />
choniogonsdotropin interference in an assay for<br />
thyrotropin (L), 1303<br />
colonimetric enzyme immunoassay with latex<br />
particles as a solid-phase reagent (A), 1572<br />
criteria for evahg. nonquant. assays: appln. to<br />
serum choniogonadotropin (SN), 150<br />
development and performance of quant. assay<br />
for whole-molecule hCG on the aca (A), 889<br />
discordant results in hCG testing by<br />
monoclonal immunoaseay methods (A), 887<br />
apitope-selective immunoassays for holo-hCG<br />
and its free subunits (A), 888<br />
evaln. of enzyme immunoassay method for<br />
HCG in serum (TB), 1256<br />
evaln. of new low-coat test pack for beta-hCG<br />
(A),889<br />
fully self-contained enzyme immunoassay kit<br />
for detecting hCG (A), 959<br />
highly sensitive qual. methods for serum<br />
choriogonadotropin: chin. specificity studies<br />
(SN), 677<br />
immunof’luorometry of choriogonadotropin by<br />
time-resolved fluorescence spectroscopy,<br />
a new Eu chelate as label, 1994<br />
immunonadiometnic assay specific for hCG,<br />
with biotin-avidin sepn. (A), 888<br />
in vivo disappearance time of hCG in healthy<br />
women and patients with Rokitonski<br />
syndrome (A), 889<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunoradiomatric assay,<br />
and further exploration of antigenid sites on<br />
choniogonadotropin, 1147<br />
microparticle-capture membranes: appln. to<br />
TestPack hCG-urine (A), 1567<br />
new immunochem. method for<br />
choriogonadotropin in urine, 800<br />
qual. immunoanzymomatnic technique evald.<br />
for detecting choriogonadotropin in serum<br />
and urine (TB), 721<br />
quant. correlation of serum to urine hCG with<br />
correction by urine creatinine in pregnancy<br />
(A),889<br />
quantn. of free beta subunit of hCG by a fully<br />
automated instrument (A), 967<br />
role of qual. choriogonadotnopin assays in<br />
diagnosis of ectopic pregnancy (SN), 1908<br />
Tandem Icon urine test for choriogonadotropin<br />
in ectopic pregnancy (A), 889<br />
two immunoenzymatic assays of<br />
choriogonadotropin in serum compared<br />
(TB), 1947<br />
two-monoclonal-antibody “sandwich”-type<br />
assay of hutropin, with no cross reaction with<br />
choniogonadotropin, 1603<br />
Chrosnatofocusing<br />
apolipoproteins C-Il and C-Ill in serum<br />
quantified by zone immunoelectrophoresis,<br />
664<br />
Chromatography, affinity<br />
affinity-chromatog. isolation of howsubstitution<br />
ratio conjugates and their<br />
performance in phanobarbital enzyme<br />
immunoassays (A), 923<br />
fructoeamina: structure, anal, and chin.<br />
usefulness (R), 2153<br />
identn. of human haukocyte esterases (A), 981<br />
isolation and pur’ifn. of placental-type elk.<br />
phosphat.ase from a seminoms, 248<br />
Chromatography, affinity-gel<br />
screening with glycated Mb for gestational<br />
diabetic-associated macrosomia (A), 1001<br />
Chromatography, anion-exchange<br />
early diagnosis of acute myocerdial infarction<br />
by rapid anal, of creatine kinase isoanzyme-3<br />
(CR-MM) sub-types, 358<br />
evaln, and improvement of homovanilhic acid<br />
methodology, and a critique of liq.<br />
chromatog. with electrochem, detection<br />
(SN), 600<br />
simultaneous aepn. of cardiac iaoenzymes CE-<br />
MB, LD-1, and LD-2 by two-dimensional<br />
(anion-exchange/immuno-affinity) column<br />
chromatog. (A), 991<br />
urinary org. acids: isoln, and quantn. for<br />
routine metabolic screening, 473<br />
Chromatography, capillary<br />
capillary GC and GCIMS of cocaine and heroin<br />
urinary matabolites (A), 970<br />
capillary GC/MS anal, of varapamil and<br />
norverapamil in serum (A), 1017<br />
detn. of antidepressants by capillary column<br />
GC with N-selective detection (A), 1025<br />
datn. of methsuximide and Ndesmethylmethsuximida<br />
by capillary column<br />
GC (A), 1020<br />
datn. of two urinary prosteglandins by<br />
capillary gas chromatog.-high-resolution<br />
mass spectromatry (A), 891<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2367
measurement of nimantadina in plasma by<br />
capillary GC/MS (A), 1022<br />
microbore liquid-chromatog. anal, of<br />
chloramphanicol for pediatric drug<br />
monitoring (A), 1021<br />
Chromatography, cation-exchange<br />
evaln. of plasma catecholamine control<br />
material by two liquid-chromatog.<br />
approaches (A), 886<br />
liquid -chromatog. analysis of 20 human Hb’s<br />
(A), 1001<br />
trianiterene interference in detn. of urine free<br />
catecholamines by cation-exchange<br />
chromatog./fluorometry (A), 887<br />
Chromatography, column<br />
evain. of Sap-Pak C18 for sepn. of bound and<br />
unbound steroid during saturation anal. (A),<br />
962<br />
urinary org. acids: isoln, and quantn. for<br />
routine metabomc screening, 473<br />
Chnomatography, gas<br />
anal. for HbCO by gas chromatog. and<br />
multicomponent spectrophotom. compared<br />
(SN), 694<br />
detection and confirmation of cocaine use by<br />
chnomatog. anal. for methylecgonina in urine<br />
(SN), 118<br />
enzymic ethanol assay: colorimetric method<br />
based on mess, of H202, 486<br />
fluorescence polarn. immunoassey avald, for<br />
screening for amphetamine and<br />
mathamphetainina in urine (SN), 1200<br />
gas-chrometog. detn. of ethanol in blood with<br />
0.53-mm fused-silica open tubular columns<br />
(SN), 2094<br />
gas-chromatog. mess, of volatile shksnes from<br />
single-breath samples (SN), 140<br />
highly sensitive immunoassays with gas-hiq.<br />
chromatog. (A), 1562<br />
identn. snd qusntn. of a protein-bound higand<br />
in uremic serum (SN), 682<br />
lack of interference of<br />
tris(hydroxymethyl)methylamine with the<br />
detn. of volatile alcohols or ethylene glycol in<br />
serum by capillary gas chromatog. (L), 2324<br />
melatonin secretion assessed by measuring its<br />
metabolite, 6-sulfatoxymelatonin, 1343<br />
metabolic profiles of urinary org. acids recd.<br />
from absorbent filter paper (SN), 572<br />
more sensitive direct oxalate oxidase assay of<br />
urinary oxalate (SN), 1931<br />
oxybuprocaine and five metabolites<br />
simultaneously detd. in urine by gas<br />
chromatog. and gas chromatog.-mass<br />
spectrom. after extraction with Extrelut<br />
(SN), 697<br />
qusntn. of 5a- and 5-androstanediols in urine<br />
by gas chromatog.-mess spectrom., 256<br />
Chromatography, gas-liquid<br />
alternative explanation for changes in<br />
erythrocyte fatty acids in diabetes (SN),<br />
2083<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in serum<br />
(SN), 2296<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gss-liq. chromatog., 1869<br />
detn. of antidepressants by capillary column<br />
GC with N-selective detection (A), 1025<br />
detn. of methsuximide end Ndesmethylmethsuximide<br />
by capillary column<br />
GC (A), 1020<br />
quantn. of serum flecainide by gas chromatog.<br />
with N-P detector (A), 1016<br />
rapid gas-chromatog. method for quantn. of<br />
flecainide in serum or plasma (A), 1016<br />
serum propoxyphene concns. in opiate addicts<br />
on long-term propoxyphene maintenance<br />
therapy. evidence for drug tolerance in<br />
humans (A), 974<br />
Chromatography, gel filtration<br />
micro-chromatog. method for measuring deltabilirubin<br />
in serum (A), 1013<br />
Chromatography, immunoaffinity<br />
simultaneous sepn. of cardiac isoenzymes CX-<br />
MB, LD-1, and LD-2 by two-dimensional<br />
(anion-exchsnge/immuno-effinity) column<br />
chromatog. (A), 991<br />
Chromatography, ion-exchange<br />
automated anal, for taunine in biol. fluids,<br />
tissues (SN). 835<br />
automated anal. of taurine in biol. fluids and<br />
tissues (A), 962<br />
direct quantn. of coproporphynins,<br />
unoponphyrins in urine by deny, synchronous<br />
fluorescence spectroscopy, 1826<br />
2368 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
affects of collection methods on amino acid<br />
profiles (A), 936<br />
evaln. of ion-exchange chromatog. system for<br />
quant. detn. of CK-MB (A), 988<br />
glycohemoglobin method for the doctor’s office<br />
(A), 1002<br />
N-ecetyl--D-ghucossminidase isoenzymes in<br />
urine assayed by ion-exchange chromstog.,<br />
1796<br />
Chromatography, ion-pair<br />
strategy for benzoylecgonine testing:<br />
confirmation by TLC/HPLC (A), 971<br />
Chnomatognaphy, liquid<br />
accelerated glycated Hb A1 anal. with Bio-<br />
Red’s “Diamat” analyzer (A), 1002<br />
administered viloxazine interferes in hiq.chromatog.<br />
assay of nonmetanaphrines (TB),<br />
1677<br />
alk. phosphetase isoanzymes incompletely<br />
resolved by “fast protein hiq. chnomatog.”<br />
(L), 2327<br />
ascorbic acid as antioxidant in measurements<br />
of catecholamines in plasma (SN), 569<br />
ascorbic, dehydroascorbic acids simultaneously<br />
quantified in biol. fluids by liq. chrometog.<br />
with fluorescence detection; colorimetnic<br />
assay compared, 1874<br />
assay of amiodarona and desethylamiodarone<br />
by HPLC and specimen preparation with Du<br />
Pont Prep (A), 1014<br />
assay of gemfibrozil in plasma by “highperformance”<br />
liq. chromatog. (TB), 1938<br />
assessment of abnormal creatinine condo, by<br />
HPLC (A), 1009<br />
automated solid-phase extraction and hiq.<br />
chromatog. for essay of cycloeporine in whole<br />
blood (SN), 2272<br />
Bio-Rad cyclosporine assay compared with<br />
cyclosporine assayed in our lab, by Moyer’s<br />
HPLC method (A), 978<br />
detn. of i-aminobutynic acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase liq. chromatog., 1736<br />
detn. of cydlosponine condos, with monoclonal<br />
antibodies, 2225<br />
detn, of methylxanthine stimulants in urine of<br />
racing greyhounds by HPLC; resolution of a<br />
contested drug-administration case (A), 975<br />
detn. of tamoxifen and four metabohites in<br />
serum by how-dispersion liq. chromatog.,<br />
1608<br />
detn. of unconjugated 3-methoxy-4hydroxyphenyhglycol<br />
by hg. chromatog. for<br />
monitoring inhibition of monoamine oxidase<br />
acty. in plasma (SN), 2078<br />
direct, simultaneous mess, of chhoramphenicol<br />
and its monoauccinste eater in microsamples<br />
of plasma by radial-compression hg.<br />
chromatog., 1814<br />
distribn, of cyclosponine in blood of a renal<br />
transplant recipient with type V<br />
hyperhipoproteinemia (CR), 423<br />
effect of diet and specimen collection protocol<br />
on urinary 5-HIAA excretion as measured by<br />
direct HPLC: comparison of normals and<br />
carcinoid patients (A), 931<br />
error in assays of plasma catecholamines by liq.<br />
chromatog. with ehectrochem. detection<br />
(TB), 1938<br />
evaln. and improvement of homovanilhic acid<br />
methodology, end a critique of hg.<br />
chromatog. with electrochem. detection<br />
(SN), 600<br />
forensic methaqualone assay by two HPLC<br />
systems (A), 974<br />
free 3-methoxy-4-hydroxyphenylethylene<br />
glycol dead, in plasma and in CSF by hiq.<br />
chromstog. with coulometric detection (SN),<br />
844<br />
hemoglobin Aic by hg. chromatog. (L), 445<br />
HPLC test for retinol-binding protein (A), 935<br />
identn. and qusntn. of a protein-bound ligend<br />
in uremic serum (SN), 682<br />
improved assay for etoposide in plasma by<br />
radial-compression hiq. chromatog. with<br />
electrochem. detection, 803<br />
improved extn. and chrometog. of cyclosponins<br />
(A), 978<br />
improved hiq.-chrometog. assay of labetalol in<br />
plasma (SN), 1450<br />
improved sepn. of fetal Hb by mini-column<br />
chromatog. (SN), 288<br />
interference by cychobenzaprine in liq.chromstog.<br />
assays of tnicydhic<br />
antidepressants (SN), 819<br />
lipoperoxides in plasma as measured by liq.chromatog.<br />
sepn. of<br />
mahondialdehyde-thioberbituric acid<br />
adduct, 214<br />
hg. chromatog. and fluorescence polarization<br />
immunoassay methods compared for<br />
measuring flecainide acetate in serum (SN),<br />
1898<br />
hg. chromatog. and RIA compared for detn. of<br />
cortisol and conticosterone in plasma after a<br />
dexamethasone suppression test (SN), 1639<br />
hig.-chromatog. assay of metoehopramide in<br />
plasma (TB), 190<br />
liq.-chromatog. detn. of tocainide in plasma,<br />
with N-acyh derivatives of tocainide as<br />
intern. stds. (TB), 1069<br />
hiq.-chromatog. measurement of<br />
catecholemines and metabolites in plasma<br />
and urine, 2209<br />
hiq.-chromatog. method for detn. of<br />
homovanillic acid in plasma, with<br />
ehectrochem. detection, 72<br />
hg. chromatog. with muhtichanneh UV<br />
detection for studying disorders of purina<br />
metab., 2052<br />
hiquid.chnomatog. measurement of amiodaroni<br />
and N-dasethylsmiodarone in serum (A),<br />
1014<br />
measurement of flecainida by HPLC with<br />
fluorescence detection (A), 1016<br />
measurement of plasma imipramine,<br />
dasipramine, and their respective 2-hydnoxy<br />
metabohites (A), 1025<br />
measurement of plasma nortniptyhine and its<br />
isomenic 10-hydnozy metabohites (A), 1024<br />
optimized hiq.-chromatog. method for<br />
fluorometry of urinary i-sminolevulinic acid<br />
in workers exposed to Pb (SN), 1667<br />
patterns of porphyrin excretion in feces as<br />
dead, by hiq. chromatog.; ref. values and<br />
effect of flora suppression, 2164<br />
phenylahanine and tyrosine in serum and<br />
ehuates from dried blood spots as dead. by<br />
reversed-phase hiq. chrometog., 1152<br />
guantn. of antidaprassants and<br />
benzodiezepinas in a single HPLC system<br />
(A), 1025<br />
guantn. of Mb A2 by fully automated Hb<br />
analyzer (A), 1001<br />
rapid measurement of HbA1 by FPLC (TB),<br />
2306<br />
serum injection onto HPLC column for<br />
carbamazepine assay (A), 1018<br />
simple and rapid hig.-chromatog. method for<br />
simultaneous mess. of vanillylmandelic acid<br />
homovanilhic acid (TB), 1262<br />
simple assay to detect and confirm urinary<br />
benzodiezepinas by HPLC utilizing photodiode-array<br />
detection (A), 974<br />
simple hiq.-chromstog. mess, of<br />
vanillylmandehic acid and homovanilhic acid<br />
in urine on filter paper for mass screening oi<br />
naunoblastoma in infants, 2043<br />
simultaneous anal. for 4-hydroxy-3methoxymandehic<br />
acid, 4-hydroxy-3mathoxyphanylscetic<br />
acid, and creatmine ir<br />
urine by HPLC with column switching (A),<br />
887<br />
simultaneous detn. of neopterin and creatinin<br />
in serum with solid-phase extraction and on<br />
line elution hiq. chromatog., 2028<br />
simultaneous micro datn. of carbamazepine<br />
end its 10,11-epoxida in plasma by HPLC<br />
(A), 1019<br />
stereoselective disposition of salbutamol<br />
enantiomers in man: investigation with<br />
chiral HPLC (A), 1026<br />
three commercial kits and one liquid.<br />
chromatog. method evald, for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
tolerances for sample-loop vols, (L), 1297<br />
total cholesterol in serum dead, by isotope<br />
diln.-mass spectrom., with hiq,-chromatog.<br />
aepn., 1113<br />
urinary catecholamines, vanihlylmandelic acid<br />
5-hydroxyindoleecetic acid, and<br />
homovanillic acid measured by hiq.<br />
chromatog. with ehectrochem, detection and<br />
use of a single mobile phase (L), 1696<br />
use of alumina columns to prepare plasma<br />
samples for hiq.-chnomatog. detn, of<br />
catecholamines (SN), 286<br />
validation and appln. of a hg.chromstog./enzymic<br />
assay for individual bil<br />
acids in rat serum, 1856<br />
validation of HPLC-ECD method for urinary<br />
VMA and HVA by comparison with GCMS<br />
(A),887
Chromatography, paper<br />
noninstrumented enzyme immunochromatog.<br />
assay for qusntn. of carbamazepine in whole<br />
blood (A), 1019<br />
Chromatography, reversed-phase<br />
See also Chromatography, liquid<br />
ascorbic, dehydroascorbic acids simultaneously<br />
quantified in biol. fluids by hg. chromatog.<br />
with fluorescence detection; cohorimetnic<br />
assay compared, 1874<br />
assay of flecainide in serum by HPLC after<br />
microscale protein pptn. (A), 1016<br />
deproteinizing methods evald, for detn. of uric<br />
acid in serum by reversed-phase liq.<br />
chromatog. with UV detection (SN), 1427<br />
detn. of clomiphene citrate and tamoxifen in<br />
blood and seminal plasma using reversedphase<br />
HPLC (A), 1025<br />
datn, of neopterin in serum and urine, 62<br />
detn. of retinol, a-tocopherol, and fl-carotene<br />
in serum by hiq. chromatog. with absonbance<br />
and electrochem, detection, 1585<br />
evahn. of plasma catecholsmine control<br />
material by two higuid-chromatog.<br />
approaches (A), 886<br />
flecainide monitoring by reversed-phase liquid<br />
chromatog. with a phenyh column (A), 1016<br />
HPLC detn, of amphotericin B in human urine<br />
and serum (A), 1021<br />
hydrocortisone succinate and hydrocortisone<br />
simultaneously dead. in plasma by reversedphase<br />
liq. chomatog. and their<br />
pharmacokinetics in asthmatic children,<br />
1412<br />
identn. and anal, of 9 metabohites of<br />
cyclosporine in blood by hg. chromatog. 1:<br />
punifn. of anal. stds. and assay optimization,<br />
1841<br />
identn. and anal, of 9 metabolites of<br />
cyclosponine in blood by hg. chromatog. 2:<br />
comparison of patients’ results, 1851<br />
improved quantn. of vitamin D in proprietary<br />
infants’ formulas and in breast milk, 796<br />
improved RIA of melatonin in serum (SN), 604<br />
liq.-chromatog, detn. of five orally active<br />
cephalosporins-cefixime, cefechor,<br />
cafadroxil, cephalexin, and cephrsdina-in<br />
serum, 1788<br />
hiq.-chnomatog. detn, of fl2-microglobulin, aacid<br />
glycoprotein, and albumin in urine, 1756<br />
mess, of glycated protein by a rapid, specific<br />
method for absolute qusntn. of lyaine-bound<br />
glucose (SN), 1656<br />
measurement of serum free salicylate concns,<br />
by ultrafiltration end HPLC (A), 1026<br />
modifn. of rugged cydhosponine assay by HPLC,<br />
to decrease anal. time by 50% (A), 977<br />
rapid detn. of serum acetaminophen by HPLC<br />
with a column-switching technique-on-line<br />
punifn. and anal. (A), 1026<br />
rapid, sensitive method for simultaneous<br />
quantn. of nicotine and cotinine in biol.<br />
fluids by HPLC (A), 975<br />
simultaneous detn, of prednisone/prednisolone<br />
in plasma by HPLC (A), 1027<br />
simultaneous mess, of eight corticosteroids by<br />
hiq.-chromatog. and appln. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
therapeutic drug monitoring of imipramine<br />
and desipramine in maintenance therapy of<br />
patients (A), 1025<br />
three commercial kits and one liquidchrometog.<br />
method evald. for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
Chromatography, thin-layer<br />
automated enzymatic measurement of lecithin,<br />
sphingomyehin, and phosphatidyhglycerol in<br />
amniotic fluid, 81<br />
detection and confirmation of cocaine use by<br />
chromatog. anal. for methylecgonine in urine<br />
(SN), 118<br />
evaln. of rapid TLC technique for detection of<br />
cannabinoid metabohites in urine (A), 972<br />
recovery studies with two methods of<br />
visualizing thin-layer chromatog. plates for<br />
detn, of LIS radio in amniotic fluid (A), 900<br />
strategy for benzoylecgonine testing:<br />
confirmation by TLC/HPLC (A), 971<br />
thin-layer chromatog. detn, of urine excretion<br />
of hactuhose, simplified and applied to cystic<br />
fibrosis patients (SN), 1211<br />
variables affecting resolution of hung<br />
phosphohipids in thin-layer chromatog. (SN),<br />
135<br />
Chromogen oxidase<br />
“chromogen oxidese” acty. of bihirubin oxidase<br />
(L), 1304<br />
Chromosomal analysis<br />
detection of isoenzymes associated with drug<br />
resistance or specific chromosomes by<br />
agarose ehectrophoresis (A), 998<br />
Circadian rhythm<br />
improved RIA of melatonin in serum (SN), 604<br />
melatonin secretion assessed by measuring its<br />
metabolite, 6-suhfatoxymehatonin, 1343<br />
Cirrhosis<br />
intra-individual variation of anahytes in serum<br />
from patients with chronic liver diseases,<br />
1133<br />
Citrate<br />
adaptation of manual citric acid method to<br />
Roche Cobas-Bio (A), 964<br />
centrifugal anal, for urinary citrate with the IL<br />
Multistat analyzer (A), 1009<br />
chem. factors important to Ca nephrohithissis:<br />
evidence for impaired hydroxycarboxyhic<br />
acid absorption causing hyperoxalunia, 243<br />
citrate in urine estimated by a citrate lyase<br />
technique adapted to the Cobss-Bio (TB),<br />
1948<br />
colorimetnic, enzymic methods compared for<br />
assay of citrate in urine (TB), 1074<br />
detn, of citrate in urine by simple direct<br />
photometry (TB), 1259<br />
glucose interferes in fluonometry of serum<br />
citrate in diabetic patients with<br />
hyperglycemia (TB), 1940<br />
Clearance<br />
prediction of creatinine clearance from plasma<br />
creatinine (A), 1009<br />
use of creatinine for eatn. of glomerular<br />
filtration rate in isolated perfused rat kidney<br />
model (A), 1037<br />
<strong>Clinical</strong> Chemist, The<br />
205, 346,451,637,750, 1111, 1310, 1498, 1700,<br />
1961, 2134, 2333<br />
<strong>Clinical</strong> chemistry<br />
advanced technol. and its impact on the chin.<br />
lab. (R), 352<br />
cham. tests in “wellness programs”; test choice<br />
and participant outcomes (A), 1035<br />
COMACC-accredited programs, 451<br />
in-vivo and ex-vivo monitoring of the critically<br />
ill patient (A), 865<br />
journal report, 750<br />
on the origins of papers in <strong>Clinical</strong> <strong>Chemistry</strong><br />
1980-1986, and a query on poster abstracts<br />
(L), 743<br />
Clofibrate<br />
dihydrocapsaicin, 4-(4-chhorophenyh)-2hydroxytetronic<br />
acid, and clofibrate and<br />
intestinal cholesterol absorption in the rat<br />
(A), 895<br />
Chomiphene citrate<br />
detn, of clomiphene citrate and tamoxifen in<br />
blood and seminal plasma using reversedphase<br />
HPLC (A), 1025<br />
Clotting<br />
See Coagulation<br />
Coagulation<br />
anal, of fibninogenolysis/fibninolysis in patients<br />
with chronic liver disease (A), 1004<br />
coagulation profile in a baboon colony (Papio<br />
species) (A), 1036<br />
evahn, of a fully automated centrifugal analyzer<br />
for hemostasis tests (SN), 1888<br />
evaln. of latex agglutination essay for D dimer<br />
for diagnosis of thrombotic disorders (A),<br />
1003<br />
four methods compared for measuring descarboxy-prothrombin<br />
(PIVKA.l1) (SN), 2074<br />
improved enzyme immunoasssy for factor<br />
VIhI-raleted antigen (von Wihlebnand factor<br />
antigen) (TB), 1935<br />
investigation of congenital factor XIII<br />
deficiency and of the carrier state by<br />
immunofixation (A), 1003<br />
quality-control system for the “activated<br />
clotting time” test (TB), 1261<br />
Coagulation assays<br />
ChromoTime-new system for photometric<br />
detn, of coagulation parameters (A), 1004<br />
Cocaine<br />
capillary GC and GC/MS of cocaine and heroin<br />
urinary metabohites (A), 970<br />
detection and confirmation of cocaine use by<br />
chromatog. anal, for methylecgonine in urine<br />
(SN), 118<br />
drug of abuse profile: cocaine (S), 66B<br />
little cross neacty. of local anesthetics with<br />
Abuscreen, EMIT d.a.u,, and TDX<br />
immunoassays for cocaine metabohite (L),<br />
747<br />
qual. assurance in a forensic lab.: GC/MS<br />
confirmation ofTHC and cocaine (A), 971<br />
serum cocaine concns. by RIA after intranasal<br />
apphicn. (A), 1026<br />
Codeine<br />
concns. of morphine and codeine in serum and<br />
urine after ingestion of poppy seeds, 806<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A),<br />
Colorimetry<br />
969<br />
See also Spectrophotometry<br />
adaptation of simple colorimetric<br />
urea N with IQ’Mimmunochem.<br />
1010<br />
assay for<br />
system (A),<br />
ascorbic, dehydroascorbic acids simultaneously<br />
quantified in biol. fluids by liq. chrometog.<br />
with fluorescence detection; colonimetnic<br />
assay compared, 1874<br />
assay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of biol. variation, 269<br />
automated detns. for total iron and UIBC<br />
serum (A), 932<br />
in<br />
colorimetnic<br />
particles<br />
enzyme immunoassey<br />
as a solid-phase reagent<br />
with latex<br />
(A), 1572<br />
colorimetnic, enzymic methods compared for<br />
assay of citrate in urine (TB), 1074<br />
duel fluoromatric/colonimetric detection<br />
system for an automated random-access<br />
instrument utilizing sad. polystyrene test<br />
tubes as precision cuvettes (5), 1554<br />
enzymatic colorimetric assay of inorganic P04,<br />
312<br />
enzymic ethanol assay: colonimatric method<br />
based on mess, of H202, 486<br />
improved dye procedure for detg. urea concn.<br />
by using o-phthsladehyde and<br />
naphthylethyhenediamine (TB), 192<br />
improved measurement of serum amylase with<br />
a chnomogenic substrate (A), 997<br />
lab, assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
hiposome-bssad colonimatric immunoasaay of<br />
serum thyroxin (A), 1565<br />
mass, of acatylchohinestersse<br />
the field, 1731<br />
in enythnocytes in<br />
more sensitive direct ozalate oxidase assay of<br />
urinary oxahate (SN), 1931<br />
new enzymic detn. of guanidinoacetic acid in<br />
urine, 394<br />
optimized hig.-chromatog. method for<br />
fluorometry of urinary #{244}-aminolevuhinic acid<br />
in workers exposed to Pb (SN), 1667<br />
plasma Fe and transferrin iron-binding<br />
capacity evald. by colonimetnic and<br />
immunopptn. methods, 273<br />
quentn. of desferrioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
spectrophotometry of urinary albumin by dyebinding<br />
with use of bromphenol blue, 223<br />
stable colonimetnic method for detn. of serum<br />
Mg (A), 1006<br />
stable reagent for direct assay of alpha-amylase<br />
in patients’ samples using 2-chlono-4nitrophenyl-alpha-maltotnioside<br />
as substrate<br />
(A), 997<br />
two colonimetric methods for serum glycated<br />
proteins compared (TB), 1474<br />
Competitive binding assay<br />
temp-dependent binding of cychosporine<br />
erythrocyte protein, 481<br />
to an<br />
Competitive protein-binding assay<br />
improved quantn. of vitamin D in proprietary<br />
infants’<br />
Complement<br />
formulas and in breast milk, 796<br />
detection of leukemia cells with a complementmediated<br />
cytolytic reaction and an imaging<br />
sensor system (SN), 558<br />
IgG subclass measurements<br />
(R), 1707<br />
in the din, lab.<br />
Computer-assisted<br />
computer-assisted<br />
diagnosis<br />
information system for<br />
automatized diagnosis and file-organization<br />
of oral glucose tolerance test data (A), 983<br />
evaln. of diagnostic tests by using a MUMPS<br />
program to generate receiver operating<br />
characteristic<br />
(A),983<br />
curves and likelihood ratios<br />
implementation of inexpensive microcomputer<br />
expert programs for interpretive reporting of<br />
lipid profiles and coronary heart disease risk<br />
factors (A), 983<br />
Computer-drawn Chernoff faces<br />
data from rats with mesenteric artery<br />
infarction<br />
985<br />
presented as Chernoff faces (A),<br />
CLINICAL CHEMISTRY, Vol.33, No. 12,1987 2369
Computers<br />
ability of the 1, rule to detect substandard<br />
performance in interlab. proficiency testing,<br />
788<br />
apphicn. of the EXPERT consultation system to<br />
accelerated lab, testing and interpretation<br />
(A),867<br />
assessment of the use of fixed limits to<br />
characterize intralab. performance by<br />
proficiency testing (SN), 1901<br />
automation of graphical qual. -control<br />
monitoring with IBM personal computer and<br />
comm. available software (A), 984<br />
computer-aided hR anal, of urinary calculi<br />
(SN), 2070<br />
computer applicns. in lab. med. (A), 1056<br />
computer-assisted insulin delivery for NPH<br />
and regular insulins based on solid-phase<br />
reagent glucose values (A), 985<br />
computer-assisted therapeutic drug monitoring<br />
(A), 982<br />
computer-based method for hematocnit effect<br />
correction in blood viscosity measurement<br />
(TB), 1071<br />
computer-integrated lab. (A), 869<br />
computer-intensive enhancements to the chin.<br />
lab.: image cytomatry and database.denived<br />
decision tables (A), 868<br />
computerized neal-time quality-assurance<br />
program for integration of lab. qualitycontrol<br />
data (A), 909<br />
computerprogram for comparison-of-methods<br />
evaln. (TB), 1262<br />
computer programs for lab. statistics developed<br />
on IBM-RT aupermicrocomputer (A), 985<br />
computers that do physical work-robotics in<br />
the chin, lab. (A), 1057<br />
customized cardiac profile reporting for<br />
isoenzyme electrophoresis (A), 982<br />
development of default interpretive criteria for<br />
flexible “map” system for on-line automatic<br />
interpretation of blood gas data (A), 982<br />
evaln, of Beckman Interhink software for cm.<br />
instrument programming, data-collection<br />
and reporting (A), 984<br />
evaln. of Beckman InterhinkTNsystems director<br />
(A),984<br />
flexible, multiple-parameter, compact color<br />
graphics report (A), 986<br />
foreground interface of Abbott Spectrum to<br />
mainframe computer (A), 984<br />
Informix Database Management software in<br />
the chin. chem. lab. (TB), 1077<br />
integrated microcomputer program for anal.<br />
method development (A), 981<br />
intenlab. proficiency-testing programs:<br />
computer model to assess their capability to<br />
correctly characterize intraleb. performance,<br />
784<br />
interpretive report generation with the Rutgers<br />
EXPERT artificial intelligence language (A),<br />
1057<br />
lab, inventory control using dBASE III Plus’<br />
(A), 911<br />
Lotus 1.2-3 in the chin, lab.: apphicns. for<br />
electronic spreadsheets (A), 986<br />
microcomputer apphicns. integrated into lab.<br />
operations: practical uses of databases,<br />
spreadsheets, and word processing (A), 985<br />
modifn, of programmed, interactive, “map”<br />
system for blood gas result interpretation for<br />
management of patients needing ventiletory<br />
support: a teaching hospital’s experience (A),<br />
982<br />
multisystem micro-computer for the docton’s<br />
office (A), 985<br />
programming language for automated timedependent<br />
decision-making in chin. chem.<br />
(A),984<br />
relational database system to manage lab, data<br />
on personal computers (A), 983<br />
software program for cslcn. of amylase<br />
isoenzymes (A), 982<br />
use of desktop computers as terminals to a lab.<br />
information system (A), 911<br />
workload recording and productivity<br />
measurement with the Compaq portable<br />
microcomputer (A), 986<br />
Congenital disorders<br />
See Heritable disorders<br />
Conjunctivitis<br />
lacnimal IgE assessment with paper strips (A),<br />
918<br />
Continuous-flow analysis<br />
automated anal. for taurine in biol. fluids,<br />
tissues (SN), 835<br />
automated anal, of taurine in biol. fluids and<br />
tissues (A), 962<br />
2370 CLINICALCHEMISTRY, Vol. 33, No. 12, 1987<br />
Cobas-Bio and Technicon RA-1000 assays of<br />
direct bihirubin compared (TB), 1670<br />
evain. of Beckman reagents on Technicon<br />
SMAC instrument (A), 956<br />
evaln. of several analytes by Cobas Mira and<br />
comparison with Technicon SMA-II-C<br />
analyzer (A), 965<br />
improved Ca and uric acid methods for<br />
Technicon SMAC system (A), 956<br />
performance characteristics of <strong>Clinical</strong> System<br />
700 (A), 941<br />
performance characteristics of Model 700 chin.<br />
analyzer (A), 941<br />
pyruvate interference with continuous-flow<br />
(SMAC) methods for aspantate and alanine<br />
aminotransferases (TB), 616<br />
stabilized reagents for SMAC triglycerides (A),<br />
900<br />
Control materials<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
quality control material for urine toxicol.<br />
testing (A), 976<br />
Copper<br />
intestinal Zn, Cu, and Mn concns. in Crohn’s<br />
disease (A), 933<br />
Coproporphyrin<br />
direct quantn. of coproporphynins,<br />
uroporphynins in urine by deny, synchronous<br />
fluorescence apectroscopy, 1826<br />
Coronary artery bypass<br />
plasma levels of atnial natniuretic peptida and<br />
digoxin-like immunoreactiva substances in<br />
patients undergoing cardiopulmonary bypass<br />
(A),890<br />
Coronary artery disease<br />
identn. of hipopnotein(e) by gradient-gel<br />
electrophoresis: relationship to coronary<br />
artery disease (A), 897<br />
monoclonal antibodies-based radial<br />
immunodiffusion assay of spohipoprotein A-I<br />
and B in angiographically assessed coronary<br />
artery disease (A), 898<br />
Coronary risk factors<br />
implementation of inexpensive microcomputer<br />
expert programs for interpretive reporting of<br />
lipid profiles and coronary heart disease risk<br />
factors (A), 983<br />
mild exercise improves cardiovascular risk<br />
factors in obese pubescent children (A), 1030<br />
Corrections<br />
724, 1316, 1500, 2130<br />
Corticostaroids<br />
hydrocortisone succinste and hydrocortisone<br />
simultaneously dead, in plasma by reversedphase<br />
hg. chomatog. and their<br />
pharmacokinetics in asthmatic children,<br />
1412<br />
simultaneous mass, of eight corticosteroids by<br />
hiq.-chnometog. and appln. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
Corticosterone<br />
corticosterone response to stress and anxiohytic<br />
agents (A), 1059<br />
hg. chrometog. and RIA compared for detn. of<br />
cortisol and corticosterone in plasma after a<br />
dexamethasona suppression test (SN), 1639<br />
Corticotropin<br />
meas. of corticotropin in unextracted plasma:<br />
time-resolved immunofluoromatric assay<br />
and immunoradiometric assay compared<br />
with use of same monoclonal antibodies,<br />
1747<br />
Cortisol<br />
comparison of plasma cortisol detna. by Abbott<br />
TDx’M and competitive protein binding for<br />
daxamethasone suppression test (A), 959<br />
comparison of serum and salivary cortisol<br />
condos, in the dexamethasone suppression<br />
test (A), 1033<br />
cortisol and thynoxin fluorescence<br />
immunoassay by the semlautomated system<br />
IMMPULSE (A), 922<br />
evain. of the cross reactivity of fludrocortisone<br />
with the “Corti-Cota” (Becton Dickinson)<br />
cortisoh assay (TB), 1254<br />
free cortiaoh and crastinine in urine of healthy<br />
children, 2047<br />
hiq. chromatog. and RIA compared for detn, of<br />
cortisol and corticosterone in plasma after a<br />
dexamethasone suppression test (SN), 1639<br />
one-tube radiotransinassay for detn, of cortisol<br />
at ambient temp., 1137<br />
serum cortisol and urine free cortisol as<br />
indicators of dexamethssona suppression<br />
and metyrapone inhibition (A), 886<br />
simple adaptation of an RIA kit for serum<br />
cortisol used to measure salivary cortisol<br />
(TB), 191<br />
simple, direct coated-tube enzyme<br />
immunoassay of cortisol in serum (TB), 422<br />
Cotinine<br />
measurement of cotinine in urine as an<br />
indicator of passive smoke exposure (A), 975<br />
rapid, sensitive method for simultaneous<br />
quantn. of nicotine and cotinine in biol,<br />
fluids by HPLC (A), 975<br />
Coulometry<br />
commercial electrochem, method evald, for<br />
mass. of Fe status (SN), 1645<br />
interpreting results of coulometry and<br />
immunopptn. in diagnosing Fe disorders<br />
(SN), 1215<br />
Countenimmunoelectrophoresis<br />
See Immunoalectrophoresis<br />
Coupled enzyme assay<br />
detn. of a-emylase acty. with a new<br />
chromogenic substrate, 524<br />
Clq<br />
method for serum Clg based on its<br />
hydroxyprohine content, 398<br />
C-reactive protein<br />
See also Acute-phase proteins<br />
development of latex immunoasaay of Creactive<br />
protein for Monarch’ centrif.<br />
analyzer (A), 903<br />
development of guant. automated<br />
immunoassay for C-reactive protein (A), 960<br />
development of turbidimetnic immunoassay for<br />
C-reactive protein on the Abbott Spectrum<br />
(A),903<br />
enhanced-latex aggln. essay for C-reactive<br />
protein in serum, with use of a centrif.<br />
analyzer (SN), 685<br />
evsln. of two immunoturbidimetnic C-reactive<br />
protein assays on the Hitachi 705 (A), 903<br />
fat agglutination slide test for increased<br />
condos, of C-reactive protein in serum<br />
compared with results by laser naphehometry<br />
(TB), 2301<br />
highly sensitive enzyme-linked immunoeorbent<br />
assay of human C-reactive protein in cord<br />
blood sara (A), 919<br />
measurement of human serum C-reactive<br />
protein on Abbott Vision system (A), 903<br />
microtiter-latex test for C-reactive protein, for<br />
screening large numbers of samples (TB),<br />
1258<br />
prehim. chin, studies of C-reactive protein<br />
quantified by enzyme-linked immunoassay,<br />
2185<br />
results compared for C-reactive protein detus.<br />
by Roche Cobss-Bio, Beckman ICS and Du<br />
Pont ace (A), 964<br />
Technicon C-reactive protein assay for the RA-<br />
1000 compared with Beckman ICS (A), 920<br />
Creatine<br />
simpler enzymatic detn. of crestine in serum<br />
with a commercial cneatinine kit (TB), 720<br />
Creatine kinase<br />
activity vs mass detn, of serum CK-MB<br />
isoenzyme for detecting coronary reperfusion<br />
in acute myocardial infarction after<br />
therapeutic thrombohysis (A), 989<br />
acty. of serum aspsrtate aminotnansferssa<br />
isoenzymes in acute myocardial infarction,<br />
67<br />
alternative calibration scheme for the<br />
Ektacham CK-MB slide (L), 1492<br />
anal. of creatine kinase isoenaymes and<br />
isoforms in serum to detect reperfusion after<br />
acute myocardial infarction, 507<br />
anal. performance of Reflotron’ creatine<br />
kinasa reagent carriers compared with CK<br />
NAC-mathod (A), 988<br />
appln. of novel Cr02 magnetic particles to<br />
immunoessay development (5), 1543<br />
assessment of Paramax immunoinhibition CK-<br />
MB assay in acute myocardial infarction (A),<br />
987<br />
automated detn, of CK-MB isoenzyme with<br />
Coulter CPA (A), 943<br />
cardiac enzymes and hypothyroidiam (L), 2131<br />
carrier detn, in Duchanne muscular dystrophy<br />
utilizing DNA probes and creatine kinase<br />
actys. (A), 1034<br />
CK.BB and .MB condos, in premature infants<br />
(A),990<br />
chin, usefulness of Encore” adaptation of<br />
immunoenzymetric assay for creatine kinasa<br />
MB (A), 988<br />
comparison of methods for CK-MB detection<br />
in 58 patients in a coronary-care unit (A),<br />
989
comparison of solutions for extracting CK, AK,<br />
and LD from brain samples (TB), 2304<br />
creetine kinase-MB as a marker of doxorubicin<br />
cardiotoxicity (A), 1036<br />
Du Pont ace CK-MB method, verified for use<br />
in reporting 100% recovery of CK-MB (TB),<br />
1268<br />
early diagnosis of acute myocardial infarction<br />
by rapid anal, of creatina kinase isoanzyma-3<br />
(CK-MM) sub-types, 358<br />
elactrophoresis and the isomune-LD and LD-1<br />
immuno methods compared to mess, of<br />
lactate dehydrogenase isoenzyme-1 (SN),<br />
1884<br />
elevated CK-BB isoenzyme condos. in a patient<br />
with carcinoid tumor (A), 1034<br />
evaln, of EMDS CK.MB test pack for Du Pont<br />
ace analyzer (A), 988<br />
evaln. of ion-exchange chrometog. system for<br />
quant. detn, of CK-MB (A), 988<br />
avahn. of Kodak thin-film slides for<br />
theophylhina, Mg, and creatine kinase-MB<br />
(A),951<br />
evaln, of multiple trauma patients by using<br />
direct assay of CK isoenzymes (A), 1034<br />
evain. of Paramax CK-M inhibitory antibody<br />
single-tablet assay for screening elevated<br />
serum CK-MB acty. (A), 987<br />
evidence that human, rabbit, and bovine<br />
creatine kinasa isoenzymes are glycoproteins<br />
(A),991<br />
hypothanmic myxedema coma erroneously<br />
diagnosed as myocardial infarct, because of<br />
increased cneatine kinese MB (CR), 1083<br />
identifying CK-MB and mscro-CK by<br />
ehectrophoresis (L), 1954<br />
immunochamiluminomatry of creatine kinase<br />
MB with a monochonal antibody to the MB<br />
isoenzyma (S), 1517<br />
increased activities of CK-MB and LD-2 ins<br />
patient with metestatic ovarian tumor (A),<br />
930<br />
increased activities of crestina kinsse and<br />
lactate dahydrogensse isoenzymes in a<br />
patient with metestatic ovarian tumor (CR),<br />
1484<br />
increased creatina kinase and CK.MB in<br />
patients with acute respiratory distress (A),<br />
989<br />
increased serum lactate dehydrogensse<br />
isoenzyme 1 and “flipped” LD-1/LD-2 ratio<br />
in myopathy associated with partial<br />
carnitina palmitoyltranaferase deficiency<br />
(CR), 2111<br />
isoforms of creetine kinase isoenzymes in<br />
serum in acute myocard. infarct after<br />
intracoronary thrombolysis, 2039<br />
kinetic immunochem. method for simultaneous<br />
quantn. of creatina kinasa isoenzymes, 237<br />
low-end creatine kinsse threshold for CK<br />
isoenzyme testing (A), 990<br />
measurement of creatina kinase and lactate<br />
dehydroganase with Kodak Ektachem DTSC<br />
module designed for physician’s office<br />
testing (A), 937<br />
3 methods compared for anal, of creatine<br />
kinase isoenzyme MB in a tertiary-care hosp.<br />
(A),989<br />
Mg2 and creatine kinase in myocard. infarct.:<br />
new data (L), 739<br />
monochonal antibodies specific for the CK-M<br />
subunit and the CK-MM diman (A), 986<br />
myoghobin and creatine phosphokinase.MB<br />
radioasssys for early detection of acute<br />
myocardial infarction for myocardial salvage<br />
therapies (A), 989<br />
normal baseline values for CK-MB by two<br />
methods compared (L), 1951<br />
performance characteristics of EM Diagnostic<br />
Syatem CK-MB teet parke on Du Pont ace<br />
analyzer (A), 949<br />
performance of immunoinhibition assay for<br />
CK-MB with a dry-reagent strip test for CK<br />
(A), 987<br />
persistent elevation of creetine kinase in<br />
patients with chronic obstructive pulmonary<br />
disease (A), 1033<br />
radial partition immunoassay: quant. CK-MB<br />
in human serum (A), 988<br />
rapid protocol to rule out acute myocardisl<br />
infarction (A), 990<br />
ratios of creatine kinase to lactate<br />
dehydrogenase and sspantate<br />
aminotransfenase in evaln. of patients with<br />
elevated CK (A), 990<br />
reassessment of creatine kinase BB as a marker<br />
for cancer of prostate, breast, and lung (SN),<br />
809<br />
semisutomated, colonimetric measurement of<br />
creatina kinase-MB ecty. in serum after<br />
extn. with CK-MB-specific monochonal<br />
antibody (A), 987<br />
Se, Zn, Mg, Ca, K, cholesterol, and creetine<br />
kinase concns, in men during 12 days after<br />
acute myocardial infarction, 21<br />
simultaneous sepn. of cardiac isoenzymes CK-<br />
MB, LD-1, and LD-2 by two-dimensional<br />
(anion-exchange/iinmuno-effinity) column<br />
chromsto. (A), 991<br />
solid-phase immunoessay for direct<br />
measurement of cneatine kinase MB<br />
isoenzyme acty. in serum (A), 987<br />
subnormal serum creatine kinase activity in<br />
acute myocard. infarct. (L), 1306<br />
total absence of serum CK-MM and the<br />
presence of a CK-BB isoenzyme migrating to<br />
CK-MB position on agarose gel<br />
electrophoresis (A), 990<br />
Creatinine<br />
assessment of abnormal creatinine concn. by<br />
HPLC (A), 1009<br />
biol, variation in analyte condos, in urine of<br />
apparently healthy men, women (SN), 847<br />
comparison of effects of native bihirubin and<br />
added bihirubin on the Paramex and DT6O<br />
creatinina assays (A), 912<br />
development and field performance of<br />
enzymatic creatinine method for Analyst’”<br />
physician’s office profiler (A), 949<br />
effect of Tnizma’ carbonate on results by the<br />
Kodak Ektachem single-slide method for<br />
creatinina (TB), 1476<br />
evaln. of cold-stable rate-Jaff#{233} creatinine<br />
reagent for use on Beckman<br />
4 (A), 951<br />
evaln. of hidocaina interference<br />
Synchron CX’”in<br />
the Kodak<br />
Ektachem 700 analyzer single-slide method<br />
for creatinina (TB), 2311<br />
evain, of single-side creatinine method<br />
Kodak Ektachem 700 shows poe.<br />
in<br />
interference from hignocalne metabohites<br />
(TB), 1674<br />
evaln. of the TDX<br />
(TB), 311<br />
procedure for craatinine<br />
faster creatinina assay in the Abbott<br />
Spectrum’ system (TB), 1466<br />
free cortisol and creatinine in urine of healthy<br />
children, 2047<br />
improved Jaff#{233} creetinine reagent for the<br />
“Parallel” analyzer (TB), 2124<br />
influence of sample preservative on electrolyte,<br />
urea, creatinine, and glucose levels (A), 915<br />
intra-individual variation in 24-h creetinine<br />
excretion and 24-h urinary volume (A), 1033<br />
kinetic study of Jaff#{233} reaction for creatinine<br />
and quantn. of creatinine in serum (A), 1009<br />
kinetic study of the Jaff#{233} reaction for<br />
creatinine in serum: 1. alkalinity controlled<br />
with NaOH, 278<br />
mechanism of interference with the Jaff#{233}<br />
reaction for creatinine, 1129<br />
more on urinary alb. and creatinine (L), 740<br />
muhtilab, avahn. of single-slide enzymatic<br />
crestinine method on Kodak Ektachem<br />
analyzer (A), 951<br />
performance results for single working liquid<br />
creetinine reagent on Gilford SBA (A), 953<br />
prediction of creatinine clearance from plasma<br />
crastinine<br />
proteinunis<br />
(A), 1009<br />
in health and disease assessed by<br />
measuring<br />
(SN), 297<br />
the urinary protein/crestine ratio<br />
qusnt. detn, of NH4, Na, K, Mg2, Ca2,<br />
and creatinine in human urine by capillary<br />
isotachophoresis (A), 1005<br />
serum retinol-binding protein and creetinine in<br />
onset of and recovery from acute renal<br />
failure<br />
simpler<br />
(TB), 1942<br />
enzymatic detn. of creatine in serum<br />
with a commercial craatinine kit (TB),<br />
simultaneous anal, for 4-hydroxy-3methoxymandehic<br />
acid, 4-hydroxy-3-<br />
720<br />
methoxyphenylacetic acid, and creatinine in<br />
urine by HPLC with column switching (A),<br />
887<br />
simultaneous datn. of neopterin and crestinine<br />
in serum with solid-phase extraction and online<br />
elution liq. chromatog., 2028<br />
use of BUN/crestinine ratio and creatinine<br />
concn. as indicators of potential ketone<br />
interference in a kinetic crestinine method<br />
(A), 913<br />
use of creatinine for estn. of glomarular<br />
filtration rate in isolated<br />
model (A), 1037<br />
perfused rat kidney<br />
Crohn’s disease<br />
intestinal Zn, Cu, and Mn condos. in Crohn’s<br />
disease (A), 933<br />
Crossed immunoelectrophore.is<br />
stability of free apolipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hyperhipidemic subjects, 1163<br />
Cross reactivity<br />
See antigen-antibody system of interest<br />
Cumulative distribution analysis graphs<br />
cumulative distribution anal. graphs-an<br />
alternative to ROC curves (TB), 2305<br />
Cushing’s syndrome<br />
serum cortisol and urine free cortisol as<br />
indicators of dexemethasone suppression<br />
and metyrapone inhibition (A), 886<br />
Cutoff value<br />
availability of plasma with target values for<br />
certain lipids (L), 2323<br />
evalg. the chin. effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
evaln. of a monoclonal immunoradiometric<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
lab, assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
low-end creatine kinase threshold for CK<br />
isoenzyme testing (A), 990<br />
modified lamellar body phospholipid assay<br />
compared with L/S ratio and<br />
phosphatidylglycerol assay for assessment of<br />
fetal pulmonary statua, 24<br />
prehim, chin, studies of C-reactive protein<br />
quantified by enzyme-linked immunoassay,<br />
2185<br />
prospective clinical evaln. of an improved<br />
fluorescence polarization assay for predicting<br />
fetal lung maturity (SN), 554<br />
prostate-specific antigen as a marker for<br />
prostatic cancer: monoclonal and polyclonal<br />
immunoassay compared (SN), 1916<br />
proteinuria in health and disease assessed by<br />
measuring the urinary protein/creatine ratio<br />
(SN), 297<br />
renal differentiated from non-renal hematunia<br />
by micros, axamn, of arythrocytes in urine,<br />
1791<br />
selecting the optimum specimen for assessing<br />
slight albuminunia, and a strategy for chin.<br />
investigation: novel uses of data on biol.<br />
variation, 2034<br />
Cyanide<br />
CN- condos, in blood after cigarette smoking,<br />
as dead. fluorimetrically (SN), 1228<br />
fast kinetic method for methemoglobin<br />
adapted for quantn. of Hb in whole blood,<br />
493<br />
toxicity of Na nitroprusside, 490<br />
Cyanocobahamin<br />
See Vitamin B12<br />
Cyclobenzaprine<br />
interference by cyclobenzsprine in hiq.chromatog.<br />
assays of tricychic<br />
antidepressants (SN), 819<br />
Cyclophosphamide<br />
are cyclophosphamide and phosphoramide<br />
mustard related in high-dose bone-marrow<br />
transplant patients? (A), 1035<br />
Cyclosporine<br />
automated solid-phase extraction and liq.<br />
chromatog. for assay of cycloeponine in whole<br />
blood (SN), 2272<br />
Bio-Rad cychoeponine assay compared with<br />
cychosporine assayed in our lab, by Moyer’s<br />
FIPLC method (A), 978<br />
capillary blood, dried on filter paper, as sample<br />
for monitoring cycloeponin A concns., 1643<br />
changes in cychoeporine metabolism with<br />
coadminintration of ketoconazolo (A), 979<br />
chin, variability of cydloeporine<br />
pharmacokinetics (A), 978<br />
currant issues in cyclosponine monitoring (A),<br />
1056<br />
cyclosporine: interhaboratory Q.C. program (L),<br />
2128<br />
detn. of cychoeporine condos. with monoclonal<br />
antibodies, 2225<br />
distribn. of cychosporine in blood of a renal<br />
transplant recipient with type V<br />
hyperlipoproteinemia (CR), 423<br />
effect of gentamicin and cycloeporin on<br />
permeability of model membranes (A), 1027<br />
effects of sample prepn. on Cyclosporin G<br />
(NVA2-Cycloeponin) concn, (TB), 1257<br />
identn, and anal. of 9 matabohites of<br />
cyclosporina in blood by hiq. chromatog. 1:<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2371
purifn. of anal. stds. and assay optimization,<br />
1841<br />
identn. and anal, of 9 metabolites of<br />
cyclosponine in blood by liq. chromatog. 2:<br />
comparison of patients’ results, 1851<br />
improved extn. and chromatog. of cychosponins<br />
(A), 978<br />
method comparison of two cychosporine assays<br />
by RIA (A), 977<br />
modifn. of rugged cyclosporine assay by }IPLC,<br />
to decrease anal. time by 50% (A), 977<br />
potential of monoclonal antibodies to improve<br />
therapeutic monitoring of cyclosponina, 32<br />
predictor of plasma cyclosponine concn. at 37<br />
“C from whole-blood condos, at room temp.<br />
(A), 979<br />
results from natl. intenleb. quality-control<br />
survey for cyclosporin assay (A), 978<br />
specimen collection in plastic containers gives<br />
rise to interferents in liq.-chnomatog. assay<br />
of cyclosporine (L), 1493<br />
temp. -dependent binding of cyclosporine to an<br />
erythrocyte protein, 481<br />
temp-dependent distribution of cychosponine<br />
metabolites amongst cells/plasma in whole<br />
blood (A), 979<br />
Cystic fibrosis<br />
apphicns. of linkage anal, in cystic fibrosis<br />
testing (A), 1060<br />
pitfall in anal. of proteins synthesized by sweat<br />
glands from patients with cystic fibrosis by<br />
two-dimensional gel electrophoresis and<br />
double-label autoradiography (TB), 2310<br />
sweat osmolality values in normal adults (TB),<br />
612<br />
thin-layer chromatog. detn. of urine excretion<br />
of hactuhose, simplified and applied to cystic<br />
fibrosis patients (SN), 1211<br />
two indirect tests of exocnine pancreatic<br />
function avald. (R), 5<br />
use of amniotic fluid enzymes for prenatal<br />
diagnosis of cystic fibrosis (A), 1059<br />
Cystine<br />
qusntn. of pipecohic acid in plasma, and of<br />
urinary cystine in the presence of<br />
penicillamine-cystina disulfida, with the<br />
Beckman 6300 Amino Acid Analyzer (L),<br />
1302<br />
Cystinurie<br />
quantn. of pipecohic acid in plasma, and of<br />
urinary cystina in the presence of<br />
penicillamine-cystine disulfide, with the<br />
Beckman 6300 Amino Acid Analyzer (L),<br />
1302<br />
Cytochemistry<br />
mol, mechanisms of human lymphocyte and<br />
complement cytotoxicity and control by<br />
target membrane regulatory protein (A), 863<br />
Data handling<br />
assay design influence on ES-600 performances<br />
(A), 946<br />
error propagation in predictive value estimates:<br />
effect of anal, precision on confidence limits<br />
(A),908<br />
evaln. of a second-wavelength correction<br />
technique (A), 963<br />
evaln. of diagnostic tests by using a MUMPS<br />
program to generate receiver operating<br />
characteristic curves and likelihood ratios<br />
(A),983<br />
fractional error as a means of assessing<br />
agreement between two methods measuring<br />
the same variable (TB), 1944<br />
how to make lab, information more informative<br />
(A),868<br />
Informix Database Management software in<br />
the din. chem. lab. (TB), 1077<br />
interlab. proficiency-testing programs:<br />
computer model to assess their capability to<br />
correctly characterize intralab. performance,<br />
784<br />
math. treatment of data for cslcuhatin&<br />
activities of a-amylese isoanzymes (SN), 689<br />
operation and performance evaln. of glucose<br />
“out-of-range detection and connection”<br />
feature in Synchnon AS’”/Astra systems<br />
(A), 961<br />
why not use the sad, deviation index as a<br />
common scale for data qusntn.? (L), 1294<br />
Data processing<br />
data-redn. methods for immunoradiometnic<br />
essays of thyrotropin compared (SN), 1207<br />
Definitive methods<br />
candidate Definitive Method for measurement<br />
of serum cholesterol (A), 894<br />
comparability of Nath, Ref. System total<br />
cholesterol Ref. and Definitive Methods (A),<br />
894<br />
2372 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
isotope dihn./mess spectrom. of serum<br />
cholesterol with [3,4- 13CJcholtroh proposed<br />
Definitive Method, 1403<br />
precision of glucose measurements in control<br />
sara by isotope dihn./msss spectrom.:<br />
proposed Definitive Method compared with<br />
a Reference Method, 1397<br />
Dehydroascorbic acid<br />
ascorbic, dahydrosscorbic acids simultaneously<br />
quantified in biol. fluids by hiq. chromatog.<br />
with fluorescence detection; colorimetric<br />
assay compared, 1874<br />
Densitometry<br />
See also Reflection densitometry<br />
performance of Corning 780 Multitrac<br />
fluorometer/densitometer (A), 943<br />
Desethyhamiodarone<br />
assay of amiodarone and desethylamiodarone<br />
by HPLC and specimen preparation with Du<br />
Pont Prep* (A), 1014<br />
liquid -chromatog. measurement of amiodarone<br />
and N-desathylamiodarone in serum (A),<br />
1014<br />
Desfarrioxamine<br />
quantn. of desfarnioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
Desiprsmine<br />
measurement of plasma imipramine,<br />
desipramine, and their respective 2-hydroxy<br />
metabohites (A), 1025<br />
therapeutic drug monitoring of imipramine<br />
and dasipramine in maintenance therapy of<br />
patients (A), 1025<br />
Desmathylmethsuximide<br />
detn. of methsuximide and Ndesmethylmethsuximide<br />
by capillary column<br />
CC (A), 1020<br />
Dexamethasona<br />
comparison of plasma cortisol detns. by Abbott<br />
TDx’” and competitive protein binding for<br />
dexamethasone suppression test (A), 959<br />
comparison of serum end salivary cortisol<br />
concns. in the dexamethasone suppression<br />
test (A), 1033<br />
Dextran<br />
dextren interference in biuret-based assays for<br />
serum proteins (TB), 1073<br />
Dextromethorphan<br />
false-positive EMIT’ D.A.U. phencychidine<br />
assay as a result of an overdose of<br />
daxtromethorphsn (A), 974<br />
Diabetes<br />
absence of statistical assoc. between<br />
hyperglycemia, metabolic acidosis in type I<br />
and type II diabetic patients on chronic<br />
dialysis (TB), 1076<br />
alternative explanation for changes in<br />
erythrocyte fatty acids in diabetes (SN),<br />
2083<br />
anal, and chin. evaln, of apohipoproteins (A),<br />
899<br />
animal model of diabetes mellitus: spontaneous<br />
and inherited canine diabetes mehlitus (A),<br />
1058<br />
spohipoprotein condos, in cord sera of<br />
newborns from diabetic and nondiabetic<br />
mothers (A), 897<br />
assay of disatunated phosphatidylchohine in<br />
amniotic fluid as a test of fetal lung<br />
maturity: experience with 2000 analyses<br />
(SN), 1648<br />
assay of serum fructosamina that minimizes<br />
standn. and matrix problems: use to assess<br />
components of biol. variation, 269<br />
automated procedure for reading and<br />
calculating ghycated Hb fractions (TB), 2305<br />
bedside glucose monitoring by nurses and<br />
chemists (A), 912<br />
clinical usefulness of glycated Hb in<br />
monitoring diabetes: long-term study, 55<br />
computer-assisted information system for<br />
automatized diagnosis and file-organization<br />
of oral glucose tolerance test data (A), 983<br />
computer-assisted insulin delivery for NPH<br />
and regular insulins based on solid-phase<br />
reagent glucose values (A), 985<br />
contribution of tubular proteins to proteinuria<br />
of diabetes melhitus (A), 1033<br />
correlation of Ames Micro-Bumintest”’ tablet<br />
with total protein and albumin in diabetic<br />
urines (A), 980<br />
enzyme-linked immunosorbent assay for<br />
urinary albumin at low concns. (SN), 609<br />
enzymic glycation may decrease acty. of<br />
erythrocytic i-aminohevuhinste dehydratase<br />
in diabetes, 1807<br />
enythrocyte glutathione concns. in diabetics<br />
with cataracts, with and without glucose-6phosphate<br />
dehydrogenase deficiency (TB),<br />
1936<br />
evaln. of Roche fructosamine test for<br />
monitoring diabetic patients (A), 954<br />
factors affecting glycation of human plasma<br />
proteins (A), 1002<br />
false-positive Ketostix in a diabetic on<br />
antihypertensive therapy (L), 1490<br />
feasibility of centralized mess. of glycated Hb<br />
in the Diabetes Control and Complications<br />
Trial: a multicenter study (SN), 2267<br />
fructosamine and protein concns. in serum (L),<br />
2326<br />
fructosamine assay in management of diabetes:<br />
anal. and chin. evaln. (A), 1002<br />
fructosamine: structure, anal. and chin.<br />
usefulness (R), 2153<br />
glucose interferes in fluorometry of serum<br />
citrate in diabetic patients with<br />
hyperglycemia (TB), 1940<br />
glycated proteins in serum: effect of their<br />
relative proportions on their alk, reducing<br />
acty. in the fructosamine test (SN), 1895<br />
hyponstremis in spontaneous hyperglycemia:<br />
correlation studies in 100 patients (TB), 1941<br />
immunochem. methods for early detection of<br />
microalbuminuria in diabetic nephropathy<br />
(A), 902<br />
intra-individual variation of some analytes in<br />
serum in insulin-dependent diabetes, 57<br />
lab. assessment of a commercial kit for<br />
fructosainine in serum (SN), 158<br />
lactate and pyruvate ehectrochem. biosensors<br />
for whole blood in extracorporesh<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
laser immunonephelometry for routine quantn.<br />
of urinary albumin, 209<br />
liq.-chromatog. detn. of $2-micnoglobuhin, niacid<br />
glycoprotein, and albumin in urine, 1756<br />
meas. of glycated protein by a rapid, specific<br />
method for absolute quantn. of lysine-bound<br />
glucose (SN), 1656<br />
monitoring and management of diabetic<br />
patients (A), 870<br />
non-enzymic glycation of individual plasma<br />
proteins in normoghycemic and<br />
hyperglycemic patients, 2220<br />
plasma protein glycation as measured by<br />
fructosamine assay, 1141<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
pronounced decrease of Tamm-Horsfall<br />
proteinuria in diabetics (TB), 1264<br />
relation between fructosamine and plasma<br />
lipid concns. in diabetes mellitus (L), 629<br />
results with a fructosamine kit for a group of<br />
diabetics in Southeast Asia (TB), 1948<br />
role of nonenzymetic glycation in altered renal<br />
function in exptl. diabetes (A), 1037<br />
screening with glycated Hb for gestationsh<br />
diabetic-associated macrosomia (A), 1001<br />
selecting the optimum specimen for assessing<br />
slight ahbuminunia, and a strategy for din.<br />
investigation: novel uses of data on biol.<br />
variation, 2034<br />
superoxide dismutase inhibits fructosamine<br />
assay (SN), 147<br />
urinary alb. and retinol-binding protein in<br />
diabetes (TB), 713<br />
Dialysis patients<br />
See also Hemodialysis<br />
dialyzed patients having high serum Al values<br />
(A), 933<br />
pynidoxsl-5-phosphate depletion in renal<br />
dialysis patients causes din, significant<br />
errors in ALT detns. (A), 992<br />
Diet-related effects<br />
assessment of monthly, weekly, and daily<br />
variability of chin. chem. procedures on<br />
women fed a constant on self-selected diet<br />
(A), 935<br />
dietary micronutrients in cancer prevention<br />
(A), 1062<br />
effect of diet and specimen collection protocol<br />
on urinary 5-HIAA excretion as measured by<br />
direct HPLC: comparison of normals and<br />
carcinoid patients (A), 931<br />
effect of high-lipid diet on serum lipid<br />
parameters in the rat and monkey (A), 1035<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
Diffuse reflectance infrared spectroscopy<br />
diffuse reflectance technique for infrared anal.<br />
of urinary calculi, 780
Digitalis<br />
problems in standn, of digitalis-like substance<br />
assays by means of competitive immunohog.<br />
methods (L), 340<br />
Digitoxin<br />
radial partition immunoassay: monitoring<br />
digitoxin in serum and plasma (A), 1015<br />
Digoxin<br />
adaptation and evaln, of CED1A”' digoxin on<br />
Coulter CPA chem. analyzer (A), 943<br />
adaptation and evaln. of CEDIA’ digoxin on<br />
Coulter Dacos’ chem. analyzer (A), 1014<br />
alternative approaches to monitoring cardiac<br />
gycosides and the concept of endogenous<br />
digoxin (A), 1053<br />
comparison of two digoxin immunoessays using<br />
a Cobas Bio with Kallestadt RIA (A), 1014<br />
detn. of free digoxin concns. in serum for<br />
monitoring Fab treatment of digoxin<br />
overdose (SN), 1652<br />
development of rapid nonradioactive assay for<br />
digoxin based on enhanced luminescence<br />
(A), 1015<br />
digoxin immunoassays (A), 1052<br />
digoxin-hika immunoreactivity eliminated from<br />
serum by centnif. ultrafiltration before<br />
fluorescence polarization immunoassay of<br />
digoxin (SN), 606<br />
digoxin metabolism (A), 1052<br />
digoxin RIA that doss not detect dioxin-hike<br />
substance in serum of newborns, infants, or<br />
patients with renal failure (TB), 420<br />
effect of digoxin-hike immunoreactiva factor on<br />
the TDx Digoxin II essay (L), 629<br />
effect of digoxin-hike immunoreactive<br />
substances on the “Dac-Cel” digoxin assay<br />
(L), 1697<br />
elimination of digoxin-like immunoreactivity<br />
prior to digoxin measurement by<br />
fluorescence polarization immunoassey (A),<br />
914<br />
endoganous digoxin-hike immunoneactive<br />
factors and digoxin immunoassays (A), 1052<br />
endogenous digoxin-like immunoreactive<br />
factors eliminated from serum samples by<br />
hydrophobic silica-gel extraction and<br />
enzyme immunosssey, 401<br />
andogenous digoxin-hike immunoreactive<br />
substances eliminated from serum samples<br />
from patients with liver disease by the EMIT<br />
column digoxin assay (L), 1490<br />
avaln. of CEDIATUdigoxin immunoassay on<br />
Cobss-Bio analyzer (A), 955<br />
evaln. of 6 digoxin kits for accuracy and DLIS<br />
interference (A), 1015<br />
goat-derived anti-lymphocyte globulin<br />
interferes in a double-antibody RIA of<br />
digoxin (CR), 619<br />
immunoassay of digoxin by differential<br />
centnifn. (5), 1548<br />
improved intenassay correlation of digoxin<br />
results in patients with and without renal<br />
failure by elimination of digoxin-hika<br />
immunoreactive factors (SN), 837<br />
improved labels for use in digoxin multilayer<br />
enzyme immunoassays (A), 923<br />
Inocor”' (smninone lactate) interferences with<br />
TD, digoxin mess. (TB), 1944<br />
measurement of digoxin-like immunoreactive<br />
substances from patients receiving digoxin<br />
(A),890<br />
negative interference with the Du Pont aca<br />
method for measuring digoxin (L), 446<br />
negative interference with the Du Pont ace<br />
method for measuring digoxin-a reply (L),<br />
1303<br />
new method for obtaining endogenous digoxinlike<br />
substance (TB), 1470<br />
plasma endogenous digitalis-like factors in<br />
healthy individuals and in dialysisdependent<br />
and kidney-transplant patients<br />
(A),890<br />
plasma levels of atnial natniuretic peptide and<br />
digoxin-like immunoreactive substances in<br />
patients undergoing cardiopulmonary bypass<br />
(A),890<br />
problems in standn. of digitalis-like substance<br />
assays by means of competitive immunohog.<br />
methods (L), 340<br />
recently identified substances with digoxin-like<br />
immunoresctivity do not account for DLIF<br />
measured in humans (A), 890<br />
sensitive, automated, nonisotopic enzyme<br />
immunoassay for detn. of digoxin (A), 1014<br />
solid-phase coated-tube digoxin hiposomebased<br />
fluorescent immunoasasy for Becton<br />
Dickinson IQ din. chem. analyzer (A), 1015<br />
TDX’ Digoxin III nonextraction immunoaasay<br />
for serum digoxin (A), 923<br />
Dihydrocapealcin<br />
dihydrocapsaicin, 4-(4-chlonophenyl)-2hydroxytetronic<br />
acid, and chofibrate and<br />
intestinal cholesterol absorption in the rat<br />
(A), 895<br />
Dipeptidyh peptidase<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl paptidase IV in mice with lupus<br />
erythematosus.hike syndrome and in patients<br />
with hupus erythematosus and rheumatoid<br />
arthritis (SN), 1463<br />
Diphosphoghycerate<br />
modn. of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with 31 NMR,<br />
76<br />
Dipsticks<br />
See also Test strips<br />
Ames Clinitek 200/Multistix 9 urinalysis<br />
compared with manual and microscopic<br />
methods (SN), 1660<br />
din, significance of dipstick-negative,<br />
sediment-positive urines: two reagent<br />
dipsticks compared (TB), 418<br />
false-positive Ketostix in a diabetic on<br />
antihypentensiva therapy (L), 1490<br />
false-positive results for katone with the drug<br />
mesna and other free-SH cmpds. (SN), 289<br />
interference with dipstick tests for glucose and<br />
Hb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
new dip-and-read test for datg. leukocytes in<br />
urine (SN), 1242<br />
Seralyzer reagent-strip system evald. for mess.<br />
of phenobarbital in serum (TB), 191<br />
suitability of solid-phase chem. for quantn. of<br />
leukocytes in cerebrospinal, seminal, and<br />
penitoneal fluid (TB), 1475<br />
Discrete analysis<br />
See also analyte of interest, Instrumentation,<br />
Random-access analysis, etc.<br />
adaptation and avahn. of CEDIA’” digoxin on<br />
Coulten Dacos’ chem. analyzer (A), 1014<br />
adsptation and avaln. of Dart’ Mg reagent to<br />
Couhter Dacos’ chem. analyzer (A), 1007<br />
adaptation of Technicon RA systems’”<br />
theophylline reagents to Coulter Dacos’<br />
(A), 1023<br />
anal, performance of the Eppendorf “Easy<br />
6160” analyzer (TB), 1072<br />
anal. performance of the Vision System evald.<br />
(TB), 1672<br />
chin, performance of the Abbott “Vision<br />
System”: ref. intervals and specimen type<br />
comparisons (TB), 1078<br />
commercial electrochem, method evald. for<br />
mess, of Fe status (SN), 1645<br />
detg. amylase acty. with EM Diagnostic<br />
Systems test packs (A), 950<br />
development and performance of quant. assay<br />
for whole-molecule hCG on the acaa (A), 889<br />
development, characterization of an automated<br />
assay of affective heparmn acty. in plasma,<br />
1630<br />
development of rate BUN method for Hitachi<br />
737 (A), 1010<br />
effect of 8-hydroxyquinoline on response to Ce<br />
and Mg of Beckman Astra’ Cs detn. (A),<br />
1007<br />
enzymatic measurement of sialic acid in serum<br />
by Hitachi 736 analyzer and applicn. for<br />
maker of acute-phase reactants (A), 1011<br />
evaln. of Beckman reagents on Kone Progress<br />
analyzer (A), 967<br />
evaln. of calibration stability on Coulter Dacos<br />
chem. analyzer (A), 965<br />
evaln. of Du Pont ace plasma NH3 procedure<br />
for use with urine (A), 980<br />
evain. of EM Diagnostic Systems Ca and Mg<br />
test packs on Du Pont ace’ (A), 950<br />
evaln, of EMDS CE-MB test pack for Du Pont<br />
ace analyzer (A), 988<br />
evsln. of Mg procedure for Hitachi 737 (A),<br />
1006<br />
evaln. of optimized Ca dye reagent for<br />
Beckman Astra’ system (A), 1007<br />
avaln. of performance of Beckman reagents on<br />
Hitachi 737 (ADAM) analyzer (A), 966<br />
improved measurement of serum amylsse with<br />
a chromogenic substrate (A), 997<br />
interference from immunoghobulins in Hitachi<br />
737 endpoint ureasa method for BUN (A),<br />
1010<br />
lab, and field e’ahn. of three desktop<br />
instruments for assay of cholesterol and<br />
triglyceride (SN), 1230<br />
lab. evain. of the Kone “Progress” discrete<br />
analyzer (SN), 123<br />
performance characteristics of EM Diagnostic<br />
Systems CE-MB test pecks on Du Pont acs<br />
analyzer (A), 949<br />
performance characteristics of EM Diagnostic<br />
Systems liquid test packs on Du Pont ada<br />
analyzer (A), 949<br />
performance characteristics of EM Diagnostic<br />
Systems test pack methods for<br />
sminotransferasas in ace analyzer (A), 950<br />
performance of 7 EM Diagnostic Systems drypackaged<br />
chem, test packs on Du Pont ace<br />
analyzer (A), 950<br />
results compared for LD and alcohol anal. with<br />
EM Diagnostics Systems testpacks in Du<br />
Pont ace HI (A), 949<br />
serum Fe assay on Abbott Spectrum’ and VP”<br />
(A), 957<br />
substrates and inhibitors in reagents for datg.<br />
‘y-glutamyltransfersse (A), 994<br />
Discniminant analysis<br />
validation and appln. of a hiq.chromatog./enzymic<br />
assay for individual bile<br />
acids in rat serum, 1856<br />
Disulfiram<br />
disulfiram (Antabuse) inhibits alcohol<br />
dehydrogenase acty. (SN), 1906<br />
DNA<br />
protein recognition of immobilized uganda:<br />
promotion of selective adsorption (S), 1502<br />
use of restriction fragment length<br />
polymorphism anal, for detecting carriers of<br />
“Fragile X” syndrome (R), 1726<br />
DNA probes<br />
applicns. of linkage anal, in cystic fibrosis<br />
testing (A), 1060<br />
carrier detn. in Duchenne muscular dystrophy<br />
utilizing DNA probes and creatine kinase<br />
actys. (A), 1034<br />
DNA probe-based technol. and sad, culture<br />
methodol. compared for detecting<br />
periodontal pathogens (A), 963<br />
immunolog. capture of nucleic acid hybrids,<br />
appln. to nonradioactive DNA probe assay<br />
(5), 1526<br />
nonisotopic M13 probes for detecting the betaglobin<br />
gene: appln. to diagnosis of sickle cell<br />
anemia, 1368<br />
Down’s syndrome<br />
humoral immune responses in<br />
noninstitutionahizad Down’s syndrome<br />
children (A), 1029<br />
Doxorubicin<br />
crestine kinase-MB as a marker of doxorubicin<br />
candiotoxicity (A), 1036<br />
Drug abuse<br />
detn, of neoptenin in serum and urine, 62<br />
United States’ drug abuse scene: an overview<br />
(S),7B<br />
Drug assay<br />
See also specific drug of interest, Abused<br />
drugs, Toxicology<br />
adaptation and evaln. of monoclonal-antibodybased<br />
therapeutic drug assays on Coulter<br />
CPA (A), 943<br />
anal. chem. at the Games of the XXIhIrd<br />
Olympiad in Los Angeles, 1984 (SR), 319<br />
assay of gemfibrozil in plasma by “highperformance”<br />
liq. chromatog. (TB), 1938<br />
automated fluorescence immunoassays for<br />
theophylline, phenytoin, and phenobarbital<br />
(A),923<br />
computer-assisted therapeutic drug monitoring<br />
(A),982<br />
critical issues in cyclosporine monitoring:<br />
report of the Task Force on Cyclosporine<br />
Monitoring (SR), 1269<br />
current issues in cyclosponine monitoring (A),<br />
1056<br />
detn. of tamoxifen and four metabolites in<br />
serum by low-dispersion hiq. chromatog.,<br />
1608<br />
drug-anal. technol.: overview and state of the<br />
art (S), 13B<br />
drug-anal. technol-pitfalls, problems of drug<br />
testing (S), 33B<br />
drugs in blood donors (TB), 189<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: cardioactive<br />
drugs (A), 1013<br />
enzyme immunoassay method for<br />
comprehensive drug screening in microsamples<br />
of urine, 367<br />
evaln. of drug extn. system from Amer. Toxicol,<br />
Service (A), 974<br />
fluorescence pohsnn. immunoassay avald. for<br />
screening for amphetamine and<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2373
methamphatamina in urine (SN), 1200<br />
improved assay for etoposide in plasma by<br />
radial-compression hiq. chromatog. with<br />
ehectrochem. detection, 803<br />
incidence of drugs in a pediatric population as<br />
assessed through drug screening (A), 977<br />
it’s time to take the initiative (E), 1682<br />
lab. assessments in treatments of substance<br />
abuse: utilization and effects on treatment<br />
design (S), 95B<br />
liq. chromatog. and fluorescence polarization<br />
immunoassay methods compared for<br />
measuring flecalnide acetate in serum (SN),<br />
1898<br />
pharmacol. monitoring in acute care (A), 866<br />
phenylpropanolamine and (d)norpseudoephednine<br />
are indistinguishable by<br />
Toxihsb’ (TB), 1678<br />
proficiency testing for therapeutic drugs in<br />
physician office and small clinic labs (A), 908<br />
quality assurance in drug-use testing (S), 4th<br />
quinine directly dead. in serum or urine by<br />
sepn. fluonoimmunoassay, 463<br />
serum morphine and morphine glucuronides in<br />
man: renal failure elevates glucuronide levels<br />
(A),969<br />
statistical considerations of the random<br />
selection process in a drug-testing program<br />
(S),46B<br />
status of drugs-of-abuse testing in urine: an<br />
AACC study (SR), 1683<br />
strategy for banzoylecgonine testing:<br />
confirmation by TLC/HPLC (A), 971<br />
technological and legal issues of drug-usa<br />
testing (panel discussion) (5), 49B<br />
temp.-dapendent binding of cydlosporine to an<br />
erythrocyte protein, 481<br />
Drug dependence<br />
See Abused drugs, Drug assay, Toxicology<br />
Drug metabolism<br />
potential of monoclonal antibodies to improve<br />
therapeutic monitoring of cychosporine, 32<br />
stereosehective disposition of salbutamol<br />
enantiomers in man: investigation with<br />
chiral HPLC (A), 1026<br />
Drug monitoring<br />
direct, simultaneous mess. of chhoramphenicol<br />
and its monosuccinate ester in microsamples<br />
of plasma by radial-compression hiq.<br />
chromatog., 1814<br />
internal clock reaction used in one-step enzyme<br />
immunochromatog. assay of theophylhine in<br />
blood (5), 1521<br />
Drug screening<br />
single-reagent polarization fluonoimmunoasaay<br />
of methamphetamine in urine (SN), 1903<br />
Drugs of abuse<br />
See Abused drugs<br />
Duchenne muscular dystrophy<br />
carrier detn. in Duchenne muscular dystrophy<br />
utilizing DNA probes and creetine kinase<br />
actys. (A), 1034<br />
Dye-binding procedures<br />
bromcresol purple dye-binding methods<br />
underestimate albumin that is carrying<br />
covalantly bound bihirubin (SN), 821<br />
bromcrasol purple method for albumin on the<br />
“Monarch” centrifugal analyzer (TB), 614<br />
Coomassie Brilliant Blue protein dye-binding<br />
assays compared for detn. of urinary protein<br />
concn. (SN), 577<br />
interference by an 1gM paraprotein in<br />
bromcresol green method for dath. of serum<br />
albumin (TB), 1075<br />
massive overestimation of albumin in<br />
analbuminemic ret serum by bnomcrasol<br />
green (TB), 2121<br />
spectrophotometry of urinary albumin by dyebinding<br />
with use of bromphenol blue, 223<br />
Dyslipoproteinemias<br />
flow-cytomatnic detn, of high-densityhipoprotein<br />
binding sites on leukocytes, 2195<br />
Economics of laboratory operation<br />
spplicn. of cost-management system in the<br />
chin, lab. (A), 911<br />
chin, utility of Ektachem’-datd. bihirubin<br />
fractions for classifying adult inpatients<br />
(SN), 1662<br />
cost-effective EMIT d.a.u. assay with improved<br />
sensitivity (A), 976<br />
cost-affective use of cham. technol. (A), 910<br />
cost of operating a chin, lab, in a VA hosp. (A),<br />
911<br />
deciding optimum interval between specimen<br />
collections: theory and nomognams (SN),<br />
1436<br />
detecting errors in blood-gas measurement by<br />
anal, with two instruments, 512<br />
2374 CLINICAL CHEMISTRY, Vol. 33, No. 12,1987<br />
economy and efficiency in routine thyroidfunction<br />
testing’ use of a sensitive<br />
immunoradiometnic assay for thyrotropin in<br />
a general hosp. lab,, 1635<br />
lactate dahydrogenese isoenzyme<br />
inhibition with 1,6-hexanediol<br />
1 as dead. by<br />
and by two<br />
other methods in myocardial infarction or<br />
cardiac-bypass surgery (SN), 589<br />
mess, of acetylcholinesterase in erythrocytes in<br />
the field, 1731<br />
prepn. and stability of low-cost hiq. qualitycontrol<br />
serum stabilized with ethanedioh<br />
(SN), 851<br />
proteinuria in health and disease assessed by<br />
measuring the urinary protein/crestine ratio<br />
(SN), 297<br />
re-usa of Random Access Fluid recovered from<br />
the waste of the Technicon RA-1000 (TB),<br />
1261<br />
role of qual. choniogonadotropin assays in<br />
diagnosis of ectopic pregnancy<br />
Ektachem<br />
See Multilayer film analysis<br />
Electrochemical detection<br />
(SN), 1908<br />
detn, of unconjugated<br />
hydroxyphenylglycoh3-methoxy-4-<br />
by hiq. chromatog. for<br />
monitoring inhibition of monoamine oxidase<br />
ecty. in plasma (SN), 2078<br />
differential pH meas. to determine analytes in<br />
erythrocytes (A), 1558<br />
effect of pretresting samples with boric acid<br />
before liq. chromatography of urinary<br />
catecholamines, 108<br />
electrochem. detn, of Hb, hematocnit, and<br />
hemolysis<br />
erythrocytic<br />
(SN), 153<br />
glucose-6-phosphate<br />
dehydrogenase measured by differential pH<br />
(SN), 579<br />
lactate and pyruvate electrocham. biosensors<br />
for whole blood in extracorponeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
hiq.-chromatog, method for detn, of<br />
homovanillic acid in plasma, with<br />
ehectrochem, detection, 72<br />
recent advances in electrochem, sensors (A),<br />
1061<br />
simple hiq.-chromatog. mess, of<br />
vanillylmandelic acid and homovanillic acid<br />
in urine on filter paper for mass screening<br />
neuroblastoma in infants, 2043<br />
of<br />
stereosehective<br />
enantiomers<br />
disposition of salbutamol<br />
in man: investigation with<br />
chiral HPLC (A), 1026<br />
validation of HPLC-ECD method<br />
VMA and HVA by comparison<br />
(A),887<br />
for urinary<br />
with GCMS<br />
Elactrochemical techniques<br />
See Ion-selective<br />
Potentiomatry<br />
electrodes, Electrochemistry,<br />
Electrodes<br />
See Ion-selective<br />
Electroimniunoassay<br />
electrodes<br />
alectroimmunoassay for detn, of ApoB in sara<br />
by using a mixture<br />
(TB), 1070<br />
Electroimmunodiffusion<br />
of monoclonal antibodies<br />
use of “gamma-protein index” and free kappa<br />
light chains<br />
(A),904<br />
Electrolytes<br />
in diagnosis of multiple sclerosis<br />
See also specific electrolyte<br />
acty. measurements of Caz,<br />
of interest<br />
Na, K+, and Cl<br />
after equilibrium dial, used to show lack of<br />
evidence for protein interference with Ca<br />
electrodes, 1811<br />
bioL variation in analyte condos, in urine of<br />
apparently healthy men, women (SN), 847<br />
Cl binding to serum proteins (L), 625<br />
comparative measurements for detn. of alkali<br />
ions in blood serum by ion-chromstog. (TB),<br />
617<br />
detn. of inorganic F- in blood with a<br />
selective electrode, 253<br />
alectrochem, detn, of Hb, hematocrit, and<br />
hemohysis (SN), 153<br />
avaln, of NOVA Biomedical Stat Profile 1<br />
analyzer (A), 939<br />
influence of sample preservative on electrolyte,<br />
urea, creetinine, and glucose levels (A), 915<br />
invasive<br />
method<br />
sensors (A), 872<br />
for simultaneously estg. plasma,<br />
erythrocyte, and haukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
variation data, 1326<br />
modn, of intra-erythrocytic homeostasis in<br />
uremic<br />
76<br />
patients, as studied with 31p NMR,<br />
performance characteristics of Beckman<br />
Synchron CX”3 din. system for detn. of Na,<br />
K, Cl, and CO2 (A), 940<br />
performance avaln. of desk-top electrolyte<br />
analyzer designed for doctor’s office and<br />
outpatient clinics(A), 938<br />
pK1’ and bicarbonate concn. in plasma, 13<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
problems of gahstion in detn. of electrolytes in<br />
serum from a patient with IgA myeloms<br />
(TB), 618<br />
quant. datn. of NH4, Na, K, Mg2, Cs2,<br />
and crestinine in human urine by capillary<br />
isotachophorasis (A), 1005<br />
temp.-dapendent results with the ChemPro-<br />
1000 (L), 443<br />
Electron-impact mass spectrometry<br />
total cholesterol in serum dead. by isotope<br />
diln.-mass spectrom., with hiq.-chromatog.<br />
sepn., 1113<br />
Electrophoresis<br />
customized cardiac profile reporting for<br />
isoenzyma alectrophonesis (A), 982<br />
electrophoresis and the isomune-LD and LD-1<br />
immuno methods compared to mess. of<br />
lactate dahydrogenase isoenzyme-1 (SN),<br />
1884<br />
identifying CK-MB and macro-CK by<br />
electrophorasis (L), 1954<br />
lactate dehydrogenssa isoenzyme 1 as dead. by<br />
inhibition with 1,6-hexanediol and by two<br />
other methods in myocardial infarction on<br />
cardiac-bypass surgery (SN), 589<br />
serum M-proteins in B-cell<br />
lymphomas/leukemias by high-resolution<br />
electrophoreais/inimunofixation (A), 904<br />
serum protein ehectrophoreais changes in 4<br />
infants with severe combined<br />
immunodeficiency (A), 1028<br />
Electrophoresis, aff’mity<br />
isoehectrofocusing of serum prostatic acid<br />
phosphatase (A), 927<br />
Ehectrophoresis, agar gel<br />
oligoclonal bands and post--ghobulin in<br />
ehectrophoretograms of CSF (L), 628<br />
Electrophorasis, agarose<br />
detection of isoenzymes associated with drug<br />
resistance or specific chromosomes by<br />
agarose electrophoreais (A), 998<br />
ehectrophoresis and the isomuna-LD and LD-1<br />
immune methods compared to mess. of<br />
lactate dehydnoganase iaoenzyme-1 (SN),<br />
1884<br />
enzyme-amplified immunodetection of<br />
monoclonal proteins in unconcd. body fluids<br />
after immobilization on glyoxyl agaroae (A),<br />
916<br />
isolation of mitochondrial lactate<br />
dehydrogenase (A), 995<br />
lactate dehydrogenase isoenzyme<br />
elactrophoretic assay utilizing kinetic<br />
techniques (A), 991<br />
props. of alk. phosphetase isoenzymes in<br />
plasma of pneterm and term neonates, 1778<br />
rapid typing of serum paraproteins by<br />
immunoblotting without antigen-excess<br />
artifacts (SN), 1433<br />
Electrophoresis, agarose gel<br />
Bence Jones proteinurie in multiple sclerosis<br />
(SN), 1923<br />
evaln. of Isopal system (Analis/Balgium) for<br />
sepn. of alk. phosphatese isoenzymes (A),<br />
958<br />
increased activities of creatine kinase and<br />
lactate dehydrogenase isoenzymes in a<br />
patient with metastatic ovarian tumor (CR),<br />
1484<br />
lactate dehydrogenase-immunolobulin G1<br />
complex, not blocked by anti-idiotype<br />
antibody, in apatient with IgGl-X type Mproteinamis<br />
(CR), 1478<br />
nitroblue tetrazolium staining of serum<br />
fructosamine on agarose gel<br />
electrophoretograms (TB), 1949<br />
sepn. and identn, of alk. phosphatase<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoelactric focusing, 2171<br />
simple sihver-stainin technique for detecting<br />
Bence Jones proteins in unconcd, urine (SN),<br />
561<br />
total absence of serum CK-MM and the<br />
presence of a CK-BB isoenzyme migrating to<br />
CK-MB position on egarose gel<br />
ehectrophoresis (A), 990<br />
use of immunoglobuhin heavy- and ligbt-chain<br />
measurements compared with existing
techniques in typing monoclonal<br />
immunoglobuhins, 1771<br />
Electrophoresis, cellulose acetate<br />
adaptation and evsln, of kinetic color reagent<br />
for electrophonetic visualization of 5’nucheotidase<br />
isoenzymes (A), 957<br />
early diagnosis of acute myocardial infarction<br />
by rapid anal, of creatine kinase isoenzyma-3<br />
(CK-MM) sub-types, 358<br />
electrophoretic aapn. of 5’-nucleotidese by<br />
using a single substrate-color reagent (A),<br />
995<br />
interference by platelets in electrophoretic<br />
detn, of enolsse isoenzymes in plasma (SN),<br />
164<br />
sensitive method for sepn. of hepatomaspecific<br />
gamma-glutamyltransfanase<br />
isoenzymes on cellulose acetate media, using<br />
Tniton-X 100 and concanavahin A (A), 994<br />
source of “intestinal” alk. phosphatase as<br />
observed with cellulose acetate<br />
alectrophoresis re-examined (A), 999<br />
transient hypenphosphatasemia of infancy and<br />
early childhood: chin, and biochem. features<br />
of 21 cases and literature review (CR), 313<br />
underestimation of monoclonal proteins by<br />
serum protein electrophoresis on cellulose<br />
acetate (SN), 182<br />
Ehectrophoresis, gel<br />
identn. of circulating immune complexes by<br />
high-resolution electrophoresis (A), 904<br />
performance of Corning 780 Multitrac<br />
fluorometer/densitometer (A), 943<br />
serum protein elactrophoresis and<br />
immunoglobulin measurements in subjects<br />
at risk for AIDS (A), 1028<br />
Ehectrophoresis, gradient-gel<br />
characteristics of intermediate-density<br />
lipoproteins (A), 896<br />
identn, of hipopnotein(a) by gradient-gal<br />
electrophorasis: relationship to coronary<br />
artery disease (A), 897<br />
Electrophoresis, high-voltage<br />
early dianosis of acute myocardial infarction<br />
by rapid anal. of creatine kinase isoenzyme-3<br />
(CK-MM) sub-types, 358<br />
Ehectrophoresis, polyacrylamide gel<br />
See also Electrophoresis, two-dimensional<br />
electrophoresis indicates protein loss on<br />
centnifn, of whole saliva (TB), 1263<br />
evidence that human, rabbit, and bovine<br />
crestine kinase isoenzymes are glycoproteins<br />
(A), 991<br />
high-density alphaz-hipoproteins: isolation and<br />
ehectrophoretic anal. (A), 896<br />
prope. of alk. phosphatase isoenxymes in<br />
plasma ofpraterm and term neonates, 1778<br />
simplified SDS-PAGE of unconcd, urine with<br />
enhanced resolution and detection<br />
sensitivity (SN), 1886<br />
value of polyacrylamide gradient gel<br />
ehectrophoresis of lipoproteins for<br />
determining HDL cholesterol (TB), 1266<br />
Electrophoresis, two-dimensional<br />
evain, of hipoproteins and apolipoproteins in<br />
serum of a Tangier patient by micro-scale 2-<br />
D electrophoresis, 468<br />
examn, of heart proteins by 2-D<br />
ehectnophoresis, 2011<br />
pitfall in anal, of proteins synthesized by sweat<br />
glands from patients with cystic fibrosis by<br />
two-dimensional gel electrophoresis and<br />
double-label autoradiography (TB), 2310<br />
plasma spohipoproteins in Tangier disease, as<br />
studied with 2-D electrophoresia (SN), 120<br />
Electrophoresis, zone<br />
stability of model immune complexes during<br />
zone elactrophorasis and isoelectnic focusing<br />
in agarose gals, 1741<br />
Emergency procedure<br />
anal, performance of the Eppendonf “Easy<br />
6160” analyzer (TB), 1072<br />
enzymic assay for the specific detn. of<br />
methanol in serum, 2204<br />
role of qush. choniogonadotropin assays in<br />
diagnosis of ectopic pregnancy (SN), 1908<br />
EMIT<br />
See Enzyme immunoassay<br />
Encephalopathy<br />
quantn. of desferriozamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
Energy-dispersive x-ray fluorescence<br />
simultaneous detn. of trace elements in havage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence. 3. routine<br />
anal., 2234<br />
Energy metabolism<br />
nonestenified and acylcarnitine in<br />
polymorphonuclear leukocytes and<br />
mononuclear cells, 533<br />
Enolase<br />
enzyme immunoassay for detection of‘enolase<br />
in serum (A), 928<br />
interference by platelets in elactrophoretic<br />
deth. ofenolase isoenzymes in plasma (SN),<br />
164<br />
neuron-specific enolase as a tumor marker (A),<br />
928<br />
postsynthetic modn. of enohase isoenzymea, 757<br />
Environmental hazards<br />
chem, exposure: from basic science to govt.<br />
negulation-methylene chloride (A), 878<br />
common-sense approaches to evaluating<br />
individual health problems of humans<br />
exposed to man-made organic biohazerds<br />
(A), 878<br />
optimized liq.-chromatog, method for<br />
fluorometry of urinary i-aminolevuhinic acid<br />
in workers exposed to Pb (SN), 1667<br />
toxicol, of biohezards (A), 877<br />
Enzyme activity<br />
automated detn. of angiotenain-converting<br />
enzyme in serum (SN), 1248<br />
characterization and assay of tartrate-resistant<br />
acid phosphatese acty. in serum: potential<br />
use to assess bone resorption, 458<br />
detn, by RIA of the mass of lactate<br />
dehydrogenase iaoenzyme I in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
differential assay of salivary, pancreatic aamyhase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
amylsse immobilized on bacterial cell wall<br />
(SN), 1235<br />
disulfiram (Antabusa) inhibits alcohol<br />
dahydnogenasa acty. (SN), 1906<br />
effect of two anticoagulants on leukocyte yield,<br />
function and lysosomal enzyme acty. (A), 915<br />
evaln, of Coulter CPA chem. analyzer with<br />
Dart enzyme reagents (A), 942<br />
avaln, of 5 enzyme methods on the Spirit<br />
analyzer (A), 945<br />
math, treatment of data for calculatin&<br />
activities of a-amylase isoenzymes (SN), 689<br />
mess. of 6 enzymes with the Kodak DTSC<br />
module, a physician’s office analyzer (SN),<br />
1911<br />
measurement of liver enzymes by Reflotnon<br />
and Vision for blood-donor screening (A),<br />
945<br />
performance of six enzyme assays in the<br />
Technicon Chem I’ system (TB), 723<br />
prodn, and certifn, of an enzyme ref. material<br />
for ‘y-glutamyltransfarase (CRM 319). part 1:<br />
prepn. and characterization, 1971<br />
sensitive assay with 1,2-diglyceride as substrate<br />
for pancreatic lipase in serum (A), 962<br />
temp,-conversion factors for enzyme activities<br />
in commercial control sara (L), 200<br />
enzyme immunoassay<br />
accelerated enzyme immunoasasy for<br />
choniogonadotropin in urine, involving reflow<br />
of specimen through capillary tubes, 498<br />
adaptation and evaln. of CEDIA’TMdigoxin on<br />
Coulter Dacos chem. analyzer (A), 1014<br />
adaptation of Auszyme monoclonal test for<br />
detection of hepatitis B surface antigen to<br />
Encore’s centrif, analyzer (A), 906<br />
adaptation of Syva caffeine EMIT reagents to<br />
Baker Encore System 11(A), 1023<br />
sffinity-chromsto. isolation of lowsubstitution<br />
ratio conjugates and their<br />
performance in phenobarbitah enzyme<br />
immunoassays (A), 923<br />
spphicn. of chromium dioxide magnetic<br />
particles to immunoassays (A), 920<br />
epphicn. of EMIT amphetamine drug of abuse<br />
assay to the ETh system (A), 975<br />
applicn. of EMIT cannabinoid 20 ng and 100 ng<br />
drugs of abuse (d.s.u.) assays to the ETS<br />
system (A), 971<br />
applicn. of EMIT drugs of abuse assays to the<br />
ETS system (A), 975<br />
applicn. of EMIT quant. tnicyclic antidepressant<br />
essays to Encore’ centrifugal analyzer (A),<br />
1024<br />
applicn, of EMIT quant. tricydlic<br />
antidepressant assays to Hitachi 705 chem.<br />
analyzer (A), 1024<br />
apphicns. for homogeneous enzyme<br />
immunoaasay for measurement of serum on<br />
plasma thyroid hormone uptake (A), 886<br />
assay design influence on ES-600 performances<br />
(A),946<br />
automated and manual quant. assays of<br />
choriogonadotropin in serum compared<br />
(SN), 167<br />
automated fluorescent enzyme immunoassay<br />
for detn. of human alpha-fetoprotein (A),<br />
919<br />
automated hCG assay: a rapid, quant. enzyme<br />
immunoassay (A), 888<br />
automated, microparticle-based fluorimetnic<br />
enzyme immunoassay for CEA in human<br />
serum end plasma (A), 920<br />
automated quantn. of choniogonadotropin:<br />
anal. correlation between serum and urine<br />
with craatinine correction (SN), 1424<br />
automated solid-phase enzyme immunoassay<br />
for measuring thyroxin (A), 883<br />
din. avaln. and performance characteristics of<br />
enzyme immunoassay for CA 125 (A), 931<br />
chin, evaln. of Corzyme-M (nDNA) and<br />
Corab-M (nDNA) (A), 1031<br />
comparison of51Cr-RBC and Hemoccult<br />
method for gastrointestinal blood loss with a<br />
monoclonal antibody method for detecting<br />
Hb in stool (A), 1001<br />
comparison of enzyme immunoassay and RIA<br />
for cancer antigen 125 (CA 125) (A), 931<br />
comparison of ES 600 automated enzyme<br />
immunoassay system with Stratus<br />
immunofluorometry and manual RIA (A),<br />
947<br />
comparison of 8 immunoassay procedures for<br />
fernitin in human serum (A), 958<br />
comparison of Roche RIA, Roche EtA, and<br />
Hybnitech EtA methods for CEA (A), 924<br />
comparison of two digoxin immunoassays using<br />
a Cobas Bio with Kallestadt EtA (A), 1014<br />
competitive EtA for urinary albumin (A), 979<br />
convenient enzyme immunoessay system for<br />
detection of drugs of abuse: morphine in<br />
urine (A), 970<br />
convenient enzyme immunoessay s’stem for<br />
detection of drugs of abuse: cocaine<br />
metabohite (benzoylecgonine) in urine (A),<br />
971<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: cannabinoids in<br />
urine (A), 972<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: barbiturates in<br />
urine (A), 973<br />
cost-effective EMIT d.a.u, assay with improved<br />
sensitivity (A), 976<br />
cost-effective optimization of EMIT<br />
theophylhine assay for Technicon RA-1000<br />
analyzer (A), 1023<br />
development of rapid nonradioactive assay for<br />
digoxin based on enhanced luminescence<br />
(A), 1015<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
drugs-of-abuse screen for the Analyst’ (A),<br />
976<br />
endogenous digoxin-hike immunoreactive<br />
factors eliminated from serum samples by<br />
hydrophobic silica-gel extraction and<br />
enzyme immunoassay, 401<br />
endogenous digoxin-hike immunoreactive<br />
substances eliminated from serum samples<br />
from patients with liver disease by the EMIT<br />
column digoxin assay (L), 1490<br />
enzyme immunoassay for detection of ‘yenolase<br />
in serum (A) 928<br />
enzyme immunoassay br datn, of human<br />
luteinizing hormone in serum (A), 891<br />
enzyme immunoassay for simultaneous mess.<br />
of sutoantibodies against thyroglobuhin and<br />
thyroid microsome in serum (SN), 2286<br />
enzyme immunoassay method for<br />
comprehensive drug screening in microsamples<br />
of urine, 367<br />
enzyme immunoassay of angiotensin I and<br />
nenin, 1774<br />
enzyme immunoasaay of free triiodothyronine<br />
in serum (SN), 172<br />
enzyme immunoassays compared for detection<br />
of antibodies to toxoplasmosis, rubella,<br />
cytomegale, and chhamydia (A), 924<br />
enzyme-linked immunosorbent essay for 17ahydroxyprogesterone<br />
in dried blood spotted<br />
on filter paper, 761<br />
evahn, of CEDIAN digoxin immunoassay on<br />
Cobas-Bio analyzer (A), 955<br />
evaln, of EMIT-chlorampheflicol essay in a<br />
pediatric hosp. (A), 1021<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2375
evaln. of enzyme immunoassay method for<br />
HCG in serum (TB), 1256<br />
evahn. of Enzymun-Test AF’P end CEA on the<br />
Enzymun-test system ES-600 (A), 925<br />
evaln. of fernitin enzyme immunoassay based<br />
on monochonal antibodies (A), 958<br />
evahn. of lipase enzyme immunosssay (EIA) kit<br />
based on monoclonal antibodies (A), 996<br />
evaln. of monoclonal antibody-based enzyme<br />
immunoassay for detection of hepatitis B<br />
infection (A), 959<br />
evsln. of new low-cost test pack for beta-hCG<br />
(A),889<br />
experiences with synthesized peptides gp4l<br />
and p24 in HIV antibodies assay kit (A), 905<br />
false-positive EMIT’ D.A.U. phencyclidine<br />
assay as a result of an overdose of<br />
dextromethorphan (A), 974<br />
fluorescence enzyme immunoassay for<br />
allergen-specific IgG4 (A), 918<br />
fluorescence polarn. immunoassay evald. for<br />
screening for amphetamine and<br />
methamphetamine in urine (SN), 1200<br />
four immunoassay methods and stds.<br />
compared for measuring fibronectin (SN),<br />
126<br />
four methods compared for measuring descanboxy-prothrombin<br />
(PIvKA.lI) (SN), 2074<br />
fully self-contained enzyme immunoassay kit<br />
for detecting hCC (A), 959<br />
generation and epitope analysis of TSHspecific<br />
monochonal antibodies for enzyme<br />
immunoassays (A), 882<br />
high incidence of false-positive enzyme<br />
immunoaasay for antibodies to HIV in<br />
patients with renal failure (A), 1029<br />
highly sensitive enzyme-linked immunosorbent<br />
assay of human C-reactive protein in cord<br />
blood sara (A), 919<br />
immunoassay of estrogen and progesterone<br />
receptors in human breast cancer (A), 959<br />
immunolog. capture of nucleic acid hybrids,<br />
apphn. to nonradioactive DNA probe assay<br />
(5), 1526<br />
improved enzyme immunoassay for factor<br />
VIlI-rehated antigen (von Wihlebrand factor<br />
antigen) (TB), 1935<br />
improved labels for use in digoxin multilayer<br />
enzyme immunoassays (A), 923<br />
latex-agglutn. essay for D dimer: evaln. and<br />
appln. to diagnosis of thrombotic disease,<br />
1837<br />
Magiwel’TM enzyme immunoassay for CEA and<br />
AFP using microtiter wells as solid phase<br />
(A), 925<br />
measuring sex-hormone-binding globulin by<br />
enhanced luminescence (A), 921<br />
micropanticle-capture membranes: appin. to<br />
TestPack hCG-unine (A), 1567<br />
noninstrumented enzyme immunochrometog.<br />
assay for quantn. of carbamazepine in whole<br />
blood (A), 1019<br />
nortriptyline monoclonal antibody for quantn.<br />
of nortriptylina in serum (A), 1024<br />
one-step enzyme immunoassay for free<br />
thyroxin (A), 884<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
performance of totally automated enzyme<br />
immunoessay system (ES-600) (A), 947<br />
potential of monoclonal antibodies to improve<br />
therapeutic monitoring of cyclosporine, 32<br />
preparation and evaln. of in-lab. EMIT<br />
calibrator for drugs of abuse assay (A), 976<br />
radial partition fluorometric enzyme<br />
immunoassay for detection of hepatitis B<br />
surface antigen with the Stratus’ analyzer<br />
(A),906<br />
radial partition immunoassay: monitoring<br />
digitoxin in serum and plasma (A), 1015<br />
rapid enzyme immunoassay for detection of<br />
urinary human luteinizing hormone (A), 921<br />
rapid solid-phase enzyme immunoessay of<br />
serum fenritin using thermo-kinetic<br />
enhancement (A), 947<br />
reassessment of creatine kinsse BB as a marker<br />
for cancer of prostate, breast, end lung (SN),<br />
809<br />
receptor-antibody “sandwich” assay for<br />
teicoplenin, 1615<br />
removal of interference by immunoglobuhins in<br />
an enzyme-amplified immunoassay for<br />
thyrotropin in serum (TB), 414<br />
role of qual. choriogonadotropin assays in<br />
diagnosis of ectopic pregnancy (SN), 1908<br />
sensitive, automated, nonisotopic enzyme<br />
2376 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
immunosssay for detn. of digoxin (A), 1014<br />
simple, direct coated-tube enzyme<br />
immunoassay of cortisol in serum (TB), 422<br />
simplification and standardization of IgG<br />
subclass quantn. by using monoclonal<br />
antibodies in an enzyme immunoassay (A),<br />
917<br />
solid-phase enzyme immunoassay of terminal<br />
deoxynucleotidyl transferase evald. (SN),<br />
293<br />
solid-phase non-isotopic immunoassay for<br />
quantn. of free thyroxin in serum (A), 884<br />
storage stability of urine THC as measured by<br />
EMIT urine cannabinoid assay (A), 972<br />
strategy for benzoylacgonine testing:<br />
confirmation by TLC/HPLC (A), 971<br />
Stratus fluorometnic enzyme immunoasaay<br />
system evaluated for detn. of total thynoxin<br />
(A),883<br />
studies of alpha-fetoprotein in ascitic fluid of<br />
hepatoma-bearing patients (A), 925<br />
use of liposome encapsulation in a combined<br />
single-liq. reagent for homogeneous enzyme<br />
immunoassay (5), 1579<br />
Enzyme immunochromatographic assay<br />
internal clock reaction used in one-step enzyme<br />
immunochromatog. sssay of thaophylline in<br />
blood (S), 1521<br />
Enzyme-immunoglobulin complexes<br />
total absence of serum CK-MM and the<br />
presence of a CK-BB isoenzyme migrating to<br />
CK-MB position on agarose gel<br />
electrophoresis (A), 990<br />
Enzyme inhibition assay<br />
applcn. of stable, chromogenic serum alphaamylase<br />
reagent to various din. cham.<br />
analyzers (A), 996<br />
chem. synthesis, hypocholesterolemic acty. and<br />
hydroxymethylglut.aryl-CoA reductase<br />
inhibition of two oxysterols (A), 1035<br />
detn. of angiotensin-convarting enzyme acty. in<br />
vitro: dose-response study in human and dog<br />
serum (A), 893<br />
differential assay of salivary, pancreatic aamyhase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
amyhase immobilized on bacterial cell wall<br />
(SN), 1235<br />
enzyme immuno-inhibition assay for<br />
theophylline on Abbott Vision system (A),<br />
1022<br />
lactate dehydrogenase isoenzyme 1 detd. by<br />
inhibition with 1,6-hexenediol (A), 992<br />
selective detn. of lactate dehydrogenase<br />
isosnzyma 1 by using NsClO4 (A), 991<br />
Enzyme inhibition immunoassay<br />
automated detn. of CK-MB isoenzyme with<br />
Coulter CPA (A), 943<br />
Enzyme kinetics<br />
detn. by RIA of the mass of lactate<br />
dehydroganase isoenzyme I in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
isoforms of creatine kinase isoenzymes in<br />
serum in acute myocard. infarct after<br />
intracoronary thrombolysis, 2039<br />
Enzyme-labeled immunosorbent assay<br />
See Enzyme immunoassay<br />
Enzyme-linked immunosorbent assay<br />
cohonimetnic enzyme immunoassay with latex<br />
particles as a solid-phase reagent (A), 1572<br />
enzyme-linked immunosorbent assay for<br />
urinary albumin at low concns. (SN), 609<br />
enzyme-linked immunosorbent asaay of serum<br />
argininosuccinate synthetase (TB), 1941<br />
high-performance immobn. membrane for<br />
diagnostic immunoassays (A), 1568<br />
kinetic ELISA in microtiter plates (A), 1573<br />
monoclonal antibody-based enzyme-linked<br />
immunosorbent assay of a1-acid glycoprotein<br />
(SN), 2275<br />
peptide moieties and adhesion of antigenic<br />
msnnans of Candida albicans to the plastic<br />
microtiter plate in enzyme-linked<br />
immunosorbent essay (SN), 1925<br />
prehiin. chin, studies of C-reactive protein<br />
quantified by enzyme-linked immunoassay,<br />
2185<br />
quantn. of two different types of<br />
apohipoprotein A-i containing lipoprotein<br />
particles in plasma by enzyme-linked<br />
differential-antibody immunosorbent assay,<br />
38<br />
using whole bacteria, lipopolysaccharide, and<br />
sol, antigens to detect IgG, 1gM, and IgA in<br />
brucellosis by Dot-ELISA with nitnocalluose<br />
as solid phase (A), 1570<br />
Enzyme-multiplied immunoassay<br />
See Enzyme<br />
Enzymes<br />
immunoassay<br />
Flauobacterium and Sphingobacterium<br />
species: enzyme profiles compared by use of<br />
pattern recognition of two-dimensional<br />
fluorescence data, 377<br />
Enzymic assay<br />
enzymic ethanol essay: colorimetnic method<br />
based on mess. of H202, 486<br />
validation and appln. of a liq.chromstog./enzymic<br />
assay for individual<br />
acids in rat serum, 1856<br />
bile<br />
Enzymic methods<br />
accuracy of three triglycerides methods on<br />
Technicon RA-l000’ (A), 900<br />
essay of serum methanol and ethylene glycol<br />
with yeast alcohol dehydrogenase (A), 968<br />
automated enzymatic measurement of lecithin,<br />
sphingomyahin, and phosphatidylghycarol in<br />
amniotic fluid, 81<br />
automated enzymatic method for oxalate in<br />
urine (TB), 1076<br />
bias among enzymatic methods for cholesterol<br />
(A), 894<br />
bias and precision of cholesterol anal. by<br />
physician’s office analyzers (SN), 2262<br />
bihirubin and free glycerol interferences in<br />
GPO Trinder triglyceride assays using RA-<br />
1000 (A), 899<br />
centrifugal anal, for urinary citrate with the IL<br />
Multistat analyzer (A), 1009<br />
colonimatric, anzymic methods compared for<br />
essay of citrate in urine (TB), 1074<br />
comparison of ascorbic acid interference in<br />
HDL-cholesteroh estn. by six pptn. methods<br />
with use of a sensitive enzymic cholesterol<br />
reagent (TB), 1467<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in serum<br />
(SN), 2296<br />
concns. of supenoxide dismutase and<br />
superoxide<br />
respiratory<br />
anion in blood of patients with<br />
infections, compromised immune<br />
systems, 2230<br />
dath. of conjugated and total bilirubin in serum<br />
of neonates,<br />
1822<br />
with use of bihirubin oxidase,<br />
development<br />
enzymatic<br />
and field performance of<br />
creatinine method for Analyst”<br />
physician’s office profiler (A), 949<br />
direct bihirubin measured<br />
oxidase, 1349<br />
effects of a-ketobutyrete<br />
by use of bihirubin<br />
and ahydroxybutyrate<br />
on the enzymatic dath. of<br />
acatoacetate, -hydroxybutyrate (TB), 1469<br />
enzymatic assay for bilirubin using uridine<br />
diphosphate<br />
1013<br />
glucuronosyltransferase (A),<br />
enzymatic<br />
312<br />
calorimetric assay of inorganic P04,<br />
enzymatic<br />
systems<br />
enzymatic<br />
enzymatic<br />
CO2 method for Technicon RA”‘<br />
(A), 1009<br />
detn, of mum (TB), 1070<br />
measurement of sialic acid in serum<br />
by Hitachi 736 analyzer and applicn. for<br />
maker of acute-phase reactants (A), 1011<br />
anzymic assay for the specific<br />
methanol in serum, 2204<br />
datn. of<br />
enzymic method for acetaminophen adapted to<br />
an Abbott ABA-200 analyzer (TB), 612<br />
enzym#{243}matric assay for vit. B12 with magnetic<br />
particles as solid support (A), 963<br />
evaln. of enzymatic reagent system for serum<br />
Mg on Alpkem’ Chinalyzer”‘ (A), 1006<br />
evain. of liquid BUN reagent for Abbott<br />
Spectrum and VP analyzers (A), 951<br />
avain. of quant. enzymatic essay for<br />
phosphatidyhghycerol in amniotic fluid (A),<br />
900<br />
extension of Abbott Spectrum’ HCO3 reagent<br />
stability (A), 1008<br />
HDL cholesterol on the Reflotron’ system (A),<br />
895<br />
interference from immunoglobulins in Hitachi<br />
737 endpoint urease method for BUN (A),<br />
1010<br />
liquid, stable alpha-amylase reagent for Abbott<br />
Vision”‘ system (A), 996<br />
manual enzymic assay of non-esterified fatty<br />
acids adapted toa centnif. analyzer (TB),<br />
1073<br />
measurement of glucose in serum by<br />
hexokinase method with Ames seralyzer (A),<br />
1011<br />
measurement of uric acid in urine on Kodak<br />
Ektachem 700(A), 966
method to assay serum concns. of total bile<br />
acids by using a sensitive chromogen<br />
(BAHM) (A), 1013<br />
more sensitive direct ozalate oxidase assay of<br />
urinary<br />
multilab.<br />
oxelate (SN), 1931<br />
eveln. of single-slide enzymatic<br />
cneatinine method on Kodak Ektachem<br />
analyzer (A), 951<br />
new enzymic detn. of guanidinoacetic<br />
urine, 394<br />
acid in<br />
office-testing systems: cholesterol<br />
triglycerides (A), 948<br />
and<br />
performance of sensitive color reagent for<br />
enzymatic datn. of uric acid (A), 956<br />
precision of glucose measurements in control<br />
sena by isotope diln./msss spectrom.:<br />
proposed Definitive Method compared with<br />
a Reference Method, 1397<br />
rapid enzymatic assay of flucytosine in serum<br />
with a centrifugal analyzer (A), 1022<br />
rapid ultraviohet-spectrophotom. method<br />
detn. of serum guanase scty. (A), 995<br />
for<br />
screening for cerebrotendinous xsnthomatosis<br />
by enzymatic assay for 7a-hydroxylated<br />
steroids in urine (SN), 142<br />
sepn. and identn. of elk, phosphatase<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoehectnic focusing,<br />
Enzynioimmunoassay<br />
2171<br />
See Enzyme immunoassay<br />
Epilepsy<br />
See also Anticonvulsant drugs<br />
Equilibrium dialysis<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
deth, of free digoxin concns. in serum for<br />
monitoring Feb treatment of digoxin<br />
overdose (SN), 1652<br />
enzyme immunoassay of free triiodothyronine<br />
in serum (SN), 172<br />
free thyroxin estn. by analog assays with chem.<br />
blockers (A), 884<br />
on albumin-dependence of measurements of<br />
free thyroxin. II. non-thyroidal illness, 87<br />
two-step RIA for free triiodothyronine in<br />
serum, 372<br />
Ergocalciferol<br />
detection of bromocniptine-like substances in<br />
urine<br />
Errata<br />
of an infant on soy formula (TB), 414<br />
See Corrections<br />
Erythrocytes<br />
alternative explanation for changes in<br />
enythrocyte fatty acids in diabetes (SN),<br />
2083<br />
detg. Me-Hb in blood by zero-crossing-point<br />
first-deny. spectrophotometry, 1767<br />
detn. of inorganic F- in blood with a<br />
selective electrode, 253<br />
effect of gosaypol on the activity of anythrocyte<br />
Ns-K ATPase acty. in vitro (TB), 309<br />
enzymic glycation may decrease acty. of<br />
erythrocytic #{244}-sminohevuhinate dehydratase<br />
in diabetes, 1807<br />
anythrocytic ghucose-6-phosphste<br />
dehydrogenase measured by differential<br />
(SN), 579<br />
immobilized purified folate-binding protein<br />
binding characteristics and use for<br />
pH<br />
quantifying folate in erythrocytes, 1360<br />
indirect vs direct measurement of Mg and Zn<br />
in arythrocytes, 529<br />
mess. of acetyhcholinesterase in erythrocytes<br />
the field, 1731<br />
method for simultaneously estg. plasma,<br />
erythrocyte, and leukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
in<br />
variation data, 1326<br />
method of isolating arythrocytes influences<br />
their measured<br />
1081<br />
pohyamine content (TB),<br />
modn. of intrs-erythrocytic homeoetasis in<br />
uremic patients, as studied with 3’P NMR,<br />
76<br />
nonestenified and acylcarnitine in<br />
polymorphonuchear heukocytes and<br />
mononuclear cells, 533<br />
normal range ofNs influx in erythrocytes<br />
from black males and females (A), 1004<br />
optimized at. absorp. spectrophotom. of Ca in<br />
erythrocytes, 2004<br />
plasma, erythrocyte, and urinary Zn in<br />
critically ill pstients effect of intravenous Zn<br />
therapy (A), 933<br />
31p nuclear NMR study of variations in intra-<br />
erythrocytic ATP concn. and pH induced by<br />
surgical trauma (SN), 2284<br />
predictor of plasma cychosporine concn. at 37<br />
“C from whole-blood concns. at room temp.<br />
(A), 979<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
renal differentiated from non-renal hematuria<br />
by micros. ezamn. of erythnocytes in urine,<br />
1791<br />
Se and vit, E relationship in malnourished<br />
children before and during parenteral<br />
supplementation (A), 934<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinsse concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
temp.-dependent binding of cyclosponine to an<br />
erythrocyte protein, 481<br />
temp-dependent distribution of cyclosporine<br />
metabohites amongst cells/plasma in whole<br />
blood (A), 979<br />
Esterase<br />
low A-esterase acty. in serum in fish-eye<br />
disease (SN), 587<br />
Estradiol<br />
discrepancies in plasma estrediol values with<br />
commercial kits (TB), 1672<br />
mass, of serum estradiol: comparison of three<br />
“direct” RIAs and effects of org. solvent<br />
extn. (TB), 1946<br />
plasma estradiol concns. in neonates (TB),<br />
1934<br />
Estrogen receptors<br />
estrogen receptor degradation: common cause<br />
of nonlinear Scatchard plots (A), 929<br />
protein recognition of immobilized higands:<br />
promotion of selective adsorption (5), 1502<br />
Estrogens<br />
See also specific estrogen of interest<br />
Ethanol<br />
See also Alcohol<br />
comparison of whole blood, plasma, and serum<br />
ethanol levels-legal interpretation? (A), 968<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in senum<br />
(SN), 2296<br />
concerning accuracy and precision of breathalcohol<br />
measurements (0), 1701<br />
enzymic ethanol assay: colorimetric method<br />
based on mess, of H202, 486<br />
gas-chromatog. detn. of ethanol in blood with<br />
0,53-mm fused-silica open tubular columns<br />
(SN), 2094<br />
involvement of hormones in ethanol metab.<br />
(A), 1059<br />
performance characteristics of Ca, Mg, alcohol,<br />
and HCO3 reagents in the EASY analyzer<br />
(A), 944<br />
reinvestigation of Widmark’s method for<br />
quant. evaln. of blood-ethanol profiles:<br />
influence of alcohol dose and mode of<br />
drinking (TB), 1469<br />
relationship of blood alcohol and morphine<br />
levels in heroin deaths (A), 969<br />
results compared for LD and alcohol anal, with<br />
EM Diagnostics Systems testpacks in Du<br />
Pont aca Ill (A), 949<br />
results of breath-alcohol analyses on two<br />
consecutive samples (A), 968<br />
Ethylene glycol<br />
assay of serum methanol and ethylene glycol<br />
with yeast alcohol dehydrogenase (A), 968<br />
lack of interference of<br />
tnis(hydroxymethyl)methylamine with the<br />
detn, of volatile alcohols or ethylene glycol in<br />
serum by capillary gas chromatog. (L), 2324<br />
Etoposide<br />
improved assay for etoposide in plasma by<br />
radial-compression hiq. chromatog. with<br />
electrochem. detection, 803<br />
interference of the chemotharepeutic agent<br />
etoposide with the direct phosphotungstic<br />
acid method for uric acid (CR), 2109<br />
Euglobulin<br />
method for serum CIq based on its<br />
hydroxyproline content, 398<br />
Europium labels<br />
Eu and Sm as labels in time-resolved<br />
immunofluonometric assay of follitropin, 48<br />
mess. of corticotropin in unextracted plasma:<br />
time-resolved immunofluorometnic assay<br />
and immunoradiometric essay compared<br />
with use of same monoclonal antibodies,<br />
1747<br />
Exercise, effects of<br />
mild exercise improves cardiovascular risk<br />
factors in obese pubescent children (A), 1030<br />
Factor XIII<br />
investigation ofcongenitel factor XIII<br />
deficiency and of the carrier state by<br />
immunofixation (A), 1003<br />
Fat agglutination slide test<br />
fat agglutination slide test for increased<br />
concns. of C-reactive protein in serum<br />
compared with results by laser nephelometry<br />
(TB), 2301<br />
Fatty acid deficiency<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-hiq. chromatog., 1869<br />
Fatty acids<br />
See also Lipids, Tniacylglycerols, Triglycerides<br />
alternative explanation for changes in<br />
erythrocyte fatty acids in diabetes (SN),<br />
2083<br />
concns, of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-liq. chromstog., 1869<br />
effect of free fatty acids and nonlipid inhibitors<br />
of thyroid hormone binding in the<br />
immunoradiometric assay of thyroxinbinding<br />
globulin, 1752<br />
estg. fat in feces by near-infrared reflectance<br />
spectroscopy, 502<br />
improved Ni radiochem. assay of free fatty<br />
acids in plasma (SN), 176<br />
manual enzymic assay of non-esterified fatty<br />
acids adapted to a centnif. analyzer (TB),<br />
1073<br />
Faces<br />
comparison of 51Cr-RBC and Hemoccult<br />
method for gastrointestinal blood loss with a<br />
monochonal antibody method for detecting<br />
Hb in stool (A), 1001<br />
estg. fat in feces by near-infrared reflectance<br />
spectroscopy, 502<br />
immunolog. capture of nucleic acid hybrids,<br />
apphn. to nonradioective DNA probe assay<br />
(5), 1526<br />
patterns of porphyrin excretion in feces as<br />
detd. by liq. chromatog.; ref. values and<br />
effect of flora suppression, 2164<br />
Federal regulations<br />
lab. performance and regulatory requirements<br />
(SR), 1087<br />
Ferritin<br />
comparison of 8 immunoassay procedures for<br />
ferritin in human serum (A), 958<br />
comparison of RIA and enzyme immunoassay<br />
measurement of fernitin concn, in pre- and<br />
post-menopausal females (A), 1032<br />
cord transfernin and fennitin in newborn infants<br />
with uteroplacental insufficiency (A), 1030<br />
development of rapid nonradiosctive<br />
immunoassay for fennitin based on enhanced<br />
luminescence (A), 906<br />
evaln. of ferritin enzyme immunoaasay based<br />
on monoclonal antibodies (A), 958<br />
investigations on “hook effect” by using<br />
monoclonal antibodies against human<br />
ferritin (A), 936<br />
nonenzymstic glycation of immunoglobuhins<br />
does not impair antigen-antibody binding<br />
(SN), 692<br />
nonisotopic immunoenzymetric assay for<br />
serum fernitin (A), 936<br />
rapid solid-phase enzyme immunosssay of<br />
serum ferritin using thermo-kinetic<br />
enhancement (A), 947<br />
ref. values for Fe, TIBC, and fennitin in a<br />
baboon colony (Papio species) (A), 1036<br />
sensitive fluoroimmunoeaaays for ferritin and<br />
IgE (A), 1563<br />
Fertility<br />
kinetic immunonephelometnic detn. of protein<br />
concns. in follicular fluid, 1185<br />
Fertility studies<br />
See also Infertility<br />
Fetal status<br />
See also Amniotic fluid,<br />
Lecithin/sphingomyelin ratio, etc.<br />
assay of disaturated phosphatidylchohine in<br />
amniotic fluid as a test of fetal lung<br />
maturity: experience with 2000 analyses<br />
(SN), 1648<br />
automated enzymatic measurement of lecithin,<br />
sphingomyelin, and phosphatidylglycerol in<br />
amniotic fluid, 81<br />
calibrated fluorescence polarization assay for<br />
assessment of fetal lung maturity, 1177<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2377
cost-effective screening of amniotic fluids for<br />
phosphatidylglycerol before the Amniostet-<br />
FLN procedure (TB), 715<br />
currant methods for antenatal assessment of<br />
fatal hung maturity (A), 1060<br />
emergency test for fetal lung maturity: OD 650<br />
or Amniostat-FLM? (TB), 2123<br />
evalg. the din, effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
evaln. of fetal lung maturity by a fluorescence<br />
polarization method and comparison with<br />
L/S ratio (A), 901<br />
modified lemellar body phosphohipid assay<br />
compared with L/S ratio and<br />
phosphatidylglycerol assay for assessment of<br />
fetal pulmonary status, 24<br />
placental transfer of drugs (A), 1028<br />
prospective clinical evaln, of an improved<br />
fluorescence polarization assay for predicting<br />
fetal lung maturity (SN), 554<br />
screening with glycated Hb for gestational<br />
diabetic-associated macrosomia (A), 1001<br />
Fetoprotein<br />
alphs-fetoprotein and estrogen/progeatin<br />
receptors in breast cancer patients (A), 929<br />
alpha-fetoprotein concns. in serum of healthy<br />
males and females (A), 925<br />
automated fluorescent enzyme immunoessay<br />
for deth. of human alpha-fetoprotein (A),<br />
919<br />
automation of Abbott’s AFP on the Baker<br />
Procore”‘/Encore”‘ system (A), 919<br />
comparison of Abbott monoclonal and<br />
pohyclonal AFP-EIA assays as serum tumor<br />
markers (A), 926<br />
computer-assisted evaln, and implementation<br />
of an alpha-fetopnotein assay (A), 925<br />
development of simple fluorescence<br />
immunoassay for alphe-fetoprotein (A), 919<br />
double-monoclonal immunoenzymometnic<br />
assay for alphai-fetopnotein modified for<br />
increased anal. precision (SN), 583<br />
(A), 926<br />
evaln. of Enzymun-Test AFP and CEA on the<br />
Enzymun-test system ES-600 (A), 925<br />
Magwal”‘ enzyme immunoassay for CEA and<br />
AFP using microtiter wells as solid phase<br />
(A), 925<br />
maternal alpha-fatopnotein testing (A), 1060<br />
rapid quantn. of shpha-fetoprotein in serum<br />
with a latex photometric immunoassay<br />
system (TB), 2306<br />
studies of alphe-fetoprotein in ascitic fluid of<br />
hepatoma-bearing patients (A), 925<br />
time-resolved fluoroimmunoassay for datn. of<br />
alpha-fetoprotein in serum (A), 919<br />
time-resolved immunofluorometny of alphafatoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
Fiber optic sensors<br />
development of fiber optic cham. sensors for<br />
biomolecules (A), 1061<br />
extrecorponeal, tissue, and transcutaneous<br />
monitoring (A), 872<br />
invasive sensors (A), 872<br />
optical response immunosensors-instant,<br />
quant. immunoassay technol. for chin,<br />
diagnosis (A), 1061<br />
performance of an in-vivo, continuous bloodas<br />
monitor with disposable probe (5), 1538<br />
Fibrin<br />
latex-agglutn, assay for D dimer: avain. and<br />
appln. to diagnosis of thrombotic disease,<br />
1837<br />
Fibrinogen<br />
kinetic detn. of fibninogen with a random<br />
access analyzer (TB), 420<br />
kinetic immunonephelometnic detn. of protein<br />
concns. in folhicular fluid, 1185<br />
Fibrinolysis<br />
anal. of fibninogenolysis/fibninolysis in patients<br />
with chronic liver disease (A), 1004<br />
Fibroblasts<br />
use of Nile red in detecting cholesteryl ester<br />
accumulation in acid-hipase-deficiant<br />
fibroblssta (A), 895<br />
Flbronectin<br />
See also Prealbumin<br />
four immunoassay methods and stda.<br />
compared for measuring fibnonectin (SN),<br />
126<br />
Field methods<br />
indirect vs direct measurement of Mg and Zn<br />
in erythnocytes, 529<br />
Fish-eye disease<br />
low A-estenase acty. in serum in fish-aye<br />
disease (SN), 587<br />
2378 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Flecainide<br />
assay of flecainide in serum by HPLC after<br />
microscale protein pptn. (A), 1016<br />
flecainida monitoring by reversed-phase liquid<br />
chromatog. with a phenyl column (A), 1016<br />
fluorescence polarization immunoassay for<br />
quantn. of flecainida acetate (A), 1017<br />
liq. chromatog. and fluorescence polarization<br />
immunoassay methods compared for<br />
measuring flecainide acetate in serum (SN),<br />
1898<br />
measurement of flecainide by HPLC with<br />
fluorescence detection (A), 1016<br />
quantn. of serum flecainide by gas chromatog,<br />
with N-P detector (A), 1016<br />
rapid gas-chromatog. method for quantn. of<br />
flecainida in serum on plasma (A), 1016<br />
Flow cytofluorometry<br />
HLA-B27 typing by flow cytofluorometry, 1619<br />
Flow cytometry<br />
detection of circulating platelet antibodies and<br />
platelet-associated IgG by flow cytometry<br />
(A), 1004<br />
flow-cytomatric detn. of high-densityhipoprotein<br />
binding sites on leukocytes, 2195<br />
lab, support of transplantation (A), 870<br />
Flucytosine<br />
rapid enzymatic essay of flucytosine in serum<br />
with a centrifugal analyzer (A), 1022<br />
Fludrocortisone<br />
evaln. of the cross reactivity of fludrocortisone<br />
with the “Corti-Cote” (Becton Dickinson)<br />
cortisol assay (TB), 1254<br />
Fluid dynamics<br />
“architextured” fluid management of biol,<br />
liquids (5), 1531<br />
Fluorescain<br />
interference of fluorescein, used in retinal<br />
angiography, with certain din, lab, tests (L),<br />
2126<br />
Fluorescence depolarization assay<br />
automated fluorescence depolarization essay<br />
for total smylasa acty. evald. (TB), 615<br />
Fluorescence immunoassay<br />
See Fluoroimmunoasaay, Immunoassay<br />
Fluorescence polarization<br />
calibrated fluorescence polarization assay for<br />
assessment of fetal lung maturity, 1177<br />
effect of albumin and hamellar bodies on<br />
fluorescence polarn, of amniotic fluid (SN),<br />
1194<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: cardioactive<br />
drugs (A), 1013<br />
evaln. of fetal hung maturity by a fluorescence<br />
polarization method and comparison with<br />
LIS ratio (A), 901<br />
evaln, of 11 Roche fluorescence polarization<br />
assays (A), 955<br />
fluorescence polarization of amniotic fluid<br />
lamellar bodies compared with whole<br />
amniotic fluid (A), 901<br />
multiple drugs of abuse in urine detected with<br />
a single reagent and fluorescence<br />
polarization (SN), 1921<br />
prospective clinical avain. of an improved<br />
fluorescence polarization assay for predicting<br />
fetal lung maturity (SN), 554<br />
single-reagent polarization fluoroimmunoassay<br />
of methamphetamine in urine (SN), 1903<br />
Fluorescence polarization immunoassay<br />
assessment of evacuated serum separator gel<br />
blood-collection tubas for antiapileptic<br />
monitoring by FPIA (A), 1017<br />
can a single measurement of carbamazepine<br />
suffice for therapeutic monitoring? (SN), 812<br />
cm. evahn. of TDx’ fluorescence polarization<br />
immunoassay for detection of<br />
benzodiazepinas in urine (A), 973<br />
comparison of thyroxin detns. by TDx”‘ T4<br />
Plus and TDz”‘ thyroxin (A), 883<br />
dath. of free dgoxin condos. in serum for<br />
monitoring Fab treatment of digoxin<br />
overdose (SN), 1652<br />
deth. of serum amikacin on Cobas Bio FP<br />
centrifugal analyzer (A), 1021<br />
development of TDx’ fluorescence polarization<br />
immunoassay for detection of cannabinoids<br />
in urine (A), 972<br />
digoxin-hike immunoreactivity eliminated from<br />
serum by centnif. ultrafiltration before<br />
fluorescence polarization immunoasaay of<br />
digoxin (SN), 606<br />
discrepant thyroid-function test results by<br />
fluorescent polarization and RIA in<br />
nonthynoidal illness (TB), 613<br />
elimination of digoxin-lika iminunoreactivity<br />
prior to digoxin measurement by<br />
fluorescence polarization immunoassay (A),<br />
914<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: anticonvulsant<br />
drugs (A), 1018<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: theophyhline<br />
(A), 1022<br />
evahn. of Colony gentamicin fluorescence<br />
polarization immunoassey (A), 955<br />
fluorescence polarization immunoassay for<br />
quantn. of flacainida acetate (A), 1017<br />
fluorescence polarn. immunoassay eveld. for<br />
screening for amphetamine and<br />
methamphatamine in urine (SN), 1200<br />
FPIA for detecting benzodiazepines in serum<br />
(A), 973<br />
hiq. chromatog. and fluorescence polarization<br />
immunoassay methods compared for<br />
measuring flecainide acetate in serum (SN),<br />
1898<br />
performance evaln. of Abbott TDx Turbo<br />
Specific Protein system (A), 901<br />
second-generation fluorescence polarization<br />
immunoassay for serum gentamicin detn. on<br />
Cobas’ Bio FP centrifugal analyzer (A), 1021<br />
second-generation serum procainamide assay<br />
for Cobas’ Bio FP centrifugal analyzer using<br />
fluorescence polarization methodology (A),<br />
1017<br />
serum carbaxnazapina datn. on Cobas’ Bio FP<br />
centrifugal analyzer (A), 1018<br />
serum pentobarbital deth. by fluorescence<br />
polarization immunoassay (A), 1026<br />
serum phenytoin datn. on Cobas’ Bio FP<br />
centrifugal analyzer (A), 1020<br />
TDx’ T4 Plus, fully automated essay<br />
eliminating serum-denaturing pretreatment<br />
procedure (A), 883<br />
testing for drugs of abuse with the Abbott TDx<br />
(A),976<br />
theophylline method of the Abbott “Vision”<br />
analyzer evald. (SN), 130<br />
Fluorescence spectroscopy<br />
direct quantn. of coproporphynins,<br />
uroporphynins in urine by deny, synchronous<br />
fluorescence spectroscopy, 1826<br />
Fluoride<br />
detn. of inorganic F- in blood with a Fselective<br />
electrode, 253<br />
interference in an ehectrochem, detection<br />
system for peroxidsse-linked reactions based<br />
on a fluoride ion-selective electrode (SN),<br />
1458<br />
Fluoroimmunoassay<br />
alternative fluorescence enhancement solution<br />
for use in hanthanide-based time-resolved<br />
fhuoroimmunoaasays (SN), 2292<br />
automated fluorescence immunoessays for<br />
theophylline, phenytoin, and phenobarbital<br />
(A), 923<br />
cortisol and thyroxin fluorescence<br />
immunoassay by the semiautomated system<br />
IMMPULSE (A), 922<br />
development of simple fluorescence<br />
immunoassay for alpha-fetoprotein (A), 919<br />
development of solid-phase coated-tube total<br />
T4 hiposome-basad fluorescent immunosssay<br />
for Becton Dickinson IQ”‘ immunochem.<br />
system (A), 883<br />
fluorescence immunoassays for phenobarbital<br />
and phenytoin (A), 1020<br />
laser-frequency-optimized fluorescent energy<br />
transfer phycobiliprotein dye (A), 917<br />
liposome-based, coated-tube<br />
fluoroimmunoassey for theophylhine (A),<br />
1023<br />
phase-sepn. immunoesaays (5), 1509<br />
quinine directly deul. in serum or urine by<br />
sepn. fluoroimmunoasaay, 463<br />
sensitive fluonoimmunoasaays for ferritin and<br />
IgE (A), 1563<br />
simple fluorescence immunoassay for serum<br />
IgE (A), 918<br />
solid-phase coated-tube digoxin liposomebased<br />
fluorescent immunoassay for Becton<br />
Dickinson 14 chin. chem. analyzer (A), 1015<br />
time-resolved fluoroimmunoassay for detn. of<br />
alpha-fetoprotein in serum (A), 919<br />
time-resolved fluoroimmunoassay vs ELISA for<br />
detn, of a-2-interferon (TB), 1070<br />
Fluorometry<br />
ascorbic, dehydroascorbic acids simultaneously<br />
quantified in bioL fluids by hiq. chromatog.<br />
with fluorescence detection; colorimetnic<br />
assay compared, 1874<br />
automated anal. for taunine in biol, fluids,<br />
tissues (SN), 835
automated fluorescent enzyme immunoassay<br />
for detn. of human alpha.fatoprotein (A),<br />
919<br />
automated, microparticla-based fluonimetnic<br />
enzyme immunoasaay for CEA in human<br />
serum and plasma (A), 920<br />
CN concns. in blood after cigarette smoking,<br />
as detd. fluonimetnically (SN), 1228<br />
detn. of 1-aminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase hiq. chrometog., 1736<br />
detn. of chomiphene citrate and tamoxifen in<br />
blood and seminal plasma using reversedphase<br />
HPLC (A), 1025<br />
direct quantn. of coproporphyrins,<br />
uroporphynins in urine by deny, synchronous<br />
fluorescence spectroscopy, 1826<br />
dual fluorometric/colorimetnic detection<br />
system for an automated random-access<br />
instrument utilizing std, polystyrene test<br />
tubes as precision cuvettes (5), 1554<br />
evaln, and improvement of homovanilhic acid<br />
methodology, and a critique of liq.<br />
chromatog. with elactrochem. detection<br />
(SN), 600<br />
Flavobacterium and Sphingobacterium<br />
species: enzyme profiles compared by use of<br />
pattern recognition of two-dimensional<br />
fluorescence data, 377<br />
fluorescence enzyme immunoassay for<br />
allergen-specific IgG4 (A), 918<br />
fluorometry of iodocyanine green in plasma,<br />
765<br />
glucose interferes in fluorometry of serum<br />
citrate in diabeticpatients with<br />
hyperglycemia (TB), 1940<br />
HPLC test for natinol-binding protein (A), 935<br />
improved hiq.-chromatog. assay of labetalol in<br />
plasma (SN), 1450<br />
measurement of flacainide by HPLC with<br />
fluorescence detection (A), 1016<br />
N-acetyl-$-D-ghucosaminidase isoenzymes in<br />
urine assayed by ion-exchange chromatog.,<br />
1796<br />
performance of an in-vivo, continuous bloodgas<br />
monitor with disposable probe (S), 1538<br />
radial partition t’huorometnic enzyme<br />
immunoassay for detection of hepatitis B<br />
surface antigen with the Stratus’ analyzer<br />
(A),906<br />
radial partition immunoassay monitoring<br />
digitoxin in serum and plasma (A), 1015<br />
radial partition immunoassay: rapid automated<br />
detn, of total IgE on the Stratus analyzer<br />
(A),904<br />
Stratus fluorometric enzyme immunoassay<br />
system evaluated for detn. of total thyroxin<br />
(A),883<br />
TDx’ Digoxin III nonextraction immunoessay<br />
for serum digoxin (A), 923<br />
triamterane interference in deth. of urine free<br />
catecholemines by cation-exchange<br />
chromatog./fluorometry (A), 887<br />
validation and apphn. of a hiq.chromatog./enzymic<br />
essay for individual bile<br />
acids in rat serum, 1856<br />
Fluoronephehometry<br />
sensitive fluoronephelometnic assay of slight<br />
albuminuria (TB), 717<br />
Fluorouracil<br />
stability of 5-fluorouradil in whole blood and<br />
plasma (SN), 2299<br />
Folate<br />
See also specific folate of interest<br />
immobilized purified folate-binding protein<br />
binding characteristics and use for<br />
quantifying folate in erythrocytes, 1360<br />
monoclonal antibody-based RIA for vit. B12<br />
(57Co)/folate (I) detns. (A), 922<br />
Folate-binding proteins<br />
immobilized purified fohate-binding protein<br />
binding characteristics and use for<br />
quantifying fohate in erythrocytes, 1360<br />
Folic acid<br />
See Folate<br />
Fohlicular fluid<br />
kinetic immunonephelometnic detn. of protein<br />
concns. in follicular fluid, 1185<br />
Follitropin<br />
apphn. of novel Cr02 magnetic particles to<br />
immunoasaay development (S), 1543<br />
double-label time-resolved<br />
immunofluorometry of hutropin and<br />
follitropin in serum (SN), 2281<br />
Eu and Sm as labels in time-resolved<br />
immunofluorometnic assay of follitropin, 48<br />
follitropin and hutropin simultaneously<br />
measured in urine with a commercial RIA kit<br />
(TB), 1674<br />
fully automated immunoenzymetric assays for<br />
detection of FSH and LH (A), 892<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunoradiometric assay,<br />
and further exploration of antigenic sites on<br />
choniogonadotropin, 1147<br />
simultaneous immunoenzymatnic essay for<br />
FSH in serum (A), 892<br />
simultaneous incubation, two-site<br />
immunomatric assay for FSH based on<br />
enhanced luminescence (A), 892<br />
Forensic medicine<br />
accuracy and precision of breath-alcohol<br />
measurements for a random subject in the<br />
postabsonptive state, 261<br />
accuracy, precision of breath alcohol<br />
measurements for subjects in the absorptive<br />
state, 753<br />
comparison of whole blood, plasma, and serum<br />
ethanol levels-legal interpretation? (A), 968<br />
concerning accuracy and precision of breathalcohol<br />
measurements (0), 1701<br />
datn. of methylxanthina stimulants in urine of<br />
racing greyhounds by HPLC; resolution of a<br />
contested drug-administration case (A), 975<br />
drug of abuse profile: cannabis (5), 72B<br />
employee drug screening issues to be resolved<br />
in implementing a program (S), 54B<br />
enzymic ethanol essay: colorimetnic method<br />
based on mess, of H202, 486<br />
forensic methaqualone assay by two HPLC<br />
systems (A), 974<br />
prelim. thoughts on the wisdom of govt.<br />
prohibition or regn. of private employee<br />
urinalysis testing (5), 19B<br />
qual. assurance in a forensic lab,: GC/MS<br />
confirmation of THC and cocaine (A), 971<br />
reliability of breath-alcohol meas. during the<br />
absorption phase (L), 2128<br />
results of breath-alcohol analyses on two<br />
consecutive samples (A), 968<br />
Formaldehyde<br />
anzymic assay for the specific detn. of<br />
methanol in serum, 2204<br />
Formate<br />
serum formic acid concns. in formic acid<br />
poisoning (A), 1031<br />
Fosinopril<br />
specific h RIA for SQ 27,519 in human serum<br />
(A), 1027<br />
Free thyroxin index<br />
on albumin-dependence of measurements of<br />
free thyroxin. II. non-thyroidal illness, 87<br />
Fructosamine<br />
assay of serum fructosamine: internal vs<br />
external standn. (L), 1955<br />
assay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of bioL variation, 269<br />
centrifugal anal, for serum fructosamine with<br />
the IL Multistat analyzer (A), 1003<br />
comment on fructosamine qual. -assessment<br />
survey (L), 1952<br />
correction of serum fructosamine concn. in<br />
hypoalbuminamia (A), 1003<br />
effect of anticoagulants on fructosamine detn.<br />
(TB), 1947<br />
evaln, of Roche fructosamine test for<br />
monitoring diabetic patients (A), 954<br />
fructosamine and protein concns, in serum (L),<br />
2326<br />
fructosamine assay in management of diabetes:<br />
anal, and chin. avaln. (A), 1002<br />
fructoeamina: structure, anal, and din.<br />
usefulness (R), 2153<br />
glycated proteins in serum: effect of their<br />
relative proportions on their alk. reducing<br />
acty. in the fructosamine test (SN), 1895<br />
lab. assessment of a commercial kit for<br />
fructoeamine in serum (SN), 158<br />
measurement of serum fructosamine by Cobas<br />
chem. instruments (A), 954<br />
more on serum fructoeamine assay (L), 446<br />
nitroblue tetrazohium staining of serum<br />
fructosamine on egarose gel<br />
elactrophoretograms (TB), 1949<br />
plasma protein glycation as measured by<br />
fructosamine assay, 1141<br />
precision and accuracy of serum fructosamina<br />
assays and correlation with Hb A1, and<br />
serum glucose and protein concns. (A), 1002<br />
relation between fructosamine and plasma<br />
lipid concns, in diabetes mellitus (L), 629<br />
results with a fructoeamina kit for a group of<br />
diabetics in Southeast Asia (TB), 1948<br />
superoxide dismutase inhibits fructosamine<br />
assay (SN), 147<br />
Fucosidosis<br />
urinary glycoconjugates excreted by patients<br />
with type<br />
44<br />
Galactose<br />
I and type II fucosidosis compared,<br />
alternative methods evald, for assaying low<br />
concns, of galactose in plasma (TB), 420<br />
Galactose-l -phosphate uridyltransferase<br />
reagent that restores galactoee-1-phosphate<br />
uridylyltransferase<br />
(TB), 1471<br />
Galactosidase<br />
acty. in dry blood spots<br />
enzyme immunoassay of angiotensin I and<br />
renin, 1774<br />
Gammopathies<br />
See also Monoclonal gammopathies<br />
macroghobulinemia associated with IgA<br />
gammopethy in a patient with different<br />
light-chain specificity and no associated<br />
clinical findings (TB), 1945<br />
multiple myeloma with serum IgG kappa and<br />
Bence Jones lambda biclonal gammopathy<br />
(L), 1305<br />
Gas<br />
See Blood gases, Breath analysis<br />
Gas chromatography<br />
gas chrometog.-mass<br />
hydroxymelatoninhydroxymelatonin<br />
spectrometric assay for 6-<br />
S042 and 6-<br />
glucuronide in urine, 453<br />
Gas chromatography/mass spectrometry<br />
capillary GC and GC/MS of cocaine and heroin<br />
urinary metabolites (A), 970<br />
capillary GC/MS anal. of verapamil<br />
norverapamil in serum (A), 1017<br />
comparison of Diagnostic Products<br />
and<br />
Coat-A-<br />
Count (RIA) with gsa chromatog./mass<br />
spectrometry for deth. of morphine in blood<br />
(A),970<br />
detn. of two urinary proateglandins by<br />
capillary gas chromatog.-high-rasolution<br />
mess spectrometry (A), 891<br />
gas chromatog.-electron impact mass<br />
fragmentomatric idantn. and quantn.<br />
in urine (A), 971<br />
of LSD<br />
high-pass filtering of data gives estimate of no.<br />
of individual molecules in steroid profiling<br />
by GC/MS (A), 962<br />
measurement of rimantadine in plasma<br />
capillary GC/MS (A), 1022<br />
by<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
oxybuprocaine and five metabohites<br />
simultaneously detd. in urine by gas<br />
chromatog. and gas chrometog.-rnass<br />
spectnom. after extraction with Extrelut<br />
(SN), 697<br />
qual. assurance in a forensic lab.: GC/MS<br />
confirmation of THC and cocaine (A), 971<br />
relationship of blood alcohol and morphine<br />
levels in heroin deaths (A), 969<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
total cholesterol in serum deW. by isotope<br />
dihn.-mass spectrom.,<br />
sepn., 1113<br />
with liq.-chromatog.<br />
urinary org. acids: isoln. and quanth. for<br />
routine<br />
Gastrin<br />
metabolic screening, 473<br />
autoantibody against diiodinated tyrosinegastnin<br />
in a patient with Graves’ disease, 97<br />
Gastrointestinal function<br />
decreased drug absorption in a patient with<br />
Behcet’s syndrome (CR), 1679<br />
Gaucher’s disease<br />
antibodies to porcine uteroferrin used in mess.<br />
of tartrate-resistant acid phosphatase, 1832<br />
GELLAB<br />
See Ehectrophonesis, two-dimensional<br />
Gemflbrozih<br />
assay of gamfibrozil in plasma by “highperformance”<br />
hiq. chromatog. (TB), 1938<br />
Gene therapy<br />
approach to gene therapy<br />
(A), 876<br />
Genetic counseling<br />
for human disease<br />
ethics of presymptomatic genetic testing:<br />
principles and problems (A), 876<br />
Genetic engineering<br />
biotechnol. and medicine of the future (A), 875<br />
Genetics<br />
See also Heritable disorders<br />
carrier deth. in Duchenne muscular dystrophy<br />
utilizing DNA probes and creatme kinase<br />
actys. (A), 1034<br />
cellular oncogenes and carcinogenesis (R), 641<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2379
detection of isoenzymes associated with drug<br />
resistance or specific chromosomes by<br />
aganose electrophoresis (A), 998<br />
genetic and environmental factors that affect<br />
plasma apolipoprotein concns. (A), 1051<br />
IgG subclass measurements in the din, lab.<br />
(R), 1707<br />
Gentamicin<br />
effect of gentamicin and cychosporin on<br />
permeability of model membranes (A), 1027<br />
evahn. of Colony gentamicin fluorescence<br />
polarization immunoassay (A), 955<br />
second-generation fluorescence polarization<br />
immunoassay for serum gentamicin detn, on<br />
Cobas5 Bio FP centrifugal analyzer (A), 1021<br />
Globulins<br />
ohigochonal bands and post--y-globulin in<br />
ehectrophoretograms of CSF (L), 628<br />
precision of essays for sex-hormone binding<br />
globulin: an I-IRMA kit and two Eu-IFMA kits<br />
compared (TB), 2120<br />
Glomaruhar basement membrane<br />
role of nonenzymatic glycation in altered renal<br />
function in exptl. diabetes (A), 1037<br />
Glomarular filtration rate<br />
use of creatinine for estn, of glomeruhar<br />
filtration rate in isolated perfused rat kidney<br />
model (A), 1037<br />
Glucocorticoids<br />
specificity of sensitive assays of thyrotnopin<br />
used to screen for thyroid disease in<br />
hospitalized patients, 1391<br />
Glucosaminidase<br />
measurement of urine N-acetyl-fl-SMCNDglucosaminidese<br />
with a centnif. analyzer<br />
(TB), 616<br />
N-acetyl--D-glucosaminidase assay by the pnitrophanol<br />
technique: inhibit, effects of<br />
urine as decreased by gel filtration and by<br />
simple diln. (TB), 713<br />
N-acetyl-9-D-glucosaminidase isoenzymes in<br />
urine assayed by ion-exchange chromatog.,<br />
1796<br />
urinary N-acetyl-fl-D-ghucosaininidase and<br />
albumin not increased in mildly hypertensive<br />
subjects (TB), 1075<br />
Glucose<br />
assessment of two glucose meters in the<br />
operating room (TB), 1676<br />
bedside glucose monitoring by nurses end<br />
chemists (A), 912<br />
calibration of the aca for glucose in CSF, 311<br />
computer-assisted information system for<br />
automatized diagnosis and file-organization<br />
of oral glucose tolerance test data (A), 983<br />
computer-assisted insulin delivery for NPH<br />
and regular insulins based on solid-phase<br />
reagent glucose values (A), 985<br />
D-mannose as a preservative of glucose in blood<br />
samples (SN), 708<br />
effect of hipemia, hyperosmolality, and uremia<br />
on whole blood glucose measured by dry<br />
reagent strips and reflectometry (A), 912<br />
evahn. of accuracy of Seralyzer5 glucose<br />
(hexokinase) and 5 glucose methods<br />
compared to National Glucose Ref. Method<br />
(A), 952<br />
evaln, of Paramaz’ CSF glucose assay (A), 952<br />
F’I’IR-spectroscopy of glucose in whole blood<br />
(A),961<br />
glucose test “carryover” affects drug assays in<br />
the IL “Monarch” (L), 1695<br />
glucose test “carryover” affects drug assays on<br />
the IL Monarch (L), 743<br />
hematocrit effect on glucose reagent strip<br />
systems and verification of the effect with<br />
neonate samples (A), 912<br />
improved Serahyzer glucose method (A), 952<br />
influence of sample preservative on electrolyte,<br />
urea, creatinine, and glucose levels (A), 915<br />
interference in an electrochem. detection<br />
system for peroxidase-linked reactions based<br />
on a fluoride ion-selective electrode (SN),<br />
1458<br />
interference with dipstick tests for glucose and<br />
Hb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
lactate and pyruvate electrochem. biosansors<br />
for whole blood in extracorporeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
measurement of glucose in serum by<br />
hexokinase method with Ames senalyzer (A).<br />
1011<br />
operation end performance evaln. of glucose<br />
“out-of-range detection and correction”<br />
feature in Synchron AS’/Astra5 systems<br />
(A),961<br />
2380 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
performance of BUN, glucose, and total<br />
protein on the Spirit electrolyte chem.<br />
system (A), 946<br />
performance of three new blood-glucose<br />
reflectometers evald. by nursing and lab.<br />
staffs (TB), 2312<br />
precision and accuracy of serum fructosamine<br />
essays and correlation with Hb A1, and<br />
serum glucose and protein condns. (A), 1002<br />
precision of glucose measurements in control<br />
sara by isotope dihn./mass spectrom.:<br />
proposed Definitive Method compared with<br />
a Reference Method, 1397<br />
quality-control materials for use with monitors<br />
of blood glucose: “Refloflux II” (Boehningen<br />
Mannheim) and “Sugar-Chex” (Streck<br />
Laboratories) controls (L), 1294<br />
quality control scheme for blood glucose<br />
measured outside the laboratory (SN), 1233<br />
quality of bedside glucose data (L), 1108<br />
Glucose-6-phosphate dehydroganase<br />
erythnocyte glutathiona concns, in diabetics<br />
with cataracts, with and without glucose-6phosphate<br />
dehydrogenase deficiency (TB),<br />
1936<br />
erythrocytic glucose-6-phosphate<br />
dehydrogenase measured by differential pH<br />
(SN), 579<br />
neonatal hyperbilirubinemie due to glucose-6phosphate<br />
dehydnogenase deficiency (A),<br />
1013<br />
Glucose tolerance test<br />
lab, assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
Glucuronidase<br />
acid phosphatase acty. in -<br />
glucuronidase/suhfatase preparation from<br />
Helix pomatia (TB), 418<br />
Glucuronosyltransferase .<br />
enzymatic assay for bihirubin using unidine<br />
diphosphata glucuronosyltransferase (A),<br />
1013<br />
Glutamate dehydrogenase<br />
optimized kinetic glutamate dehydrogenase<br />
essay adapted to the Cobas Bio centnif,<br />
analyzer (TB), 1673<br />
stabilized aqueous glutamate dehydrogenase<br />
solution for use in detg. urea N (A), 951<br />
Glutamine<br />
chin. apphicn. of CSF glutamina measurements<br />
for diagnosis of hepatic encephalopathy (A),<br />
1031<br />
Glutamyltransferase<br />
detg. serum isoenzyme pattern of -<br />
glutamyltrenspeptidase: ref. intervals for<br />
normal subjects and patients with<br />
hepatobihiary diseases (A), 994<br />
evaln. of liquid GGT reagent method (A), 957<br />
liquid reagent for deth. of gammaglutamyltransferase<br />
on Abbott Vision system<br />
(A), 994<br />
optimization of IFCC-recommended method<br />
for detg. gamma-glutamyltransferasa at 37<br />
C with the Du Pont Dimension” chin. chem.<br />
system (A), 994<br />
performance of Kodak Ektacham DTSC<br />
module for detn. of alk. phosphatese and<br />
GGT (A), 937<br />
prodn. and certifn. of an enzyme ref. material<br />
for ‘y-glutamyltransfersse (CRM 319). part 1:<br />
prepn. and characterization, 1971<br />
prodn. and certifn, of an enzyme ref. material<br />
for y-glutamyltransfenase (CRM 319). part 2:<br />
certifn, campaign, 1978<br />
Reflotron assays of alanine aminotransfenase<br />
and glutamyltransferase in whole-blood<br />
samples evald. (SN), 826<br />
relationship between y-glutamyltransferase 1<br />
isoenzyme and “fast liver” alk, phosphatase<br />
isoenzyme in serum (A), 993<br />
sensitive method for sepn. of hepatomaspecific<br />
gamma-glutamyltranaferase<br />
isoenzymes on cellulose acetate media, using<br />
Tniton-X 100 and concanavahin A (A), 994<br />
serum amylase and -y-glutamyltransfenase<br />
assay in the Abbott “Vision” system (TB),<br />
722<br />
substrates and inhibitors in reagents for detg.<br />
‘y-ghutamyltransferase (A), 994<br />
Glutathione<br />
erythrocyte glutathione concns, in diabetics<br />
with cataracts, with and without ghucose-6phosphate<br />
dehydnogenase deficiency (TB),<br />
1936<br />
improved procedure for datg. glutathione in<br />
plasma as an index of myocardial oxidetive<br />
stress (SN), 1448<br />
quantn. of glutathione and glutathione<br />
disulfide in plasma (TB), 1675<br />
Glutathiona peroxidase<br />
evaln. of Ransel kit for detn. of glutathione<br />
peroxidase acty. in plasma, possibility of<br />
interlab. standardization (A), 957<br />
methods compared for detg. glutathione<br />
peroxidase acty. in blood, 539<br />
Glycated hemoglobin<br />
accelerated glycated Hb A1, anal. with Bio-<br />
Red’s “Diemat” analyzer (A), 1002<br />
automated procedure for reading and<br />
calculating glycated Hb fractions (TB), 2305<br />
clinical usefulness of glycated Hb in<br />
monitoring diabetes: hong-term study, 55<br />
enzymic glycation may decrease acty. of<br />
arythrocytic 1-eminolevuhinate dehydratase<br />
in diabetes, 1807<br />
feasibility of centralized mess. of glycated Hb<br />
in the Diabetes Control and Complications<br />
Trial: a multicenten study (SN), 2267<br />
fructosamine: structure, anal. and chin.<br />
usefulness (R), 2153<br />
glycohemoglobin method for the doctor’s office<br />
(A), 1002<br />
lab, assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
mess. of stable glycated Hb, 341<br />
more on glycated Hb mess, from samples dried<br />
on filter paper (L), 741<br />
plasma protein glycation as measured by<br />
fructosamine assay, 1141<br />
precision and accuracy of serum fructosamine<br />
assays and correlation with Hb A1, and<br />
serum glucose and protein concns. (A), 1002<br />
quantn. of Hb A2 by fully automated Hb<br />
analyzer (A), 1001<br />
screening with glyceted Hb for gestational<br />
diabetic-associated macrosomia (A), 1001<br />
Glycated proteins<br />
factors affecting glycation of human plasma<br />
proteins (A), 1002<br />
glycated proteins in serum: effect of their<br />
relative proportions on their elk, reducing<br />
acty. in the fructosamine test (SN), 1895<br />
mess. of glycated protein by a rapid, specific<br />
method for absolute quantn. of lysine-bound<br />
glucose (SN), 1656<br />
non-enzymic glycation of individual plasma<br />
proteins in normoglycemic and<br />
hyperglycemic patients, 2220<br />
plasma protein glycation as measured by<br />
fructosamine assay, 1141<br />
suparoxida dismutase inhibits fructosamine<br />
assay (SN), 147<br />
two colonimetnic methods for serum glycated<br />
proteins compared (TB), 1474<br />
Glycoconjugates<br />
urinary glycoconjugates excreted by patients<br />
with type hand type II fucosidosis compared,<br />
44<br />
Glycogen storage disease<br />
glycogen storage disease type I: lab, data,<br />
diagnosis, 2008<br />
Glycohemoglobin<br />
See Glycated hemoglobin<br />
Glycolysis<br />
D-mannoae as a preservative of glucose in blood<br />
samples (SN), 708<br />
Glycopeptides<br />
chem, characterization of urinary<br />
glycopeptides, 2214<br />
Glycoprotein hormones<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunonadiometnic assay,<br />
and further exploration of antigenic sites on<br />
choriogonadotropin, 1147<br />
Glycoproteins<br />
evidence that human, rabbit, and bovine<br />
creatine kinese lsoenxymas are glycopnoteins<br />
(A),991<br />
intracellular precursor forms of plasma<br />
proteins: functions and possible occurrence<br />
in plasma (R), 1317<br />
MCA, a new serum marker for breast cancer<br />
(A), 929<br />
monochonal antibody-based enzyme-linked<br />
immunosonbent assay of a1-acid glycoprotein<br />
(SN), 2275<br />
solid-phase RIA for measuring free alpha<br />
subunit of pituitary glycoprotein hormones<br />
(A), 891<br />
Gossypol<br />
effect of gossypol on the activity of erythrocyte<br />
Na-K ATPase acty. in vitro (TB), 309<br />
Gout<br />
hiq. chromatog. with multichennel UV
detection for studying disorders of purina<br />
metab., 2052<br />
Granuhocytes<br />
detn. of Mg in granulocytes (A), 1006<br />
identn. of human leukocyte esterases (A), 981<br />
Graves’ disease<br />
autoantibody against diiodinated tyrosinegastnin<br />
in a patient with Graves’ disease, 97<br />
measurement of thyroid-stimulating<br />
immunoghobuhin by FRTL-5 cell biochem,<br />
assay: diagnostic sensitivity and specificity<br />
in Graves’ disease (A), 1032<br />
Guanase<br />
rapid ultraviolet.spectnophotom. method for<br />
detn, of serum guanase acty. (A), 995<br />
serum guansse acty. in expl. models of hepatic<br />
injury (A), 995<br />
Guanidinoacatate<br />
new enzymic detn. of guanidinoacatic acid in<br />
urine, 394<br />
Hair<br />
detection of morphine in hair with the Abbott<br />
TDX (TB), 2125<br />
Sb accumn. in hair during treatment of<br />
leishmaniasis (SN), 2081<br />
Haptoglobin<br />
automated turbidimetry of serum haptoglobin<br />
by the Ames “Optimate” (TB), 1466<br />
immunoturbidimetry of haptoglobin and<br />
transfernin in the EPOS 5060 analyzer (TB),<br />
1257<br />
serum haptoghobin concns. in concurrent<br />
hemohysia and acute-phase reaction (TB),<br />
1265<br />
Heart disease<br />
See also Myocardial infarction<br />
assessment of Mg status (R), 1965<br />
bias and precision of cholesterol anal, by<br />
physician’s office analyzers (SN), 2262<br />
detn. by RIA of the mass of lactate<br />
dehydrogenase iaoenzyme 1 in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
direct detn, of angiotensin-converting enzyme<br />
inhibitors in plasma by radioenzymatic<br />
assay, 549<br />
effect of personality type on biochem. risk<br />
factors of coronary heart disease (A), 897<br />
examn, of heart proteins by 2-D<br />
electrophoresis, 2011<br />
flow-cytonietric detn, of high-densityhipoprotein<br />
binding sites on leukocytes, 2195<br />
importance of time between repeated meas. of<br />
total or high-density hipoprotein cholesterol<br />
when estg. an individual’s baseline concns,<br />
(SN), 1913<br />
lactate dehydrogenase isoenzyme 1 as detd. by<br />
inhibition with 1,6-haxanediol and by two<br />
other methods in myocardial infarction or<br />
cardiac-bypass surgery (SN), 589<br />
new assay of apohipoproteins A-I and B by rate<br />
naphelometny evald, (SN), 2065<br />
ref. intervals for apolipoproteins A-I and B by<br />
rate nephelometry and associated CHD risk<br />
assessment (A), 898<br />
RIA of atnial natniuretic pohypeptide in heattreated<br />
plasma, 674<br />
Se, Zn, Mg, Ca, K, cholesterol, and cneatine<br />
kinase concns, in men during 12 days after<br />
acute myocardial infarction, 21<br />
vit, B6 deficiency and coronary heart disease:<br />
new perspective in assessment of vit. B6<br />
nutritional status (A), 935<br />
Hematocrit<br />
ahectrochem, detn. of Hb, hematocnit, and<br />
hemohysis (SN), 153<br />
Hematology<br />
avaln, of ENI hematology analyzer for the<br />
doctor’s office (A), 938<br />
utilization of the Yellow Iris”’ automated<br />
urinalysis workstation for performing body<br />
fluid cell counts (A), 981<br />
Hamaturia<br />
renal differentiated from non-renal hematunia<br />
by micros, axamn, of erythrocytes in urine,<br />
1791<br />
Hemodialysis<br />
See also Dialysis patients<br />
identn, and quantn. of a protein-bound higand<br />
in uremic serum (SN), 682<br />
hiq-chromatog. detn, of inoaine, xanthine, and<br />
hypoxanthine in uremic patients receiving<br />
hemodialysis treatment (SN), 2278<br />
Lp(a) hipoprotein in patients with chronic renal<br />
failure treated by hemodialysis (TB), 721<br />
methanol overdose: predicting lengths of<br />
hemodialysis therapy (A), 969<br />
modn. of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with 3i NMR,<br />
76<br />
Hemoglobin<br />
See also Glycated hemoglobin<br />
accuracy and precision of simple method for<br />
hemoglobinometry (A), 1001<br />
comparison of automated CN-containing and<br />
CN-free methods for Hb detn. on Technicon<br />
H*1lN (A), 1000<br />
detg. Me-Hb in blood by zero-crossing-point<br />
first-deny, spectrophotometry, 1767<br />
detn, of total Hb in whole blood: further tests<br />
of the “Hemocue” method (TB), 2307<br />
electrochem. detn. of Hb, hematocnit, and<br />
hemolysis (SN), 153<br />
evaln. of the IL 482 CO-Oximeter (TB), 1942<br />
fast kinetic method for methemoglobin<br />
adapted for quantn. of Hb in whole blood,<br />
493<br />
% functional oxyhemoglobin saturation by<br />
pulse oximatry and oxyhemoglobin<br />
saturation compared in critically ill patients<br />
(A), 939<br />
hemoglobin Aic by liq. chromatog. (L), 445<br />
improved sepn. of fetal Hb by mini-column<br />
chromatog. (SN), 288<br />
interference with dipstick tests for glucose and<br />
Hb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
kinetics of inhibition of Hb-catalyzed oxidation<br />
of 3,3’,5,5’-tetramethylbenzidene by<br />
bihirubin and ascorbic acid (A), 912<br />
lactate measurement in the TDx and aca: Hb<br />
interference assessed (TB), 189<br />
performance of Radiometer OSM3<br />
hemoximeter compared with spectrophotom.<br />
multiwevelength method (A), 939<br />
quantn. of Hb with the Vision chin, analyzer<br />
(A), 1000<br />
rapid measurement of HbA1, by FPLC (TB),<br />
2306<br />
total protein, alb,, Ca, and Hb detd. with the<br />
Abbott “Vision” system (TB), 711<br />
Hemoglobinopathies<br />
nonisotopic M13 probes for detecting the betaglobin<br />
gene: appln. to diagnosis of sickle call<br />
anemia, 1368<br />
Hemoglobin variants<br />
liquid-chromatog. analysis of 20 human Hb’s<br />
(A), 1001<br />
Hemolysis<br />
electrochem. detn, of Hb, hematocrit, and<br />
hemohysis (SN). 153<br />
Hemostasis<br />
evaln, of a fully automated centrifugal analyzer<br />
for hemostaais tests (SN), 1888<br />
kinetic detn. of fibrinogen with a random<br />
access analyzer (TB), 420<br />
Heparin<br />
artefactual hyperkalemia induced by hepanin<br />
in patients with extreme leukocytosis (A),<br />
914<br />
development, characterization of an automated<br />
assay of effective hepanin acty. in plasma,<br />
1630<br />
Hepatic disease<br />
See also Liver disease<br />
Hepatic encephahopathy<br />
din, apphicn. of CSF glutamine measurements<br />
for diagnosis of hepatic encaphalopathy (A),<br />
1031<br />
Hepatitis<br />
acute toxic hepatitis in a child with Bendectin<br />
overdose (A), 1031<br />
intra-individual variation of analytes in serum<br />
from patients with chronic liver diseases,<br />
1133<br />
Hepatitis B<br />
evaln. of monoclonal antibody-based enzyme<br />
immunoassay for detection of hepatitis B<br />
infection (A), 959<br />
Hepatitis B core antigen<br />
chin. evain. of Corzyme5-M (rDNA) and<br />
Corab5-M (rDNA) (A), 1031<br />
Hepatitis B surface antigen<br />
adaptation of Auszyme monoclonal test for<br />
detection of hepatitis B surface antigen to<br />
Encore’” centnif, analyzer (A), 906<br />
radial partition fluorometnic enzyme<br />
immunoassay for detection of hepatitis B<br />
surface antigen with the Stratus analyzer<br />
(A),906<br />
rapid test for hepatitis B surface antigen (A),<br />
906<br />
Hepatobihiary disorders<br />
detg. serum isoenzyme pattern of -yglutamyltranspeptidase:<br />
ref. intervals for<br />
normal subjects and patients with<br />
hepatobihiary diseases (A), 994<br />
Hepatoma<br />
sensitive method for sepn. of hepatomaspecific<br />
gamma-ghutamyltranaferase<br />
isoenzymes on cellulose acetate media, using<br />
Triton-X 100 and concanavalin A (A), 994<br />
studies of alpha-fetoprotein in ascitic fluid of<br />
hapstoma-bearing patients (A), 925<br />
time-resolved immunofluorometry of 34-kDa<br />
sometomedin-binding protein, 1126<br />
Heritable disorders<br />
See also Genetics<br />
artifacts in RFLP analyses of human DNA<br />
samples co-precipitated with t-RNA (TB),<br />
2304<br />
enzyme-linked immunosonbent assay for 17ahydnoxyprogestenona<br />
in dried blood spotted<br />
on filter paper, 761<br />
enythrocytic ghucose-6-phosphate<br />
dehydrogenase measured by differential pH<br />
(SN), 579<br />
flow-cytomatnic detn, of high-densitylipoprotein<br />
binding sites on leukocytes, 2195<br />
investigation of congenital factor XIII<br />
deficiency and of the carrier state by<br />
immunofixation (A), 1003<br />
liq. chrometog. with multichannel UV<br />
detection for studying disorders of purina<br />
matab,, 2052<br />
low A-esterase acty. in serum in fish-eye<br />
disease (SN), 587<br />
metabolic profiles of urinary org. acids recd.<br />
from absorbent filter paper (SN), 572<br />
neonatal hyperbihirubinemia due to ghucose-6phosphate<br />
dehydnogenese deficiency (A),<br />
1013<br />
nonisotopic M13 probes for detecting the betaglobin<br />
gene: appln. to diagnosis of sickle cell<br />
anemia, 1368<br />
phenylalanine and tyrosine in serum and<br />
eluates from dried blood spots as detd. by<br />
reversed-phase hiq. chromatog., 1152<br />
plasma apolipoproteins in Tangier disease, as<br />
studied with 2-D elactrophonesis (SN), 120<br />
revised method of ‘H-NMR urinalysis for<br />
detecting inborn errors of metab. (TB), 714<br />
simultaneous mesa, of eight corticosteroids by<br />
liq.-chnomatog. and appin. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
urinary glycoconjugates excreted by patients<br />
with type land type II fucoaidosis compared,<br />
44<br />
urinary org. acids: isoln, and quanth. for<br />
routine metabolic screening, 473<br />
use of restriction fragment length<br />
polymorphism anal, for detecting carriers of<br />
“Fragile X” syndrome (R), 1726<br />
Heroin<br />
capillary GC and GCIMS of cocaine and heroin<br />
urinary metabohites (A), 970<br />
relationship of blood alcohol and morphine<br />
levels in heroin deaths (A), 969<br />
“High-performance” chromatography<br />
See Chromatorsphy, liquid<br />
“High-pressure ‘chromatography<br />
See Chromatography, liquid<br />
Histocompatibihity complex<br />
HLA-B27 typing by flow cytofluonometry, 1619<br />
History<br />
Henry Bence Jones (1813-1873): the best<br />
“chemical doctor” in London, 1687<br />
Israel Mordecai Rabinowitch (1890-1983): a<br />
father of chin, chem, in Canada, 196<br />
organ. and history of the New York<br />
Metropolitan Section, AACC: some<br />
recollections, 1486<br />
(H), 1486<br />
HIV (See also AIDS)<br />
appln. of novel Cr02 magnetic particles to<br />
immunoassay development (S), 1543<br />
din, utility of several assays for detection of<br />
HIV antigen or antibody (A), 1028<br />
experiences with synthesized peptides gp4l<br />
and p24 in HIV antibodies assay kit (A), 905<br />
hih incidence of false-positive enzyme<br />
Immunoassay for an#{252}bodiesto HIV in<br />
patients with renal failure (A), 1029<br />
high-titer anti-HIV antibodies associated with<br />
paraprotein spike in an asymptometic<br />
homosexual male (A), 1028<br />
oligoclonal immunoghobuhins in healthy<br />
homosexual and heterosexual couples<br />
exposed to human immunodeficiency virus<br />
(A),905<br />
single-use diagnostic system for rapid<br />
colonimetric detection of HIV-1 antibody in<br />
CLINICAL CHEMISTRY, Vol. 33, No, 12, 1987 2381
human serum or plasma specimens-SUDS<br />
HIV-1 Ab test (A), 905<br />
Homeostasis<br />
modn. of intra-enythnocytic homeostasis in<br />
uremid patients, as studied with 3i NMR,<br />
76<br />
Homovanihhic acid<br />
evaln. and improvement of homovanillic acid<br />
methodology, and a critique of liq.<br />
chromatog. with electrochem, detection<br />
(SN), 600<br />
hiq.-chnomatog. method for detn, of<br />
homovanillic acid in plasma, with<br />
ehectrochem. detection, 72<br />
simple and rapid hiq.-chromatog. method for<br />
simultaneous mess. of vanilhyhnandelic acid,<br />
homovanilhic acid (TB), 1262<br />
simple liq.-chrometog. mess. of<br />
vanillylmandelic acid and homovanillic acid<br />
in urine on filter paper for mass screening of<br />
neuroblastoma in infants, 2043<br />
simultaneous anal, for 4-hydroxy-3mathoxymandahic<br />
acid, 4-hydroxy-3mathoxyphenylacetic<br />
acid, and creatinine in<br />
urine by HPLC with column switching (A),<br />
887<br />
urinary catecholamines, vanillylmandehic acid,<br />
5-hydroxyindoleacetic acid, and<br />
homovanillic acid measured by hiq.<br />
chromatog. with electrochem. detection and<br />
use of a single mobile phase (L), 1696<br />
validation of HPLC-ECD method for urinary<br />
VMA and HVA by comparison with GCMS<br />
(A),887<br />
Hormones<br />
See also specific hormone of interest<br />
involvement of hormones in ethanol metab.<br />
(A), 1059<br />
proteins and hormones in Echinococcosis (A),<br />
907<br />
RIA of somatomedin-C in filter paper discs<br />
containingdnied blood, 536<br />
solid-phase RIA for measuring free alpha<br />
subunit of pituitary glycoprotein hormones<br />
(A), 891<br />
HPLC<br />
See Chromatography, liquid; or analyte of<br />
interest<br />
Human genome<br />
on mapping the human genome (0), 349<br />
Human immunodeflciency virus<br />
See HIV, Acquired immunodeficiency<br />
syndrome<br />
Hyahne membrane disease<br />
modified lamellar body phosphohipid assay<br />
compared with L/S ratio and<br />
phosphatidylghycerol assay for assessment of<br />
fetal pulmonary status, 24<br />
Hydrocortisone<br />
hydrocortisone succinate and hydrocortisone<br />
simultaneously detd. in plasma by reversedphase<br />
hiq. chomatog. and their<br />
pharmacokinetics in asthmatic children,<br />
1412<br />
Hydroxybutyrate<br />
acty. of serum aspartate aminotrsnafenase<br />
isoanzymes in acute myocardial infarction,<br />
67<br />
effects of a-ketobutyrate and ahydnoxybutyrate<br />
on the enzymatic deth. of<br />
acetoacetate, $.hydroxybutyrate (TB), 1469<br />
optimized kinetic automated detn. of -<br />
hydroxybutyrate, 1761<br />
Hydrozyoorticosteroids<br />
cefoxitin interferes with “Chini-Skraen”<br />
column method for urinary 17hydnoxycorticosteroids<br />
(SN), 1219<br />
Hydroxyindoheacetic acid<br />
effect of diet and specimen collection protocol<br />
on urinary 5-HIAA excretion as measured by<br />
direct HPLC: comparison of normals and<br />
carcinoid patients (A), 931<br />
urinary catechohamines, vanillylmandeic acid,<br />
5-hydroxyindoleacetic acid, and<br />
homovanillic acid measured by liq.<br />
chromatog. with electrochem. detection and<br />
use of a single mobile phase (L), 1696<br />
urinary 5-HIAA measured by three methods:<br />
cohonimetric, HPLC with electrochemical<br />
detector, and automated fluorescence<br />
polarization immunoassay (A), 931<br />
Hydroxyl radical<br />
novel spectrophotometric method for OH’<br />
detection (A), 1008<br />
Hydroxyprohine<br />
method for serum Clq based on its<br />
hydnoxyprohine content, 398<br />
2382 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Hydroxyvitamin D3<br />
three commercial kits and one liquidchromatog.<br />
method evald. for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
Hyperamylasemia<br />
hethanachol-inducad hypenamylasemia of<br />
salivary and pancreatic types without P3 in a<br />
patient without acute pancreatitis (A), 998<br />
Hyperbihirubinemia<br />
neonatal hyperbilirubinamia due to glucose-6phosphate<br />
dehydrogensse deficiency (A),<br />
1013<br />
Hypercalcemia<br />
highly sensitive two-site immunoradiometnic<br />
assay of parathyrmn, and cm. use in evaig.<br />
patients with hyparcalcemia, 1364<br />
is theophylhine toxicity associsted with<br />
hypercalcemia? (A), 1030<br />
Hypercholesterohamia<br />
See also Heart disease, Hypenhipidemia<br />
apohipoproteins C-Il and C-Ill in serum<br />
quantified by zone immunoelactrophoresis,<br />
664<br />
Hypergainmaglobulinemia<br />
ohigoclonal banding in<br />
hypergammaglobuhinemie (A), 905<br />
Hyperglycemia<br />
absence of statistical assoc. between<br />
hyperglycemia, metabolic ecidosis in type I<br />
and type II diabetic patients on chronic<br />
dialysis (TB), 1076<br />
glucose interferes in fluorometry of serum<br />
citrate in diabeticpatients with<br />
hyperglycemia (TB), 1940<br />
hyponatremia in spontaneous hyperglycemia:<br />
correlation studies in 100 patients (TB), 1941<br />
Hyperkahemia<br />
artefactual hyperkalamia induced by heparmn<br />
in patients with extreme leukocytosis (A),<br />
914<br />
Hyperlipidamia<br />
a1-antitrypain in hyperlipidamie (TB), 421<br />
stability of free apohipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hypenhipidemic subjects, 1163<br />
Hyperhipoproteinemia<br />
apohipoproteins C-Il and C-Ill in serum<br />
quantified by zone immunoelectrophonesis,<br />
664<br />
distnibn, of cychosponine in blood of a renal<br />
transplant recipient with type V<br />
hyperhipoproteinemia (CR), 423<br />
flow-cytometric datn. of high-densitylipoprotein<br />
binding sites on laukocytes, 2195<br />
Hypermagnesemia<br />
extreme hypermagnesemia caused by ingestion<br />
of epsom salts (A), 1031<br />
Hyperoxalurla<br />
two-carbon oxalogenasis compared in recurrent<br />
Ca oxalate stone formers, normal subjects,<br />
1118<br />
Hyperparathyroldism<br />
highly sensitive two-site immunoradiometnic<br />
assay of parathynin, end cm, use in evalg.<br />
patients with hypercalcemis, 1364<br />
measurement of intact parathynin by<br />
extracting two-site immunoradiomatry, 1376<br />
Hypertension<br />
assessment of Mg status (R), 1965<br />
direct detn, of angiotensin-converting enzyme<br />
inhibitors in plasma by redioanzymatic<br />
assay, 549<br />
enzyme immunossaay of angiotensin I and<br />
nenin, 1774<br />
enzyme-linked immunosorbent essay for<br />
urinary albumin at how concns. (SN), 609<br />
improved hiq.-chromatog. assay of labetalol in<br />
plasma (SN), 1450<br />
RIA of atnial natniuretic polypeptida in heattreated<br />
plasma, 674<br />
urinary N-acetyl--D-glucosaminidese and<br />
albumin not increased in mildly hypertensive<br />
subjects (TB), 1075<br />
Hyperthyroidism<br />
anomalous thyrotropin values (SN), 1213<br />
diagnostic performance of sensitive<br />
measurements of serum thyrotropin dunin<br />
severe nonthyroidal illness: role in diagnosis<br />
of hyperthyroidism, 2178<br />
economy and efficiency in routine thyroidfunction<br />
testing use of a sensitive<br />
immunoradiometnic assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
recognizing hyperthyroidism in the elderly<br />
(CR), 429<br />
Hypertriglyceridemia<br />
apohipoproteins C-Il and C-Ill in serum<br />
quantified by zone immunoelectrophoresis,<br />
664<br />
Hypoalbuminemia<br />
correction of serum fructosamine doncn. in<br />
hypoalbuminemia (A), 1003<br />
Hypopituitarism<br />
monoclonal and polyclonal antibodies<br />
compared for RIA of sometomedin-C in<br />
acromegaly or hypopituitanism, 1593<br />
Hypothermia<br />
cardiac enzyme changes in myxedema coma<br />
(CR), 622<br />
Hypothyroidism<br />
cardiac enzymes and hypothyroidism (L), 2131<br />
economy and efficiency in routine thyroidfunction<br />
testing: use of a sensitive<br />
immunoradiometric assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
Hypoxanthine<br />
hiq-chnomato. detn. of inosine, xanthine, and<br />
hypoxanthine in uremic patients receiving<br />
hemodialysis treatment (SN), 2278<br />
IFCC<br />
adaptation of IFCC-recommended method for<br />
ALT at 37 ‘C on Du Pont Dimension’” cm,<br />
chem, system (A), 992<br />
IFCC documents, 1111<br />
2334<br />
nath. ref. system for AST: RM 8430,a primary<br />
AST ref. material from NBS with U/Lwec<br />
assigned by the IFCC Ref. Method (A), 993<br />
nath. ref. system for AST: use of IFCC Ref.<br />
Method and NBSJRM 8430 for unification of<br />
daily AST results as detd. on 3 analyzers (A),<br />
993<br />
use of IFCC Ref. Method for unification of alk.<br />
phosphatasa results as determined on 4<br />
analyzers (A), 1000<br />
See Immunoglobulins<br />
Image-analysis techniques<br />
computer-intensive enhancements to the chin,<br />
lab,: image cytometry and database-derived<br />
decision tables (A), 868<br />
Image processing<br />
detection of leukemia cells with a complementmediated<br />
cytohytic reaction and an imaging<br />
sensor system (SN), 558<br />
Imipramine<br />
measurement of plasma imipramine,<br />
desipramine, and their respective 2-hydroxy<br />
metabolites (A), 1025<br />
placental transfer of drugs (A), 1028<br />
therapeutic drug monitoring of imipremine<br />
and desipramine in maintenance therapy of<br />
patients (A), 1025<br />
Immobilized antibody<br />
monoclonal antibodies used in solid-phase and<br />
liquid-phase assays, exemplified by<br />
progesterone assay, 1331<br />
surface modn. with Protein A for uniform<br />
binding of monoclonal antibodies (A), 1338<br />
Immune complexes<br />
identn. of circulating immune complexes by<br />
hih-resolution ehectrophoresis (A), 904<br />
stability of model immune complexes during<br />
zone electrophoresis and isoelectric focusing<br />
in egarose gels, 1741<br />
Immunity<br />
hymphokine technol.: its chin, and diagnostic<br />
applicn. (A), 864<br />
mol. interactions of antibodies (A), 863<br />
Immunoaffinity<br />
immunoaffinity pretreatment method for<br />
improved chromatog. detn. of fractionated<br />
bihrubin (A), 1012<br />
Immunoassay<br />
See also Immunomqtnic essay, specific type of<br />
assay<br />
accelerated-degradation testing of<br />
immunodiagnostic reagents (L), 202<br />
acty. of serum aspartate aminotransferase<br />
isoenzymes in acute myocardial infarction,<br />
67<br />
adaptation and evain, of CEDIA’” digoxin on<br />
Coulter CPA chem. analyzer (A), 943<br />
anomalous between-lab, variability in a<br />
collaborative study of CEA immunoassay<br />
(L), 1694<br />
antibodies to porcine uterofernin used in mess.<br />
of tartrate-resistant acid phosphatase, 1832<br />
appln. of novel Cr02 magnetic particles to<br />
immunoassay development (S), 1543<br />
BioMAT’”: a rapid, self-washing immunoassay<br />
system with a microparticulete solid phase<br />
(A), 1566<br />
comparison of high-sensitivity TSH assays
used to evaluate suppressed patients (TB),<br />
1943<br />
comparison of several solid supports for<br />
covalent antibody immobilization for use in<br />
immunoassays (A), 922<br />
“Delfia” and “Amanhite”: two sensitive<br />
nonisotopic immunoassey systems for assay<br />
of thyrotropin compared (SN), 1421<br />
digoxin immunoassays (A), 1052<br />
discordant results in hCG testing by<br />
monoclonal immunoasaay methods (A), 887<br />
ehectrophoresis and the isomune-LD and LD-1<br />
immuno methods compared to mess, of<br />
lactate dehydrogenase isoenzyme-1 (SN),<br />
1884<br />
eliminating interfering nonspecific binding in<br />
membrane-based solid-phase immunoassays<br />
(A),916<br />
EMIT quantitative tnicyclic antidepressant<br />
assays applied to the Hitachi 705’ <strong>Chemistry</strong><br />
Analyzer (TB), 1471<br />
EMIT’ quantitative tnicychic antidepressant<br />
assays applied to the Encore’” <strong>Chemistry</strong><br />
System (TB), 1472<br />
endogenous digoxin-hike immunoreactive<br />
factors and di?oxin immunoassays (A), 1052<br />
enhanced sensitivity immunoassay for the TDx<br />
analyzer (A), 1570<br />
epitope-selective immunoassays for holo-hCG<br />
and its free subunits (A), 888<br />
four immunoassay methods and stds.<br />
compared for measuring fibronectin (SN),<br />
126<br />
VF-IR spectroscopy in immunoassay of<br />
selected tnicychic antidepressant drugs (A),<br />
924<br />
highly sensitive immunoassays with gas-liq.<br />
chrometog. (A), 1562<br />
high-performance immobn. membrane for<br />
diagnostic immunoasseys (A), 1568<br />
immunoassay of digoxin by differential<br />
centnifn. (S), 1548<br />
Inocor’” (amrinone lactate) interferences with<br />
TI), digoxin mess. (TB), 1944<br />
lactate dahydrogenase isoenzyme 1 as detd. by<br />
inhibition with 1,6-hexanadiol and by two<br />
other methods in myocardial infarction on<br />
cardiac-bypass surery (SN), 589<br />
liposome-based colonimetric immunoassay of<br />
serum thyroxin (A), 1565<br />
multipoint kinetic immunoassay methods for<br />
quanth. of immunoglobulins (A), 917<br />
novel imnlunoesaay procedure for on-site<br />
detection of theophylhine in blood, serum, or<br />
plasma (A), 924<br />
OASIS’”: automated solid-phase immunoassay<br />
system for the decentralized lab. (A), 1571<br />
optical response immunosensors-instant,<br />
quant. immunoassay technol. for chin,<br />
diagnosis (A), 1061<br />
optimizing a membrane solid support for<br />
specific immunoassay apphns. (A), 1568<br />
phase-sepn. immunoassays (S), 1509<br />
12-protein immunoassay profile on the Cobas<br />
FARA (A), 917<br />
quant. correlation of serum to urine hCG with<br />
correction by urine creatinine in pregnancy<br />
(A),889<br />
rapid, colonimetric immunoassay for detection<br />
of human urinary huteinizing hormone and<br />
prediction of ovulation (A), 891<br />
reliability of immunoassays to detect<br />
tetrahydro-cannabinol in urine samples (A),<br />
972<br />
Roche Isomune amylsse reagent-a pancreatic<br />
amylase immunoseparation technique (A),<br />
997<br />
semiautomated, colonimetric measurement of<br />
creatine kinase-MB acty. in serum after<br />
extn. with CK-MB-specific monochonal<br />
antibody (A), 987<br />
significance of urine assay sensitivity in<br />
marijuana detection (TB), 613<br />
simultaneous sandwich photometric<br />
immunoassay with tabletted reagents (A),<br />
920<br />
solid-phase double-antibody hiposoma<br />
immunoassay for TSH in Becton-Dickinson<br />
IQ immunochem. system (A), 882<br />
solid-phase immunoassay for direct<br />
measurement of creatine kinase MB<br />
isoenzyma acty. in serum (A), 987<br />
Tandem Icon urine test for choriogonadotropin<br />
in ectopic pregnancy (A), 889<br />
thaophylline method of the Abbott “Vision”<br />
analyzer evald. (SN), 130<br />
three immunoassay methods evald. for<br />
quantifying prealbumin in serum (SN), 1430<br />
Immunoblot technique<br />
high-affinity monoclonal antibodies specific for<br />
prostatic acid phosphatase, 103<br />
immunoblottinifon detecting Bence Jones<br />
proteinuria (TB), 1079<br />
immunoblotting on polyvinyldifluonide<br />
improves detection of ohigoclonal IgG bands<br />
in CSF (TB), 1669<br />
qual. control of anti-human IgG subclass<br />
munine monoclonal antibodies in ascites by<br />
using isoelactnic focusing/affinity<br />
immunoblot anal. (A), 963<br />
rapid typing of serum paraproteins by<br />
immunoblotting without antigen-excess<br />
artifacts (SN), 1433<br />
Immunochemiluminometric assay<br />
chemiluminescence immunoassay of<br />
thyrotropin with acridinium-ester-labehed<br />
antibody evald, and compared with two<br />
other immunoassays (SN), 2096<br />
development of rapid nonradioactive<br />
immunoassay for fernitin based on enhanced<br />
luminescence (A), 906<br />
immunochemiluminometnic assay of TSH (A),<br />
882<br />
immunochemiluminometry of creatine kinase<br />
MB with a monoclonal antibody to the MB<br />
isoenzyme (5), 1517<br />
Immunochemistry<br />
See also specific analyte of interest<br />
mt. collaborative study on standn. of<br />
apolipoproteins A-I and B. part II. evaln. of<br />
contributions of antisera to amonglaboratory<br />
variance components, 2250<br />
lmmunoehectrophoresis<br />
See also specific technique of interest<br />
use of immunoglobulin heavy- and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoglobuhins, 1771<br />
Immunoenzymometric assay<br />
See also Enzyme immunoassay<br />
automation of Abbott’s AFP on the Baker<br />
Procore’”/Encore’” system (A), 919<br />
automation of a particle solid-phase hCG<br />
immunoassay (A), 888<br />
CEA, AFP, and prostate-specific antien<br />
assays developed for the Photon Elite (A),<br />
967<br />
din, usefulness of Encore’” adaptation of<br />
immunoenzymatnic essay for creatine kinase<br />
MB (A), 988<br />
comparison of Abbott monoclonal and<br />
polydlonal AFP-EIA assays as serum tumor<br />
markers (A), 926<br />
comparison of GDC’s ELISA and Syva’s EMIT<br />
for qual. detg. benzodiazepines in human<br />
urine (A), 973<br />
comparison of Hybnitech immunoradiometric<br />
and immunoenzymetnic assays of prostatespecific<br />
antigen (A), 928<br />
comparison of RIA and enzyme immunoassay<br />
measurement of ferritin concn. in pre- and<br />
post-menopausal females (A), 1032<br />
double-monoclonal immunoanzymometnic<br />
assay for alphai-fetopnotein modified for<br />
increased anal, precision (SN), 583<br />
(A), 926<br />
ELISA for detn, of insulin autoantibodies (A),<br />
921<br />
fully automated immunoenzymetnic assays for<br />
detection of FSH and LH (A), 892<br />
immunoenzymatic quantn. of low concns. of<br />
thyrotropin (SN), 1223<br />
interference in immunoenzymometnic assays<br />
using mouse monoclonal antibodies caused<br />
by human 1gM antibody to mouse IgG (A),<br />
918<br />
investigations on “hook affect” by using<br />
monoclonal antibodies against human<br />
fennitin (A), 936<br />
measurement of progesterone receptors in<br />
breast-tumor cytosols by immunoenzymatic<br />
asaa prehim. results (TB), 2308<br />
37-mm., totally automated immunoenzymetnic<br />
hTSH assay with sensitivity of 0.04 milhi-int.<br />
unit/L (A), 881<br />
nonisotopic immunoenzymetnic assay for<br />
serum fernitin (A), 936<br />
phssa.sepn. immunoassays (5), 1509<br />
qual. immunoenzymometnic technique evald,<br />
for detecting choniogonadotropin in serum<br />
and urine (TB), 721<br />
quantn. of serum prostate specific antigen by<br />
simultaneous immunoenzymetnic assay (A),<br />
928<br />
rapid (4-h) enzyme-linked RAST test for<br />
allergen-specific IgE (A), 918<br />
rapid simultaneous immunoenzymetric assay<br />
for quantn. of hLH in human serum (A), 921<br />
rapid test for hepatitis B surface antigen (A),<br />
906<br />
sensitive, specific ELISA for detection of<br />
sutoantibody to n-DNA (A), 923<br />
simultaneous immunoenzymetnic assay for<br />
FSH in serum (A), 892<br />
TDx’ Digoxin III nonextraction immunoassay<br />
for serum digoxin (A), 923<br />
two immunoenzymatic assays of<br />
choniogonadotropin in serum compared<br />
(TB), 1947<br />
Immunofixation<br />
characterization of small monoclonal protein<br />
bands with Beckman’s “Paragon”<br />
immunofixation system (TB), 617<br />
double IgA bands in serum from a patient with<br />
lymphoplasmscytoid leukemia with hairycell<br />
morphology (CR), 2317<br />
high-titer anti-HIV antibodies associated with<br />
paraprotein spike in an asymptomatic<br />
homosexual male (A), 1028<br />
investigation of congenital factor XIII<br />
deficiency and of the carrier state by<br />
immunofization (A), 1003<br />
monochonal proteins: low concn. detection by<br />
immunofixation electrophoresis (A), 904<br />
serum M-proteins in B-cell<br />
lymphomss/leukemias by high-resolution<br />
ehectrophoresis/immunofixation (A), 904<br />
serum protein electnophoresis and<br />
immunoglobulin measurements in subjects<br />
at risk for AIDS (A), 1028<br />
serum protein electrophonesis changes in 4<br />
infants with severe combined<br />
immunodeficiency (A), 1028<br />
simple silver-staining technique for detecting<br />
Bence Jones proteins in unconcd, urine (SN),<br />
561<br />
Immunofluorometric assay<br />
chemiluminescence immunoassay of<br />
thyrotropin with acridinium-esten-labeled<br />
antibody evald. and compared with two<br />
other immunoassays (SN), 2096<br />
double-label time-resolved<br />
immunofluorometry of lutropin and<br />
follitropin in serum (SN), 2281<br />
Eu and Sm as labels in time-resolved<br />
immunofhuorometric assay of follitropin, 48<br />
high-affinity monoclonal antibodies specific for<br />
prostatic acid phosphetase, 103<br />
HLA-B27 typing by flow cytofluorometny, 1619<br />
immunofluorometry of choniogonadotropin by<br />
time-resolved fluorescence spectroscopy,<br />
with a new Eu chelate as label, 1994<br />
mess, of corticotropin in unextracted plasma:<br />
time-resolved immunofluoromatric assay<br />
and immunoradiometnic assay compared<br />
with use of same monoclonal antibodies,<br />
1747<br />
time-resolved immunofluorometny of 34-kDa<br />
somatomedin-binding protein, 1126<br />
time-resolved immunofluorometry of ovarian<br />
carcinoma-associated antigenic determinant<br />
CA 125 in serum, 2191<br />
Immunofluorometry<br />
immunofluoromatry of choniogonadotropin by<br />
time-resolved fluorescence spectroscopy,<br />
with a new Eu chelate as label, 1994<br />
time-resolved imniunofluorometry of alphafetoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
Immunoglobuhln-’enzyme complex<br />
lactate dehydrogenase-immunoglobuhin Gi<br />
complex, not blocked by anti-idiotype<br />
antibody, in a patient with IgG1.X type Mproteinemia<br />
(CR), 1478<br />
patient with an IgG paraprotein and complexes<br />
of lactate dehydrogenase and IgG in the<br />
serum (TB), 1937<br />
Imniunoghobuhin-protein complexes<br />
developments in the field of the anti-LDs of<br />
the IgA, class (L), 745<br />
immunoglobuhin A (X chains) conjuated with<br />
lactate dehydrogenase in serum (CR), 1085<br />
Immunoglobulins<br />
changes in CSF IgG and apohipoprotein E<br />
indices in patients with multiple sclerosis<br />
during demyelination, remyehnation, 1155<br />
detection of circulating platelet antibodies end<br />
platelet-associated IgG by flow cytometry<br />
(A), 1004<br />
double IgA bands in serum from a patient with<br />
lymphoplasmacytoid leukemia with hairycell<br />
morphology (CR), 2317<br />
enzyme-amplified immunodetection of<br />
monoclonal proteins in unconcd. body fluids<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12,1987 2383
after immobilization on glyoxyl agarose (A),<br />
916<br />
enzyme immunoassays compared for detection<br />
of antibodies to toxoplasmosis, rubella,<br />
cytomegaha, and chlamydia (A), 924<br />
evaln. of Dart’ reagent system for detn. of<br />
immunoglobulins M, A, and G on Coulter<br />
Dacos5 chem, analyzer (A), 960<br />
evaln, of serum IgE and anti-mite-specific<br />
IgE’s in Kawasaki disease (A), 1029<br />
fluorescence enzyme immunoassay for<br />
allergen-specific IgG4 (A), 918<br />
humorsl immune responses in<br />
noninstitutionalized Down’s syndrome<br />
children (A), 1029<br />
IgG subclass measurements in the chin, lab.<br />
(R), 1707<br />
immunoblotting on pohyvinyldifluonide<br />
improves detection of ohigoclonal IgG bands<br />
in CSF (TB), 1669<br />
immunoglobulin A (A chains) conjugated with<br />
lactate dehydrogenase in serum (CR), 1085<br />
lacrimal IgE assessment with paper stripe (A),<br />
918<br />
meas. of glycated protein by a rapid, specific<br />
method for absolute quantn. of lysmne-bound<br />
glucose (SN), 1656<br />
monoclonal proteins: low concn. detection by<br />
immunofixation electrophoresis (A), 904<br />
multipoint kinetic immunoassay methods for<br />
quantn. of immunoglobulins (A), 917<br />
nonenzymatic glycation of immunoglobulins<br />
does not impair antigen-antibody binding<br />
(SN), 692<br />
ohigoclonal immunoglobulins in healthy<br />
homosexual and heterosexual couples<br />
exposed to human immunodeficiency virus<br />
(A), 905<br />
phase-sepn. immunoassays (S), 1509<br />
protein recognition of immobilized higands:<br />
promotion of selective adsorption (S), 1502<br />
radial partition immunoassay: rapid automated<br />
detn, of total IgE on the Stratus analyzer<br />
(A),904<br />
rapid (4-h) enzyme-linked RAST test for<br />
allergen-specific IgE (A), 918<br />
rate of synthesis of IgG within the blood-brain<br />
barrier and the IgG index compared in<br />
diagnosis of multiple sclerosis (SN), 113<br />
removal of interference by immunoglobuhins in<br />
an enzyme-amplified immunoassay for<br />
thyrotropin in serum (TB), 414<br />
sensitive fluoroimmunoassays for ferritin and<br />
IgE (A), 1563<br />
serum M-proteins in B-cell<br />
hymphomas/leukemias by high-resolution<br />
ehectrophonesis/immunofixation (A), 904<br />
serum protein electrophoresis and<br />
immunoglobulin measurements in subjects<br />
at risk for AIDS (A), 1028<br />
simple fluorescence immunoassay for serum<br />
IgE (A), 918<br />
simplification and standardization of IgG<br />
subclass quantn. by using monoclonal<br />
antibodies in an enzyme immunoassay (A),<br />
917<br />
turbidimetnic measurement of<br />
immunoglobuhins with bichromatic randomaccess<br />
analyzer (A), 917<br />
use of immunoglobuhin heavy- and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoglobuhins, 1771<br />
using whole bacteria, hipopolysaccharide, and<br />
sol, antigens to detect IgG, 1gM, and IgA in<br />
brucehhosis by Dot-ELISA with nitrocelluose<br />
as solid phase (A), 1570<br />
Immunoinhibition<br />
assessment of Paramax immunoinhibition CK-<br />
MB assay in acute myocardial infarction (A),<br />
987<br />
enzyme immuno-inhibition assay for<br />
theophylhine on Abbott Vision system (A),<br />
1022<br />
evahn. of pancreas-specific alphe-amylase<br />
antibody assay with different automated<br />
systems (A), 998<br />
evaln. of Paramax CK-M inhibitory antibody<br />
single-tablet assay for screening elevated<br />
serum CK-MB acty. (A), 987<br />
pancreas-specific alpha-amylase assay with<br />
synergistic action of two different<br />
monoclonah antibodies (A), 997<br />
performance of immunoinhibition assay for<br />
CK-MB with a dry-reagent strip test for CX<br />
(A), 987<br />
2384 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Immunologic disorders<br />
evaln. of immunologic disorders: selected crit.<br />
review (A), 869<br />
Immunology<br />
immunolog. capture of nucleic acid hybrids,<br />
appln. to nonradioactive DNA probe assay<br />
(5), 1526<br />
Immunometric assay<br />
chin. application of a sensitive non-isotopic<br />
. immunometric assay of thyrotropin, 179<br />
kinetic immunochem. method for simultaneous<br />
quantn. of creatine kinese isoenzymes, 237<br />
Immunonephehometry<br />
immunonephelom. of apohipoprotein B with a<br />
centrifugal analyzer (SN), 1882<br />
kinetic immunonephelometnic detn. of protein<br />
doncns. in folhicuhar fluid, 1185<br />
laser immunonephelometny for routine quantn.<br />
of urinary albumin, 209<br />
Immunoprecipitation<br />
four procedures compared for sepg.<br />
apohipoprotein A- and apohipoprotein Bcontaining<br />
hipoproteins in plasma, 1597<br />
immunohog. measurement of aspartate<br />
aminotransferase isoenzymea in health<br />
screening (A), 993<br />
plasma Fe and tnansferrin iron-binding<br />
capacity evald, by colorimetric and<br />
immunopptn. methods, 273<br />
Immunoradiometric assay<br />
caution against spuriously increased<br />
thyrotropmn values as detd. by two-site<br />
immunoradiometry (L), 1290<br />
chemiluminescence immunoassay of<br />
thynotropin with acnidinium-ester-labehed<br />
antibody evald, and compared with two<br />
other immunoessays (SN), 2096<br />
chin, value of immunoradiometry of<br />
thyrotnopin for patients with nonthyroidal<br />
illness and taking various drugs (SN), 566<br />
comparison of Hybnitech immunoradiometric<br />
and immunoenzymetric assays of prostatespecific<br />
antigen (A), 928<br />
comparison of monoclonal and polyclonal<br />
immunoassay for prostate-specific antigen<br />
(A), 927<br />
data-redn. methods for immunonadiometnic<br />
assays of thyrotnopin compared (SN), 1207<br />
development and utility of a monoclonalantibody-based,<br />
highly sensitive<br />
immunoradiometnic assay of thyrotnopin,<br />
1387<br />
discordant inter-kit results in<br />
immunoradiometry of serum thynotropin<br />
(L), 632<br />
economy and efficiency in routine thyroidfunction<br />
testing: use of a sensitive<br />
immunonadiometric assay for thyrotnopin in<br />
a general hosp. lab., 1635<br />
effect of free fatty acids and nonhipid inhibitors<br />
of thyroid hormone binding in the<br />
immunoradiometnic assay of thyroxinbinding<br />
globulin, 1752<br />
Eu and Sm as labels in time-resolved<br />
immunofluorometnic assay of folhitnopin, 48<br />
evaln. of a monoclonal immunoradiometnic<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
evahn, of Bio-Rad EchoClonal’ ultrasenaitive<br />
immunonadiometric assay for serum HTSH<br />
(A),880<br />
evaln. of Hybritech assay for prostate-specific<br />
antigen (A), 926<br />
evaln. of new breast cancer tumor marker in<br />
patients with advanced stage breast cancer<br />
(A), 929<br />
evaln. of sensitive thyrotropin assay for various<br />
thyroid disorders (A), 959<br />
highly sensitive two-site immunoradiometric<br />
sassy of parathyrmn, and chin. use in evalg.<br />
patients with hypercalcamia, 1364<br />
immunofluorometry of choriogonadotnopin by<br />
time-resolved fluorescence spectroscopy,<br />
with a new Eu chalate as label, 1994<br />
immunoradiometnic assay specific for hCG,<br />
with biotin-avidin sepn. (A), 888<br />
insulin-hike growth factor I specific<br />
monoclonal-antibody-based IRMA assay (A),<br />
893<br />
interference by anti-immunoglobuhmn G<br />
antibodies in immunoradiometric assays of<br />
thyrotropmn involving mouse monochonal<br />
antibodies (SN), 840<br />
mess. of cortidotropin in unextracted plasma:<br />
time-resolved immunofluorometric assay<br />
and immunoradiometric essay compared<br />
with use of same monochonal antibodies,<br />
1747<br />
meas. of sex-hormone-binding globulin:<br />
immunoradiometric vs binding capacity<br />
techniques (TB), 1253<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunoradiometric assay,<br />
aild further exploration of antigenic sites on<br />
choriogonadotropin, 1147<br />
measurement of intact panathynin by<br />
extracting two-site immunoradiometry, 1376<br />
myoglobin and creatine phosphokinase-MB<br />
radioassays for early detection of acute<br />
myocandial infarction for myocardial salvage<br />
therapies (A), 989<br />
prostate-specific antigen as a marker for<br />
prostatic cancer: monoclonal and polyclonal<br />
immunoassay compared (SN), 1916<br />
removal of interference by immunoglobuhins in<br />
an enzyme-amplified immunoassay for<br />
thynotropin in serum (TB), 414<br />
simultaneous solid-phase high-sensitivity TSH<br />
and free thyroxin assay (A), 881<br />
specific immunoradiometry of insulin-hike<br />
growth factor I with usa of monoclonal<br />
antibodies, 2019<br />
tech, and chin. performance of six sensitive<br />
immunoradiometnic assays of thyrotropin in<br />
serum (SN), 1439<br />
thyroid function in hospitalized patients: effect<br />
of illness and serum albumin concns. (SN),<br />
1445<br />
time-resolved immunofluonometny of ovarian<br />
carcinoma-associated antigenic determinant<br />
CA 125 in serum, 2191<br />
two-site immunoradiometric assay for TSH<br />
using magnetic sepn. (A), 881<br />
value and limitations of a highly sensitive<br />
immunonadiometric assay for thyrotropin in<br />
the study of thyrotroph function (SN), 303<br />
Immunosuppressive drugs<br />
are cychophosphamide and phosphoramide<br />
mustard related in high-dose bone-marrow<br />
transplant patients? (A), 1035<br />
capillary blood, dried on filter paper, as sample<br />
for monitoring cyclosporin A concns., 1643<br />
goat-derived anti-lymphocyte globulin<br />
interferes in a double-antibody RIA of<br />
digoxmn (CR), 619<br />
graft preservation and immunosuppression in<br />
heart-lung transplantation (A), 1056<br />
identn. and anal, of 9 metabohites of<br />
cyclosponine in blood by liq. chromatog. 1:<br />
punifn. of anal. st4s. and assay optimization,<br />
1841<br />
identn, and anal, of 9 metabohites of<br />
cyclosporina in blood by hiq. chrometog. 2:<br />
comparison of patients’ results, 1851<br />
potential of monoclonal antibodies to improve<br />
therapeutic monitoring of cyclosponine, 32<br />
Immunoturbidimetry<br />
changes in CSF IgG and apohipoprotemn E<br />
indices in patients with multiple sclerosis<br />
during demyelination, remyahination, 1155<br />
detn. of serum proteins on Boehringer<br />
Mannheim-Hitachi 704 analyzer (A), 958<br />
development of turbidimetnic immunoasaay for<br />
C-reactive protein on the Abbott Spectrum<br />
(A), 903<br />
evain. of Dart’ reagent system for detn. of<br />
immunoglobuhins M, A, and G on Coulter<br />
Dacos’ chem, analyzer (A), 960<br />
evahn. of two immunoturbidimetric C-reactive<br />
protein assays on the Hitachi 705 (A), 903<br />
four immunoassay methods and stds.<br />
compared for measuring fibronectin (SN),<br />
126<br />
immunotunbidimetric measurement of retinolbinding<br />
protein (A), 935<br />
immunoturbidimetry for detg. apohipoprotein<br />
E (A), 896<br />
immunoturbidimetry of albumin in serum,<br />
CSF, and urine with a unique calibration<br />
curve (TB), 1260<br />
immunoturbidimetry of apolipoprotein A-Il in<br />
a centnif, analyzer (L), 1302<br />
immunoturbidimetry of apohipoprotein B in<br />
serum (TB), 1267<br />
immunoturbidimetry of haptoglobin and<br />
transfernin in the EPOS 5060 analyzer (TB),<br />
1257<br />
immunoturbidimatry of transthyretin<br />
(prealbumin) in serum (TB), 1260<br />
immunotunbidimetny (RA’” System,<br />
Technicon) of serum theophylhine in a<br />
Hitachi 705 (TB), 1077<br />
hiq.-chromatog. detn, of 2-microglobuhin, niacid<br />
glycoprotein, and albumin in urine, 1756<br />
measurement of human serum C-reactive
protein on Abbott Vision’” system (A), 903<br />
more on immunoturbidimetry of urinary<br />
albumin (L), 198<br />
quant. detn. of apohipoproteins A-I and B with<br />
a rapid immunoturbidimetnic assay (A), 897<br />
quantn. of prealbumin in human serum by<br />
immunoturbidimetry (A), 902<br />
rapid, economical immunoturbidimetric<br />
method for microalbuminunia (L), 204<br />
three immunoassay methods evald, for<br />
quantifying prealbumin in serum (SN), 1430<br />
Inborn errors of metabolism<br />
See Heritable<br />
Infection<br />
disorders<br />
enzyme immunoassays compared for detection<br />
of antibodies to toxoplasmosis, rubella,<br />
cytomegala, and chlamydia (A), 924<br />
immunolog. capture of nucleic acid hybrids,<br />
apphn. to nonnadioactive<br />
(S), 1526<br />
DNA probe assay<br />
phosphohipids turnover in avian tuberculosis<br />
(A), 1036<br />
proteins<br />
907<br />
Infertility<br />
and hormones in Echinococcosis (A),<br />
Sea also Fertility<br />
Inflammation<br />
studies<br />
prehim. chin, studies of C-reactive protein<br />
quantified<br />
2185<br />
by enzyme-linked immunoassay,<br />
proteins and hormones in Echinococcosis (A),<br />
907<br />
Inflammatory bowel disease<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-hiq.<br />
Information<br />
chromatog., 1869<br />
for Authors<br />
Information for Authors, 1<br />
proposed change to Information for Authors:<br />
precision (L), 2323<br />
Infrared spectroscopy<br />
computer-aided IR anal, of urinary calculi<br />
(SN), 2070<br />
FT-IR spectroscopy in immunoassay of<br />
selected tnicychic antidepressant drugs (A),<br />
924<br />
FTIR-spectroscopy<br />
(A),961<br />
of glucose in whole blood<br />
Inherited anomalies<br />
See Heritable<br />
Inosine<br />
disorders<br />
hiq-chnomatog. detn. of inosine, xanthine, and<br />
hypoxanthine in unemic patients receiving<br />
hemodialysis treatment (SN), 2278<br />
Instrumentation<br />
See also Discrete analysis, Continuous-flow<br />
analysis, etc.<br />
adaptation<br />
bihirubin<br />
and evaln, of Dart#{174} total and direct<br />
reagent to Couhten CPA (A), 942<br />
Amdev’s “Lytening 1” Na+ and K+ analyzer<br />
evald. (TB), 416<br />
applicn. of Behring reagents to EM<br />
Diagnostics, EPOS’” analyzer (A), 954<br />
assessment<br />
operating<br />
of two glucose meters<br />
room (TB), 1676<br />
in the<br />
blood collection to results: new system that<br />
performs<br />
correlation<br />
all steps of chin, anal. (A), 1560<br />
studies for whole blood vs plasma<br />
with the “Vision” analyzer (TB), 1268<br />
dual fluorometnic/colorimetric detection<br />
system for an automated random-access<br />
instrument utilizing std. polystyrene test<br />
tubes as precision cuvettes (5), 1554<br />
estimates of precision<br />
CX’”3 chin, system<br />
on Beckman Synchron<br />
according to NCCLS<br />
guidelines (A), 940<br />
evaln. of anal, and operational performance of<br />
Labsystems FP 901 chem. analyzer (A), 944<br />
evaln. of Coulter CPA chem. analyzer<br />
Dart’ chem, reagents (A), 942<br />
evaln. of Coulter CPA chem, analyzer<br />
with<br />
with<br />
Dart#{174} enzyme reagents (A), 942<br />
evahn. of the Ames “Senalyzer” (TB), 1255<br />
evaln. of the Boehninger Mannhaim<br />
“Reflotron” analyzer (TB), 1254<br />
evaln. of the Hitachi 704 automatic<br />
(SN), 2089<br />
avahn. of the IL 482 CO-Oximeter<br />
analyzer<br />
(TB), 1942<br />
evaln. of the Kodak “DT 60” analyzer (TB),<br />
1255<br />
improved Jaff#{233} creatinine reagent for the<br />
“Parallel” analyzer (TB), 2124<br />
measurement of spohipoprotein A-I in serum<br />
with the Technicon<br />
1266<br />
negative interference<br />
RA-1000 system (TB),<br />
with the Du Pont aca<br />
method<br />
1303<br />
for measuring digoxin-a reply (L),<br />
OASIS’”: automated solid-phase immunoassay<br />
system for the decentralized lab. (A), 1571<br />
performance characteristics of Beckman Ideal<br />
chin. analyzer (A), 964<br />
performance characteristics of Beckman<br />
Synchron CX’”3 chin, system for detn. of Na,<br />
K, Cl, and CO2 (A), 940<br />
performance characteristics of Beckman<br />
Synchron CX’”3 chin. system for detn. of<br />
urea N, glucose, Ca, and creatinine (A), 940<br />
performance characteristics of <strong>Clinical</strong> System<br />
100 (A), 941<br />
performance evaln. of DataChem’s clinical<br />
analyzer (TB), 1934<br />
performance of two time-dependent analyses<br />
compared with an end-point analysis, in<br />
DataChem’s clinical analyzer (TB), 2121<br />
performance testing of Synchnon CX’”3 system<br />
(A), 940<br />
precision evaln. of the Olympus “Demand” in<br />
chin, use (TB), 416<br />
prehim. evaln. of Shimadzu CL-20D selective<br />
batch chem. analyzer (A), 946<br />
protocol for detn, of cuvette washer efficiency<br />
in automated chem. analyzers applied to<br />
Beckman Synchron CX’”4 (A), 940<br />
reagent comparison on the EPOS system (A),<br />
954<br />
re-use of Random Access Fluid recovered from<br />
the waste of the Technicon RA-1000 (TB),<br />
1261<br />
serum protein reagent for use in the Parallel#{174}<br />
analytical system not susceptible to<br />
interference by daxtrans (L), 1953<br />
Insulin<br />
computer-assisted insulin delivery for NPH<br />
and regular insulins based on solid-phase<br />
reagent glucose values (A), 985<br />
ELISA for detn. of insulin autoantibodies (A),<br />
921<br />
free and total insulin as detd. after pptn. with<br />
polyethylene glycol: anal. characteristics,<br />
effects of sample handing, storage, 93<br />
lactate and pyruvate ehectrochem. biosensors<br />
for whole blood in extracorporeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
monoclonal and polyclonal antibodies<br />
compared for RIA of somatomedin-C in<br />
acromegaly or hypopituitarism, 1593<br />
Insulin-like growth factor<br />
chemiluminescence immunoessay for<br />
somatomedin C in serum, 1989<br />
insulin-hike growth factor I specific<br />
monochonal-antibody-based IRMA assay (A),<br />
893<br />
natural and recombinant DNA-derived insulinhike<br />
growth factor-I compared for use in<br />
nadiohigand assays, 544<br />
RIA for human glucose-dependent<br />
insuhinotropic polypeptide (GIP) (A), 893<br />
specific immunoradiomatry of insulin-like<br />
growth factor I with use of monoclonah<br />
antibodies, 2019<br />
time-resolved immunofluorometny of 34-kDa<br />
somatomedin-binding protein, 1126<br />
Interference<br />
See Analytical error; Variation, source of<br />
“Interferographs”<br />
rating chin. chem, instruments: evaln, of effect<br />
of interferences under std. conditions (A),<br />
964<br />
Interferon<br />
time-resolved fluoroimmunoassay vs ELISA for<br />
detn. of a-2-interferon (TB), 1070<br />
Inter-instrument comparison<br />
anal, systems ranked by freedom from<br />
interferences (SN), 1453<br />
Interlaboratory performance<br />
cholesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
hipoprotein, 390<br />
collaborative study on CEA immunoassay<br />
shows large variability of measurements and<br />
uncertainty of chin, assessment (A), 924<br />
comment on fructosamine qual.-assessment<br />
survey (L), 1952<br />
evaln. of lutropin and prolactin kits in an<br />
intenlab, survey (A), 907<br />
feasibility of centralized mass, of glycated Hb<br />
in the Diabetes Control and Complications<br />
Trial: a multicenten study (SN), 2267<br />
mt. collaborative study on standn. of<br />
apohipoproteins A-I and B. part I. evaln, of a<br />
hyophihizad candidate ref. and calibration<br />
material, 2240<br />
lab, performance and regulatory requirements<br />
(SR), 1087<br />
performance of quant. urine anal. in<br />
Australasia critically assessed, 792<br />
results from natl. interlab. quality-control<br />
survey for cyclosponin assay (A), 978<br />
Intermethod comparison<br />
accuracy of three triglycerides methods on<br />
Technicon RA-1000’ (A), 900<br />
alpha-fetoprotein and estrogen/progestin<br />
receptors in breast cancer patients (A), 929<br />
Ames Clinitek 200/Multistix 9 urinalysis<br />
method: comparison with manual methods<br />
(A), 980<br />
applicn. of Ciba-Corning Diagnostics Mg<br />
reagent to various din. chem. analyzers (A),<br />
1008<br />
Beckman Array’” and Behring nephelometer<br />
system compared for five protein analytes<br />
(A), 947<br />
bias among enzymatic methods for cholesterol<br />
(A), 894<br />
Bio-Rad cyclosponine assay compared with<br />
cychosporine assayed in our lab. by Moyer’s<br />
HPLC method (A), 978<br />
chin, utility of several assays for detection of<br />
HIV antigen or antibody (A), 1028<br />
comparability of NatI. Ref. System total<br />
cholesterol Ref. and Definitive Methods (A),<br />
894<br />
comparative study between deutenium arc and<br />
Zeeman background correction systems for<br />
measurement of Pb in biol, fluids by<br />
electrothermal atomic absorption<br />
spectrometry (A), 934<br />
comparison of Abbott monochonal and<br />
polyclonal AFP-EIA assays as serum tumor<br />
markers (A), 926<br />
comparison of Abbott TDX and traditional<br />
radiometnic methods for assay of thyroxin<br />
uptake in serum from four classes of sick<br />
patients (A), 885<br />
comparison of automated CN-containing and<br />
CN.free methods for Hb detn. on Technicon<br />
H1’” (A), 1000<br />
comparison of Beckman, Bio-Rad, and Tago<br />
anal, systems for detn. of serum<br />
apohipoproteins A-I and B (A), 898<br />
comparison of Diagnostic Products Coat-A-<br />
Count (RIA) with gas chromatog./mass<br />
spectrometry for detn, of morphine in blood<br />
(A), 970<br />
comparison of enzyme immunoassay and RIA<br />
for cancer antigen 125 (CA 125) (A), 931<br />
comparison of ES 600 automated enzyme<br />
immunoessay system with Stratus<br />
immunofluonometny and manual RIA (A),<br />
947<br />
comparison of GDC’s ELISA and Syva’s EMIT<br />
for qual. detg. benzodiazepines in human<br />
urine (A), 973<br />
comparison of Gilford and BMD reagents for<br />
Hitachi 705 analyzer (A), 966<br />
comparison of high-sensitivity TSH assays<br />
used to evaluate suppressed patients (A), 881<br />
comparison of Hybritech immunonadiometnic<br />
and immunoenzymetric assays of prostatespecific<br />
antigen (A), 928<br />
comparison of 8 immunoassay procedures for<br />
fernitin in human serum (A), 958<br />
comparison of methods for CK-MB detection<br />
in 58 patients in a coronary-care unit (A),<br />
989<br />
comparison of 4 methods for detg. amyhase in<br />
serum and urine (A), 997<br />
comparison of monochonal and pohychonah<br />
immunoassay for prostate-specific antigen<br />
(A), 927<br />
comparison of plasma cortisol detns. b Abbott<br />
TDx’” and competitive protein binding for<br />
dexamethasone suppression test (A), 959<br />
comparison of RIA and enzyme immunoassay<br />
measurement of ferritin concn. in pre- and<br />
post-menopausal females (A), 1032<br />
comparison of Roche RIA, Roche EIA, and<br />
Hybnitech EIA methods for CEA (A), 924<br />
comparison of thin-layer chromatog., immunol.<br />
and enzymatic methods for determining<br />
phosphatidyhglycerol in amniotic fluid (A),<br />
900<br />
comparison of thyroxin detns. by TDx’” T4<br />
Plus and TDx’” thyroxin (A), 883<br />
comparison of two essays for prostate-specific<br />
antigen (A), 926<br />
comparison of two digoxin immunoasseys using<br />
a Cobas Bio with Kahlestadt EllA (A), 1014<br />
computer-assisted evaln, and implementation<br />
of an ahphe-fetoprotein essay (A), 925<br />
enzyme immunoassays compared for detection<br />
of antibodies to toxoplasmosis, rubella,<br />
CLINICAL CHEMISTRY, Vol.33, No. 12,1987 2385
cytomegala, and chlamydia (A), 924<br />
evaln, of accuracy of Seralyzer’ glucose<br />
(haxokinase) and 5 glucose methods<br />
compared to National Glucose Ref. Method<br />
(A), 952<br />
evaln. of 6 digoxin kits for accuracy and DLIS<br />
interference (A), 1015<br />
evaln. of DuPont Analyst and Ne/K analyzers<br />
for physician office testing (A), 936<br />
evaln. of pancreas-specific alpha-amyhase<br />
antibody assay with different automated<br />
systems (A), 998<br />
evaln. of portable Eastman Kodak DT-60<br />
system in hosp. environment (A), 961<br />
evain. of 8 procedures for human lipasa (A),<br />
958<br />
evaln, of prostate-specific antigen for follow-up<br />
of prostate cancer using two commercially<br />
available kits (A), 928<br />
avaln. of several analytes by Cobas Mina and<br />
comparison with Technicon SMA-II-C<br />
analyzer (A), 965<br />
four immunoaasay methods and stda.<br />
compared for measuring fibronectin (SN),<br />
126<br />
improved correlation of Trinder uric acid<br />
reagent to ultraviolet uric acid reagent (A),<br />
956<br />
measurement of liver enzymes by Reflotron<br />
and Vision for blood-donor screening (A),<br />
945<br />
method comparison of two cychosponina assays<br />
by RIA (A), 977<br />
3 methods compared for anal. of creatine<br />
kinase isoenzyma MB in a tertiary-care hosp.<br />
(A), 989<br />
office.testing systems: cholesterol and<br />
triglycerides (A), 948<br />
rating chin. chem. instruments: evaln. of affect<br />
of interferences under sul. conditions (A),<br />
964<br />
reliability of immunoassays to detect<br />
tetrahydro-cannabinol in urine samples (A),<br />
972<br />
results compared for C-reactive protein detns.<br />
by Roche Cobas-Bio, Beckman ICS and Du<br />
Pont aca (A), 964<br />
RIA for methadone in urine with comparisons<br />
to other anal, techniques (A), 970<br />
sensitive essays for thyrotnopin (A), 880<br />
TDx’ T4 Plus, fully automated assay<br />
eliminating serum-denaturing pretreatment<br />
procedure (A), 883<br />
Technicon C-reactive protein assay for the RA-<br />
1000 compared with Beckman ICS (A), 920<br />
urinary 5-HIAA measured by three methods:<br />
colorimetnic, HPLC with ehectrochemical<br />
detector; and automated fluorescence<br />
polarization immunoassay (A), 931<br />
use of IFCC Ref. Method for unification of alk.<br />
phoaphetase results as determined on 4<br />
analyzers (A), 1000<br />
International Federation of <strong>Clinical</strong><br />
<strong>Chemistry</strong><br />
See IFCC<br />
Intestinal permeability<br />
thin-layer chromatog. detn, of urine excretion<br />
of lactulose, simplified and applied to cystic<br />
fibrosis patients (SN), 1211<br />
Intra-individual variation<br />
accuracy and precision of breath-alcohol<br />
measurements for a random subject in the<br />
postabsorptive state, 261<br />
assay of serum fructosamina that minimizes<br />
standn. and matrix problems: use to assess<br />
components of biol. variation, 269<br />
assessment of monthly, weekly, and daily<br />
variability of chin. chem. procedures on<br />
women fed a constant or self-selected diet<br />
(A),935<br />
double-monoclonal immunoenzymometnic<br />
assay for alphai-fetoprotein modified for<br />
increased anal. precision (SN), 583<br />
examn. of heart proteins by 2-D<br />
electrophoresis, 2011<br />
importance of time between repeated mess, of<br />
total or high-density lipoprotein cholesterol<br />
when estg. an individual’s baseline concns.<br />
(SN), 1913<br />
intra-individual variation in 24-h craatinine<br />
excretion and 24-h urinary volume (A), 1033<br />
intra-individual variation of analytes in serum<br />
from patients with chronic liver diseases,<br />
1133<br />
intra-individual variation of some analytes in<br />
serum in insulin-dependent diabetes, 57<br />
melatonin secretion assessed by measuring its<br />
matabolite, 6-sulfatoxymalatonin, 1343<br />
2386 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Intralaboratory performance<br />
assessment of the use of fixed limits to<br />
characterize intralab. performance by<br />
proficiency testing (SN), 1901<br />
interlab. proficiency-testing programs:<br />
computer model to assess their capability to<br />
correctly characterize intralab, performance,<br />
784<br />
Inuhin<br />
enzymatic detn. of inuhin (TB), 1070<br />
Iodothyronines<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
Ion-pair chromatography<br />
comparative measurements for datn. of alkali<br />
ions in blood serum by ion-chromatog. (TB),<br />
617<br />
Ion-selective electrodes<br />
acty. measurements of Ca2, Na+, K+, and C1<br />
after equilibrium dial, used to show lack of<br />
evidence for protein interference with Cs<br />
electrodes, 1811<br />
detn. of inorganic F- in blood with a Fselective<br />
electrode, 253<br />
deth. of Li in human serum using an<br />
automated direct ion-selective electrode<br />
analyzer (A), 1027<br />
direct ion-selective electrode analyzer (NOVA<br />
11+11) evald, for detg. Li in serum (TB),<br />
1668<br />
effects of PO4 and HEPES/MOPS buffers on<br />
calibration of Na+ and K+ ion-selective<br />
electrodes for chin, anal. (A), 1005<br />
alectrochem, detn, of Hb, hemetocnit, and<br />
hemolysis (SN), 153<br />
evain. of Cl ion-selective electrode for the<br />
Paramax’ anal. system (A), 953<br />
generation 04 Na+ slides and generation 04 ref.<br />
fluid evald, for use with the Ektachem 400<br />
Analyzer (SN), 845<br />
interference in an ehectrochem. detection<br />
system for penoxidase-linked reactions based<br />
on a fluoride ion-selective electrode (SN),<br />
1458<br />
ion-selective electrodes: theory and new<br />
pplicns. (A), 871<br />
LITE: device for coupling ion-selective<br />
electrode assay to an optical reading<br />
instrument (A), 960<br />
more on detn, of Ca2’ in blood with ionselective<br />
electrodes (L), 444<br />
naproxen interference with the ion-selective<br />
electrode in the RA-1000 (TB), 421<br />
new developments in electrode technol. (A),<br />
873<br />
recent advances in design of anion and gas<br />
selective potentiometric sensors (A), 1061<br />
temp. -dependent results with the ChemPro-<br />
1000 (L), 443<br />
Ion-selective field effect transistors<br />
intravascular performance of cathetermounted<br />
pH.ISFET5 (A), 960<br />
Iron<br />
automated detns. for total iron and UIBC in<br />
serum (A), 932<br />
commercial alactrochem. method evald. for<br />
mess. of Fe status (SN), 1645<br />
detn, of serum Fe and TIBC by Du Pont<br />
Dimension’” chin. chem. system (A), 944<br />
interpreting results of coulometry and<br />
immunopptn. in diagnosing Fe disorders<br />
(SN), 1215<br />
plasma Fe and transfernin iron-binding<br />
capacity evald. by cohonimetnic and<br />
immunopptn. methods, 273<br />
ref. values for Fe, TIBC, and ferritin in a<br />
baboon colony (Papio species) (A), 1036<br />
serum Fe assay on Abbott Spectrum’ and VP’<br />
(A), 957<br />
serum transferrin concns. and indices of Fe<br />
stores in normal subjects (A), 1032<br />
thin-film cohorimetnic assay for serum iron (A),<br />
932<br />
transfenrin binding of Al3 and Fe3’, 405<br />
Iron-binding capacity<br />
plasma Fe and transferrin iron-binding<br />
capacity evald. by cohorimetnic and<br />
immunopptn. methods, 273<br />
Isehemia<br />
improved procedure for detg. glutathione in<br />
plasma as an index of myocerdial oxidative<br />
stress (SN), 1448<br />
serum guansse acty. in expl. models of hepatic<br />
injury (A), 995<br />
ISO-DALT<br />
See Electrophorasis, two-dimensional<br />
Isoelectric focusing<br />
See also Ehectrophonesis, two-dimensional<br />
alk. phosphatase isoenzymes by isoehectric<br />
focusing: correlation with chin. findings (A),<br />
999<br />
spohipoproteins C-hI and C-Ill in serum<br />
qusntified by zone imxnunoelectrophoresis,<br />
664<br />
intact tissue specimens obtained by fine-needle<br />
aspiration of the prostate used to<br />
demonstrate tissue acid phosphatase<br />
isoenzymas (A), 927<br />
isoehactnic focusing of fine-needle aspirates of<br />
prostate: demonstration of tissue acid<br />
phoephatase isoenzyme pattern in<br />
hyperplasis and malignancy (A), 927<br />
isoehectrofocusing of serum prostatic acid<br />
phosphatase (A), 927<br />
qual. control of anti-human IgG subclass<br />
murine monochonal antibodies in ascites by<br />
using isoehectnic focusing/affinity<br />
immunobhot anal. (A), 963<br />
rapid typing of serum paraproteins by<br />
immunoblotting without antigen-excess<br />
artifacts (SN), 1433<br />
sepn. and identn, of alk. phosphatase<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoelectnic focusing, 2171<br />
serum alk. phosphatase isoenzymes in<br />
hepatobihiary disorders resolved by use of<br />
immobilized pH gradients, 653<br />
stability of model immune complexes during<br />
zone alectrophoresis and isoehectnic focusing<br />
in agarose gels, 1741<br />
Isoenzynies<br />
See also enzyme of interest<br />
activity vs mass detn. of serum CK-MB<br />
isoenzyma for detecting coronary repenfusion<br />
in acute myocardial infarction after<br />
therapeutic thrombolysis (A), 989<br />
acty. of serum aspartate aminotransferese<br />
isoenzymes in acute myocardial infarction,<br />
67<br />
adaptation and evaln. of kinetic color reagent<br />
for ahectrophoretic visualization of 5’nucheotidese<br />
isoenzymes (A), 957<br />
alk. phosphatasa isoenzymes by isoelectnic<br />
focusing: correlation with chin. f’mdings (A),<br />
999<br />
alk. phosphatase isoenzymes incompletely<br />
resolved by “fast protein hiq. chromatog.”<br />
(L), 2327<br />
alk, phosphatase iaoenzymes in the plasma of<br />
preterm and term infants: serial<br />
measurements and chin, correlations, 1783<br />
alternative calibration scheme for the<br />
Ektachem CK.MB slide (L), 1492<br />
anal, of cneatine kinase iaoenzymes and<br />
isoforms in serum to detect raperfusion after<br />
acute myocardial infarction, 507<br />
antibodies to porcine uteroferrin used in mess.<br />
of tartrate-resistant acid phosphatase, 1832<br />
epphn. of novel Cr02 magnetic particles to<br />
immunoassay development (5), 1543<br />
assessment of Paramax immunoinhibition CK-<br />
MB assay in acute myocerdial infarction (A),<br />
987<br />
automated detn. of CK-MB isoenzyme with<br />
Coulter CPA (A), 943<br />
bethanechol-induced hyperamylasemia of<br />
salivary and pancreatic types without P3 in a<br />
patient without acute pancraatitis (A), 998<br />
cardiac enzymes and hypothyroidism (L), 2131<br />
changes in elk. phosphatase isozyme from<br />
normal subjects and patients with various<br />
diseases (A), 999<br />
characterization and assar of tartrate-resistant<br />
acid phosphatase acty. in serum: potential<br />
use to assess bone resorption, 458<br />
CK-BB and -MB concns, in premature infants<br />
(A),990<br />
cm, usefulness of Encore’” adaptation of<br />
immunoenzymatnic assay for creatine kinase<br />
MB (A), 988<br />
commercial prapn. of lactate dehydrogenasa<br />
isoenzymes are not homo[enaous (L), 1289<br />
comparison of methods for CK-MB detection<br />
in 58 patients in a coronary-care unit (A),<br />
989<br />
creatine kinasa-MB as a marker of doxorubicin<br />
cardiotoxicity (A), 1036<br />
customized cardiac profile reporting for<br />
isoenzyme electnophoresis (A), 982<br />
detection of isosnzymes associated with drug<br />
resistance on specific chromosomes by<br />
agarose electrophoresis (A), 998<br />
detg. serum isoenzyme pattern of ‘yglutamyhtranspeptidase:<br />
ref. intervals for
normal subjects and patients with<br />
hepetobihiary diseases (A), 994<br />
detn. by RIA of the mass of lactate<br />
dehydrogenasa isoenzyme 1 in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
developments in the field of the anti-LDs of<br />
the IgA. class (L), 745<br />
differential assay of salivary, pancreatic oamyhese<br />
in serum, urine, with use of<br />
monochonal antibody to human salivary<br />
amylase immobilized on bacterial cell wail<br />
(SN), 1235<br />
distribution of lactate dehydroganase<br />
isoenzymes in various organs of male albino<br />
Sprague-Dawley rats (A), 1036<br />
Du Pont aca CK-MB method, verified for use<br />
in reporting 100% recovery of CK-MB (TB),<br />
1268<br />
early dia#{231}nosis of acute myocardial infarction<br />
by rapid anal, of creatine kinese isoenzyma-3<br />
(CK-MM) sub-types, 358<br />
ehectrophoresis and the isomune-LD and LD-1<br />
immuno methods compared to mess, of<br />
lactate dahydroganase isoenzyme.l (SN),<br />
1884<br />
electrophoretic sepn. of 5’-nucheotidase by<br />
using a single substrate-color reagent (A),<br />
995<br />
elevated CK-BB isoenzyme concns. in a patient<br />
with carcinoid tumor (A), 1034<br />
avaln, of EMDS CK-MB test pack for Du Pont<br />
aca analyzer (A), 988<br />
evaln, of ion-exchange chromatog. system for<br />
quant. detn, of CK-MB (A), 988<br />
avaln. of Isopal system (Anahis/Behgium)<br />
sepn. of elk. phosphatase isoenzymes<br />
958<br />
for<br />
(A),<br />
evahn, of Kodak thin-film slides for<br />
theophyhline, Mg, and creatine kinase-MB<br />
(A),951<br />
evain, of multiple trauma patients by using<br />
direct assay of CK isoenzymes (A), 1034<br />
evain, of pancreas-specific alpha-amyhase<br />
antibody assay with different automated<br />
systems (A), 998<br />
evaln. of Paramax CK-M inhibitory antibody<br />
single-tablet assay for screening elevated<br />
serum<br />
evidence<br />
CK-MB acty. (A), 987<br />
that human, rabbit, and bovine<br />
creatine kinese iaoenzymes are ghycoproteins<br />
(A),991<br />
heterogeneity of comm. preparations of human<br />
lactate dehydrogenese<br />
hypothermic myxademe<br />
isoanzymes (A), 991<br />
coma erroneously<br />
diagnosed<br />
increased<br />
as myocardial infarct, because<br />
creatine kmase MB (CR), 1083<br />
of<br />
identifying CK-MB and macro-CK by<br />
ehectrophoresis (L), 1954<br />
immunochemiluminometry<br />
MB with a monoclonal<br />
of creatine kinase<br />
antibody to the MB<br />
isoenzyme (5), 1517<br />
immunoghobulin A (A chains) conjugated with<br />
lactate dehydrogenase<br />
immunolog. measurement<br />
in serum (CR),<br />
of aspartate<br />
1085<br />
aminotransferase isoenzymes in health<br />
screening (A), 993<br />
increased activities of CK-MB and LD-2 in a<br />
patient with metastatic ovarian tumor (A),<br />
930<br />
increased activities of creatina kinase and<br />
lactate<br />
patient<br />
1484<br />
dehydrogenase<br />
with metastatic<br />
isoenzymes in a<br />
ovarian tumor (CR),<br />
increased creatine kinase and CK-MB in<br />
patients with acute respiratory distress<br />
989<br />
(A),<br />
increased serum lactate dahydrogenase<br />
isoenzyme 1 and “flipped” LD-1/LD-2 ratio<br />
in myopathy associated with partial<br />
carnitine palmitoyltransfaraae deficiency<br />
(CR), 2111<br />
intact tissue<br />
aspiration<br />
specimens obtained by fine-needle<br />
of the prostate used to<br />
demonstrate tissue acid phosphatase<br />
isoenzymes (A), 927<br />
interference by platelets in electrophoratic<br />
detn. of enolase isoenzymes in plasma (SN),<br />
164<br />
isoehectric focusing of fine-needle aspirates<br />
prostate: demonstration of tissue acid<br />
of<br />
phoaphatese<br />
hyperplasia<br />
isoenzyme pattern in<br />
and malignancy (A), 927<br />
isoehectnic focusing of siehidase-treated<br />
phosphatase isoenzymes on agarose<br />
alk.<br />
gal (SN),<br />
830<br />
isoehectrofocuaing of serum prostatic acid<br />
phosphatase (A), 927<br />
isoforms of creatine kinase isoenzymes in<br />
serum in acute myocand. infarct after<br />
intracoronary thrombohysis, 2039<br />
isolation and punifn. of placental-type alk.<br />
phosphatase from a seminoma, 248<br />
isolation of mitochondnial lactate<br />
dehydrogenase (A), 995<br />
kinetic immunochem, method for simultaneous<br />
quantn. of creatine kinase isoenzymes, 237<br />
lactate dehydnogenase-immunoglobuhin G1<br />
complex, not blocked by anti -idiotype<br />
antibody, in apatient with IgGl-A type Mproteinemia<br />
(CR), 1478<br />
lactate dehydrogenase isoenzyme I as detd. by<br />
inhibition with 1,6-hexanedioh and by two<br />
other methods in myocardial infarction or<br />
cardiac-bypass surgery (SN), 589<br />
lactate dehydrogenase isoenzyme 1 detd, by<br />
inhibition with 1,6-hexanediol (A), 992<br />
lactate dehydnogenase isoenzyme<br />
electrophoretic essay utilizing kinetic<br />
techniques (A), 991<br />
lactate dehydrogenase isoenzymes in serum<br />
during recent acute myocardial infarction<br />
(SN), 1419<br />
low-and creatine kinase threshold for CK<br />
isoenzyme testing (A), 990<br />
math, treatment of data for calculating<br />
activities of a-amylase isoenzymes (SN), 689<br />
3 methods compared for anal, of creetine<br />
kinase iaoenzyme MB in a tertiary-care hosp.<br />
(A), 989<br />
monoclonal antibodies specific for the CK-M<br />
subunit and the CK-MM dimer (A), 986<br />
monochonal antibody that specifically inhibits<br />
salivary a-amyhase, 1158<br />
myoglobin and creatine phosphokinase-MB<br />
radioaasays for early detection of acute<br />
myocardial infarction for myocardial salvage<br />
therapies (A), 989<br />
N-acetyl--D-ghucosaininidase isoenzymes in<br />
urine assayed by ion-exchange chromatog.,<br />
1796<br />
new aspects of certain properties of human<br />
urinary elk. phosphetaaes (A), 999<br />
no catalase isoenzymes in serum (TB), 2302<br />
normal baseline values for CK-MB by two<br />
methods compared (L), 1951<br />
pancreas-specific ahpha-amylase essay with<br />
synergistic action of two different<br />
monocloneh antibodies (A), 997<br />
performance characteristics of EM Diagnostic<br />
Systems CK-MB test packs on Du Pont aca<br />
analyzer (A), 949<br />
performance of immunoinhibition assay for<br />
CK-MB with a dry-reagent strip test for CK<br />
(A), 987<br />
postsynthetic modn. of enohase isoenzymas, 757<br />
pptn. of serum proteins by the lectin from<br />
wheat-germ (SN), 185<br />
props. of elk. phosphatase isoenzymes in<br />
plasma of preterm and term neonates, 1778<br />
radial partition immunoassay: quant. CK-MB<br />
in human serum (A), 988<br />
rapid protocol to rule Out acute myocardial<br />
infarction (A), 990<br />
reactivity of human macroemylases with mouse<br />
monochonal anti-salivary amylase antibodies<br />
(A), 998<br />
reassessment of creatine kinase BB as a marker<br />
for cancer of prostate, breast, and hung (SN),<br />
809<br />
relationship between -y-ghutamyltransferese 1<br />
isoenzyme and “fast liver” alk. phosphatase<br />
isoenzyme in serum (A), 993<br />
Roche Isomune amylase reagent-a pancreatic<br />
amyhase immunoseparation technique (A),<br />
997<br />
selective detn, of lactate dehydrogenase<br />
isoenzyme 1 by using NaChO4 (A), 991<br />
semiautomated, colorunetnic measurement of<br />
creatine kinase-MB arty. in serum after<br />
extn. with CK-MB-apecific monochonal<br />
antibody (A), 987<br />
sensitive method for sepn. of hepatomaspecific<br />
gamma-ghutaxnyltransferase<br />
isoenzymes on cellulose acetate media, using<br />
Triton-X 100 and concanavalin A (A), 994<br />
sepn. and identn. of alk, phosphatase<br />
isoanzymas and isoforms in serum of healthy<br />
persons by isoehectnic focusing, 2171<br />
serum elk. phosphatase isoenzymes in<br />
hepatobihiary disorders resolved by use of<br />
immobilized pH gradients, 653<br />
serum lactate dehydrogenase isoenzyme 1 as<br />
tumor marker in testicular cancer (A), 932<br />
signif. of increased serum lactate<br />
dehydroganase isoenzyme 5 in acute infero.<br />
posterior myocardial infarction (TB), 2309<br />
simultaneous sepn. of cardiac isoenzymes CK-<br />
MB, LD-1, and LD-2 by two-dimensional<br />
(enion-exchange/immuno-effinity) column<br />
chromatog. (A), 991<br />
software program for cahcn. of amylasa<br />
isoenzymes (A), 982<br />
solid-phase immunoassay for direct<br />
measurement of creatine kinase MB<br />
isoenzyma acty. in serum (A), 987<br />
source of “intestinal” elk. phosphatase as<br />
observed with cellulose acetate<br />
electrophoresis re-examined (A), 999<br />
stabilizing LD isoanzymes<br />
(TB), 1940<br />
in control serum<br />
studies on reaction system of Reflotron’ AST<br />
assay, with cardiac and hepatic AST (A), 992<br />
time-dependent changes in bone, placental,<br />
intestinal, and hepatic elk. phosphatase<br />
activities in serum during pregnancy, 1801<br />
total absence of serum CK-MM and the<br />
presence of a CK-BB isoenzyme<br />
CK-MB position on agarose gel<br />
migrating to<br />
electrophoresis (A), 990<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: chin. and biocham. features<br />
of 21 cases and literature review (CR), 313<br />
Isomatheptene<br />
isometheptene cross reacts in the EMIT<br />
amphetamine assay (TB), 1264<br />
Isoniazid<br />
kinetics of isoniazid in children<br />
adolescents (A), 1030<br />
Isotachophoresis<br />
and<br />
quant. detn. of NH4, Na1’, K, Mg21’,Ca2,<br />
and creatinine in human urine by capillary<br />
isotachophoraais<br />
Isotope dilution-mass<br />
(A), 1005<br />
spectrometry<br />
detn. of vit. C in non-fat powdered milk by<br />
isotope-dilution-mesa spectrometry (A), 963<br />
three commercial kits end one liquidchromatog.<br />
method evahd, for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
total cholesterol in serum detd, by isotope<br />
diln,-mass spectnom., with hiq.-chromstog.<br />
sepn., 1113<br />
Jaff#{233} reaction<br />
See Creatinine<br />
Kawasaki disease<br />
evaln, of serum IgE and anti-mite-specific<br />
IgE’s in Kawasaki disease (A), 1029<br />
Ketoacidosis<br />
use of BUN/crestinine ratio and creatinine<br />
concn. as indicators of potential ketone<br />
interference in a kinetic creatinine method<br />
(A), 913<br />
Ketobutyrate<br />
effects of a-ketobutyrate and ahydroxybutyrate<br />
on the enzymatic detn. of<br />
acatoacetate, -hydnoxybutyrste (TB), 1469<br />
Ketone bodies<br />
false-positive results for ketone with the drug<br />
mesna and other free-SH cmpds. (SN), 289<br />
studies on ketone body ratio in rat plasma with<br />
ahpha-naphthyhisothiocyanate-induced<br />
chohestatic liver injury (A), 1035<br />
Ketones<br />
effect of captopril on reagent strip tests for<br />
urinary ketones (A), 981<br />
sample contamination by test strips (TB), 414<br />
Ketonuria<br />
spurious ketonunis after mesne therapy (A),<br />
913<br />
Kidney disease<br />
See also Renal disease, Renal function<br />
biotin radiohigand assay with an i2SI.labehed<br />
biotin deny,, avidin, and avidin doubleantibody<br />
reagents, 1983<br />
immunochem, methods for early detection of<br />
microalbuminunia in diabetic nephropathy<br />
(A),902<br />
improved interaasay correlation of digoxin<br />
results in patients with and without renal<br />
failure by elimination of digoxin’hike<br />
immunoreactive factors (SN), 837<br />
intra-individual variation of some analytes in<br />
serum in chronic renal failure, 670<br />
laser immunonephehometry for routine quantn.<br />
of urinary albumin, 209<br />
hiq.-chromatog. detn, of 2-microglobuhin, niacid<br />
glycoprotein, and albumin in urine, 1756<br />
Lp(a) hipoprotein in patients with chronic renal<br />
failure treated by hemodialysis (TB), 721<br />
modn. of intra-enythnocytic homeostasis in<br />
uremic patients, as studied with 31p NMR,<br />
76<br />
N-acetyl--D-glucosaminidaae assay by the pnitrophenoh<br />
technique: inhibit, effects of<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2387
urine as decreased by gel filtration and by<br />
simple diln, (TB), 713<br />
proteinuria in health and disease assessed by<br />
measuring the urinary protein/creatine ratio<br />
(SN), 297<br />
quantn. of desfernioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometny (SN), 132<br />
renal differentiated from non-renal hematuria<br />
by micros, examn. of erythrocytes<br />
1791<br />
in urine,<br />
selecting the optimum specimen for assessing<br />
slight albuminurie, and a strategy for cm,<br />
investigation: novel uses of data on biol.<br />
variation, 2034<br />
serum retinol-binding protein and creetinine<br />
onset of and recovery from acute renal<br />
in<br />
failure (TB), 1942<br />
urinary retinol.binding protein as an index of<br />
proximal tubular injury, 775<br />
Kinetic analysis<br />
cholesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
hipoprotein, 390<br />
evaln. of Ministat-S chem. analyzer (A), 939<br />
kinetics of inhibition of Hb-catalyzed oxidation<br />
of 3,3’,5,5’.tetramethylbenzidene by<br />
bihinubin and ascorbic acid (A), 912<br />
kinetic study of Jaff#{233} reaction for creetinine<br />
and quantn. of creatinine in serum (A), 1009<br />
kinetic study of the Jaff#{233} reaction for<br />
creatinine in serum: 1. alkalinity controlled<br />
with NaOH, 278<br />
lactate dehydrogenase isoanzyma<br />
ehectrophoretic essay utilizing kinetic<br />
techniques (A), 991<br />
multipoint kinetic immunoessay methods for<br />
quantn. of immunoglobulins (A), 917<br />
Kinetic assays<br />
delta bihirubin: absorption spectre, molar<br />
absonptivity, and reactivity in the diazo<br />
reaction, 769<br />
fast kinetic method for methamoghobin<br />
adapted<br />
493<br />
for quantn. of Hb in whole blood,<br />
kinetic immunochem.<br />
quantn. of creatine<br />
method for simultaneous<br />
kinase isoenzymes, 237<br />
optimized kinetic glutamate dehydrogenase<br />
assay adapted to the Cobas Bio cantnif,<br />
analyzer (TB), 1673<br />
Kinetic enzyme analysis<br />
rate assay for detg. carboxypeptidase<br />
serum (A), 962<br />
acty. in<br />
Kinetic enzyme assay<br />
development of rate BUN method for Hitachi<br />
737 (A), 1010<br />
kinetic method for uric acid detn. on RA<br />
system and effect of endogenous<br />
interferences<br />
(A), 1010<br />
in the presence of bivalent ions<br />
Kinetic iinmunonephelometry<br />
kinetic immunonephehomatric measurement of<br />
very low concns. of albumin in urine (A), 902<br />
“Kit” methods<br />
Abbott ER-EIA monochonal kit (L), 1105<br />
Amerhite and Amerhex-M assays for total<br />
tniiodothyronine compared (L), 627<br />
anal. and chin, evahn. of Enzymum-test HCG<br />
for detg. choniogonadotnopin<br />
715<br />
in serum (TB),<br />
anomalous thyrotropin values (SN), 1213<br />
automated<br />
enzyme<br />
detn. of angiotensin-converting<br />
in serum (SN), 1248<br />
cafoxitin interferes with “Chini-Skreen”<br />
column method for urinary 17hydroxycorticosteroids<br />
(SN), 1219<br />
Ciba Corning Diagnostics’<br />
truly a highly sensitive<br />
monochonal TSR:<br />
TSH assay? (TB),<br />
2122<br />
chin, significance of a low concn. of thyrotropin:<br />
five immunometric “kit” assays compared<br />
(SN), 1237<br />
comparison of two parathyrmn assays<br />
misleading? (L), 744<br />
criteria for avalg. nonquant. assays: appln. to<br />
serum choriogonadotropin (SN), 150<br />
“Delfia” and “Amerhite”: two sensitive<br />
nonisotopic immunoassay systems for assay<br />
of thyrotropin compared (SN), 1421<br />
diagnostic value of a modified assay of free<br />
tniiodothyronine<br />
different reagent<br />
in serum (SN), 2093<br />
kits compared in centnif. anal.<br />
for cholesterol in plasma<br />
discordant inter-kit results<br />
(TB),<br />
in<br />
1071<br />
immunorediomatry<br />
(L), 632<br />
of serum thyrotropin<br />
discrepancies in plasma estradiol values with<br />
commercial kits (TB), 1672<br />
2388 CLINICAL CHEMISTRY, Vol. 33, No. 12,1987<br />
endogenous digoxin-hike immunoreactive<br />
factors eliminated from serum samples by<br />
hydrophobic silica-gal extraction and<br />
enzyme immunoassay, 401<br />
evahn. of a commercial enzyme kit (Sigma) for<br />
datg. oxalate in urine (SN), 1203<br />
evahn. of 6 digoxin kits for accuracy and DLIS<br />
interference (A), 1015<br />
evaln, of enzyme immunoasaay method for<br />
HCG in serum (TB), 1256<br />
avain. of prostate-specific antigen for follow-up<br />
of prostate cancer using two commercially<br />
available kite (A), 928<br />
evain. of Ranseh kit for detn. of glutathione<br />
peroxidese ecty. in plasma, possibility of<br />
interhab. standardization (A), 957<br />
evaln. of the cross reactivity of fludnocontisone<br />
with the “Corti-Cote” (Becton Dickinson)<br />
cortisol essay (TB), 1254<br />
fohlitropin and lutropin simultaneously<br />
measured in urine with a commercial RIA kit<br />
(TB), 1674<br />
four immunoassay methods and stds.<br />
compared for measuring fibronectin (SN),<br />
126<br />
fully self-contained enzyme immunoassay kit<br />
for detecting hCG (A), 959<br />
highly sensitive qual. methods for serum<br />
choniogonadotropin: chin, specificity studies<br />
(SN), 677<br />
immunoenzymatic quantn. of low concns. of<br />
thyrotropin (SN), 1223<br />
inexpensive alternative to kit methods for<br />
extraction of urinary catechohamines (TB),<br />
2122<br />
kinetic amylase kit adapted to the Technicon<br />
RA-1000 (TB), 722<br />
lab, assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
new immunochem. method for<br />
choniogonadotropin in urine, 800<br />
nonanzymatic glycation of immunoglobulins<br />
does not impair antigen-antibody binding<br />
(SN), 692<br />
qual. immunoenzymomatric technique avald.<br />
for datectinj choniogonadotropin in serum<br />
and urine (TB), 721<br />
rapid detn. of phospholipase A in serum and<br />
plasma (TB), 1259<br />
screening for cerebrotendinous xanthomatosis<br />
by enzymatic assay for 7a-hydroxyhated<br />
steroids in urine (SN), 142<br />
serum Mg deed, with methylthymol blue (TB),<br />
614<br />
simple adaptation of an RIA kit for serum<br />
cortisol used to measure salivary cortisol<br />
(TB), 191<br />
simpler enzymatic detn. of creatine in serum<br />
with a commercial creatinine kit (TB), 720<br />
tech, and cm. performance of six sensitive<br />
immunoradiometnic assays of thynotropin in<br />
serum (SN), 1439<br />
three commercial kits and one liquidchromatog.<br />
method evald. for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
two assays of intact parethyrmn compared (TB),<br />
2312<br />
two monoclonal-based assays for<br />
carcinoembryonic antigen compared (SN),<br />
700<br />
two-step RIA for free tniiodothyronine in<br />
serum, 372<br />
Labetalol<br />
improved hiq.-chromatog. essay of labetahol in<br />
plasma (SN), 1450<br />
Laboratory management<br />
computer-integrated lab. (A), 869<br />
avsln. of incentive program for lab. personneh<br />
(A), 911<br />
lab, inventory control using dBASE III Plus’<br />
(A), 911<br />
Lotus 1-2-3 in the din, lab.: apphicns. for<br />
electronic spreadsheets (A), 986<br />
manpower and regulatory issues in the critical<br />
care lab, and intensive care unit (A), 866<br />
microcomputer apphicns. integrated into lab,<br />
operations: practical uses of databases,<br />
spreadsheets, and word processing (A), 985<br />
relational database system to manage lab, data<br />
on personal computers (A), 983<br />
workload recording and productivity<br />
measurement with the Compaq portable<br />
microcomputer (A), 986<br />
Laboratory performance<br />
lab, performance and director qualns. (SR), 725<br />
Laboratory safety<br />
anti-HTLV-III/LAV in pooled sara (TB), 308<br />
chin. chem. anal. of samples from patients with<br />
AIDS (TB), 188<br />
effect of heat-inactivation of HIV on lab.<br />
results (TB), 1474<br />
Lactate<br />
automated micro’method for detg. L-(+)lactate<br />
in artenialized whole blood (TB), 188<br />
evahn, of plasma and CSF lactates on Abbott<br />
TDx (A), 961<br />
KOdak Ektachem thin-film assay for quantn. of<br />
serum lactic acid (A), 1008<br />
lactate and pyruvate electrochem. biosensors<br />
for whole blood in extracorporeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
lactate measurement in the TDx and aca: Rb<br />
interference assessed (TB), 189<br />
Lactate dehydrogenase<br />
acty. of serum aspartate aminotransferase<br />
isoenzymes in acute myocardial infarction,<br />
67<br />
artifactual increase in plasma lactate<br />
dehydrogenase acty. caused by a surfactant<br />
(TB), 192<br />
commercial prepn. of lactate dehydrogenase<br />
isoenzymes are not homogeneous (L), 1289<br />
comparison of solutions for extracting CK, AK,<br />
and LD from brain samples (TB), 2304<br />
detn. by RIA of the mass of lactate<br />
dehydrogenase isoenzyme I in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
developments in the field of the anti-LDs of<br />
the IgA. class (L), 745<br />
distribution of lactate dehydrogenase<br />
isoenzymes in various organs of male albino<br />
Sprague-Dawley rats (A), 1036<br />
electrophorasia and the isomune-LD and LD-1<br />
immuno methods compared to mess, of<br />
lactate dehydrogenase isoenzyme-1 (SN),<br />
1884<br />
heterogeneity of comm. preparations of human<br />
lactate dehydrogenase isoenzymea (A), 991<br />
immunoghobulin A (A chains) conjugated with<br />
lactate dehydnogenase in serum (CR), 1085<br />
increased activities of CK.MB and LD.2 in a<br />
patient with metastatic ovarian tumor (A),<br />
930<br />
increased activities of creetine kinasa and<br />
lactate dehydrogenase isoenzymes in a<br />
patient with metastatic ovarian tumor (CR),<br />
1484<br />
increased lactate dehydrogenase in serum in<br />
measles infection, 661<br />
increased serum lactate dehydrogenase<br />
isoenzyme 1 and “flipped” LD-1/LD-2 ratio<br />
in myopathy associated with partial<br />
carnitine palmitoyhtnansferase deficiency<br />
(CR), 2111<br />
isolation of mitochondnial lactate<br />
dehydroganase (A), 995<br />
lactate dehydroganase-immunoghobuhin Gi<br />
complex, not blocked by anti.idiotype<br />
antibody, in apetiant with IgGl.X type Mproteinemia<br />
(CR), 1478<br />
lactate dehydroganase isoenzyme 1 as deed, by<br />
inhibition with 1,6-hexanedioh and by two<br />
other methods in myocardial infarction or<br />
cardiac-bypass surgery (SN), 589<br />
lactate dehydrogenase iaoenzyme 1 deed, by<br />
inhibition with 1,6-hexanediol (A), 992<br />
lactate dehydrogenase isoenzyme<br />
electrophonatic assay utilizing kinetic<br />
techniques (A), 991<br />
lactate dehydroganase isoenzymes in serum<br />
during recent acute myocardial infarction<br />
(SN), 1419<br />
macro-lactate dehydrogenase in serum after<br />
acute myocerdial infarct, (L), 1103<br />
measurement of creatina kinese and lactate<br />
dehydrogenase with Kodak Ektachem DTSC<br />
module designed for physician’s office<br />
testing (A), 937<br />
measurement of LDH in body fluids on Kodak<br />
Ektachem 700(A), 966<br />
patient with an IgG paraprotein and complexes<br />
of lactate dehydrogenase and IgG in the<br />
serum (TB), 1937<br />
ratios of creatine kinase to lactate<br />
dehydrogenasa and aspartete<br />
aminotransferase in evain, of patients with<br />
elevated CK (A), 990<br />
results compared for LD and alcohol anal. with<br />
EM Diagnostics Systems testpacks in Du<br />
Pont aca III (A), 949<br />
selective detn. of lactate dehydrogenasa<br />
isoenzyme 1 by using NaCIO4 (A), 991<br />
serum lactate dehydrogenese isoenzyme I as
tumor marker in testicular cancer (A), 932<br />
signif. of increased serum lactate<br />
dehydrogenase isoenzyme 5 in acute inferoposterior<br />
myocardial infarction (TB), 2309<br />
simultaneous sepn. of cardiac isoenzymes CK-<br />
MB, LD-1, and LD-2 by two-dimensional<br />
(anion-exchange/immuno-affinity) column<br />
chromatog. (A), 991<br />
stabilizing LD isoenzymes in control serum<br />
(TB),<br />
Lactation<br />
1940<br />
decrease of free thyroxin in serum of lactating<br />
woman (SN), 1217<br />
Lactoferrin<br />
limited cleavage of human milk hactofenrin<br />
using thermolysin (A), 906<br />
Lactuhose<br />
thin-layer chromatog. detn. of urine excretion<br />
of hactuhose, simplified and applied to cystic<br />
fibrosis patients<br />
Lamellar body<br />
effect of albumin<br />
(SN), 1211<br />
and hamehlanbodies on<br />
fluorescence<br />
1194<br />
poharn. of amniotic fluid (SN),<br />
fluorescence polarization of amniotic fluid<br />
lamellar bodies compared with whole<br />
amniotic fluid (A), 901<br />
Laser nephahometry<br />
fat agglutination slide test for increased<br />
concns, of C-reactive protein in serum<br />
compared with results by laser nephelometry<br />
(TB),<br />
Lasers<br />
2301<br />
laser immunonephelometry for routine quantn.<br />
of urinary albumin, 209<br />
Latex agglutination assay<br />
adaptation of Technicon RA systems”'<br />
theophylhine<br />
(A), 1023<br />
reagents to Coulter’ Dacos’<br />
automated latex photometric immunoassay for<br />
detn. of CEA (A), 920<br />
characterization of urinary interference factors<br />
and suggested mechanism of false positivity<br />
in latex agglutination tests (A), 914<br />
development of latex immunoassay of Creactive<br />
protein for Monarch”' centnif.<br />
analyzer (A), 903<br />
enhanced-latex agghn. assay for C-reactive<br />
protein in serum, with use of a centnif,<br />
analyzer (SN), 685<br />
avahn, of latex agglutination<br />
for diagnosis of thrombotic<br />
1003<br />
assay for D dimer<br />
disorders (A),<br />
immunoassay of digoxin by differential<br />
centnifn. (S), 1548<br />
hatex-egghutn. assay for D dimer: evaln. and<br />
epphn. to diagnosis<br />
1837<br />
of thrombotic disease,<br />
microtiter-hatex test for C-reactive protein, for<br />
screening<br />
1258<br />
large numbers of samples (TB),<br />
prehim, chin, studies of C-reactive protein<br />
quantified<br />
2185<br />
by enzyme-linked immunoassay,<br />
single-use diagnostic system for rapid<br />
cohorimetric detection of HIV-1 antibody in<br />
human serum or plasma specimens-SUDS<br />
HIV-1 Ab test (A), 905<br />
Latex agglutination inhibition assay<br />
development of latex-based theophylline assay<br />
for the IL Monarch”' chem, system (A), 967<br />
Latex particle counting<br />
immunoassay of rheumatoid factor by latex<br />
particle counting (SN), 704<br />
Latex photometric immunoassay<br />
rapid quantn. of alpha-fetoprotein in serum<br />
with a latex photometric<br />
system (TB), 2306<br />
immunoassay<br />
Lead<br />
comparative study between deuterium arc and<br />
Zeeman background connection systems for<br />
measurement of Pb in biol, fluids by<br />
electrothermal atomic absorption<br />
spactrometny (A), 934<br />
optimized hiq.-chromatog. method for<br />
fluorometry of urinary #{244}-aminolevulinic acid<br />
in workers exposed to Pb (SN), 1667<br />
screening methods for Pb compared: ethanol<br />
paper-disc extraction method vs ethyl<br />
acetate extraction method (TB), 309<br />
Lecithin<br />
automated enzymatic measurement of lecithin,<br />
sphingomyehin, and phosphatidyhghycaroh in<br />
amniotic fluid, 81<br />
Lecithin/sphingomyehin ratio<br />
assay of disaturated phosphatidylchohine in<br />
amniotic fluid as a test of fetal lung<br />
maturity: experience with 2000 analyses<br />
(SN), 1648<br />
evalg. the chin. effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
evaln. of fetal lung maturity by a fluorescence<br />
polarization method and comparison with<br />
L/S ratio (A), 901<br />
modified lamellar body phospholipid assay<br />
compared with L/S ratio and<br />
phosphatidylglycerol assay for assessment of<br />
fetal pulmonary status, 24<br />
prospective clinical evaln. of en improved<br />
fluorescence polarization assay for predicting<br />
fetal hung maturity (SN), 554<br />
recovery studies with two methods of<br />
visualizing thin-layer chromatoj. plates for<br />
detn. of L/S radio in amniotic fluid (A), 900<br />
variables affecting resolution of lung<br />
phosphohipids in thin-layer chromatog. (SN),<br />
135<br />
Lectins<br />
pptn, of serum proteins by the hectin from<br />
wheat-germ (SN), 185<br />
Leishmaniasis<br />
Sb accumn. in hair during treatment of<br />
leishmaniasis (SN), 2081<br />
Leukemia<br />
detection of leukemia cells with a complementmediated<br />
cytolytic reaction and an imaging<br />
sensor system (SN), 558<br />
double IgA bands in serum from a patient with<br />
hymphophasmacytoid leukemia with hairycell<br />
morphology (CR), 2317<br />
ehectrophoratic mobility, concn., and acty. of<br />
ni-antitrypsin in serum of patients<br />
undergoing bone-marrow transplantation<br />
(CR), 193<br />
interference of the chemothenspeutic agent<br />
etoposida with the direct phosphotungstic<br />
acid method for uric acid (CR), 2109<br />
serum M-pnoteins in B-cell<br />
lymphomas/leukemiss by high-resolution<br />
ehectrophonesis/immunofixation (A), 904<br />
solid-phase enzyme immunoassay of terminal<br />
deoxynucleotidyl transferase evald, (SN),<br />
293<br />
xanthine hithiasis, nephrocahcinosis, renal<br />
failure in a leukemia patient treated with<br />
allopuninol (CR), 2314<br />
Leukocyta elastase<br />
identn. of human heukocyte esterases (A), 981<br />
Leukocyte esterase<br />
identn. of human heukocyte estenases (A), 981<br />
Leukocytes<br />
effect of two anticoaguhants on heukocyte yield,<br />
function end hysosomah enzyme acty. (A), 915<br />
method for simultaneously estg. plasma,<br />
erythrocyte, and leukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
variation data, 1326<br />
new dip-and-read test for detg. leukocytes in<br />
urine (SN), 1242<br />
nonestenified and acylcarnitine in<br />
pohymorphonuclear leukocytes and<br />
mononuclear calls, 533<br />
suitability of solid-phase chem. for quantn. of<br />
heukocytes in cerebrospinal, seminal, and<br />
penitoneah fluid (TB), 1475<br />
Leukocytosis<br />
artefactual hyperkalemia induced by heparin<br />
in patients with extreme leukocytosis (A),<br />
914<br />
Ligand assay<br />
protocols for use of ultrafiltn. in detn. of free<br />
higand concn. and of complexity of<br />
higand/protein interactions (SN), 115<br />
Light chain disease<br />
simple silver-staining technique for detecting<br />
Bence Jones proteins in unconcd. urine (SN),<br />
561<br />
Light chains<br />
optimization of sodium dodecyl sulfate concns.<br />
in Coomassia Brilliant Blue G250 method for<br />
urinary light-chain proteins (A), 905<br />
use of “gamma-protein index” and free kappa<br />
light chains in diagnosis of multiple sclerosis<br />
(A),904<br />
Likelihood ratios<br />
distribution-associated likelihood ratios (A),<br />
910<br />
Lipase<br />
acty. of phosphohipase A compared in serum in<br />
pancreatic and nonpancreatic diseases (SN),<br />
594<br />
evaln, of hipase enzyme immunoassay (EIA) kit<br />
based on monochonal antibodies (A), 996<br />
heat-inactivated serum dramatically increases<br />
pancreatic fluid lipase acty. (A), 996<br />
likelihood calcn. by means of different aamylase<br />
end lipase tests in inflammatory<br />
pancreatitis (A), 998<br />
performance characteristics of Paramax’ anal.<br />
system for detn. of hipase (A), 953<br />
response-surface optimized tableted reagent<br />
for detn. of serum lipase activity on the<br />
Paremax’ analyzer (A), 953<br />
sensitive assay with 1,2-diglyceride as substrate<br />
for pancreatic lipase in serum (A), 962<br />
turbidimetric lipase assay adapted to a<br />
centrifugal analyzer (TB), 1946<br />
turbidimetny of hipase acty.-problems and<br />
some solutions, 1624<br />
Lipemia<br />
assessment of parenteral fat emulsion to<br />
emulate serum lipemie on the Paramax’<br />
anal, system (A), 913<br />
Lipids<br />
availability of plasma with target values for<br />
certain lipids (L), 2323<br />
effect of high-lipid diet on serum lipid<br />
parameters in the rat and monkey (A), 1035<br />
evaln. of lipid profile anal. on the Spirit’<br />
electrolyte chem. system (A), 945<br />
implementation of inexpensive microcomputer<br />
expert programs for interpretive reporting of<br />
lipid profiles and coronary heart disease risk<br />
factors (A), 983<br />
relation between fructosamine and plasma<br />
lipid concns. in diabetes melhitus (L), 629<br />
Lipolysis<br />
sample lipolysis for quantn. of apolipoprotein<br />
B, 338<br />
Lipoparoxides<br />
gas-chromatog. meas, of volatile alkanes from<br />
single-breath samples (SN), 140<br />
lipoparoxides in plasma as measured by liq.chromatog.<br />
sepn. of<br />
malondialdehyde-thiobarbitunic acid<br />
adduct, 214<br />
ref. intervals for plasma lipoperoxides: age-,<br />
sex-, and specimen-related variations (SN),<br />
2289<br />
Lipoproteins<br />
alterations in how-density hipopnoteins in<br />
nephrotic syndrome (A), 897<br />
anal, for hipoproteins in horse serum (TB), 1081<br />
availability of plasma with target values for<br />
certain lipids (L), 2323<br />
characteristics of intermediate-density<br />
lipoproteins (A), 896<br />
cholesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
lipoprotein, 390<br />
evaln. of hipoproteins and apohipoproteins in<br />
serum of a Tangier patient by micro-scale 2-<br />
D electrophoresis, 468<br />
falsely high values for triglyceride in<br />
ultnefihtened HDL supernetes (TB), 418<br />
flow-cytometric detn. of high-densityhipoprotein<br />
binding sites on leukocytea, 2195<br />
four procedures compared for sepg.<br />
apohipoprotein A- and apolipoprotein Bcontaining<br />
hipoproteins in plasma, 1597<br />
Fniedewald formula: another restriction? (L),<br />
1301<br />
FIDL cholesterol assay on the Technicon Chem<br />
1”' system (A), 946<br />
HDL cholesterol assay using liquid-stable<br />
reagents (A), 895<br />
HDL-chohesterol assay with the Abbott “Vision<br />
System” avald. (TB), 1943<br />
HDL cholesterol on the Reflotron’ system (A),<br />
895<br />
high-density ahphaz-hipoproteins: isolation and<br />
electnophoretic anal. (A), 896<br />
identn. of hipopnotein(a) by gradient-gel<br />
electrophoresia: relationship to coronary<br />
artery disease (A), 897<br />
importance of time between repeated meas, of<br />
total or high-density lipoprotein cholesterol<br />
when estg. an individual’s baseline concns.<br />
(SN), 1913<br />
Lp(s) hipoprotein in patients with chronic renal<br />
failure treated by hemodialysis (TB), 721<br />
mess. of ghyceted protein by a rapid, specific<br />
method for absolute quantn. of lysina-bound<br />
glucose (SN), 1656<br />
new assay of apohipoproteins A-I and Ii by rate<br />
nephehometry avald, (SN), 2065<br />
performance characteristics of Paramax’ anal,<br />
system for detn, of HDL cholesterol (A), 952<br />
serum ainyhoid A is major component of acutephase<br />
plasma very-how-density hipoprotemns<br />
(A),896<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2389
Se, Zn, Mg, Ce, K, cholesterol, and creatina<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
specificity of in vitro loading of hipoproteins<br />
with carotenoids (A), 935<br />
validity of Fniedewald equation for astg.<br />
plasma how-density hipoprotein cholesterol at<br />
various concns, of triglycerides (A), 896<br />
value of polyacryhamide gradient gel<br />
electrophoresis of hipoproteins for<br />
determining HDL cholesterol (TB), 1266<br />
Liposomas<br />
development of solid-phase coated-tube total<br />
T4 hiposome-based fluorescent immunoassay<br />
for Becton Dickinson IQ”’ immunochem,<br />
system (A), 883<br />
effect of gentamicin and cyclosporin on<br />
permeability of model membranes (A), 1027<br />
liposome-based, coated-tube<br />
fluoroimmunoessay for theophyhline (A),<br />
1023<br />
hiposoma-based colorimetric immunoessay of<br />
serum thyroxin (A), 1565<br />
solid.phase costed-tube digoxin liposomebased<br />
fluorescent immunoassay for Becton<br />
Dickinson IQ chin, chem, analyzer (A), 1015<br />
solid-phase double-antibody liposome<br />
immunoassay for TSR in Becton-Dickinson<br />
IQ immunochem, system (A), 882<br />
use of liposome encapsulation in a combined<br />
singla-liq. reagent for homogeneous enzyme<br />
immunoassay (S), 1579<br />
Lithiasis<br />
See Calculous disease<br />
turbidimetry study of Ca oxalate<br />
mineralization (A), 980<br />
Lithium<br />
detn, of Li in human serum using an<br />
automated direct ion-selective electrode<br />
analyzer (A), 1027<br />
direct ion-selective electrode analyzer (NOVA<br />
11+11) evald, for detg. Li in serum (TB),<br />
1668<br />
Li stability in clotted blood: storage guidelines<br />
(TB), 1944<br />
Liver damage<br />
studies on katone body ratio in ret plasma with<br />
elpha-naphthyhisothiocyanate-induced<br />
chohestatic liver injury (A), 1035<br />
Liver disease<br />
See also Liver function, Hepatic disease<br />
alanine aminopeptidsse in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
anal. of fibrinogenohysia/fibrinohysis in patients<br />
with chronic liver disease (A), 1004<br />
chin, utility of Ektacham’-detd. bihirubin<br />
fractions for classifying adult inpatients<br />
(SN), 1662<br />
CN concns. in blood after cigarette smoking,<br />
as deed, fluonimetnically (SN), 1228<br />
ehectrophoretic sepn. of 5’-nucheotidase by<br />
using a single substrate-color reagent (A),<br />
995<br />
endogenous digoxin-hike immunoreactive<br />
substances eliminated from serum samples<br />
from patients with liver disease by the EMIT<br />
column digoxin assay (L), 1490<br />
glycogen storage disease type I: lab, data,<br />
diagnosis, 2008<br />
intra-individual variation of anahytes in serum<br />
from patients with chronic liver diseases,<br />
1133<br />
rapid ultraviohat-spectrophotom. method for<br />
detn, of serum guanase acty. (A), 995<br />
screening for carebrotendinous xanthomatosis<br />
by enzymatic assay for 7a-hydroxylated<br />
steroids in urine (SN), 142<br />
serum elk. phosphatase isoenzymes in<br />
hepatobiliery disorders resolved by use of<br />
immobilized pH gradients, 653<br />
validation and apphn. of a liq.chromatog./enzymic<br />
assay for individual bile<br />
acids in rat serum, 1856<br />
Liver function<br />
See also Liver disease<br />
fluorometry of iodocyanine green in plasma,<br />
765<br />
serum guanasa acty. in exph. models of hepatic<br />
injury (A), 995<br />
validation and appln. of a liq.chnomatog./enzymic<br />
assay for individual bile<br />
acids in rat serum, 1856<br />
Luminescence<br />
development of rapid nonradioactive assay for<br />
digoxin based on enhanced luminescence<br />
(A), 1015<br />
2390 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Luminescence immunoassay<br />
measuring sex-hormone-binding globulin by<br />
enhanced luminescence (A), 921<br />
simultaneous incubation, two-site<br />
immunomatnic essay for FSH based on<br />
enhanced luminescence (A), 892<br />
Lung disease<br />
concns. of auperoxide dismutase and<br />
superoxide anion in blood of patients with<br />
respiratory infections, compromised immune<br />
systems, 2230<br />
persistent elevation of creatine kinase in<br />
patients with chronic obstructive pulmonary<br />
disease (A), 1033<br />
simultaneous detn, of trace elements in lavage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence, 3. routine<br />
anal., 2234<br />
Lupus erythematosus<br />
See also Systemic lupus erythematosus<br />
activities of dipeptidyl peptidase II and<br />
dipeptidyl peptidaae IV in mice with lupus<br />
erythematosus-hike syndrome and in patients<br />
with hupus erytheniatosus and rheumatoid<br />
arthritis (SN), 1463<br />
method for serum Clq based on its<br />
hydroxyproline content, 398<br />
Lutropin<br />
double-label time-resolved<br />
immunofluorometry of lutropin and<br />
follitropin in serum (SN), 2281<br />
enzyme immunoassay for detn. of human<br />
huteinizing hormone in serum (A), 891<br />
evsln, of lutropin and prolactin kits in an<br />
interlab. survey (A), 907<br />
follitropin and lutropin simultaneously<br />
measured in urine with a commercial RIA kit<br />
(TB). 1674<br />
fully automated immunoenzymetnic essays for<br />
detection of FSH end LH (A), 892<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunoradiometric assay,<br />
and further exploration of antigenic sites on<br />
choriogonadotropin, 1147<br />
rapid, colorimetnic immunoassay for detection<br />
of human urinary huteinizing hormone and<br />
prediction of ovulation (A), 891<br />
rapid enzyme immunoassay for detection of<br />
urinary human lutainizing hormone (A), 921<br />
rapid simultaneous immunoenzymetnic assay<br />
for quantn. of hLH in human serum (A), 921<br />
two-monochonal-antibody “sandwich”-type<br />
assay of lutropin, with no cross reaction with<br />
choriogonadotropin, 1603<br />
Lymphocytes<br />
in vitro prediction of phenytoin toxicity (A),<br />
1019<br />
mol. mechanisms of human lymphocyte and<br />
complement cytotoxicity end control by<br />
target membrane regulatory protein (A), 863<br />
serum protein electrophoresischanges in 4<br />
infants with severe combined<br />
immunodeficiancy (A), 1028<br />
Lymphokines<br />
lymphokine technol.: its chin, and diagnostic<br />
apphicn. (A), 864<br />
Lysergic acid dlethylamide<br />
gas chromatog.-electron impact mass<br />
fragmentometnic identn. and quantn. of LSD<br />
in urine (A), 971<br />
Lysosomah acid lipase<br />
use of Nile red in detecting cholesteryl aster<br />
accumulation in acid-lipase-daficient<br />
fibroblasts (A), 895<br />
Macroansylase<br />
reactivity of human macroamylasea with mouse<br />
monoclonal anti-salivary amylase antibodies<br />
(A), 998<br />
Macroglobuhin<br />
kinetic immunonaphalometnic deth. of protein<br />
concns. in follicular fluid, 1185<br />
Macroglobulinemia<br />
macroglobulinemia associated with IgA<br />
gainmopathy in a patient with different<br />
light-chain specificity and no associated<br />
clinical findings (TB), 1945<br />
Magnesium<br />
adaptation and evain, of Dart’ Mg reagent to<br />
Coulter CPA (A), 943<br />
adaptation and evain. of Dart’ Mg reagent to<br />
Coulter Dacos’ chem, analyzer (A), 1007<br />
anal, of Mg in serum and urine by KOdak<br />
Ektachem analyzer (A), 1006<br />
apphicn. of Ciba-Corning Diagnostics Mg<br />
reagent to various chin, chem. analyzers (A),<br />
1008<br />
assessment of Mg status (R), 1965<br />
avoiding serum matrix effect in calmagite<br />
compleximatnic measurements of Mg2 (TB),<br />
719<br />
Ca does not interfere with mess. of Mg in the<br />
DuPont “oca-III” (TB), 1936<br />
correlation between Ca and Mg in plasma or<br />
serum? (L), 1304<br />
detn, of Mg in granuhocytes (A), 1006<br />
effect of 8-hydroxyquinohine on response to Ca<br />
and Mg of Beckman Astra’ Ca detn, (A),<br />
1007<br />
evaln, of EM Diagnostic Systems Ca and Mg<br />
test pecks on Du Pont ace’ (A), 950<br />
evain, of enzymatic reagent system for serum<br />
Mg on Alpkem’ Chinalyzer”' (A), 1006<br />
evaln. of Kodak thin-film slides for<br />
theophyllina, Mg, and creatina kinase-MB<br />
(A), 951<br />
evaln, of Mg procedure for Hitachi 737 (A),<br />
1006<br />
indirect vs direct measurement of Mg and Zn<br />
in erythrocytes, 529<br />
intra-individual seasonal variation of Mg in<br />
blood (A), 1006<br />
method for simultaneously estg. plasma,<br />
erythrocyte, and heukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
variation data, 1326<br />
Mgi+ and creatine kinase in myocard. infarct,:<br />
new data (L), 739<br />
performance characteristics of Ca, Mg, alcohol,<br />
and HCO reagents in the EASY analyzer<br />
(A),944<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
serum Mg deed, with methyhthymol blue (TB),<br />
614<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
stable cohonimetnic method for detn. of serum<br />
Mg (A), 1006<br />
Malabsorption<br />
decreased drug absorption in a patient with<br />
Behcet’s syndrome (CR), 1679<br />
Malaria<br />
quinine directly deed. in serum or urine by<br />
sepn. fluoroimmunoassay, 463<br />
Manganese<br />
atomic absorption spectrophotometry of Mn in<br />
plasma (TB), 1253<br />
intestinal Zn, Cu, and Mn concns. in Crohn’s<br />
disease (A), 933<br />
Mannitol<br />
mannitol interference in an automated serum<br />
hcephate assay (TB), 2308<br />
Marijuana<br />
significance of urine assajr sensitivity in<br />
marijuana detection (TB), 613<br />
Mass spectrometry<br />
detection of bromocriptine-hike substances in<br />
urine of an infant on soy formula (TB), 414<br />
detn. of tamoxifen and four metabohites in<br />
serum by low-dispersion liq. chrometog.,<br />
1608<br />
gas chromatog.-mass spectrometnic essay for 6hydroxymelatonin<br />
S042 and 6hydroxymelatonin<br />
glucuronida in urine, 453<br />
identh. and quanth. of a protein-bound ligand<br />
in uremic serum (SN), 682<br />
isotope diln./masa spectrom. of serum<br />
cholesterol with (3,4.iiclcbol.sterol proposed<br />
Definitive Method, 1403<br />
precision of glucose measurements in control<br />
sara by isotope diln./mess spectrom.:<br />
proposed Definitive Method compared with<br />
a Reference Method, 1397<br />
qusntn. of 5a- and 5fl-androstanediois in urine<br />
by gas chromatog.-mass spectrom., 256<br />
total cholesterol in serum deed, by isotope<br />
diln.-mass spectrom., with liq.-chromatog.<br />
sepn., 1113<br />
Mass apectroscopy<br />
melatonin secretion assessed by measuring its<br />
metabolite, 6-sulfatoxymelatonin, 1343<br />
Measles<br />
increased lactate dehydrogenase in serum in<br />
measles infection, 661<br />
Medical decision-making<br />
anal, of relationship between intralab.<br />
performance characteristics (CV end bias)<br />
and med. usefulness limits (A), 910<br />
strategy for dealing with values close to med.<br />
decision point (A), 910<br />
Mehanogen<br />
mehanogenuria: lab. evaln. of Thormshlen and<br />
FeCI3 tests and their chin, utility (A), 981
Melanoma<br />
mehanogenuria: lab. evaln. of Thormahhen and<br />
FeC!3 tests and their chin, utility (A), 981<br />
Mehatonin<br />
diagnostic, chin, implications of plasma and<br />
salivary meletonin assay (L), 1295<br />
disturbed mehatonin secretion in chronic<br />
alcoholism and withdrawal (L), 1291<br />
gas chromatog.-mess spectromatric assay for 6hydroxymelatonin<br />
SO42- and 6hydroxymehetonin<br />
glucuronide in urine, 453<br />
improved RIA of mahatonin in serum (SN), 604<br />
melatonin secretion assessed by measuring its<br />
metabohite, 6-sulfatoxymehatonin, 1343<br />
salivary melatonin assay in lab.<br />
med.-hongitudinal profiles of secretion in<br />
healthy men (L), 1957<br />
Meningitis<br />
direct, simultaneous meas. of chhoramphenicol<br />
and its monosuccinate ester in microsamples<br />
of plasma by radial-compression hiq.<br />
chromatog., 1814<br />
Menopausal status<br />
comparison of RIA and enzyme immunoassay<br />
measurement of ferritin concn. in pre- and<br />
post-menopausal females (A), 1032<br />
Mental disorders<br />
detn. of unconjugated 3-methoxy-4hydroxyphanylghycol<br />
by hiq. chromatog. for<br />
monitoring inhibition of monoamine ozidase<br />
acty. in plasma (SN), 2078<br />
Mental retardation<br />
use of restriction fragment length<br />
polymorphism anal. for detecting carriers of<br />
“Fraihe X” syndrome (R), 1726<br />
Metabolic acidosis<br />
absence of statistical assoc. between<br />
hyperglycemia, metabolic acidosis in type I<br />
and type II diabetic patients on chronic<br />
dialysis (TB), 1076<br />
Metabolism<br />
alternative explanation for changes in<br />
erythrocyte fatty acids in diabetes (SN),<br />
2083<br />
assessment of Mg status (R), 1965<br />
biotin radiohigand assay with an ‘25Iiabehed<br />
biotin deny., avidin, and avidin doubleantibody<br />
reagents, 1983<br />
characterization and assay of tartrate-resistant<br />
acid phosphetaae acty. in serum: potential<br />
use to assess bone resorption, 458<br />
deproteinizing methods evald. for detn, of uric<br />
acid in serum by reversed-phase hiq.<br />
chromatog. with UV detection (SN), 1427<br />
gas chromatog.-mass spectromatric assay for 6hydroxymelatonin<br />
S042_ and 6hydroxymelatonin<br />
ghucuronide in urine, 453<br />
highly sensitive two-site immunoradiometric<br />
assay of parathyrin, and chin. use in eveig.<br />
patients with hypercalcemia, 1364<br />
intracellular precursor forms of plasma<br />
proteins: functions and possible occurrence<br />
in plasma (R), 1317<br />
lactate and pyruvate ahectrochem. biosensors<br />
for whole blood in extracorporeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
liq. chromatog. with multichannel UV<br />
detection for studying disorders of purine<br />
matab., 2052<br />
nonesterified and acylcarnitina in<br />
polymorphonuclear laukocytes and<br />
mononuclear calls, 533<br />
specificity of in vitro loading of hipoproteins<br />
with cerotenoids (A), 935<br />
stability of free apohipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hyperhipidemic subjects, 1163<br />
urinary org. acids: isoln, and quentn. for<br />
routine metabolic screening, 473<br />
Methadone<br />
RIA for methadone in urine with comparisons<br />
to other anal. techniques (A), 970<br />
Methamphetamine<br />
fluorescence poharn. immunoassay evald. for<br />
screening for amphetamine and<br />
methampheteniine in urine (SN), 1200<br />
single-reagent polarization fluoroimmunoassay<br />
of mathaniphetamina in urine (SN), 1903<br />
Methanol<br />
assay of serum methanol and ethylene ghycoh<br />
with yeast alcohol dehydrogenese (A), 968<br />
enzymic assay for the specific detn. of<br />
methanol in serum, 2204<br />
anzymic ethanol assay: colorimetric method<br />
based on mess, of H202, 486<br />
methanol overdose: predicting lengths of<br />
hemodialysis therapy (A), 969<br />
Mathaqualone<br />
forensic methaqualone assay by two HPLC<br />
systems (A), 974<br />
Methemoglobin<br />
detg. Me-Hb in blood by zero-crossing-point<br />
first-deny. spectrophotometry, 1767<br />
fast kinetic method for methemoghobin<br />
adapted for quantn. of Hb in whole blood,<br />
493<br />
Method evaluation<br />
medical utility frequency, 221<br />
Methotraxate<br />
degradation of methotrexate in an automated<br />
proced. for extracting it from serum (TB),<br />
1072<br />
3-Methoxy-4-hydroxyphenyhethylena glycol<br />
free 3-methoxy-4-hydroxyphenyhethylene<br />
glycol deed. in plasma and in CSF by hiq.<br />
chromatog. with couhometric detection (SN),<br />
844<br />
3-Methoxy-4-hydroxyphenylglycol<br />
detn, of unconjugeted 3-methoxy-4hydroxyphenylglycol<br />
by liq. chromatog. for<br />
monitoring inhibition of monoamine ozidase<br />
acty. in plasma (SN), 2078<br />
Methsuximide<br />
detn, of methsuximide and Ndesmethylmethsuzimide<br />
by capillary column<br />
GC (A), 1020<br />
Methyhecgonine<br />
detection and confirmation of cocaine use by<br />
chromatog. anal, for methylecgonine in urine<br />
(SN), 118<br />
Methylumbehhiferone<br />
4-methyhumbelhiferone and its glucuronide<br />
interfere with protein estn, by the Lowry<br />
method (TB), 1475<br />
Methylxanthines<br />
detn. of methyhxanthine stimulants in urine of<br />
racing greyhounds by HPLC; resolution of a<br />
contested drug-administration case (A), 975<br />
Metoclopramide<br />
hiq.-chromatog. assay of metoclopramide in<br />
plasma (TB), 190<br />
Microalbuminuria<br />
See Albumin<br />
Microbiological assay<br />
microbiol. assay for vitamin B12 with use of a<br />
cohistin-sulfate-resistant organism, 52<br />
Microglobuhin<br />
liq.-chromatog. detn. of fli-microglobuhin, ni’<br />
acid glycoprotein, and albumin in urine, 1756<br />
Microscopy<br />
utilization of the Yellow Iris” automated<br />
urinalysis workstation for performing body<br />
fluid cell counts (A), 981<br />
Milk<br />
alk. phosphatase isoenzymes in the plasma of<br />
preterm and term infants: serial<br />
measurements and chin, correlations, 1783<br />
Mitochondria<br />
isolation of mitochondrial lactate<br />
dehydrogenase (A), 995<br />
Mongolism<br />
time-resolved immunofluorometry of alphafetoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
Monitoring pregnancy<br />
See also Amniotic fluid, Fetal status, etc.<br />
Monitoring therapy<br />
anal. and physiol. characteristics of prostatespecific<br />
antigen and prostatic acid<br />
phosphatase in serum compared (SN), 2086<br />
assessment of evacuated serum separator gel<br />
blood-collection tubes for antiepileptic<br />
monitoring by FPIA (A), 1017<br />
can a single measurement of carbamazepine<br />
suffice for therapeutic monitoring? (SN), 812<br />
clinical usefulness of glycated Hb in<br />
monitoring diabetes: long-term study, 55<br />
chin, significance of a how concn. of thyrotropin:<br />
five immunometric “kit” assays compared<br />
(SN), 1237<br />
computer-assisted therapeutic drug monitoring<br />
(A),982<br />
current issues in cyclosponine monitoring (A),<br />
1056<br />
desirable stds. of performance for therapeutic<br />
drug monitoring, 387<br />
detn. of cyclosporine concns, with monoclonal<br />
antibodies, 2225<br />
direct detn. of angiotensin-converting enzyme<br />
inhibitors in plasma by radioenzymatic<br />
assay, 549<br />
distribn. of cyclosporine in blood of a renal<br />
transplant recipient with type V<br />
hyperhipoproteinemia (CR), 423<br />
double-monoclonal immunoenzymometric<br />
assay for aiphat-fetoprotein modified for<br />
increased anal. precision (SN), 583<br />
economy and efficiency in routine thyroid.<br />
function testing: use of a sensitive<br />
immunoradiometric assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
enzymic assay for the specific detn. of<br />
methanol in serum, 2204<br />
evaln. 0fEMIT-chloramphenicol assay in a<br />
pediatric hosp. (A), 1021<br />
fahse.positive results for ketone with the drug<br />
mesna and other free-SM cmpds. (SN), 289<br />
flecainide monitoring by reversed-phase liquid<br />
chromatog. with a phenyl column (A), 1016<br />
immunol. monitoring in renal allograft<br />
recipients (A), 1056<br />
instrument artifact affects TDM assays in the<br />
IL “Monarch” (L), 1951<br />
interference of the chemotherapeutic agent<br />
etoposide with the direct phosphotungstic<br />
acid method for uric acid (CR), 2109<br />
in vitro prediction of phenytoin toxicity (A),<br />
1019<br />
in vivo disappearance time of hCG in healthy<br />
women and patients with Rokitonski<br />
syndrome (A), 889<br />
lack of mezlocilhin and piperacillin interference<br />
in measurement of vancomycin in the Abbott<br />
TDx (TB), 2304<br />
measurement of plasma nortriptyhine and its<br />
isomenic lO-hydroxy metabolites (A), 1024<br />
microbore liquid-chromatog. anal. of<br />
chloramphenicol for pediatric drug<br />
monitoring (A), 1021<br />
monitoring and management of diabetic<br />
patients (A), 870<br />
plasma lipid-bound siahic acid in monitoring<br />
surgical therapy of patients with colonic<br />
adenocarcinomas (A), 932<br />
potential of monochonal antibodies to improve<br />
therapeutic monitoring of cyclosponine, 32<br />
quinine directly detd. in serum or urine by<br />
sepn. fluoroimmunoassay, 463<br />
speeding assay of therapeutic drugs with the<br />
“Cobes.Bio-FP” (TB), 1256<br />
temp.-dependent binding of cyclosporine to an<br />
erythrocyte protein, 481<br />
therapeutic drug monitoring of imipramine<br />
and desipramine in maintenance therapy of<br />
patients (A), 1025<br />
Monoamine oxidase<br />
detn. of unconjugated 3.methoxy-4’<br />
hydroxyphenylglycol by hiq. chromatog. for<br />
monitoring inhibition of monoamine oxidase<br />
acty. in plasma (SN), 2078<br />
Monocloual antibodies<br />
Abbott ER-EIA monoclonal kit (L), 1105<br />
accelerated enzyme immunoassey for<br />
choriogonadotropin in urine, involving reflow<br />
of specimen through capillary tubes, 498<br />
adaptation and evaln. of monoclonal-antibodybased<br />
therapeutic drug assays on Coulter<br />
CPA (A), 943<br />
CEA, AFP. and prostate.specific antigen<br />
assays developed for the Photon Elite (A),<br />
967<br />
chemiluminescence immunoassay of<br />
thyrotropin with acnidinium-ester.habeled<br />
antibody evald, and compared with two<br />
other immunoassays (SN), 2096<br />
choniogonadotropin and pregnancy testing:<br />
prozona phenomenon defined (L), 742<br />
chin, trials of immunotoxins (A), 1054<br />
comparison of 51Cr.RBC and Hemoccult<br />
method for gastrointestinal blood loss with a<br />
monodonal antibody method for detecting<br />
Hb in stool (A), 1001<br />
detection of leukemia cells with a complementmediated<br />
cytolytic reaction and an imaging<br />
sensor system (SN), 558<br />
detn. of cyclosporine concns. with monoclonal<br />
antibodies, 2225<br />
development and utility of a monoclonalantibody.based,<br />
highly sensitive<br />
immunoradiometric assay of thyrotropin,<br />
1387<br />
development of rapid nonradioactive<br />
immunoassay for fernitin based on enhanced<br />
luminescence (A), 906<br />
differential assay of salivary, pancreatic namylase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
amyhase immobilized on bacterial cell wall<br />
(SN), 1235<br />
discordant results in hCG testing by<br />
monoclonal immunoassay methods (A), 887<br />
double-label time-resolved<br />
immunofluorometry of lutropin and<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12,1987 2391
folhitropin in serum (SN), 2281<br />
double.monoclonal immunoenzymometric<br />
assay for alpha1-fetoprotein modified for<br />
increased anal, precision (A), 926<br />
dry-reagent immunoassay for vahproic acid for<br />
use with Ames Saralyzer reflectance<br />
photometer (A), 1020<br />
dry-reagent immunoassay strip for detn, of<br />
quinidine with Ames Seralyzar relectance<br />
photometer (A), 1017<br />
ahectroimmunoassay for detn. of ApoB in sara<br />
by using a mixture of monoclonal antibodies<br />
(TB), 1070<br />
ELISA for detn, of insulin autoantibodies (A),<br />
921<br />
enzyme immunoassay for detn. of human<br />
luteinizing hormone in serum (A), 891<br />
Eu and Sm as labels in time.rasolved<br />
immunofluorometnic assay of follitropin, 48<br />
evaln, of a monochonal immunoradiometric<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
avain. of ferritin enzyme immunoassay based<br />
on monoclonal antibodies (A), 958<br />
evaln, of hipase enzyme immunoassay (EtA) kit<br />
based on monochonal antibodies (A), 996<br />
evaln. of monoclonal antibody-based enzyme<br />
immunoassay for detection of hepatitis B<br />
infection (A), 959<br />
evaln. of new low-cost test peck for beta-hCG<br />
(A),889<br />
evaln, of pancreas-specific alpha-amyhese<br />
antibody assay with different automated<br />
systems (A), 998<br />
generation and epitope analysis of TSHspecific<br />
monochonal antibodies for enzyme<br />
immunoassays (A), 882<br />
high-affinity monochonal antibodies specific for<br />
prostatic acid phosphatase, 103<br />
HLA.B27 typing by flow cytofluorometry, 1619<br />
IgG subclass measurements in the chin, lab.<br />
(R), 1707<br />
immunochemiluminometry of creatine kinase<br />
MB with a monochonal antibody to the MB<br />
isoenzyme (5), 1517<br />
initial assessment of tumor-associated antigen<br />
CA-125 in patients with ovarian, cervical,<br />
testicular tumors, 1124<br />
insulin-like growth factor I specific<br />
monochonal-antibody-based IRMA assay (A),<br />
893<br />
interference in immunoenzymometric assays<br />
using mouse monochonal antibodies caused<br />
by human 1gM antibody to mouse IgG (A),<br />
918<br />
internal chock reaction used in one-step enzyme<br />
immunochromatog. essay of theophyhline in<br />
blood (S), 1521<br />
investigations on “hook effect” by using<br />
monoclonal antibodies against human<br />
ferritin (A), 936<br />
hatex-egglutn. sssay for D dimar: avaln. and<br />
appln. to diagnosis of thrombotic disease,<br />
1837<br />
Megiwaltm enzyme immunoassay for CEA and<br />
AFP using microtiter wells as solid phase<br />
(A), 925<br />
mass, of corticotropin in unextracted plasma:<br />
time-resolved immunofhuorometric assay<br />
end immunoradiometric assay compared<br />
with use of same monoclonal antibodies,<br />
1747<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monochonal<br />
antibody-based immunoradiometric assay,<br />
end further exploration of antigenic sites on<br />
choriogonadotropin, 1147<br />
moh. interactions of antibodies (A), 863<br />
monochonal end polyclonal antibodies<br />
compared for RIA of somatomedin-C in<br />
acromegaly or hypopituitarism, 1593<br />
monochonal antibodies-based radial<br />
immunodiffusion assay of apohipoprotein A-I<br />
and B in angiogrephicalhy assessed coronary<br />
artery disease (A), 898<br />
monoclonel antibodies specific for the CK-M<br />
subunit and the CK-MM dimer (A), 986<br />
monochonal antibodies used in solid-phase and<br />
liquid-phase assays, exemplified by<br />
progesterone assay, 1331<br />
monochonel antibody-based enzyme-linked<br />
immunosorbent assay of ni-acid glycoprotein<br />
(SN), 2275<br />
monoclonal antibody.based RIA for vit. B12<br />
(57Co)/folate (I) detns. (A), 922<br />
monoclonal antibody-based urinary assays for<br />
renal antigens to monitor and prevent drug.<br />
induced nphrotoxicity (A), 1058<br />
2392 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
monoclonal antibody specific for salivary<br />
amyhase (L), 1695<br />
monoclonal antibody that specifically inhibits<br />
salivary a-amyhase, 1158<br />
noninstrumanted enzyme immunochnomatog.<br />
assay for quantn. of carbamazepine in whole<br />
blood (A), 1019<br />
nortriptyhine monoclonal antibody for quantn.<br />
of nortniptyhine in serum (A), 1024<br />
novel immunoassay procedure for on-site<br />
detection of theophyhhine in blood, serum, or<br />
plasma (A), 924<br />
pancreas-specific alpha-amylase assay with<br />
synergistic action of two different<br />
monoclonal antibodies (A), 997<br />
potential of monochonal antibodies to improve<br />
therapeutic monitoring of cychosponina, 32<br />
prechin. imaging and therapy studies with<br />
radiolabehad anti-CEA antibodies (A), 1053<br />
prechin. immunotherapy studies with<br />
monochonal antibody-drug conjugates (A),<br />
1053<br />
prostate-specific antigen as a marker for<br />
prostatic cancer: monochonal and polyclonal<br />
immunoassay compared (SN), 1916<br />
protein recognition of immobilized higands:<br />
promotion of selective adsorption (S), 1502<br />
qua!. control of anti-human IgG subclass<br />
murine monoclonal antibodies in ascites by<br />
using isoelectnic focusing/affinity<br />
immunoblot anal. (A), 963<br />
quantn. of free beta subunit of hCG by a fully<br />
automated instrument (A), 967<br />
quantn. of serum prostate specific antigen by<br />
simultaneous immunoanzymetric assay (A),<br />
928<br />
reactivity of human macroamyhases with mouse<br />
monochonal anti-salivary amylase antibodies<br />
(A),998<br />
Roche Isomune amylase reagent-a pancreatic<br />
amyhase immunosaparation technique (A),<br />
997<br />
semlautomated, cohorimatric measurement of<br />
creatine kinase-MB acty. in serum after<br />
extn. with CR-MB-specific monochonal<br />
antibody (A), 987<br />
simplification and standardization of IgG<br />
subclass quantn. by usin monoelonal<br />
antibodies in an enzyme immunoassay (A),<br />
917<br />
sohid.phase immunoassay for direct<br />
measurement of creatina kinase MB<br />
isoenzyme acty. in serum (A), 987<br />
solid-phase RIA for measuring free alpha<br />
subunit of pituitary ghycoprotein hormones<br />
(A),891<br />
specific immunoradiomatry of insulin-like<br />
growth factor I with use of monoclonal<br />
antibodies, 2019<br />
surface modn. with Protein A for uniform<br />
binding of monochonal antibodies (A), 1338<br />
time.resolved immunofluorometry of alpha.<br />
fetoprotein in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
two-monoclonal-antibody “sandwich”-type<br />
assay of hutropin, with no cross reaction with<br />
choniogonadotropin, 1603<br />
two monoclonal-baaed assays for<br />
carcinoembryonic antigen compared (SN),<br />
700<br />
Monochonal ganunopathies<br />
monoclonal gamniopathies in asymptomatic<br />
HIV-seropositiva patients (L), 1697<br />
underestimation of monochonal proteins by<br />
serum protein electrophoresis on cellulose<br />
acetate (SN), 182<br />
use of immunoglobulin heavy- and hight.chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoghobulins, 1771<br />
Monochonal immunoghobuhins<br />
rapid typing of serum paraproteins by<br />
immunobhotting without antigen-excess<br />
artifacts (SN), 1433<br />
Monoclonal proteins<br />
characterization of small monoclonal protein<br />
bands with Beckman’s “Paragon”<br />
immunofixation system (TB), 617<br />
underestimation of monoclonal proteins by<br />
serum protein ehectrophoresis on cellulose<br />
acetate (SN), 182<br />
use of immunoghobulin heavy, and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoghobulins, 1771<br />
Morphine<br />
comparison of Diagnostic Products Coat-A-<br />
Count (RIA) with gas chrometog./mass<br />
spectrometry for detn. of morphine in blood<br />
(A), 970<br />
concns. of morphine end codeine in serum and<br />
urine after ingestion of poppy seeds, 806<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: morphine in<br />
urine (A), 970<br />
detection of morphine in hair with the Abbott<br />
TDX (TB), 2125<br />
relationship of blood alcohol and morphine<br />
levels in heroin deaths (A), 969<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
serum concns, of morphine and its major<br />
metabolites after oral administration (A),<br />
969<br />
serum morphine and morphine glucuronides in<br />
man: renal failure elevates glucuronide levels<br />
(A),969<br />
Mucopohysaccharides<br />
variations in urinary mucopohysaccharides<br />
after injection of fibroblasts into patients<br />
with mucopohysacchanidoses (SN), 1879<br />
Mucopolysaccharidosis<br />
variations in urinary mucopolysaccharides<br />
after injection of fibroblasts into patients<br />
with mucopolyaaccharidoses (SN), 1879<br />
Multilayer film analysis<br />
accuracy of Ektacham DT system for urea<br />
improved by using 70 g/L albumin solution<br />
as diluent (TB), 1078<br />
alternative calibration scheme for the<br />
Ektachem CR-MB slide (L), 1492<br />
anal. of Mg in serum and urine by Kodak<br />
Ektacham analyzer (A), 1006<br />
anal, performance of Kodak Ektachem 400 on<br />
misc, body fluids (A), 966<br />
din, utility of Ektachem-daed, bilirubin<br />
fractions for classifying adult inpatients<br />
(SN), 1662<br />
detn. of conjugated and total bihirubin in serum<br />
of neonates, with use of bilirubin oxidese,<br />
1822<br />
affect of Trizma’ carbonate on results by the<br />
Kodak Ektachem single’slida method for<br />
creatinine (TB), 1476<br />
evaln. of body fluids on the Kodak-Ektachem<br />
(A), 915<br />
evaln. of Kodak thin-film slides for<br />
theophylline, Mg, and creatina kinase-MB<br />
(A), 951<br />
evaln, of hidocaine interference in the Kodak<br />
Ektacham 700 analyzer single-slide method<br />
for creatinine (TB), 2311<br />
eveln. of portable Eastman Kodak DT-60<br />
system in hoap. environment (A), 961<br />
evain. of single-side creatinina method in<br />
Kodak Ektachem 700 shows poe.<br />
interference from hignocaine metabolites<br />
(TB), 1674<br />
generation 04 Na slides and generation 04 ref.<br />
fluid evald. for use with the Ektachem 400<br />
Analyzer (SN), 845<br />
heat-inactivated serum dramatically increases<br />
pancreatic fluid hipase ecty. (A), 996<br />
impact of periodic recalibration on precision of<br />
stable anal, system: effect on two Kodak<br />
Ektachem analyzers (A), 909<br />
improved labels for use in digoxin multilayer<br />
enzyme immunoassays (A), 923<br />
influence of ambient temp. on the Ektachem<br />
DT6O results for total bihirubin and total<br />
protein (SN), 138<br />
Kodak Ektachem DTSC module evald. for<br />
measuring transaminases (ALT and AST)<br />
(A), 937<br />
Kodak Ektachem thin-film assay for quantn. of<br />
serum lactic acid (A), 1008<br />
mess, of 6 enzymes with the KOdak DTSC<br />
module, a physician’s office analyzer (SN),<br />
1911<br />
measurement of creatine kinase and lactate<br />
dehydrogenase with Kodak Ektachem DTSC<br />
module designed for physician’s office<br />
testing (A), 937<br />
measurement of LDH in body fluids on Kodak<br />
Ektachem 700(A), 966<br />
measurement of theophylline with Kodak<br />
Ektachem DTSC module (A), 1023<br />
measurement of total serum Ca with Kodak<br />
Ektachem DTSC module (A), 1007<br />
measurement of uric acid in urine on Kodak<br />
Ektachem 700(A), 966<br />
mobile lab, unit based on Ektachem DT<br />
system: use in hosp. setting (A), 937<br />
multilab, evaln, of single-slide enzymatic<br />
creatinine method on KOdak Ektachem<br />
analyzer (A), 951
multilayer element for detn. urea Ni in whole<br />
blood (TB), 310<br />
pediatric ref. intervals for Ektachem 700<br />
analyzer (A), 1029<br />
performance of improved ionophore with<br />
better Na1’ selectivity in multilayered film<br />
element (A), 1005<br />
performance of Kodak Ektachem DTSC<br />
module for detn, of elk. phosphatase and<br />
GGT (A), 937<br />
quality-control system for KOdak Ektachem<br />
400 & 700 analyzers (A), 909<br />
thin-film cohonimetnic assay for measuring CSF<br />
protein (A), 902<br />
thin-film colorimetric essay for serum iron (A),<br />
932<br />
Multiple myehonia<br />
improved meas. of urinary total protein<br />
(including light-chain proteins) with a<br />
Coomassie Brilliant Blue G-250-sodium<br />
dodecyh sulfate reagent (SN), 2099<br />
multiple myaloma with serum IgG kappa and<br />
Bence Jones lambda biclonal gammopathy<br />
(L), 1305<br />
Multiple sclarosis<br />
Bence Jones proteinurie in multiple sclerosis<br />
(SN), 1923<br />
changes in CSF IgG and apohipoprotein F<br />
indices in patients with multiple sclerosis<br />
during demyehination, remyahination, 1155<br />
CSF apohipoprotein E index in patients with<br />
multiple sclerosis during remission (A), 1032<br />
rate of synthesis of IgG within the blood-brain<br />
barrier and the IgG index compared in<br />
diagnosis of multiple sclerosis (SN), 113<br />
use of “gamma-protein index” and free kappa<br />
light chains in diagnosis of multiple sclerosis<br />
(A),904<br />
Myasthenia gravis<br />
isolation of receptor protein from autopsy<br />
muscle for development of assay for antiacetyhchohine<br />
receptor (A), 922<br />
Myahoma<br />
macroghobulinemia associated with IgA<br />
gammopathy in a patient with different<br />
light-chain specificity and no associated<br />
clinical findings (TB), 1945<br />
problems of gahetion in detn. of electrolytes in<br />
serum from a patient with IgA myehome<br />
(TB), 618<br />
use of immunoglobuhin heavy, and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoglobuhins, 1771<br />
Myocardiah infarction<br />
See also Heart disease<br />
activity vs mass detn, of serum CK.MB<br />
isoenzyma for detecting coronary reperfusion<br />
in acute myocardial infarction after<br />
therapeutic thrombolysis (A), 989<br />
acty. of serum aspartete aminotransferase<br />
isoenzymes in acute myocardial infarction,<br />
67<br />
anal. of creatine kinase isoenzymes and<br />
isoforms in serum to detect reperfusion after<br />
acute myocardial infarction, 507<br />
assessment of Paramax immunoinhibition CR.<br />
MB assay in acute myocardiel infarction (A),<br />
987<br />
cardiac enzyme changes in myxedema coma<br />
(CR), 622<br />
data, by RIA of the mass of lactate<br />
dehydrogenase isoenzyme 1 in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
early diagnosis of acute myocardial infarction<br />
by rapid anal. of creatine kinase isoeazyme-3<br />
(CR-MM) sub-types, 358<br />
electrophoresis and the isomune-LD and LD-1<br />
immuno methods compared to meas. of<br />
lactate dehydrogenase isoenzyma.1 (SN),<br />
1884<br />
hypothermic myxedema coma erroneously<br />
diagnosed as myocerdial infarct, because of<br />
increased creatine kinase MB (CR), 1083<br />
increased activities of creatine kinase and<br />
lactate dehydrogenase isoenzymes in a<br />
patient with metastatic ovarian tumor (CR),<br />
1484<br />
isoforms of creatine kinasa isoenzymes in<br />
serum in acute myocard. infarct after<br />
intracoronary thrombolysis, 2039<br />
is paraoxon hydrolytic acty. in serum<br />
predictive of myocard. infarct.? (L), 742<br />
lactate dehydrogenase isoenzyme 1 as detd. by<br />
inhibition with 1,6-hexanediol and by two<br />
other methods in myocardial infarction or<br />
cardiac-bypass surgery (SN), 589<br />
lactate dehydrogenase isoenzymes in serum<br />
during recent acute myocardial infarction<br />
(SN), 1419<br />
macro-lactate dahydroganase in serum after<br />
acute myocardial infarct. (L), 1103<br />
Mg21’and creatine kinase in myocard. infarct.:<br />
new date (L), 739<br />
myoglob’inand creatine phosphokinase-MB<br />
radioassays for early detection of acute<br />
myocardial infarction for myocardial salvage<br />
therapies (A), 989<br />
rapid protocol to rule out acute myocardial<br />
infarction (A), 990<br />
ratios of creatine kinase to lactate<br />
dehydrogenase and aspartate<br />
aminotransferasa in evaln, of patients with<br />
elevated CR (A), 990<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in man during 12 days after<br />
acute myocardial infarction, 21<br />
signif. of increased serum lactate<br />
dehydrogenase isoenzyme 5 in acute infaroposterior<br />
myocardial infarction (TB), 2309<br />
statistical signif. of paraoxonase acty. in a<br />
control group of children and a group of<br />
children of parents who had had early<br />
myocardial infarction (L), 1496<br />
subnormal serum creatine kinase activity in<br />
acute myocard. infarct. (L), 1306<br />
Myoglobin<br />
isolation and characterization of myoglobin<br />
from sheep heart and preparation of antimyoglobin<br />
(A), 1037<br />
myoghobin and creatina phosphokinase-MB<br />
radioassays for early detection of acute<br />
myocardiah infarction for myocardial salvage<br />
therapies (A), 989<br />
Myoglobinuria<br />
Amicon ultrafiltration device evald. for<br />
detection of myoghobinuria (TB), 1074<br />
increased serum lactate dehydrogenase<br />
isoenzyme 1 and “flipped” LD-1/LD-2 ratio<br />
in myopathy associated with partial<br />
carnitina palmitoyltransferase deficiency<br />
(CR), 2111<br />
Myxadema<br />
cardiac enzyme changes in myxedema coma<br />
(CR), 622<br />
hypothermic myxedema come erroneously<br />
diagnosed as myocardial infarct, because of<br />
increased creetine kinase MB (CR), 1083<br />
Naproxen<br />
naproxen interference with the ion-selective<br />
electrode in the RA-1000 (TB), 421<br />
Natal chemistry<br />
See Pediatric chemistry, Newborns, Pregnancy<br />
National Committee for <strong>Clinical</strong> Laboratory<br />
Standards<br />
See NCCLS<br />
NCCLS<br />
correction of precision equations in NCCLS<br />
EP5-T (L), 1104<br />
effect of icterus on 19 methods for Technicon<br />
Chem 1’ system evaluated by NCCLS EP7-<br />
P (A), 956<br />
effect of hipemia on 19 methods for Technicon<br />
Chem 1’ system evaluated by NCCLS EP7.<br />
P (A), 955<br />
estimates of precision on Beckman Synchron<br />
CX’3 din, system according to NCCLS<br />
guidelines (A), 940<br />
NCCLS publication, 1498<br />
news from NCCLS, 1111<br />
2334<br />
physician office protocol for assessing anal.<br />
instrument or method (A), 938<br />
Neonates<br />
See also Newborns<br />
alk. phosphatase isoenzyines in the plasma of<br />
pretenm and term infants: serial<br />
measurements and chin, correlations, 1783<br />
anal, for HbCO by gas chromatog. and<br />
muhticomponent spectrophotom. compared<br />
(SN), 694<br />
assay of neonatal total and direct bihirubin on<br />
Technicon RA 1000’ system (A), 1012<br />
detn. of conjugated and total bihirubin in serum<br />
of neonates, with use of biirubin oxidsse,<br />
1822<br />
evelg. the chin, effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
false-positive elevation of serum 17.<br />
hydroxyprogesterone in neonates, as<br />
measured by direct RIA (A), 886<br />
hemetocnit effect on glucose reagent strip<br />
systems and verification of the effect with<br />
neonate samples (A), 912<br />
maternal hypozincemia and how-birth-weight<br />
infants (L), 1950<br />
modified lamehhar body phospholipid assay<br />
compared with L/S ratio and<br />
phosphetidyhglyceroh assay for assessment of<br />
fetal pulmonary status, 24<br />
neonatal hyperbilirubinemia due to glucose-6phosphate<br />
dehydrogenase deficiency (A),<br />
1013<br />
plasma estradiol concns. in neonates (TB),<br />
1934<br />
props. of alk. phosphatase isoenzymes in<br />
plasma ofpreterm and term neonates, 1778<br />
simple hiq.-chromatog. mess. of<br />
vanfflyimandehic acid and homovanilhic acid<br />
in urine on filter paper for mass screening of<br />
neuroblastoma in infants, 2043<br />
Neopterin<br />
detn, of neopterin in serum and urine, 62<br />
serum neopterin levels in newborns of opiateaddicted<br />
mothers (A), 970<br />
simultaneous data. of neoptenin and craatinine<br />
in serum with solid-phase extraction and online<br />
elution hiq. chromatog., 2028<br />
Nephehometry<br />
See also Rate nephehometry<br />
age-related changes in plasma proteins<br />
measured by nephehometry in pediatric<br />
patients (A), 1029<br />
Beckman Arrayv and Behring nephehometer<br />
system compared for five protein anelytes<br />
(A), 947<br />
evahn. of Beckman reagent for apo A-I and apo<br />
B lipoproteins (A), 898<br />
naphehometnic assay of rheumatoid factor in<br />
patients with juvenile rheumatoid arthritis<br />
(A),903<br />
“Quantimetric” kappa:hambde ratio test (L),<br />
448<br />
ref. values for 9 plasma proteins in healthy<br />
subjects of various ages by nephahometry (A),<br />
902<br />
use of immunoghobuhin heavy- and hight’chein<br />
measurements compared with existing<br />
techniques in typing monoclonal<br />
immunoghobulins, 1771<br />
Nephrocahcinosls<br />
xanthine hithiasis, nephrocahcinosis, renal<br />
failure in a leukemia patient treated with<br />
allopurmnol (CR), 2314<br />
Nephrotic syndrome<br />
alterations in low-density hipoproteins in<br />
nephrotic syndrome (A), 897<br />
proteinuria in health and disease assessed by<br />
measuring the urinary protein/creatine ratio<br />
(SN), 297<br />
Naphrotoxiclty<br />
changes in cyclosponine metabolism with<br />
coadministration of ketoconezole (A), 979<br />
chin, significance of nephrotoxicity asaocd. with<br />
cancer therapy (A), 1058<br />
kidney as a target of toxicity (A), 1057<br />
monochonal antibody-based urinary assays for<br />
renal antigens to monitor and prevent druginduced<br />
nephrotoxicity (A), 1058<br />
urinary anahytes in exptl. nephrotoxicity (A),<br />
1057<br />
Nerve growth factor<br />
development of chin, useful redioreceptor assay<br />
for nerve growth factor (A), 893<br />
Neural tube defects<br />
time-resolved immunofluorometry of alphafetoprotein<br />
in serum, amniotic fluid, with a<br />
novel detection system, 2000<br />
Neurasninic acid<br />
chem, characterization of urinary<br />
glycopeptides, 2214<br />
Neuraminidase<br />
See Siahidase<br />
isoelectric focusing of sialidase-treated elk.<br />
phosphatasa isoenzymes on agarose gel (SN),<br />
830<br />
Neuroblaatoma<br />
simple hiq.-chromstog. mess, of<br />
vanillyimandehic acid and homovanilhic acid<br />
in urine on filter paper for mass screening of<br />
neuroblastoma in infants, 2043<br />
Neurotranamitters<br />
detn. of 6-aminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase hiq. chromatog., 1736<br />
hiq..chromatog. measurement of<br />
catechohamines and metabohites in plasma<br />
and urine, 2209<br />
Neutron activation analysis<br />
Sb eccumn, in heir during treatment of<br />
leishmaniasis (SN), 2081<br />
trace-element concns. in autopsy tissue, 2057<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12,1987 2393
Newborns<br />
See also Neonates, Pediatric chemistry<br />
apolipoprotein concns. in cord sara of<br />
newborns from diabetic and nondiabetic<br />
mothers (A), 897<br />
CK.BB and -MB concns. in premature infants<br />
(A), 990<br />
cord transferrin and ferritin in newborn infants<br />
with uterophacental insufficiency (A), 1030<br />
digoxin RIA that doss not detect digoxin-hike<br />
substance in serum of newborns, infants, or<br />
patients with<br />
effects of shortrenal<br />
failure (TB), 420<br />
and long-term prenatal<br />
steroids on rapid-turnover proteins in<br />
premature<br />
enzyme-linked<br />
infants (A), 934<br />
immunosorbent assay for 17ahydroxyprogesterone<br />
in dried blood spotted<br />
on filter paper, 761<br />
four methods compared<br />
carboxy-prothrombin<br />
for measuring des-<br />
(PIvKA-iI) (SN), 2074<br />
highly sensitive enzyme-linked immunosorbent<br />
assay of human<br />
blood sera (A),<br />
C-reactive<br />
919<br />
protein in cord<br />
improved<br />
infants’<br />
quantn, of vitamin D in proprietary<br />
formulas and in breast milk, 796<br />
percentile estimates of ref. values for total<br />
protein and albumin in sara of prematures<br />
(SN), 411<br />
plasma transthyretin concns. in low-birthweight<br />
infants after hosp. discharge (A), 934<br />
rapid’turnover serum proteins to evaluate<br />
protein status of reterm infants (A). 934<br />
ref. intervals for Ca-i in full-term and pre-term<br />
infants (A), 1030<br />
RIA of somatomedin-C in filter paper discs<br />
containing dried blood, 536<br />
serum neopterin levels in newborns of opiateaddicted<br />
mothers (A), 970<br />
turbidimetry of transthyretin (prealbumin)<br />
with a centrif. analyzer (SN), 144<br />
Nickel<br />
hipoperoxides in plasma as measured by hiq..<br />
chromatog. sepn. of<br />
malondialdehyde-thiobarbituric acid<br />
adduct,<br />
Nicotine<br />
214<br />
rapid, sensitive method for simultaneous<br />
quantn. of nicotine and cotinine in biol.<br />
fluids by HPLC (A), 975<br />
Nitroprusside<br />
false-positive results for ketone with the drug<br />
mesna and other free-SH cmpds. (SN), 289<br />
toxicity of Na nitroprusside, 490<br />
toxicity of Na nitroprusside (continued) (L),<br />
1693<br />
Nonesterified fatty acide<br />
See Fatty acids<br />
Nonthyroidal illness<br />
diagnostic performance of sensitive<br />
measurements of serum thyrotropin during<br />
severe nonthyroidal illness: role in diagnosis<br />
of hyperthyroidism, 2178<br />
validity of analog free thyroxin immunoassays.<br />
part II (response p. 2148) (01,2145<br />
validity of analog free thyroxin immunoassays<br />
(response, p. 2150)<br />
Normal values<br />
(0), 2137<br />
See Reference interval<br />
Normetanephrine<br />
administered viloxazine interferes in hiq.chromatog.<br />
1677<br />
assay of normetanephrines (TB),<br />
Norpseudoephedrine<br />
phenylpropanolamine<br />
norpseudoephedrine<br />
and (d)-<br />
are indistinguishable by<br />
Toxilab (TB), 1678<br />
Nortriptyline<br />
measurement of plasma nortriptyline and its<br />
isomeric lO-hydroxy metabohites (A), 1024<br />
nortriptyhine monoctonal antibody for quantn.<br />
of nortriptyhine<br />
Norverapamil<br />
in serum (A), 1024<br />
capillary GC/MS anal, of verapamil and<br />
norverapamil in serum (A), 1017<br />
Nuclear magnetic resonance<br />
accurate quantn. of phosphohipids in amniotic<br />
fluid by #{176}P.NMR (A), 901<br />
modn. of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with H NMR,<br />
76<br />
noninvasive evaln. of mineral content of bone<br />
without use of ionizing radiation, 227<br />
#{176}P nuclear NMR study of variations in intraerythrocytic<br />
AT!->concn. and pH induced by<br />
surgical trauma (SN), 228-4<br />
revised method of’H-NMR urinalysis for<br />
detecting inborn errors of metab. (TB). 714<br />
toxicity of Na nitroprusside, 490<br />
2394 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
urinary glycoconjugates excreted by patients<br />
with type I and type II fucosidosis compared,<br />
44<br />
Nucleic acids<br />
immunolog. capture of nucleic acid hybrids,<br />
apphn. to nonradioactive DNA probe assay<br />
(S), 1526<br />
Nucheotidase<br />
adaptation and evain. of kinetic color reagent<br />
for electrophoretic visualization of 5’nucleotidase<br />
isoenzymes (A), 957<br />
adaptation of 5’-nucheotidese assay for use with<br />
the Olympus Demand (TB), 310<br />
ehectrophoretic sepn. of 5’-nucleotidase by<br />
using a single substrate-color reagent (A),<br />
995<br />
Nutrition<br />
See Perenteral nutrition<br />
assessment of Mg status (R), 1965<br />
chin, nutrition and chin, chem. (A), 875<br />
din, problems of nutritional support (A), 874<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-hiq. chromatog., 1869<br />
improved quantn, of vitamin D in proprietary<br />
infants’ formulas and in breast milk, 796<br />
Nutritional status<br />
approaches to accurate anal, of organic<br />
micronutrients in serum (A), 1062<br />
hospital malnutrition (A), 873<br />
indirect vs direct measurement of Mg and Zn<br />
in erythrocytes, 529<br />
methods compared for detg. glutathione<br />
peroxidase ecty. in blood, 539<br />
plasma transthyretin concns, in low-birthweight<br />
infants after hoap. discharge (A), 934<br />
rapid-turnover serum proteins to evaluate<br />
protein status of preterm infants (A), 934<br />
Se and vit. F relationship in malnourished<br />
children before and during parenteral<br />
supplementation (A), 934<br />
vit. B deficiency and coronary heart disease:<br />
new perspective in assessment of vit. B6<br />
nutritional status (A), 935<br />
Oak Ridge Conference<br />
adv. anal. concepts, 19th, intro, (5), 1501<br />
Obesity<br />
mild exercise improves cardiovascular risk<br />
factors in obese pubescent children (A), 1030<br />
Obituaries<br />
Weisberg, Harry Frank, 440<br />
Occult blood<br />
comparison of 5>Cr-RBC and Hemoccult<br />
method for gastrointestinal blood loss with a<br />
monoclonal antibody method for detecting<br />
Hb in stool (A), 1001<br />
Occupationally-induced disease<br />
simultaneous detn. of trace elements in lavage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence, 3. routine<br />
anal., 2234<br />
Ohigoclonal bends<br />
oligoclonal banding in<br />
hypergammaghobulinemia (A), 905<br />
oligoclonal immunoglobulins in healthy<br />
homosexual and heterosexual couples<br />
exposed to human immunodeficiency virus<br />
(A), 905<br />
Oncogenes<br />
cellular oncogenes and carcinogenesis (R), 641<br />
Opiates<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
serum neopterin levels in newborns of opiateaddicted<br />
mothers (A), 970<br />
serum propoxyphene concns. in opiate addicts<br />
on long-term propoxyphene maintenance<br />
therapy. evidence for drug tolerance in<br />
humans (A), 974<br />
Organic acids<br />
chem. factors important to Ca nephrohithiasis:<br />
evidence for impaired hydroxycarboxyhic<br />
acid absorption causing hyperoxaluria, 243<br />
metabolic profiles of urinary org. acids recd.<br />
from absorbent filter paper (SN), 572<br />
urinary org. acids: isohn. and quantn. for<br />
routine metabolic screening, 473<br />
Organ transplants<br />
chin, variability of cyclosporine<br />
pharmacokinetics (A), 978<br />
examn. of heart proteins by 2-D<br />
electrophoresis, 2011<br />
goat-derived anti-lymphocyte globulin<br />
interferes in a double-antibody RIA of<br />
digoxin (CR), 619<br />
graft preservation and immunosuppression in<br />
heart-lung transplantation (A), 1056<br />
high incidence of subnormal, as well as<br />
elevated, serum thyrotropin after major<br />
cardiac surgery or cardiac transplantation, in<br />
patients with no history of thyroid disease<br />
(A),882<br />
lab. support of transplantation (A), 870<br />
recent advances in transplantation and some<br />
associated ethical controversies (A), 1055<br />
Ornithine carbamoyhtransferase<br />
how early can ornithine carbamoyltransferase<br />
be meas. in fetal liver? (L), 1953<br />
Orotic acid<br />
source of error in the assay of urinary orotic<br />
acid (TB), 713<br />
Osmometry<br />
See Osmotic pressure<br />
refractometry, test strip, and osmometry<br />
compared as measures of reh, density of urine<br />
(TB), 190<br />
Osmotic pressure<br />
sweat osmohahity values in normal adults (TB),<br />
612<br />
yet more on osmohal gaps in urine (L), 746<br />
Osteocalcin<br />
RIA of human osteocalcin (A), 907<br />
Osteoporosis<br />
improved quantn. of vitamin D in proprietary<br />
infants’ formulas and in breast milk, 796<br />
noninvasive evaln. of mineral content of bone<br />
without use of ionizing radiation, 227<br />
Ovarian tumors<br />
time-resolved immunofluorometry of Ovarian<br />
carcinoma-associated antigenic determinant<br />
CA 125 in serum, 2191<br />
Ovulation<br />
detn. of chomiphene citrate and tamoxifen in<br />
blood and seminal plasma using reversed.<br />
phase HPLC (A), 1025<br />
in vivo disappearance time of hCG in healthy<br />
women and patients with Rokitonski<br />
syndrome (A), 889<br />
rapid, cohorimetric immunoassay for detection<br />
of human urinary huteinizing hormone and<br />
prediction of ovulation (A), 891<br />
rapid enzyme immunoassay for detection of<br />
urinary human huteinizing hormone (A), 921<br />
Oxalate<br />
automated enzymatic method for oxalate in<br />
urine (TB), 1076<br />
chem. factors important to Ca nephrolithiasis:<br />
evidence for impaired hydroxycarboxyhic<br />
acid absorption causing hyperoxaluria, 243<br />
convenient urine oxahate assay with an oxalate<br />
oxidase reagent and a cantrif. analyzer (TB),<br />
2301<br />
deficiencies of Sigma Diagnostic’s urinary<br />
oxalate method in the presence of ascorbate<br />
(TB), 419<br />
effect of tetrasodium EDTA on enzymatic<br />
detns. of urinary oxahate, 833<br />
evain. of a commercial enzyme kit (Sigma) for<br />
detg. oxalate in urine (SN), 1203<br />
more sensitive direct oxahate oxidase assay of<br />
urinary oxalate (SN), 1931<br />
obviating interferences in essay of urinary<br />
oxalate (SN), 855<br />
turbidimetry study of Ca oxahate<br />
mineralization (A), 980<br />
Oxalate oxidase<br />
effect of tetrasodium EDTA on enzymatic<br />
detns. of urinary oxalate, 833<br />
Oxalogenesis<br />
two-carbon oxalogenesis compared in recurrent<br />
Ca oxalate stone formers, normal subjects,<br />
1118<br />
Oxidative stress<br />
improved procedure for detg. glutathione in<br />
plasma as an index of myocardiah oxidative<br />
stress (SN), 1448<br />
Oxybuprocaine<br />
oxybuprocaine and five metabohites<br />
simultaneously detd. in urine by gas<br />
chromatog. and gas chromatog.-mass<br />
spectrom. after extraction with Extrelut<br />
(SN), 697<br />
Pancreatic disease<br />
acty. of phosphohipase A compared in serum in<br />
pancreatic and nonpancreatic diseases (SN),<br />
594<br />
evaln. of CA 19-9 concns. as marker for<br />
pancreatic cancer (A), 1034<br />
sensitive assay with 1,2-diglyceride as substraU<br />
for pancreatic lipase in serum (A), 962<br />
serum pancreatic oncofetal antigen and<br />
carbohydrate antigen 19-9 in pancreatic<br />
cancer patients (A), 932<br />
two indirect tests of exocrine pancreatic<br />
function evald. (R), 5
Pancreatic enzymes<br />
salivary anlyhase and pancreatic enzymes in<br />
Sjogren’s syndrome (SN), 305<br />
Pancreatic fluid<br />
heat-inactivated serum dramatically increases<br />
pancreatic fluid hipase acty. (A), 996<br />
Pancreatitis<br />
differential assay of salivary, pancreatic aamylase<br />
in serum, urine, with use of<br />
monochonal antibody to human salivary<br />
ansylase immobilized on bacterial cell wall<br />
(SN), 1235<br />
likelihood calcn, by means of different aamylase<br />
and lipase tests in inflammatory<br />
pancreatitis (A), 998<br />
Paraozonase<br />
low A-esterasa acty. in serum in fish-eye<br />
disease (SN), 587<br />
statistical signif. of paraoxonese acty. in a<br />
control group of children and a group of<br />
children of parents who had had early<br />
myocardial infarction (L), 1496<br />
Paraproteins<br />
high-titer anti-HIV antibodies associated with<br />
paraprotein spike in an asymptomatic<br />
homosexual male (A), 1028<br />
patient with an IgG paraprotein and complexes<br />
of lactate dehydrogenase and IgG in the<br />
serum (TB), 1937<br />
“Quantimetric” kappa:lambda ratio test (L),<br />
448<br />
rapid typing of serum paraproteins by<br />
immunoblotting without antigen-excess<br />
artifacts (SN), 1433<br />
use of immunoghobulin heavy- and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoghobulins, 1771<br />
Parasitic disease<br />
RIA of tumor necrosis factor in serum, 2024<br />
Parathyrin<br />
comparison of two parathyrin assays<br />
misleading? (L), 744<br />
evaln, of a mid-molecule perathyrin RIA (TB),<br />
1074<br />
highly sensitive two-site immunoradiometric<br />
assay of parathyrin, and chin, use in evalg.<br />
patients with hypercalcemia, 1364<br />
measurement of intact parathyrin by<br />
extracting two-site immunoradiometry, 1376<br />
mid-molecule perathyrin stability (A), 892<br />
two assays of intact parathyrin compared (TB),<br />
2312<br />
Parathyroid<br />
measurement of Al in micro tissue samples by<br />
electrothermal atomic abaorption<br />
spectrometry (A), 933<br />
Parenteral nutrition<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-liq. chromatog., 1869<br />
metabolic consequences of TPN therapy (A),<br />
874<br />
plasma, erythrocyte, and urinary Zn in<br />
critically ill patients: effect of intravenous Zn<br />
therapy (A), 933<br />
Se and vit. E relationship in malnourished<br />
children before and during parenteral<br />
supplementation (A), 934<br />
Particle-enhanced turbidinsetric<br />
immunoassay<br />
development of quant. automated<br />
immunoassay for C-reactive protein (A), 960<br />
Particle-enhanced turbidimetric inhibition<br />
immunoassay<br />
See also PE’TINIA<br />
Patent law<br />
patent law primer for chin, chemists and other<br />
scientists (SR), 432<br />
Pattern recognition<br />
Flavobacterium and Sphingobacterium<br />
species: enzyme profiles compared by use of<br />
pattern recognition of two-dimensional<br />
fluorescence data, 377<br />
P002<br />
See Blood gases<br />
Pediatric chemistry<br />
See also Fetal status, Heritable disorders,<br />
Neonates, Newborns<br />
acute toxic hepatitis in a child with Bandectm<br />
overdose (A), 1031<br />
age-related changes in plasma proteins<br />
measured by nephehometry in pediatric<br />
patients (A), 1029<br />
elanina aminopeptidase in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
anal. for HbCO by gas chromatog. and<br />
multicomponent spectrophotom. compared<br />
(SN), 694<br />
can a single measurement of carbamazepine<br />
suffice for therapeutic monitoring? (SN), 812<br />
commercial electrochem. method evald, for<br />
mess. of Fe status (SN), 1645<br />
detn. of b-aminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase liq. chromatog., 1736<br />
direct, simultaneous mess, of chhoramphenicol<br />
and its monosuccinate ester in microsamples<br />
of plasma by radial-compression liq.<br />
chromatog., 1814<br />
evein. of EMrF-chloramphenicol assay in a<br />
pediatric hosp. (A), 1021<br />
evaln. of serum IgE and anti-mite-specific<br />
IgE’s in Kawasaki disease (A), 1029<br />
evaln. of Technicon Chem 1’ random-access<br />
analyzer in a pediatric setting (A), 968<br />
four methods compared for measuring descarboxy-prothrombin<br />
(PIvKA-H) (SN), 2074<br />
free cortisol and craatinine in urine of healthy<br />
children, 2047<br />
humoral immune responses in<br />
noninstitutionalized Down’s syndrome<br />
children (A), 1029<br />
hydrocortisone succinate and hydrocortisone<br />
simultaneously deed. in plasma by reversedphase<br />
liq. chomatog. and their<br />
pharmacokinetics in asthmatic children,<br />
1412<br />
incidence of drugs in a pediatric population as<br />
assessed through drug screening (A), 977<br />
kinetics of isoniazid in children and<br />
adolescents (A), 1030<br />
metabolic profiles of urinary org. acids recd,<br />
from absorbent filter paper (SN), 572<br />
methods compared for detg. glutathione<br />
peroxidase acty. in blood, 539<br />
microbore liquid-chromatog. anal. of<br />
chloramphenicol for pediatric drug<br />
monitoring (A), 1021<br />
mild exercise improves cardiovascular risk<br />
factors in obese pubescent children (A), 1030<br />
neuron-specific enohase as a tumor marker (A),<br />
928<br />
one-tube radiotransinessay for detn. of cortisol<br />
at ambient temp., 1137<br />
pediatric ref. intervals for Ektachem 700<br />
analyzer (A), 1029<br />
quantn. of 5a- and 5-androstanediols in urine<br />
by gas chromatog.-mass spectroni., 256<br />
quantn. of desferrioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
Se and vit. F relationship in malnourished<br />
children before and during paranteral<br />
supplementation (A), 934<br />
serum protein ehectrophoresis changes in 4<br />
infants with severe combined<br />
immunodeficiency (A), 1028<br />
simple liq.-chromatog. mass, of<br />
vanillyimandelic acid and homovanillic acid<br />
in urine on filter paper for mass screening of<br />
neuroblastoma in infants, 2043<br />
three iminunoassay methods evahd. for<br />
quantifying prealbumin in serum (SN), 1430<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: din, and biochem. features<br />
of 21 cases and literature review (CR), 313<br />
two indirect tests of exocrina pancreatic<br />
function evald. (R), 5<br />
urinary glycoconugates excreted by patients<br />
with type I and type II fucosidosis compared,<br />
44<br />
Pentobarbital<br />
serum pentobarbital detn. by fluorescence<br />
polarization immunoassay (A), 1026<br />
Peptide hormones<br />
double-label time-resolved<br />
immunofluorometry of hutropin and<br />
follitropin in serum (SN), 2281<br />
interference by anti-iminunoghobulin G<br />
antibodies in immunoradiometric assays of<br />
thyrotropin involving mouse monoclonal<br />
antibodies (SN), 840<br />
mess, of corticotropin in imextracted plasma:<br />
time-resolved immunofluorometric assay<br />
and immunorediometric assay compared<br />
with use of same monochonal antibodies,<br />
1747<br />
monochonal and polychonal antibodies<br />
compared for RIA of somatomadin-C in<br />
acromegaly or hypopituitarism, 1593<br />
specific immunoradiometry of insulin-like<br />
growth factor I with use of monochonal<br />
antibodies, 2019<br />
two-monoclonal-antibody “sandwich”-type<br />
assay of lutropin, with no cross reaction with<br />
choriogonadotropin, 1603<br />
Peritoneal fluid<br />
suitability of solid-phase cham, for quanta. of<br />
heukocytes in cerebrospinal, seminal, and<br />
peritoneal fluid (TB), 1475<br />
Perozidase<br />
quantn. of two different types of<br />
apolipoprotein A-i containing lipoprotein<br />
particles in plasma by enzyme-linked<br />
differential-antibody immunosorbent assay,<br />
38<br />
PETINIA<br />
particle-enhanced turbidimetric inhibition<br />
immunoassay for thyroxin (A), 884<br />
pH<br />
differential pH mess. to determine analytes<br />
erythrocytes (A), 1558<br />
intravascular performance of cathetermounted<br />
pH-ISFETs (A), 960<br />
modn. of intra-erythrocytic homeoetasis in<br />
uremic patients, as studied with np NMR,<br />
76<br />
Pharniacokinetlcs<br />
are cychophosphamide and phosphoramide<br />
mustard related in high-dose bone-marrow<br />
in<br />
transplant patients? (A), 1035<br />
chin, variability of cychoeporine<br />
pharmacokinetics (A), 978<br />
critical issues in cycloeporine monitoring<br />
report of the Task Force on Cyclosporine<br />
Monitoring (SR), 1269<br />
decreased drug absorption in a patient with<br />
Behcet’s syndrome (CR), 1679<br />
datn, of tamoxifen and four metabolites in<br />
serum by low-dispersion hiq. chromatog.,<br />
1608<br />
drug of abuse profile: cocaine (S), 668<br />
fluorometry of iodocyanine green in plasma,<br />
765<br />
hydrocortisone succinate and hydrocortisone<br />
simultaneously detd, in plasma by reversedphase<br />
hiq. chomatog. and their<br />
pharmacokinetics<br />
1412<br />
in asthmatic children,<br />
identn. and anal. of 9 metabohites of<br />
cychosporine in blood by hiq. chromatog.<br />
comparison of patients’ results, 1851<br />
2:<br />
improved liq.-chromatog. assay of habetalol in<br />
plasma (SN), 1450<br />
kinetics of isoniazid in children and<br />
adolescents<br />
Pharmacology<br />
(A), 1030<br />
alcohol, an abused drug (S), 82B<br />
drug of abuse profile: cannabis (S), 72B<br />
drug of abuse profile: cocaine (S), 66B<br />
Phencychidine<br />
false-positive EMIT D.A.U. phencyclidine<br />
assay as a result of an overdose of<br />
dextromethorphan<br />
Phenobarbital<br />
(A), 9’74<br />
See also Barbiturates<br />
adaptation of Syva QST assays of theophylline,<br />
phenytoin, and phenobarbital to the EASY<br />
analyzer (A), 944<br />
affmity.chromatog. isolation of howsubstitution<br />
ratio conjugates and their<br />
performance in phenobarbital enzyme<br />
immunoassays (A), 923<br />
automated fluorescence immunoassays for<br />
theophyhhine, phenytoin,<br />
(A), 923<br />
fluorescence immunoassays<br />
and phenobarbital<br />
for phenobarbital<br />
and phenytoin (A), 1020<br />
Seralyzer reagent-strip system evald, for mess.<br />
of phenobarbital in serum (TB), 191<br />
Phenylketonurla<br />
phenylalanine and tyrosine in serum and<br />
eluates from dried blood spots as detd, by<br />
reversed-phase<br />
Phenylpropanolamine<br />
hiq. chromatog., 1152<br />
phanyhpropanolamine and (d)norpseudoephedrina<br />
are indistinguishable<br />
Toxilab (TB), 1678<br />
Phenytoin<br />
by<br />
adaptation of Syva QST assays of theophyffine,<br />
phenytoin, and phanobarbital to the EASY<br />
analyzer<br />
automated<br />
(A), 944<br />
fluorescence immunoassays for<br />
theophylline, phenytoin, and phenobarbital<br />
(A), 923<br />
evain. of free phenytoin and free<br />
cerbamazepina concns, by Abbott TDx<br />
reagent system for total drug detns, (A), 1018<br />
fluorescence immunoassays for phenobarbital<br />
and phenytoin (A), 1020<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2395
in vitro prediction of phenytoin toxicity (A),<br />
1019<br />
serum phenytoin detn. on Cobast Bio FP<br />
centrifugal analyzer (A), 1020<br />
Phosphate<br />
See Phosphorus<br />
biol. variation in anahyte concns. in urine of<br />
apparently healthy men, women (SN), 847<br />
enzymatic colorimetric essay of inorganic P04,<br />
312<br />
mannitol interference in an automated serum<br />
phosphate assay (TB), 2308<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: chin. and biochem. features<br />
of 21 cases and literature review (CR), 313<br />
Phosphatidyhchohine<br />
assay of disaturated phosphatidylchohine in<br />
amniotic fluid as a test of fetal lung<br />
maturity: experience with 2000 analyses<br />
(SN), 1648<br />
Phosphatidyhghycerol<br />
automated enzymatic measurement of lecithin,<br />
sphingomyelin, and phosphatidyhglycerol in<br />
amniotic fluid, 81<br />
comparison of thin-layer chromatog., immunol.<br />
and enzymatic methods for determining<br />
phosphatidylglycerol in amniotic fluid (A),<br />
900<br />
coat-effective screening of amniotic fluids for<br />
phosphatidylglycerol before the Amniostat-<br />
FLN procedure (TB), 715<br />
emergency test for fetal hung maturity: OD 650<br />
or Amniostat-FLM? (TB), 2123<br />
evalg. the din, effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
evaln. of quant. enzymatic assay for<br />
phosphatidyhglycerol in amniotic fluid (A),<br />
900<br />
modified lameilar body phospholipid assay<br />
compared with L/S ratio and<br />
phosphatidylglycerol assay for assessment of<br />
fetal pulmonary status, 24<br />
Phosphatidyhinositol<br />
phosphohipase C and phosphatidyhinositol<br />
phosphohipase C (L), 337<br />
Phosphohexose isomerase<br />
automated method for phosphohexose<br />
isomerase with a centrif. analyzer (TB), 2120<br />
Phospholipase<br />
acty. of phospholipase A compared in serum in<br />
pancreatic and nonpancreatic diseases (SN),<br />
594<br />
phosphohipase C and phosphatidylinositol<br />
phosphohipase C (L), 337<br />
rapid detn. of phospholipase A in serum and<br />
plasma (TB), 1259<br />
Phoephohipids<br />
accurate quantn. of phosphohipids in amniotic<br />
fluid by 31P-NMR (A), 901<br />
effect of albumin and lamellar bodies on<br />
fluorescence polarn. of amniotic fluid (SN),<br />
1194<br />
effect of gentamicin and cyclosporin on<br />
permeability of model membranes (A), 1027<br />
modified lamellar body phosphohipid assay<br />
compared with L/S ratio and<br />
phosphatidylglycerol assay for assessment of<br />
fetal pulmonary status, 24<br />
phosphohipids turnover in avian tuberculosis<br />
(A), 1036<br />
variables effecting resolution of lung<br />
phospholipids in thin-layer chromatog. (SN),<br />
135<br />
Phycobiliprotein<br />
laser-frequency-optimized fluorescent energy<br />
transfer phycobihiprotein dye (A), 917<br />
Physician’s office testing<br />
adaptation of simple colorimetric assay for<br />
urea N with IQ’” immunochem. system (A),<br />
1010<br />
anal, performance of the Vision System avald.<br />
(TB), 1672<br />
anal, systems ranked by freedom from<br />
interferences (SN), 1453<br />
bias end precision of cholesterol anal, by<br />
physician’s office analyzers (SN), 2262<br />
BioMATTM: a rapid, self-washing immunoassay<br />
system with a microparticuhate solid phase<br />
(A), 1566<br />
chem. assays-new opportunities (S), 1574<br />
comparison of physician office analyzers for<br />
cholesterol anal, in screening centers (A), 898<br />
decentralization of cholesterol and triglyceride<br />
assays by using three “SPOT” instruments<br />
(A), 938<br />
development and field performance of<br />
enzymatic creatinine method for Analyst’TM<br />
2396 CLINICAL CHEMISTRY, Vol.33,No. 12,1987<br />
physician’s office profiler (A), 949<br />
evahn. of DuPont Analyst and Na/K analyzers<br />
for physician office testing (A), 936<br />
evaln. of EN! hematology analyzer for the<br />
doctor’s office (A), 938<br />
evahn. of physician office lab. analyzer,<br />
Boehringer Mannheim Reflotron (A), 938<br />
avaln. of the Ames “Seralyzer” (TB), 1255<br />
evaln. of the Boehringer Mannheim<br />
“Reflotron” analyzer (TB), 1254<br />
evaln. of the Kodak “DT 60” analyzer (TB),<br />
1255<br />
experience in 3 physicians’ office labs, with<br />
carbamazepine dry-reagent strip system (A),<br />
1019<br />
glycohemoglobin method for the doctor’s office<br />
(A), 1002<br />
interference studies with physician office<br />
analyzers (A), 915<br />
internal chock reaction used in one.step enzyme<br />
immunochromatog. assay of theophyhhine in<br />
blood (S), 1521<br />
Kodak Ektachem DTSC module evald. for<br />
measuring transaminases (ALT and AST)<br />
(A), 937<br />
lab, and field evahn. of three desktop<br />
instruments for assay of cholesterol and<br />
triglyceride (SN), 1230<br />
mess, of 6 enzymes with the Kodak DTSC<br />
module, a physician’s office analyzer (SN),<br />
1911<br />
measurement of creatine kinase and lactate<br />
dehydrogenase with Kodak Ektachem DTSC<br />
module designed for physician’s office<br />
testing (A), 937<br />
multisystem micro-computer for the doctor’s<br />
office (A), 985<br />
performance evahn. of desk-top electrolyte<br />
analyzer designed for doctor’s office and<br />
outpatient clinics (A), 938<br />
performance of Kodak Ektechem DTSC<br />
module for detn. of elk. phosphatase and<br />
GGT (A), 937<br />
performance of 3 Reflotron tests in 2 physician<br />
office labs, (A), 948<br />
performance of three new blood-glucose<br />
reflectometers evald. by nursing and lab.<br />
staffs (TB), 2312<br />
physician office protocol for assessing anal.<br />
instrument or method (A), 938<br />
physician’s office analyzer, Abbott “Vision”,<br />
evald, (SN), 817<br />
proficiency testing for therapeutic drugs in<br />
physician office and small clinic labs (A), 908<br />
quality control scheme for blood glucose<br />
measured outside the laboratory (SN). 1233<br />
quality of bedside glucose data (L), 1108<br />
Reflotron’ assays of alanine aminotransferase<br />
and glutamyltransferase in whole-blood<br />
samples evald. (SN), 826<br />
temp.-dependent results with the ChemPro-<br />
1000 (L), 443<br />
theophylhine method of the Abbott “Vision”<br />
analyzer evald. (SN), 130<br />
Pineal function<br />
mehatonin secretion assessed by measuring its<br />
metabohite, 6-sulfatoxymehstonin, 1343<br />
Pipecohic acid<br />
quantn. of pipecohic acid in plasma, and of<br />
urinary cystine in the presence of<br />
penicihlsmine-cystine disuhfida, with the<br />
Beckman 6300 Amino Acid Analyzer (L),<br />
1302<br />
Pituitary-adrenal disorders<br />
evahn. of pituitary-adrenal axis (A), 871<br />
Plaque<br />
DNA probe-based technol. and atd. culture<br />
mathodoh, compared for detecting<br />
periodontal pathogens (A), 963<br />
Plasma cells<br />
underestimation of monoclonal proteins by<br />
serum protein electrophoresis on cellulose<br />
acetate (SN), 182<br />
Plasma emission spectroscopy<br />
simultaneous detn. of trace elements in havage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence. 3. routine<br />
anal., 2234<br />
Plasminogen<br />
evaln, of a fully automated centrifugal analyzer<br />
for hemostasis tests (SN), 1888<br />
kinetic immunonephelometric detn, of protein<br />
concns, in folhicuhar fluid, 1185<br />
Platelets<br />
automated anal. for taurine in biol, fluids,<br />
tissues (SN), 835<br />
detection of circulating platelet antibodies and<br />
platelet-associated IgG by flow cytometry<br />
(A), 1004<br />
interference by platelets in electrophoretic<br />
detn. of enolase isoenzymes in plasma (SN),<br />
164<br />
serum thromboxane B2 test of patient<br />
compliance in chin. studies of plateletaffecting<br />
drugs (A), 1004<br />
P02<br />
See Blood gases<br />
Polarization fluoroimmunoassay<br />
single-reagent polarization fluoroimmunoassay<br />
of methamphetamine in urine (SN), 1903<br />
Polarization immunoassay<br />
rapid fluorescence polarization immunoassay<br />
for antimicrobial drugs: gentamicin,<br />
tobramycin, and amikacin (A), 1020<br />
Pohyamines<br />
method of isolating erythrocytes influences<br />
their measured polyamine content (TB),<br />
1081<br />
Polyanionic precipitation<br />
four procedures compared for sepg.<br />
apohipoprotein A- and apolipoprotein Bcontaining<br />
lipoproteins in plasma, 1597<br />
Poppy seeds<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
Porphyria<br />
patterns of porphyrin excretion in feces as<br />
detd. by hiq. chromatog.; ref. values and<br />
effect of flora suppression, 2164<br />
(Washington Univ. case conference) dual<br />
porphyria-an underdiagnosed entity? (CC)<br />
1190<br />
Porphyrins<br />
direct quantn. of coproporphyrins,<br />
uroporphyrins in urine by deny. synchronou<br />
fluorescence spectroscopy, 1826<br />
patterns of porphyrin excretion in feces as<br />
deed, by hiq. chromatog.; ref. values and<br />
effect of flora suppression, 2164<br />
Potassium<br />
Sea also Electrolytes<br />
Amdev’s “Lytening 1” Na and K analyzer<br />
evald, (TB), 416<br />
colorimetric K reagent for Abbott Vision<br />
system (A), 1005<br />
effects of PO4 and HEPES/MOPS buffers on<br />
calibration of Na end K ion.selective<br />
electrodes for din, anal. (A), 1005<br />
LITE: device for coupling ion-selective<br />
electrode assay to en optical reading<br />
instrument (A), 960<br />
method for simultaneously estg. plasma,<br />
erythrocyte, and heukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
variation data, 1326<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
Potentiometry<br />
See also Electrochemical techniques, Ionselective<br />
electrodes<br />
ecty. measurements of Ca2’, Na+, K”, and C1<br />
after equilibrium dish, used to show hack of<br />
evidence for protein interference with Ca<br />
electrodes, 1811<br />
Prealbumin<br />
See also Fibronectin<br />
immunoturbidimetry of transthyretin<br />
(prealbumin) in serum (TB), 1260<br />
quantn. of prealbumin in human serum by<br />
immunoturbidimetry (A), 902<br />
rate nephelometry, radial immunodiffusion<br />
compared for measuring serum prealbumin<br />
(SN), 161<br />
three immunoassay methods evald. for<br />
quantifying prealbumin in serum (SN), 143(<br />
turbidimetry of transthyretin (prealbumin)<br />
with a centrif. analyzer (SN), 144<br />
Prednisolone<br />
simultaneous detn. of prednisone/prednisoloni<br />
in plasma by HPLC (A), 1027<br />
Prednisone<br />
simultaneous detn. of prednisone/prednisoloni<br />
in plasma by HPLC (A), 1027<br />
Pregnancy<br />
accelerated enzyme immunosssay for<br />
choriogonadotropin in urine, involving reflo’<br />
of specimen through capillary tubes, 498<br />
automated quantn. of choriogonadotropin:<br />
anal, correlation between serum and urine<br />
with creatinine correction (SN), 1424
choriogonadotropin and pregnancy testing:<br />
prozone phenomenon defined (L), 742<br />
choriogonadotropin datg. in serum is preferable<br />
for early diagnosis of ectopic pregnancy<br />
(TB), 1669<br />
comparison of successive pregnancies provides<br />
evidence for a maternal component in detg.<br />
circulating steroid concns. (TB), 1476<br />
enzyme immunoassay of free triiodothyronine<br />
in serum (SN), 172<br />
evain. of new low-cost test pack for beta-hCG<br />
(A),889<br />
highly sensitive qual. methods for serum<br />
choriogonadotropin: ci specificity studies<br />
(SN), 677<br />
how early can ornithine carbamoyltransferase<br />
be mess, in fetal liver? (L), 1953<br />
immunofluorometry of choriogonadotropin by<br />
time-resolved fluorescence spectroscopy,<br />
with a new Eu chehate as label, 1994<br />
maternal hypozincemia and how-birth-weight<br />
infants (L), 1950<br />
quant. correlation of serum to urine hCG with<br />
correction by urine creatinina in pregnancy<br />
(A), 889<br />
role of qual. choriogonadotropin essays in<br />
diagnosis of ectopic pregnancy (SN), 1908<br />
sepn. and identn. of alk. phosphatasa<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoehectric focusing, 2171<br />
Tandem Icon urine test for choriogonadotropin<br />
in ectopic pregnancy (A), 889<br />
time-dependent changes in bone, placental,<br />
intestinal, and hepatic alk. phosphatase<br />
activities in serum during pregnancy, 1801<br />
time-resolved immunofluorometry of 34-kDa<br />
somatomedin-binding protein, 1126<br />
two-step RIA for free tniiodothyronine in<br />
serum, 372<br />
validity of analog free thyroxin immunoassays.<br />
part II (response p. 2148) (0), 2145<br />
validity of analog free thyroxin immunoassays<br />
(response, p. 2150) (0), 2137<br />
Premenstrual syndrome<br />
assessment of Mg status (R), 1965<br />
Prenatal diagnosis<br />
See also Amniotic fluid, Fetal status, Heritable<br />
disorders<br />
use of amniotic fluid enzymes for prenatal<br />
diagnosis of cystic fibrosis (A), 1059<br />
Procainamide<br />
enhanced fluorescence polarization assays for<br />
therapeutic drug monitoring: cardioactive<br />
drugs (A), 1013<br />
second-generation serum procainamide assay<br />
for Cobas5 Bio FP centrifugal analyzer using<br />
fluorescence polarization methodology (A),<br />
1017<br />
Proficiency testing<br />
See also Interhaboratory performance<br />
ability of the 1 rule to detect substandard<br />
performance in interhab. proficiency testing,<br />
788<br />
assessment of proficiency testing programs<br />
using fixed limits as a means to evaluate<br />
intralab. performance (A), 908<br />
assessment of the use of fixed limits to<br />
characterize intralab. performance by<br />
proficiency testing (SN), 1901<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
improved accuracy of chohinesterase<br />
phenotyping after participation in a<br />
proficiency survey (SN), 823<br />
interlab. proficiency-testing programs:<br />
computer model to assess their capability to<br />
correctly characterize intralab. performance,<br />
784<br />
more on proficiency testing (L), 2321<br />
performance of quant. urine anal, in<br />
Australasia critically assessed, 792<br />
proficiency testing for therapeutic drugs in<br />
physician office and small clinic labs (A), 908<br />
Progesterone<br />
effect of time of exposure of serum to gelbarrier<br />
tubes on results for progesterone and<br />
some other endocrine tests (L), 203<br />
enzyme-linked immunosorbent assay for 17ahydroxyprogesterone<br />
in dried blood spotted<br />
on filter paper, 761<br />
false-positive elevation of serum 17hydroxyprogesterone<br />
in neonates, as<br />
measured by direct RIA (A), 886<br />
measurement of progesterone receptors in<br />
breast-tumor cytosols by immunoenzymatic<br />
essay: prehim. results (TB), 2308<br />
monochonal antibodies used in solid-phase and<br />
liquid-phase assays, exemplified by<br />
progesterone assay, 1331<br />
progesterone receptors should be meas. in<br />
postmenopausal women negative for<br />
estrogen receptor (L), 741<br />
surface modn. with Protein A for uniform<br />
binding of monochonal antibodies (A), 1338<br />
Prolactin<br />
evaln. of hutropin and prolactin kits in an<br />
interhab, survey (A), 907<br />
Propoxyphena<br />
serum propoxyphene concns. in opiate addicts<br />
on hong-term propoxyphene maintenance<br />
therapy. evidence for drug tolerance in<br />
humans (A), 974<br />
Prostaglandins<br />
detn. of two urinary prostaghandins by<br />
capillary gas chromatog.-high’resolution<br />
mess spectromatry (A), 891<br />
Prostate<br />
receptor-antibody “sandwich” assay for<br />
teicophanin, 1615<br />
Prostate-specific antigen<br />
anal, and biol. variation of serum proetatic<br />
specific antigen compared with prostatic acid<br />
phosphatese (A), 927<br />
anal, and physiol. characteristics of prostatespecific<br />
antigen and prostatic acid<br />
phosphetasa in serum compared (SN), 2086<br />
comparison of Hybritech immunoradiomatric<br />
and immunoenzymatric assays of prostatespecific<br />
antigen (A), 928<br />
comparison of monochonal and polychonal<br />
immunoassay for prostate-specific antigen<br />
(A), 927<br />
comparison of two assays for prostate-specific<br />
antigen (A), 926<br />
evaln. of a monoclonal immunoradiometric<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
evaln, of Hybnitech assay for prostate-specific<br />
antigen (A), 926<br />
evahi. of prostate-specific antigen for follow-up<br />
of prostate cancer using two commercially<br />
available kits (A), 928<br />
quantn. of serum prostate specific antigen by<br />
simultaneous immunoenzymetric assay (A),<br />
928<br />
Prostatic acid phosphatase<br />
See Acid phosphatase<br />
Protein/creatinine index<br />
more on urinary protem/creatinine index (L),<br />
199<br />
Proteins<br />
age-related changes in plasma proteins<br />
measured by nephehomatry in pediatric<br />
patients (A), 1029<br />
Beckman Array’TMand Behring nephehometer<br />
system compared for five protein analytes<br />
(A), 947<br />
bromcresoh purple dye-binding methods<br />
underestimate albumin that is carrying<br />
covalenthy bound bihirubin (SN), 821<br />
contribution of tubular proteins to proteinurie<br />
of diabetes melhitus (A), 1033<br />
Coomassie Brilliant Blue and benzethonium Cl<br />
methods adapted to Cobas-Bio for<br />
measurement of urinary protein (A), 964<br />
Coomassie Brilliant Blue G250 method for<br />
urinary protein adapted to Cobas-Bio<br />
centrifugal analyzer (A), 979<br />
Coomassie Brilliant Blue protein dye-bindin<br />
assays compared for detn, of urinary protein<br />
concn. (SN), 577<br />
correlation of Ames Micro-Buminteat’ tablet<br />
with total protein and albumin in diabetic<br />
urines (A), 980<br />
CSF total protein deed. with the Hitachi 705<br />
Analyzer (TB), 711<br />
deproteinizing methods evald. for detn, of uric<br />
acid in serum by reversed-phase iq.<br />
chrometog. with UV detection (SN), 1427<br />
datn. of serum proteins on Boehringer<br />
Mannheim-Hitachi 704 analyzer (A), 958<br />
development of protein assays usin? research<br />
mode option of the 0M300 protein analyzer<br />
(A),916<br />
dextran interference in biurat-based assays for<br />
serum proteins (TB), 1073<br />
effects of short’ and long-term prenatal<br />
steroids on rapid-turnover proteins in<br />
premature infants (A), 934<br />
electrophoresis indicates protein loss on<br />
centrifn, of whole saliva (TB), 1263<br />
errors in estg. urinary protein by use of<br />
benzethonium Cl (L), 2127<br />
evahn. of Technicon Demand improved total<br />
protein reagent and albumin method on the<br />
Olympus Demand chem. analyzer (A), 965<br />
examn. of heart proteins by 2-D<br />
electrophoresis, 2011<br />
fructosamine and protein concns. in serum (L),<br />
2326<br />
improved mess. of urinary total protein<br />
(including light-chain proteins) with a<br />
Coomassie Brilliant Blue G-250-sodium<br />
dodecyh sulfate reagent (SN), 2099<br />
influence of ambient temp. on the Ektachem<br />
DT6O results for total bulirubin and total<br />
protein (SN), 138<br />
intracellular precursor forms of plasma<br />
proteins: functions and possible occurrence<br />
in plasma (R), 1317<br />
kinetic immunonephelometric detn. of protein<br />
concns. in follicular fluid, 1185<br />
4-methylumbelliferone and its glucuronide<br />
interfere with protein estn. by the Lowry<br />
method (TB), 1475<br />
microtiter-plate method for estg protein in<br />
biopsies ofsmalh intestine (TB), 1671<br />
monochonal proteins: how concn. detection by<br />
immunofixation electrophoresis (A), 904<br />
non-enzymic glycation of individual plasma<br />
proteins in normoghycemic and<br />
hyperglycemic patients, 2220<br />
optimization of sodium dodecyl sulfate concns.<br />
in Coomassie Brilliant Blue G250 method for<br />
urinary light-chain proteins (A), 905<br />
percentile estimates of ref. values for total<br />
protein and albumin in sere of prematures<br />
(SN), 411<br />
performance evaln. of Abbott TDx Turbo<br />
Specific Protein system (A), 901<br />
performance of BUN, glucose, and total<br />
protein on the Spirit electrolyte chem.<br />
system (A), 946<br />
performance of two time-dependent analyses<br />
compared with an end-point analysis, in<br />
DataChem’s chinical analyzer (TB), 2121<br />
pitfall in anal, of proteins synthesized by sweat<br />
glands from patients with cystic fibrosis by<br />
two-dimensional gel electrophoreais and<br />
double.labeh autorediography (TB), 2310<br />
pptn. of serum proteins by the lectin from<br />
wheat-germ (SN), 185<br />
precision and accuracy of serum fructosasnine<br />
assays and correlation with Hb A1 and<br />
serum glucose and protein concns. (A), 1002<br />
pronounced decrease of Tamm-Horsfall<br />
proteinuria in diabetics (TB), 1264<br />
12-protein immunoassay profile on the Cobas<br />
FARA (A), 917<br />
proteins and hormones in Echinococcosis (A),<br />
907<br />
rapid-turnover serum proteins to evaluate<br />
protein status of preterm infants (A), 934<br />
ref. ranges for 16 specific proteins assayed by<br />
rate nephelometry (A), 901<br />
ref. values for 9 plasma proteins in healthy<br />
subjects of various ages by nephehometry (A),<br />
902<br />
serum M-proteins in B-cell<br />
hysnphomas/leukemias by high-resolution<br />
electrophoresis/immunofixation (A), 904<br />
serum protein electrophoresis and<br />
immunoglobuhin measurements in subjects<br />
at risk for AIDS(A), 1028<br />
serum protein ehectrophoresis changes in 4<br />
infants with severe combined<br />
immunodeficiancy (A), 1028<br />
serum protein reagent for use in the ParallelC<br />
analytical system not susceptible to<br />
interference by dextrans (L), 1953<br />
simplified SDS-PAGE of unconcd. urine with<br />
enhanced resolution and detection<br />
sensitivity (SN), 1886<br />
specificprotein anal. in body fluids by<br />
Kallestad Diagnostics QM300 nephelomatry<br />
system (A), 948<br />
thin-film cohorimetric essay for measuring CSF<br />
protein (A), 902<br />
total protein, alb., Ca, and Hb deed. with the<br />
Abbott”Vision” system (TB), 711<br />
total-protein reagent interferes with mess, of<br />
urate in the Hitachi 737 (TB), 712<br />
urinary and CSF protein measured with<br />
pyrogalhoh red-mohybdete on Hitachi 705 (A),<br />
980<br />
Proteinuria<br />
contribution of tubular proteins to proteinuria<br />
of diabetes mallitus (A), 1033<br />
immunoblotting for detecting Benca Jones<br />
proteinuria (TB), 1079<br />
improved mess, of urinary total protein<br />
(including light-chain proteins) with a<br />
Coomassie Brilliant Blue G-250-sodium<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12,1987 2397
dodecyl sulfate reagent (SN), 2099<br />
proteinuria in health and disease assessed by<br />
measuring the urinary protein/creatine ratio<br />
(SN), 297<br />
Prothrombin<br />
evaln. ofa fully automated centrifugal’analyzer<br />
for hemostasis tests (SN), 1888<br />
four methods compared for measuring descarboxy-prothrombin<br />
(PIVKA.ll) (SN), 2074<br />
prothrombin assay standardized with an<br />
international normalization ratio (NR): goal<br />
and reality, 342<br />
validation of prothrombin measurement in<br />
RIA by using HPLC (A), 1003<br />
Psychotropic drugs<br />
See also Anticonvulsant drugs, Tricychic<br />
antidepressants, etc.<br />
Pulmonary disease<br />
See Lung disease<br />
Purines<br />
deproteinizing methods evald, for datn, of uric<br />
acid in serum by reversed-phase hiq.<br />
chromatog. with UV detection (SN), 1427<br />
liq. chromatog. with multichannel UV<br />
detection for studying disorders of purina<br />
metab., 2052<br />
Pyridoxal phosphate<br />
low-ultraviolet “white” fluorescent lamps fail<br />
to protect pyridoxal phosphate from<br />
photohysis (L), 631<br />
Pyruvate<br />
lactate and pyruvate ehectrochem. biosensors<br />
for whole blood in axtracorporeal<br />
experiments with an endocrine artificial<br />
pancreas (SN), 591<br />
pyruvate interference with continuous-flow<br />
(SMAC) methods for aspartate and shanine<br />
aminotransferases (TB), 616<br />
Quality assurance<br />
qual. assurance in a forensic lab,: GC/MS<br />
confirmation of THC and cocaine (A), 971<br />
quah. assurance in changing times: proposals<br />
for reform and res, in the chin, lab. field (SR),<br />
328<br />
Quality control<br />
ability of the 1 rule to detect substandard<br />
performance in interlab, proficiency testing,<br />
788<br />
anomalous between-lab, variability in a<br />
collaborative study of CEA immunoassay<br />
(L), 1694<br />
automation of graphical qual. -control<br />
monitoring with IBM personal computer and<br />
comm. available software (A), 984<br />
calibration stability of IL Monarchtv systems<br />
(A).908<br />
computerized real.time quality-assurance<br />
program for integration of lab. quality.<br />
control data (A), 909<br />
critical issues in cychosporine monitoring:<br />
report of the Task Force on Cyclosporine<br />
Monitoring (SR), 1269<br />
cychosporine: interlaboratory Q.C. program (L),<br />
2128<br />
desirable stds. of performance for therapeutic<br />
drug monitoring (L), 1299<br />
detecting errors in blood-gas measurement by<br />
anal. with two instruments, 512<br />
effect of anahyte concn. of short- and hong-term<br />
within- and among-lab. anal, variance (A),<br />
908<br />
effects of long-term components of variance on<br />
performance of rules for statistical quality<br />
control (A), 910<br />
evaln. of alternative quality control statistics<br />
for RIA procedures (A), 907<br />
impact of periodic recahibretion on precision of<br />
stable anal. system: effect on two Kodak<br />
Ektacham analyzers (A), 909<br />
medical utility frequency, 221<br />
optical kinetic method for calibration of<br />
spectrophotometer temp.: demonstration<br />
with the Cobas-Bio analyzer (SN), 1891<br />
optimized guidelines for inter-instrument<br />
validation (A), 909<br />
performance of quent. urine anal, in<br />
Australasia critically assessed, 792<br />
prepn. and stability of low-cost liq. qualitycontrol<br />
serum stabilized with ethanediol<br />
(SN), 851<br />
qua!. control of anti-human IgG subclass<br />
murine monoclonal antibodies in ascites by<br />
using isoelectric focusing/affinity<br />
immunoblot anal, (A), 963<br />
quality-control materials for use with monitors<br />
of blood glucose: “Refloflux II” (Boehringer<br />
Mannheim) and “Sugar.Chex” (Streck<br />
Laboratories) controls (L), 1294<br />
2398 CLINICAL CHEMISTRY, Vol.33, No. 12,1987<br />
quality control scheme for blood glucose<br />
measured outside the laboratory (SN), 1233<br />
quality-control system for Kodak Ektachem<br />
400 & 700 analyzers (A), 909<br />
quality-control system for the “activated<br />
clotting time” test (TB), 1261<br />
qual. of measurements for micronutrients of<br />
interest to cancer prevention (A), 1063<br />
simulated comparison of multi-rule protocols<br />
for statistical quality control (A), 909<br />
Quinidine<br />
dry.reagent immunoassay strip for detn. of<br />
quinidine with Ames Serahyzer relectance<br />
photometer (A), 1017<br />
enhanced fluorescence polarization essays for<br />
therapeutic drug monitoring: cardioactive<br />
drugs (A), 1013<br />
Quinine<br />
quinine directly deed. in serum or urine by<br />
aepn. fluoroiinmunoassay, 463<br />
Radial immunodiffusion<br />
enhanced-latex agghn. assay for C-reactive<br />
protein in serum, with use of a centnif,<br />
analyzer (SN), 685<br />
monochonal antibodies-based radial<br />
immunodiffusion assay of apohipoprotein A-I<br />
and B in angiographicafly assessed coronary<br />
artery disease (A), 898<br />
new assay of apohipoproteins A-I and B by rate<br />
nephelometry avald. (SN), 2065<br />
rate nephahometry, radial immunodiffusion<br />
compared for measuring serum preahbumin<br />
(SN), 161<br />
spectrophotometry of urinary albumin by dye’<br />
binding with use of bromphenoh blue, 223<br />
stability of free apohipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hyparhipidemic subjects, 1163<br />
three immunoassay methods evald, for<br />
quantifying prealbumin in serum (SN), 1430<br />
Radial partition immunoassay<br />
evaln, of radial-partition fluorescent<br />
immunoassay (StratustTM)at how concns. of<br />
thyrotropin (A), 880<br />
radial partition fluorometnic enzyme<br />
immunoassay for detection of hepatitis B<br />
surface antigen with the Stratus’ analyzer<br />
(A),906<br />
radial partition immunoassay for free thyroxin<br />
(A),885<br />
radial partition immunoessay: monitoring<br />
digitoxin in serum and plasma (A), 1015<br />
radial partition immunoassay: quant. CK.MB<br />
in human serum (A), 988<br />
radial partition immunoassay: rapid automated<br />
detn. of total IgE on the Stratus analyzer<br />
(A), 904<br />
radial partition immunoassay: rapid automated<br />
quantn. of human thyrotropin on the<br />
Stratus’ analyzer (A), 882<br />
Radiative energy attenuation<br />
competitive inhibitor used in kinetic enzymatic<br />
method for measuring ethanol in serum<br />
(SN), 2296<br />
evaln, of plasma and CSF lactates on Abbott<br />
TDx (A), 961<br />
Radioassay<br />
cholesteryl ester transfer acty. in plasma<br />
measured by using solid-phase-bound highdensity<br />
hipoprotein, 39(1<br />
immobilized purified fohete.binding protein<br />
binding characteristics and use for<br />
quantifying fohete in erythrocytes, 1360<br />
temp.-dependent binding of cychosponine to an<br />
erythrocyte protein, 481<br />
Radioenzymatic assay<br />
direct detn. of angiotensin-converting enzyme<br />
inhibitors in plasma by rsdioenzymatic<br />
assay, 549<br />
Radioimmunoassay<br />
Abuscreen’ RIA for detection of<br />
benzodiazepinas and their metabohites (A),<br />
973<br />
autoantibody against diiodinated tyrosinegastrin<br />
in a patient with Graves’ disease, 97<br />
capillary blood, dried on filter paper, as sample<br />
for monitoring cyclosporin A concris., 1643<br />
characterization of a human antibody that<br />
interferes ins RIA system (A), 913<br />
chamiluminescence immunoassay for<br />
somatomedin C in serum, 1989<br />
chin. evaln, of Corzyme’-M (rDNA) and<br />
Corab’.M (rDNA) (A), 1031<br />
chin. evaln, of thyroghobulin RIA kit (A), 886<br />
comparison of Diagnostic Products Coat-A-<br />
Count (RIA) with gas chromatog./mess<br />
spectrometry for detn. of morphine in blood<br />
(A), 970<br />
comparison of enzyme inununoassay and RIA<br />
for cancer antigen 125 (CA 125) (A), 931<br />
comparison of monochonal and pohyclonal<br />
immunoassey for prostate-specific antigen<br />
(A), 927<br />
comparison of RLk and enzyme immunoassay<br />
measurement of ferritin concn. in pre- end<br />
post-menopausal females (A), 1032<br />
comparison of Roche RIA, Roche ELk, and<br />
Hybritech EIA methods for CEA (A), 924<br />
comparison of serum and salivary cortisol<br />
concns. in the dexemethasone suppression<br />
test (A), 1033<br />
cross reactions in RIA: a math. model for<br />
correcting assay results, as exemplified by<br />
ehimg. the interference of intact thyrotropin<br />
in an assay of its beta subunit, 658<br />
detn, by RIA of the mass of lactate<br />
dehydrogenase isoenzyme 1 in serum and of<br />
its rate of removal from serum after<br />
myocardial infarct, 1863<br />
detn, of antidiuretic hormone in random urine<br />
and its chin, apphicns. (A), 921<br />
detn. of cychosporina concns. with monochonal<br />
antibodies, 2225<br />
detn. of free thyroxin by combining<br />
ultrafiltration with RIA (A), 884<br />
detn. of naopterin in serum and urine, 62<br />
development and utility of a monoclonalantibody-based,<br />
highly sensitive<br />
immunoradiometric assay of thyrotropin,<br />
1387<br />
diagnostic value of <strong>Clinical</strong> Assays’ two-step<br />
“immunoextraction” RIA for free thyroxin in<br />
nonthyroidal illnesses (TB), 188<br />
digoxin RIA that does not detect digoxin-hike<br />
substance in serum of newborns, infants, or<br />
patients with renal failure (TB), 420<br />
direct measurement of human serum free<br />
testosterone (A), 922<br />
discrepancies in carcinoembryonic antigen<br />
measurements: survey and control values vs<br />
values for patients (SN), 563<br />
discrepant thyroid-function test results by<br />
fluorescent polarization and RIA in<br />
nonthyroidal illness (TB), 613<br />
effect of iodinated contrast media on a<br />
radioimmunoassay of C3a (TB), 1470<br />
enzyme immunoessay of angiotensin I and<br />
renin, 1774<br />
enzyme immunoassay of free triiodothyronine<br />
in serum (SN), 172<br />
evahn. of alternative quality control statistics<br />
for RIA procedures (A), 907<br />
avahn, of a mid-molecule parathyrin RIA (TB),<br />
1074<br />
evain. of direct RIA for androstenedione (A),<br />
891<br />
fahse’positive elevation of serum 17hydroxyprogesterone<br />
in neonates, as<br />
measured by direct RIA (A), 886<br />
folhitropin and hutropin simultaneously<br />
measured in urine with a commercial RIA kit<br />
(TB), 1674<br />
free and total insulin as deed, after pptn. with<br />
polyethylene glycol: anal. characteristics,<br />
effects of sample handing, storage, 93<br />
free T4 and free T3 analog RIAs designed to<br />
eliminate albumin-related artifacts (A), 885<br />
goat-derived anti-lymphocyte globulin<br />
interferes in a double-antibody RIA of<br />
digoxin (CR), 619<br />
improved RIA of melatonin in serum (SN), 604<br />
improved separation of antigen-antibody<br />
complex in RIA involving (NH4)2S04 (TB),<br />
415<br />
interference of sex-hormone binding globulin<br />
in the “Coat-A-Count” testosterone noextraction<br />
RIA (SN), 300<br />
linear method for detg. specific acty. of tracers<br />
in RIAs (SN), 1245<br />
hiq. chromatog. and RIA compared for detn, of<br />
cortisol and corticosterone in plasma after a<br />
dexamethasone suppression test (SN), 1639<br />
hiq.-chromatog. detn. of 2’microglobuhin, ajacid<br />
glycoprotein, and albumin in urine, 1756<br />
mess, of serum estradiol: comparison of three<br />
“direct” RhAs and effects of org. solvent<br />
extn, (TB), 1946<br />
melatonin secretion assessed by measuring its<br />
metabohite, 6-sulfatoxymehatonin, 1343<br />
method comparison of two cyclosporine essays<br />
by RIA (A), 977<br />
monoclonal and pohyclonal antibodies<br />
compared for RIA of somatomedin-C in<br />
acromegaly or hypopituitanism, 1593<br />
monoclonal antibodies used in solid-phase and<br />
liquid-phase assays, exemplified by
progesterone assay, 1331<br />
monoclonal antibody-based RIA for vit. B12<br />
(57Co)/folate (‘I) detns. (A), 922<br />
myoghobin and creatine phosphokinase-MB<br />
radioassays for early detection of acute<br />
myocerdial infarction for myocardial salvage<br />
therapies (A), 989<br />
natural and recombinant DNA-derived insulinhike<br />
growth factor-I compared for use in<br />
radioligand assays, 544<br />
on albumin-dependence of measurements of<br />
free thyroxin. II. non-thyroidal illness, 87<br />
parallelism of dilution curves in RIA (L), 2320<br />
plasma acidn. increases atrial natriuretic<br />
peptide as measured by RIA (L), 1104<br />
results from nath, interlab. quality-control<br />
survey for cycloeporin assay (A), 978<br />
RIA for human glucose-dependent<br />
insulinotropic polypeptide (GIP) (A), 893<br />
RIA for methadone in urine with comparisons<br />
to other anal, techniques (A), 970<br />
RIA of apohipoprotein A-I in serum and EDTA<br />
plasma, and effects of freeze-thaw cycles<br />
(TB), 308<br />
RIA of atrial natriuratic polypeptida in heattreated<br />
plasma, 674<br />
RIA of human osteocalcin (A), 907<br />
RIA of somatomedin-C in filter paper discs<br />
containing dried blood, 536<br />
RIA of tumor necrosis factor in serum, 2024<br />
serum cocaine concns. by RIA after intranasal<br />
apphicn. (A), 1026<br />
serum concns. of morphine and its major<br />
metabolitea after oral administration (A),<br />
969<br />
serum thromboxane B2 test of patient<br />
compliance in chin, studies of plateleteffecting<br />
drugs (A), 1004<br />
simple adaptation of an RIA kit for serum<br />
cortisol used to measure salivary cortisol<br />
(TB), 191<br />
simultaneous detn. of neopterin and creatinine<br />
in serum with solid-phase extraction and online<br />
elution hiq. chromatog., 2028<br />
simultaneous mess, of eight corticosteroids by<br />
hiq.-chromatog. and apphn. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
simultaneous solid-phase high-sensitivity TSH<br />
and free thyroxin assay (A), 881<br />
solid-phase RIA for measuring free alpha<br />
subunit of pituitary glycoprotein hormones<br />
(A),891<br />
specific immunoradiometry of insulin-hike<br />
growth factor I with use of monochonal<br />
antibodies, 2019<br />
specific I RIA for SQ 27,519 in human serum<br />
(A), 1027<br />
tech, and chin, performance of six sensitive<br />
immunoradiometric assays of thyrotropin in<br />
serum (SN), 1439<br />
three commercial kits and one liquidchromato.<br />
method evald, for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
time-resolved immunofluorometry of 34-kDa<br />
somatomedin-binding protein, 1126<br />
total testosterone, free-androgen index, calcd.<br />
free testosterone, and free testosterone by<br />
analog RIA compared in hirsute women and<br />
in otherwise-normal women with altered<br />
binding of sex-hormone-binding globulin,<br />
1372<br />
two-step RIA for free triiodothyronine in<br />
serum, 372<br />
validation of prothrombin measurement in<br />
RIA by using HPLC (A), 1003<br />
Radiohigand-based assay<br />
biotin radioligand assay with an i2Sllabehed<br />
biotin deny., avidin, and avidin doubleantibody<br />
reagents, 1983<br />
natural and recombinant DNA-derived insulin.<br />
like growth factor-I compared for use in<br />
radiohigand assays, 544<br />
Radiometric assay<br />
improved Ni radiochem, assay of free fatty<br />
acids in plasma (SN), 176<br />
Radiorecaptor assay<br />
development of chin, useful radioreceptor assay<br />
for nerve growth factor (A), 893<br />
natural and recombinant DNA-derived insulinlike<br />
growth factor-I compared for use in<br />
radiohigand assays, 544<br />
radioreceptor assay for measurement of 1,25dihydroxy<br />
vit. D (A), 892<br />
three commercial kits and one liquidchromato.<br />
method avald. for detg. 25hydroxyvitamin<br />
D3 in serum (SN), 1226<br />
Radiotransinassay<br />
one-tube radiotransinessay for deth. of cortisoh<br />
at ambient temp., 1137<br />
Random-access analysis<br />
adaptation of IFCC-recommended method for<br />
ALT at 37 #{176}C on Du Pont Dimension’ chin.<br />
chem. system (A), 992<br />
adaptation of Syva QST assay’s of theophylline,<br />
phenytoin, and phenobarbital to the EASY<br />
analyzer (A), 944<br />
applicn. ofEMrF cannabinoid 20 ng and 100 ng<br />
drugs of abuse (d.a.u.) essays to the ETS<br />
system (A), 971<br />
applicn. of EMI’J’#{149} quant. tricychic<br />
antidepressant essays to Hitachi’ 705 chem.<br />
analyzer (A), 1024<br />
assay of neonatal total and direct bilirubin<br />
Tachnicon RA 1000’ system (A), 1012<br />
on<br />
assessment<br />
emulate<br />
of parenteral fat emulsion to<br />
serum hipemia on the Paramax’<br />
anal. system (A), 913<br />
CEA, AFP, and prostate-specific antien<br />
assays developed for the Photon Elite (A),<br />
967<br />
chin. evaln. ofAbbott Spectrum’ (A), 939<br />
chin. evaln. of the EASY analyzer (A), 965<br />
comparison of Gilfond and BMD reagents for<br />
Hitachi 705 analyzer (A), 966<br />
cost-effective optimization of EMIT<br />
theophyhline assay for Technicon RA-i000<br />
analyzer (A), 1023<br />
detection of sample contamination of urine<br />
submitted for drugs of abuse testing in a<br />
high-volume setting with the Olympus 5000<br />
analyzer (A), 977<br />
detn. of serum<br />
Dimension”<br />
Fe and TIBC by Du Pont<br />
chin. chem, system (A), 944<br />
detn. of serum proteins on Boehringer<br />
Mannheim-Hitachi 704 analyzer (A), 958<br />
development of latex-based theophyhhine assay<br />
for the IL Monarch” chem. system (A), 967<br />
differentiation of direct and total biirubin by<br />
selection of appropriate surfactants (A), 1012<br />
effect of icterus on 19 methods for Technicon<br />
Chem P system evaluated by NCCLS EP7-<br />
P (A), 956<br />
effect of lipemla on 19 methods for Technicon<br />
Chem I” system evaluated by NCCLS EP7.<br />
P (A), 955<br />
effects of hipemia on Technicon RA-l000<br />
measurements (A), 913<br />
enzymatic CO2 method for Technicon RA”<br />
systems (A), 1009<br />
evaln. of Abbott Vision” system (A), 945<br />
evaln. of Cl ion-selective electrode for the<br />
Paramax’ anal, system (A), 953<br />
evaln, of 5 enzyme methods on the Spirit<br />
analyzer (A), 945<br />
evain. of lipid profile anal. on the Spirit’<br />
electrolyte chem. system (A), 945<br />
avaln. of liquid BUN reagent for Abbott<br />
Spectrum and VP analyzers (A), 951<br />
avahn. of Paramax’ CSF glucose assay (A), 952<br />
evaln. of several analytas by Cobas Mire and<br />
comparison with Technicon SMA-II-C<br />
analyzer (A), 965<br />
evaln, of Tachnicon Chem 1” random-access<br />
analyzer in a pediatric setting (A), 968<br />
evaln. of Technicon Demand improved total<br />
protein reagent and albumin method on the<br />
Olympus Demand chem, analyzer (A), 965<br />
avaln. of threshold algorithm for drugs of abuse<br />
profiling on the Monarch random-access<br />
analyzer (A), 977<br />
evaln. of two immunoturbidimetric C-reactive<br />
protein assays on the Hitachi 705 (A), 903<br />
foreground<br />
mainframe<br />
interface of Abbott Spectrum<br />
computer (A), 984<br />
to<br />
improved direct bihirubin<br />
Paramax’ anal, system<br />
method for<br />
(A), 1012<br />
kinetic method for uric acid detn. on RA’<br />
system and effect of endogenous<br />
interferences in the presence of bivalent ions<br />
(A), 1010<br />
messurament of serum concns, of CA-549, an<br />
experimental breast cancer<br />
Photon Elite random-access<br />
marker, by<br />
analyzer (A),<br />
930<br />
optimization of IFCC-recommended method<br />
for detg. gamma.glutamyhtransferase at 37<br />
#{176}C with the Du Pont Dimension” chin, chem.<br />
system (A), 994<br />
performance characteristics of Ca, Mg, alcohol,<br />
and HC03<br />
(A),944<br />
reagents in the EASY analyzer<br />
performance characteristics of Paramax’ anal.<br />
system for detn. of HDL cholesterol (A), 952<br />
performance characteristics of Paramax anal,<br />
system for detn. of P; reduction of<br />
interference through serum blank correction<br />
(A), 952<br />
performance characteristics of Paramax’ anal.<br />
system for detn. of hipase (A), 953<br />
performance of Abbott Vision” system for<br />
anal. of albumin, ALT, AST, creatinine, Hb,<br />
and total protein (A), 945<br />
performance of BUN, glucose, and total<br />
protein on the Spirit’ electrolyte chem.<br />
system (A), 946<br />
performance of six enzyme assays in the<br />
Tachnicon Chem I’” system (TB), 723<br />
performance testing of Du Pont Dimension<br />
(A),944<br />
prelim. evain. of prototype Du Pont<br />
Dimension” chn, chem. system (A), 96<br />
quantn. of free beta subunit of hCG by a fully<br />
automated instrument (A), 967<br />
response-surface optimized tableted reagent<br />
for datn. of serum hipase activity on the<br />
Paramax’ analyzer (A), 953<br />
specific protein anal, in body fluids by<br />
Kallestad Diagnostics QM300 nephelometry<br />
system (A), 948<br />
system performance evaln. of random access<br />
multichannel immunosnzymetnic analyzer<br />
(A),967<br />
turbidimetnic measurement of<br />
immunoghobulins with bichromatic randomaccess<br />
analyzer (A), 917<br />
urinary and CSF protein measured with<br />
pyrogallol red-mohybdete on Hitachi 705 (A),<br />
980<br />
Rate immunonephelometry<br />
development of protein assays usin research<br />
mode option of the OM300 protein analyzer<br />
(A), 916<br />
Rate naphehometry<br />
four immunoassay methods and stds,<br />
compared for measuring fibronectin (SN),<br />
126<br />
new assay of apohipoproteins A-I and B by rate<br />
nephelometry evald. (SN), 2065<br />
prelim. chin, studies of C-reactive protein<br />
quantified by enzyme-linked immunoessay,<br />
2185<br />
rate nephelometry, radial immunodiffusion<br />
compared for measuring serum prealbuinin<br />
(SN), 161<br />
ref. intervals for apohipoproteins A-I and B b<br />
rate naphelometry and associated CHD na<br />
assessment (A), 898<br />
ref. ranges for 16 specific proteins essayed by<br />
rate nephehometry (A), 901<br />
specific protein anal. in body fluids by<br />
Kallestad Diagnostics QM300 naphelometry<br />
system (A), 948<br />
three immunoassay methods evald, for<br />
quantifying prealbumin in serum (SN), 1430<br />
Rats<br />
deth, of inorganic F- in blood with a<br />
selective electrode, 253<br />
lipoperoxides in plasma as measured by hiq.chromatog.<br />
sepn. of<br />
malondialdehyde-thiobarbitunic acid<br />
adduct, 214<br />
validation and appln. of a liq..<br />
chromatog./enzymic assay for individual bile<br />
acids in rat serum, 1856<br />
Reagent strips<br />
effect of lipemia, hyperosmolality, and uremia<br />
on whole blood glucose measured by dry<br />
reagent strips and reflactometry (A), 912<br />
Receiver-operating characteristic curves<br />
See also Statistics<br />
cumulative distribution anal, graphs-an<br />
alternative to ROC curves (TB), 2305<br />
evaln. of diagnostic tests by using a MUMPS<br />
program to enerate receiver operating<br />
characteristic curves and likelihood ratios<br />
(A), 983<br />
rate of synthesis of IgG within the blood-brain<br />
barrier and the IgO index compared in<br />
diagnosis of multiple sclerosis (SN), 113<br />
renal differentiated from non’renal hematunia<br />
by micros. examn. of erythrocytes in urine,<br />
1791<br />
Receptor assays<br />
effect of methylene blue on estrogen and<br />
progesterone receptor essays (A), 914<br />
Receptors<br />
alpha-fetoprotein and estrogen/progestin<br />
receptors in breast cancer patients (A), 929<br />
flow-cytometnic detn. of high-densityhipoprotein<br />
binding sites on heukocytes, 2195<br />
isolation of receptor protein from autopsy<br />
muscle for development of assay for anti-<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12,1987 2399
acetylcholine receptor (A), 922<br />
measurement of progesterone receptors in<br />
breast-tumor cytosols by immunoenzymatic<br />
assay: prehim. results (TB), 2308<br />
progesterone receptors should be mess, in<br />
postmenopausah women negative for<br />
estrogen receptor (L), 741<br />
Recombinant DNA<br />
adaptation and evaln. of CEDIA” digoxin on<br />
Coulter Dacos’ chem. analyzer (A), 1014<br />
chin, evaln. of Corzyme’-M (rDNA) end<br />
Corab’.M (rDNA) (A), 1031<br />
ethics of presymptomatic genetic testing:<br />
principles and problems (A), 876<br />
recombinant DNA diagnosis of acquired and<br />
inherited disease (A), 876<br />
Reference interval<br />
acty. of phosphohipase A compared in serum in<br />
pancreatic and nonpancreatic diseases (SN),<br />
594<br />
alpha-fetoprotein concns. in serum of healthy<br />
males and females (A), 925<br />
assay of serum fructosamine that minimizes<br />
standn, and matrix problems: use to assess<br />
components of hiol, variation, 269<br />
assessment of Mg status (R), 1965<br />
automated detn, of angiotensin-converting<br />
enzyme in serum (SN), 1248<br />
biol, variation of blood acid-base status:<br />
consequences for anal. goal-setting and<br />
interpretn. of results, 1416<br />
biotin radioligand assay with an ‘25I-habeled<br />
biotin deny., avidin, and avidin doubleantibody<br />
reagents, 1983<br />
chin, performance of the Abbott “Vision<br />
System”: ref. intervals and specimen type<br />
comparisons (TB), 1078<br />
criteria for essential fatty acid deficiency in<br />
plasma as assessed by capillary column<br />
gas-liq. chromatog., 1869<br />
detg. serum isoenzyme pattern of -<br />
glutamyltranspeptidase: ref. intervals for<br />
normal subjects and patients with<br />
hepatobihiary diseases (A), 994<br />
detn. of 3-eminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase liq. chromatog., 1736<br />
detn. of a.amylase acty. with a new<br />
chromogenic substrate, 524<br />
detn. of inorganic F- in blood with a Fselective<br />
electrode, 253<br />
detn. of neopterin in serum and urine, 62<br />
different ref. intervals for kinetic assay of<br />
angiotensin-converting enzyme (L), 2324<br />
direct quantn. of coproporphynins,<br />
uroporphynins in urine by deny, synchronous<br />
fluorescence spectroscopy, 1826<br />
double-monoclonal immunoenzymometnic<br />
assay for ahphai-fetoprotein modified for<br />
increased anal. precision (SN), 583<br />
enzyme immunoassay of free triiodothyronine<br />
in serum (SN), 172<br />
enzyme-linked immunosorbent assay for<br />
urinary albumin at low concns, (SN), 609<br />
erythrocytic glucose-6.phosphate<br />
dehydrogenase measured by differential pH<br />
(SN), 579<br />
evaln. of a monoclonal immunoradiometnic<br />
assay for prostate-specific antigen (SN),<br />
2257<br />
four methods compared for measuring descarboxy.prothrombin<br />
(PiVKA-ti) (SN), 2074<br />
free cortisol and creatinine in urine of healthy<br />
children, 2047<br />
highly sensitive two-site immunoradiometric<br />
assay of parathynin, and din, use in evalg.<br />
patients with hypercalcemia, 1364<br />
hgG subclass measurements in the din, lab.<br />
(R), 1707<br />
immobilized purified fohate-binding protein<br />
binding characteristics and use for<br />
quantifying folate in erythrocytes, 1360<br />
mt. collaborative study on standn, of<br />
apolipoproteins A-I and B. part I. evaln, of a<br />
lyophihized candidate ref. and calibration<br />
material, 2240<br />
intra-individual variation of some analytes in<br />
serum in insulin-dependent diabetes, 57<br />
lab. assessment of a commercial kit for<br />
fructosamine in serum (SN), 158<br />
hatex-agglutn. assay for D dimer: evahn. and<br />
appln. to diagnosis of thrombotic disease,<br />
1837<br />
lipoperoxides in plasma as measured by hiq.chromatog.<br />
sepn. of<br />
malondialdehyde-thiobarbitunic acid<br />
adduct, 214<br />
2400 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
mess. of acetylcholinestenase in erythnocytes in<br />
the field, 1731<br />
measurement of intact parathynin by<br />
extracting two-site immunoradiometry, 1376<br />
method for simultaneously estg. plasma,<br />
enythrocyte, and heukocyte Na, K, and Mg:<br />
ref. values and considerations from biol.<br />
variation data, 1326<br />
methods compared for detg. glutathione<br />
peroxidese acty. in blood, 539<br />
more on ref. intervals for some vitamins (L),<br />
441<br />
normal baseline values for CK-MB by two<br />
methods compared (L), 1951<br />
patterns of porphyrin excretion in feces as<br />
datd. by hiq. chromatog.; ref. values and<br />
effect of flora suppression, 2164<br />
pediatric ref. intervals for Ektachem 700<br />
analyzer (A), 1029<br />
percentile estimates of ref. values for total<br />
protein and albumin in sara of prematures<br />
(SN), 411<br />
plasma Fe and transfernin iron-binding<br />
capacity evald. by cohonimetnic and<br />
immunoppth. methods, 273<br />
prehim. chin. studies of C-reactive protein<br />
quantified by enzyme-linked immunoassay,<br />
2185<br />
prospective clinical evain. of an improved<br />
fluorescence polarization assay for predicting<br />
fetal lung maturity (SN), 554<br />
prostate-specific antigen as a marker for<br />
prostatic cancer: monoclonal and polychonal<br />
immunoassay compared (SN), 1916<br />
quantn. of 5a- and 5-androstanediols in urine<br />
by gas chromatog.-mass spectrom., 256<br />
quantn. of two different types of<br />
apolipoprotein A-i containing hipoprotein<br />
particles in plasma by enzyme-linked<br />
differential-antibody immunosorbent assay,<br />
38<br />
ref. intervals for apohipoproteins A.I and B by<br />
rate nephelometry and associated CHD risk<br />
assessment (A), 898<br />
ref. intervals for Ca2+ in full-term and pre-term<br />
infants (A), 1030<br />
ref. intervals for plasma lipoperoxides: age-,<br />
sex-, and specimen-related variations (SN),<br />
2289<br />
ref. interval study for the IL Monarch’”<br />
analyzer (A), 946<br />
ref. ranges for 16 specific proteins assayed by<br />
rate nephelometry (A), 901<br />
ref. values for 9 plasma proteins in healthy<br />
subjects of various ages by nephelometry (A),<br />
902<br />
RIA of tumor necrosis factor in serum, 2024<br />
sepn. and identn, of alk, phosphetase<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoelectnic focusing, 2171<br />
simultaneous detn. of neoptenin and creatinine<br />
in serum with solid-phase extraction and online<br />
elution hiq. chromatog., 2028<br />
simultaneous detn, of trace elements in lavage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence, 3. routine<br />
anal., 2234<br />
simultaneous mess, of eight corticosteroids by<br />
liq..chromatog, and apphn. to diagnosis of<br />
congenital adrenal hyperphesia, 1354<br />
solid-phase enzyme immunoassay of terminal<br />
deoxynucleotidyl transfenase evald. (SN),<br />
293<br />
spectrophotometry of urinary albumin by dyebinding<br />
with use of bromphenol blue, 223<br />
stability of free spolipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hyperhipidamic subjects, 1163<br />
three immunoassay methods evald, for<br />
quantifying prealbumin in serum (SN), 1430<br />
trace-element concns. in autopsy tissue, 2057<br />
turbidimetry of hipase acty.-pnoblems and<br />
some solutions, 1624<br />
tunbidimetry of transthyretmn (prealbumin)<br />
with a centnif, analyzer (SN), 144<br />
two.stage transformation systems for<br />
normalization of ref. distributions evald,, 381<br />
why are there different ref. intervals for the<br />
kinetic angiotensin-converting enzyme<br />
assay? (L), 1491<br />
Reference materials<br />
candidate std. for use in calibration of total<br />
bilirubin in serum, 1817<br />
mt. collaborative study on standn. of<br />
apolipoproteins A-I and B. part I. evaln. of a<br />
lyophilized candidate ref. and calibration<br />
material, 2240<br />
isotope dihn./mass spactrom. of serum<br />
cholesterol with [3,4.13CkhoItmt proposed<br />
Definitive Method, 1403<br />
natl. ref. system for AST: RM 8430, a primary<br />
AST ref. material from NBS with U/Lc<br />
assigned by the IFCC Ref. Method (A), 993<br />
natl, ref. system for AST: use of IFCC Ref.<br />
Method and NBS/RM 8430 for unification of<br />
daily AST results as detd. on 3 analyzers (A),<br />
993<br />
prodn. and certifn, of an enzyme ref. material<br />
for ‘y-glutmnyhtnansferase (CRM 319). part 1:<br />
prepn. and characterization, 1971<br />
prodn. and certifn, of an enzyme ref. material<br />
for -y-glutamyhtransferesa (CRM 319). part 2:<br />
certifn. campaign, 1978<br />
Reference methods<br />
nath, ref. system for AST: RM 8430, a primary<br />
AST ref. material from NBS with U/Lwcc<br />
assigned by the IFCC Ref. Method (A), 993<br />
nath, ref. system for AST: use of IFCC Ref.<br />
Method and NBS/RM 8430 for unification of<br />
daily AST results as detd. on 3 analyzers (A),<br />
993<br />
precision of glucose measurements in control<br />
sara by isotope diln./mass spectrom.:<br />
proposed Definitive Method compared with<br />
a Reference Method, 1397<br />
use of IFCC Ref. Method for unification of alk.<br />
phosphatase results as determined on 4<br />
analyzers (A), 1000<br />
Reference values<br />
estrogen and progesterone receptors in cancer<br />
tissue of nonbneast origin (A), 930<br />
highly sensitive enzyme-linked immunosorbent<br />
assay of human C-reactive protein in cord<br />
blood sara (A), 919<br />
immunoassay of rheumatoid factor by latex<br />
particle counting (SN), 704<br />
normal range of 22Na influx in erythrocytes<br />
from black males and females (A), 1004<br />
patterns of porphyrin excretion in feces as<br />
deed. by hiq. chromatog.; ref. values and<br />
effect offlora suppression, 2164<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
ref. values for Fe, TIEC, and fernitin in a<br />
baboon colony (Papio species) (A), 1036<br />
sweat osmohahity values in normal adults (TB),<br />
612<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: chin. and biochem, features<br />
of 21 cases and literature review (CR), 313<br />
Reflectance densitometry<br />
quality control scheme for blood glucose<br />
measured outside the laboratory (SN), 1233<br />
Reflectance photometry<br />
a-amylese, new test in the Reflotnon’ system<br />
(A),996<br />
anal, performance of Reflotron ALT And AST<br />
test methods (A), 949<br />
anal, performance of Reflotnon creatine<br />
kinase reagent carriers compared with CX<br />
NAC-method (A), 988<br />
dry.reagent immunoassay for valproic acid for<br />
use with Ames Seralyzer reflectance<br />
photometer (A), 1020<br />
dry-reagent immunoassay strip for detn, of<br />
quinidine with Ames Seralyzer’ nelectance<br />
photometer (A), 1017<br />
effect of lipemia, hyperosmohahity, and uremia<br />
on whole blood glucose measured by dry<br />
reagent strips and reflectometny (A), 912<br />
estg. fat in feces by near.infrared reflectance<br />
spectroscopy, 502<br />
evahn, of accuracy of Seralyzer’ glucose<br />
(hexokinase) and 5 glucose methods<br />
compared to National Glucose Ref. Method<br />
(A), 952<br />
evaln, of physician office lab. analyzer,<br />
Boehninger Mannheim Reflotron (A), 938<br />
evaln, of Reflotron as cholesterol screening<br />
system (A), 895<br />
evaln, of Reflotron cholesterol and triglycerides<br />
test methods (A), 948<br />
improved Serahyzer’ glucose method (A), 952<br />
measurement of glucose in serum by<br />
hexokinase method with Ames seralyzer (A),<br />
1011<br />
new parameter in Reflotron’ system: total<br />
bilirubin (A), 1011<br />
performance of 3 Reflotron tests in 2 physician<br />
office labs. (A), 948<br />
performance of three new blood-glucose<br />
reflactometers evald. by nursing and lab.<br />
staffs (TB), 2312<br />
Reflotron’ assays of ahanine aminotransferase
and glutamyltnansferase in whole-blood<br />
samples evald. (SN), 826<br />
studies on reaction system of Reflotron’ AST<br />
assay, with cardiac and hepatic AST (A), 992<br />
systematic drug interference studies on<br />
Reflotron’ (A), 916<br />
Relative density<br />
refractometry, test strip, and osmometry<br />
compared as measures of rel. density of urine<br />
(TB), 190<br />
Renal disease<br />
See also Kidney disease<br />
Renal failure<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
digoxin RIA that does not detect di?oxin.like<br />
substance in serum of newborns, infants, or<br />
patients with renal failure (TB), 420<br />
hih incidence of false-positive enzyme<br />
immunoassay for antibodies to HIV in<br />
patients with renal failure (A), i029<br />
pyridoxal-5-phosphate depletion in renal<br />
dialysis patients causes cm. significant<br />
errors in ALT detns. (A), 992<br />
serum morphine and morphine glucuronides in<br />
man: renal failure elevates glucuronide levels<br />
(A),969<br />
Renal function<br />
plasma endogenous digitalis-like factors in<br />
healthy individuals and in dialysis.<br />
dependent and kidney-transplant patients<br />
(A),890<br />
role of nonenzymetic lycation in altered renal<br />
function in exptl. diabetes (A), 1037<br />
Renal transplant<br />
detn. of cyclosporine concns. with monoclonal<br />
antibodies, 2225<br />
distnibn. of cychosponine in blood of a renal<br />
transplant recipient with type V<br />
hyperhipoprotememia (CR), 423<br />
immunol. monitoring in renal allograft<br />
recipients (A), 1056<br />
plasma endogenous digitalis-like factors in<br />
healthy individuals and in dialysisdependent<br />
and kidney-transplant patients<br />
(A),890<br />
Renal tubular function<br />
effect of gentamicin and cyclosporin on<br />
permeability of model membranes (A), 1027<br />
Ream<br />
enzyme immunoassay of angiotensin I and<br />
renin, 1774<br />
Respiratory disorders<br />
See Lung disease<br />
Respiratory distress syndrome<br />
See Amniotic fluid, Fetal status<br />
evalg. the chin, effectiveness of amniotic fluid<br />
assays in predicting respiratory distress<br />
syndrome in the neonate, 647<br />
increased creatine kinase end CK-MB in<br />
patients with acute respiratory distress (A),<br />
989<br />
Restriction fragment length polymorphism<br />
artifacts in RFLP analyses of human DNA<br />
samples co-precipitated with t-RNA (TB),<br />
2304<br />
nonisotopic M13 probes for detecting the betaglobin<br />
gene: appln. to diagnosis of sickle cell<br />
anemia. 1368<br />
Retinol<br />
detn, of retinol, a-tocopherol, and -cerotene<br />
in serum by hiq. chromatog. with absorbance<br />
and electrochem. detection, i585<br />
Retinol-binding protein<br />
HPLC test for retinol-binding protein (A), 935<br />
imniunoturbidimetnic measurement of retinoh.<br />
binding protein (A), 935<br />
serum retinol-binding protein and creatmine in<br />
onset of and recovery from acute renal<br />
failure (TB), 1942<br />
urinary alb. and retinol-binding protein in<br />
diabetes (TB), 713<br />
urinary retinoh.binding protein as an index of<br />
proximal tubular injury, 775<br />
Reviewers<br />
invited reviawers-1987, 2330<br />
Reye’s syndrome<br />
diagnostic quality of lab, tests as evald. by<br />
graphic comparison of “first test” data, with<br />
Reye’s syndrome “workup” assays as a<br />
model, 100<br />
Rhabdomyosarcoma<br />
increased activities of creatine kinase and<br />
lactate dehydrogenase isoenzymes in a<br />
patient with metastatic ovarian tumor (CR),<br />
1484<br />
Rheumatoid arthritis<br />
activities of dipeptidyl peptidese II and<br />
dipeptidyl peptidasa IV in mice with lupus<br />
enythemetosus-hike syndrome and in patients<br />
with lupus erythematosus and rheumatoid<br />
arthritis (SN), 1463<br />
inimunoessay of rheumatoid factor by latex<br />
partiche counting (SN), 704<br />
method for serum Ciq based on its<br />
hydroxyproline content, 398<br />
mA of tumor necrosis factor in serum, 2024<br />
Rheumatoid factor<br />
IgG subclass measurements in the chin. lab.<br />
(R), 1707<br />
immunoassay of rheumatoid factor by latex<br />
particle counting (SN), 704<br />
nephelometnic assay of rheumatoid factor in<br />
patients with juvenile rheumatoid arthritis<br />
(A),903<br />
Rimantadine<br />
measurement of nimantadine in plasma by<br />
capillary GCIMS (A), 1022<br />
Risk factors<br />
cha. effect of methodolog. bias for cholesterol<br />
(A), 894<br />
Robotics<br />
computers that do physical work-robotics in<br />
the chin, lab. (A), 1057<br />
robotic automation of blood gas anal, in<br />
remote, unmanned critical-care lab. (A), 960<br />
use of a robotic arm for specimen handling in a<br />
remote, unmanned chin. chem. lab. (A), 1560<br />
Rocket lnununoelectrophoresls<br />
See Immunoehectrophoresis<br />
Salbutamol<br />
stereoeelective disposition of salbutamol<br />
enantiomers in man: investigation with<br />
china! HPLC (A), 1026<br />
Salicylate<br />
measurement of serum free salicylate concns.<br />
by ultrafiltration and HPLC (A), 1026<br />
Saliva<br />
can a single measurement of carbamazepine<br />
suffice for therapeutic monitoring? (SN), 812<br />
comparison of serum and salivary cortisol<br />
concns. in the daxasnathasone suppression<br />
test (A), 1033<br />
diagnostic, chin, implications of plasma and<br />
salivary melatonin assay (L), 1295<br />
differential assay of salivary, pancreatic asmylase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
emyhasa immobilized on bacterial cell wail<br />
(SN), 1235<br />
electrophoresis indicates protein loss on<br />
centrifn. of whole saliva (TB), 1263<br />
enzymic ethanol assay- colorimetnic method<br />
based on mass, of H202, 486<br />
monoclonal antibody specific for salivary<br />
esnylase (L), 1695<br />
monoclonal antibody that specifically inhibits<br />
salivary a-emylase, 1158<br />
one-tube radiotransinassay for data. of cortisol<br />
at ambient temp., 1137<br />
salivary mehatonin assay in lab.<br />
med.-longitudinal profiles of secretion in<br />
healthy men (L), 1957<br />
serum urea and salivary urea, correlated (TB),<br />
2303<br />
simple adaptation of an RIA kit for serum<br />
cortisol used to measure salivary cortisol<br />
(TB), 191<br />
Samarium<br />
Eu and Sm as labels in time-resolved<br />
immunofluorometric assay of follitropin, 48<br />
Sample collection<br />
deciding optimum interval between specimen<br />
collections: theory and nomograms (SN),<br />
1436<br />
despite correlation, random spot and 24-h<br />
urine specimens are not interchangeable<br />
(TB), 1080<br />
effects of collection methods on amino acid<br />
profiles (A), 936<br />
Sample handling<br />
analog vs. non-analog free T4 assay effect of<br />
sample dihn. (L), 200<br />
assessment of evacuated serum separator gel<br />
blood-collection tubes for antiapileptic<br />
monitoring by FPIA (A), 1017<br />
chin. chem. anal, of samples from patients with<br />
AiDS (TB), 188<br />
chin, performance of the Abbott “Vision<br />
System”: ref. intervals and specimen type<br />
comparisons (TB), 1078<br />
D-mannose ass preservative of glucose in blood<br />
samples (SN), 708<br />
effect of pretreating samples with boric acid<br />
before liq. chromatography of urinary<br />
catecholamines, 108<br />
effect of time of exposure of serum to gelbarrier<br />
tubes on results for progesterone and<br />
some other endocrine tests (L), 203<br />
elimination of digoxin-like immunoreactivity<br />
prior to digoxin measurement by<br />
fluorescence polarization immunoassay (A),<br />
914<br />
avaln. of drug extn. system from Amer. ToxicoL<br />
Service (A), 974<br />
free and total insulin as deed. after pptn. with<br />
polyethylene glycol: anal. characteristics,<br />
effects of sample handing, storage, 93<br />
influences of sampling method and sample<br />
handling during anal. on ionized Ca results<br />
(A), 1007<br />
Li stability in clotted blood: storage guidelines<br />
(TB), 1944<br />
metabolic profiles of urinary org. acids reed.<br />
from absorbent filter paper (SN), 572<br />
mid-molecule parathyrin stability (A), 892<br />
modified hamallar body phosphohipid assay<br />
compared with L/S ratio and<br />
phosphatidyhghycerol essay for assessment of<br />
fetal pulmonary status, 24<br />
RIA of atrial natriuretic pohypeptide in heat.<br />
treated plasma, 674<br />
simple role for automatically processing a<br />
single blood sample into multiple microhiter<br />
aliquots of plasma (A), 1558<br />
sOlid-phase cholesterol assay involving a<br />
unique whole-blood separator (A), 1561<br />
specimen collection in plastic containers gives<br />
rise to interferents in liq.-chromatog. assay<br />
of cychosponine (L), 1493<br />
specimen prepn. for assay of albumin in urine<br />
(L), 199<br />
stability of 5-fluorouracil in whole blood and<br />
plasma (SN), 2299<br />
stability of free apohipoprotein A-i concn. in<br />
serum, and measurement in normal and<br />
hypenhipidemic subjects, 1163<br />
storage conditions and stability of thyrotnopin<br />
and thyroid hormones on filter paper (SN),<br />
853<br />
storage of specimens in “Microtainer Amber<br />
Tubes” protects biirubin from degradn. by<br />
light (TB), 712<br />
storage stability of urine THC as measured by<br />
EMIT urine cannabinoid assay (A), 972<br />
trace-element concns. in autopsy tissue, 2057<br />
use of a robotic arm for specimen handling in a<br />
remote, unmanned chin. cham. lab. (A), 1560<br />
Sample preparation<br />
ascorbic acid as antioxidant in measurements<br />
of catecholamines in plasma (SN), 569<br />
assay of ansiodarone and desethyhamiodarone<br />
by HPLC and specimen preparation with Du<br />
Pont Prep’ (A), 1014<br />
assay of flecainide in serum by HPLC after<br />
microscale protein ppth. (A), 1016<br />
effect of tetrasodium EDTA on enzymatic<br />
detns. of urinary oxalate, 833<br />
effects of sample prepn. on Cyclosporin G<br />
(NVA2-Cyclosponin) concn, (TB), 1257<br />
evaln. and improvement of homovanillic acid<br />
methodology, and a critique of liq.<br />
chromatog. with ehectrochem. detection<br />
(SN), 600<br />
evaln. of the polyester gel barrier Microtainer<br />
(TB), 1468<br />
identn, and anal, of 9 metabohites of<br />
cycloeponine in blood by liq. chromatog. 1:<br />
purifn. of anal. stds. and assay optimization,<br />
1841<br />
immunoaff’mity pretreatment method for<br />
improved chromatog. data, of fractionated<br />
bihirubin (A), 1012<br />
improved esNi nadiochem. assay of free fatty<br />
acids in plasma (SN), 176<br />
improved RIA of metatonin in serum (SN), 604<br />
Sarcoidosli<br />
automated data. of angiotensin-converting<br />
enzyme in serum (SN), 1248<br />
Screening<br />
assay of serum fructosamine that minimizes<br />
standn. and matrix problems: use to assess<br />
components of bioL variation, 269<br />
automated quantn. of choniogonadotropin:<br />
anal. correlation between serum and urine<br />
with creatinine correction (SN), 1424<br />
chemihuminescence immunoassay of<br />
thyrotropin with acridinium-ester-labehed<br />
antibody evald, and compared with two<br />
other immunoassays (SN), 2096<br />
chin, significance of a low concn, of thyrotropm:<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2401
five immunometnic “kit” assays compared<br />
(SN), 1237<br />
chin, value of immunorediomatry of<br />
thyrotropin for patients with nonthyroidal<br />
illness and taking various drugs (SN), 566<br />
commercial ehectrochem. method evald, for<br />
mess. of Fe status (SN), 1645<br />
comparison of physician office analyzers for<br />
cholesterol anal, in screening centers (A), 898<br />
detection of sample contamination of urine<br />
submitted for drugs of abuse testing in a<br />
high-volume setting with the Olympus 5000<br />
analyzer (A), 977<br />
direct quantn. of coproporphyrins,<br />
uroporphyrins in urine by deny. synchronous<br />
fluorescence spectroscopy, 1826<br />
drugs-of-abuse screen for the Analyst’TM (A),<br />
976<br />
economy and efficiency in routine thyroid.<br />
function testing: use of a sensitive<br />
immunonadiometnic assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
employee drug screening: issues to be resolved<br />
in implementing a program (S), MB<br />
enzyme immunoassay method for<br />
comprehensive drug screening in microsamples<br />
of urine, 367<br />
enzyme-linked immunosorbent assay for 17ahydroxyprogesterone<br />
in dried blood spotted<br />
on filter paper, 761<br />
erythrocytic glucose.6-phosphete<br />
dehydrogensse measured by differential pH<br />
(SN), 579<br />
evaln. of Paramax CK-M inhibitory antibody<br />
single-tablet essay for screening elevated<br />
serum CK-MB acty. (A), 987<br />
factors affecting urinary screens for<br />
acetaminophen (L), 1695<br />
immunohog. measurement of aspartate<br />
aminotransferase isoenzymes in health<br />
screening (A), 993<br />
incidence of drugs in a pediatric population as<br />
assessed through drug screening (A), 977<br />
it’s time to take the initiative (E), 1682<br />
laser immunonephelometry for routine quantn.<br />
of urinary albumin, 209<br />
mess. of acetyhchohinestenasa in erythrocytes in<br />
the field, 1731<br />
measurement of liver enzymes by Reflotron<br />
and Vision for blood.donor screening (A),<br />
945<br />
methods compared for detg. glutathione<br />
peroxidase acty. in blood, 539<br />
microtiter-letex test for C-reactive protein, for<br />
screening large numbers of samples (TB),<br />
1258<br />
neonatal hyperbihirubinemia due to ghucose-6’<br />
phosphate dehydrogensse deficiency (A),<br />
1013<br />
phenylahanine and tyrosine in serum and<br />
eluates from dried blood spots as detd. by<br />
reversed-phase hiq. chromatog., 1152<br />
phenyhpropanoleinine and (d)norpseudoephedrine<br />
are indistinguishable by<br />
Toxilab’ (TB), 1678<br />
postsynthetic modn, of enolase isoenzymes, 757<br />
reagent that restores galactosa.l ‘phosphate<br />
uridyhyltransferase acty. in dry blood spots<br />
(TB), 1471<br />
renal differentiated from non-renal hematunie<br />
by micros. examn. of erythnocytes in urine,<br />
1791<br />
routine urinalysis (dipstick) findings in mass<br />
screening of healthy adults (SN), 2106<br />
screening for cerebrotendinous xanthomatosis<br />
by enzymatic assay for 7a’hydroxylated<br />
steroids in urine (SN), 142<br />
screening methods for Pb compared: ethanol<br />
paper-disc extraction method vs ethyl<br />
acetate extraction method (TB), 309<br />
screening with glyceted Hb for gestational<br />
diabetic-associated macrosomia (A), 1001<br />
simple hiq.-chromatog. mess, of<br />
vanillylmandehic acid and homovanilhic acid<br />
in urine on filter paper for mess screening of<br />
neuroblastome in infants, 2043<br />
simultaneous data. of trace elements in havage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence. 3. routine<br />
anal., 2234<br />
specificity of sensitive assays of thyrotropin<br />
used to screen for thyroid disease in<br />
hospitalized patients, 1391<br />
stability of model immune complexes during<br />
zone electrophoreaia and isoslectnic focusing<br />
in agarosa gels, 1741<br />
status of drugs-of-abuse testing in urine: an<br />
AACC study (SR), 1683<br />
2402 CLINICAL CHEMISTRY, Vol.33,No. 12,1987<br />
storage conditions and stability of thyrotropin<br />
and thyroid hormones on filter paper (SN),<br />
853<br />
tech. and chin. performance of six sensitive<br />
immunorediometnic assays of thyrotropin in<br />
serum (SN), 1439<br />
total or free thyroxin as a primary test of<br />
thyroid function (SN), 170<br />
two indirect tests of exocnine pancreatic<br />
function evald. (R), 5<br />
urinary glycoconjugates excreted by patients<br />
with type I and type II fucosidosis compared,<br />
44<br />
urinary org. acids: isohn. and quantn. for<br />
routine metabolic screening, 473<br />
use of restriction fragment length<br />
polymorphism anal. for detecting carriers of<br />
“Fragile X” syndrome (R), 1726<br />
Selenium<br />
methods compared for detg. glutathione<br />
peroxidase ecty. in blood, 539<br />
Se and vit. E relationship in malnourished<br />
children before and during parenteral<br />
supplementation (A), 934<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
Seminal fluid<br />
suitability of solid-phase chem. for quantn. of<br />
leukocytes in cerabrospinal, seminal, and<br />
penitoneal fluid (TB), 1475<br />
Seminal plasma<br />
detn. of chomiphene citrate and tanioxifen in<br />
blood and seminal plasma using reversedphase<br />
HPLC (A), 1025<br />
Serotonin<br />
melatonin secretion assessed by messuning its<br />
metabolite, 6-sulfatoxymehatonin, 1343<br />
Severe combined immunodeficiency<br />
serum protein electrophoresis changes in 4<br />
infants with severe combined<br />
immunodeficiency (A), 1028<br />
Sex- and age-related effects<br />
age-related changes in plasma proteins<br />
measured by nephelometry in pediatric<br />
patients (A), 1029<br />
alanine aminopeptidase in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
biol. variation in analyte concns, in urine of<br />
apparently healthy men, women (SN), 847<br />
detn, of 6-aminobutyric acid and other amino<br />
acids in CSF of pediatric patients by<br />
reversed-phase liq. chromatog., 1736<br />
detn. of neoptenin in serum and urine, 62<br />
free cortisol and creetinina in urine of healthy<br />
children, 2047<br />
intra-individual variation of analytas in serum<br />
from patients with chronic liver diseases,<br />
1133<br />
intra-individual variation of some analytes in<br />
serum in insulin-dependent diabetes, 57<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
quantn. of 5a’ and 5fl-androstanediois in urine<br />
by gas chromatog.-mass spectrom., 256<br />
quantn. of two different types of<br />
spohipoprotein A-i containing hipoprotein<br />
particles in plasma by enzyme.hinked<br />
differential-antibody immunosorbent assay,<br />
38<br />
ref. intervals for plasma hipoperoxides: age-,<br />
sex-, and specimen-related variations (SN),<br />
2289<br />
sepn. and identn. of alk. phosphatasa<br />
isoenzymes and isoforms in serum of healthy<br />
persons by isoelectnic focusing, 2171<br />
simultaneous detn. of neopterin and creatinine<br />
in serum with solid-phase extraction and online<br />
ehution hiq. chromatog., 2028<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: chin, and biochem. features<br />
of 21 cases and literature review (CR), 313<br />
turbidimetny of transthyretin (prealbumin)<br />
with a centrif. analyzer (SN), 144<br />
Sex- and race-related effects<br />
intra-individual seasonal variation of Mg in<br />
blood (A), 1006<br />
Sex-hormone binding globulin<br />
interference of sex-hormone binding globulin<br />
in the “Cost.A-Count” testosterone noextraction<br />
RIA (SN), 300<br />
mass, of sex-hormone-binding globulin:<br />
immunoradiometnic vs binding capacity<br />
techniques (TB), 1253<br />
measuring sax.hormone.binding globulin by<br />
enhanced luminescence (A), 921<br />
total testosterone, free-androgen index, calcd.<br />
free testosterone, and free testosterone by<br />
analog RIA compared in hirsute women and<br />
in otherwise-normal women with altered<br />
binding of sex-hormone-binding globulin,<br />
1372<br />
Sex-hormone globulin<br />
precision of assays for sex-hormone binding<br />
globulin: an I-IRMA kit and two Eu-IFMA kits<br />
compared (TB), 2120<br />
Sialic acid<br />
enzymatic measurement of sialic acid in serum<br />
by Hitachi 736 analyzer and apphicn. for<br />
maker of acute-phase reactants (A), 1011<br />
plasma lipid-bound sislic acid in monitoring<br />
surgical therapy of patients with colonic<br />
adenocarcinomas (A), 932<br />
Sialidase<br />
props. of alk, phosphatase isoenzymes in<br />
plasma of preterm and term neonates, 1778<br />
Sickle cell anemia<br />
nonisotopic M13 probes for detecting the betaglobin<br />
gene: apphn. to diagnosis of sickle cell<br />
anemia, 1368<br />
Sj#{246}gren’.syndrome<br />
salivary amyhase and pancreatic enzymes in<br />
Sjogren’s syndrome (SN), 305<br />
Skin<br />
receptor-antibody “sandwich” assay for<br />
teicophanin, 1615<br />
Smoking<br />
alanine aminopeptidase in serum: automated<br />
optimized assay, and effects of age, sex,<br />
smoking, and alcohol consumption in a<br />
selected popn., 363<br />
CN concns. in blood after cigarette smoking,<br />
as detd. fluonimetnically (SN), 1228<br />
measurement of cotinine in urine as an<br />
indicator of passive smoke exposure (A), 975<br />
prevalence of Mg and K deficiencies in the<br />
elderly, 518<br />
Sodium<br />
Amdev’s “Lytening 1” Na and K analyzer<br />
evald. (TB) 416<br />
effects of PO4 and HEPES/MOPS buffers on<br />
calibration of Na and K ion-selective<br />
electrodes for chin, anal. (A), 1005<br />
hyponatremia in spontaneous hyperglycemia:<br />
correlation studies in 100 patients (TB), 1941<br />
method for simultaneously eetg. plasma,<br />
erythrocyte, and heukocyte Na, K, and Mg:<br />
ref. values and considerations from biol,<br />
variation data 1326<br />
normal range of 2Na influx in erythrocytes<br />
from black males and females (A), 1004<br />
performance of improved ionophore with<br />
batter Ns selectivity in multilayered film<br />
element (A), 1005<br />
Solid-phase-based assays<br />
appln. of novel Cr02 magnetic particles to<br />
immunoassay development (S), 1543<br />
automated solid-phase extraction and hiq.<br />
chromatog. for assay of cyclosponine in whole<br />
blood (SN), 2272<br />
BioMAT”: a rapid, self-washing immunoassay<br />
system with a microparticuhate solid phase<br />
(A), 1566<br />
cham. assays-new opportunities (S), 1574<br />
cohonimatnic enzyme immunoassay with latex<br />
particles as a solid-phase reagent (A), 1572<br />
comparison of several solid supports for<br />
covalent antibody immobilization for use in<br />
immunoassays (A), 922<br />
enhanced sensitivity immunoassay for the TDx<br />
analyzer (A), 1570<br />
high-performance immobn. membrane for<br />
diagnostic immunoasaays (A), 1568<br />
immunochemiluminometry of creatine kinase<br />
MB with a monoclonal antibody to the MB<br />
isoenzyme (S), 1517<br />
microparticle.capture membranes: epphn. to<br />
TestPack hCG-urmne (A), 1567<br />
OASIS: automated solid-phase immunoassay<br />
system for the decentralized lab. (A), 1571<br />
optimizing a membrane solid support for<br />
specific immunoassay epplna. (A), 1568<br />
phsse-sepn. immunosssays (S), 1509<br />
receptor-antibody “sandwich” assay for<br />
teicop!anin, 1615<br />
using whole bacteria, hipopolysaccharide, and<br />
so!. antigens to detect IgG, 1gM, and IgA in<br />
brucellosis by Dot-ELISA with nitrocelluose<br />
as solid phase (A), 1570<br />
Somatomedin<br />
chemiluminescence immunoessay for<br />
somatomedin C in serum, 1989<br />
monoclonal and pohyclonal antibodies<br />
compared for RIA of aomatomedin-C in
acromegaly or hypopituitarism, 1593<br />
specific immunoradiometry of insuhin.like<br />
growth factor I with use of monoclonal<br />
antibodies, 2019<br />
Somatomedin-binding protein<br />
time-resolved immunofluorometry of 34-kDa<br />
somatomedin-binding protein, 1126<br />
Somatomedin C<br />
natural and recombinant DNA-derived insulinlike<br />
growth factor-I compared for use in<br />
radiohigand assays, 544<br />
RIA of somatomedin-C in filter paper discs<br />
containing dried blood, 536<br />
Somatotropin<br />
monoclonal and polychonah antibodies<br />
compared for RIA of somatomedin-C in<br />
acromegaly or hypopituitarism, 1593<br />
Specific gravity<br />
See Relative density<br />
Specimen handling<br />
See Sample handling<br />
Spectrofluorometry<br />
See Fluorometry<br />
Spectrophotofluorometry<br />
See Fluorometry<br />
Spectrophotometry<br />
See also Atomic absorption<br />
spectrophotometry, Colorimetry<br />
anal, for HbCO by gas chromatog. and<br />
multicomponent apectrophotom. compared<br />
(SN), 694<br />
blood collection to results: new system that<br />
performs all steps of chin. anal. (A), 1560<br />
caffeine-splitting of bihirubin/albumin<br />
complex: its relevance to spectrophotometry<br />
of bihirubin in serum (SN), 597<br />
characterization and assay of tartrete-resistant<br />
acid phosphatase acty. in serum: potential<br />
use to assess bone resorption, 458<br />
delta bihinubin: absorption spectra, molar<br />
absorptivity, and reactivity in the diazo<br />
reaction, 769<br />
detg. Me.Hb in blood by zero-crossing-point<br />
first-deny. spectrophotometry, 1767<br />
detn. of a-amylase acty. with a new<br />
chromogenic substrate, 524<br />
detn, of citrate in urine by simple direct<br />
photometry (TB), 1259<br />
evaln, of a second-wavelength correction<br />
technique (A), 963<br />
fluorometry of iodocyanine green in plasma,<br />
765<br />
methods compared for detg. glotathione<br />
peroxidase acty. in blood, 539<br />
novel spectrophotometric method for OH’<br />
detection (A), 1008<br />
apectrophotometry of urinary albumin by dyebinding<br />
with use of bromphenol blue, 223<br />
Spectroseopy<br />
improvement in lower CoHb range detn. by<br />
second-derivative spectroscopy (TB), 2311<br />
Sphingomyelin<br />
automated enzymatic measurement of lecithin,<br />
sphingomyehin, and phosphatidylghyceroh in<br />
amniotic fluid, 81<br />
Spleen<br />
antibodies to porcine uterofernin used in mess.<br />
of tantrate-resistant acid phosphatase, 1832<br />
Standardization<br />
assay of serum fructosamine: interns! vs<br />
external standn. (L), 1955<br />
calibration of triglyceride assay in the DuPont<br />
ace IV by use of aq. primary stds. (L), 2324<br />
candidate std. for use in calibration of total<br />
bihirubin in serum, 1817<br />
identn. and anal, of 9 metabohites of<br />
cychosponine in blood by liq. chromatog. 1:<br />
purifn. of anal. stds. and assay optimization,<br />
1841<br />
igG subclass measurements in the din. lab.<br />
(R), 1707<br />
natl. ref. system for AST: RM 8430, a primary<br />
AST ref. material from NBS with U/Lipcc<br />
assigned by the IFCC Ref. Method (A), 993<br />
nath, ref. system for AST: use of IFCC Ref.<br />
Method and NBSJRM 8430 for unification of<br />
daily AST results as detd. on 3 analyzers (A),<br />
993<br />
prothrombin assay standardized with an<br />
international normalization ratio (NR): goal<br />
and reality, 342<br />
Statistics<br />
ability of the i rule to detect substandard<br />
performance in interlab. proficiency testing,<br />
788<br />
anal, of relationship between intralab,<br />
performance characteristics (CV and bias)<br />
and med. usefulness limits (A), 910<br />
assessment of proficiency testing programs<br />
using fixed limits as a means to evaluate<br />
intralab, performance (A), 908<br />
assessment of the use of fixed limits to<br />
characterize intralab. performance by<br />
proficiency testing (SN), 1901<br />
computerized real-time quality-assurance<br />
program for integration of lab. qualitycontrol<br />
data (A), 909<br />
computer programs for lab, statistics developed<br />
on IBM-RT supermicrocomputer (A), 985<br />
data-redn. methods for immunorsdiometric<br />
sssays of thyrotropin compared (SN), 1207<br />
distribution-associated likelihood ratios (A),<br />
910<br />
effects of long-term components of variance on<br />
performance of rules for statistical quality<br />
control (A), 910<br />
error propagation in predictive value estimates:<br />
effect of anal. precision on confidence limits<br />
(A),908<br />
evaln. of alternative quality control statistics<br />
for RIA procedures (A), 907<br />
fractional error as a means of assessing<br />
agreement between two methods measuring<br />
the same variable (TB), 1944<br />
interlab. proficiency-testing programs:<br />
computer model to assess their capability to<br />
correctly characterize intralab. performance,<br />
784<br />
likelihood calcn. by means of different aamylasa<br />
and hipsse tests in inflammatory<br />
pancreetitis (A), 998<br />
medical utility frequency, 221<br />
optimized guidelines for inter-instrument<br />
validation (A), 909<br />
simulated comparison of multi-rule protocols<br />
for statistical quality control (A), 909<br />
statistical considerations of the random<br />
selection process in a drug-testing program<br />
(S),46B<br />
two-stage transformation systems for<br />
normalization of ref. distributions evald., 381<br />
using the coefficient of correlation in methodcomparison<br />
studies, 1170<br />
why not use the std. deviation index as a<br />
common scale for data quantn.? (L), 1294<br />
Steatorrhea<br />
estg. fat in feces by near-infrared reflectance<br />
spectnoscopy, 502<br />
Steptokinase<br />
early diagnosis of acute myocerdial infarction<br />
by rapid anal. of creatine kinase isoenzyme-3<br />
(CK-MM) sub-types, 358<br />
Steroid hormones<br />
cefoxitin interferes with “Chini-Skreen”<br />
column method for urinary 17hydroxycorticostenoids<br />
(SN), 1219<br />
hiq. chromatog. and RIA compared for detn, of<br />
cortisol and corticosterone in plasma after a<br />
daxamethasona suppression test (SN), 1639<br />
one-tube radiotransinassay for detn, of cortisoh<br />
at ambient temp., 1137<br />
Steroid receptors<br />
See also specific steroid of interest<br />
distribution and levels of androgen receptors in<br />
human breast cancer (A), 930<br />
estrogen and progesterone receptor content in<br />
breast cancer cytosols: relationship to tumor<br />
marker expression (A), 930<br />
estrogen and progesterone receptors in cancer<br />
tissue of nonbresst origin (A), 930<br />
immunoassay of estrogen and progesterone<br />
receptors in human breast cancer (A), 959<br />
Steroids<br />
See also specific steroid of interest<br />
comparison of successive pregnancies provides<br />
evidence for a maternal component in detg.<br />
circulating steroid concns. (TB), 1476<br />
effects of short- and long’term prenatal<br />
steroids on rapid-turnover proteins in<br />
premature infants (A), 934<br />
evaln. of Sep-Pak C18 for sepn. of bound and<br />
unbound steroid during saturation anal. (A),<br />
962<br />
free cortisol and creatinine in urine of healthy<br />
children, 2047<br />
high-pass filtering of data gives estimate of no,<br />
of individual molecules in steroid profiling<br />
by GC/MS (A), 962<br />
isotope di!n./mess spectrom. of serum<br />
cholesterol with 13,4.i3Clcholeteol proposed<br />
Definitive Method, 1403<br />
mess, of corticotropin in unextracted plasma:<br />
time-resolved immunofluorometric essay<br />
and immunoradiometric assay compared<br />
with use of same monoclonal antibodies,<br />
1747<br />
monochonal antibodies used in solid-phase and<br />
liquid-phase assays, exemplified by<br />
progesterone assay, 1331<br />
quantn. of 5a- and 5-androstanediols in urine<br />
by gas chromatog.-masa spectrom,, 256<br />
screening for cerebrotendinous zanthomatosis<br />
by enzymatic assay for 7a’hydroxylated<br />
steroids in urine (SN), 142<br />
simultaneous mess. of eight corticoeteroids by<br />
hiq.-chromatog. and appin. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
surface modn. with Protein A for uniform<br />
binding of monoclonal antibodies (A), 1338<br />
Streptokinase<br />
anal. of creatine kinase isoanzymes and<br />
isoforms in serum to detect reperfusion after<br />
acute myocardial infarction, 507<br />
Succinyldicholina<br />
succinyldichohine as substrate in measurement<br />
of chohinesterase activity (L), 746<br />
Sugars<br />
thin.layer chromatog. data. of urine excretion<br />
of lactulose, simplified and applied to cystic<br />
fibrosis patients (SN), 1211<br />
Sulfatase<br />
acid phosphatase ecty. in figlucuronidase/sulfetase<br />
preparation from<br />
Helix pomatia (TB), 418<br />
Superoxide<br />
novel spectrophotometnic method for OH’<br />
detection (A), 1008<br />
Suparoxide dismutase<br />
concns, of superoxide dismutaae and<br />
superoxide anion in blood of patients with<br />
respiratory infections, compromised immune<br />
systems, 2230<br />
superoxide dismutase inhibits fructosamine<br />
assay (SN), 147<br />
Surgery<br />
high incidence of subnormal, as well as<br />
elevated, serum thyrotropin after major<br />
cardiac surgery or cardiac transplantation, in<br />
patients with no history of thyroid disease<br />
(A),882<br />
31P nuclear NMR study of variations in intreerythroeytic<br />
ATP concn. and pH induced by<br />
surgical trauma (SN), 2284<br />
Sweat<br />
pitfall in anal. of proteins synthesized by sweat<br />
glands from patients with cystic fibrosis by<br />
two-dimensional gel ehectrophoresis and<br />
double-label eutoradiography (TB), 2310<br />
sweat oamolality values in normal adults (TB),<br />
612<br />
Symposia<br />
Beckman Conf., 10th, preface (S), 5B<br />
Synovial fluid<br />
xylosyhtransferase as a marker of cartilage<br />
destruction in chronic joint diseases (A),<br />
1000<br />
Systemic hupus erythematosus<br />
cross-reactivity of anti-DNA antibodies with<br />
polyanions (A), 1029<br />
sensitive, specific ELBA for detection of<br />
autoantibody to n-DNA (A), 923<br />
Tamoxifan<br />
detn. of chomiphene citrate and tamoxifen in<br />
blood and seminal plasma using reversedphase<br />
HPLC (A), 1025<br />
detn, of tamoxifen and four metabohites in<br />
serum by low-dispersion hiq. chromatog.,<br />
1608<br />
Tangier disease<br />
evaln, of hipoproteins and epohipoproteins in<br />
serum of a Tangier patient by micro-scale 2-<br />
D ehactrophoresis, 468<br />
flow-cytometnic detn, of high-densityhipoprotein<br />
bindin sites on leukocytes, 2195<br />
plasma apohipoproteins in Tangier disease, as<br />
studied with 2-D elactrophoresis (SN), 120<br />
Taurine<br />
automated anal. for taurine in biol. fluids,<br />
tissues (SN), 835<br />
automated anal. of taunine in biol. fluids and<br />
tissues (A), 962<br />
Tears<br />
lacnimal IgE assessment with paper strips (A),<br />
918<br />
Teicoplanin<br />
receptor-antibody “sandwich” assay for<br />
teicophanin, 1615<br />
Terminal deoxynucheotidyl transferase<br />
sohid.phase enzyme immunoassay of terminal<br />
deoxynucheotidyl transferase evald. (SN),<br />
293<br />
Test evaluations<br />
diagnostic quality of lab, tests as evald, by<br />
graphic comparison of “first test” data, with<br />
CLINICAL CHEMISTRY, Vol.33, No. 12,1987 2403
Reye’s syndrome “workup” assays as a<br />
model, 100<br />
Testicular cancer<br />
serum lactate dehydrogenase isoenzyme 1 as<br />
tumor marker in testicular cancer (A), 932<br />
Testosterone<br />
direct measurement of human serum free<br />
testosterone (A), 922<br />
interference of sex-hormone binding globulin<br />
in the “Coat-A-Count” testosterone noextraction<br />
RIA (SN), 300<br />
total testosterone, free-androgen index, cahcd.<br />
free testosterone, and free testosterone by<br />
analog RIA compared in hirsute women and<br />
in otherwise-normal women with altered<br />
binding of sex-hormone-binding globulin,<br />
1372<br />
Test strip.<br />
dry-reagent immunoassay for valproic acid for<br />
use with Ames Seralyzer reflectance<br />
photometer (A), 1020<br />
dry-reagent immunoassay strip for detn, of<br />
quinidine with Ames Serahyzer relectance<br />
photometer (A), 1017<br />
effect of captopnil on reagent strip tests for<br />
urinary ketones (A), 981<br />
avaln. of dry-reagent strip test for<br />
carbamazepina (A), 1019<br />
experience in 3 physicians’ office labs, with<br />
carbamazepine dry-reagent strip system (A),<br />
1019<br />
performance of immunoinhibition assay for<br />
CK-MB with a d.ry-raagant strip test for CK<br />
(A), 987<br />
sample contaminstion by test strips (TB), 414<br />
serum or plasma oxidativa system: total<br />
biirubin reagent with FaCt3 (A), 1011<br />
Tbniassenila<br />
plasma Fe and transferrin iron-binding<br />
capacity evald. by colorimetric and<br />
immunopptn. methods, 273<br />
quantn. of deaferrioxamine in plasma by<br />
inductively coupled plasma atomic emission<br />
spectrometry (SN), 132<br />
Theophyhhlne<br />
adaptation of Syva QST assays of theophyhline,<br />
phenytoin, and phenobarbital to the EASY<br />
analyzer (A), 944<br />
adaptation of Technicon RA systems’<br />
theophyiline reagents to Coulter Dacos<br />
(A), 1023<br />
automated fluorescence immunoassays for<br />
theophylline, phenytoin, and phanobarbital<br />
(A), 923<br />
coat-effective optimization of EMI’F<br />
theophylhine assay for Technicon RA-1000<br />
analyzer (A), 1023<br />
development of latex-based theophyiline assay<br />
for the IL Monerchiu cham. system (A), 967<br />
enhanced fluorescence polarization essays for<br />
therapeutic drug monitorinr theophylline<br />
(A), 1022<br />
enzyme immuno-inhibition assay for<br />
theophyllina on Abbott Vision system (A),<br />
1022<br />
evaln, of Abbott Vision assay for theophyhline<br />
(A), 1022<br />
avaln. of Kodak thin-film slides for<br />
theophylline, Mg, and creatine kinase-MB<br />
(A), 951<br />
immunoturbidimetry (RA1V System,<br />
Tachnicon) of serum theophyllina in a<br />
Hitachi 705 (TB), 1077<br />
internal chock reaction used in one-step enzyme<br />
immunochromatog. assay of theophylline in<br />
blood (5), 1521<br />
is theophylhine toxicity associated with<br />
hypercalcemie? (A), 1030<br />
liposome-basad, coated.tube<br />
fluoroimmunoassay for theophyiline (A),<br />
1023<br />
measurement of theophylhine with Kodak<br />
Ektachem DTSC module (A), 1023<br />
novel immunosssay procedure for on-site<br />
detection of theophylhine in blood, serum, or<br />
plasma (A), 924<br />
theophyhhina method of the Abbott “Vision”<br />
analyzer evald, (SN), 130<br />
Therapeutic drug monitoring<br />
See Monitoring therapy<br />
critical issues in cyclosporine monitoring:<br />
report of the Task Force on Cyclosporine<br />
Monitoring (SR), 1269<br />
desirable stds. of performance for therapeutic<br />
drug monitoring (L), 1299<br />
goals for TDM: a correction (L), 1298<br />
2404 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
Thiols<br />
effect of daylight on the reaction of thiols with<br />
EhIman’s reagent (SN), 1928<br />
Thiophihic adsorption<br />
protein recognition of immobilized higands:<br />
promotion ofselective adsorption (S), 1502<br />
Thrombocytopenla<br />
detection of circulating platelet antibodies and<br />
platelet-associated IgO by flow cytometry<br />
(A), 1004<br />
Thromboplastin<br />
evain. of a fully automated centrifugal analyzer<br />
for hemostasis tests (SN), 1888<br />
Thrombosis<br />
avain. of latex agglutination assay for D dimer<br />
for diagnosis of thrombotic disorders (A),<br />
1003<br />
isoforms of creatine kinase isoenzymes in<br />
serum in acute myocard. infarct after<br />
intracoronary thrombolysis, 2039<br />
latex-agglutn. assay for D dimar: evaln. and<br />
apphn. to diagnosis of thrombotic disease,<br />
1837<br />
Thromboxane<br />
serum thromboxane B2 test of patient<br />
compliance in chin, studies of plateletaffecting<br />
drugs (A), 1004<br />
Thyroglobulin<br />
ci evaln. of thyroglobulin RIA kit (A), 886<br />
enzyme immunoassay for simultaneous mess.<br />
of autoantibodies against thyroglobulin and<br />
thyroid microsome in serum (SN), 2286<br />
Thyroid disease<br />
diagnostic value of a modified essay of free<br />
tniiodothyronine in serum (SN), 2093<br />
Thyroid function<br />
total or free thyroxin as a primary test of<br />
thyroid function (SN), 170<br />
Thyroid-hormone binding proteins<br />
revised nomenclature for tests of thyroid<br />
hormones and thyroid-related proteins in<br />
serum (SR), 2114<br />
Thyroid hormones<br />
applicns. for homogeneous enzyme<br />
immunoassay for measurement of serum or<br />
plasma thyroid hormone uptake (A), 886<br />
decrease of free thyroxin in serum of lactating<br />
women (SN), 1217<br />
effect of free fatty acids and nonhipid inhibitors<br />
of thyroid hormone binding in the<br />
immunoradiometric assay of thyroxinbinding<br />
globulin, 1752<br />
relation between thyroid hormones and<br />
angiotensin-converting enzyme (L), 1103<br />
revised nomenclature for tests of thyroid<br />
hormones and thyroid-related proteins in<br />
serum (SR), 2114<br />
storage conditions and stability of thyrotropin<br />
and thyroid hormones on filter paper (SN),<br />
853<br />
thyroid hormone and histopsthoh. responses of<br />
Fischer 344 rats and B6C3F1 mice to H.C.<br />
Yellow No. 4 (A), 1037<br />
Thyroid microsoma<br />
enzyme immunoessay for simultaneous mess.<br />
of autoantibodies against thyroglobulin and<br />
thyroid microsome in serum (SN), 2286<br />
Thyroid status<br />
albumin-dependence of free thyroxin in<br />
nonthyroidal illness (L), 1494<br />
albumin in analog FT4 assay reagents: the facts<br />
(L), 1293<br />
anomalous thyrotropin values (SN), 1213<br />
chemiluminescence immunoassay of<br />
thyrotropin with acridinium-ester-labehed<br />
antibody evald, and compared with two<br />
other immunoassays (SN), 2096<br />
cm. sinificance of a how concn, of thyrotropin:<br />
five immunometnic “kit” assays compared<br />
(SN), 1237<br />
cm. value of immunoradiomatry of<br />
thyrotropin for patients with nonthyroidal<br />
illness and taking various drugs (SN), 566<br />
comment on the “albumin effect” in analog<br />
free-thyroxin dates, (L), 1291<br />
concns, of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
decrease of free thyroxin in serum of lactating<br />
women (SN), 1217<br />
development and utility of a monoclonal.<br />
antibody-based, highly sensitive<br />
immunorediomatric assay of thyrotropin,<br />
1387<br />
discrepant thyroid-function test results by<br />
fluorescent polarization and RIA in<br />
nonthyroidal illness (TB), 613<br />
economy and efficiency in routine thyroidfunction<br />
testing: use of a sensitive<br />
immunoradiometnic assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
hypothermic myxedema coma erroneously<br />
diagnosed as myocardial infarct. because of<br />
increased creatine kinase MB (CR), 1083<br />
immunoenzymatic quantn. of low concns. of<br />
thyrotropin (SN), 1223<br />
interference by anti-immunoglobulin G<br />
antibodies in immunoradiometnic assays of<br />
thyrotropin involving mouse monoclonal<br />
antibodies (SN), 840<br />
performance criteria for appropriate<br />
characterization of “(highly) sensitive”<br />
thyrotropin assays (L), 630<br />
serum Fl’4 and FT3: modified analog assays<br />
compared with dialysis methods in thyroid<br />
dysfunction and nonthyroida! illness (TB),<br />
716<br />
specificity of sensitive assays of thyrotropin<br />
used to screen for thyroid disease in<br />
hospitalized patients, 1391<br />
statistics, common sense, and serum free T4 in<br />
disease (L), 1293<br />
storage conditions and stability of thyrotropin<br />
and thyroid hormones on filter paper (SN),<br />
853<br />
tech. and chin. performance of six sensitive<br />
immunoradiometric assays of thyrotropin in<br />
serum (SN), 1439<br />
thyroid function in hospitalized patients: effect<br />
of illness and serum albumin concns. (SN),<br />
1445<br />
two-step RIA for free triiodothyronine in<br />
serum, 372<br />
value and limitations of a highly sensitive<br />
immunoradiometric assay for thyrotropin in<br />
the study of thyrotroph function (SN), 303<br />
Thyroid-stimulating immunoglobuhin<br />
measurement of thyroid-stimulating<br />
immunoghobulin by FRTL-5 cell biocham.<br />
assay: dianostic sensitivity and specificity<br />
in Graves disease (A), 1032<br />
Thyroliberin<br />
value and limitations of a highly sensitive<br />
immunoradiometric assay for thyrotropin in<br />
the study of thyrotroph function (SN), 303<br />
Thyrotropin<br />
anomalous thyrotropin values (SN), 1213<br />
caution against spuriously increased<br />
thyrotropin values as detd. by two-site<br />
immunoradiometry (L), 1290<br />
chemihumineacance immunoassay of<br />
thyrotropin with acridinium-ester-labaled<br />
antibody avald. and compared with two<br />
other immunoassays (SN), 2096<br />
choriogonadotropin interference in an assay for<br />
thyrotropin (L), 1303<br />
Ciba Corning Diagnostics’ monoclonal TSH:<br />
truly a highly sensitive TSH assay? (TB),<br />
2122<br />
chin, application of a sensitive non-isotopic<br />
immunometric assay of thyrotropin, 179<br />
chin. sinificance of a low concn. of thyrotropin:<br />
five immunometric “kit” assays compared<br />
(SN), 1237<br />
chin, value of immunoradiometry of<br />
thyrotropin for patients with nonthyroidal<br />
illness and taking various drugs (SN), 566<br />
comparison of high-sensitivity TSH assays<br />
used to evaluate suppressed patients (A), 881<br />
(TB), 1943<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidah illnesses: role of free fatty<br />
acids, 1382<br />
cross reactions in RIA: a math, modal for<br />
correcting assay results, as exemplified by<br />
elimg. the interference of intact thyrotropin<br />
in an assay of its beta subunit, 658<br />
data-redn. methods for immunoradiometric<br />
assays of thyrotropin compared (SN), 1207<br />
“Dehfia” and “Amerlite”: two sensitive<br />
nonisotopic immunosssay systems for assay<br />
of thyrotropin compared (SN), 1421<br />
development and utility of a monochonalantibody-based,<br />
highly sensitive<br />
immunoradiometnic assay of thyrotropin,<br />
1387<br />
diagnostic performance of sensitive<br />
measurements of serum thyrotropin durin<br />
severe nonthyroidal illness: role in diagnosis<br />
of hyperthyroidism, 2178<br />
discordant inter-kit results in<br />
immunoradiometry of serum thyrotropin<br />
(L), 632
economy and efficiency in routine thyroidfunction<br />
testing: use of a sensitive<br />
immunorediometric assay for thyrotropin in<br />
a general hosp. lab., 1635<br />
evaln. of Bio-Rad EchoClonah5 ultresensitive<br />
immunoradiometric assay for serum HTSH<br />
(A),880<br />
evaln. of how-end sensitive thyrotropin essays<br />
(A),881<br />
evaln. of radial-partition fluorescent<br />
immunoassay (Stratus”) at how concns. of<br />
thyrotropin (A), 880<br />
avain. of sensitive thyrotropin assay for various<br />
thyroid disorders (A), 959<br />
free thyroxin, TSH interrelationships (A), 1033<br />
generation and epitope analysis of TSHspecific<br />
monochonal antibodies for enzyme<br />
immunoessays (A), 882<br />
high incidence of subnormal, as well as<br />
elevated, serum thyrotropin after major<br />
cardiac surgery or cardiac transplantation, in<br />
patients with no history of thyroid disease<br />
(A),882<br />
immunochemiluminometric assay of TSH (A),<br />
882<br />
immunoenzymatic quantn. of low concns. of<br />
thyrotropin (SN), 1223<br />
interference by anti-immunoghobulin G<br />
antibodies in immunoradiometric assays of<br />
thyrotropin involving mouse monoclonal<br />
antibodies (SN), 840<br />
measurement of free alpha subunit of<br />
glycoprotein hormones by monoclonal<br />
antibody-based immunoradiometric essay,<br />
and further exploration of antiganic sites on<br />
choriogonadotropin, 1147<br />
37-mm,, totally automated immunoenzymatric<br />
hTSH essay with sensitivity of 0.04 milli-int.<br />
unitfL (A), 881<br />
nonenzymatic glycation of immunoglobulins<br />
does not impair antigen-antibody binding<br />
(SN), 692<br />
performance criteria for appropriate<br />
characterization of “(highly) sensitive”<br />
thyrotropin assays (L), 630<br />
radial partition immunoassay: rapid automated<br />
quantn. of human thyrotropin on the<br />
Stratus analyzer (A), 882<br />
removal of interference by immunoglobulins in<br />
an enzyme-amplified immunoassay for<br />
thyrotropin in serum (TB), 414<br />
sensitive assays for thyrotropin (A), 880<br />
simultaneous solid-phase high-sensitivity TSH<br />
and free thyroxin assay (A), 881<br />
solid-phase double-antibody lipoeome<br />
immunoasaay for TSH in Becton-Dickinson<br />
IQ immunochem. system (A), 882<br />
specificity of sensitive assays of thyrotropin<br />
used to screen for thyroid disease in<br />
hospitalized patients, 1391<br />
storage conditions and stability of thyrotropin<br />
and thyroid hormones on filter paper (SN),<br />
853<br />
tech, and chin, performance of six sensitive<br />
immunoradiometric assays of thyrotropin in<br />
serum (SN), 1439<br />
thyroid function in hospitalized patients: effect<br />
of illness and serum albumin concns. (SN),<br />
1445<br />
two-site immunoradiometric assay for TSH<br />
using magnetic sapn. (A), 881<br />
value and limitations of a highly sensitive<br />
immunoradiometric assay for thyrotropin in<br />
the study of thyrotroph function (SN), 303<br />
Thyroxin<br />
albumin-dependence of free thyroxin in<br />
nonthyroidal ifiness (L), 1494<br />
albumin in analog FT4 assay reagents: the facts<br />
(L), 1293<br />
analog vs. non-analog free T4 assay: effect of<br />
sample diln. (L), 200<br />
appin. of novel Cr02 magnetic particles to<br />
immunoassay development (S), 1543<br />
automated solid-phase enzyme immunoessay<br />
for measuring thyroxin (A), 883<br />
comment on the “albumin effect” in analog<br />
free-thyroxin dates. (L), 1291<br />
comparison of Abbott TDX and traditional<br />
radiometric methods for assay of thyroxin<br />
uptake in serum from four classes of sick<br />
patients (A), 885<br />
comparison of thyroxin datns. by TDx”1 T4<br />
Plus and TDx”1 thyroxin (A), 883<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
cortisol and thyroxin fluorescence<br />
immunosssay by the semiautomated system<br />
IMMPUtSE (A), 922<br />
decrease of free thyroxin in serum of lactating<br />
women (SN), 1217<br />
detn. of free tbyroxin by combining<br />
ultrafiltration with RIA (A), 884<br />
development of solid-phase coated-tube total<br />
T4 liposome-based fluorescent immunoassay<br />
for Becton Dickinson IQ”1 immunochem.<br />
system (A), 883<br />
diagnostic value of <strong>Clinical</strong> Assays’ two-step<br />
“immunosxtraction” RIA for free thyroxin in<br />
nonthyroidal illnesses (TB), 188<br />
effect of albumin on results of an “improved”<br />
analog-type for free thyrozin, 337<br />
free T4 and free T3 analog RIAs designed to<br />
eliminate albumin-related artifacts (A), 885<br />
free thyroxin estn. by analog assays with chem,<br />
blockers (A), 884<br />
free thyroxin, TSH interrelationships (A), 1033<br />
hiposome.bssed colorimetric immunoassey of<br />
serum thyroxin (A), 1565<br />
on albumin-dependence of measurements of<br />
free thyroxin. II. non-thyroidal illness, 87<br />
one-step enzyme immunoassay for free<br />
thyroxin (A), 884<br />
particle-enhanced turbidimetric inhibition<br />
immunoassay for thyroxin (A), 884<br />
radial partition immunoassay for free thyroxin<br />
(A),885<br />
recognizing hyperthyroidism in the elderly<br />
(CR), 429<br />
serum FF4 and FT3: modified analog assays<br />
compared with dialysis methods in thyroid<br />
dysfunction and nonthyroidal illness (TB),<br />
716<br />
simultaneous solid-phase high-sensitivity TSH<br />
and free thyroxin assay (A), 881<br />
solid-phase non-isotopic immunoassay for<br />
quantn. of free thyroxin in serum (A), 884<br />
statistics, common sense, and serum free T4 in<br />
disease (L), 1293<br />
Stratus fluorometric enzyme immunoassay<br />
system evaluated for detn. of total thyroxin<br />
(A),883<br />
TDx T4 Plus, fully automated essay<br />
eliminating serum-denaturing pretreatment<br />
procedure (A), 883<br />
thyroid function in hospitalized patients: effect<br />
of illness and serum albumin concns. (SN),<br />
1445<br />
thyroid-function testing with the TDx:<br />
interference from endogenous fluorophore<br />
(TB), 1467<br />
total or free thyroxin as a primary test of<br />
thyroid function (SN), 170<br />
validity of analog free thyroxin immunoassays.<br />
part II (response p. 2148) (0), 2145<br />
validity of analog free thyroxin immunosssays<br />
(response, p. 2150) (0), 2137<br />
Thyroxin-binding globulin<br />
effect of free fatty acids and nonlipid inhibitors<br />
of thyroid hormone binding in the<br />
immunoradiometric assay of thyroxinbinding<br />
globulin, 1752<br />
Thyroxin-binding proteins<br />
decrease of free thyroxin in serum of lactating<br />
women (SN), 1217<br />
Tissue analysis<br />
microtiter-plate method for estg. protein in<br />
biopsies of small intestine (TB), 1671<br />
trace-element concns. in autopsy tissue, 2057<br />
Titrunetry<br />
estg. fat in feces by near-infrared reflectance<br />
spectroscopy, 502<br />
turbidimetry of lipase acty.-problems and<br />
some solutions, 1624<br />
Tocainide<br />
liq.-chromatog. date, of tocainide in plasma,<br />
with N.acyl derivatives of tocainide as<br />
intern. stds. (TB), 1069<br />
Tocopherol<br />
dclxi. of retinol, a-tocopherol, and a-carotene<br />
in serum by hiq. chrometog. with absorbance<br />
and electrochem. detection, 1585<br />
Tonometry<br />
performance of an in-vivo, continuous bloodgas<br />
monitor with disposable probe (S), 1538<br />
Total iron-binding capacity<br />
date. of serum Fe and TIBC by DuPont<br />
Dimansionm cm. chem. system (A), 944<br />
interpreting results of couhometry and<br />
immunopptn. in diagnosing Fe disorders<br />
(SN), 1215<br />
Toxicology<br />
acute toxic hepatitis in a child with Bendectin<br />
overdose (A), 1031<br />
anal. chem. at the Games of the XXhIIrd<br />
Olympiad in Los Angeles, 1984 (SR), 319<br />
anal. for HbCO by gas chromatog. and<br />
multicomponant<br />
(SN), 694<br />
chem. exposure:<br />
spectrophotom.<br />
from basic science<br />
compared<br />
to govt.<br />
regulation-methyhene chloride (A), 878<br />
common-sense approaches to evaluating<br />
individual health problems of humans<br />
exposed to man.made<br />
(A), 878<br />
organic biohazarda<br />
creatine kinase-MB as a marker of doxorubicin<br />
cardiotoxicity (A), 1036<br />
detection of bromocriptine-like substances in<br />
urine of an infant on soy formula (TB), 414<br />
dclxi. of free digoxin concns. in serum for<br />
monitoring Fab treatment of digoxin<br />
overdose (SN), 1652<br />
enzymic assay for the specific<br />
methanol in serum, 2204<br />
date. of<br />
enzymic ethanol assay’ colorimetric method<br />
based on mass. of H202, 486<br />
extreme hypermagnesemia caused<br />
ofepsom salts (A), 1031<br />
by ingestion<br />
false-positive EMI’I’#{149} D.A.U. phencycidine<br />
assay as a result of an overdose of<br />
dextromethorphan (A), 974<br />
FPIA for detecting banzodiazepines<br />
(A), 973<br />
lipoperoxidee in plasma as measured<br />
in serum<br />
by hiq.chromatog.<br />
sepn. of<br />
malondialdehyde-thiobarbituric acid<br />
adduct, 214<br />
mess, of acetylcholinesterase in erythrocytee in<br />
the field, 1731<br />
med.-legal aspects of chin. toxicoL (A), 877<br />
methanol overdose: predicting lengths<br />
hemodialysis therapy (A), 969<br />
of<br />
optimized hq.-chroniatog. method for<br />
fluorometry of urinary i-aminolevuhinic<br />
in workers exposed to Pb (SN), 1667<br />
acid<br />
osmoharap, false isopropanol, and an amine<br />
a child with boric acid ingestion (A), 914<br />
protocol for EMFI-st reagents with a centrif.<br />
in<br />
analyzer (TB), 1671<br />
quality control material for urine toxicoL<br />
testing (A), 976<br />
serum formic acid concns, in formic acid<br />
poisoning (A), 1031<br />
thyroid hormone and histopathoL responses of<br />
Fischer 344 rats and B6C3F1 mice to H.C.<br />
Yellow No.4 (A), 1037<br />
toxicity of Na nitroprusaide, 490<br />
toxicity of Na nitroprusside (continued)<br />
1693<br />
(L),<br />
toxicol, of biohazards<br />
urinary retinol-binding<br />
(A), 877<br />
protein as an index of<br />
proximal tubular injury, 775<br />
validation and appln. of a liq.chromatog./enzymic<br />
acids in rat serum,<br />
essay for individual<br />
1856<br />
bile<br />
Trace elements<br />
See also specific<br />
atomic absorption<br />
element of interest<br />
spectrophotometry of Mn in<br />
plasma (TB), 1253<br />
indirect vs direct measurement of Mg and Zn<br />
in erythrocytes, 529<br />
performance of diammonium hydrogen<br />
phosphate-nitric acid-graphite furnace<br />
atomic abeorp. spectrom. method<br />
Cd date. (L), 1298<br />
Sb accumn. in hair during treatment<br />
for urinary<br />
of<br />
leishmeniasis (SN), 2081<br />
serum Mg detd. with methylthymol blue (TB),<br />
614<br />
simultaneous detn. of trace elements in lavage<br />
fluids from bronchial alveoli by energydispersive<br />
X-ray fluorescence. 3. routine<br />
anal., 2234<br />
trace-element concns. in autopsy tissue, 2057<br />
transfarrin binding of Ah3 and Pe3, 405<br />
Training programs<br />
COMACC-accredited programs,<br />
Trnmin.es<br />
Kodak Ektachem DTSC module<br />
451<br />
avald. for<br />
measuring transaminases (ALT and AST)<br />
(A),937<br />
Transcutaneous<br />
extracorporeal,<br />
monitoring<br />
tissue, and transcutaneous<br />
monitoring (A), 872<br />
Transferrin<br />
cord transfarrin and ferritin in newborn infants<br />
with uterophacental insufficiency (A), 1030<br />
interpreting results of coulometry and<br />
immunopptn. in diagnosing Fe disorders<br />
(SN), 1215<br />
nonenzymatic glycation of immunoglobulins<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2405
doss not impair antigen-antibody binding<br />
(SN), 692<br />
plasma Fe and transferrin iron-binding<br />
capacity evald. by colorimetric and<br />
immunopptn. methods, 273<br />
serum transferrin concns. and indices of Fe<br />
stores in normal subjects (A), 1032<br />
transferrin binding of Ah3 and Fe3’, 405<br />
Transient hyperphosphatasemia of infancy<br />
transient hyperphosphatasemia of infancy and<br />
early childhood: din, and biochem, features<br />
of 21 cases and literature review (CR), 313<br />
Transthyretin<br />
See Prealbumin<br />
plasma transthyretin concns. in low-birthweight<br />
infants after hosp. discharge (A), 934<br />
Trauma<br />
evaln. of multiple trauma patients by using<br />
direct assay of CK isoenzymes (A), 1034<br />
Triacyhghycarols<br />
See Triglycerides<br />
Tricyclic antidepressants<br />
See also Antidepressanta<br />
apphicn. of EMIT quant. tricydic antidepressant<br />
assays to Encore”‘ centrifugal analyzer (A),<br />
1024<br />
applicn. of EMIT5 quant. tricyclic<br />
antidepressant assays to Hitachi5 705 chem.<br />
analyzer (A), 1024<br />
datn. of antidepressants by capillary column<br />
GC with N-selective detection (A), 1025<br />
EMIT5 quantitative tricyclic antidepressant<br />
assays applied to the Hitachi 705 <strong>Chemistry</strong><br />
Analyzer (TB), 1471<br />
EMIT5 quantitative tricydlic antidepressant<br />
assays applied to the Encore” <strong>Chemistry</strong><br />
System (TB), 1472<br />
FT-rn spectroscopy in immunoassay of<br />
selected tricychic antidepressant drugs (A),<br />
924<br />
interference by cychobenzaprine in liq.chromatog.<br />
assays of tricyclic<br />
antidepresaanta (SN), 819<br />
measurement of plasma imiprainine,<br />
desipramine, and their respective 2-hydroxy<br />
metabolites (A), 1025<br />
measurement of plasma nortriptylina and its<br />
isomeric lO-hydroxy metabolites (A), 1024<br />
nortriptyline monoclonal antibody for quantn.<br />
of nortriptyline in serum (A), 1024<br />
quantn. of antidepressants and<br />
benzodiazepines in a single HPLC system<br />
(A), 1025<br />
therapeutic drug monitoring of imipramine<br />
and desipramine in maintenance therapy of<br />
patients (A), 1025<br />
Triglycerides<br />
accuracy of three triglycerides methods on<br />
Technicon RA-1000 (A), 900<br />
bilirubin and free glycerol interferences in<br />
GPO Trinder triglyceride assays using RA-<br />
1000 (A), 899<br />
calibration of triglyceride assay in the DuPont<br />
aca IV by use of aq. primary sods. (L), 2324<br />
decentralization of cholesterol and triglyceride<br />
assays by using three “SPOT” instruments<br />
(A),938<br />
effect of detergent on triglyceride assay (L),<br />
202<br />
evaln. of Reflotron cholesterol and triglycerides<br />
test methods (A), 948<br />
falsely high values for triglyceride in<br />
ultrafiltered HDL supernates (TB), 418<br />
glycogen storage disease type I: lab, data,<br />
diagnosis, 2008<br />
lab. and field evain. of three desktop<br />
instruments for assay of cholesterol and<br />
triglyceride (SN), 1230<br />
low A-esterase acty. in serum in fish-eye<br />
disease (SN), 587<br />
office-testing systems: cholesterol and<br />
triglycerides (A), 948<br />
performance of triglycerides method in Chem 1<br />
with bichromatic measurements (A), 899<br />
stabilized reagents for SMAC triglycerides (A),<br />
900<br />
triglycerides and cholesterol snal.-a<br />
sequential approach (A), 899<br />
Triiodothyronine<br />
Amerlite and Amerlex-M assays for total<br />
triiodothyronine compared (L), 627<br />
concns. of iodothyronines in serum of patients<br />
with chronic renal failure and other<br />
nonthyroidal illnesses: role of free fatty<br />
acids, 1382<br />
diagnostic value of a modified assay of free<br />
triiodothyronine in serum (SN), 2093<br />
2406 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
enzyme immunoassay of free triiodothyronine<br />
in serum (SN), 172<br />
free T4 and free T3 analog RIAs designed to<br />
eliminate albumin-related artifacts (A), 885<br />
serum FT4 and F’F3: modified analog assays<br />
compared with dialysis methods in thyroid<br />
dysfunction and nonthyroidal illness (TB),<br />
716<br />
TDX’ Total T3 II. biphssic serum<br />
pretreatment procedure improves essay<br />
performance (A), 885<br />
thyroid function in hospitalized patients: effect<br />
of illnesa end serum albumin concns. (SN),<br />
1445<br />
two-step RIA for free triiodothyronine in<br />
serum, 372<br />
Trnasferrin<br />
immunoturbidimetry of haptoglobin and<br />
transferrin in the EPOS 5060 analyzer (TB),<br />
1257<br />
Tuberculosis<br />
kinetics of isoniazid in children and<br />
adolescents (A), 1030<br />
Tumor markers<br />
anal. and biol, variation of serum prostatic<br />
specific antigen compared with prostatic acid<br />
phosphatase (A), 927<br />
biochem. markers in bone cancer (A), 929<br />
CEA, AFP, and prostate-specific antigen<br />
essays developed for the Photon Elite (A),<br />
967<br />
chin. evaln. and performance characteristics of<br />
enzyme immunoassay for CA 125 (A), 931<br />
chin. avaln. of Abbott’s CEA-EIA and CA 125-<br />
RIA in patients with various malignant<br />
diseases (A), 1034<br />
comparison of Abbott monoclonal and<br />
polyclonal AFP-EIA assays as serum tumor<br />
markers (A), 926<br />
evaln, of CA 19-9 concns. as marker for<br />
pancreatic cancer (A), 1034<br />
avaln. of new breast cancer tumor marker in<br />
patients with advanced stage breast cancer<br />
(A), 929<br />
MCA, a new serum marker for breast cancer<br />
(A), 929<br />
measurement of serum concns. of CA-549, an<br />
experimental breast cancer marker, by<br />
Photon Elite random-access analyzer (A),<br />
930<br />
neuron-specific enolase as a tumor marker (A),<br />
928<br />
reassessment of creatine kinsse BB as a marker<br />
for cancer of prostate, breast, and lung (SN),<br />
809<br />
serum lactate dehydrogenase isoenayme 1 as<br />
tumor marker in testicular cancer (A), 932<br />
serum pancreatic oncofetal antigen and<br />
carbohydrate antigen 19-9 in pancreatic<br />
cancer patients (A), 932<br />
Tumor necrosis factor<br />
RIA of tumor necrosis factor in serum, 2024<br />
Turbidimetric inhibition immunoassay<br />
particle-enhanced turbidimetric inhibition<br />
immunoessay for thyroxin (A), 884<br />
Turbidimetry<br />
See also Rate turbidimetry<br />
automated turbidimetry of serum haptoglobin<br />
by the Ames “Optimate” (TB), 1466<br />
“Quantimetric” kappa:lambda ratio test (L),<br />
448<br />
response-surface optimized tableted reagent<br />
for detn. of serum lipase activity on the<br />
Paramax5 analyzer (A), 953<br />
Technicon C-reactive protein assay for the RA-<br />
1000 compared with Beckman ICS (A), 920<br />
turbidimetric measurement of<br />
immunoglobulins with bichromatic randomaccess<br />
analyzer (A), 917<br />
turbidimetry of hipase acty.-problems and<br />
some solutions, 1624<br />
turbidimetry of transthyretin (prealbumin)<br />
with a centrif. analyzer (SN), 144<br />
turbidimetry study of Ce oxalate<br />
mineralization (A), 980<br />
use of immunoglobulin heavy- and light-chain<br />
measurements compared with existing<br />
techniques in typing monochonal<br />
immunoglobulins, 1771<br />
Two-dimensional centrifugation<br />
See Centrifugation, two-dimensional<br />
Two-dimensional ehectrophoresis<br />
See Elactrophoresis, two-dimensional<br />
Ulteacentrifugation<br />
four procedures compared for aepg.<br />
apolipoprotein A- and apolipoprotein Bcontaining<br />
lipoproteins in plasma, 1597<br />
Ultrafiltration<br />
Amicon ultrafiltration device evald. for<br />
detection of myoglobinuria (TB), 1074<br />
detn. of free digoxin concns. in serum for<br />
monitoring Fab treatment of digoxin<br />
overdose (SN), 1652<br />
detn. of free thyrozin by combining<br />
ultrafiltration with RIA (A), 884<br />
direct measurement of human serum free<br />
testosterone (A), 922<br />
measurement of serum free sahicyhate condos.<br />
by ultrafiltration end HPLC (A), 1026<br />
protocols for use of ultrafiltn. in datn. of free<br />
higand condo. and of complexity of<br />
higand/protein interactions (SN), 115<br />
Urea<br />
accuracy of Ektachem DT system for urea<br />
improved by using 70 g/L albumin solution<br />
as diluent (TB), 1078<br />
biol. variation in analyte condos. in urine of<br />
apparently healthy man, women (SN), 847<br />
improved dye procedure for detg. urea condo.<br />
by using o.phthaladehyde and<br />
naphthyhethylenediamine (TB), 192<br />
influence of sample preservative on electrolyte,<br />
urea, creatinine, and glucose levels (A), 915<br />
kinetic o-phthalahdehyde method for urea<br />
eliminates errors due to interference by<br />
monoclonal proteins (TB), 723<br />
serum urea and salivary urea, correlated (TB),<br />
2303<br />
Urea nitrogen<br />
adaptation of simple colorimetric assay for<br />
urea N with IQ”‘ immunochem. system (A),<br />
1010<br />
development of rate BUN method for Hitachi<br />
737 (A), 1010<br />
evaln, of liquid BUN reagent for Abbott<br />
Spectrum and VP analyzers (A), 951<br />
interference from immunoghobulins in Hitachi<br />
737 endpoint urease method for BUN (A),<br />
1010<br />
multilayer element for detn. urea Ni in whole<br />
blood (TB), 310<br />
performance of BUN, glucose, and total<br />
protein on the Spirit electrolyte chem.<br />
system (A), 946<br />
stabilized aqueous glutamate dehydrogenase<br />
solution for use in detg. urea N (A), 951<br />
use of BUN/creatinine ratio and creatinine<br />
concn. as indicators of potential ketone<br />
interference in a kinetic creatinine method<br />
(A), 913<br />
Uremia<br />
identn. and quantn. of a protein-bound higand<br />
in uremid serum (SN), 682<br />
liq-chromatog. detn, of inosine, xanthine, and<br />
hypoxanthine in uremic patients receiving<br />
hemodialysis treatment (SN), 2278<br />
modn, of intra-erythrocytic homeostasis in<br />
uremic patients, as studied with #{176}PNMR,<br />
76<br />
Uric acid<br />
deproteinizing methods evald. for detn. of uric<br />
acid in serum by reversed-phase liq.<br />
chromatog. with UV detection (SN), 1427<br />
improved Ca and uric acid methods for<br />
Technicon SMAC system (A), 956<br />
improved correlation of Trinder uric acid<br />
reagent to ultraviolet uric acid reagent (A),<br />
956<br />
kinetic method for uric acid detn. on RA<br />
system and effect of endogenous<br />
interferences in the presence of bivalant ions<br />
(A), 1010<br />
measurement of uric acid in urine on Kodak<br />
Ektachem 700(A), 966<br />
performance evaln. qf Ciba-Corning<br />
Diagnostics uric acid reagent on Gilford<br />
Impact 400E (A), 953<br />
performance of sensitive color reagent for<br />
enzymatic date. of uric acid (A), 956<br />
performance of two time-dependent analyses<br />
compared with an end-point analysis, in<br />
DataChem’s clinical analyzer (TB), 2121<br />
total-protein reagent interferes with mass, of<br />
urate in the Hitachi 737 (TB), 712<br />
xanthine interference in the Kodak<br />
“Ektachem” datn. of uric acid (TB), 1265<br />
Urinalysis<br />
Ames Clinitek 200/Multistix 9 urinalysis<br />
compared with manual and microscopic<br />
methods (SN), 1660<br />
Ames Clinitek 200/Multistix 9 urinalysis<br />
method: comparison with manual methods<br />
(A),980
prelim. thoughts on the wisdom of govt.<br />
prohibition or regn. of private employee<br />
urinalysis testing (S), 19B<br />
renal differentiated from non-renal hematuria<br />
by micros. examn. of erythrocytes in urine,<br />
1791<br />
routine urinalysis (dipstick) findings in mass<br />
screening of healthy adults (SN), 2106<br />
utilization of the Yellow Iris”‘ automated<br />
urinalysis workstation for performing body<br />
fluid cell counts (A), 981<br />
wisdom of proposals for govt. prohibition or<br />
regulation of urinalysis testing in private<br />
industry (A), 1054<br />
Urine<br />
See also specific analyte of interest, Urinalysis<br />
accelerated enzyme immunosssay for<br />
choriogonadotropin in urine, involving reflow<br />
of specimen through capillary tubes, 498<br />
anal, of Mg in serum and urine by Kodak<br />
Ektachem analyzer (A), 1006<br />
anal, performance of Kodak Ektachem 400 on<br />
misc, body fluids (A), 966<br />
sscorbic, dehydroascorbic acids simultaneoushy<br />
quantified in biol. fluids by liq. chromatog.<br />
with fluorescence detection; cohorimatric<br />
assay compared, 1874<br />
automated anal, for taurmne in biol. fluids,<br />
tissues (SN), 835<br />
automated enzymatic method for oxalate in<br />
urine (TB), 1076<br />
automated quante. of choriogonedotropin:<br />
anal. correlation between serum and urine<br />
with creatinine correction (SN), 1424<br />
Bence Jones proteinuria in multiple sclerosis<br />
(SN), 1923<br />
benzathine interference in the EMIT-st urine<br />
amphetamine assay (TB), 1080<br />
biol. variation in analyte concns. in urine of<br />
apparently healthy men, women (SN), 847<br />
capillary GC and GC/MS of cocaine and heroin<br />
urinary metabolites (A), 970<br />
cafoxitin interferes with “Clini-Skreen”<br />
column method for urinary 17hydroxycorticosteroids<br />
(SN), 1219<br />
centrifugal anal, for urinary citrate with the IL<br />
Multistat analyzer (A), 1009<br />
characterization of urinary interference factors<br />
and suggested mechanism of false positivity<br />
in latex agglutination tests (A), 914<br />
chem. characterization of urinary<br />
glycopeptides, 2214<br />
citrate in urine estimated by a citrate lyase<br />
technique adapted to the Cobes-Bio (TB),<br />
1948<br />
chin. evaln. of TDx fluorescence polarization<br />
immunoessay for detection of<br />
benzodiezepines in urine (A), 973<br />
chin, significance of dipstick-negative,<br />
sediment-positive urines: two reagent<br />
dipsticks compared (TB), 418<br />
colorimetric, anzymic methods compared for<br />
assay of citrate in urine (TB), 1074<br />
comparison of GDC’s ELISA and Syva’s EMIT<br />
for qual. detg. benzodiazepines in human<br />
urine (A), 973<br />
comparison of 4 methods for detg. smylase in<br />
serum and urine (A), 997<br />
competitive EIA for urinary albumin (A), 979<br />
computer-aided IR anal, of urinary calculi<br />
(SN), 2070<br />
concns. of morphine and codeine in serum end<br />
urine after ingestion of poppy seeds, 806<br />
contribution of tubular proteins to proteinuria<br />
of diabetes mehlitus (A), 1033<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: morphine in<br />
urine (A), 970<br />
convenient enzyme immunosssay system for<br />
detection of drugs of abuse: cocaine<br />
metabolite (benzoylecgonine) in urine (A),<br />
971<br />
convenient enzyme iinmunoessay system for<br />
detection of drugs of abuse: cannabinoids in<br />
urine (A), 972<br />
convenient enzyme immunoassay system for<br />
detection of drugs of abuse: barbiturates in<br />
urine (A), 973<br />
convenient urine oxalate assay with an oxalate<br />
oxidase reagent and a centrif. analyzer (TB),<br />
2301<br />
Coomassie Brilliant Blue and benzethonium Cl<br />
methods adapted to Cobas-Bio for<br />
measurement of urinary protein (A), 964<br />
Coomassie Brilliant Blue G250 method for<br />
urinary protein adapted to Cobas-Bio<br />
centrifugal analyzer (A), 979<br />
Coomessie Brilliant Blue protein dye-binding<br />
assays compared for detn. of urinary protein<br />
condo. (SN), 577<br />
correlation of Ames Micro-Bumintest” tablet<br />
with total protein and albumin in diabetic<br />
urmnes (A), 980<br />
deficiencies of Sigma Diagnostic’s urinary<br />
oxalate method in the presence of ascorbate<br />
(TB), 419<br />
despite correlation, random spot and 24-h<br />
urine specimens are not interchangeable<br />
(TB), 1080<br />
detection and confirmation of cocaine use by<br />
chromatog. anal. for methylecgonine in urine<br />
(SN), 118<br />
detection of bromocriptine-like substances in<br />
urine ofan infant on soy formula (TB), 414<br />
detection of sample contamination of urine<br />
submitted for drugs of abuse testing in a<br />
high-volume setting with the Olympus 5000<br />
analyzer (A), 977<br />
date. of antidiuretic hormone in random urine<br />
end its din. apphicns. (A), 921<br />
date. of citrate in urine by simple direct<br />
photometry (TB), 1259<br />
data. of methylxenthine stimulants in urine of<br />
racing greyhounds by HPLC; resolution of a<br />
contested dru-administretion case (A), 975<br />
detn. of neopterin in serum and urine, 62<br />
date. of two urinary prostaglandins by<br />
capillary gas chromatog.-high-resolution<br />
mass spectrometry (A), 891<br />
development of TDx fluorescence polarization<br />
immunoasaay for detection of cannabinoids<br />
in urine (A), 972<br />
differential assay of salivary, pancreatic aamylase<br />
in serum, urine, with use of<br />
monoclonal antibody to human salivary<br />
smylase immobilized on bacterial cell wall<br />
(SN), 1235<br />
direct quanta. of coproporphyrins,<br />
uroporphyrins in urine by deny, synchronous<br />
fluorescence spectroscopy, 1826<br />
drugs in blood donors (TB), 189<br />
affect of captopril on reagent strip tests for<br />
urinary ketones (A), 981<br />
effect of diet and specimen collection protocol<br />
on urinary 5-HIAA excretion as measured by<br />
direct HPLC: comparison of normals and<br />
carcinoid patients (A), 931<br />
effect of pretreating samples with boric acid<br />
before hiq. chromatography of urinary<br />
catecholamines, 108<br />
effect of tetrasodium EDTA on enzymatic<br />
detns. of urinary oxalate, 833<br />
enzyme-amplified immunodetection of<br />
monoclonal proteins in unconcd. body fluids<br />
after immobilization on glyoxyl agarose (A),<br />
916<br />
enzyme immunoessay method for<br />
comprehensive drug screening in microsamples<br />
of urine, 367<br />
enzyme-linked immunosorbent assay for<br />
urinary albumin at low condos. (SN), 609<br />
errors in estg. urinary protein by use of<br />
benzathonium Cl (L), 2127<br />
evaln. and improvement of homovanilhic acid<br />
methodology, and a critique of liq.<br />
chromatog. with ehectrochem. detection<br />
(SN), 600<br />
evain. of a commercial enzyme kit (Sigma) for<br />
detg. oxalate in urine (SN), 1203<br />
evaln. of colorimetric essay of N-acetyl--Dglucosaminidase<br />
in urine (A), 1000<br />
eveln, of drug extn. system from Amer. Toxicol.<br />
Service (A), 974<br />
evaln, of Du Pont ada plasma NH3 procedure<br />
for use with urine (A), 980<br />
evaln. of rapid TLC technique for detection of<br />
cannabinoid metabohites in urine (A), 972<br />
extn. of epidermal growth factor (urogastrone)<br />
from urine (A), 893<br />
factors effecting urinary screens for<br />
acetaminophen (L), 1695<br />
false-positive results for katone with the drug<br />
means and other frae-SH cmpds. (SN), 289<br />
false-positive urinalysis results with acidified<br />
urine (L), 2321<br />
fluorescence polarn. immunoassay evald. for<br />
screening for amphetamine and<br />
methamphetamine in urine (SN), 1200<br />
follitropin and lutropin simultaneously<br />
measured in urine with a commercial RIA kit<br />
(TB), 1674<br />
free cortisol and craatinine in urine of healthy<br />
children, 2047<br />
gas chromatog.-electron impact mass<br />
fragmentometric identn. and quantn. of LSD<br />
in urine (A), 971<br />
HPLC detn, of amphotericin B in human urine<br />
and serum (A), 1021<br />
I contamination of urine samples by test strips<br />
(TB), 1935<br />
immunoblotting for detecting Bence Jones<br />
proteinuria (TB), 1079<br />
immunochem. methods for early detection of<br />
microalbuminunia in diabetic nephropathy<br />
(A),902<br />
inimunoturbidimetry of albumin in serum,<br />
CSF, and urine with a unique calibration<br />
curve (TB), 1260<br />
improved mess. of urinary total protein<br />
(including light-chain proteins) with a<br />
Coomssaie Brilliant Blue G-250-sodium<br />
dodecyl sulfate reagent (SN), 2099<br />
inexpensive alternative to kit methods for<br />
extraction of urinary catecholamines (TB),<br />
2122<br />
interference with dipstick tests for glucose and<br />
Hb in urine by ascorbic acid in cranberry<br />
juice (L), 1297<br />
intra-individual variation in 24-h creatinine<br />
excretion end 24-h urinary volume (A), 1033<br />
kinetic immunonephelometnic measurement of<br />
very low concns. of albumin in urine (A), 902<br />
laser immunonephalometry for routine quantn.<br />
of urinary albumin, 209<br />
hiq.-chromatog, detn, of2-microglobuhin, a1acid<br />
glycoprotein, and albumin in urine, 1756<br />
liq..chromatog. measurement of<br />
catecholamines and metabolites in plasma<br />
and urine, 2209<br />
liq. chromatog. with multichannel UV<br />
detection for studying disorders of purina<br />
metab., 2052<br />
measurement of cotinine in urine as an<br />
indicator of passive smoke exposure (A), 975<br />
measurement of uric acid in urine on Kodak<br />
Ektachem 700 (A), 966<br />
measurement of urine N-acetyl.-SMCND.<br />
glucosaminidase with a centnif. analyzer<br />
(TB), 616<br />
melanogenunia: lab. evaln. of Thormahlen and<br />
FeCh3 tests and their chin, utility (A), 981<br />
melatonin secretion assessed by measuring its<br />
metabolite, 6-sulfatoxymalatonin, 1343<br />
metabolic profiles of urinary org. acids recd.<br />
from absorbent filter paper (SN), 572<br />
microparticle-capture membranes: appln. to<br />
TestPack hCG-urine (A), 1567<br />
modified method for quantifying urinary<br />
vanillylmandeic acid (TB), 1258<br />
monoclonal antibody-based urinary assays for<br />
renal antigens to monitor and prevent druginduced<br />
nephrotoxicity (A), 1058<br />
more on detn, of urinary albumin by<br />
centrifugal anal. (L), 1497<br />
more on immunoturbidimetry of urinary<br />
albumin (L), 198<br />
more on urinary alb. and creatinine (L), 740<br />
more on urinary protein/creatinine index (L),<br />
199<br />
more sensitive direct oxalate oxidase assay of<br />
urinary oxalate (SN), 1931<br />
multiple drugs of abuse in urine detected with<br />
a single reagent and fluorescence<br />
polarization (SN), 1921<br />
N-acetyl-fl-D-ghucosaminidsse assay by the p.<br />
nitrophenol technique: inhibit, effects of<br />
urine as decreased by gel filtration and by<br />
simple din. (TB), 713<br />
N-ecetyl--D-glucosaminidsse isoenzymes in<br />
urine assayed by ion-exchange chromatog.,<br />
1796<br />
new sspects of certain properties of human<br />
urinary alk. phoephatasea (A), 999<br />
new dip-and-read test for detg. heukocytes in<br />
urine (SN), 1242<br />
new enzymic detn, of guanidinoacetic acid in<br />
urine, 394<br />
new immunochem. method for<br />
choniogonadotropin in urine, 800<br />
obviating interferences in assay of urinary<br />
oxalate (SN), 855<br />
one-tube radiotransinassay for detn. of cortisol<br />
at ambient temp., 1137<br />
opiates in poppy seed: effect on urinalysis<br />
results after consumption of poppy seed<br />
cake-filling (SN), 1251<br />
oxybuprocaine and five metabohites<br />
simultaneously detd. in urine by gas<br />
chrometog. and gas chromatog.-mess<br />
spectrom. after extraction with Extrelut<br />
(SN), 697<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2407
performance of diammonium hydrogen<br />
phosphate-nitric acid-graphite furnace<br />
atomic absorp. spectrom. method for urinary<br />
Cd detn. (L), 1298<br />
performance of quant. urine anal. in<br />
Australssia critically assessed, 792<br />
plasma, erythrocyte, and urinary Zn in<br />
critically ill patients: effect of intravenous Zn<br />
therapy (A), 933<br />
pronounced decrease of Tamm-Horsfall<br />
proteinuria in diabetics (TB), 1264<br />
proteinunia in health and disease assessed by<br />
measuring the urinary protein/creatine ratio<br />
(SN), 297<br />
quality control material for urine toxicol.<br />
testing (A), 976<br />
quant. correlation of serum to urine hCG with<br />
correction by urine creatinine in pregnancy<br />
(A),889<br />
quant. dete. of NH4, Na, K, Mg2, Ca2,<br />
and creatinina in human urine by capillary<br />
isotachophoresis (A), 1005<br />
quantn. of Sn. and 5-androstanediols in urine<br />
by gas chromatog.-mass spectrom., 256<br />
quantn. of pipecoic acid in plasma, and of<br />
urinary cystine in the presence of<br />
panicillamine-cystine disulfide, with the<br />
Beckman 6300 Amino Acid Analyzer (L),<br />
1302<br />
quinine directly detd. in serum or urine by<br />
sepn. fluoroimmunoasaay, 463<br />
rapid, economical immunoturbidimetric<br />
method for microalbuminuria (L), 204<br />
rapid urinary screen for acetaminophen<br />
modified to avoid false-negative results<br />
(TB), 718<br />
refractometry, test strip, and osmometry<br />
compared as measures of rel, density of urine<br />
(TB), 190<br />
reliability of immunoassays to detect<br />
tetrahydro-cannabinol in urine samples (A),<br />
972<br />
renal differentiated from non-renal hematuria<br />
by micros. examn. of erythrocytes in urine,<br />
1791<br />
revised method of 1H-NMR urinalysis for<br />
detecting inborn errors of metab, (TB), 714<br />
RIA for methadone in urine with comparisons<br />
to other anal. techniques (A), 970<br />
routine urinalysis (dipstick) findings in mass<br />
screening of healthy adults (SN), 2106<br />
sample contamination by test strips (TB), 414<br />
screening for cenebnotendinous xanthomatoais<br />
by enzymatic assay for 7a-hydroxylated<br />
steroids in urine (SN), 142<br />
selecting the optimum specimen for assessing<br />
slight albuminunia, and a strategy for chin.<br />
investigation: novel uses of data on bioL<br />
variation, 2034<br />
sensitive fluoronephelomatric assay of slight<br />
albuminuria (TB), 717<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
serum cortisol and urine free cortisol as<br />
indicators of dexamethasone suppression<br />
and matyrapone inhibition (A), 886<br />
significance of urine aesgy sensitivity in<br />
marijuana detection (TB), 613<br />
simple assay to detect and confirm urinary<br />
banzodiazepines by HPLC utilizing photodiode-array<br />
detection (A), 974<br />
simple liq.-chromatog. mess, of<br />
vanillyimendelic acid and homovanillic acid<br />
in urine on filter paper for mass screening of<br />
neuroblastoma in infants, 2043<br />
simple sihver-stainin technique for detecting<br />
Benca Jones proteins in unconcd. urine (SN),<br />
561<br />
simplified SDS-PAGE of unconcd. urine with<br />
enhanced resolution and detection<br />
sensitivity (SN), 1886<br />
simultaneous anal, for 4-hydroxy-3methoxymandeic<br />
acid, 4-hydroxy.3methoxyphenylacetic<br />
acid, and creatinine in<br />
urine by HPLC with column switching (A),<br />
887<br />
simultaneous meas. of eight corticoeteroids by<br />
iq..chromatog. and appln. to diagnosis of<br />
congenital adrenal hyperplasia, 1354<br />
single-reagent polarization fluoroimmunoassay<br />
of methamphetamine in urine (SN), 1903<br />
source of error in the assay of urinary orotic<br />
acid (TB), 713<br />
specimen prepn. for assay of albumin in urine<br />
(L), 199<br />
spectrophotometry of urinary albumin by dyebinding<br />
with use of bromphanol blue, 223<br />
2408 CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987<br />
status of drugs-of-abuse testing in urine: an<br />
AACC study (SR), 1683<br />
storage stability of urine THC as measured by<br />
EMIT urine cannabinoid assay (A), 972<br />
Tandem Icon urine test for choniogonadotropin<br />
in ectopic pregnancy (A), 889<br />
thin-layer chromato. date. of urine excretion<br />
of lactulose, siinphfiad and applied to cystic<br />
fibrosis patients (SN), 1211<br />
tniemterene interference in detn. of urine free<br />
catechohamines by cation-exchange<br />
chromatog./fluorometny (A), 887<br />
urinary alb. and retinol-binding protein in<br />
diabetes (TB), 713<br />
urinary anahytes in axptl. naphrotoxicity (A),<br />
1057<br />
urinary end CSF protein measured with<br />
pyrogallol red-molybdate on Hitachi 705 (A),<br />
980<br />
urinary catecholamines, vanillylmandehic acid,<br />
5-hydroxyindoleacetic acid, and<br />
homovanillic acid measured by liq.<br />
chromatog. with electrochem. detection and<br />
use of a single mobile phase (L), 1696<br />
urinary glycoconjugates excreted by patients<br />
with type land type II fucosidosis compared,<br />
44<br />
urinary 5-HIAA measured by three methods:<br />
colonimetric, HPLC with electrochemical<br />
detector; end automated fluorescence<br />
polarization immunoassay (A), 931<br />
urinary N-acetyl--D-glucosaminidase and<br />
albumin not increased in mildiy hypertensive<br />
subjects (TB), 1075<br />
urinary org. acids: isoln, and quantn. for<br />
routine metabolic screening, 473<br />
urinary ratinol-binding protein as an index of<br />
proximal tubular injury, 775<br />
validation of HPLC-ECD method for urinary<br />
VMA and HVA by comparison with GCMS<br />
(A),887<br />
variations in urinary mucopolysaccharides<br />
after injection of fibroblasts into patients<br />
with mucopolysaccharidosea (SN), 1879<br />
yet more on osmolal gaps in urine (L), 746<br />
Urogastrone<br />
extn. of epidermal growth factor (urogastrone)<br />
from urine (A), 893<br />
Urokinase<br />
isoforms of creatine kinase isoenzymes in<br />
serum in acute myocard. infarct after<br />
intracoronary thrombolysis, 2039<br />
Urolitbiasis<br />
See Calculous disease<br />
chem. factors important to Ca nephrolithiasis:<br />
evidence for impaired hydroxycarboxylic<br />
acid absorption causing hyperoxaluria, 243<br />
liq. chromatog. with multichannel UV<br />
detection for studying disorders of purina<br />
metab., 2052<br />
xanthine lithiesis, nephrocalcinosis, renal<br />
failure in a leukemia patient treated with<br />
allopurinol (CR), 2314<br />
Uroprophyrin<br />
direct quanta. of coproporphyrins,<br />
uroporphynins in urine by deny, synchronous<br />
fluorescence spectroecopy, 1826<br />
Valproic acid<br />
dry-reagent immunoassay for valproic acid for<br />
use with Ames Seralyzer reflectance<br />
photometer (A), 1020<br />
Vancomycin<br />
lack of mezlocillin and piperacillin interference<br />
in measurement of vancomycin in the Abbott<br />
TDx (TB), 2304<br />
Vanlliylmandelic acid<br />
modified method for quantifying urinary<br />
vanillylmandeic acid (TB), 1258<br />
simple and rapid iq.-chromatog. method for<br />
simultaneous mess, of vanillylmandeic acid,<br />
homovanihlic acid (TB), 1262<br />
simple hiq.-chromatog. mess, of<br />
vanillylmandelic acid and homovanillic acid<br />
in urine on filter paper for mass screening of<br />
neurobhastoma in infants, 2043<br />
simultaneous anal, for 4-hydroxy-3methoxymandalic<br />
acid, 4-hydroxy-3’<br />
methoxyphenylacatic acid, and creatinine in<br />
urine by HPLC with column switching (A),<br />
887<br />
urinary catecholaminea, vanihlylmandeic acid,<br />
5-hydroxyindoleacetic acid, and<br />
homovanillic acid measured by liq.<br />
chromatog. with electrochem, detection and<br />
use of a single mobile phase (L), 1696<br />
validation of IIPLC-ECD method for urinary<br />
VMA and HVA by comparison with GCMS<br />
(A),887<br />
Variation, source of<br />
See also Analytical error<br />
elk. phosphatase isoenzymes in the plasma of<br />
preterm and term infants: serial<br />
measurements and chin. correlations, 1783<br />
anal, systems ranked by freedom from<br />
interferences (SN), 1453<br />
assay design influence on ES-600 performances<br />
(A), 946<br />
bethanachol-induced hypersmylasemia of<br />
salivary and pancreatic types without P3 in a<br />
patient without acute pancreatitis (A), 998<br />
bias and precision of cholesterol anaL by<br />
physician’s office analyzers (SN), 2262<br />
biol. variation in analyte condos. in urine of<br />
apparently healthmen, women (SN), 847<br />
3 cases of macro-AST exhibiting increased<br />
activation by pynidoxal-5’-phosphate (A),<br />
992<br />
changes in cycloeporine metabolism with<br />
coadministration of ketoconazohe (A), 979<br />
characterization of a human antibody that<br />
interferes in a RIA system (A), 913<br />
characterization of urinary interference factors<br />
and suggested mechanism of false positivity<br />
in latex agglutination tests (A), 914<br />
chin, sipificance of a low concn. of thyrotropin:<br />
five immunometric “kit” assays compared<br />
(SN), 1237<br />
comparison of effects of native biirubin and<br />
added biirubin on the Paramax and DT6O<br />
creatinine assays (A), 912<br />
correction of serum fructosamine concn, in<br />
hypoalbuminemia (A), 1003<br />
cross-reactivityof anti-DNA antibodies with<br />
polyanions (A), 1029<br />
data-redn. methods for immunoradiometnic<br />
assays of thyrotropin compared (SN), 1207<br />
despite correlation, random spot and 24-h<br />
urine specimens are not interchangeable<br />
(TB), 1080<br />
detection of sample contamination of urine<br />
submitted for drugs of abuse testing ina<br />
high-volume setting with the Olympus 5000<br />
analyzer (A), 977<br />
discordant results in hCG testing by<br />
monoclonal immunoassay methods (A), 887<br />
do bioL-variation data shed light on the demise<br />
of some historical indices used to assess Ca<br />
homeostasis? (TB), 1267<br />
effect of analyte concn. of short- and long-term<br />
within-and among-lab. anal, variance (A),<br />
908<br />
effect of daylight on the reaction of thiols with<br />
Ellmsn’s reagent (SN), 1928<br />
effect of 8-hydroxyquinoline on response to Ca<br />
and Mg of Beckman Astra Ca detn. (A),<br />
1007<br />
effect of icterus on 19 methods for Technicon<br />
Chem 11 system evaluated by NCCLS EP7-<br />
P (A), 956<br />
effect of lipemia, hyperosmohahity, and uremia<br />
on whole blood glucose measured by dry<br />
reagent strips and reflectometry (A), 912<br />
effect of ipemia on 19 methods for Technicon<br />
Chem 1”‘ system evaluated by NCCLS EP7-<br />
P (A), 955<br />
effect of methylene blue on estrogen and<br />
progesterone receptor assays (A), 914<br />
effect of two anticoagulants on leulcocyte yield,<br />
function and lysosomal enzyme acty. (A), 915<br />
effect of vit. B2 and its derivatives on<br />
apoenzyme immunoassay (A), 1032<br />
effects of PO4’ and HEPES/MOPS buffers on<br />
calibration of N&’ and K ion-selective<br />
electrodes for chin, anal. (A), 1005<br />
affects of short- and long-term prenatal<br />
steroids on rapid-turnover proteins in<br />
premature infants (A), 934<br />
endogenous digoxin-hike inimunoreactive<br />
factors and digoxin imniunoassays (A), 1052<br />
endoganous digoxin-like immunoreactive<br />
factors eliminated from serum samples by<br />
hydrophobic silica-gel extraction and<br />
enzyme immunoassay, 401<br />
estrogen receptor degradation: common cause<br />
of nonlinear Scatchard plots (A), 929<br />
avein, of body fluids on the Kodak-Ektachem<br />
(A), 915<br />
avaln, of origin of bias between enzymatic<br />
methods and Ref. Method for cholesterol<br />
(A), 894<br />
false-positive EMPI’ D.A.U. phencycidine<br />
assay as a result of an overdose of<br />
dextromethorphan (A), 974<br />
genetic and environmental factors that affect<br />
plasma apolipoprotein concas. (A), 1051
hematocrit effect on glucose reagent strip<br />
systems<br />
neonate<br />
and verification of the effect with<br />
samples (A), 912<br />
heterogeneity of comm. preparations of human<br />
lactate dehydrogenase isoenzymes (A), 991<br />
imniunolog. measurement of aspartate<br />
aminotransferase isoenzymes in health<br />
screening (A), 993<br />
improved Ni radiochem, assay of free fatty<br />
acids in plasma (SN), 176<br />
individual variations of carcinoembryonic<br />
antigen in serum of healthy subjects (TB),<br />
2123<br />
influence of sample preservative on electrolyte,<br />
urea, creatinine, and glucose<br />
influences of sampling method<br />
levels (A), 915<br />
and sample<br />
handling during anal, on ionized Ca results<br />
(A), 1007<br />
interference by platelets in electrophonetic<br />
detn. of enolase iaoenzymes in plasma (SN),<br />
164<br />
interference from immunoglobulins in Hitachi<br />
737 endpoint unease method for BUN (A),<br />
1010<br />
interference in immunoenzymometnic assays<br />
using mouse monoclonal antibodies caused<br />
by human 1gM antibody to mouse IgG (A),<br />
918<br />
intra-individual seasonal variation of Mg in<br />
blood (A), 1006<br />
intra-individual variation of some analytee in<br />
serum in chronic renal failure, 670<br />
kinetics of inhibition of Hb-catalyzed oxidation<br />
of 3,3’,5,5’-tetramethylbenzidene by<br />
bilirubin and ascorbic acid (A), 912<br />
longer-term bioL variation of commonly<br />
analyzed serum constituents<br />
measurement of LDH in body<br />
(TB), 717<br />
fluids on Kodak<br />
Ektachem 700(A), 966<br />
method for simultaneously estg. plasma,<br />
erythrocyte, and leukocyte Na, K, and Mg<br />
ref. values and considerations from bioL<br />
variation data, 1326<br />
method<br />
their<br />
of isolating erythrocytes influences<br />
measured polyamine content (TB),<br />
1081<br />
predictor of plasma cycloeponine concn. at 37<br />
#{176}C from whole-blood concns, at room temp.<br />
(A), 979<br />
recently identified substances with digoxin-like<br />
immunoreactivity do not account for DLIF<br />
measured in humans (A), 890<br />
serum and urine levels of morphine and<br />
codeine after poppy seed ingestion (A), 969<br />
substrates and inhibitors in reagents<br />
‘y-glutamyltransferaae (A), 994<br />
systematic drug interference studies<br />
for detg.<br />
on<br />
Reflotron0 (A), 916<br />
temp.-dependent distribution of tycloeponine<br />
metabolites amongst cells/plasma in whole<br />
blood (A), 979<br />
triamterene interference in detn, of urine free<br />
catecholamines by cation-exchange<br />
chromatog./fluorometry (A), 887<br />
turbidimetry of lipase acty.-problems and<br />
some solutions, 1624<br />
using the coefficient of correlation in methodcomparison<br />
studies, 1170<br />
validity of Friedewald equation for estg.<br />
plasma low-density lipoprotein cholesterol at<br />
various concns, of triglycerides (A), 896<br />
variables affecting resolution of lung<br />
phospholipids in thin-layer chromatog. (SN),<br />
135<br />
Veterinary chemistry<br />
absorption of Al from either citrate or Cl in rat<br />
averted gut sacs (A), 933<br />
animal model of diabetes mellitus: spontaneous<br />
and inherited canine diabetes melhitus (A),<br />
1058<br />
coagulation profile ins baboon colony (Papio<br />
species) (A), 1036<br />
data from rats with masentenc artery<br />
infarction presented as Chernoff faces (A),<br />
985<br />
distribution of lactate dehydrogenaae<br />
isoenzymes in various organs of male albino<br />
Sprague-Dawley rats (A), 1036<br />
effect of high-lipid diet on serum lipid<br />
parameters in the rat and monkey (A), 1035<br />
fundamentals of diagnostic evaln, in animal<br />
chin. endocninoL (A), 1058<br />
isolation and characterization of myoglobin<br />
from sheep heart and preparation of antimyoglobin<br />
(A), 1037<br />
phospholipids turnover in avian tuberculosis<br />
(A), 1036<br />
ref. values for Fe, TIBC, and fernitin in a<br />
baboon colony (Papio species) (A), 1036<br />
role of nonenzymatic lycation in altered renal<br />
function in exptl. diabetes (A), 1037<br />
serum guanase acty. in expi. models of hepatic<br />
injury (A), 995<br />
studies on ketone body ratio in nat plasma with<br />
alpha.naphthylisothiocyanate.induced<br />
cholestatic liver injury (A), 1035<br />
thyroid hormone and histpathoL responses of<br />
Fischer 344 rats and B6C3F1 mice to H.C.<br />
Yellow No, 4 (A), 1037<br />
use of creatinine for este, of glomerular<br />
filtration rate in isolated perfused rat kidney<br />
model (A), 1037<br />
Viscosity<br />
computer-based method for hematocnit effect<br />
correction in blood viscosity measurement<br />
(TB), 1071<br />
Vitamin A<br />
vitamin A concns, in lung cancer (TB), 716<br />
Vitamin B2<br />
effect of vit, B2 and its derivatives on<br />
apoenzyme immunoassay (A), 1032<br />
VItamin B<br />
low-ultraviolet “white” fluorescent lamps fail<br />
to protect pyridoxal phosphate from<br />
photolysis (L), 631<br />
vit. B6 deficiency and coronary heart disease:<br />
new perspective in assessment of vit. B6<br />
nutritional status (A), 935<br />
Vitamin B12<br />
enzymometric assay for vit, B12 with magnetic<br />
particles as solid support (A), 963<br />
microbioL assay for vitamin 812 with use of a<br />
colistin-sulfate-nesistant organism, 52<br />
monoclonal antibody-based RIA for vit 812<br />
(57Co)/folate (I) detns, (A), 922<br />
Vitamin D<br />
detection of bnomocriptine-like substances in<br />
urine of an infant on soy formula (TB), 414<br />
improved quantn. of vitamin Din proprietary<br />
infants’ formulas and in breast milk, 796<br />
radioreceptor assay for measurement of 1,25dihydroxy<br />
vit. D (A), 892<br />
rapid, selective sepn. of la,25-dihydroxyvitamin<br />
D1from serum with Extnelut-1<br />
columns (TB), 187<br />
simple method for extracting vitamin D<br />
metabolites from bioLsamples (TB), 720<br />
three commercial kits and one liquidchromatog.<br />
method evald, for detg. 25hydnoxyvitamin<br />
D2 in serum (SN), 1226<br />
Vitamin E<br />
Se and vit. E relationship in malnourished<br />
children before and during parenteral<br />
supplementation (A), 934<br />
Vitamin K<br />
founmethods compared for measuring descarboxy-prothrombin<br />
(PIVKA.II) (SN), 2074<br />
Vitamins<br />
more on ref. intervals for some vitamins (L),<br />
441<br />
Voltammetry<br />
effect of pretreating samples with boric acid<br />
before liq. chromatography of urinary<br />
catecholamines, 108<br />
Xanthlne<br />
liq-chromato. detn, of inosine, xanthine, and<br />
hypoxanthine in uremic patients receiving<br />
hemodislysis treatment (SN), 2278<br />
xanthine interference in the Kodak<br />
“Ektachem” detn. of uric acid (TB), 1265<br />
Xyhose<br />
new deproteinizing agent for detn, of xylose in<br />
serum (TB), 418<br />
Xylosyltranaferase<br />
xylosyltransferase as a marker of cartilage<br />
destruction in chronic joint diseases (A),<br />
1000<br />
Yeast infection<br />
xanthina lithissis, nephrocalcinosis, renal<br />
failure in a leukemia patient treated with<br />
allopurmnol (CR), 2314<br />
Zinc<br />
indirect vs direct measurement of Mg and Zn<br />
in enythrocytes, 529<br />
intestinal Zn, Cu, and Mn concns. in Crohn’s<br />
disease (A), 933<br />
maternal hypozincemia and low-birth-weight<br />
infants (L), 1950<br />
plasma, erythrocyte, and urinary Zn in<br />
critically ill patients: effect of intravenous Zn<br />
therapy (A), 933<br />
Se, Zn, Mg, Ca, K, cholesterol, and creatine<br />
kinase concns. in men during 12 days after<br />
acute myocardial infarction, 21<br />
Zone immunoelectrophoresi.<br />
apolipopnoteins C-fl and C-Ill in serum<br />
quantified by zone immunoslectrophonesis,<br />
664<br />
CLINICAL CHEMISTRY, Vol. 33, No. 12, 1987 2409
January: pages 1-208<br />
February: pages 209-348<br />
March: pages 349-452<br />
April: pages 453-640<br />
May: pages 641-752<br />
June: pages 753-1112<br />
July: pages 1113-1316<br />
August: pages 1317-1 500<br />
September: pages 1501-1 700<br />
October: pages 1701-1964<br />
November: pages 1965-2136<br />
December: pages 2137-2336<br />
Beckman Supplement Issue:<br />
pages 1B-112B
January: pages 1-208<br />
February: pages 209-348<br />
March: pages 349-452<br />
April: pages 453-640<br />
May: pages 641-752<br />
June: pages 753-1112<br />
July: pages 1113-1316<br />
August: pages 1317-1500<br />
September: pages 1501-1700<br />
October: pages 1701-1964<br />
November: pages 1965-2136<br />
December: pages 2137-2336<br />
Beckman Supplement Issue:<br />
pages 1B-112B